data_1p6t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p6t _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.712 -0.477 . . . . 2.57 109.712 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 3.69 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.15 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 3.32 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 1.82 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 3.05 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.94 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 1.87 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 1.42 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.86 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 3.13 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 3.1 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.61 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 3.02 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 2.17 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 1.84 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 1.78 109.046 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 2.13 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 5.33 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 1.6 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.97 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 5.28 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.75 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 2.45 109.588 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 2.55 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 4.12 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 2.81 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.94 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 2.58 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 1.95 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.14 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 1.91 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 2.06 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 2.07 106.877 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.64 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 2.83 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.76 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 1.89 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.66 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 2.36 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 1.99 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 4.48 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 1.66 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 2.06 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 3.03 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.42 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.5 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 1.97 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 1.78 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.78 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 1.55 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 1.57 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 1.66 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 1.89 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.85 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.05 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 3.08 108.997 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 1.8 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.56 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.98 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 3.31 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.72 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 3.21 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 3.17 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 1.73 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 1.97 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 2.02 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.33 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 3.33 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 1.72 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.89 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 3.68 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 1.6 108.926 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.58 109.865 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.83 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 5.0 113.177 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.733 -0.469 . . . . 3.2 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 2.25 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 2.08 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.32 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.9 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 3.81 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 4.76 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 4.41 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 2.17 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.69 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 5.48 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 2.43 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.94 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 1.65 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 1.55 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 1.74 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.57 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 2.61 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.97 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 4.4 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 2.27 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 2.75 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 1.8 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 1.6 107.847 166.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 1.61 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 1.71 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.53 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 3.03 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 3.02 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.68 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 8.32 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.64 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 1.65 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.9 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 2.5 114.604 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 1.05 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.92 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 1.95 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.78 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.83 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 1.96 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 2.99 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.14 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.86 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 1.89 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.95 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 3.5 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.95 106.37 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 2.93 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.84 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 2.38 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 4.39 107.516 173.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.906 -0.775 . . . . 2.69 108.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 6.02 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.53 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 2.82 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 1.9 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 3.4 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 3.11 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 1.87 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 1.81 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.78 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 5.04 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 2.29 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.92 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 4.69 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 2.54 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 1.78 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 1.88 110.147 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 1.89 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 4.73 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 1.7 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.61 110.538 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 2.66 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.85 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 3.77 110.748 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 3.34 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 3.62 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 2.43 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.89 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 2.27 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 2.38 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.08 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 1.58 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 2.1 110.14 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.85 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 2.52 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.73 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 1.74 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 1.86 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 1.58 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 3.38 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 1.57 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 2.21 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 3.08 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.23 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 2.17 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.92 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.9 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.92 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 2.66 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 1.77 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 1.9 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 2.09 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.37 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 4.7 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 1.62 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.18 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 3.3 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 3.4 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.94 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 3.47 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 3.2 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 1.83 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 2.06 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 2.05 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.44 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 4.02 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.58 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.94 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 3.51 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.53 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 1.87 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.36 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp . . . . . 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 3.34 114.676 177.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.704 -0.85 . . . . 2.95 108.704 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 2.58 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 1.85 110.209 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.45 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 6.0 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 4.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 4.38 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 3.76 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 2.39 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.65 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 5.47 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 2.63 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.67 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.71 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 1.74 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 1.53 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.87 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 1.71 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.78 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 3.66 109.342 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 2.34 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 4.07 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.99 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 2.06 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.05 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 1.89 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 1.95 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 1.98 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 1.91 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.85 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 3.62 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 3.25 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 6.1 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.72 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 1.97 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.54 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 2.54 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 1.11 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 1.88 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 5.49 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 1.76 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 2.47 111.796 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.07 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 3.51 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 2.26 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 3.26 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 4.87 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 3.89 108.547 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.74 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 4.06 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 4.23 108.861 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.141 -0.689 . . . . 2.81 109.141 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 3.09 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 4.23 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 1.61 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 2.68 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.68 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 1.97 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.86 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.96 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 3.19 109.11 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 3.01 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.5 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 4.22 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 2.01 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 2.14 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 1.72 110.985 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 1.78 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.97 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 2.15 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 2.81 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.72 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 4.69 110.56 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 2.55 112.18 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 4.21 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 2.5 111.382 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.97 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 3.77 109.448 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 2.42 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.05 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 1.57 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 2.22 108.925 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.73 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.98 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.93 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 2.08 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.58 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 1.99 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 1.58 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 3.05 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 1.74 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 2.76 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 3.07 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.09 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 1.03 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 2.3 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 1.72 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.96 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.62 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 1.65 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 1.75 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 3.09 110.095 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.63 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.63 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 3.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 1.87 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.19 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 5.37 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 3.67 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.63 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 3.4 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 3.26 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 1.67 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 2.25 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 1.97 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.14 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 4.28 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 1.79 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.45 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 3.3 108.764 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 1.97 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.14 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.33 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 5.14 109.524 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 2.86 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 2.42 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 1.67 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.76 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 5.22 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 2.8 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 3.76 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 3.45 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 2.95 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.49 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 5.68 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 2.45 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.76 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.73 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 1.69 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 1.77 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.72 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 1.57 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.7 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 2.65 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 3.6 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 4.15 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 2.13 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 2.61 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 2.29 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 1.74 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 1.82 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 2.26 107.373 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.61 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 3.6 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 3.24 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.72 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 6.4 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.94 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 1.92 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 2.82 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 2.75 111.14 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.88 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.07 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 2.45 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 4.22 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.05 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 1.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 3.04 111.04 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.64 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 3.16 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.97 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.37 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 3.3 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 5.61 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 2.68 108.489 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 2.72 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 4.17 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 4.28 108.594 172.648 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 110.25 -0.278 . . . . 2.79 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 3.53 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.74 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 3.98 107.834 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 1.74 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.9 110.426 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 2.34 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 1.9 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 1.83 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.79 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 3.36 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 2.6 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.76 109.558 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 3.55 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 2.73 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 1.66 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 1.93 109.063 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 1.77 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 3.28 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 1.87 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.53 110.342 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 2.77 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.71 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 2.46 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 4.09 112.415 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 4.53 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 2.47 110.018 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.22 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 1.06 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 3.56 110.41 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 1.93 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.26 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 1.79 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.62 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 2.26 109.848 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 2.75 111.87 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 2.23 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 2.05 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.91 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 1.73 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 1.69 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 3.16 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 1.71 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 3.1 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 2.97 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.07 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 1.0 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 1.8 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.89 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 1.88 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.72 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 1.57 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 1.75 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 1.76 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 1.52 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.94 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 4.5 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 1.96 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 4.1 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 3.81 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.82 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 3.33 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 3.19 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 2.03 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.82 111.582 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.92 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.15 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.78 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 1.88 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.38 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 2.98 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.63 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 1.8 110.144 -167.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.59 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 5.27 113.131 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 113.148 0.796 . . . . 2.36 113.148 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 1.9 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 1.75 110.839 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 5.5 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 2.9 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.89 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 4.3 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 6.99 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 2.87 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.37 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 5.87 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 2.58 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.81 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 1.72 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 1.56 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 1.77 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.67 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 3.64 109.209 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 3.07 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 3.64 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 2.67 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 2.37 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.67 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 1.78 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 1.64 108.837 168.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 1.94 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 1.98 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 2.99 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.87 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.61 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 6.4 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.06 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 1.69 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.91 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 3.2 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.95 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.17 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 1.81 109.603 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 3.97 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.69 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 1.84 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 2.77 109.1 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.07 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 3.2 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 2.06 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.83 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 3.6 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 4.09 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 2.62 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 3.71 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 2.67 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 3.38 108.914 178.322 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 . . . . . 0 C--O 1.239 0.506 0 N-CA-C 107.927 -1.138 . . . . 3.57 107.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 4.14 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.87 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 3.51 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 1.73 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 2.79 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 2.25 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 1.74 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 2.04 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 3.4 111.286 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 4.02 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 5.84 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 4.16 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 2.65 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 1.71 111.09 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 1.97 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.7 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 1.66 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.28 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.89 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.72 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 3.93 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 3.39 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 4.46 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 2.6 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.42 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.85 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 2.28 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 1.89 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 1.82 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.32 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 2.01 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.69 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 2.79 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 2.07 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 1.88 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 1.76 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 1.51 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 4.52 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 1.82 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 2.52 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 3.1 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.22 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.13 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 2.32 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.01 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 1.84 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.79 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 1.61 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 1.57 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 1.95 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 1.83 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.85 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 3.16 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 1.82 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.32 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 4.34 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 3.31 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.65 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 3.59 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 3.62 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 1.64 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 1.8 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 2.22 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.42 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 4.16 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 1.59 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.28 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 3.03 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.58 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 2.09 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.57 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.82 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 4.45 112.738 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 2.35 111.852 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 2.25 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 2.26 109.946 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 5.59 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.83 110.926 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.14 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.91 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 3.55 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 3.18 111.264 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.85 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 6.64 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 2.54 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.51 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.86 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 1.71 107.496 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 1.96 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.14 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 1.85 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.85 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 2.89 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.67 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 4.66 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 2.63 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 3.01 110.467 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 2.46 110.45 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 1.78 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 1.7 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 1.84 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 3.12 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 3.6 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.83 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 6.14 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.85 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 1.58 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 2.44 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 2.89 112.684 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.99 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 2.19 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 4.68 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.05 110.065 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 1.59 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 2.53 110.604 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HZ1' ' CD ' ' A' ' 130' ' ' GLU . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 3.24 113.295 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 1.89 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.62 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 3.33 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 4.24 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 3.1 106.839 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 3.16 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 2.81 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 4.61 108.384 174.57 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.181 -0.674 . . . . 2.15 109.181 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 2.77 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.74 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 3.6 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 1.56 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 2.72 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.59 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 1.93 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 2.1 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.91 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 3.52 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 2.32 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.58 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.44 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 2.98 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 1.86 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 1.81 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 2.19 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 3.07 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 1.73 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.65 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.8 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.75 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 2.41 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 3.11 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 5.75 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 2.62 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.18 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.87 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 2.47 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 1.89 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 1.34 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 2.09 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 2.01 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 3.26 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 2.06 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 2.64 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.22 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 2.04 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 1.75 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.64 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 1.59 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 2.17 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 3.38 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.01 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.9 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.24 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.4 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 1.73 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 1.02 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 1.68 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 1.61 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 1.79 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 1.42 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.86 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.05 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 3.91 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.67 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.89 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 3.81 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.71 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 3.37 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 3.54 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 1.89 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 2.12 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 2.1 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 4.38 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 1.72 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.92 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 3.43 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.62 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 1.77 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.56 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.5 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 4.03 112.047 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.742 1.015 . . . . 2.38 113.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 1.88 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 1.78 110.408 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.96 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 5.59 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 2.85 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.45 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.94 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 6.1 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 2.9 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.64 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 5.16 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.78 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.6 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.74 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 1.79 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 1.72 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.85 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 1.78 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.67 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 3.63 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 2.14 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 3.71 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.91 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 2.54 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.92 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 1.85 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 1.73 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.9 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 1.98 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 2.98 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 3.27 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.69 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 8.69 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.59 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 1.84 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 2.6 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 2.67 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 1.36 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 1.89 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 4.62 109.136 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.43 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 1.59 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 2.82 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.78 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 3.39 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 2.32 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.74 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 3.39 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.94 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 4.01 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 3.93 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 3.38 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 4.02 109.196 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.35 105.316 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 3.29 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.84 108.868 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.93 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 1.73 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 2.72 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.06 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 2.1 108.883 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 1.58 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 4.08 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 2.13 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.47 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 4.8 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 2.81 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 2.2 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 2.7 110.882 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 2.27 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 4.79 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 1.98 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.33 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 4.73 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.8 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 4.07 110.086 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 2.71 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 5.54 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 2.9 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.87 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 2.22 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 2.25 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.85 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 1.74 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 2.3 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 2.12 110.054 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 2.96 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 2.06 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.82 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 1.5 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 1.62 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 5.35 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 1.76 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 2.49 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 3.4 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.37 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.1 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 2.18 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.92 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 1.68 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.97 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.75 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 1.75 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 2.01 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 1.68 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.56 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 4.85 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 2.34 109.866 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.13 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 4.04 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 3.34 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.71 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 3.26 109.275 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 3.3 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 1.81 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 2.06 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 2.22 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.69 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 4.28 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 1.73 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.69 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 3.57 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.86 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 2.56 109.778 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.65 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.81 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 4.3 112.83 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.214 0.054 . . . . 2.4 111.087 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 1.97 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 1.79 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.18 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 6.88 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 3.08 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.49 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.99 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.89 111.192 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 2.97 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.52 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 4.63 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 2.48 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.61 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.9 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 1.67 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 1.7 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.99 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 1.65 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.69 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 2.79 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.83 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 3.81 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.99 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 2.51 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.61 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 1.86 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 1.87 107.664 156.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 1.78 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 1.59 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.67 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 3.09 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 3.17 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.86 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 6.73 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.41 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 1.97 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 3.11 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 3.21 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 1.12 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.83 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 2.6 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 4.18 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' A' ' 134' ' ' LYS . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.92 110.403 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 1.66 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 2.81 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.58 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HZ3' ' CD ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 3.55 113.022 175.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 1.8 111.966 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 3.63 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 4.62 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 2.54 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 3.62 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 2.52 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt . . . . . 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 4.01 109.519 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.88 106.605 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 3.28 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.84 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 4.39 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 1.7 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 3.12 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 2.47 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 1.85 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 1.65 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 4.88 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 2.07 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.65 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 5.13 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 2.55 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 2.07 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 2.12 110.56 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 1.75 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 4.17 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 1.73 108.137 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.03 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 3.23 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.72 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 2.64 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 2.67 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 3.69 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 2.56 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.14 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 2.31 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 2.37 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.68 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 1.65 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.22 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 2.39 109.288 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.16 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 2.71 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 2.26 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 2.29 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.88 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 1.7 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 1.57 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.98 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 1.9 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 2.13 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 3.5 111.909 -171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.76 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.48 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 2.12 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.05 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 2.01 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.7 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 1.83 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 1.52 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 1.6 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 1.91 108.15 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.91 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.4 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 4.18 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 1.73 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 3.44 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 2.9 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.69 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 3.3 109.466 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 3.44 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 1.59 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 1.75 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 1.94 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 3.32 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 1.97 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 2.92 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 2.03 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.58 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.41 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? . . . . . 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 3.72 110.07 172.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.273 0.842 . . . . 2.11 113.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 1.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 1.77 110.674 170.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 2.1 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 5.55 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 2.79 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 4.58 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 4.19 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 2.9 111.011 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.82 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 5.09 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 3.19 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.8 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.77 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 1.8 107.755 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 1.56 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.86 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 1.62 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.57 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 3.45 109.28 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 3.05 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 3.78 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 2.28 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 2.58 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.78 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 1.89 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 1.8 108.971 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 1.9 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 2.21 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.83 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 3.42 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 3.32 107.342 -172.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.85 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' ASN . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 5.69 108.364 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 1.49 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 2.29 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 2.95 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.87 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 1.83 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 4.6 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.22 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 1.71 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 2.68 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.63 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.96 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 2.28 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.85 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 3.4 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 6.93 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 2.65 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 3.32 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 2.7 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 4.11 108.669 172.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.43 112.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 4.02 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.08 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.94 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 1.95 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 3.68 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 3.16 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 1.8 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 1.63 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.86 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 4.22 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.83 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.86 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 4.01 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 2.1 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 2.08 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 1.75 112.278 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 1.69 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.93 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 2.05 108.157 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.12 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 2.61 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 2.47 109.99 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 3.35 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 4.41 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 2.79 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.14 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 2.31 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 2.37 111.311 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 2.35 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.31 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 1.54 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.38 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.98 108.731 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.35 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 5.01 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 2.69 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 2.21 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.92 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 2.29 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 1.63 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.67 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 1.93 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 2.38 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 3.23 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.23 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 2.32 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.87 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 1.59 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.75 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 2.22 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 1.78 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 1.67 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 1.77 107.609 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.45 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 3.1 108.155 -175.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 1.7 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.68 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 3.4 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 3.0 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.74 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 3.34 108.769 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 2.96 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 1.78 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 2.35 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 2.49 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.45 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 5.8 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.87 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 3.75 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 2.09 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.99 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.58 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 6.05 109.499 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.433 0.16 . . . . 2.34 111.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 2.29 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 1.76 110.237 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.55 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 4.62 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 2.79 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 4.65 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 3.68 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 2.97 111.465 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.56 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 5.22 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 3.37 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.74 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.89 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 1.84 107.527 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 1.96 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 1.58 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.63 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 3.67 108.727 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.96 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 3.53 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.9 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 2.16 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 2.15 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 2.07 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.72 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 1.76 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.65 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 3.19 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 3.38 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.95 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 6.06 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.26 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 1.68 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 2.31 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 2.72 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 1.32 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.28 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 2.03 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 5.03 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.31 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 1.72 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 2.91 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.97 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 2.33 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 3.61 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 4.72 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 2.68 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 3.74 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 2.61 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 3.21 108.116 172.237 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.92 108.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 4.0 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.81 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 3.11 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 1.77 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 2.67 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.58 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 1.73 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 1.69 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.77 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 3.45 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 2.64 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 6.11 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 4.47 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 2.78 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 1.66 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 1.9 110.732 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 2.49 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.84 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 1.82 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 3.49 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.78 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 2.56 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 2.74 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 3.28 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 2.68 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.35 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 2.31 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 2.42 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 1.7 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.78 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 1.89 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 2.06 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 1.89 110.081 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 2.39 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 3.02 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.96 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 2.15 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.07 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 1.66 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 1.7 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 3.17 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 1.87 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 2.13 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 3.31 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.09 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.49 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 2.31 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.15 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 1.68 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.69 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.72 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 1.68 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 1.75 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 1.85 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.26 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.65 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 4.76 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 1.71 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.44 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.88 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 3.19 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.92 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 3.2 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 3.18 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 1.68 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 1.72 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 1.84 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.51 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.96 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.05 110.88 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 3.53 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.22 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 2.17 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.13 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 7.39 112.673 -176.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.631 -0.877 . . . . 2.47 108.631 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 2.46 108.445 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 1.74 110.397 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.98 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 6.32 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 3.05 111.387 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.85 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 4.96 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 4.0 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 2.43 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 6.67 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 2.58 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.62 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.69 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 1.73 107.97 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.86 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 1.72 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.62 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 2.76 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.99 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 3.66 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.84 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 2.05 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 1.71 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 1.72 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 1.8 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 1.82 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 3.05 111.003 -170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 121' ' ' LYS . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 3.34 107.058 -169.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 119' ' ' ASN . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 6.5 110.764 171.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.52 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 1.8 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.75 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 3.52 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 1.13 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.28 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 2.1 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 5.05 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.518 ' CD ' ' HZ2' ' A' ' 134' ' ' LYS . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.05 111.25 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 1.98 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 2.84 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.49 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.518 ' HZ2' ' CD ' ' A' ' 130' ' ' GLU . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 3.6 112.869 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 2.3 112.032 171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.86 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 3.18 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 5.65 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 2.65 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.87 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 2.48 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 3.65 107.938 172.372 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 3.0 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.61 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 4.21 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 2.08 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.55 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 1.74 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 1.72 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 1.23 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 4.39 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.93 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 5.07 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.63 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 3.21 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.81 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 2.57 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 2.85 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 4.39 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 3.26 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.11 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.92 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.91 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 2.93 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 4.0 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 4.05 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.91 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 2.08 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.43 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 2.69 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 2.16 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.81 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 1.52 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.72 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 2.24 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.35 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 3.25 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.81 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 1.67 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.13 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 2.07 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 1.65 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 4.17 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 1.84 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 2.86 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 3.33 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.35 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.77 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 2.54 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 2.55 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.28 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 2.36 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 2.2 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 2.35 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 1.94 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.47 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.18 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.88 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 1.61 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 4.15 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 3.61 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.8 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 3.37 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 3.93 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 2.36 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 1.81 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.96 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.63 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 3.72 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 1.59 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 3.42 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.83 107.827 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 1.77 109.444 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.26 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 4.08 111.521 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.305 0.574 . . . . 2.83 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.97 107.896 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 1.72 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.29 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 6.47 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 2.77 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.77 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 4.4 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 3.22 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 5.63 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 2.62 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.58 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 1.07 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 1.87 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 1.75 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 1.18 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 1.98 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.96 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 2.76 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 2.11 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 3.56 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.97 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 2.73 110.659 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 1.94 111.545 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 1.62 108.314 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 2.34 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 1.92 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.47 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 3.19 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.93 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.9 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 8.91 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.89 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 1.93 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 3.21 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 2.63 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.93 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.22 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 2.08 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 4.74 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.11 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 1.63 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 2.72 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.47 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 4.71 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 2.1 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 3.36 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 4.77 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 2.59 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 4.02 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 4.68 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.93 110.667 -173.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.779 0.323 . . . . 3.01 110.49 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.66 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.72 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 3.95 107.851 165.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 1.69 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 3.29 108.407 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 3.13 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 1.82 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.76 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.94 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 3.84 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 2.18 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.28 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 4.34 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 2.36 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 1.61 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 1.7 110.929 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 1.83 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 5.3 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 1.65 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.84 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 2.55 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.76 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 2.6 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 2.67 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 4.14 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 3.0 110.6 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 1.04 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 3.34 110.538 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.15 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 1.53 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 2.04 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 2.83 111.254 171.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.69 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 4.65 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 2.3 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 2.22 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.56 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 1.97 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 1.78 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 3.42 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 1.73 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 2.16 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 3.37 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.22 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 1.04 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 1.81 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.05 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 1.71 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.7 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 1.97 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 1.74 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 1.71 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 1.89 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.17 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 4.33 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 1.72 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 5.56 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 3.36 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.77 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 3.47 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 3.57 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 1.77 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 2.22 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 1.92 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 3.18 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 1.73 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 3.54 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.37 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 2.19 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 3.28 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.93 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 3.87 112.089 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.497 -0.557 . . . . 2.87 109.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 1.8 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 1.94 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.92 110.884 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 6.21 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 2.82 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.43 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 4.11 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 4.48 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 3.33 111.328 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.31 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 5.26 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 2.68 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.4 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.86 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 1.79 108.831 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 2.06 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.83 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 1.76 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.96 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 2.57 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 2.8 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 4.1 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 2.08 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 2.4 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.28 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 1.92 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 1.87 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 1.96 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 1.84 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 3.56 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 3.22 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.72 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 6.45 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 1.52 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 2.44 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 2.43 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.91 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 1.89 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.9 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.22 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 1.56 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 3.14 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.63 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 3.14 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 2.04 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.82 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 3.54 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 4.22 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 2.39 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 4.37 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 2.69 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 3.83 108.622 178.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.28 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 2.73 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.57 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 3.75 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 1.72 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 2.62 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.18 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 1.84 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 2.05 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.94 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 3.67 112.049 -173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 2.36 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 4.11 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 3.32 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 3.03 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.66 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 2.31 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 2.43 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.93 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 2.06 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.86 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.65 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 2.54 110.558 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 3.27 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 4.0 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 2.31 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.33 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.84 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 2.39 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 2.01 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 1.81 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.69 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 2.42 113.2 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 2.09 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 2.35 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.79 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 2.29 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.84 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 1.79 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 1.63 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.7 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 1.62 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 2.04 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 3.14 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.87 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 1.07 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.75 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 2.0 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.78 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 1.56 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 1.8 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 1.86 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 1.75 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.65 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.05 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 3.2 109.233 -175.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 1.8 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 3.21 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 2.98 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.83 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 3.36 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 3.27 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 1.66 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 1.93 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 2.09 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.64 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 3.69 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 1.62 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.92 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 3.88 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.41 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 1.88 110.17 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.23 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 3.8 112.202 -171.262 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.426 -0.583 . . . . 3.31 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 2.18 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 2.24 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.88 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 5.0 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 2.91 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.41 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 4.27 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 3.82 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 2.53 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.93 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 6.03 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 3.54 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.93 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.71 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 1.84 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 1.59 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 1.62 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.7 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 2.9 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.9 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 4.56 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 2.54 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 3.61 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.69 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 1.96 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 1.72 107.922 167.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 1.81 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 1.68 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.83 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 3.39 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 3.05 108.554 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.72 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 6.15 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 1.48 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.99 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 2.44 113.831 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 1.13 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 1.82 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 4.11 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.64 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 1.75 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 2.89 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.58 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 3.7 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 1.9 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.6 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 3.16 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 4.35 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 2.66 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 3.62 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 2.42 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 6.73 109.042 162.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.316 -0.624 . . . . 2.43 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 3.15 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.92 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 3.67 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 1.6 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 3.52 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.89 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 2.37 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 2.18 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.34 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 3.95 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 2.89 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.05 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 4.8 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 2.61 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 2.62 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 2.36 110.109 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 2.47 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 3.32 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 2.02 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.68 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 3.42 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.9 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 2.75 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 3.11 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 3.6 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 3.17 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.99 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 2.43 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 1.61 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.67 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 1.82 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.06 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 2.77 111.873 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 3.16 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 2.67 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 2.62 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.36 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 2.2 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 1.82 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.62 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 1.67 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 1.91 108.117 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 3.02 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.43 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.29 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 2.15 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.3 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 1.71 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.87 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 2.34 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 1.77 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 1.76 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 1.46 107.57 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.91 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 3.2 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 1.79 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.34 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.85 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 3.47 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.89 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 5.3 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 2.98 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 1.75 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 2.1 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 1.87 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.73 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.86 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 1.72 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.86 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 3.61 109.745 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.66 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 1.87 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.61 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.62 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 4.44 114.042 -174.791 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.124 0.416 . . . . 2.3 112.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 137' ' ' TYR . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 2.52 110.815 -165.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 1.74 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 3.12 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 6.21 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 2.77 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 3.41 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 4.75 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 2.93 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.8 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 5.62 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 2.44 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.78 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 2.0 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 1.54 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.81 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 1.57 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.61 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 3.01 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 2.0 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 3.54 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.97 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 2.04 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.68 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 1.78 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 1.98 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 2.03 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 1.72 104.877 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.85 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 3.5 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.93 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 8.46 109.315 171.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 121' ' ' LYS . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.81 109.243 -172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 1.56 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.65 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 3.41 113.915 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 1.7 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 2.68 111.447 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 3.5 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.16 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 2.11 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 3.06 111.85 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 3.83 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 1.95 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 88' ' ' CYS . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 3.71 108.331 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.67 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 3.64 106.624 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 4.16 108.071 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 3.8 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 4.51 106.92 172.17 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.735 -0.839 . . . . 2.32 108.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 5.55 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 3.52 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 3.19 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 2.02 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.94 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 2.08 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 1.92 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 1.46 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.66 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 3.57 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 2.71 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.47 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 3.15 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 2.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 1.72 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 2.08 109.028 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 2.29 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 3.08 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 1.53 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 3.74 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.1 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 2.68 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 2.69 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 3.5 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 2.99 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.98 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 2.4 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 1.84 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.68 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 1.41 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.03 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 2.13 107.981 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.78 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 2.72 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.95 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 2.08 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 2.18 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 1.44 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 3.32 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 1.71 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 2.63 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 3.76 111.909 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.24 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.99 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.97 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.03 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 2.06 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.92 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 2.04 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.98 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 2.05 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.07 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.92 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 4.79 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 1.78 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.58 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 4.12 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 3.37 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.67 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 3.46 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 3.18 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 1.67 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.95 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 2.4 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.3 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 3.5 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 1.55 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.89 111.717 172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 3.83 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.57 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 1.83 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.63 104.648 168.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.95 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.82 112.512 176.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 122.031 0.92 . . . . 2.28 112.095 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.433 ' SG ' ' CE1' ' A' ' 137' ' ' TYR . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 2.63 110.143 -162.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 2.38 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.19 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 6.05 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 2.98 110.623 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 3.74 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 4.22 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 3.29 111.151 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.71 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 6.82 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 3.38 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.69 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 1.48 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 1.95 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 2.26 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.98 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 2.08 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.19 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 3.45 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.45 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 4.38 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 2.56 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 3.0 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 1.97 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 1.7 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 2.2 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 1.75 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.33 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 3.75 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 3.29 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.14 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 6.49 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.72 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 2.12 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 3.01 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 2.39 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 1.24 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 2.18 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.95 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.74 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 2.05 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 2.83 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 4.89 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 2.13 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.99 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' SG ' ' A' ' 88' ' ' CYS . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 3.11 108.126 172.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 5.31 107.616 172.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 3.87 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 4.58 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 2.99 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 3.52 107.199 173.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.21 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 3.2 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.96 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.89 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 1.67 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 3.12 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.68 109.244 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 1.97 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 1.37 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.99 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 3.81 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 2.18 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.63 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 4.03 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 2.67 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 1.8 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 1.89 110.475 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 2.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 4.85 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 2.06 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.03 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 2.44 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.73 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 2.78 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 3.1 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 3.4 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 2.74 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.88 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 2.36 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 1.78 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 1.55 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.98 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 2.65 111.915 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 2.37 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 4.14 111.565 167.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 2.54 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 2.37 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 1.9 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 2.16 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 3.48 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 1.77 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 2.4 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 3.0 111.078 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.3 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.96 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.86 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.81 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 1.75 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.72 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 1.85 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 2.1 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 2.01 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 1.81 107.726 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 3.22 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 1.83 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.86 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 3.67 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 3.14 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.26 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 3.48 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 3.23 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 1.73 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 2.3 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 1.94 108.671 -166.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.17 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 5.52 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 1.93 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.78 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 3.02 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.57 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 1.99 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.84 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.415 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 4.18 111.708 167.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 110.759 -0.089 . . . . 2.84 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 2.76 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.415 ' CB ' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 1.66 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.97 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 4.54 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 3.95 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.64 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 3.81 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 6.49 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 3.21 111.68 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 6.59 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 4.49 108.149 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.58 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.72 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 1.84 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 1.64 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.74 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 1.84 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.75 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 3.72 108.99 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 2.28 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 3.77 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 2.65 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 2.27 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.38 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 2.08 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 1.85 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 1.86 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 1.7 106.337 169.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 3.43 112.017 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 3.21 109.203 -170.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.61 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 8.44 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.59 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 1.72 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.73 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 3.09 113.644 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 1.38 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.22 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 2.93 110.494 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 4.02 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.89 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 1.79 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 2.59 112.035 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.06 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 3.52 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 1.99 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 3.22 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 5.69 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 3.11 108.731 -175.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 3.21 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 2.58 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 3.73 108.647 173.289 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.635 -0.506 . . . . 2.3 109.635 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 3.19 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.49 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 3.55 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 1.64 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 2.69 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 3.28 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 2.0 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 2.77 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.06 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 4.22 110.691 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 2.5 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.26 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 4.74 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 2.5 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 1.7 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 1.77 111.478 171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 2.03 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.97 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 1.55 108.447 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 2.81 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.7 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 2.55 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 3.25 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 5.8 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 2.52 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.32 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 1.13 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 2.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 2.09 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.92 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 2.08 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 2.31 109.623 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 3.1 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 4.29 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 2.7 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 2.3 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.01 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.94 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 1.84 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.39 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 1.83 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 2.42 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 3.88 112.126 -170.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.15 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 2.44 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.94 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 2.13 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.89 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 2.31 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 1.85 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 1.99 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 1.88 107.344 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.16 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.01 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 3.17 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 3.33 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 3.41 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 2.99 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.63 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 3.31 108.929 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 3.71 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 1.66 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 2.27 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 1.87 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 5.7 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 1.81 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 3.32 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 1.78 111.123 -165.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.41 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 3.49 110.11 172.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.778 -0.453 . . . . 2.56 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.64 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 2.17 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 2.02 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 4.59 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 4.02 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.36 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 4.56 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 4.45 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 2.63 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 5.48 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.08 107.557 159.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.89 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 1.01 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 1.96 108.832 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 1.8 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 1.03 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 1.83 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.59 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 2.81 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 2.25 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 4.17 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 2.16 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 2.39 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.74 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 1.93 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 1.55 107.24 167.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 1.82 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 2.07 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.53 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 3.51 112.318 -165.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 3.12 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 7.78 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.26 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 1.92 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.63 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 3.45 112.854 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 1.06 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.09 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 2.2 109.669 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 4.48 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.89 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 1.87 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 2.56 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.61 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 4.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 1.66 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.73 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 3.67 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 5.47 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 2.34 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 3.82 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 2.4 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 3.7 107.793 175.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.113 -0.329 . . . . 2.47 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 3.2 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.96 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 1.83 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.91 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 2.2 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 1.66 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 1.55 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.69 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 3.45 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 2.02 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.91 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 5.0 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 2.61 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 1.91 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 1.91 110.629 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 1.81 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 3.07 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 1.82 107.723 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.59 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 2.44 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.88 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 2.43 110.291 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 3.12 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 3.64 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 2.75 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.94 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 2.6 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 1.96 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 1.89 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.62 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 1.92 108.914 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.79 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 2.99 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 2.67 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 2.38 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.11 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 2.06 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 1.93 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 3.67 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 1.57 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 2.4 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 3.2 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.33 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.92 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.99 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 1.62 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.75 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 1.7 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 2.07 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 1.95 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 1.66 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.19 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.47 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.97 109.047 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 1.73 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.55 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 5.02 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 3.1 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.65 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 3.34 108.235 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 3.73 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 1.92 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.85 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 2.11 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.65 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 3.43 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 1.86 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.31 108.816 -173.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 3.72 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.87 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 1.72 110.295 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.8 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 2.27 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 5.68 111.271 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 3.21 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 1.8 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 2.19 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.77 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 5.24 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 4.29 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.03 107.241 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 4.82 111.908 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 4.12 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 2.55 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.59 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.9 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 2.76 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.66 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.82 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 1.79 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 1.67 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.18 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 1.79 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 1.01 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 3.23 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.09 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 5.22 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 2.2 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 3.3 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.65 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 2.12 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 1.7 108.347 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 2.33 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 1.75 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.9 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 3.09 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.85 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.7 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 6.35 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.03 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 1.45 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 3.23 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 2.9 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 1.25 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.61 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 1.95 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.88 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.24 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 1.74 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 3.04 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 3.45 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 2.14 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.83 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 3.41 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 3.84 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 2.78 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 5.68 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 2.94 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 4.1 108.185 173.657 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.01 106.215 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.89 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.07 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.98 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 1.85 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 2.76 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 2.46 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 1.69 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 2.07 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.79 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.95 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 2.03 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.68 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 3.42 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 2.14 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.8 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 2.04 111.067 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 1.7 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.74 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 1.89 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.65 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.92 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.73 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 4.05 111.479 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 4.62 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 4.1 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 2.53 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.4 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.86 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 2.41 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 1.93 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.64 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 1.39 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 2.32 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 2.03 109.692 168.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.28 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 3.21 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 2.16 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 2.06 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.81 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 1.74 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 1.78 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 3.14 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 1.66 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 2.57 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 3.45 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.41 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.27 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.91 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 2.03 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.81 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 2.23 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 2.04 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 2.11 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 2.17 107.067 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.62 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.95 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 1.8 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.81 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 3.34 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.7 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 3.13 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 3.2 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 1.56 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 1.82 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 2.07 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.33 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 4.81 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 1.77 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.33 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 3.46 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 1.86 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.49 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 4.26 111.825 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 111.662 0.245 . . . . 3.37 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 2.24 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 1.81 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.54 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 6.27 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.86 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.07 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 5.25 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 4.66 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 2.71 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.57 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 6.39 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 2.74 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.03 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.72 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 1.64 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 1.65 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.86 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 1.63 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.8 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 2.57 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.24 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 4.37 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.71 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 2.57 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.94 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 1.86 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 1.63 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 1.88 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 1.89 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.84 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 3.09 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 3.48 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.75 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 6.31 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.69 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 1.51 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.63 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 2.39 110.841 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.86 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.14 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 2.3 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.93 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.64 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 1.81 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 2.66 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 3.41 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 2.09 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 4.05 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 4.19 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 2.48 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 3.5 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 2.45 107.793 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 4.03 108.901 -175.606 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.925 -0.398 . . . . 3.51 109.925 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 3.53 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.9 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 3.92 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 1.65 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 2.52 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 3.01 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 1.71 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 1.98 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 3.56 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 3.21 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 5.0 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 4.07 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 2.04 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 2.03 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 1.93 111.158 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 2.0 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 3.22 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 2.58 108.556 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 3.07 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 1.1 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 2.65 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 3.7 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 5.51 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 2.27 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.4 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 1.07 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 3.69 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.5 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.45 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.8 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.62 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 2.34 112.312 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.91 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 3.34 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 2.11 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 2.56 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.94 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.78 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 1.69 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.82 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 1.79 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 2.22 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 3.38 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.84 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 1.75 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.89 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 1.66 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 1.77 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 1.84 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 1.92 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.12 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.83 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 4.83 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 1.83 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.44 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.78 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 3.66 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.79 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 3.3 109.318 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 3.51 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 1.86 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 2.17 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 1.99 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 3.26 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 1.85 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.05 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 2.89 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.3 108.194 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 1.96 109.971 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.31 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.63 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 4.16 113.696 -168.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.85 108.807 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 2.54 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 2.16 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.29 109.064 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 5.8 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 2.76 111.651 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.99 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 5.34 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 2.68 110.705 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.46 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 5.34 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 2.41 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.61 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.71 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 1.66 107.638 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 1.66 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.98 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 1.6 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.55 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 3.48 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.93 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 3.98 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.33 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 2.92 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.31 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 2.4 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 1.69 107.131 161.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 1.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 2.0 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.88 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 3.37 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 3.07 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.7 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 6.09 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.8 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 1.81 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.57 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 2.5 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 1.25 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 2.08 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 3.87 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 1.98 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 2.93 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 5.44 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 2.47 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.67 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 3.71 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 4.0 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 2.61 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 3.34 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.81 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 5.74 108.679 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.3 109.227 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 3.03 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.18 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 3.06 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 1.61 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 3.24 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 2.21 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 2.23 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 1.62 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.32 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 3.55 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 2.15 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.69 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 4.18 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 3.0 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.9 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 1.97 109.961 173.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 2.02 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.96 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 2.08 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.56 110.706 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.95 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 1.08 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 2.95 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.89 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 5.6 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 2.68 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.33 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.86 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 2.5 109.973 176.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 2.22 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.85 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 1.61 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 2.03 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 2.38 110.215 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.71 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 2.77 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.91 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 2.33 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.55 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 2.45 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 1.74 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 3.5 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 1.97 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 2.3 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 3.41 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 1.07 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.99 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.68 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 1.06 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.88 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 1.81 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 2.01 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 2.04 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.93 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 3.84 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 1.85 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.88 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 5.83 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 3.63 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.07 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 4.41 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 3.53 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 2.09 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 2.07 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 2.08 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.57 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 3.6 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 1.64 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 3.56 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.63 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 1.95 107.647 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.14 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 3.05 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.85 112.441 -176.396 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.56 0.219 . . . . 2.9 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 1.96 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 2.02 109.683 173.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 6.15 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 2.91 110.719 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 4.66 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 5.3 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 3.23 111.942 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.41 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 4.67 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 2.4 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.43 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.68 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 1.72 108.008 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 1.82 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.82 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 1.78 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.85 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 3.85 110.968 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.16 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 3.83 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 2.05 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 2.44 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 2.3 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 1.7 107.873 168.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 2.08 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 1.78 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 3.44 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.88 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.59 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 6.52 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 1.41 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.59 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 2.86 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 1.58 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 1.92 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 4.61 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 1.62 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 2.59 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.31 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 4.14 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 1.86 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.69 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 3.43 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 4.44 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 2.47 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 3.26 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 4.91 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 6.0 108.826 170.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.505 -0.554 . . . . 2.98 109.505 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.93 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.7 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 4.29 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 2.34 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 6.1 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.75 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 2.03 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 2.09 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.11 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 4.7 110.667 176.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 3.25 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 3.43 109.523 174.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 4.56 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 3.38 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 2.36 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 2.25 109.925 168.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 2.45 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 3.86 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 1.76 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.64 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 3.68 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.21 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 2.53 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 2.54 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.78 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 2.77 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.51 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 1.21 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 2.67 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 1.82 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 1.73 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.18 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 2.18 109.65 175.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.82 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 2.76 111.652 174.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 2.06 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 2.34 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.99 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 2.05 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 1.71 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.99 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 3.01 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 3.41 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.81 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.49 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 2.84 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.43 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 1.69 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.8 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 2.42 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 2.4 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 2.24 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 2.61 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.54 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 4.92 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 1.82 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.12 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 3.3 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 4.33 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.92 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 3.61 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 3.64 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 2.22 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 2.11 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 3.01 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.49 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 3.59 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 1.92 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.22 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 3.13 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 1.64 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.12 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 4.53 111.297 170.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.173 0.511 . . . . 3.31 110.12 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.94 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 2.18 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.98 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 5.4 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 2.95 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 4.61 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.9 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 3.14 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.75 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 5.42 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 2.83 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.82 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.69 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 2.08 112.828 -170.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 2.77 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 2.01 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.31 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 3.15 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.17 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 3.95 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 2.46 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 3.05 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.91 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 1.89 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 1.71 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 2.44 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 1.82 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.28 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 3.69 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 3.39 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 9.01 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.36 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.74 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 3.14 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 3.44 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 1.08 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.91 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 2.02 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 4.76 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.72 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 1.74 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 2.69 110.223 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.57 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 4.21 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 2.07 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.31 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 3.32 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 4.38 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 2.48 110.404 173.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 3.3 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 4.36 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 4.07 108.073 176.513 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 3.47 116.764 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 3.31 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.26 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 2.78 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 1.79 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 3.23 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.66 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 1.94 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 2.1 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.87 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 4.53 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 2.23 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.5 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 3.58 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 2.68 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 1.71 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 2.07 110.089 178.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 1.99 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.87 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 2.12 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.17 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 2.81 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.69 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 2.61 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 3.22 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 4.82 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 3.7 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.16 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.89 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 2.33 110.079 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 1.97 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.18 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 1.33 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.41 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 1.87 111.952 -173.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.74 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 2.61 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 1.61 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 1.87 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.03 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 2.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 1.9 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 4.5 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 1.68 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 2.17 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 3.59 109.604 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.3 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.92 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.92 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.83 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 1.66 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.71 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 1.79 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 1.71 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 2.01 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 1.68 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.14 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.63 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 3.3 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 1.65 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.85 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 3.28 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 3.74 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.7 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 3.42 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 3.27 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 1.7 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 2.1 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 2.16 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 3.3 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 1.79 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 2.87 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.88 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 1.81 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.02 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 4.25 111.21 173.028 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 108.469 -0.937 . . . . 2.42 108.469 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.64 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 2.07 109.612 168.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 5.2 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 2.83 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 3.24 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 4.27 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 3.01 112.109 -176.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 2.0 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 7.14 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 2.66 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.96 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 1.73 107.886 175.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 1.78 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 1.76 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.95 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 2.89 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 3.67 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 2.02 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 2.68 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.49 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 2.07 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 1.83 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 2.32 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 1.69 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.87 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 3.03 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 3.45 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 1.12 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 8.19 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.62 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 1.92 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.71 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 2.93 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 1.13 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.22 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 1.81 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.97 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 1.64 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 2.67 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.56 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 5.06 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 1.73 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.73 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 3.5 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.86 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 2.37 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 3.46 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 2.54 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.86 108.567 172.004 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.66 108.695 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 4.12 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.63 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 2.9 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 1.66 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 2.8 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 3.26 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 2.32 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 2.21 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 1.04 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 4.32 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 2.31 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.58 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 5.55 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.89 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.59 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 1.92 110.452 170.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 2.53 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 3.65 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 1.94 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.69 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 3.21 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 1.0 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 2.47 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 3.32 112.774 174.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 4.74 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 2.67 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.28 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 1.02 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 2.67 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 2.18 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.58 112.925 172.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 2.03 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 2.01 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 1.94 110.641 177.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 2.09 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 2.62 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 2.36 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 2.65 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.57 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.59 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 1.54 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.94 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 1.85 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 2.03 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 3.05 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.64 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 2.07 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 2.2 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 2.17 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.43 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 2.31 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 2.08 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 2.24 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 1.51 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.57 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.58 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 3.46 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 1.93 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 3.45 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 3.31 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.1 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 3.75 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 3.3 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 2.36 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.97 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 3.39 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.68 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 5.53 109.257 174.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 1.56 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 3.36 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.78 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.98 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 3.11 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.41 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 4.38 112.126 167.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.994 0.738 . . . . 2.83 112.994 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 2.01 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 2.07 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 2.43 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 4.37 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 2.76 111.812 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 4.43 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 4.45 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 2.77 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.5 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 6.33 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 2.54 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.11 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.22 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 1.97 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 2.15 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.17 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 1.95 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 1.01 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 2.94 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 2.61 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 3.76 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.35 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 3.02 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.59 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 2.02 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 1.77 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 1.97 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 1.94 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.72 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 3.32 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.86 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.43 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 6.13 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.76 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 2.11 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 3.0 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 3.54 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.81 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 1.9 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.86 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.93 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 1.84 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 3.07 111.51 -178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.28 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 3.04 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 2.32 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 3.88 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 4.6 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 3.86 106.482 -175.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 3.77 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.97 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 3.17 109.166 174.985 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 121.895 0.855 . . . . 2.73 109.592 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 2.66 106.168 166.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 3.6 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 1.89 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 2.9 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.94 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 1.64 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 1.85 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.69 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 4.2 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 2.29 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.56 109.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 3.73 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 3.12 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.62 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 2.08 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 2.33 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 3.51 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 1.68 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.72 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 3.78 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.94 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 4.35 110.528 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 5.18 112.555 175.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 3.73 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 2.33 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.91 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 4.04 109.212 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 2.21 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.06 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 2.24 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 2.25 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 1.84 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 2.08 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 2.54 111.14 171.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 2.09 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 2.02 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 1.88 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 1.66 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.98 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 1.72 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 2.2 107.051 -179.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 3.07 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.68 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.16 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.74 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 1.91 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.93 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 1.88 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 1.68 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 1.69 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 2.39 107.64 177.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.01 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.15 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 4.73 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 1.88 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 3.42 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 3.58 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 1.03 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 3.19 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 3.03 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 1.75 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 2.07 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 2.06 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.76 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.97 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 1.62 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.49 111.216 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 3.58 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 1.8 110.255 -173.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 4.11 113.618 -175.349 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 111.707 0.262 . . . . 3.02 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 2.19 109.404 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 1.82 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.31 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 4.14 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 2.84 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 4.33 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 3.77 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 2.92 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.38 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 5.2 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 2.39 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.72 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 1.78 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 1.8 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.73 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 1.58 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.57 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 2.67 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 3.01 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 4.22 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 2.08 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.78 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.76 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 1.93 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 1.65 107.749 172.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 1.59 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 1.77 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.61 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 3.48 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.92 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.71 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 5.25 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.37 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 1.92 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.59 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 2.72 112.758 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.96 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.55 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 2.18 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 4.08 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.86 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 1.62 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 2.83 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.62 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 5.2 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 2.26 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.77 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 3.26 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 4.0 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 2.55 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 4.09 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 2.44 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.93 109.188 179.277 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.843 0.354 . . . . 2.26 111.592 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 3.34 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 3.0 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 1.71 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 3.3 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.96 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 1.76 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.92 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 1.13 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 3.36 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 2.44 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.64 109.511 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 3.55 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 2.48 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.66 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 2.14 109.402 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 1.7 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 3.08 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 1.56 108.488 174.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.78 111.285 -175.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 2.7 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.67 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 2.55 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 3.51 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 4.03 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 2.27 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.87 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 2.53 109.94 178.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 1.66 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.81 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 1.76 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 2.22 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 2.0 110.822 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.23 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 2.62 111.308 173.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 1.98 111.462 175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 2.0 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 1.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 1.68 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.85 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 1.51 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 3.08 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 3.04 111.321 -172.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.07 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.97 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 1.74 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.88 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 1.5 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.78 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 1.84 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 1.58 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 1.83 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 1.71 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.19 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.53 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 3.49 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 1.66 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.14 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 3.64 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 3.03 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.68 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 3.24 109.838 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 3.21 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 2.05 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 2.51 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 2.04 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.92 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 5.27 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 1.55 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.72 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 2.92 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 1.78 109.637 -167.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.58 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.39 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.88 110.559 176.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 113.259 0.837 . . . . 2.75 113.259 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 2.14 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 1.8 111.242 173.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.11 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 5.7 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 2.84 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.34 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 5.54 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 4.0 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 2.94 111.322 -174.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.63 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 5.61 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 3.81 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.49 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.69 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 1.66 108.027 178.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 1.62 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 1.55 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.68 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 3.47 109.472 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.89 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 5.36 112.028 -168.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 2.59 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 2.33 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.72 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 1.86 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 1.91 108.516 168.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 1.74 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 1.67 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.86 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 2.99 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 3.42 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.59 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 7.72 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 1.42 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 3.33 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 3.66 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 1.1 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.03 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 1.94 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 4.14 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.7 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 2.88 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.83 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 4.35 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 2.16 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.84 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 3.21 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 3.49 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 2.61 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.99 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 2.37 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 3.68 109.67 178.793 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.14 108.68 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 3.7 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.55 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 3.49 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 1.82 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 3.25 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 2.26 110.374 172.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 1.8 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 1.61 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.68 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 5.12 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 2.73 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.05 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 4.35 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 2.25 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 2.16 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 1.7 111.856 169.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 1.93 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 5.66 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 2.05 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 4.25 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.65 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 4.21 110.81 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 3.15 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 3.76 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 3.23 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.43 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.89 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 2.34 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 2.01 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.09 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 1.8 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 2.33 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 2.83 111.183 174.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 3.21 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 3.74 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.97 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 1.68 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.06 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 2.11 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 1.97 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.23 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 1.79 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 2.24 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 3.08 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.05 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 1.1 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.89 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.12 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 2.12 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 1.1 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 2.4 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 2.13 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 2.09 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 3.23 109.466 178.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.56 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.9 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 3.38 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 1.61 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.93 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 3.25 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.68 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 3.51 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 3.7 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 1.72 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 2.04 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 2.23 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.87 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 3.51 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 1.52 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.45 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 3.39 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 1.6 109.103 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.48 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtm . . . . . 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.92 112.514 178.802 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 N-CA-C 109.851 -0.425 . . . . 3.78 109.851 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 1.88 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 1.68 111.651 -179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.39 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 5.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 4.03 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 3.77 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.85 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 2.43 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.75 113.762 174.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 7.89 110.164 176.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 2.4 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.62 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 1.29 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 1.97 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 2.03 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.22 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 1.89 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.8 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 4.33 110.658 -175.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 4.61 112.979 -176.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 2.61 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 3.13 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.69 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 2.36 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 1.66 107.477 163.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 1.67 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 1.77 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.94 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 3.1 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 3.06 108.846 -177.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 6.3 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.62 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 1.9 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.64 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 2.82 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 1.24 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.19 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 1.93 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 4.74 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.22 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 1.56 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 2.59 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.31 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 4.69 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 1.91 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.78 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 3.3 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.85 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 2.56 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.99 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 2.35 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 5.07 110.097 -179.452 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.302 -0.629 . . . . 2.33 109.302 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 3.07 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.13 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.94 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 1.79 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 2.75 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.26 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 1.86 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 2.08 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.74 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 4.56 109.615 175.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 2.4 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.63 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.77 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 2.23 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 1.71 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 2.04 109.437 177.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 2.27 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.72 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 1.81 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.02 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 3.69 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.94 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 2.51 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.97 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 4.85 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 2.48 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 1.0 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 2.59 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 1.94 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' HD22 ' A' ' 38' ' ' ASN . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.35 112.53 179.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 1.61 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.452 HD22 ' CG ' ' A' ' 36' ' ' ASP . 43.4 m-80 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.15 110.481 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 1.83 109.468 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.33 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 2.99 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 2.17 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 1.69 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.15 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 1.64 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 1.74 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 3.02 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 1.68 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 2.28 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 3.06 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.28 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.11 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 2.14 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.28 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 1.86 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.8 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 1.99 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 1.55 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 1.79 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 1.89 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.89 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 4.3 110.581 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 1.78 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 3.1 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 3.09 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.7 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 3.32 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 3.44 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 1.9 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 2.24 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 2.19 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.42 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 3.44 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 1.77 109.135 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.47 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 3.36 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.68 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 1.86 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.99 108.878 172.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 5.27 113.728 -177.421 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 113.105 0.779 . . . . 3.35 113.105 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.95 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 2.46 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 5.01 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 2.86 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.69 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.97 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 4.22 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 2.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.61 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 5.17 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 2.37 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.71 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 1.69 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 1.7 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 1.06 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 1.72 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.59 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 3.66 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 2.1 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 3.7 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.64 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 2.11 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 2.02 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 1.83 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 1.94 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 3.11 105.638 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.01 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 3.35 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 3.52 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 8.71 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.38 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 1.42 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.63 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 2.27 110.781 173.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 1.02 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 1.85 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 3.89 110.702 174.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 1.69 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 3.04 110.038 -175.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.09 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 3.25 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 2.05 112.236 169.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.7 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 3.48 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 4.61 107.383 176.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 2.62 108.299 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 3.91 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 2.44 108.691 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt . . . . . 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 4.31 108.585 175.373 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 3.24 110.322 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 3.08 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.87 108.466 173.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.94 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 1.91 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 3.11 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 3.31 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 1.68 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 1.79 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.74 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.98 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 2.58 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 4.35 110.72 171.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 3.76 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 2.77 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 2.46 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.131 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 2.22 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.9 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 1.66 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 3.63 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.98 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 2.62 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 3.18 112.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 3.82 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 2.5 110.122 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.97 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 3.52 109.488 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 2.3 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.18 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 1.45 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.56 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 2.29 108.362 -177.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 3.34 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 3.5 111.69 175.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 2.79 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 2.78 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.3 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 1.91 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 1.49 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 4.02 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 1.45 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 2.45 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 3.58 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.19 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.18 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 2.2 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.13 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.97 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 1.97 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 2.03 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 2.09 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.401 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 1.85 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.8 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.62 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 3.32 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 1.56 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.58 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 3.45 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 3.36 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.94 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 3.34 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 3.19 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 1.77 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 1.92 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 2.33 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.38 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 5.32 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.92 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.45 111.424 176.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 3.32 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.11 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 1.72 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.51 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 3.57 112.694 -176.093 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 2.64 110.564 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.7 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 1.75 111.174 175.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.46 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 4.19 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 3.91 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1 108.159 -177.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 3.56 111.906 -178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 3.5 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 3.04 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 2.37 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 5.15 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 2.47 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 1.02 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 1.75 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 1.83 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 1.02 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 1.8 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.78 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 2.86 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.83 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 4.86 113.797 -170.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 2.08 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 3.28 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.3 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 2.59 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 1.71 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 1.89 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 1.85 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.86 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 3.41 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 3.32 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 1.02 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 6.16 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 1.81 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 2.57 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 3.39 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.23 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.94 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 2.12 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 4.57 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.64 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 1.71 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 2.92 110.836 -175.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.76 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.89 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 1.91 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.95 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 3.47 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 3.48 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 2.9 107.788 -171.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 3.53 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 3.52 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 4.02 107.915 174.422 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 3.24 110.322 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 3.08 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.87 108.466 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.94 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 1.91 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 3.11 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 3.31 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 1.68 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 1.79 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.74 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.98 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 2.58 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 4.35 110.72 171.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 3.76 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 2.77 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 2.46 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.131 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 2.22 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.9 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 1.66 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 3.63 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.98 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 2.62 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 3.18 112.233 172.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 3.82 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 2.5 110.122 -173.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.97 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 3.52 109.488 -177.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 2.3 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.18 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 1.45 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.56 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 2.29 108.362 -177.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 3.34 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 3.5 111.69 175.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 2.79 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 2.78 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.3 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 1.91 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 1.49 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 4.02 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 1.45 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 2.45 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 3.58 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.19 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.18 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 2.2 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.13 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.97 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 1.97 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 2.03 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 2.09 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.401 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 1.85 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.8 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.62 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 3.32 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 1.56 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.58 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 3.45 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 3.36 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.94 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 3.34 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 3.19 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 1.77 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 1.92 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 2.33 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.38 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 5.32 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.92 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.45 111.424 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 3.32 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.11 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 1.72 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.51 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 3.57 112.694 -176.093 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 2.64 110.564 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.7 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 1.75 111.174 175.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.46 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 4.19 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 3.91 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1 108.159 -177.275 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 3.56 111.906 -178.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 3.5 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 3.04 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 2.37 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 5.15 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 2.47 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 1.02 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 1.75 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 1.83 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 1.02 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 1.8 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.78 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 2.86 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.83 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 4.86 113.797 -170.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 2.08 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 3.28 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.3 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 2.59 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 1.71 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 1.89 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 1.85 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.86 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 3.41 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 3.32 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 1.02 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 6.16 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 1.81 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 2.57 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 3.39 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.23 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.94 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 2.12 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 4.57 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.64 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 1.71 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 2.92 110.836 -175.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.76 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.89 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 1.91 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.95 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 3.47 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 3.48 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 2.9 107.788 -171.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 3.53 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 3.52 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 4.02 107.915 174.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.712 -1.218 . . . . 14.08 107.712 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.74 -172.97 4.45 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.828 0.705 . . . . 9.5 109.432 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m 84.92 146.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.781 2.032 . . . . 4.73 109.158 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -138.81 81.9 1.87 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.775 -1.194 . . . . 5.85 107.775 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -48.91 129.05 16.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.496 -1.229 . . . . 2.57 109.712 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 3.69 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.15 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 3.32 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 1.82 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 3.05 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.94 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 1.87 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 1.42 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.86 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 3.13 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 3.1 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.61 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 3.02 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 2.17 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 1.84 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 1.78 109.046 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 2.13 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 5.33 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 1.6 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.97 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 5.28 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.75 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 2.45 109.588 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 2.55 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 4.12 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 2.81 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.94 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 2.58 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 1.95 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.14 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 1.91 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 2.06 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 2.07 106.877 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.64 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 2.83 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.76 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 1.89 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.66 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 2.36 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 1.99 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 4.48 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 1.66 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 2.06 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 3.03 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.42 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.5 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 1.97 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 1.78 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.78 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 1.55 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 1.57 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 1.66 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 1.89 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.85 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.05 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 3.08 108.997 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 1.8 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.56 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.98 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 3.31 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.72 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 3.21 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 3.17 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 1.73 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 1.97 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 2.02 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.33 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 3.33 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 1.72 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.89 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 3.68 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 1.6 108.926 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.58 109.865 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.83 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 165.39 4.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 5.0 113.177 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 t -179.53 -53.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.957 -1.498 . . . . 4.32 106.957 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.8 t -92.5 32.57 1.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.342 -0.849 . . . . 6.05 110.451 -165.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 41.87 27.37 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.165 1.786 . . . . 6.66 114.159 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -116.57 -50.81 2.61 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.865 0.866 . . . . 3.2 109.733 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 2.25 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 2.08 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.32 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.9 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 3.81 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 4.76 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 4.41 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 2.17 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.69 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 5.48 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 2.43 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.94 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 1.65 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 1.55 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 1.74 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.57 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 2.61 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.97 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 4.4 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 2.27 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 2.75 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 1.8 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 1.6 107.847 166.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 1.61 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 1.71 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.53 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 3.03 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 3.02 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.68 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 8.32 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.64 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 1.65 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.9 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 2.5 114.604 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 1.05 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.92 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 1.95 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.78 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.83 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 1.96 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 2.99 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.14 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.86 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 1.89 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.95 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 3.5 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.95 106.37 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 2.93 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.84 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 2.38 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.44 83.05 5.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 4.39 107.516 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.82 -54.96 4.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.484 0.564 . . . . 2.09 112.056 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 59.02 32.44 22.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.944 1.297 . . . . 5.13 111.454 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.85 -47.34 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.736 -0.603 . . . . 6.29 110.392 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.84 52.95 5.04 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 123.164 1.459 . . . . 8.71 109.013 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m 63.75 16.05 9.46 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.989 1.716 . . . . 7.75 114.069 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.12 72.54 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.9 0.773 . . . . 10.0 109.65 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -112.76 131.01 55.87 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.407 -1.701 . . . . 14.18 106.407 161.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.31 -74.06 0.34 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.482 -1.047 . . . . 15.09 110.482 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 N-CA-C 103.996 -2.594 . . . . 16.81 103.996 161.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.044 -0.724 . . . . 17.88 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.76 127.76 1.36 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 106.094 -1.817 . . . . 9.83 106.094 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -173.08 165.2 4.95 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.767 2.027 . . . . 5.55 106.499 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.43 62.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.732 1.613 . . . . 5.75 108.317 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -86.79 158.62 19.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.27 -0.877 . . . . 2.69 108.906 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 6.02 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.53 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 2.82 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 1.9 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 3.4 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 3.11 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 1.87 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 1.81 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.78 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 5.04 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 2.29 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.92 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 4.69 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 2.54 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 1.78 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 1.88 110.147 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 1.89 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 4.73 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 1.7 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.61 110.538 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 2.66 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.85 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 3.77 110.748 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 3.34 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 3.62 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 2.43 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.89 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 2.27 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 2.38 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.08 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 1.58 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 2.1 110.14 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.85 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 2.52 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.73 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 1.74 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 1.86 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 1.58 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 3.38 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 1.57 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 2.21 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 3.08 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.23 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 2.17 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.92 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.9 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.92 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 2.66 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 1.77 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 1.9 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 2.09 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.37 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 4.7 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 1.62 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.18 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 3.3 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 3.4 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.94 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 3.47 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 3.2 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 1.83 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 2.06 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 2.05 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.44 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 4.02 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.58 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.94 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 3.51 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.53 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 1.87 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.36 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp -51.61 73.33 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 3.34 114.676 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t -77.03 51.16 0.79 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.068 0.947 . . . . 5.51 109.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t 68.95 -132.95 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 5.69 108.029 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.58 -78.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.16 1.784 . . . . 4.4 110.738 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.52 40.28 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.039 2.136 . . . . 2.95 108.704 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 2.58 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 1.85 110.209 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.45 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 6.0 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 4.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 4.38 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 3.76 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 2.39 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.65 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 5.47 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 2.63 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.67 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.71 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 1.74 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 1.53 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.87 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 1.71 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.78 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 3.66 109.342 -175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 2.34 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 4.07 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.99 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 2.06 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.05 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 1.89 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 1.95 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 1.98 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 1.91 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.85 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 3.62 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 3.25 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 6.1 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.72 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 1.97 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.54 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 2.54 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 1.11 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 1.88 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 5.49 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 1.76 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 2.47 111.796 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.07 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 3.51 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 2.26 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 3.26 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 4.87 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 3.89 108.547 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.74 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 4.06 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 74.65 4.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 4.23 108.861 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.83 -59.12 3.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.376 -1.09 . . . . 2.75 110.376 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.61 47.34 24.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.997 1.319 . . . . 5.38 109.995 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.75 -53.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.234 1.813 . . . . 8.12 107.795 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.83 -5.57 11.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.411 1.084 . . . . 7.0 112.18 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -153.88 30.5 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.964 1.306 . . . . 7.52 110.013 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.3 mt -43.37 -66.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.774 1.23 . . . . 8.36 111.195 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.65 167.42 1.39 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.963 2.105 . . . . 14.53 106.851 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -89.89 94.64 2.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.184 -1.566 . . . . 14.98 109.184 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.85 -1.548 . . . . 17.96 109.829 174.009 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 106.233 -1.766 . . . . 13.87 106.233 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.31 121.48 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.087 -1.079 . . . . 10.78 108.087 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m 72.73 126.7 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.125 1.77 . . . . 4.76 112.93 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 54.42 1.68 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.481 1.134 . . . . 4.77 109.731 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -57.96 155.96 9.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.937 1.295 . . . . 2.81 109.141 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 3.09 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 4.23 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 1.61 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 2.68 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.68 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 1.97 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.86 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.96 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 3.19 109.11 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 3.01 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.5 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 4.22 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 2.01 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 2.14 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 1.72 110.985 172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 1.78 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.97 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 2.15 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 2.81 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.72 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 4.69 110.56 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 2.55 112.18 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 4.21 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 2.5 111.382 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.97 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 3.77 109.448 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 2.42 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.05 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 1.57 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.38 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 2.22 108.925 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.73 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.98 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.93 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 2.08 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.58 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 1.99 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 1.58 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 3.05 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 1.74 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 2.76 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 3.07 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.09 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 1.03 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 2.3 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 1.72 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.96 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.62 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 1.65 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 1.75 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 3.09 110.095 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.63 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.63 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 3.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 1.87 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.19 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 5.37 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 3.67 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.63 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 3.4 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 3.26 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 1.67 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 2.25 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 1.97 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.14 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 4.28 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 1.79 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.45 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 3.3 108.764 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 1.97 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.14 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.33 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm 45.74 -136.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 5.14 109.524 -171.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.0 p 36.56 56.21 1.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.394 2.677 . . . . 6.6 114.056 159.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.82 -160.58 1.18 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.493 -1.669 . . . . 5.93 106.493 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.07 -47.99 8.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.323 1.049 . . . . 4.95 112.25 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.33 48.58 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 2.86 110.974 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 2.42 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 1.67 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.76 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 5.22 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 2.8 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 3.76 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 3.45 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 2.95 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.49 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 5.68 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 2.45 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.76 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.73 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 1.69 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 1.77 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.72 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 1.57 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.7 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 2.65 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 3.6 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 4.15 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 2.13 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 2.61 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 2.29 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 1.74 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 1.82 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 2.26 107.373 -176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.61 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 3.6 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 3.24 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.72 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 6.4 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.94 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 1.92 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 2.82 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 2.75 111.14 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.88 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.07 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 2.45 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 4.22 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.05 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 1.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 3.04 111.04 -175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.64 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 3.16 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.97 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.37 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 3.3 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 5.61 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 2.68 108.489 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 2.72 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 4.17 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -79.96 82.91 5.95 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 4.28 108.594 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.6 3.52 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.459 -1.056 . . . . 2.41 110.459 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 44.09 49.23 7.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.395 1.078 . . . . 3.99 110.919 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -166.19 -54.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.345 2.258 . . . . 8.77 107.309 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.66 -25.94 11.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.444 1.098 . . . . 7.65 112.033 -170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.9 m -109.45 23.83 13.92 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.157 1.383 . . . . 8.28 111.261 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.76 78.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.828 0.823 . . . . 8.03 108.992 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -81.08 60.74 4.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 15.15 111.215 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.43 147.0 4.74 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.826 -2.109 . . . . 13.68 107.826 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.354 -2.091 . . . . 17.08 105.354 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.826 -0.435 . . . . 17.15 109.826 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -78.91 67.82 4.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.464 -0.569 . . . . 12.62 109.464 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.5 m -75.37 53.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.214 1.406 . . . . 5.97 112.864 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -84.51 79.31 9.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.493 -1.299 . . . . 4.98 107.493 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -45.41 149.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.904 -1.498 . . . . 2.79 110.25 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 3.53 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.74 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 3.98 107.834 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 1.74 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.9 110.426 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 2.34 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 1.9 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 1.83 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.79 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 3.36 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 2.6 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.76 109.558 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 3.55 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 2.73 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 1.66 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 1.93 109.063 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 1.77 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 3.28 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 1.87 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.53 110.342 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 2.77 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.71 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 2.46 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 4.09 112.415 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 4.53 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 2.47 110.018 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.22 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 1.06 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 3.56 110.41 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 1.93 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.26 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 1.79 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.62 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 2.26 109.848 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 2.75 111.87 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 2.23 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 2.05 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.91 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 1.73 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 1.69 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 3.16 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 1.71 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 3.1 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 2.97 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.07 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 1.0 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 1.8 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.89 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 1.88 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.72 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 1.57 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 1.75 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 1.76 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.4 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 1.52 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.94 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 4.5 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 1.96 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 4.1 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 3.81 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.82 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 3.33 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 3.19 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 2.03 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.82 111.582 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.92 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.15 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.78 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 1.88 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.38 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 2.98 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.63 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 1.8 110.144 -167.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.59 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.25 138.73 9.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 5.27 113.131 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 44.36 0.91 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.668 -0.864 . . . . 4.62 108.668 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.8 t 67.43 45.0 1.66 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.906 0.86 . . . . 5.65 111.133 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.53 43.33 3.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.588 1.155 . . . . 4.64 108.144 168.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.4 25.62 4.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.441 1.496 . . . . 2.36 113.148 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 1.9 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 1.75 110.839 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 5.5 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 2.9 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.89 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 4.3 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 6.99 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 2.87 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.37 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 5.87 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 2.58 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.81 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 1.72 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 1.56 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 1.77 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.67 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 3.64 109.209 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 3.07 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 3.64 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 2.67 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 2.37 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.67 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 1.78 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 1.64 108.837 168.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 1.94 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 1.98 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 2.99 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.87 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.61 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 6.4 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.06 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 1.69 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.91 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 3.2 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.95 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.17 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 1.81 109.603 -175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 3.97 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.69 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 1.84 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 2.77 109.1 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.07 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 3.2 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 2.06 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.83 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 3.6 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 4.09 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 2.62 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 3.71 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 2.67 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -81.02 79.99 7.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 3.38 108.914 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -65.84 3.62 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.129 -1.188 . . . . 2.06 110.129 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 35.73 56.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.224 1.409 . . . . 4.27 111.513 -168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.07 -53.24 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 106.676 -1.601 . . . . 6.78 106.676 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.7 t0 54.29 98.24 0.01 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.805 1.642 . . . . 9.71 110.98 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m 57.34 30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.09 -0.505 . . . . 7.8 110.293 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 62.78 -71.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.261 2.224 . . . . 10.2 111.899 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . 0.403 0.0 OUTLIER 52.61 -24.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.746 3.218 . . . . 11.37 118.6 -174.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.58 161.93 28.6 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.944 -2.462 . . . . 11.8 106.944 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.576 -1.678 . . . . 15.69 109.603 168.408 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.28 9.3 ptt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.936 0.717 . . . . 19.16 112.936 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.32 139.84 48.19 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.443 -1.317 . . . . 13.39 107.443 167.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m 63.49 169.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.256 1.023 . . . . 7.05 110.708 -167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -75.41 33.85 0.11 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.772 1.229 . . . . 5.53 111.535 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -125.45 140.78 52.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.767 1.227 . . . . 3.57 107.927 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 4.14 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.87 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 3.51 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 1.73 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 2.79 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 2.25 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 1.74 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 2.04 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 3.4 111.286 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 4.02 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 5.84 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 4.16 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 2.54 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 2.65 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 1.71 111.09 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 1.97 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.7 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 1.66 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.28 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.89 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.72 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 3.93 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 3.39 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 4.46 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 2.6 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.42 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.85 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 2.28 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 1.89 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 1.82 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.32 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 2.01 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.69 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 2.79 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 2.07 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 1.88 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 1.76 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 1.51 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 4.52 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 1.82 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 2.52 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 3.1 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.22 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.13 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 2.32 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.01 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 1.84 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.79 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 1.61 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 1.57 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 1.95 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 1.83 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.85 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 3.16 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 1.82 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.32 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 4.34 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 3.31 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.65 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 3.59 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 3.62 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 1.64 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 1.8 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 2.22 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.42 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 4.16 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 1.59 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.28 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 3.03 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.58 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 2.09 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.57 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.82 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.35 145.12 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 4.45 112.738 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -121.88 28.09 7.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.768 0.827 . . . . 4.94 109.911 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.8 t 63.96 64.29 0.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 122.623 1.201 . . . . 7.11 110.88 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.73 -75.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.202 -1.407 . . . . 4.47 107.202 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.36 22.74 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 2.35 111.852 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 2.25 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 2.26 109.946 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 5.59 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.83 110.926 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.14 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.91 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 3.55 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 3.18 111.264 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.85 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 6.64 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 2.54 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.51 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.86 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 1.71 107.496 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 1.96 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.14 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 1.85 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.85 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 2.89 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.67 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 4.66 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 2.63 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 3.01 110.467 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 2.46 110.45 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 1.78 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 1.7 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 1.84 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 3.12 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 3.6 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.83 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 6.14 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.85 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 1.58 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 2.44 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 2.89 112.684 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.99 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 2.19 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 4.68 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.05 110.065 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 1.59 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 2.53 110.604 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HZ1' ' CD ' ' A' ' 130' ' ' GLU . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 3.24 113.295 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 1.89 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.62 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 3.33 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 4.24 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 3.1 106.839 -172.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 3.16 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 2.81 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -116.24 94.47 4.66 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 4.61 108.384 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.74 -62.24 3.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.836 -0.906 . . . . 3.61 110.836 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.76 37.78 21.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.937 1.295 . . . . 4.5 111.512 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -176.21 -38.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.219 0.607 . . . . 8.87 111.297 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t0 50.79 92.24 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.156 2.182 . . . . 12.52 112.322 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.83 28.36 18.12 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.578 -0.737 . . . . 10.69 110.595 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.3 mt 53.92 57.25 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.608 1.163 . . . . 9.18 109.487 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -67.69 155.29 39.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.504 -0.747 . . . . 14.99 109.705 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.43 103.05 0.18 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.936 -2.466 . . . . 15.45 106.936 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.853 2.461 . . . . 19.7 105.793 -175.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.267 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 117.477 -1.249 . . . . 15.1 110.389 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.5 53.95 1.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.391 1.905 . . . . 9.58 110.96 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t 48.26 34.27 4.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.022 1.329 . . . . 4.9 112.473 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -82.59 48.69 1.34 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.173 0.589 . . . . 5.57 109.61 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -73.54 138.96 45.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.386 -0.821 . . . . 2.15 109.181 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 2.77 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.74 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 3.6 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 1.56 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 2.72 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.59 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 1.93 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 2.1 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.91 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 3.52 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 2.32 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.58 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.44 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 2.98 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 1.86 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 1.81 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 2.19 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 3.07 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 1.73 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.65 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.8 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.75 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 2.41 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 3.11 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 5.75 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 2.62 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.18 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.87 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 2.47 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 1.89 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 1.34 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 2.09 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 2.01 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 3.26 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 2.06 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 2.64 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.22 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 2.04 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 1.75 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.64 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 1.59 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 2.17 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 3.38 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.01 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.9 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.24 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.4 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 1.73 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 1.02 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 1.68 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 1.61 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 1.79 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 1.42 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.86 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.05 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 3.91 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 1.79 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.67 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.89 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 3.81 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.71 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 3.37 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 3.54 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 1.89 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 2.12 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 2.1 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 4.38 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 1.72 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.92 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 3.43 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.62 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 1.77 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.56 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.5 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.01 168.78 0.9 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 4.03 112.047 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 p -149.04 -50.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.686 -1.143 . . . . 4.39 110.184 -173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.1 t -178.4 -48.88 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.833 -1.173 . . . . 6.21 107.833 -166.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 165.21 1.56 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.433 -0.803 . . . . 4.36 110.53 166.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.89 38.28 0.07 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.091 1.756 . . . . 2.38 113.742 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 1.88 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 1.78 110.408 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.96 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 5.59 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 2.85 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.45 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.94 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 6.1 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 2.9 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.64 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 5.16 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.78 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.6 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.74 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 1.79 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 1.72 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.85 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 1.78 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.67 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 3.63 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 2.14 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 3.71 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.91 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 2.54 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.92 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 1.85 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 1.73 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.9 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 1.98 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 2.98 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 3.27 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.69 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 8.69 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.59 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 1.84 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 2.6 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 2.67 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 1.36 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 1.89 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 4.62 109.136 165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.43 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 1.59 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 2.82 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.78 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 3.39 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 2.32 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.74 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 3.39 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.94 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 4.01 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 3.93 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 3.38 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 86.34 5.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 4.02 109.196 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.13 -50.0 4.22 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.68 -0.511 . . . . 1.98 111.905 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 61.61 28.4 17.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.011 0.925 . . . . 5.16 110.946 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.09 -47.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.662 -0.649 . . . . 6.57 110.51 -170.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t0 59.55 33.33 22.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.325 1.45 . . . . 8.99 111.498 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -158.59 32.36 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.236 1.814 . . . . 7.61 108.986 171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt 66.11 -65.71 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.404 1.882 . . . . 11.73 111.478 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.76 -161.64 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.122 0.969 . . . . 15.11 108.89 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.67 -126.91 5.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.482 -1.447 . . . . 12.93 109.482 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.068 1.747 . . . . 15.55 106.718 -174.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 118.748 -0.644 . . . . 16.74 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.83 92.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.128 0.971 . . . . 13.28 109.593 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m 70.32 168.74 0.31 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.734 1.614 . . . . 5.81 110.369 -167.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -76.3 49.73 0.6 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.398 0.679 . . . . 6.71 110.153 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -121.23 149.58 42.64 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.35 105.316 167.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 3.29 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.84 108.868 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.93 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 1.73 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 2.72 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.06 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 2.1 108.883 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 1.58 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 4.08 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 2.13 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.47 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 4.8 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 2.81 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 2.2 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 2.7 110.882 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 2.27 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 4.79 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 1.98 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.33 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 4.73 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.8 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 4.07 110.086 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 2.71 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 5.54 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 2.9 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.87 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 2.22 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 2.25 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.85 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 1.74 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 2.3 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 2.12 110.054 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 2.96 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 2.06 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.82 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 1.5 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 1.62 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 5.35 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 1.76 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 2.49 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 3.4 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.37 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.1 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 2.18 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.92 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 1.68 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.97 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.75 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 1.75 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 2.01 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 1.68 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.56 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 4.85 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 2.34 109.866 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.13 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 4.04 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 3.34 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.71 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 3.26 109.275 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 3.3 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 1.81 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 2.06 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 2.22 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.69 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 4.28 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 1.73 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.69 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 3.57 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.86 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 2.56 109.778 -175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.65 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.81 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.36 159.7 2.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 4.3 112.83 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -126.58 -54.56 1.44 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.965 -1.47 . . . . 4.97 108.598 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.6 t 177.74 -41.94 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.563 1.145 . . . . 6.46 110.163 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -42.3 -77.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.395 1.478 . . . . 4.1 113.391 -172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.11 27.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.81 0.844 . . . . 2.4 111.087 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 1.97 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 1.79 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.18 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 6.88 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 3.08 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.49 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.99 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.89 111.192 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 2.97 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.52 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 4.63 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 2.48 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.61 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.9 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 1.67 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 1.7 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.99 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 1.65 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.69 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 2.79 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.83 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 3.81 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.99 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 2.51 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.61 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 1.86 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 1.87 107.664 156.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 1.78 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 1.59 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.67 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 3.09 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 3.17 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.86 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 6.73 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.41 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 1.97 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 3.11 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 3.21 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 1.12 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.83 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 2.6 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 4.18 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' A' ' 134' ' ' LYS . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.92 110.403 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 1.66 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 2.81 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.58 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' HZ3' ' CD ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 3.55 113.022 175.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 1.8 111.966 169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 3.63 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 4.62 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 2.54 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 3.62 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 2.52 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.5 98.22 9.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 4.01 109.519 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.8 -47.57 3.83 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.01 -1.236 . . . . 2.17 110.01 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -47.63 -35.97 10.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.752 0.821 . . . . 5.3 111.524 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -26.25 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.046 -1.034 . . . . 9.84 113.696 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.73 -2.59 32.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.846 1.658 . . . . 7.93 111.662 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.6 m -151.44 24.11 0.71 Allowed 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.126 -0.984 . . . . 8.55 113.207 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.1 pt -33.38 -43.61 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.712 2.005 . . . . 11.85 115.124 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -154.82 165.36 36.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.702 -1.592 . . . . 15.67 106.702 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.15 -54.07 0.23 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.666 0.651 . . . . 14.39 112.9 -166.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.454 -2.212 . . . . 18.41 105.395 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 118.685 -0.674 . . . . 15.78 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.6 -50.01 73.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.37 0.532 . . . . 13.23 111.867 -174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m 158.63 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.971 2.909 . . . . 5.32 106.902 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 22.04 72.89 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 127.378 2.271 . . . . 6.14 113.013 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.33 157.51 19.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.88 106.605 172.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 3.28 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.84 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 4.39 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 1.7 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 3.12 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 2.47 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 1.85 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 1.65 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 4.88 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 2.07 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.65 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 5.13 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 2.55 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 2.07 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 2.12 110.56 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 1.75 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 4.17 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 1.73 108.137 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.03 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 3.23 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.72 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 2.64 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 2.67 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 3.69 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 2.56 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.14 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 2.31 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 2.37 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.68 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 1.65 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.22 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 2.39 109.288 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.16 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 2.71 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 2.26 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 2.29 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.88 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 1.7 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 1.57 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.98 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 1.9 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 2.13 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 3.5 111.909 -171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.76 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.48 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 2.12 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.05 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 2.01 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.7 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 1.83 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 1.52 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 1.6 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 1.91 108.15 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.91 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.4 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 4.18 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 1.73 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 3.44 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 2.9 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.69 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 3.3 109.466 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 3.44 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 1.59 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 1.75 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 1.94 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 3.32 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 1.97 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 2.92 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 2.03 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.58 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.41 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -60.35 120.27 9.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 3.72 110.07 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 p -135.8 38.42 2.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.851 1.26 . . . . 4.85 108.749 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.4 t 70.42 46.65 0.56 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.891 0.876 . . . . 5.36 111.27 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.76 46.64 2.6 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.404 1.081 . . . . 5.18 108.52 169.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.33 27.34 4.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.265 1.426 . . . . 2.11 113.273 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 1.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 1.77 110.674 170.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 2.1 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 5.55 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 2.79 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 4.58 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 4.19 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 2.9 111.011 -169.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.82 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 5.09 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 3.19 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.8 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.77 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 1.8 107.755 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 1.56 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.86 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 1.62 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.57 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 3.45 109.28 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 3.05 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 3.78 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 2.28 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 2.58 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.78 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 1.89 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 1.8 108.971 164.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 1.9 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 2.21 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.83 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 3.42 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 3.32 107.342 -172.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.85 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' ASN . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 5.69 108.364 174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 1.49 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 2.29 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 2.95 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.87 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 1.83 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 4.6 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.22 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 1.71 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 2.68 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.63 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.96 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 2.28 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.85 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 3.4 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 6.93 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 2.65 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 3.32 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 2.7 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -81.78 67.04 7.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 4.11 108.669 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.59 -64.55 2.18 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.707 -0.957 . . . . 2.58 110.707 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 56.18 30.93 17.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.617 1.167 . . . . 5.51 111.087 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -163.34 -58.13 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.535 1.534 . . . . 6.3 108.593 -169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.3 t0 59.31 86.27 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.165 1.786 . . . . 9.55 111.587 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 t 67.85 21.22 9.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.564 1.146 . . . . 8.26 112.628 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.8 100.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 125.21 1.404 . . . . 10.01 107.347 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -142.02 109.76 5.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.359 -1.349 . . . . 13.48 107.359 173.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.92 -97.3 0.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.37 0.509 . . . . 13.86 112.092 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 CA-C-O 115.951 -1.976 . . . . 17.03 106.145 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttm . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 106.056 -1.831 . . . . 16.01 106.056 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.8 125.12 0.96 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.009 -1.478 . . . . 12.19 107.009 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t 59.99 -175.91 0.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 5.48 111.802 -174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -84.74 30.84 0.55 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.756 1.222 . . . . 4.19 111.509 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -73.44 -176.1 2.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.43 112.477 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 4.02 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.08 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.94 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 1.95 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 3.68 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 3.16 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 1.8 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 1.63 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.86 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 4.22 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.83 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.86 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 4.01 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 2.1 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 2.08 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 1.75 112.278 167.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 1.69 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.93 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 2.05 108.157 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.12 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 2.61 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 2.47 109.99 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 3.35 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 4.41 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 2.79 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.14 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 2.31 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 2.37 111.311 172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 2.35 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.31 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 1.54 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.38 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.98 108.731 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.35 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 5.01 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 2.69 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 2.21 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.92 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 2.29 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 1.63 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.67 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 1.93 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 2.38 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 3.23 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.23 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 2.32 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.87 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 1.59 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.75 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 2.22 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 1.78 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 1.67 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 1.77 107.609 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.45 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 3.1 108.155 -175.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 1.7 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.68 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 3.4 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 3.0 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.74 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 3.34 108.769 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 2.96 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 1.78 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 2.35 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 2.49 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.45 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 5.8 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.74 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.87 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 3.75 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 2.09 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.99 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.58 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.56 74.74 0.17 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 6.05 109.499 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.6 t -58.4 -9.16 1.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.701 2.0 . . . . 4.89 111.594 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.4 t 92.0 64.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.336 0 C-N-CA 126.373 1.869 . . . . 7.14 109.511 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.04 -82.5 0.23 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.249 -1.341 . . . . 4.33 107.381 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.55 25.82 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.477 0.311 . . . . 2.34 111.433 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 2.29 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 1.76 110.237 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.55 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 4.62 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 2.79 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 4.65 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 3.68 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 2.97 111.465 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.56 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 5.22 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 3.37 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.74 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.89 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 1.84 107.527 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 1.96 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 1.58 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.63 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 3.67 108.727 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.96 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 3.53 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.9 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 2.16 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 2.15 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 2.07 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.72 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 1.76 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.65 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 3.19 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 3.38 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.95 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 6.06 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.26 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 1.68 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 2.31 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 2.72 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 1.32 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.28 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 2.03 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 5.03 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.31 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 1.72 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 2.91 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.97 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 2.33 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 3.61 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 4.72 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 2.68 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 3.74 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 2.61 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -113.42 118.14 33.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 3.21 108.116 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.62 -44.06 3.03 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.901 -1.28 . . . . 3.27 109.901 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -61.77 -28.81 69.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.818 -0.813 . . . . 4.91 112.668 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -79.46 -13.59 59.47 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.4 0.519 . . . . 9.26 112.4 174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.95 48.23 1.62 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.358 0.981 . . . . 6.59 108.769 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.3 m 45.33 43.24 8.16 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.874 2.07 . . . . 9.46 114.135 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.7 mt -21.2 -69.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.71 2.004 . . . . 8.84 113.486 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -127.96 32.9 4.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.881 1.673 . . . . 12.42 108.767 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 63.67 -79.6 0.04 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.161 0.886 . . . . 12.77 111.445 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.155 1.782 . . . . 17.92 111.87 -170.37 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 106.826 -1.546 . . . . 14.81 106.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -173.4 166.78 4.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.142 1.377 . . . . 10.74 108.452 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t 68.65 156.01 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.424 1.89 . . . . 5.56 112.078 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.4 72.65 1.28 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.766 1.226 . . . . 4.1 109.795 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -67.35 137.98 56.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.92 108.415 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 4.0 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.81 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 3.11 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 1.77 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 2.67 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.58 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 1.73 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 1.69 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.77 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 3.45 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 2.64 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 6.11 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 4.47 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 2.78 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 1.66 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 1.9 110.732 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 2.49 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.84 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 1.82 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 3.49 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.78 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 2.56 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 2.74 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 3.28 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 2.68 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.35 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 2.31 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 2.42 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 1.7 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.78 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 1.89 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 2.06 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 1.89 110.081 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 2.39 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 3.02 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.96 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 2.15 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.07 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 1.66 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 1.7 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 3.17 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 1.87 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 2.13 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 3.31 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.09 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.49 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 2.31 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.15 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 1.68 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.69 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.72 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 1.68 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 1.75 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 1.85 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.26 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.65 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 4.76 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 1.71 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.44 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.88 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 3.19 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.92 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 3.2 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 3.18 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 1.68 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 1.72 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 1.84 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.51 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.96 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 1.8 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.05 110.88 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 3.53 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.22 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 2.17 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.13 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 33.7 mmt -92.03 -6.8 50.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 7.39 112.673 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -111.23 35.51 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 126.649 1.98 . . . . 5.82 108.428 -156.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.38 -40.58 5.1 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.897 1.279 . . . . 6.74 110.176 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.9 -69.7 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.974 0.91 . . . . 4.54 108.979 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.42 41.42 0.18 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.222 1.009 . . . . 2.47 108.631 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 2.46 108.445 -171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 1.74 110.397 170.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.98 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 6.32 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 3.05 111.387 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.85 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 4.96 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 4.0 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 2.43 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 6.67 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 2.58 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.62 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.69 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 1.73 107.97 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 1.64 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.86 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 1.72 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.62 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 2.76 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.99 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 3.66 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.84 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 2.05 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 1.71 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 1.72 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 1.8 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 1.82 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 3.05 111.003 -170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 121' ' ' LYS . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 3.34 107.058 -169.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 119' ' ' ASN . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 6.5 110.764 171.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.52 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 1.8 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.75 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 3.52 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 1.13 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.28 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 2.1 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 5.05 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.518 ' CD ' ' HZ2' ' A' ' 134' ' ' LYS . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.05 111.25 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 1.98 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 2.84 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.49 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.518 ' HZ2' ' CD ' ' A' ' 130' ' ' GLU . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 3.6 112.869 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 2.3 112.032 171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.86 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 3.18 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 5.65 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 2.65 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.87 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 2.48 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -81.31 76.9 8.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 3.65 107.938 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.13 -69.41 2.49 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.177 -1.169 . . . . 2.16 110.177 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 46.98 47.54 15.75 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.924 1.29 . . . . 4.62 110.304 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.07 -44.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.188 1.795 . . . . 7.61 108.835 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.9 37.05 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.967 1.307 . . . . 6.14 111.997 -164.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m 44.07 47.92 7.4 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.246 1.418 . . . . 8.83 111.46 -170.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.0 67.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.599 0.76 . . . . 10.47 112.448 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -157.43 169.14 25.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.464 -1.31 . . . . 15.17 107.464 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.52 20.42 46.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.912 -0.938 . . . . 17.68 112.85 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.334 -1.317 . . . . 20.44 108.309 177.116 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.6 mtt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.422 -0.584 . . . . 16.48 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.11 156.47 41.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.666 -1.235 . . . . 9.45 107.666 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p 176.74 144.26 0.08 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.731 -1.952 . . . . 5.61 105.731 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -145.91 48.54 1.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.499 1.142 . . . . 4.0 108.371 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -72.11 148.86 45.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 3.0 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.61 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 4.21 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 2.08 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.55 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 1.74 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 1.72 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 1.23 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 4.39 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.93 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 5.07 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.63 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 3.21 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.81 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 2.57 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 2.85 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 4.39 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 3.26 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.11 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.92 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.91 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 2.93 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 4.0 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 4.05 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.91 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 2.08 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.43 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 2.69 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 2.16 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.81 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 1.52 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.72 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 2.24 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.35 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 3.25 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.81 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 1.67 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.13 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 2.07 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 1.65 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 4.17 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 1.84 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 2.86 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 3.33 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.35 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.77 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 2.54 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 2.55 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.28 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 2.36 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 2.2 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 2.35 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 1.94 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.47 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.18 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.88 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 1.61 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 4.15 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 3.61 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.8 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 3.37 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 3.93 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 2.36 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 1.81 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.96 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.63 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 3.72 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 1.59 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 3.42 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.83 107.827 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 1.77 109.444 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.26 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.2 135.64 57.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 4.08 111.521 -177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.1 p -92.9 -47.01 7.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.351 1.06 . . . . 4.95 109.168 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 172.02 -44.62 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.275 1.43 . . . . 7.29 109.443 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -35.63 -74.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.197 1.799 . . . . 4.0 113.594 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.94 34.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.808 1.243 . . . . 2.83 110.159 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.97 107.896 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 1.72 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.29 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 6.47 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 2.77 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.77 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 4.4 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 3.22 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 5.63 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 2.62 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.58 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 1.07 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 1.87 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 1.75 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 1.18 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 1.98 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.96 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 2.76 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 2.11 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 3.56 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.97 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 2.73 110.659 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 1.94 111.545 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 1.62 108.314 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 2.34 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 1.92 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.47 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 3.19 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.93 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.9 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 8.91 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.89 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 1.93 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 3.21 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 2.63 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.93 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.22 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 2.08 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 4.74 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.11 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 1.63 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 2.72 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.47 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 4.71 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 2.1 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 3.36 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 4.77 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 2.59 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 4.02 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 4.68 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.33 51.68 1.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.93 110.667 -173.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.05 70.29 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.108 -0.995 . . . . 4.05 111.778 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.79 -30.17 69.53 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.933 0.893 . . . . 6.15 109.486 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.09 -65.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.406 1.082 . . . . 6.67 108.869 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -158.62 41.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.561 0.744 . . . . 7.31 110.691 -166.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.5 m 50.74 42.37 27.38 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.175 -0.953 . . . . 8.22 112.936 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.5 mt 56.92 61.42 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 13.71 109.358 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.56 146.14 54.84 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.665 -0.647 . . . . 14.24 109.486 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.97 70.52 0.03 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.488 -2.245 . . . . 18.39 107.488 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.15 -1.405 . . . . 24.18 110.471 -170.264 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 106.447 -1.686 . . . . 17.7 106.447 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 156.57 1.26 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 105.997 -1.853 . . . . 9.39 105.997 -174.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 p -175.3 178.65 1.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.329 1.852 . . . . 5.3 106.057 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.8 59.56 1.66 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.908 -0.775 . . . . 3.97 108.908 -176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.66 157.74 29.19 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.018 -0.537 . . . . 3.01 110.49 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.66 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.72 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 3.95 107.851 165.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 1.69 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 3.29 108.407 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 3.13 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 1.82 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.76 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.94 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 3.84 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 2.18 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.28 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 4.34 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 2.36 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 1.61 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 1.7 110.929 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 1.83 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 5.3 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 1.65 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.84 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 2.55 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.76 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 2.6 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 2.67 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 4.14 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 3.0 110.6 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 1.04 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 3.34 110.538 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.15 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 1.53 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 2.04 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 2.83 111.254 171.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.69 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 4.65 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 2.3 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 2.22 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.56 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 1.97 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 1.78 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 3.42 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 1.73 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 2.16 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 3.37 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.22 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 1.04 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 1.81 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.05 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 1.71 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.7 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 1.97 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 1.74 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 1.71 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 1.89 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.17 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 4.33 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 1.72 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 5.56 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 3.36 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.77 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 3.47 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 3.57 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 1.77 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 2.22 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 1.92 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 3.18 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 1.73 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 3.54 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.37 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 2.19 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 3.28 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.93 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.05 121.23 5.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 3.87 112.089 -175.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 t -163.1 24.5 0.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.607 0.718 . . . . 4.74 109.939 171.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -167.78 160.04 12.2 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.661 -1.274 . . . . 5.29 108.474 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 49.66 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.305 1.842 . . . . 4.46 111.825 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -176.37 46.18 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.309 1.044 . . . . 2.87 109.497 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 1.8 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 1.94 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.92 110.884 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 6.21 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 2.82 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.43 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 4.11 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 4.48 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 3.33 111.328 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.31 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 5.26 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 2.68 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.4 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.86 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 1.79 108.831 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 2.06 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.83 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 1.76 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.96 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 2.57 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 2.8 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 4.1 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 2.08 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 2.4 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.28 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 1.92 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 1.87 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 1.96 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 1.84 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 3.56 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 3.22 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.72 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 6.45 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 1.52 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 2.44 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 2.43 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.91 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 1.89 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.9 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.22 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 1.56 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 3.14 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.63 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 3.14 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 2.04 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.82 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 3.54 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 4.22 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 2.39 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 4.37 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 2.69 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -80.23 93.84 5.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 3.83 108.622 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.95 -46.92 3.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.436 -1.066 . . . . 2.45 110.436 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -37.65 -33.02 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.554 1.941 . . . . 4.38 114.223 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -135.88 8.44 3.26 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.474 1.287 . . . . 8.93 114.474 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.49 -8.83 14.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.917 0.887 . . . . 8.68 112.036 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.0 m -172.54 55.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.339 2.255 . . . . 6.09 108.965 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 pt -49.69 -37.11 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 113.876 1.065 . . . . 8.93 113.876 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 51.64 62.71 2.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.625 1.17 . . . . 12.03 111.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.59 122.01 6.84 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 107.017 -2.433 . . . . 11.77 107.017 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.057 -1.925 . . . . 15.6 106.571 177.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.835 -1.172 . . . . 13.38 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -146.39 -77.12 0.19 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 105.029 -2.211 . . . . 8.62 105.029 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 t -176.8 115.56 0.1 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.282 1.433 . . . . 5.94 107.449 165.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -148.59 36.43 0.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.651 -0.87 . . . . 4.85 108.651 169.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -64.43 141.14 58.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.28 109.424 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 2.73 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.57 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 3.75 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 1.72 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 2.62 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.18 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 1.84 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 2.05 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.94 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 3.67 112.049 -173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 2.36 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 4.11 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 3.32 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 3.03 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.66 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 2.31 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 2.43 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.93 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 2.06 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.86 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.65 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 2.54 110.558 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 3.27 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 4.0 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 2.31 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.33 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.84 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 2.39 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 2.01 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 1.81 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.69 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 2.42 113.2 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 2.09 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 2.35 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.79 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 2.29 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.84 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 1.79 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 1.63 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.7 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 1.62 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 2.04 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 3.14 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.87 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 1.07 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.75 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 2.0 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.78 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 1.56 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 1.8 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 1.86 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 1.75 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.65 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.05 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 3.2 109.233 -175.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 1.8 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 3.21 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 2.98 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.83 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 3.36 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 3.27 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 1.66 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 1.93 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 2.09 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.64 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 3.69 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 1.62 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.92 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 3.88 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.41 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 1.88 110.17 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.23 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.95 113.17 2.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 3.8 112.202 -171.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.3 p -84.09 -21.86 31.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.95 0.9 . . . . 5.06 111.248 173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.85 176.94 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.686 -1.227 . . . . 5.98 107.686 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.47 47.23 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.759 1.224 . . . . 7.43 113.466 -171.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -121.94 -49.92 2.07 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.325 1.45 . . . . 3.31 109.426 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 2.18 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 2.24 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.88 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 5.0 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 2.91 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.41 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 4.27 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 3.82 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 2.53 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.93 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 6.03 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 3.54 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.93 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.71 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 1.84 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 1.59 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 1.62 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.7 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 2.9 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.9 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 4.56 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 2.54 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 3.61 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.69 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 1.96 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 1.72 107.922 167.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 1.81 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 1.68 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.83 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 3.39 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 3.05 108.554 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.72 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 6.15 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 1.48 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.99 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 2.44 113.831 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 1.13 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 1.82 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 4.11 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.64 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 1.75 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 2.89 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.58 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 3.7 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 1.9 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.6 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 3.16 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 4.35 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 2.66 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 3.62 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 2.42 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.32 99.82 10.24 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 6.73 109.042 162.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.99 -49.52 4.24 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 118.374 -1.237 . . . . 2.41 111.417 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -28.48 -62.32 0.11 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.74 . . . . 5.33 112.391 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.38 -10.75 14.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.995 1.318 . . . . 8.82 112.364 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.97 -20.18 59.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 122.074 0.94 . . . . 8.59 111.597 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.7 m -152.33 35.62 0.52 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.628 1.571 . . . . 6.41 111.005 173.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 mt 48.61 66.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.89 1.276 . . . . 9.87 110.86 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 156.67 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.981 -1.118 . . . . 10.65 107.981 168.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.48 -76.45 0.22 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 114.767 0.667 . . . . 13.17 114.767 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 116.287 -1.816 . . . . 15.46 106.406 -156.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.147 -1.427 . . . . 19.92 107.147 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.35 167.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.571 1.149 . . . . 13.57 111.032 -154.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -76.68 77.08 3.33 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.872 1.669 . . . . 6.9 110.033 -173.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.21 103.49 3.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.205 -1.776 . . . . 6.27 106.205 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -57.1 115.36 2.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.936 0.894 . . . . 2.43 109.316 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 3.15 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.92 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 3.67 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 1.6 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 3.52 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.89 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 2.37 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 2.18 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.34 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 3.95 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 2.89 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.05 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 4.8 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 2.61 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 2.62 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 2.36 110.109 168.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 2.47 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 3.32 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 2.02 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.68 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 3.42 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.9 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 2.75 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 3.11 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 3.6 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 3.17 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.99 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 2.43 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 1.61 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.67 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 1.82 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.06 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 2.77 111.873 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 3.16 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 2.67 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 2.62 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.36 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 2.2 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 1.82 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.62 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 1.67 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 1.91 108.117 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 3.02 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.43 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.29 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 2.15 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.3 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 1.71 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.87 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 2.34 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 1.77 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 1.76 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 1.46 107.57 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.91 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 3.2 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 1.79 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.34 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.85 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 3.47 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.89 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 5.3 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 2.98 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 1.75 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 2.1 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 1.87 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.73 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.86 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 1.72 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.86 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 3.61 109.745 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.66 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 1.87 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.61 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.62 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm -60.35 178.89 0.17 Allowed 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 4.44 114.042 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.255 4.1 t 53.45 39.14 29.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.645 -1.616 . . . . 6.44 109.841 -174.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -147.72 -61.8 0.27 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 114.816 -1.084 . . . . 7.65 109.395 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.24 49.1 2.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.006 0.922 . . . . 6.48 110.207 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 49.83 36.71 11.79 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.616 1.166 . . . . 2.3 112.124 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 137' ' ' TYR . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 2.52 110.815 -165.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 1.74 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 3.12 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 6.21 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 2.77 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 3.41 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 4.75 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 2.93 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.8 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 5.62 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 2.44 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.78 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 2.0 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 1.54 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.81 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 1.57 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.61 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 3.01 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 2.0 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 3.54 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.97 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 2.04 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.68 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 1.78 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 1.98 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 2.03 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 1.72 104.877 166.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.85 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 3.5 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.93 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 8.46 109.315 171.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 121' ' ' LYS . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.81 109.243 -172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 1.56 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.65 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 3.41 113.915 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 1.7 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 2.68 111.447 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 3.5 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.16 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 2.11 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 3.06 111.85 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 3.83 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 1.95 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 88' ' ' CYS . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 3.71 108.331 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.67 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 3.64 106.624 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 4.16 108.071 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 3.8 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -76.3 99.6 4.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 4.51 106.92 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.65 -40.94 3.07 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.041 -0.981 . . . . 3.6 111.511 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.37 57.47 0.7 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.159 0.984 . . . . 5.33 110.384 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -178.71 -55.75 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 128.587 2.755 . . . . 12.17 104.887 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 35.15 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.374 1.07 . . . . 11.97 111.133 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.93 25.97 7.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.036 1.734 . . . . 11.38 113.647 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -83.05 74.11 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.915 -1.116 . . . . 11.53 109.106 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -145.43 154.52 42.34 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 105.981 -1.859 . . . . 12.04 105.981 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.18 -178.0 47.0 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.9 -1.28 . . . . 12.52 109.9 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 126.201 1.8 . . . . 14.95 110.36 -169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.141 -0.457 . . . . 13.59 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.4 mt 70.5 -61.32 0.47 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.672 1.589 . . . . 11.58 111.9 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m -74.13 48.25 0.31 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.892 1.277 . . . . 4.89 112.725 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.82 73.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.427 1.891 . . . . 4.67 107.332 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -57.7 129.83 43.66 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.038 -0.983 . . . . 2.32 108.735 172.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 5.55 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 3.52 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 3.19 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 2.02 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.94 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 2.08 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 1.92 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 1.46 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.66 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 3.57 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 2.71 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.47 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 3.15 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 2.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 1.72 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 2.08 109.028 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 2.29 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 3.08 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 1.53 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 3.74 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.1 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 2.68 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 2.69 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 3.5 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 2.99 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.98 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 2.4 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 1.84 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.68 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 1.41 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.03 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 2.13 107.981 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.78 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 2.72 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.95 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 2.08 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 2.18 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 1.44 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 3.32 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 1.71 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 2.63 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 3.76 111.909 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.24 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.99 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.97 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.03 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 2.06 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.92 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 2.04 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.98 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 2.05 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 1.99 108.406 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.07 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.92 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 4.79 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 1.78 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.58 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 4.12 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 3.37 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.67 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 3.46 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 3.18 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 1.67 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.95 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 2.4 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.3 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 3.5 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 1.55 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.89 111.717 172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 3.83 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.57 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 1.83 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.63 104.648 168.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.95 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -46.17 152.14 0.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.82 112.512 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.261 14.9 t 62.57 32.26 16.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.508 1.923 . . . . 5.78 112.638 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.6 t -116.51 -47.55 2.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.913 0.885 . . . . 8.83 110.635 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.9 65.72 0.08 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.868 0.867 . . . . 6.09 110.665 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.3 34.63 9.17 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 2.28 112.095 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.433 ' SG ' ' CE1' ' A' ' 137' ' ' TYR . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 2.63 110.143 -162.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 2.38 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.19 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 6.05 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 2.98 110.623 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 3.74 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 4.22 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 3.29 111.151 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.71 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 6.82 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 3.38 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.69 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 1.48 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 1.95 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 2.26 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.98 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 2.08 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.19 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 3.45 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.45 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 4.38 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 2.56 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 3.0 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 1.97 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 1.7 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 2.2 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 1.75 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.33 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 3.75 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 3.29 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.14 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 6.49 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.72 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 2.12 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 3.01 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 2.39 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 1.24 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 2.18 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.95 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.74 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 2.05 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 2.83 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 4.89 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 2.13 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.99 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' SG ' ' A' ' 88' ' ' CYS . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 3.11 108.126 172.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 5.31 107.616 172.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 3.87 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 4.58 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 2.99 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -80.77 96.02 6.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 3.52 107.199 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.92 3.62 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.432 -1.067 . . . . 2.64 110.432 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 46.57 54.19 9.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.609 1.164 . . . . 5.57 110.638 -173.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -174.83 -45.73 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.677 1.191 . . . . 6.78 109.269 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -114.55 -6.94 12.82 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.626 0.77 . . . . 6.84 112.097 -170.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 p -123.36 4.38 9.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.536 1.934 . . . . 7.69 112.157 -170.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.69 77.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.854 0.835 . . . . 8.72 110.608 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.76 94.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.791 1.236 . . . . 14.11 110.044 165.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 169.48 -50.82 0.21 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.538 -0.839 . . . . 14.12 114.736 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.064 -1.445 . . . . 16.97 110.481 -161.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.59 1.33 . . . . 13.65 114.59 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.29 111.12 2.13 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.914 1.234 . . . . 9.55 107.921 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 62.95 74.73 0.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.784 0.834 . . . . 4.52 111.454 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -72.27 56.34 0.34 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.393 1.077 . . . . 4.31 110.193 171.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -69.21 157.29 37.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.21 108.078 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 3.2 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.96 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.89 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 1.67 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 3.12 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.68 109.244 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 1.97 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 1.37 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.99 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 3.81 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 2.18 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.63 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 4.03 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 2.67 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 1.8 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 1.89 110.475 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 2.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 4.85 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 2.06 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.03 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 2.44 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.73 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 2.78 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 3.1 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 3.4 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 2.74 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.88 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 2.36 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 1.78 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 1.55 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.98 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 2.65 111.915 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 2.37 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 4.14 111.565 167.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 2.54 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 2.37 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 1.9 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 2.16 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 3.48 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 1.77 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 2.4 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 3.0 111.078 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.3 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.96 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.86 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.81 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 1.75 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.72 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 1.85 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 2.1 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 2.01 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 1.81 107.726 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 3.22 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 1.83 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.86 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 3.67 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 3.14 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.26 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 3.48 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 3.23 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 1.73 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 2.3 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 1.94 108.671 -166.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.17 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 5.52 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 1.93 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.78 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 3.02 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.57 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 1.99 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.84 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.415 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -100.93 -24.19 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 4.18 111.708 167.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.3 m -79.87 71.12 6.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.079 1.352 . . . . 5.76 109.889 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.6 t -143.73 84.0 1.78 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.334 -0.987 . . . . 6.66 108.334 166.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.57 -67.46 0.16 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.783 1.633 . . . . 4.3 110.899 -166.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 41.47 0.11 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.525 0.33 . . . . 2.84 110.759 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 2.76 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' CB ' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 1.66 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.97 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 4.54 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 3.95 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.64 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 3.81 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 6.49 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 3.21 111.68 -175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 6.59 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 4.49 108.149 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.58 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.72 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 1.84 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 1.64 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.74 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 1.84 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.75 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 3.72 108.99 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 2.28 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 3.77 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 2.65 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 2.27 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.38 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 2.08 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 1.85 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 1.86 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 1.7 106.337 169.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 3.43 112.017 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 3.21 109.203 -170.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.61 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 8.44 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.59 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 1.72 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.73 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 3.09 113.644 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 1.38 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.22 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 2.93 110.494 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 4.02 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.89 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 1.79 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 2.59 112.035 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.06 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 3.52 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 1.99 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 3.22 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 5.69 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 3.11 108.731 -175.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 3.21 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 2.58 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -78.33 79.47 4.77 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 3.73 108.647 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 -60.81 3.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.412 1.006 . . . . 2.47 110.909 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 51.13 38.43 20.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.333 1.453 . . . . 4.13 111.8 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -156.84 -55.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.546 1.939 . . . . 6.99 107.693 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -128.36 1.33 5.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.174 0.99 . . . . 7.09 111.325 -161.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -132.32 23.61 4.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.696 1.198 . . . . 7.93 108.875 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.0 mt -70.29 76.04 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.362 -0.607 . . . . 8.19 109.362 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -51.01 99.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.83 1.252 . . . . 15.04 110.941 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.24 -34.62 1.62 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.715 -1.047 . . . . 14.61 114.56 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-N 118.649 1.224 . . . . 15.79 109.944 -162.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.518 -0.919 . . . . 15.34 108.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.15 167.83 20.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.196 0.998 . . . . 8.91 108.833 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -169.77 162.14 9.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.162 -1.792 . . . . 4.14 106.162 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -144.34 60.67 1.35 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.186 -1.042 . . . . 5.1 108.186 170.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -63.46 153.24 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.782 -0.644 . . . . 2.3 109.635 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 3.19 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.49 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 3.55 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 1.64 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 2.69 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 3.28 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 2.0 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 2.77 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.06 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 4.22 110.691 -177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 2.5 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.26 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 4.74 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 2.5 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 1.7 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 1.77 111.478 171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 2.03 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.97 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 1.55 108.447 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 2.81 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.7 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 2.55 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 3.25 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 5.8 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 2.52 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.32 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 1.13 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 2.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 2.09 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.92 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 2.08 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 2.31 109.623 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 3.1 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 4.29 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 2.7 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 2.3 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.01 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.94 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 1.84 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.39 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 1.83 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 2.42 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 3.88 112.126 -170.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.15 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 2.44 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.94 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 2.13 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.89 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 2.31 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 1.85 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 1.99 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 1.88 107.344 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.16 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.01 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 3.17 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 3.33 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 3.41 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 2.99 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.63 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 3.31 108.929 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 3.71 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 1.66 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 2.27 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 1.87 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 5.7 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 1.81 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 3.32 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 1.78 111.123 -165.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.41 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.09 125.3 21.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 3.49 110.11 172.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -124.63 -4.94 7.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.027 1.331 . . . . 4.43 109.952 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.92 161.53 42.5 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.34 -1.355 . . . . 5.81 107.34 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.1 69.72 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.738 1.215 . . . . 7.8 110.768 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 -57.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.528 1.131 . . . . 2.56 109.778 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.64 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 2.17 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 2.02 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 4.59 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 4.02 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.36 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 4.56 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 4.45 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 2.63 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 5.48 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.08 107.557 159.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.89 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 1.01 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 1.96 108.832 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 1.8 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 1.03 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 1.83 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.59 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 2.81 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 2.25 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 4.17 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 2.16 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 2.39 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.74 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 1.93 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 1.55 107.24 167.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 1.82 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 2.07 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.53 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 3.51 112.318 -165.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 3.12 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 7.78 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.26 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 1.92 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.63 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 3.45 112.854 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 1.06 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.09 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 2.2 109.669 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 4.48 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.89 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 1.87 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 2.56 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.61 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 4.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 1.66 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.73 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 3.67 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 5.47 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 2.34 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 3.82 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 2.4 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -79.38 84.95 5.23 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 3.7 107.793 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.73 -68.92 3.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.984 -1.246 . . . . 2.22 109.984 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 43.99 56.56 4.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.382 1.073 . . . . 3.74 111.254 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -178.6 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.356 1.862 . . . . 6.34 108.162 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.98 -11.19 14.67 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.243 0.617 . . . . 7.12 112.571 -165.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 p -102.18 -14.6 16.97 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.0 1.72 . . . . 7.5 113.007 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.1 mm -81.63 57.94 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.948 0.899 . . . . 9.3 110.13 -168.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -152.78 -75.23 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.199 1.8 . . . . 12.27 108.584 170.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.4 75.57 1.21 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 107.877 -2.089 . . . . 15.08 107.877 -161.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.156 0 CA-C-O 116.996 -1.478 . . . . 20.26 110.173 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 105.52 -2.029 . . . . 14.1 105.52 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 92.33 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.381 0.992 . . . . 11.36 111.147 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -168.88 54.04 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.648 0.779 . . . . 5.06 110.118 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -121.87 50.43 1.44 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.613 0.72 . . . . 4.97 109.239 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -66.93 141.32 57.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.777 -0.577 . . . . 2.47 110.113 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 3.2 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.96 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 1.83 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.91 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 2.2 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 1.66 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 1.55 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.69 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 3.45 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 2.02 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.91 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 5.0 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 2.61 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 1.91 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 1.91 110.629 171.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 1.81 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 3.07 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 1.82 107.723 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.59 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 2.44 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.88 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 2.43 110.291 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 3.12 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 3.64 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 2.75 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.94 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 2.6 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 1.96 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 1.89 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.62 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 1.92 108.914 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.79 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 2.99 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 2.67 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 2.38 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.11 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 2.06 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 1.93 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 3.67 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 1.57 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 2.4 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 3.2 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.33 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.92 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.99 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 1.62 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.75 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 1.7 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 2.07 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 1.95 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 1.66 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.19 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.47 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.97 109.047 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 1.73 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.55 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 5.02 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 3.1 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.65 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 3.34 108.235 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 3.73 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 1.92 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.85 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 2.11 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.65 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 3.43 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 1.86 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.31 108.816 -173.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 3.72 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.87 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 1.72 110.295 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.8 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 2.27 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.66 81.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 5.68 111.271 172.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -156.94 30.79 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.143 0.977 . . . . 4.9 110.021 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 t -160.98 168.47 24.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 7.51 107.821 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -5.72 -69.8 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 129.278 3.031 . . . . 4.56 115.339 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.32 48.49 0.37 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 3.21 109.447 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 1.8 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 2.19 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.77 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 5.24 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 4.29 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.03 107.241 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 4.82 111.908 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 4.12 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 2.55 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.59 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.9 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 2.76 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.66 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.82 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 1.79 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 1.67 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.18 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 1.79 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 1.01 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 3.23 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.09 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 5.22 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 2.2 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 3.3 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.65 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 2.12 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 1.7 108.347 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 2.33 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 1.75 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.9 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 3.09 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.85 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.7 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 6.35 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.03 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 1.45 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 3.23 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 2.9 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 1.25 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.61 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 1.95 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.88 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.24 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 1.74 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 3.04 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 3.45 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 2.14 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.83 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 3.41 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 3.84 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 2.78 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 5.68 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 2.94 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -77.27 86.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 4.1 108.185 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.87 -48.77 4.11 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 118.939 -0.923 . . . . 2.73 112.11 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 49.19 21.4 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.173 1.789 . . . . 7.24 114.059 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -148.14 -54.88 0.21 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.48 1.512 . . . . 7.09 108.687 -172.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.31 22.45 0.84 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.497 0.719 . . . . 8.14 110.461 -165.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.64 16.3 2.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.642 -0.661 . . . . 6.96 111.335 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.9 -62.4 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.439 0.296 . . . . 9.21 110.758 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.6 -178.9 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.684 -1.598 . . . . 12.95 106.684 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -76.92 -104.79 0.15 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.957 1.265 . . . . 11.87 113.597 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.304 -1.808 . . . . 15.58 108.91 -169.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 118.463 -0.779 . . . . 15.23 109.834 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp 59.7 54.65 4.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.0 -1.111 . . . . 13.25 108.0 -160.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m 65.52 174.19 0.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.745 1.618 . . . . 5.26 110.803 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.74 55.47 1.07 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.666 0.786 . . . . 6.25 109.966 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -103.73 165.14 11.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.01 106.215 164.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.89 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.07 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.98 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 1.85 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 2.76 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 2.46 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 1.69 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 2.07 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.79 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.95 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 2.03 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.68 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 3.42 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 2.14 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.8 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 2.04 111.067 169.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 1.7 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.74 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 1.89 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.65 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.92 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.73 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 4.05 111.479 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 4.62 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 4.1 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 2.53 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.4 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.86 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 2.41 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 1.93 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.64 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 1.39 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 2.32 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 2.03 109.692 168.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.28 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 3.21 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 2.16 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 2.06 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.81 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 1.74 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 1.78 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 3.14 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 1.66 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 2.57 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 3.45 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.41 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.27 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.91 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 2.03 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.81 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 2.23 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 2.04 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 2.11 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 2.17 107.067 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.62 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.95 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 1.8 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.81 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 3.34 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.7 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 3.13 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 3.2 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 1.56 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 1.82 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 2.07 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.33 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 4.81 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 1.77 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.33 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 3.46 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 1.86 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.49 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.58 121.39 11.47 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 4.26 111.825 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.9 p -135.69 10.11 3.39 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.996 0.918 . . . . 4.79 111.2 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.85 -107.26 0.32 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.123 -1.066 . . . . 5.06 108.123 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -166.0 43.6 0.07 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.835 0.854 . . . . 6.01 108.776 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.5 -48.48 0.13 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.069 0.548 . . . . 3.37 111.662 -169.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 2.24 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 1.81 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.54 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 6.27 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.86 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.07 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 5.25 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 4.66 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 2.71 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.57 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 6.39 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 2.74 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.03 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.72 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 1.64 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 1.65 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.86 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 1.63 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.8 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 2.57 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.24 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 4.37 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.71 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 2.57 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.94 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 1.86 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 1.63 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 1.88 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 1.89 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.84 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 3.09 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 3.48 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.75 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 6.31 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.69 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 1.51 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.63 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 2.39 110.841 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.86 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.14 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 2.3 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.93 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.64 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 1.81 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 2.66 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 3.41 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 2.09 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 4.05 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 4.19 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 2.48 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 3.5 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 2.45 107.793 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -80.84 94.98 6.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 4.03 108.901 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.53 -46.16 3.61 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.21 -1.156 . . . . 1.99 110.21 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -44.31 -28.04 0.49 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.892 1.677 . . . . 4.48 114.012 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -140.06 19.18 2.45 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.241 -0.912 . . . . 8.83 112.94 163.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.61 1.33 10.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.55 1.14 . . . . 10.22 111.537 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 t -164.51 34.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.793 0.837 . . . . 6.57 111.465 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.6 mm -75.97 -67.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.484 0.584 . . . . 8.85 110.593 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.31 176.87 5.9 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.604 -0.887 . . . . 16.24 108.604 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.83 6.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.588 1.09 . . . . 16.0 110.381 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 116.204 -1.855 . . . . 21.92 111.31 176.228 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.482 -1.303 . . . . 16.05 107.482 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 174.12 3.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.829 0.452 . . . . 9.36 110.053 166.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.4 t -156.95 138.46 13.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.675 -1.972 . . . . 4.91 105.675 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -121.46 59.39 0.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.036 1.334 . . . . 5.49 108.369 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.09 141.94 38.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.07 1.348 . . . . 3.51 109.925 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 3.53 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.9 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 3.92 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 1.65 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 2.52 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 3.01 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 1.71 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 1.98 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 3.56 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 3.21 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 5.0 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 4.07 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 2.04 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 2.03 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 1.93 111.158 176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 2.0 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 3.22 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 2.58 108.556 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 3.07 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 1.1 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 2.65 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 3.7 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 5.51 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 2.27 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.4 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 1.07 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 3.69 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.5 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.45 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.8 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.62 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 2.34 112.312 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.91 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 3.34 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 2.11 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 2.56 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.94 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.78 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 1.69 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.82 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 1.79 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 2.22 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 3.38 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.84 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 1.75 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.89 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 1.66 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 1.77 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 1.84 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 1.92 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.12 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.83 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 4.83 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 1.83 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.44 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.78 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 3.66 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.79 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 3.3 109.318 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 3.51 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 1.86 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 2.17 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 1.99 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 3.26 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 1.85 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.05 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 2.89 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.3 108.194 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 1.96 109.971 -168.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.31 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.63 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm 30.24 51.71 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 4.16 113.696 -168.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.9 t -143.58 53.03 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.37 1.081 . . . . 4.23 108.28 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.5 t -148.77 163.83 36.19 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.575 -1.639 . . . . 8.82 106.575 169.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -9.06 -63.73 0.0 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.956 2.902 . . . . 5.77 114.561 -172.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.54 72.6 0.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.85 108.807 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 2.54 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 2.16 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.29 109.064 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 5.8 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 2.76 111.651 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.99 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 5.34 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 2.68 110.705 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.46 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 5.34 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 2.41 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.61 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.71 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 1.66 107.638 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 1.66 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.98 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 1.6 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.55 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 3.48 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.93 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 3.98 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.33 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 2.92 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.31 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 2.4 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 1.69 107.131 161.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 1.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 2.0 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.88 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 3.37 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 3.07 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.7 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 6.09 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.8 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 1.81 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.57 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 2.5 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 1.25 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 2.08 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 3.87 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 1.98 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 2.93 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 5.44 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 2.47 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.67 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 3.71 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 4.0 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 2.61 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 3.34 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.81 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.09 70.26 8.97 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 5.74 108.679 176.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.81 2.75 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.878 -1.512 . . . . 2.51 112.034 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 38.35 52.44 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.381 1.472 . . . . 4.33 111.539 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 69.49 -15.03 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.666 1.987 . . . . 10.9 114.852 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.4 -32.9 20.66 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.796 1.238 . . . . 9.59 111.19 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -137.37 34.6 2.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.54 -1.209 . . . . 7.16 111.956 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.9 pt -75.9 54.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.262 -0.899 . . . . 8.75 112.894 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -154.83 -172.78 4.32 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.52 -0.737 . . . . 13.17 109.553 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.53 73.63 0.22 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.41 -1.476 . . . . 15.66 109.41 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.17 -1.395 . . . . 19.23 108.917 174.787 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 105.475 -2.046 . . . . 19.84 105.475 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -158.41 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.689 -1.597 . . . . 12.41 106.689 175.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 p -64.08 -174.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.466 0.706 . . . . 6.35 110.448 167.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 86.79 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 129.017 2.927 . . . . 6.91 108.536 -175.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -58.26 119.56 7.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.3 109.227 -177.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 3.03 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.18 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 3.06 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 1.61 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 3.24 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 2.21 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 2.23 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 1.62 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.32 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 3.55 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 2.15 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.69 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 4.18 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 3.0 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.9 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 1.97 109.961 173.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 2.02 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.96 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 2.08 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.56 110.706 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.95 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 1.08 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 2.95 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.89 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 5.6 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 2.68 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.33 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.86 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 2.5 109.973 176.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 2.22 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.85 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 1.61 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 2.03 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 2.38 110.215 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.71 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 2.77 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.91 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 2.33 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.55 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 2.45 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 1.74 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 3.5 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 1.97 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 2.3 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 3.41 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 1.07 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.99 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.68 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 1.06 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.88 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 1.81 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 2.01 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 2.04 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.93 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 3.84 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 1.85 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.88 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 5.83 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 3.63 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.07 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 4.41 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 3.53 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 2.09 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 2.07 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 2.08 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.57 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 3.6 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 1.64 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 3.56 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.63 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 1.95 107.647 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.14 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 3.05 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 6.9 ptt? -93.71 -30.07 15.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.85 112.441 -176.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.3 p -81.1 56.46 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.279 -0.888 . . . . 6.62 109.55 -175.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 38.5 t -113.64 -48.93 2.91 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.746 0.818 . . . . 7.98 109.623 -178.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.51 65.2 0.61 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.516 -0.92 . . . . 4.92 108.516 171.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.12 42.46 31.56 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.397 0.679 . . . . 2.9 110.685 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 1.96 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 2.02 109.683 173.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 6.15 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 2.91 110.719 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 4.66 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 5.3 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 3.23 111.942 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.41 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 4.67 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 2.4 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.43 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.68 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 1.72 108.008 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 1.82 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.82 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 1.78 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.85 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 3.85 110.968 -177.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.16 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 3.83 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 2.05 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 2.44 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 2.3 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 1.7 107.873 168.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 2.08 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 1.78 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 3.44 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.88 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.59 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 6.52 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 1.41 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.59 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 2.86 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 1.58 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 1.92 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 4.61 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 1.62 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 2.59 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.31 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 4.14 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 1.86 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.69 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 3.43 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 4.44 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 2.47 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 3.26 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 4.91 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 79.78 9.2 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 6.0 108.826 170.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.71 -46.14 2.27 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.562 1.077 . . . . 2.35 112.591 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 60.6 34.93 20.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.564 1.545 . . . . 4.75 111.769 -175.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -161.53 -65.21 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.187 -1.783 . . . . 8.91 106.187 172.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -160.46 38.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.281 -0.872 . . . . 10.25 109.698 -162.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.0 t 52.81 35.91 20.03 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.502 -0.749 . . . . 7.56 111.879 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.54 -59.79 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.363 0.665 . . . . 9.27 110.246 -170.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 52.67 56.41 7.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.688 1.195 . . . . 14.81 111.573 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 125.55 116.75 2.14 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.717 -0.953 . . . . 14.3 110.717 177.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.059 1.343 . . . . 16.36 110.689 -174.455 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.647 -0.501 . . . . 16.16 109.647 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.98 110.66 4.28 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.454 -1.313 . . . . 9.79 107.454 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -170.55 165.6 8.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.98 2.112 . . . . 4.86 106.248 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -109.31 36.22 3.0 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.171 0.988 . . . . 4.73 109.556 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -62.46 154.58 28.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.893 0.877 . . . . 2.98 109.505 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.93 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.7 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 4.29 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 2.34 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 6.1 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.75 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 2.03 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 2.09 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.11 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 4.7 110.667 176.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 3.25 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 3.43 109.523 174.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 4.56 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 3.38 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 2.36 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 2.25 109.925 168.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 2.45 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 3.86 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 1.76 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.64 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 3.68 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.21 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 2.53 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 2.54 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.78 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 2.77 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.51 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 1.21 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 2.67 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 1.82 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 1.73 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.18 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 2.18 109.65 175.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.82 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 2.76 111.652 174.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 2.06 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 2.34 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.99 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 2.05 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 1.71 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.99 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 3.01 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 3.41 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.81 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.49 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 2.84 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.43 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 1.69 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.8 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 2.42 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 2.4 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 2.24 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 2.61 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.54 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 4.92 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 1.82 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.12 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 3.3 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 4.33 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.92 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 3.61 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 3.64 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 2.22 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 2.11 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 3.01 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.49 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 3.59 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 1.92 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.22 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 3.13 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 1.64 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.12 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -173.4 1.19 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 4.53 111.297 170.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 83.64 -8.73 1.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.196 1.799 . . . . 7.8 110.541 -173.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.91 -40.96 12.06 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 121.835 -0.541 . . . . 5.94 110.527 -173.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.87 -99.16 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.936 0.894 . . . . 3.94 108.937 172.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.98 31.89 2.69 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.037 0.935 . . . . 3.31 110.12 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.94 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 2.18 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.98 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 5.4 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 2.95 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 4.61 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.9 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 3.14 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.75 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 5.42 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 2.83 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.82 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.69 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 2.08 112.828 -170.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 2.77 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 2.01 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.31 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 3.15 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.17 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 3.95 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 2.46 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 3.05 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.91 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 1.89 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 1.71 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 2.44 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 1.82 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.28 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 3.69 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 3.39 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 9.01 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.36 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.74 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 3.14 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 3.44 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 1.08 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.91 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 2.02 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 4.76 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.72 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 1.74 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 2.69 110.223 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.57 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 4.21 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 2.07 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.31 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 3.32 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 4.38 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 2.48 110.404 173.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 3.3 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 4.36 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' NZ ' ' OE2' ' A' ' 149' ' ' GLU . 3.0 mmmp? -79.16 78.06 5.64 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 4.07 108.073 176.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.32 -49.53 3.59 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.691 -1.061 . . . . 2.05 112.992 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 38.19 47.76 1.03 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.079 1.752 . . . . 4.12 111.214 -174.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 70.71 -14.98 0.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.17 1.388 . . . . 9.63 113.97 177.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.52 -43.27 19.01 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.159 1.784 . . . . 8.69 108.963 -175.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.6 m -122.25 58.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 112.805 -1.998 . . . . 8.32 109.021 169.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.3 mt 20.26 72.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.986 2.514 . . . . 10.53 112.862 160.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.419 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 8.1 tp10 41.73 51.2 4.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 13.5 112.712 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.63 -9.54 76.8 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.695 -1.058 . . . . 16.2 113.62 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.53 1.165 . . . . 21.04 108.728 173.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.714 -0.184 . . . . 15.31 111.48 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp 66.36 -57.22 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 11.98 112.803 -174.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -152.85 60.08 0.79 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.8 1.24 . . . . 7.83 108.153 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -161.43 36.15 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.976 0.91 . . . . 8.12 108.717 -164.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 61.88 148.4 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 3.47 116.764 -174.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 3.31 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.26 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 2.78 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 1.79 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 3.23 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.66 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 1.94 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 2.1 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.87 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 4.53 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 2.23 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.5 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 3.58 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 2.68 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 1.71 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 2.07 110.089 178.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 1.99 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.87 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 2.12 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.17 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 2.81 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.69 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 2.61 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 3.22 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 4.82 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 3.7 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.16 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.89 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 2.33 110.079 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 1.97 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.18 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 1.33 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.41 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 1.87 111.952 -173.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.74 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 2.61 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 1.61 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 1.87 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.03 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 2.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 1.9 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 4.5 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 1.68 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 2.17 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 3.59 109.604 -178.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.3 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.92 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.92 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.83 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 1.66 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.71 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 1.79 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 1.71 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 2.01 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 1.68 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.14 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.63 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 3.3 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 1.65 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.85 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 3.28 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 3.74 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.7 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 3.42 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 3.27 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 1.7 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 2.1 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 2.16 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 3.3 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 1.79 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 2.87 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.88 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 1.81 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.02 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 ttp -64.1 -175.82 0.17 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 4.25 111.21 173.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t 50.14 32.46 5.97 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.074 1.75 . . . . 6.31 110.984 -168.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.4 t -110.08 -48.73 3.15 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.677 -0.49 . . . . 7.71 109.677 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.81 -76.88 0.18 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.225 -0.657 . . . . 4.34 109.225 166.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.64 40.75 0.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.469 -0.937 . . . . 2.42 108.469 -175.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.64 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 2.07 109.612 168.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 5.2 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 2.83 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 3.24 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 4.27 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 3.01 112.109 -176.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 2.0 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 7.14 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 2.66 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.96 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 1.73 107.886 175.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 1.78 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 1.76 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.95 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 2.89 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 3.67 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 2.02 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 2.68 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.49 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 2.07 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 1.83 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 2.32 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 1.69 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.87 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 3.03 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 3.45 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 1.12 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 8.19 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.62 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 1.92 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.71 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 2.93 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 1.13 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.22 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 1.81 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.97 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 1.64 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 2.67 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.56 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 5.06 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 1.73 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.73 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 3.5 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.86 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 2.37 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 3.46 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 2.54 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -81.96 71.72 9.0 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.86 108.567 172.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.39 -64.73 3.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.604 -0.999 . . . . 2.59 110.604 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 51.37 34.45 11.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.72 1.208 . . . . 5.49 112.154 173.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -179.35 -49.36 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.996 1.318 . . . . 6.65 108.565 -176.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 80.29 -49.62 0.34 Allowed 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 126.594 1.958 . . . . 8.66 110.947 178.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.9 p -95.89 69.01 2.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.861 1.265 . . . . 9.5 109.825 165.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.89 -70.05 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.885 -0.413 . . . . 9.56 109.885 170.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -166.48 165.38 16.98 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.162 -2.162 . . . . 16.1 105.162 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -172.83 58.82 0.15 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.751 -1.027 . . . . 14.73 112.005 177.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 128.052 2.541 . . . . 19.82 109.397 -179.524 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.772 -1.196 . . . . 17.73 107.772 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -171.99 0.42 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.952 2.101 . . . . 12.57 105.392 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -158.89 167.86 28.3 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.195 0.907 . . . . 6.25 108.753 168.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -103.12 75.24 1.35 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.616 1.567 . . . . 5.55 110.205 -173.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -78.71 140.59 38.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.66 108.695 -178.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 4.12 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.63 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 2.9 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 1.66 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 2.8 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 3.26 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 2.32 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 2.21 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 1.04 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 4.32 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 2.31 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.58 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 5.55 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.89 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.59 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 1.92 110.452 170.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 2.53 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 3.65 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 1.94 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.69 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 3.21 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 1.0 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 2.47 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 3.32 112.774 174.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 4.74 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 2.67 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.28 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 1.02 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 2.67 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 2.18 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.58 112.925 172.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 2.03 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 2.01 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 1.94 110.641 177.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 2.09 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 2.62 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 2.36 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 2.65 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.57 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.59 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 1.54 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.94 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 1.85 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 2.03 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 3.05 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.64 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 2.07 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 2.2 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 2.17 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.43 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 2.31 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 2.08 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 2.24 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 1.51 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.57 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.58 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 3.46 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 1.93 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 3.45 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 3.31 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.1 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 3.75 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 3.3 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 2.36 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.97 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 3.39 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.68 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HZ2' ' C ' ' A' ' 151' ' ' ARG . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 5.53 109.257 174.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 1.56 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 3.36 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.78 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.98 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 3.11 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.41 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.46 177.17 0.1 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 4.38 112.126 167.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 t -177.87 -47.73 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.79 1.236 . . . . 4.99 108.0 172.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 t 178.45 21.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.12 0.785 . . . . 6.44 113.12 -168.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -123.25 39.14 4.03 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.327 1.051 . . . . 4.29 109.382 -176.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.66 23.08 4.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.024 1.33 . . . . 2.83 112.994 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 2.01 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 2.07 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 2.43 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 4.37 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 2.76 111.812 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 4.43 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 4.45 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 2.77 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.5 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 6.33 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 2.54 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.11 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.22 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 1.97 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 2.15 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.17 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 1.95 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 1.01 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 2.94 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 2.61 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 3.76 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.35 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 3.02 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.59 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 2.02 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 1.77 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 1.97 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 1.94 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.72 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 3.32 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.86 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.43 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 6.13 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.76 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 2.11 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 3.0 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 3.54 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 1.05 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.81 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 1.9 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.86 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.93 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 1.84 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 3.07 111.51 -178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.28 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 3.04 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 2.32 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 3.88 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 4.6 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 3.86 106.482 -175.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 3.77 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.97 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -78.35 74.78 4.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 3.17 109.166 174.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.82 -69.7 1.81 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.49 -1.444 . . . . 2.85 109.49 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 45.22 47.24 10.15 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.68 1.592 . . . . 4.34 111.199 -176.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.3 -67.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.289 2.635 . . . . 6.54 104.942 -177.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.89 -45.52 57.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.611 1.196 . . . . 6.79 110.184 -169.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.6 m -99.43 10.72 40.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.233 -1.803 . . . . 6.56 112.661 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.6 mt 67.93 -65.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.842 1.657 . . . . 10.01 111.686 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -139.42 177.94 7.56 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.69 1.996 . . . . 13.47 108.126 -178.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.42 10.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.16 0.41 . . . . 14.63 112.493 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.451 ' C ' ' HZ2' ' A' ' 75' ' ' LYS . 14.2 tpt180 . . . . . 0 C--O 1.251 1.155 0 CA-C-N 117.678 0.739 . . . . 23.76 109.435 -171.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.43 -0.319 . . . . 17.1 111.374 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.26 -55.13 20.15 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.029 -1.1 . . . . 14.0 108.029 173.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -100.35 -172.21 2.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 127.935 2.494 . . . . 7.84 108.101 168.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 85.69 52.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 127.902 2.481 . . . . 7.09 107.27 -171.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.63 169.5 0.16 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 127.153 2.181 . . . . 2.73 109.592 -176.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 2.66 106.168 166.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 3.6 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 1.89 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 2.9 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.94 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 1.64 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 1.85 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.69 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 4.2 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 2.29 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.56 109.699 -179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 3.73 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 3.12 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.62 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 2.08 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 2.33 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 3.51 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 1.68 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.72 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 3.78 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.94 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 4.35 110.528 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 5.18 112.555 175.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 3.73 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 2.33 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.91 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 4.04 109.212 178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 2.21 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.06 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 2.24 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 2.25 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 1.84 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 2.08 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 2.54 111.14 171.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 2.09 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 2.02 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 1.88 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 1.66 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.98 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 1.72 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 2.2 107.051 -179.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 3.07 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.68 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.16 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.74 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 1.91 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.93 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 1.88 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 1.68 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 1.69 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 2.39 107.64 177.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.01 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.15 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 4.73 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 1.88 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 3.42 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 3.58 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 1.03 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 3.19 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 3.03 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 1.75 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 2.07 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 2.06 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.76 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.97 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 1.62 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.49 111.216 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 3.58 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 1.8 110.255 -173.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -49.02 127.8 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 4.11 113.618 -175.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -154.58 36.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.773 0.797 . . . . 4.14 110.187 177.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.3 t -161.18 39.84 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.41 -0.807 . . . . 5.7 110.892 178.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 35.66 51.45 0.68 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.029 1.732 . . . . 6.78 113.798 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.43 -43.71 0.05 Allowed 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 122.913 0.485 . . . . 3.02 111.707 -170.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 2.19 109.404 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 1.82 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.31 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 4.14 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 2.84 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 4.33 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 3.77 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 2.92 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.38 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 5.2 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 2.39 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.72 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 1.78 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 1.8 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.73 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 1.58 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.57 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 2.67 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 3.01 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 4.22 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 2.08 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.78 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.76 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 1.93 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 1.65 107.749 172.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 1.59 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 1.77 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.61 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 3.48 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.92 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.71 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 5.25 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.37 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 1.92 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.59 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 2.72 112.758 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.96 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.55 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 2.18 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 4.08 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.86 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 1.62 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 2.83 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.62 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 5.2 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 2.26 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.77 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 3.26 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 4.0 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 2.55 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 4.09 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 2.44 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -80.38 75.48 7.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.93 109.188 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.24 -13.04 47.68 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.512 -1.16 . . . . 2.38 112.471 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.84 57.33 0.6 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.271 1.536 . . . . 5.46 110.755 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -47.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.248 3.019 . . . . 7.44 108.191 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.07 -10.23 12.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.191 1.397 . . . . 8.37 112.487 -165.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -152.34 33.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.929 1.692 . . . . 5.8 109.713 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.75 -58.82 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.218 -0.66 . . . . 8.38 109.218 173.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.1 150.61 31.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.741 0.816 . . . . 12.13 109.725 -178.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.04 4.75 5.68 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.815 -0.991 . . . . 12.48 113.834 -173.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.156 -1.878 . . . . 17.25 107.501 177.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.115 -0.698 . . . . 15.46 109.115 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.94 -72.13 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 106.889 -1.522 . . . . 9.93 106.889 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -178.86 166.38 1.64 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.136 -1.802 . . . . 5.04 106.136 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -143.59 52.57 1.33 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.007 0.908 . . . . 4.54 108.724 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -64.14 151.55 43.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.283 -0.871 . . . . 2.26 111.592 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 3.34 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 3.0 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 1.71 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 3.3 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.96 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 1.76 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.92 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 1.13 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 3.36 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 2.44 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.64 109.511 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 3.55 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 2.48 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.66 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 2.14 109.402 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 1.7 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 3.08 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 1.56 108.488 174.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.78 111.285 -175.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 2.7 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.67 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 2.55 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 3.51 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 4.03 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 2.27 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.87 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 2.53 109.94 178.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 1.66 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.81 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 1.76 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 2.22 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 2.0 110.822 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.23 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 2.62 111.308 173.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 1.98 111.462 175.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 2.0 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 1.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 1.68 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.85 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 1.51 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 3.08 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 3.04 111.321 -172.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.07 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.97 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 1.74 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.88 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 1.5 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.78 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 1.84 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 1.58 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 1.83 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 1.71 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.19 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.53 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 3.49 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 1.66 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.14 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 3.64 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 3.03 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.68 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 3.24 109.838 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 3.21 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 2.05 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 2.51 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 2.04 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.92 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 5.27 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 1.55 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.72 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 2.92 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 1.78 109.637 -167.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.58 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.39 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.24 128.84 39.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.88 110.559 176.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 t -154.35 31.73 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.996 0.903 . . . . 4.85 108.978 177.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -141.92 -112.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.957 -1.127 . . . . 5.06 107.957 173.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.91 41.02 0.39 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.715 1.143 . . . . 6.89 109.742 -178.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 -42.41 0.09 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.259 0.837 . . . . 2.75 113.259 -170.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 2.14 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 1.8 111.242 173.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.11 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 5.7 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 2.84 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.34 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 5.54 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 4.0 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 2.94 111.322 -174.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.63 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 5.61 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 3.81 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.49 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.69 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 1.66 108.027 178.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 1.62 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 1.55 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.68 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 3.47 109.472 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.89 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 5.36 112.028 -168.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 2.59 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 2.33 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.72 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 1.86 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 1.91 108.516 168.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 1.74 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 1.67 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.86 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 2.99 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 3.42 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.59 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 7.72 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 1.42 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 3.33 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 3.66 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 1.1 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.03 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 1.94 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 4.14 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.7 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 2.88 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.83 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 4.35 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 2.16 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.84 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 3.21 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 3.49 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 2.61 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.99 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 2.37 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -82.44 78.86 9.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 3.68 109.67 178.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -60.23 4.35 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.514 -1.034 . . . . 2.03 110.514 176.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 47.49 49.48 15.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.264 1.026 . . . . 4.02 110.78 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.21 -36.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.118 1.367 . . . . 7.87 109.869 178.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.7 t0 48.63 99.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.683 2.393 . . . . 9.48 111.635 -175.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.1 m 57.36 26.86 12.99 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.804 -0.635 . . . . 7.35 110.718 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.4 mt 55.73 52.99 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.087 1.755 . . . . 9.56 110.31 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.17 106.21 8.74 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.866 -1.161 . . . . 12.21 107.866 167.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.79 -94.83 0.1 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.515 -1.034 . . . . 12.62 110.515 177.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 105.126 -2.176 . . . . 15.5 105.126 179.216 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtm . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 116.131 -1.89 . . . . 20.04 106.647 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.46 -165.36 0.16 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.823 1.192 . . . . 13.9 108.671 -175.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 m -74.37 -166.55 0.43 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.601 0.637 . . . . 7.23 110.098 171.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 81.77 121.18 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.569 2.348 . . . . 5.71 109.05 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -61.7 117.22 5.53 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.14 108.68 176.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 3.7 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.55 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 3.49 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 1.82 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 3.25 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 2.26 110.374 172.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 1.8 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 1.61 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.68 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 5.12 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 2.73 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.05 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 4.35 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 2.25 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 2.16 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 1.7 111.856 169.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 1.93 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 5.66 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 2.05 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 4.25 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.65 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 4.21 110.81 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 3.15 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 3.76 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 3.23 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.43 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.89 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 2.34 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 2.01 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.09 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 1.8 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 2.33 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 2.83 111.183 174.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 3.21 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 3.74 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.97 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 1.68 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.06 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 2.11 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 1.97 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.23 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 1.79 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 2.24 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 3.08 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.05 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 1.1 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.89 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.12 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 2.12 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 1.1 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 2.4 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 2.13 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 2.09 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 3.23 109.466 178.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.56 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.9 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 3.38 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 1.61 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.93 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 3.25 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.68 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 3.51 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 3.7 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 1.72 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 2.04 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 2.23 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.87 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 3.51 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 1.52 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.45 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 3.39 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 1.6 109.103 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.48 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.8 mtm -52.97 93.77 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.92 112.514 178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -54.34 -24.71 20.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.659 -0.686 . . . . 5.27 112.442 173.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.74 0.7 . . . . 5.94 109.549 167.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.1 66.83 0.91 Allowed 'General case' 0 N--CA 1.458 -0.065 0 CA-C-O 121.328 0.585 . . . . 6.96 110.418 -172.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.62 -52.18 0.09 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.454 0.702 . . . . 3.78 109.851 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 1.88 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 1.68 111.651 -179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.39 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 5.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 4.03 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 3.77 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.85 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 2.43 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.75 113.762 174.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 7.89 110.164 176.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 2.4 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.62 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 1.29 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 1.97 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 2.03 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.22 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 1.89 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.8 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 4.33 110.658 -175.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 4.61 112.979 -176.154 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 2.61 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 3.13 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.69 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 2.36 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 1.66 107.477 163.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 1.67 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 1.77 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.94 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 3.1 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 3.06 108.846 -177.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 6.3 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.62 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 1.9 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.64 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 2.82 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 1.24 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.19 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 1.93 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 4.74 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.22 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 1.56 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 2.59 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.31 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 4.69 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 1.91 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.78 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 3.3 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.85 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 2.56 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.99 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 2.35 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -81.38 58.95 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 5.07 110.097 -179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.17 33.54 30.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.506 0.574 . . . . 2.63 112.376 -176.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -26.6 66.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.565 0.698 . . . . 3.75 112.23 -176.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.33 -64.3 1.05 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.192 0.997 . . . . 7.57 109.486 161.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.1 t70 73.75 147.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.081 1.752 . . . . 7.81 109.793 -156.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t 59.04 36.69 24.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.021 1.328 . . . . 11.87 111.333 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -65.38 66.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.828 1.251 . . . . 14.33 113.155 174.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -123.12 153.02 40.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.553 1.541 . . . . 19.5 108.281 170.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -114.06 -81.5 1.02 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.046 -0.822 . . . . 19.66 111.046 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.367 0 N-CA-C 104.149 -2.537 . . . . 24.56 104.149 169.154 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mtp . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.192 -1.781 . . . . 12.94 106.192 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.16 60.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.253 0.933 . . . . 10.55 110.149 -172.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 p -169.63 125.99 0.87 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.675 -1.155 . . . . 4.14 109.262 -167.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.23 70.32 1.23 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.341 -0.985 . . . . 5.42 108.341 174.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.89 144.48 55.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.635 -0.666 . . . . 2.33 109.302 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 3.07 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.13 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.94 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 1.79 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 2.75 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.26 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 1.86 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 2.08 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.74 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 4.56 109.615 175.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 2.4 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.63 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.77 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 2.23 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 1.71 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 2.04 109.437 177.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 2.27 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.72 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 1.81 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.02 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 3.69 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.94 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 2.51 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.97 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 4.85 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 2.48 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 1.0 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 2.59 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 1.94 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' HD22 ' A' ' 38' ' ' ASN . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.35 112.53 179.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 1.61 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.452 HD22 ' CG ' ' A' ' 36' ' ' ASP . 43.4 m-80 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.15 110.481 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 1.83 109.468 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.33 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 2.99 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 2.17 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 1.69 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.15 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 1.64 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 1.74 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 3.02 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 1.68 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 2.28 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 3.06 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.28 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.11 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 2.14 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.28 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 1.86 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.8 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 1.99 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 1.55 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 1.79 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 1.89 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.89 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 4.3 110.581 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 1.78 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 3.1 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 3.09 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.7 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 3.32 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 3.44 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 1.9 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 2.24 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 2.19 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.42 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 3.44 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 1.77 109.135 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.47 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 3.36 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.68 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 1.86 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.99 108.878 172.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp -50.47 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 5.27 113.728 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 t -52.11 -37.87 55.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.359 -0.837 . . . . 5.68 111.248 172.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -166.15 -52.51 0.03 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 119.814 -0.754 . . . . 5.66 110.087 -178.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.07 -166.78 2.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.788 -1.56 . . . . 5.35 106.788 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 70.75 -48.18 0.66 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.345 1.458 . . . . 3.35 113.105 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.95 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 2.46 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 5.01 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 2.86 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.69 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.97 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 4.22 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 2.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.61 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 5.17 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 2.37 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.71 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 1.69 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 1.7 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 1.06 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 1.72 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.59 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 3.66 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 2.1 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 3.7 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.64 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 2.11 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 2.02 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 1.83 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 1.94 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 3.11 105.638 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.01 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 3.35 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 3.52 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 8.71 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.38 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 1.42 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.63 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 2.27 110.781 173.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 1.02 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 1.85 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 3.89 110.702 174.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 1.69 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 3.04 110.038 -175.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.09 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 3.25 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 2.05 112.236 169.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.7 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 3.48 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 4.61 107.383 176.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 2.62 108.299 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 3.91 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 2.44 108.691 178.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -81.26 84.36 6.62 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 4.31 108.585 175.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.96 -14.38 38.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.533 -1.148 . . . . 2.55 112.775 170.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.04 53.12 0.59 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.169 1.485 . . . . 5.63 112.079 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -174.22 -45.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.996 2.918 . . . . 8.85 107.793 -176.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -112.47 -11.74 13.59 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.646 1.178 . . . . 8.5 112.922 -167.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 31.97 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.894 1.678 . . . . 5.96 109.748 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.6 mt -52.06 -57.93 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.115 0.566 . . . . 8.84 110.188 176.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -161.16 174.8 13.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.921 -1.511 . . . . 12.03 106.921 -177.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.99 -78.17 1.4 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.323 0.487 . . . . 11.7 112.055 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.838 2.455 . . . . 15.04 104.716 -169.586 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.76 109.212 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.81 108.504 175.084 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.64 112.684 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.24 108.988 -176.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 3.24 110.322 176.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 3.08 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.87 108.466 173.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.94 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 1.91 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 3.11 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 3.31 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 1.68 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 1.79 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.74 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.98 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 2.58 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 4.35 110.72 171.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 3.76 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 2.77 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 2.46 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.131 -179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 2.22 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.9 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 1.66 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 3.63 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.98 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 2.62 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 3.18 112.233 172.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 3.82 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 2.5 110.122 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.97 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 3.52 109.488 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 2.3 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.18 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 1.45 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.56 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 2.29 108.362 -177.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 3.34 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 3.5 111.69 175.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 2.79 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 2.78 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.3 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 1.91 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 1.49 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 4.02 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 1.45 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 2.45 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 3.58 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.19 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.18 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 2.2 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.13 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.97 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 1.97 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 2.03 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 2.09 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.401 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 1.85 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.8 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.62 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 3.32 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 1.56 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.58 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 3.45 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 3.36 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.94 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 3.34 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 3.19 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 1.77 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 1.92 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 2.33 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.38 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 5.32 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.92 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.45 111.424 176.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 3.32 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.11 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 1.72 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.51 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 3.57 112.694 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.91 110.594 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 5.98 110.399 174.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 4.5 107.368 174.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 2.64 110.564 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.7 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 1.75 111.174 175.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.46 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 4.19 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 3.91 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1 108.159 -177.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 3.56 111.906 -178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 3.5 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 3.04 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 2.37 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 5.15 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 2.47 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 1.02 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 1.75 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 1.83 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 1.02 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 1.8 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.78 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 2.86 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.83 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 4.86 113.797 -170.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 2.08 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 3.28 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.3 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 2.59 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 1.71 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 1.89 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 1.85 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.86 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 3.41 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 3.32 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 1.02 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 6.16 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 1.81 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 2.57 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 3.39 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.23 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.94 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 2.12 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 4.57 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.64 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 1.71 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 2.92 110.836 -175.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.76 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.89 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 1.91 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.95 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 3.47 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 3.48 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 2.9 107.788 -171.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 3.53 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 3.52 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 4.02 107.915 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.39 111.46 174.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.32 112.205 -162.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.22 109.3 -173.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.27 112.492 -167.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 11.13 108.566 178.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.06 108.149 178.063 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.76 109.212 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.81 108.504 175.084 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.64 112.684 -179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.24 108.988 -176.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 3.24 110.322 176.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 3.08 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.87 108.466 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.94 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 1.91 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 3.11 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 3.31 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 1.68 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 1.79 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.74 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.98 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 2.58 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 4.35 110.72 171.357 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 3.76 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 2.77 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 2.46 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.131 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 2.22 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.9 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 1.66 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 3.63 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.98 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 2.62 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 3.18 112.233 172.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 3.82 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 2.5 110.122 -173.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.97 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 3.52 109.488 -177.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 2.3 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.18 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 1.45 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.56 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 2.29 108.362 -177.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 3.34 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 3.5 111.69 175.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 2.79 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 2.78 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.3 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 1.91 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 1.49 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 4.02 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 1.45 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 2.45 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 3.58 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.19 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.18 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 2.2 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.13 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.97 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 1.97 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 2.03 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 2.09 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.401 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 1.85 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.8 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.62 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 3.32 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 1.56 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.58 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 3.45 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 3.36 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.94 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 3.34 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 3.19 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 1.77 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 1.92 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 2.33 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.38 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 5.32 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.92 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.45 111.424 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 3.32 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.11 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 1.72 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.51 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 3.57 112.694 -176.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.91 110.594 175.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 5.98 110.399 174.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 4.5 107.368 174.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 2.64 110.564 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.7 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 1.75 111.174 175.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.46 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 4.19 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 3.91 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1 108.159 -177.275 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.529 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 3.56 111.906 -178.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 3.5 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 3.04 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 2.37 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 5.15 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 2.47 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.44 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 1.02 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 1.75 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 1.83 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 1.02 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 1.8 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.78 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 2.86 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.83 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 4.86 113.797 -170.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 2.08 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 3.28 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.3 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 2.59 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 1.71 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 1.89 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 1.85 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.86 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 3.41 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 3.32 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 1.02 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 6.16 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 1.81 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 2.57 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 3.39 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.23 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.94 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 2.12 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 4.57 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.64 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 1.71 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 2.92 110.836 -175.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.76 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.89 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 1.91 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.95 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 3.47 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 3.48 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 2.9 107.788 -171.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 3.53 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 3.52 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 4.02 107.915 174.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.39 111.46 174.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.32 112.205 -162.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.22 109.3 -173.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.27 112.492 -167.286 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 11.13 108.566 178.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.06 108.149 178.063 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.712 -0.477 . . . . 2.5699999999999998 109.712 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 2.52 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.1499999999999999 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 0.79000000000000004 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 2.1600000000000001 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.2400000000000002 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 0.62 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 0.90000000000000002 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.85999999999999999 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 2.3599999999999999 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 2.1800000000000002 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.2699999999999996 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 2.5499999999999998 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 1.27 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 0.87 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 0.73999999999999999 109.046 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 0.98999999999999999 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 4.0300000000000002 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 0.58999999999999997 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.9700000000000002 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 4.3200000000000003 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.64000000000000001 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 1.5700000000000001 109.588 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 1.71 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 3.23 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 1.5700000000000001 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.64000000000000001 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 1.3899999999999999 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 0.83999999999999997 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.1400000000000001 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 0.69999999999999996 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 1.79 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 21' ' ' ALA . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 0.95999999999999996 106.877 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.0800000000000001 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 1.71 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.0600000000000001 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 0.91000000000000003 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.6599999999999999 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 1.22 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 0.57999999999999996 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 3.9700000000000002 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 0.51000000000000001 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 1.02 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 1.76 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.4199999999999999 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.28 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 0.98999999999999999 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 0.72999999999999998 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.70999999999999996 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.85999999999999999 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 0.76000000000000001 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 0.62 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 0.64000000000000001 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.8500000000000001 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.0499999999999998 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' HD22 ' A' ' 28' ' ' LEU . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 108.997 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 0.56000000000000005 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.5600000000000001 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.0299999999999998 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 2.2599999999999998 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.65000000000000002 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 1.8999999999999999 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 1.9099999999999999 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 0.53000000000000003 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 0.93999999999999995 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 0.81999999999999995 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.3300000000000001 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 2.7000000000000002 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 0.80000000000000004 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.8900000000000001 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 2.1600000000000001 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 114' ' ' VAL . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 0.58999999999999997 108.926 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 138' ' ' LYS . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.5800000000000001 109.865 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.5800000000000001 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 4.0899999999999999 113.177 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.733 -0.469 . . . . 1.99 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 0.98999999999999999 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 0.90000000000000002 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.3199999999999998 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.0599999999999996 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 2.79 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 3.8199999999999998 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 3.6499999999999999 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 1.27 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.28 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 4.5899999999999999 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 1.3600000000000001 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.77000000000000002 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 0.56000000000000005 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 0.59999999999999998 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79000000000000004 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 0.47999999999999998 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.53000000000000003 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 1.72 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.76 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 3.0800000000000001 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 1.3200000000000001 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 1.8200000000000001 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 0.71999999999999997 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 0.38 107.847 166.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 0.58999999999999997 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 0.56999999999999995 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.5299999999999998 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 1.8 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 2.1000000000000001 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.63 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 7.3799999999999999 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.6400000000000001 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 0.69999999999999996 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.3799999999999999 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 1.4099999999999999 114.604 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.9199999999999999 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.84999999999999998 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.0800000000000001 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.8300000000000001 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 0.75 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 1.55 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.1400000000000001 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.0499999999999998 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 0.90000000000000002 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.90000000000000002 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 2.1699999999999999 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.0299999999999998 106.37 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 1.8 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.1099999999999999 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 3.6800000000000002 107.516 173.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.906 -0.775 . . . . 2.6000000000000001 108.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 4.8499999999999996 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.5300000000000002 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 1.8700000000000001 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 0.76000000000000001 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 2.1699999999999999 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 0.71999999999999997 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 0.72999999999999998 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.67000000000000004 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 3.79 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 1.3 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 3.8399999999999999 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 1.4399999999999999 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 0.81000000000000005 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 0.78000000000000003 110.147 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 0.85999999999999999 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 3.4500000000000002 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 0.78000000000000003 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' OE2' HG12 ' A' ' 39' ' ' VAL . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.6099999999999999 110.538 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 1.8999999999999999 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.79000000000000004 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 60' ' ' ILE . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 2.4900000000000002 110.748 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 2.2000000000000002 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 2.71 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 1.3999999999999999 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.55000000000000004 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 1.3100000000000001 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.0800000000000001 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 0.68999999999999995 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.774 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 1.1399999999999999 110.14 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.7 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 1.53 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.03 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 0.90000000000000002 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1000000000000001 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 0.81000000000000005 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 0.44 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 2.6299999999999999 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 0.48999999999999999 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 1.23 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 1.8 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6000000000000001 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.1499999999999999 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 1.6499999999999999 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.9199999999999999 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.87 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 1.24 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 0.91000000000000003 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 0.75 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 0.78000000000000003 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.3700000000000001 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 3.4900000000000002 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 0.55000000000000004 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.1800000000000002 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 2.3900000000000001 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 2.25 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.93999999999999995 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 2.1499999999999999 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 1.8500000000000001 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 0.62 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.90000000000000002 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.4399999999999999 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 3.1699999999999999 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.0 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.9399999999999999 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 2.2000000000000002 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.5299999999999998 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 0.69999999999999996 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.3599999999999999 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp . . . . . 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 2.6600000000000001 114.676 177.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.704 -0.85 . . . . 1.74 108.704 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 0.90000000000000002 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 0.80000000000000004 110.209 175.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.4500000000000002 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 5.1100000000000003 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 3.1299999999999999 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 3.4500000000000002 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 2.8799999999999999 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 1.3400000000000001 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.6499999999999999 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 4.5800000000000001 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 1.3500000000000001 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.6699999999999999 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.70999999999999996 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 0.55000000000000004 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 0.62 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.78000000000000003 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 0.54000000000000004 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.71999999999999997 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 89' ' ' ALA . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 2.4700000000000002 109.342 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 1.8 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 2.73 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.1299999999999999 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 1.3400000000000001 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.0499999999999998 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 0.79000000000000004 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 0.66000000000000003 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 0.84999999999999998 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 0.59999999999999998 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.8500000000000001 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 2.5099999999999998 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67000000000000004 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 5.2999999999999998 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.7200000000000002 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.70999999999999996 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.0099999999999998 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 1.6399999999999999 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.59999999999999998 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1000000000000001 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 0.79000000000000004 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 4.25 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.77000000000000002 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 139' ' ' LEU . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 1.5600000000000001 111.796 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.0699999999999998 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 2.6600000000000001 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 0.93000000000000005 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 2.02 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 3.8199999999999998 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 132' ' ' VAL . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 2.5499999999999998 108.547 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.0699999999999998 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 3.0 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 3.0899999999999999 108.861 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.141 -0.689 . . . . 2.8100000000000001 109.141 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 2.6499999999999999 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 2.77 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 3.04 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 0.57999999999999996 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 1.8999999999999999 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.1499999999999999 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 0.87 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.04 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.95999999999999996 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 2.3799999999999999 109.11 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 1.96 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.25 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 3.0800000000000001 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 1.1899999999999999 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 0.75 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.098 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 0.72999999999999998 110.985 172.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 0.77000000000000002 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.2599999999999998 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 0.78000000000000003 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' OE2' HG12 ' A' ' 39' ' ' VAL . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 1.99 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.64000000000000001 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 60' ' ' ILE . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 3.3700000000000001 110.56 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 1.74 112.18 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 3.1600000000000001 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 1.3600000000000001 111.382 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.68999999999999995 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 2.25 109.448 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 1.1599999999999999 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.0499999999999998 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 0.68999999999999995 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.3799999999999999 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.098 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 0.93999999999999995 108.925 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.1000000000000001 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.23 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.1899999999999999 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 1.0700000000000001 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.5800000000000001 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 0.84999999999999998 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 0.5 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 2.7999999999999998 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 0.46000000000000002 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 1.5800000000000001 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 1.8100000000000001 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.0899999999999999 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 0.92000000000000004 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 1.25 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1000000000000001 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 0.84999999999999998 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.76000000000000001 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.0 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 0.68999999999999995 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 0.64000000000000001 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 28' ' ' LEU . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 1.79 110.095 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.6299999999999999 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.6299999999999999 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 2.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 0.57999999999999996 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.1899999999999999 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 4.5899999999999999 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 2.4500000000000002 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.57999999999999996 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 2.0899999999999999 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 1.9399999999999999 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 0.56000000000000005 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 1.3600000000000001 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.1400000000000001 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 3.2799999999999998 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 0.81000000000000005 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.4500000000000002 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 116' ' ' VAL . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 2.0 108.764 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 0.72999999999999998 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.1400000000000001 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.3300000000000001 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 4.2300000000000004 109.524 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 1.74 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 0.90000000000000002 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.68000000000000005 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.0 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 4.4000000000000004 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 1.73 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 2.79 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 2.7400000000000002 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 1.72 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.24 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 4.7999999999999998 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 1.3700000000000001 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.7599999999999998 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.72999999999999998 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 0.53000000000000003 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 0.64000000000000001 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.71999999999999997 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 0.52000000000000002 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.66000000000000003 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 1.7 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 2.1800000000000002 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 2.8799999999999999 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 1.3400000000000001 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 1.52 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2000000000000002 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 1.1299999999999999 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 0.56999999999999995 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 0.67000000000000004 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 78' ' ' PHE . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 1.04 107.373 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.6099999999999999 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 2.1699999999999999 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 2.5099999999999998 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.66000000000000003 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 5.6500000000000004 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.9399999999999999 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 0.68999999999999995 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 1.8500000000000001 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 125' ' ' VAL . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 1.74 111.14 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.67000000000000004 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.0699999999999998 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 1.4299999999999999 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 3.21 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.0499999999999998 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 0.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' A' ' 139' ' ' LEU . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 1.8799999999999999 111.04 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.6400000000000001 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 2.4500000000000002 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.1100000000000001 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.3700000000000001 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 2.0099999999999998 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 4.7000000000000002 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.564 ' HG ' HG11 ' A' ' 132' ' ' VAL . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 1.4199999999999999 108.489 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 1.96 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 2.9500000000000002 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 3.3399999999999999 108.594 172.648 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 110.25 -0.278 . . . . 2.79 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 1.95 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.7400000000000002 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 10' ' ' MET . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 2.9700000000000002 107.834 171.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 0.64000000000000001 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.426 ' HG3' HD11 ' A' ' 8' ' ' ILE . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.0899999999999999 110.426 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 1.79 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 0.71999999999999997 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 0.93999999999999995 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.67000000000000004 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 2.5299999999999998 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 1.54 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 41' ' ' LEU . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.3100000000000001 109.558 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 2.6299999999999999 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 1.5700000000000001 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 0.93000000000000005 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.873 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 0.71999999999999997 109.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 0.78000000000000003 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 2.5499999999999998 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 0.58999999999999997 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 39' ' ' VAL . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.5299999999999998 110.342 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 1.9299999999999999 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.64000000000000001 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 1.55 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 3.0600000000000001 112.415 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 3.6299999999999999 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.497 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 1.3300000000000001 110.018 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.1599999999999999 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 0.71999999999999997 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 2.2200000000000002 110.41 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 0.75 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.2599999999999998 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 0.71999999999999997 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.6200000000000001 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.873 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 1.21 109.848 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.458 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 1.5600000000000001 111.87 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 1.1100000000000001 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 0.93000000000000005 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.9099999999999999 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 0.81999999999999995 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 0.40999999999999998 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 2.9300000000000002 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 0.45000000000000001 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 1.76 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 1.74 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.0699999999999998 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 0.88 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 0.98999999999999999 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.8899999999999999 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 0.72999999999999998 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.67000000000000004 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 0.78000000000000003 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 0.70999999999999996 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.9399999999999999 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 3.6099999999999999 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 0.81999999999999995 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 3.3700000000000001 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 2.5600000000000001 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.76000000000000001 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 1.96 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 2.3300000000000001 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 0.93000000000000005 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 72' ' ' VAL . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.72 111.582 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.1899999999999999 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.1500000000000004 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.04 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 0.87 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.3799999999999999 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 1.79 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.6299999999999999 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 0.56000000000000005 110.144 -167.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.3599999999999999 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 4.3600000000000003 113.131 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 113.148 0.796 . . . . 1.3700000000000001 113.148 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 0.80000000000000004 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 0.67000000000000004 110.839 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2000000000000002 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 4.54 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 1.97 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.8900000000000001 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 3.3799999999999999 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 5.9500000000000002 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 1.71 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.3200000000000001 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 4.9199999999999999 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 1.4199999999999999 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.75 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 0.59999999999999998 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 0.85999999999999999 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 0.53000000000000003 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.58999999999999997 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 89' ' ' ALA . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 2.5499999999999998 109.209 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 2.23 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 2.4900000000000002 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 1.4399999999999999 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 1.6899999999999999 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.6699999999999999 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 0.95999999999999996 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 0.52000000000000002 108.837 168.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 0.76000000000000001 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 0.68000000000000005 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 1.74 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.04 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.60999999999999999 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 5.8200000000000003 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.0600000000000001 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 0.53000000000000003 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.3300000000000001 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 1.98 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.90000000000000002 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.1699999999999999 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 132' ' ' VAL . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 0.71999999999999997 109.603 -175.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 2.9399999999999999 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.6899999999999999 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 0.57999999999999996 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' LEU . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 1.71 109.1 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.0699999999999998 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 2.3700000000000001 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 1.03 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.64000000000000001 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 2.1800000000000002 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 3.1899999999999999 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 1.54 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 2.6899999999999999 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 1.6599999999999999 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 2.6499999999999999 108.914 178.322 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 . . . . . 0 C--O 1.239 0.506 0 N-CA-C 107.927 -1.138 . . . . 3.5699999999999998 107.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 3.1400000000000001 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.8700000000000001 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 2.6000000000000001 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 0.72999999999999998 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 1.8899999999999999 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 1.6799999999999999 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 0.5 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 0.88 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 2.5299999999999998 111.286 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 2.6499999999999999 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 4.54 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 3.25 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 1.55 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 1.1799999999999999 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 15' ' ' MET . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 0.69999999999999996 111.09 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 0.85999999999999999 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.1000000000000001 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 0.67000000000000004 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.2799999999999998 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.1400000000000001 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.66000000000000003 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 2.5800000000000001 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 2.3900000000000001 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 3.3300000000000001 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 1.5 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.4199999999999999 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.63 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 1.3700000000000001 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 0.73999999999999999 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 0.90000000000000002 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.3199999999999998 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 0.93000000000000005 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.1299999999999999 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 1.6000000000000001 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 1.04 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 0.91000000000000003 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 0.84999999999999998 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 0.33000000000000002 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 3.8500000000000001 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 0.54000000000000004 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 1.28 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 1.8600000000000001 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.2200000000000002 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.02 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 1.1699999999999999 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.0099999999999998 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 0.71999999999999997 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.68999999999999995 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 0.69999999999999996 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 0.80000000000000004 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 0.79000000000000004 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 0.73999999999999999 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.8500000000000001 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 2.4100000000000001 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 0.58999999999999997 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.3199999999999998 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 3.5 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 2.3100000000000001 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.59999999999999998 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 2.2400000000000002 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 2.3100000000000001 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 0.54000000000000004 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 0.83999999999999997 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 0.92000000000000004 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.4199999999999999 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 3.3599999999999999 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 0.56999999999999995 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.2799999999999998 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 1.8200000000000001 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.5800000000000001 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 0.73999999999999999 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.29 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.8100000000000001 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 3.5699999999999998 112.738 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 1.3 111.852 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 0.93000000000000005 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 92' ' ' ILE . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 1.01 109.946 172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 4.4400000000000004 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 89' ' ' ALA . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.02 110.926 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.1400000000000001 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.0700000000000003 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 2.7599999999999998 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 1.8899999999999999 111.264 -177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.8100000000000001 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 5.8600000000000003 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 1.49 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.5099999999999998 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.79000000000000004 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 96' ' ' LEU . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 0.71999999999999997 107.496 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 0.82999999999999996 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.1399999999999999 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 0.59999999999999998 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.78000000000000003 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 1.9299999999999999 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.6699999999999999 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 3.2799999999999998 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 1.8500000000000001 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' A' ' 113' ' ' THR . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 2.0600000000000001 110.467 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 1.04 110.45 -176.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 0.55000000000000004 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 0.75 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 0.63 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 1.8899999999999999 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 2.6099999999999999 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.80000000000000004 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 5.3899999999999997 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.8500000000000001 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 0.71999999999999997 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 1.54 112.684 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.02 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 0.89000000000000001 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 3.73 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.0499999999999998 110.065 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 0.60999999999999999 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 139' ' ' LEU . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 1.4099999999999999 110.604 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1000000000000001 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 2.46 113.295 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 0.81999999999999995 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.58999999999999997 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 2.0299999999999998 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 3.3599999999999999 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 1.74 106.839 -172.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 2.2599999999999998 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 1.6399999999999999 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 3.6499999999999999 108.384 174.57 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.181 -0.674 . . . . 2.1499999999999999 109.181 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 1.95 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.7400000000000002 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 2.6499999999999999 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 0.58999999999999997 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 1.79 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.3199999999999998 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 0.69999999999999996 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 1.1799999999999999 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 2.54 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 1.3100000000000001 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.1800000000000002 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.3799999999999999 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 1.76 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 0.90000000000000002 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 0.72999999999999998 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 0.93000000000000005 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 2.3599999999999999 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 0.58999999999999997 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.6499999999999999 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.02 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.66000000000000003 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 1.6000000000000001 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 2.1899999999999999 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 4.9800000000000004 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 1.52 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.1799999999999999 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.53000000000000003 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 1.3600000000000001 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 0.73999999999999999 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 0.69999999999999996 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 0.84999999999999998 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 1.96 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 2.0499999999999998 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 1.49 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 1.48 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 0.87 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 0.46999999999999997 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.4100000000000001 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 0.41999999999999998 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 1.0700000000000001 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 1.97 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.0099999999999998 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.80000000000000004 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.2400000000000002 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.3999999999999999 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 0.85999999999999999 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 0.87 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 0.87 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 0.78000000000000003 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 0.80000000000000004 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.8599999999999999 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.0499999999999998 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 2.9500000000000002 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 0.56999999999999995 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.6699999999999999 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.02 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 2.5899999999999999 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.66000000000000003 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 2.0699999999999998 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 2.4900000000000002 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 0.54000000000000004 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 0.76000000000000001 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 3.54 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 0.92000000000000004 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.9199999999999999 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 2.1299999999999999 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.6200000000000001 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 0.72999999999999998 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.5600000000000001 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.47 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 2.9700000000000002 112.047 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.742 1.015 . . . . 1.49 113.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 0.77000000000000002 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 0.65000000000000002 110.408 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.9199999999999999 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 4.5300000000000002 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 1.76 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.4500000000000002 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.02 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 5.0999999999999996 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 1.6000000000000001 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.5 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 4.3099999999999996 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.2599999999999998 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.5999999999999996 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.65000000000000002 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 0.63 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 0.73999999999999999 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.71999999999999997 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 0.46000000000000002 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 2.5099999999999998 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 1.9099999999999999 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 2.4500000000000002 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.29 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 1.3400000000000001 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.9199999999999999 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 0.69999999999999996 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 0.48999999999999999 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.25 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 0.77000000000000002 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 1.76 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 2.52 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.68999999999999995 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 7.6100000000000003 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.5899999999999999 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 0.57999999999999996 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 1.98 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 1.5 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 0.58999999999999997 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 3.5699999999999998 109.136 165.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.4299999999999997 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 0.58999999999999997 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 1.7 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.7799999999999998 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 2.4100000000000001 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 0.93000000000000005 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.69999999999999996 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 2.0099999999999998 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.1099999999999999 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 2.6699999999999999 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 2.77 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 2.3700000000000001 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 3.0600000000000001 109.196 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.3500000000000001 105.316 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 2.4300000000000002 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.0 108.868 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.0699999999999998 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 0.68999999999999995 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 1.8899999999999999 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.04 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 64' ' ' ILE . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 0.76000000000000001 108.883 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 0.93999999999999995 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 3.1600000000000001 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 1.54 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.3300000000000001 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 3.8199999999999998 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 1.8899999999999999 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 0.82999999999999996 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 1.55 110.882 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 1.1399999999999999 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 3.5600000000000001 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 0.71999999999999997 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.3300000000000001 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 3.6499999999999999 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.68999999999999995 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 28' ' ' LEU . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 2.7200000000000002 110.086 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 1.8600000000000001 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 4.25 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 1.77 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.54000000000000004 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 1.27 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 1.1100000000000001 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.8500000000000001 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 0.82999999999999996 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 1.78 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.618 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.054 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 1.78 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 1.1299999999999999 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.02 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 0.77000000000000002 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 0.39000000000000001 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 4.04 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.55000000000000004 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 1.48 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 1.98 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.3700000000000001 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.04 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 1.22 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.9199999999999999 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 0.85999999999999999 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.87 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.01 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 0.94999999999999996 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 0.78000000000000003 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 0.70999999999999996 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.5600000000000001 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 3.6499999999999999 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 69' ' ' TYR . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.88 109.866 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.1299999999999999 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 3.0099999999999998 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 2.2200000000000002 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.68999999999999995 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 64' ' ' ILE . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 1.9299999999999999 109.275 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 2.0 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 0.57999999999999996 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 0.88 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 0.97999999999999998 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.6899999999999999 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 3.3999999999999999 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 0.68999999999999995 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.6899999999999999 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 2.27 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.8600000000000001 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 114' ' ' VAL . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 1.3100000000000001 109.778 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.6499999999999999 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.6399999999999999 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 3.3100000000000001 112.83 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.214 0.054 . . . . 1.47 111.087 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 0.65000000000000002 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.1800000000000002 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 5.8700000000000001 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 2.1499999999999999 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.4900000000000002 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.1299999999999999 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 135' ' ' LEU . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.0499999999999998 111.192 168.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 1.73 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.25 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 3.8900000000000001 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 1.3700000000000001 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.6099999999999999 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.80000000000000004 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 0.60999999999999999 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 0.66000000000000003 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.85999999999999999 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 0.46999999999999997 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.64000000000000001 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 1.72 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.8200000000000001 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 2.48 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.1399999999999999 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 1.3100000000000001 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.6099999999999999 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 0.90000000000000002 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 0.69999999999999996 107.664 156.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 0.70999999999999996 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 0.52000000000000002 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.6699999999999999 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 1.8600000000000001 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 2.29 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.85999999999999999 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 5.8099999999999996 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.4100000000000001 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 0.84999999999999998 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 2.5699999999999998 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 1.97 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 0.91000000000000003 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.8300000000000001 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 1.27 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 3.1299999999999999 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.9199999999999999 110.403 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 0.58999999999999997 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 1.6899999999999999 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.5800000000000001 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 2.8399999999999999 113.022 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 95' ' ' ARG . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 0.81000000000000005 111.966 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76000000000000001 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 2.21 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 3.7999999999999998 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 1.5900000000000001 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 2.6099999999999999 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 1.6799999999999999 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt . . . . . 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 3.0299999999999998 109.519 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.8799999999999999 106.605 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 2.3900000000000001 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.8399999999999999 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 3.1299999999999999 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 0.59999999999999998 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 2.0099999999999998 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 1.9199999999999999 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 0.76000000000000001 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 0.83999999999999997 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 3.8799999999999999 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 1.24 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.4100000000000001 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 4.3200000000000003 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 1.4299999999999999 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 0.73999999999999999 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 1.01 110.56 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 0.77000000000000002 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 3.02 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG ' ' A' ' 69' ' ' TYR . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.0300000000000002 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 2.25 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.65000000000000002 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 1.7 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 1.75 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 2.96 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 1.54 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.1400000000000001 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 1.0600000000000001 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 1.45 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.02 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 0.73999999999999999 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.02 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG11 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 1.3300000000000001 109.288 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.1600000000000001 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 1.74 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 1.47 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 1.26 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.8799999999999999 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 0.72999999999999998 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 0.38 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.6600000000000001 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 0.56000000000000005 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 1.0900000000000001 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 2.1000000000000001 111.909 -171.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.7599999999999998 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.26 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 1.46 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.0499999999999998 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 0.82999999999999996 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.63 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 0.95999999999999996 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 0.70999999999999996 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 0.56999999999999995 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 0.65000000000000002 108.15 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.9099999999999999 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.3999999999999999 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 3.3700000000000001 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 0.57999999999999996 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 2.6800000000000002 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 1.95 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.68999999999999995 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' HD11 ' A' ' 24' ' ' ILE . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 1.98 109.466 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 2.1499999999999999 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 0.52000000000000002 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 0.76000000000000001 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 0.75 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 2.7200000000000002 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 0.78000000000000003 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 1.74 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 0.80000000000000004 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.5800000000000001 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.4099999999999999 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? . . . . . 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 2.9100000000000001 110.07 172.772 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.273 0.842 . . . . 1.22 113.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 0.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 0.64000000000000001 110.674 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 1.8200000000000001 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 4.5300000000000002 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 1.9199999999999999 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 3.52 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 3.2400000000000002 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 114' ' ' VAL . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 1.6399999999999999 111.011 -169.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.48 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 4.4699999999999998 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 1.8100000000000001 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.7999999999999998 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.67000000000000004 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 0.57999999999999996 107.755 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 0.68000000000000005 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.83999999999999997 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 0.52000000000000002 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.51000000000000001 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 114' ' ' VAL . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 2.3700000000000001 109.28 -173.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 2.1699999999999999 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 2.5499999999999998 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 1.1399999999999999 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.3999999999999999 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.7799999999999998 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 0.95999999999999996 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 107' ' ' VAL . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 0.56999999999999995 108.971 164.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 0.76000000000000001 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 0.93999999999999995 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.8300000000000001 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 2.0099999999999998 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 2.3199999999999998 107.342 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.84999999999999998 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 4.9699999999999998 108.364 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 0.69999999999999996 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.8700000000000001 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 1.6399999999999999 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.68000000000000005 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 0.73999999999999999 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 3.6699999999999999 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.2200000000000002 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 0.73999999999999999 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 1.7 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.6299999999999999 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.0699999999999998 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 1.0800000000000001 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.84999999999999998 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 2.1099999999999999 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 5.9299999999999997 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 1.49 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 2.5 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 1.75 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 3.25 108.669 172.913 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.3199999999999998 112.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 2.8700000000000001 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.0800000000000001 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.0299999999999998 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 0.78000000000000003 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 2.73 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 2.6600000000000001 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 0.70999999999999996 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 0.77000000000000002 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.85999999999999999 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 3.1600000000000001 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.1299999999999999 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.5800000000000001 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 3.0099999999999998 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 1.1699999999999999 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 0.84999999999999998 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 0.71999999999999997 112.278 167.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 0.78000000000000003 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.23 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 0.68000000000000005 108.157 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.1200000000000001 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 1.8100000000000001 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 1.5800000000000001 109.99 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 2.4300000000000002 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 3.4300000000000002 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 1.7 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.1400000000000001 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 0.94999999999999996 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 1.45 111.311 172.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 1.47 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.3100000000000001 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 0.66000000000000003 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.3799999999999999 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.0800000000000001 108.731 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.3500000000000001 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 3.8700000000000001 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 1.3700000000000001 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.9199999999999999 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 1.47 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 0.40000000000000002 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.2599999999999998 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 0.73999999999999999 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 1.3100000000000001 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 2.0 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.1299999999999999 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 1.1399999999999999 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.8700000000000001 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 0.69999999999999996 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.67000000000000004 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 0.96999999999999997 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 0.92000000000000004 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 0.73999999999999999 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 0.83999999999999997 107.609 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7000000000000002 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.4500000000000002 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 2.2400000000000002 108.155 -175.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 0.58999999999999997 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.6799999999999999 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 2.6899999999999999 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 1.8300000000000001 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.68000000000000005 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 2.02 108.769 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 1.75 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 0.77000000000000002 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.4500000000000002 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 4.54 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.0600000000000001 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.8700000000000001 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 2.25 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 0.81000000000000005 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.9900000000000002 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.53 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.42 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 4.9699999999999998 109.499 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.433 0.16 . . . . 1.29 111.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 0.68999999999999995 110.237 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.5499999999999998 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 3.77 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 1.8899999999999999 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 3.6200000000000001 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 2.9199999999999999 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 1.6799999999999999 111.465 -177.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.29 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 4.4800000000000004 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 2.0699999999999998 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.7400000000000002 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.82999999999999996 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 0.84999999999999998 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77000000000000002 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 0.46999999999999997 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.57999999999999996 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.441 HG11 ' HB1' ' A' ' 89' ' ' ALA . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 2.5499999999999998 108.727 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.6000000000000001 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 2.2999999999999998 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.51 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 1.51 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 0.95999999999999996 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 0.66000000000000003 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.3400000000000001 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 0.78000000000000003 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.6499999999999999 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 1.97 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 2.1699999999999999 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.79000000000000004 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 5.2400000000000002 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.2599999999999998 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 0.93999999999999995 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 1.79 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 1.78 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 0.77000000000000002 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.2799999999999998 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 0.77000000000000002 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 3.9700000000000002 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.3100000000000001 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 0.69999999999999996 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 1.6000000000000001 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.2400000000000002 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 1.1299999999999999 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 2.2400000000000002 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 3.8199999999999998 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 1.6200000000000001 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 2.7200000000000002 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 1.77 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 2.6400000000000001 108.116 172.237 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.9199999999999999 108.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 3.04 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.8100000000000001 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 2.02 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 0.76000000000000001 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 1.79 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.04 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 0.54000000000000004 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 0.77000000000000002 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.72999999999999998 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 2.4900000000000002 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 1.46 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 5.4900000000000002 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 3.52 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 1.6599999999999999 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 0.81000000000000005 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 0.91000000000000003 110.732 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 1.3600000000000001 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.23 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 0.67000000000000004 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 2.3300000000000001 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.65000000000000002 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 1.6299999999999999 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 1.95 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 2.5299999999999998 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 1.6599999999999999 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.3500000000000001 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 1.46 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.66000000000000003 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.7799999999999998 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 0.68000000000000005 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 1.8200000000000001 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 110.081 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 1.8600000000000001 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 2.1000000000000001 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.0 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 1.1000000000000001 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.0699999999999998 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 0.82999999999999996 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 0.5 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 2.7999999999999998 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 0.46999999999999997 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 1.01 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 2.0600000000000001 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.0899999999999999 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.27 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 1.4099999999999999 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.1499999999999999 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 0.81999999999999995 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.64000000000000001 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.1000000000000001 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 0.76000000000000001 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 0.67000000000000004 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.1600000000000001 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.6499999999999999 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 3.8300000000000001 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 0.62 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.4399999999999999 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.1899999999999999 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 2.0899999999999999 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.87 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 1.9099999999999999 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 1.96 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 0.51000000000000001 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 0.80000000000000004 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 0.93000000000000005 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.5099999999999998 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.0700000000000003 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 0.66000000000000003 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.0499999999999998 110.88 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 2.0499999999999998 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.2200000000000002 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 0.84999999999999998 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.3500000000000001 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.1299999999999999 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 88' ' ' CYS . 33.7 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 6.3399999999999999 112.673 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.631 -0.877 . . . . 1.4099999999999999 108.631 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' MET . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 1.1699999999999999 108.445 -171.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 0.66000000000000003 110.397 170.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.8899999999999999 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 5.3399999999999999 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.609 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 2.0 111.387 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.8500000000000001 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 3.8100000000000001 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 3.1299999999999999 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 1.24 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 5.7300000000000004 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 1.53 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.6200000000000001 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.68000000000000005 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 118' ' ' TYR . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 0.68000000000000005 107.97 175.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 0.70999999999999996 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.69999999999999996 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 0.51000000000000001 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.58999999999999997 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 1.6899999999999999 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.75 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 2.3999999999999999 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.04 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 1.22 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 0.64000000000000001 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 0.42999999999999999 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 0.66000000000000003 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 0.54000000000000004 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2000000000000002 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 102' ' ' VAL . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 1.8100000000000001 111.003 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 2.3799999999999999 107.058 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 5.7300000000000004 110.764 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.5199999999999996 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 0.68000000000000005 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.1800000000000002 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 2.46 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 0.85999999999999999 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.2799999999999998 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 1.0 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 3.9500000000000002 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.0499999999999998 111.25 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 0.63 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 1.79 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.4900000000000002 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 2.8399999999999999 112.869 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.609 ' HG ' HG22 ' A' ' 92' ' ' ILE . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 1.01 112.032 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.85999999999999999 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 1.9299999999999999 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 4.5 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 1.4399999999999999 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.0199999999999996 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 1.71 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 34.3 mtpt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 2.8700000000000001 107.938 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.6099999999999999 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 3.02 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.2999999999999998 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 0.57999999999999996 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 0.90000000000000002 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 0.95999999999999996 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 3.2599999999999998 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.1699999999999999 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 3.4900000000000002 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.2400000000000002 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 2.2200000000000002 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.02 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 1.4399999999999999 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.76 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 3.6600000000000001 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 1.6100000000000001 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.1100000000000003 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.0699999999999998 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.5900000000000001 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 1.75 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 2.8100000000000001 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 3.4100000000000001 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.2999999999999998 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 1.8100000000000001 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.02 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 1.4199999999999999 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 1.0900000000000001 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.8100000000000001 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 0.93000000000000005 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.7200000000000002 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 0.93000000000000005 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.3500000000000001 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 2.1699999999999999 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.04 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 0.83999999999999997 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.1299999999999999 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 0.96999999999999997 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 0.55000000000000004 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 3.71 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 0.81000000000000005 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 1.9299999999999999 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 2.0899999999999999 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.3500000000000001 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.6699999999999999 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 1.6699999999999999 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 1.25 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.2 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 1.4299999999999999 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 1.3799999999999999 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 1.25 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.94999999999999996 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.4700000000000002 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.1800000000000002 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.1099999999999999 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 0.89000000000000001 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 3.3900000000000001 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 2.4399999999999999 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.5700000000000001 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 2.0800000000000001 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 2.71 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 0.93000000000000005 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 0.94999999999999996 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.21 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.6299999999999999 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 2.8799999999999999 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 1.99 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 113' ' ' THR . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.8300000000000001 107.827 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 0.71999999999999997 109.444 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.2599999999999998 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 3.0299999999999998 111.521 -177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.305 0.574 . . . . 1.8 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.0900000000000001 107.896 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 0.60999999999999999 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.21 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 5.4100000000000001 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 1.8400000000000001 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.0600000000000001 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 3.23 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 1.9399999999999999 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 4.7800000000000002 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 1.5900000000000001 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.5800000000000001 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 0.87 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 0.81999999999999995 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 0.82999999999999996 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 0.95999999999999996 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 0.72999999999999998 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.87 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 1.6699999999999999 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 2.27 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.8 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' THR . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 1.6499999999999999 110.659 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 111' ' ' LEU . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 0.83999999999999997 111.545 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.564 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.54000000000000004 108.314 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 0.94999999999999996 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 0.68000000000000005 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.4700000000000002 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.96 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.0099999999999998 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.90000000000000002 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 7.8499999999999996 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.8900000000000001 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 0.69999999999999996 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 2.27 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 1.6899999999999999 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.76000000000000001 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.2200000000000002 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 0.96999999999999997 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 3.7000000000000002 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.1099999999999999 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 0.69999999999999996 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 1.6699999999999999 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.4700000000000002 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 3.7400000000000002 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 0.90000000000000002 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89000000000000001 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 2.0099999999999998 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 3.8799999999999999 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 1.4099999999999999 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 3.0600000000000001 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 3.3700000000000001 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.0699999999999998 110.667 -173.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.779 0.323 . . . . 3.0099999999999998 110.49 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.0099999999999998 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.7200000000000002 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.405 HD11 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 2.8799999999999999 107.851 165.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 0.68999999999999995 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 8' ' ' ILE . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 2.1600000000000001 108.407 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 2.5800000000000001 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 0.57999999999999996 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.05 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.93999999999999995 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 2.8300000000000001 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 1.5800000000000001 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.2000000000000002 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 3.27 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 1.3500000000000001 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 0.79000000000000004 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 0.69999999999999996 110.929 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 0.80000000000000004 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 3.98 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 0.56000000000000005 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.8399999999999999 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 1.79 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.68999999999999995 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 1.6599999999999999 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 1.79 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 2.96 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' VAL . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 1.9399999999999999 110.6 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 0.71999999999999997 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 2.3500000000000001 110.538 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 0.84999999999999998 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.1499999999999999 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 0.66000000000000003 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 1.97 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 1.6399999999999999 111.254 171.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.0099999999999998 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 3.3700000000000001 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 1.3799999999999999 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 1.0600000000000001 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.5600000000000001 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 0.48999999999999999 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 2.6600000000000001 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 0.46999999999999997 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 1.1000000000000001 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 1.95 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.2200000000000002 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 0.92000000000000004 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 0.97999999999999998 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.0499999999999998 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 0.76000000000000001 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.63 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 0.89000000000000001 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 0.69999999999999996 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 0.71999999999999997 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.1699999999999999 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1000000000000001 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 3.1699999999999999 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.58999999999999997 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 4.7300000000000004 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 2.2200000000000002 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.72999999999999998 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 2.1200000000000001 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 2.1899999999999999 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 0.59999999999999998 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 1.25 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 0.81999999999999995 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 2.54 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 0.80000000000000004 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 2.0699999999999998 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.3700000000000001 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 0.87 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 2.9300000000000002 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.9299999999999999 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 2.9500000000000002 112.089 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 90' ' ' ASN . . . . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.497 -0.557 . . . . 1.6399999999999999 109.497 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 0.78000000000000003 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 0.69999999999999996 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.498 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.5499999999999998 110.884 -178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 5.0899999999999999 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 1.9199999999999999 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.4300000000000002 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 3.27 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 3.7200000000000002 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 2.02 111.328 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.3100000000000001 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 4.5499999999999998 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 1.6899999999999999 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.3999999999999999 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.80000000000000004 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 0.72999999999999998 108.831 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 0.79000000000000004 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.82999999999999996 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 0.66000000000000003 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.87 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 1.76 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 1.97 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 2.77 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 1.04 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 1.6100000000000001 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.2799999999999998 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 0.80000000000000004 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 0.54000000000000004 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 0.88 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 0.56000000000000005 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7000000000000002 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 2.1499999999999999 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 2.3900000000000001 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.71999999999999997 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 5.6699999999999999 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6000000000000001 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 0.58999999999999997 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 1.9199999999999999 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 1.54 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.79000000000000004 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 0.80000000000000004 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.1699999999999999 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.2200000000000002 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 0.54000000000000004 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 1.72 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.6299999999999999 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 2.3900000000000001 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 0.88 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.81999999999999995 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 2.1699999999999999 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 3.4199999999999999 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 1.3999999999999999 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 3.02 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 1.76 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 2.9199999999999999 108.622 178.869 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.02 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 1.9199999999999999 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.5699999999999998 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 2.7599999999999998 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 0.56000000000000005 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 1.6799999999999999 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.1800000000000002 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 0.68999999999999995 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 1.0800000000000001 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.88 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 39' ' ' VAL . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 2.8100000000000001 112.049 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 1.98 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 3.1800000000000002 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 2.02 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.6599999999999999 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 1.1299999999999999 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 1.4099999999999999 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.2400000000000002 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 0.68999999999999995 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.04 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.56999999999999995 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 1.5700000000000001 110.558 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 2.1000000000000001 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 3.4399999999999999 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 1.3400000000000001 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.3300000000000001 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.56000000000000005 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 1.3999999999999999 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 0.73999999999999999 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 0.69999999999999996 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.6899999999999999 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' SD ' ' A' ' 15' ' ' MET . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 1.04 113.2 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 1.98 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 1.52 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.0900000000000001 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 1.0800000000000001 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.8400000000000001 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 0.72999999999999998 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 0.41999999999999998 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.4100000000000001 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 0.45000000000000001 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 1.0600000000000001 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 1.9199999999999999 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.8700000000000001 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 0.95999999999999996 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.03 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 0.80000000000000004 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.72999999999999998 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 0.81000000000000005 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 0.88 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 0.68999999999999995 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 0.79000000000000004 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.29 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.0499999999999998 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 -175.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 0.56000000000000005 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 2.3900000000000001 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 1.9099999999999999 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.82999999999999996 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 2.1000000000000001 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 2.04 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 0.53000000000000003 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 0.87 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 0.81000000000000005 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.6400000000000001 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 2.7799999999999998 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 0.56999999999999995 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.9199999999999999 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 2.3199999999999998 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.4100000000000001 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 114' ' ' VAL . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 0.78000000000000003 110.17 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.1699999999999999 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6000000000000001 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 2.98 112.202 -171.262 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.426 -0.583 . . . . 2.1000000000000001 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 0.81999999999999995 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 1.0700000000000001 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.8799999999999999 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 4.25 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 1.8999999999999999 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.4100000000000001 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 3.29 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 2.8300000000000001 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 1.4399999999999999 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.3999999999999999 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 5.0199999999999996 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 2.27 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.9300000000000002 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.70999999999999996 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 0.66000000000000003 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 0.68999999999999995 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78000000000000003 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 0.46000000000000002 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.60999999999999999 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 1.7 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.75 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 3.1600000000000001 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 1.3500000000000001 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 2.4100000000000001 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.6899999999999999 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 0.46000000000000002 107.922 167.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 0.63 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 0.54000000000000004 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.8300000000000001 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 1.97 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 2.2000000000000002 108.554 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.71999999999999997 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 5.4199999999999999 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 0.51000000000000001 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.1299999999999999 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 125' ' ' VAL . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 1.48 113.831 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 0.75 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 3.3500000000000001 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.6400000000000001 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 0.48999999999999999 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 1.6799999999999999 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.5800000000000001 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 2.8199999999999998 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 0.81999999999999995 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.59999999999999998 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 1.8799999999999999 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 3.5699999999999998 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 1.49 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 2.7200000000000002 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 1.6299999999999999 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 5.75 109.042 162.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.316 -0.624 . . . . 2.4300000000000002 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 2.3500000000000001 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.9199999999999999 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 2.6600000000000001 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 0.62 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 2.4300000000000002 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.8399999999999999 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 0.96999999999999997 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 1.1100000000000001 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.3 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 2.8700000000000001 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 1.6299999999999999 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.0499999999999998 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 3.54 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 1.5900000000000001 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 1.6299999999999999 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 1.26 110.109 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 1.3100000000000001 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 2.6299999999999999 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.94999999999999996 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.6800000000000002 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 2.4700000000000002 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.82999999999999996 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 1.6899999999999999 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 2.21 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 2.79 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 1.9299999999999999 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.73999999999999999 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 1.46 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 0.73999999999999999 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.6699999999999999 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 0.55000000000000004 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.0600000000000001 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 21' ' ' ALA . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 1.3400000000000001 111.873 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2000000000000002 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 2.1800000000000002 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 1.4099999999999999 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 1.3700000000000001 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.3599999999999999 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 0.87 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 0.44 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.0600000000000001 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 0.5 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 0.95999999999999996 108.117 -178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 1.8 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.0800000000000001 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 1.1100000000000001 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.2999999999999998 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.80000000000000004 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 0.94999999999999996 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 0.98999999999999999 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 0.73999999999999999 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 0.73999999999999999 107.57 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.9099999999999999 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 2.3500000000000001 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 0.58999999999999997 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.3399999999999999 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.1699999999999999 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 2.48 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.87 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 4.0599999999999996 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 1.8200000000000001 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 0.97999999999999998 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 0.96999999999999997 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.7300000000000004 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.0 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 0.73999999999999999 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.8599999999999999 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 2.3700000000000001 109.745 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.6599999999999999 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 0.96999999999999997 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.499 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.1600000000000001 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.6200000000000001 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 3.3700000000000001 114.042 -174.791 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.124 0.416 . . . . 1.9099999999999999 112.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 1.53 110.815 -165.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 0.68000000000000005 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 2.2200000000000002 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 5.3899999999999997 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 1.8999999999999999 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 2.7200000000000002 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 3.9700000000000002 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 1.73 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.7999999999999998 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 4.6900000000000004 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 1.45 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.76000000000000001 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 0.71999999999999997 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 0.59999999999999998 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.68000000000000005 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 0.44 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.56000000000000005 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 1.9099999999999999 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 1.97 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 2.3199999999999998 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.0700000000000001 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 1.28 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.6800000000000002 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 0.71999999999999997 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 0.65000000000000002 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 0.66000000000000003 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 128' ' ' LEU . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 0.56000000000000005 104.877 166.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.8500000000000001 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 2.0899999999999999 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.0600000000000001 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65000000000000002 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 7.6200000000000001 109.315 171.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.8100000000000001 109.243 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 0.68999999999999995 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.0600000000000001 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 125' ' ' VAL . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 2.25 113.915 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 0.81999999999999995 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 78' ' ' PHE . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 1.4299999999999999 111.447 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 2.7000000000000002 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.1600000000000001 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 0.73999999999999999 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 139' ' ' LEU . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 1.6899999999999999 111.85 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 2.73 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 0.94999999999999996 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91000000000000003 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 2.3199999999999998 108.331 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.0199999999999996 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.719 ' HB2' HG11 ' A' ' 132' ' ' VAL . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 2.5899999999999999 106.624 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 3.1699999999999999 108.071 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 2.4300000000000002 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 3.5699999999999998 106.92 172.17 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.735 -0.839 . . . . 2.0600000000000001 108.735 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 4.4699999999999998 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 2.5 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 2.2400000000000002 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 0.93999999999999995 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.0 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 1.8400000000000001 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 0.62 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 0.77000000000000002 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.64000000000000001 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 2.7999999999999998 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 1.5700000000000001 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.1900000000000004 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 2.5 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 1.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 0.71999999999999997 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 0.89000000000000001 109.028 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 1.1299999999999999 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 2.4199999999999999 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 0.58999999999999997 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 2.6499999999999999 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.01 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 1.5800000000000001 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 1.9299999999999999 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 2.7799999999999998 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 1.8100000000000001 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.76000000000000001 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 1.3799999999999999 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 0.73999999999999999 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.6799999999999999 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 0.57999999999999996 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.0299999999999998 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 0.93999999999999995 107.981 -174.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.7799999999999998 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 1.76 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.1200000000000001 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 0.98999999999999999 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 0.48999999999999999 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 2.8199999999999998 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 0.44 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 1.3799999999999999 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 2.3300000000000001 111.909 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.2400000000000002 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.93000000000000005 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.1499999999999999 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.0299999999999998 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 0.94999999999999996 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.87 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 1.1499999999999999 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.1899999999999999 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 0.96999999999999997 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 0.91000000000000003 108.406 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.0699999999999998 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.9199999999999999 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 3.8300000000000001 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 0.5 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.5800000000000001 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 3.1299999999999999 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 2.3500000000000001 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.60999999999999999 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 2.1200000000000001 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 2.1699999999999999 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 0.58999999999999997 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.1000000000000001 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 1.05 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.2999999999999998 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 2.8399999999999999 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 0.66000000000000003 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.8900000000000001 111.717 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 2.3599999999999999 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.5700000000000001 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 0.95999999999999996 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.6299999999999999 104.648 168.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.76 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.1100000000000003 112.512 176.399 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 122.031 0.92 . . . . 1.75 112.095 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 1.1000000000000001 110.143 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 1.1299999999999999 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.1899999999999999 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 4.96 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 1.8100000000000001 110.623 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 2.9199999999999999 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 3.21 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 2.1200000000000001 111.151 -177.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.54 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 5.8300000000000001 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 2.0499999999999998 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.6099999999999999 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 0.98999999999999999 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 0.91000000000000003 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.97999999999999998 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 0.94999999999999996 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.0600000000000001 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 2.1099999999999999 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.02 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 3.1899999999999999 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 1.55 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 1.98 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 0.88 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 0.42999999999999999 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 1.04 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 0.62 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.3300000000000001 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 2.3300000000000001 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 2.4700000000000002 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.1399999999999999 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 5.6299999999999999 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.7200000000000002 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 0.81000000000000005 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 2.4500000000000002 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 1.55 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 0.79000000000000004 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 0.97999999999999998 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.0 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.7400000000000002 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 0.85999999999999999 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 1.75 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 3.9399999999999999 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 1.1000000000000001 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.94999999999999996 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 1.8500000000000001 108.126 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 4.3200000000000003 107.616 172.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 2.54 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 3.48 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 1.8999999999999999 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 41.3 mtpt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 2.7400000000000002 107.199 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.2000000000000002 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.8500000000000001 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.04 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 0.56999999999999995 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 2.0699999999999998 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.413 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.6800000000000002 109.244 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 0.83999999999999997 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 0.89000000000000001 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.81000000000000005 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 2.77 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 1.48 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.6299999999999999 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 3.23 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 1.6499999999999999 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 0.94999999999999996 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 0.83999999999999997 110.475 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 1.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 3.5699999999999998 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 0.85999999999999999 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.0300000000000002 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 1.79 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.67000000000000004 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 1.6000000000000001 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 2.25 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 2.5299999999999998 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 1.5800000000000001 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.58999999999999997 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 1.3400000000000001 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 0.73999999999999999 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 0.66000000000000003 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.8200000000000001 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG13 ' HB1' ' A' ' 21' ' ' ALA . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 1.48 111.915 170.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 1.79 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 2.7000000000000002 111.565 167.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 1.6799999999999999 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 1.45 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 0.95999999999999996 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 2.9100000000000001 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 0.46000000000000002 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 1.21 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 1.75 111.078 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.2999999999999998 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.87 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.02 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.8100000000000001 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 0.71999999999999997 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.66000000000000003 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 0.88 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 1.03 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 0.81999999999999995 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 0.64000000000000001 107.726 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 2.3300000000000001 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 0.87 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.8600000000000001 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 2.7000000000000002 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 2.0899999999999999 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.1100000000000001 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 2.2000000000000002 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 1.96 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 0.56000000000000005 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 1.04 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.47 HG23 ' C ' ' A' ' 118' ' ' TYR . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 0.82999999999999996 108.671 -166.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.1699999999999999 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 4.5300000000000002 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 0.64000000000000001 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.7799999999999998 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 1.79 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.5699999999999998 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 0.82999999999999996 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.8399999999999999 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.793 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 3.7799999999999998 111.708 167.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 110.759 -0.089 . . . . 1.77 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 1.47 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 0.68000000000000005 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.2000000000000002 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 3.8399999999999999 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 2.8300000000000001 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.6400000000000001 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 2.9900000000000002 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 5.3899999999999997 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 99' ' ' ILE . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 2.0099999999999998 111.68 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 5.9299999999999997 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 96' ' ' LEU . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.5800000000000001 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.71999999999999997 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 0.60999999999999999 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 0.65000000000000002 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.73999999999999999 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 0.64000000000000001 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.69999999999999996 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 89' ' ' ALA . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 2.5299999999999998 108.99 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 1.9199999999999999 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 2.54 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 1.6599999999999999 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 1.3500000000000001 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.3799999999999999 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 0.84999999999999998 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 0.59999999999999998 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 0.70999999999999996 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 128' ' ' LEU . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 0.60999999999999999 106.337 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6000000000000001 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.47 ' C ' HG23 ' A' ' 73' ' ' THR . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 2.0099999999999998 112.017 -172.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 2.25 109.203 -170.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.60999999999999999 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 7.3700000000000001 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.5899999999999999 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 0.52000000000000002 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.1699999999999999 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 1.73 113.644 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 0.81000000000000005 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.2200000000000002 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 116' ' ' VAL . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 1.52 110.494 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 3.1000000000000001 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.8900000000000001 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 0.79000000000000004 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' A' ' 139' ' ' LEU . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 1.55 112.035 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.0599999999999996 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 2.6099999999999999 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 0.98999999999999999 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 1.9199999999999999 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 4.5199999999999996 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 1.8 108.731 -175.193 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 2.1899999999999999 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 1.73 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 2.8199999999999998 108.647 173.289 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.635 -0.506 . . . . 2.2999999999999998 109.635 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 2.2799999999999998 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.4900000000000002 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 2.54 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 0.87 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 1.78 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 2.7200000000000002 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 0.82999999999999996 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 1.5900000000000001 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.0600000000000001 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.595 ' HE2' HD12 ' A' ' 24' ' ' ILE . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 3.3100000000000001 110.691 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 1.52 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.0800000000000001 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 3.5600000000000001 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 1.4299999999999999 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 0.93000000000000005 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 0.67000000000000004 111.478 171.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 0.93000000000000005 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.25 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 15' ' ' MET . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 0.67000000000000004 108.447 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 1.8999999999999999 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.64000000000000001 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 1.6200000000000001 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 2.2200000000000002 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 4.4199999999999999 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 1.45 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.3200000000000001 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 0.85999999999999999 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 1.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.91000000000000003 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.9199999999999999 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 0.71999999999999997 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 1.03 109.623 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 2.4100000000000001 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 3.1499999999999999 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 1.5700000000000001 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 1.45 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.0099999999999998 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.1399999999999999 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 0.46999999999999997 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.3900000000000001 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 0.47999999999999998 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 1.21 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CZ ' HG13 ' A' ' 60' ' ' ILE . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 2.4100000000000001 112.126 -170.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.0800000000000001 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 1.1799999999999999 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.9399999999999999 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 0.92000000000000004 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.83999999999999997 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 0.88 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 0.90000000000000002 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 0.82999999999999996 107.344 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.04 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.0099999999999998 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 2.3100000000000001 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 1.8999999999999999 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 2.5699999999999998 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 1.9399999999999999 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.59999999999999998 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CG ' HD11 ' A' ' 24' ' ' ILE . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 1.99 108.929 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 2.5699999999999998 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 0.56000000000000005 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 1.48 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 0.81000000000000005 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 4.4800000000000004 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 0.58999999999999997 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 2.04 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 114' ' ' VAL . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 0.80000000000000004 111.123 -165.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.4100000000000001 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 2.7200000000000002 110.11 172.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.778 -0.453 . . . . 1.96 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.1200000000000001 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 0.88 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 1.73 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 3.8900000000000001 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 2.7599999999999998 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.3599999999999999 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 3.6899999999999999 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 3.29 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 1.55 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 4.4900000000000002 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 102' ' ' VAL . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.0800000000000001 107.557 159.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.8900000000000001 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 0.68999999999999995 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ILE . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 0.60999999999999999 108.832 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 0.85999999999999999 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 0.5 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.56000000000000005 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 1.79 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 1.73 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 2.8199999999999998 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 1.46 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 1.4299999999999999 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.7400000000000002 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 0.76000000000000001 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 0.40000000000000002 107.24 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 0.68000000000000005 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 0.67000000000000004 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.5299999999999998 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' A' ' 102' ' ' VAL . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 2.0899999999999999 112.318 -165.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 2.4500000000000002 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79000000000000004 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 6.7599999999999998 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.2599999999999998 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 0.67000000000000004 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.1200000000000001 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.613 ' HA ' HD12 ' A' ' 128' ' ' LEU . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 1.9299999999999999 112.854 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 0.81000000000000005 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.0899999999999999 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 125' ' ' VAL . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 1.0600000000000001 109.669 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 3.4300000000000002 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.8900000000000001 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 0.73999999999999999 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 1.48 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.6099999999999999 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 3.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 0.69999999999999996 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.72999999999999998 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 2.25 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 4.3700000000000001 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 1.3600000000000001 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 2.8300000000000001 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 1.6200000000000001 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 2.9700000000000002 107.793 175.771 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.113 -0.329 . . . . 2.0499999999999998 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 2.3300000000000001 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7000000000000002 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.0600000000000001 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 0.75 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.0800000000000001 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 1.79 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 0.53000000000000003 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 0.70999999999999996 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.67000000000000004 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 2.5899999999999999 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.4399999999999999 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 4.1500000000000004 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 1.46 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 0.70999999999999996 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 0.77000000000000002 110.629 171.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.78000000000000003 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 2.3700000000000001 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 69' ' ' TYR . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.5899999999999999 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 1.74 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.78000000000000003 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 63' ' ' LYS . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 1.45 110.291 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 2.3100000000000001 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 2.8999999999999999 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 1.46 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.75 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 1.5 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 0.97999999999999998 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 0.63 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.6200000000000001 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 0.93000000000000005 108.914 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.29 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 1.74 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 1.48 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 1.3899999999999999 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.1099999999999999 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 0.52000000000000002 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 2.8700000000000001 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 0.48999999999999999 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 1.25 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 1.9399999999999999 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.3300000000000001 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.91000000000000003 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.52 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 0.83999999999999997 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.66000000000000003 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 0.81999999999999995 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 0.93999999999999995 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 0.78000000000000003 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 0.63 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.1899999999999999 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.4700000000000002 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.0 109.047 -173.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.5499999999999998 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 4.1900000000000004 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 2.0899999999999999 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.59999999999999998 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 24' ' ' ILE . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 2.0600000000000001 108.235 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 2.4700000000000002 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 0.94999999999999996 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.1599999999999999 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 1.01 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.6499999999999999 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 2.6800000000000002 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 0.84999999999999998 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.3100000000000001 108.816 -173.391 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 2.3100000000000001 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.8700000000000001 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 114' ' ' VAL . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 0.62 110.295 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.7999999999999998 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 1.78 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 4.6900000000000004 111.271 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 1.8999999999999999 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 0.76000000000000001 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.5099999999999998 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 4.0899999999999999 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 3.1400000000000001 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 94' ' ' LYS . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.0299999999999998 107.241 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 3.8500000000000001 111.908 -178.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 3.1600000000000001 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 1.53 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.5900000000000001 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.0199999999999996 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 1.54 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.6600000000000001 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.81999999999999995 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.68000000000000005 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 0.93000000000000005 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.1799999999999999 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 0.83999999999999997 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 0.93999999999999995 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 1.99 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.0899999999999999 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 3.7200000000000002 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 1.3100000000000001 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 2.1299999999999999 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.6499999999999999 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 0.84999999999999998 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' A' ' 80' ' ' ILE . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 0.51000000000000001 108.347 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 1.1200000000000001 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 0.67000000000000004 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.8999999999999999 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 1.8300000000000001 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.1200000000000001 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.69999999999999996 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 5.7800000000000002 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.0299999999999998 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 0.51000000000000001 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 2.2400000000000002 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 1.6200000000000001 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 0.62 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.6099999999999999 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 0.81000000000000005 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.0499999999999998 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.2400000000000002 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 0.83999999999999997 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 1.8100000000000001 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 2.6299999999999999 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 0.92000000000000004 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.81999999999999995 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 2.1400000000000001 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 2.8300000000000001 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 1.6699999999999999 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 4.5700000000000003 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 1.9399999999999999 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 1.3 mptm? . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 3.1600000000000001 108.185 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.0099999999999998 106.215 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.0899999999999999 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.0699999999999998 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.1099999999999999 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 0.64000000000000001 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 1.9099999999999999 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 1.9199999999999999 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 0.55000000000000004 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 1.1000000000000001 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.73999999999999999 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.04 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 1.21 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.6800000000000002 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 2.5600000000000001 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 1.2 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.0 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 0.92000000000000004 111.067 169.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 0.81999999999999995 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.0899999999999999 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 0.67000000000000004 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.6499999999999999 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.0699999999999998 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.66000000000000003 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 60' ' ' ILE . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 2.6899999999999999 111.479 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 3.3399999999999999 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 3.2599999999999998 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 1.3600000000000001 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.3999999999999999 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.65000000000000002 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 1.3799999999999999 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 0.85999999999999999 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.6400000000000001 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 0.65000000000000002 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 1.6399999999999999 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 0.85999999999999999 109.692 168.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.2799999999999998 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 2.1600000000000001 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 1.1599999999999999 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 1.1299999999999999 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.8100000000000001 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 0.90000000000000002 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 0.39000000000000001 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 2.9900000000000002 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 0.53000000000000003 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 1.4299999999999999 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 2.02 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.4099999999999999 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.0899999999999999 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.9099999999999999 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 1.01 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.70999999999999996 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 1.3100000000000001 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 1.1399999999999999 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 0.95999999999999996 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.506 HG23 HD21 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 0.68999999999999995 107.067 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.6200000000000001 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.1800000000000002 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 0.57999999999999996 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.1699999999999999 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 2.1800000000000002 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.65000000000000002 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 1.8600000000000001 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 1.8200000000000001 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 0.48999999999999999 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 0.81999999999999995 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 0.81999999999999995 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.3300000000000001 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 3.8500000000000001 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 0.76000000000000001 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.3300000000000001 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 2.2000000000000002 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 0.57999999999999996 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.4900000000000002 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 3.2400000000000002 111.825 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 111.662 0.245 . . . . 2.1200000000000001 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 0.89000000000000001 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 0.77000000000000002 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.02 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 5.1399999999999997 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.0299999999999998 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.0699999999999998 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 4.46 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 3.75 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 1.4399999999999999 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.53 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 5.54 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 1.6100000000000001 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.0300000000000002 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.71999999999999997 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 0.60999999999999999 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 0.63 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.81999999999999995 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 0.56000000000000005 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.72999999999999998 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 1.75 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.2400000000000002 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 3.1000000000000001 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.46 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 1.53 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.9399999999999999 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 0.69999999999999996 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 0.46999999999999997 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 0.68999999999999995 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.67000000000000004 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.8399999999999999 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 1.8500000000000001 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 2.5099999999999998 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.69999999999999996 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 5.7300000000000004 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.6899999999999999 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 0.56000000000000005 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 141' ' ' LEU . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 1.48 110.841 176.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.70999999999999996 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.1400000000000001 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 0.97999999999999998 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.0 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.6400000000000001 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 0.56999999999999995 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 1.49 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 2.5699999999999998 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 0.79000000000000004 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 2.6400000000000001 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 3.3799999999999999 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 1.4199999999999999 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 2.77 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 125' ' ' VAL . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 1.71 107.793 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 3.1899999999999999 108.901 -175.606 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.925 -0.398 . . . . 2.4399999999999999 109.925 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 2.4500000000000002 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.8999999999999999 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 2.7999999999999998 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 1.6699999999999999 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 2.4700000000000002 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 0.56999999999999995 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 0.80000000000000004 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68000000000000005 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 2.7799999999999998 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 1.8799999999999999 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 4.4800000000000004 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 2.9300000000000002 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 0.90000000000000002 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 0.79000000000000004 111.158 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 0.82999999999999996 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 2.5899999999999999 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 1.26 108.556 173.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 2.1000000000000001 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 0.93000000000000005 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 1.6299999999999999 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 2.75 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 4.3300000000000001 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 1.3600000000000001 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.21 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 0.72999999999999998 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 2.23 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 1.23 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.4500000000000002 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.21 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.1499999999999999 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG13 ' HB1' ' A' ' 21' ' ' ALA . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 1.3200000000000001 112.312 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.9100000000000001 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 2.02 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 1.21 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 1.5 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.9399999999999999 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.3700000000000001 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.45000000000000001 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.5699999999999998 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 0.5 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 1.0600000000000001 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 1.96 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.8399999999999999 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91000000000000003 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 0.96999999999999997 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.76000000000000001 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 0.78000000000000003 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 0.78000000000000003 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 0.73999999999999999 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.1200000000000001 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.8300000000000001 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 3.71 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 0.60999999999999999 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.4399999999999999 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.1899999999999999 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 2.5899999999999999 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.78000000000000003 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 1.98 109.318 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 2.29 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 0.70999999999999996 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 1.5600000000000001 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 0.78000000000000003 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 2.6200000000000001 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 0.81000000000000005 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.0499999999999998 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 1.73 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.2999999999999998 108.194 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.76000000000000001 109.971 -168.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.1499999999999999 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.6299999999999999 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 3.1499999999999999 113.696 -168.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 90' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.1800000000000002 108.807 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 0.93999999999999995 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 0.93999999999999995 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.04 109.064 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 4.5499999999999998 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 80' ' ' ILE . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 1.72 111.651 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.1899999999999999 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 4.3700000000000001 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' HG11 ' A' ' 102' ' ' VAL . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 1.5900000000000001 110.705 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.3200000000000001 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 4.6699999999999999 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 1.4199999999999999 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.6099999999999999 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.69999999999999996 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 96' ' ' LEU . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 0.56999999999999995 107.638 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.97999999999999998 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 0.45000000000000001 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.51000000000000001 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 2.3100000000000001 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.79 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 2.7200000000000002 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.3300000000000001 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 1.8400000000000001 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.3099999999999996 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 1.1100000000000001 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 80' ' ' ILE . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 0.40999999999999998 107.131 161.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 0.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 0.76000000000000001 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.8799999999999999 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 1.96 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 2.23 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.69999999999999996 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 5.5300000000000002 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.7999999999999998 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 0.55000000000000004 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.0299999999999998 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 1.47 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 0.81000000000000005 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 0.79000000000000004 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 2.8399999999999999 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 0.62 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 1.6200000000000001 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 4.4500000000000002 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 1.1399999999999999 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.65000000000000002 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 2.2999999999999998 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 2.8300000000000001 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 1.47 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 2.48 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.0099999999999998 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 4.7199999999999998 108.679 176.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.2999999999999998 109.227 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 2.1699999999999999 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.1799999999999997 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 0.56000000000000005 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 2.2400000000000002 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 1.72 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 0.91000000000000003 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.0900000000000001 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 2.71 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 1.3 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.2999999999999998 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 3.3799999999999999 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 1.99 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.1100000000000001 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.861 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 0.73999999999999999 109.961 173.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 0.96999999999999997 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.2599999999999998 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 0.90000000000000002 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.491 ' OE2' HG12 ' A' ' 39' ' ' VAL . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.5600000000000001 110.706 -178.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.0099999999999998 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 0.94999999999999996 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 1.75 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.1400000000000001 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 4.5899999999999999 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 1.76 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.3300000000000001 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.58999999999999997 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 1.3700000000000001 109.973 176.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 0.93999999999999995 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.8500000000000001 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 0.67000000000000004 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 1.72 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 1.25 110.215 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.3700000000000001 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 1.6599999999999999 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.21 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 1.0700000000000001 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.5499999999999998 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 1.1100000000000001 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 0.38 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 2.6600000000000001 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 0.68999999999999995 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 1.0800000000000001 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 2.0299999999999998 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 0.93999999999999995 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.4299999999999999 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.05 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 0.94999999999999996 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.1100000000000001 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 0.96999999999999997 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 0.87 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 0.81999999999999995 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.72 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 2.8300000000000001 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 0.82999999999999996 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.8799999999999999 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 4.9000000000000004 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 2.7599999999999998 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.0700000000000001 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 2.9900000000000002 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 2.1800000000000002 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 0.94999999999999996 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 1.3600000000000001 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 0.97999999999999998 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.5699999999999998 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 2.8500000000000001 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 2.0699999999999998 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.6299999999999999 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 92' ' ' ILE . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 0.65000000000000002 107.647 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.1399999999999997 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 2.1299999999999999 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.569 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 6.9 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.4199999999999999 112.441 -176.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.56 0.219 . . . . 1.8500000000000001 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 0.80000000000000004 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB1' HG21 ' A' ' 107' ' ' VAL . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 0.84999999999999998 109.683 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 4.8200000000000003 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 80' ' ' ILE . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 1.99 110.719 -178.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 3.7599999999999998 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 4.0899999999999999 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.429 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 1.9299999999999999 111.942 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.2 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 3.8399999999999999 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 1.3899999999999999 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.4300000000000002 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.65000000000000002 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 96' ' ' LEU . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 0.54000000000000004 108.008 178.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 0.57999999999999996 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.78000000000000003 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.73999999999999999 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.694 HG21 ' HB1' ' A' ' 89' ' ' ALA . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 2.6800000000000002 110.968 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.1600000000000001 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 2.4500000000000002 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 1.0900000000000001 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 1.3899999999999999 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7000000000000002 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 1.0 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 0.62 107.873 168.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 0.80000000000000004 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 0.54000000000000004 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 2.02 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.0600000000000001 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.58999999999999997 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 5.6900000000000004 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 0.56999999999999995 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.0699999999999998 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 1.8600000000000001 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 0.78000000000000003 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 0.76000000000000001 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 3.6800000000000002 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 0.52000000000000002 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 1.5800000000000001 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.3100000000000001 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 3.1400000000000001 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 0.77000000000000002 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.68999999999999995 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 2.1600000000000001 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 3.5800000000000001 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 1.4099999999999999 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 2.3399999999999999 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 3.7400000000000002 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 4.8200000000000003 108.826 170.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.505 -0.554 . . . . 2.98 109.505 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.1099999999999999 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.3100000000000001 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 3.0600000000000001 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 1.5800000000000001 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 5.1100000000000003 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.04 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 0.73999999999999999 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 1.01 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.1100000000000001 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 21' ' ' ALA . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 3.8399999999999999 110.667 176.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 1.95 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 41' ' ' LEU . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 2.9100000000000001 109.523 174.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 3.6099999999999999 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 2.2400000000000002 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 1.1799999999999999 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 1.23 109.925 168.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 1.5900000000000001 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 2.6899999999999999 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 0.87 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.6400000000000001 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 2.73 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.1599999999999999 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 1.5900000000000001 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 1.76 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.0999999999999996 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 1.6799999999999999 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.3600000000000001 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 0.92000000000000004 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 1.3999999999999999 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 0.56999999999999995 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.1800000000000002 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.94999999999999996 109.65 175.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.72 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 17' ' ' CYS . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 1.76 111.652 174.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 1.22 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 1.22 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.9900000000000002 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 1.1399999999999999 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 0.53000000000000003 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.79 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 0.56000000000000005 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 2.0600000000000001 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.8100000000000001 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.3700000000000001 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 1.8400000000000001 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.4300000000000002 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 0.95999999999999996 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.80000000000000004 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 1.28 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 1.0 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 1.25 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.0 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.5099999999999998 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 3.98 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 0.81999999999999995 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.1200000000000001 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 2.3399999999999999 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 3.0800000000000001 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.89000000000000001 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 2.27 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 2.2599999999999998 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 0.88 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 1.2 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 1.74 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.4900000000000002 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 2.75 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 0.92000000000000004 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.2200000000000002 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 1.8799999999999999 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 0.71999999999999997 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.1200000000000001 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 3.77 111.297 170.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.173 0.511 . . . . 2.1899999999999999 110.12 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.27 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 1.0900000000000001 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.6899999999999999 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 4.1900000000000004 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 1.9399999999999999 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7000000000000002 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 3.6899999999999999 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.1299999999999999 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 1.8400000000000001 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.3 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 4.5700000000000003 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 1.8400000000000001 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.8199999999999998 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.6899999999999999 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 102' ' ' VAL . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 1.3 112.828 -170.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 1.04 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.1899999999999999 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 1.95 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.1200000000000001 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 2.5699999999999998 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 1.75 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 1.8999999999999999 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.9100000000000001 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 0.77000000000000002 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 1.0700000000000001 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 0.93999999999999995 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.2799999999999998 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 2.4700000000000002 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 2.8500000000000001 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 8.2599999999999998 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.3600000000000003 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.1899999999999999 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 2.6499999999999999 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 2.0899999999999999 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 0.95999999999999996 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.9100000000000001 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 0.92000000000000004 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 3.6000000000000001 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.7200000000000002 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 0.67000000000000004 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 139' ' ' LEU . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 1.5 110.223 -178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.5699999999999998 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 3.23 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 1.1599999999999999 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.23 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 2.02 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 3.3700000000000001 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 132' ' ' VAL . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 1.3600000000000001 110.404 173.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 2.52 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 3.4199999999999999 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 176.513 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 2.7599999999999998 116.764 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 2.3500000000000001 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.2599999999999998 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 1.9099999999999999 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 0.63 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 2.1299999999999999 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.0 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 0.81000000000000005 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 0.97999999999999998 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.84999999999999998 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 3.5099999999999998 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 1.77 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.25 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 2.8700000000000001 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 1.45 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 0.88 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 110.089 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 0.90000000000000002 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.1699999999999999 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 0.85999999999999999 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.1699999999999999 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 1.99 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.65000000000000002 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 1.6299999999999999 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 2.21 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 3.79 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 2.3500000000000001 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.1599999999999999 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.54000000000000004 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 1.3 110.079 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 0.93999999999999995 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.1800000000000002 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 0.65000000000000002 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.3199999999999998 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.721 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 0.85999999999999999 111.952 -173.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 1.52 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 0.91000000000000003 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 0.93999999999999995 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 1.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 0.51000000000000001 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 3.8399999999999999 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 0.40999999999999998 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 2.1699999999999999 109.604 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.2999999999999998 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.80000000000000004 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.8300000000000001 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 0.76000000000000001 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.60999999999999999 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 0.75 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 0.75 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 0.70999999999999996 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.1400000000000001 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.6299999999999999 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 2.3999999999999999 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 0.57999999999999996 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.8500000000000001 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 2.4199999999999999 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 2.6099999999999999 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.65000000000000002 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 2.1299999999999999 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 2.0800000000000001 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 0.58999999999999997 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 1.0 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 0.92000000000000004 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2000000000000002 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 2.7200000000000002 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 0.76000000000000001 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 1.7 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.8799999999999999 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 0.81000000000000005 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.0199999999999996 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.54 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.3 ttp . . . . . 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 3.4300000000000002 111.21 173.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 108.469 -0.937 . . . . 1.46 108.469 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.23 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' MET . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 109.612 168.162 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 4.21 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 1.6699999999999999 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 2.5099999999999998 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 3.5699999999999998 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.401 ' O ' HG11 ' A' ' 102' ' ' VAL . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 1.8899999999999999 112.109 -176.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 1.97 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 6.46 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 1.6799999999999999 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6000000000000001 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.81999999999999995 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 96' ' ' LEU . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 0.71999999999999997 107.886 175.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 0.98999999999999999 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 0.65000000000000002 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.87 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 1.8200000000000001 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 2.4199999999999999 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 1.1699999999999999 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 1.6599999999999999 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.4900000000000002 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 0.65000000000000002 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 0.65000000000000002 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.8700000000000001 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 1.77 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 2.3500000000000001 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 0.93000000000000005 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 7.2800000000000002 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.6200000000000001 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 0.66000000000000003 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.0299999999999998 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 1.7 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 0.68999999999999995 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.2200000000000002 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 0.81999999999999995 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.04 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 0.51000000000000001 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 1.5900000000000001 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.5600000000000001 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 3.8900000000000001 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 0.80000000000000004 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.71999999999999997 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 2.1800000000000002 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.1000000000000001 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 1.3700000000000001 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 2.5499999999999998 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 1.72 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.0199999999999996 108.567 172.004 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.6499999999999999 108.695 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 3.0800000000000001 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.6299999999999999 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 1.9299999999999999 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 0.65000000000000002 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 1.79 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 2.52 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 1.0 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 1.0600000000000001 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 0.92000000000000004 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 3.4500000000000002 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 1.73 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.2699999999999996 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 4.5099999999999998 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.02 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.1599999999999999 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 0.84999999999999998 110.452 170.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 1.26 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 2.9399999999999999 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 0.80000000000000004 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.6899999999999999 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 2.2400000000000002 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 0.92000000000000004 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 1.5800000000000001 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 2.0699999999999998 112.774 174.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 3.8700000000000001 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 1.5600000000000001 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.1899999999999999 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 0.68999999999999995 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 1.49 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 0.95999999999999996 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.5800000000000001 112.925 172.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 0.81999999999999995 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 1.7 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.863 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 0.94999999999999996 110.641 177.096 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 1.9199999999999999 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 1.48 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 1.5900000000000001 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.5699999999999998 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.3200000000000001 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 0.56999999999999995 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.6699999999999999 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 0.5 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 1.79 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 1.79 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 1.4399999999999999 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 1.3100000000000001 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.22 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 1.0600000000000001 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 1.3 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 1.1299999999999999 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 0.93999999999999995 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.4199999999999999 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.5800000000000001 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 0.92000000000000004 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 2.8199999999999998 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 2.25 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.04 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 2.4500000000000002 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 1.05 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.0800000000000001 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 2.1200000000000001 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.6799999999999997 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 4.3300000000000001 109.257 174.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 0.81999999999999995 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 2.1400000000000001 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.7799999999999998 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.0600000000000001 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 2.7200000000000002 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.3999999999999999 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 3.3700000000000001 112.126 167.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.994 0.738 . . . . 1.74 112.994 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 1.0600000000000001 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 1.03 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 1.75 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 3.5099999999999998 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 132' ' ' VAL . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 1.8200000000000001 111.812 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 3.5099999999999998 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 3.3500000000000001 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 1.53 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.0299999999999998 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 5.4199999999999999 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 1.71 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.1099999999999999 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.1000000000000001 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 0.85999999999999999 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 1.0800000000000001 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.1699999999999999 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 0.77000000000000002 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 0.90000000000000002 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 1.8400000000000001 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 1.8500000000000001 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 2.4900000000000002 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.0499999999999998 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 1.8799999999999999 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.5899999999999999 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 0.63 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 0.81000000000000005 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 0.68999999999999995 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.7200000000000002 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 2.0699999999999998 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.1299999999999999 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.3500000000000001 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 5.4400000000000004 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.7599999999999998 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 0.95999999999999996 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 2.27 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 2.4300000000000002 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 0.83999999999999997 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.8100000000000001 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 0.77000000000000002 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.02 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.9299999999999997 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 0.68000000000000005 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 139' ' ' LEU . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 1.72 111.51 -178.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.2799999999999998 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 2.27 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 1.03 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 2.4900000000000002 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 3.8100000000000001 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.84 ' CB ' HG11 ' A' ' 132' ' ' VAL . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 2.6200000000000001 106.482 -175.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 2.9700000000000002 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.0 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 2.48 109.166 174.985 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 121.895 0.855 . . . . 2.73 109.592 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 1.95 106.168 166.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6000000000000001 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 2.5600000000000001 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 0.67000000000000004 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 1.8 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.4300000000000002 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 0.5 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 0.83999999999999997 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.62 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 3.21 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 1.47 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' HD13 ' A' ' 41' ' ' LEU . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.1800000000000002 109.699 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 2.9100000000000001 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 2.1200000000000001 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.05 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 0.91000000000000003 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 1.3400000000000001 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 2.8100000000000001 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 0.67000000000000004 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.7200000000000002 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 2.75 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.78000000000000003 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 60' ' ' ILE . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 3.0 110.528 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' HG11 ' A' ' 34' ' ' VAL . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 4.3300000000000001 112.555 175.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 2.8199999999999998 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 1.3500000000000001 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.62 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 2.6000000000000001 109.212 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 1.25 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.0600000000000001 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 0.78000000000000003 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 1.99 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 0.84999999999999998 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 1.72 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 1.6399999999999999 111.14 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 1.02 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 0.88 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 0.95999999999999996 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 0.46000000000000002 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.6499999999999999 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 0.45000000000000001 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 1.8300000000000001 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.6800000000000002 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.0 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.03 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.88 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 0.96999999999999997 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 0.77000000000000002 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 0.68999999999999995 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 28' ' ' LEU . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 0.85999999999999999 107.64 177.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.0099999999999998 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.1499999999999999 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 3.6299999999999999 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 0.67000000000000004 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 2.6800000000000002 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 2.3900000000000001 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 0.92000000000000004 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 1.95 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 1.79 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 0.54000000000000004 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 0.93999999999999995 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 0.79000000000000004 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.7599999999999998 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 0.58999999999999997 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.4900000000000002 111.216 -176.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 114' ' ' VAL . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 0.59999999999999998 110.255 -173.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2000000000000002 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 3.4 ptt? . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 3.02 113.618 -175.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 111.707 0.262 . . . . 1.75 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 0.81999999999999995 109.404 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 0.68999999999999995 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.3100000000000001 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 3.5299999999999998 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 1.98 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6000000000000001 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 3.4700000000000002 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 2.9300000000000002 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 1.6499999999999999 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.3799999999999999 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 4.3200000000000003 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 1.3899999999999999 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.67000000000000004 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 0.59999999999999998 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 0.58999999999999997 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.72999999999999998 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 0.46000000000000002 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.53000000000000003 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 1.71 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 2.96 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 1.24 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 1.6799999999999999 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.7599999999999998 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 0.73999999999999999 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 0.44 107.749 172.262 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 0.59999999999999998 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 0.55000000000000004 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.6099999999999999 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 2.0699999999999998 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.4700000000000002 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.70999999999999996 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 4.7199999999999998 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.3700000000000001 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 0.63 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.0099999999999998 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 1.55 112.758 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.68999999999999995 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.5499999999999998 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 1.02 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 3.1000000000000001 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.8599999999999999 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 0.57999999999999996 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 1.73 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.6200000000000001 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 4.1200000000000001 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 1.0600000000000001 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.73999999999999999 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 1.98 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 3.2799999999999998 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 1.3899999999999999 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 3.1699999999999999 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 1.6399999999999999 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 8.5 mtpt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.21 109.188 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.843 0.354 . . . . 2.2599999999999998 111.592 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 2.2000000000000002 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7000000000000002 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 1.9299999999999999 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 0.55000000000000004 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 2.3199999999999998 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.54 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 0.66000000000000003 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.1200000000000001 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 0.93999999999999995 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 2.5899999999999999 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 1.5800000000000001 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.464 ' SG ' HD13 ' A' ' 41' ' ' LEU . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.1099999999999999 109.511 179.088 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 2.73 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 1.5600000000000001 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.1499999999999999 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.898 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 0.85999999999999999 109.402 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 0.76000000000000001 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 2.3599999999999999 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.507 HD11 ' CE2' ' A' ' 69' ' ' TYR . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 0.56000000000000005 108.488 174.393 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' OE2' HG12 ' A' ' 39' ' ' VAL . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.7799999999999998 111.285 -175.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 1.8700000000000001 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.57999999999999996 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 1.6000000000000001 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 2.5 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 3.1699999999999999 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 1.23 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.57999999999999996 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 1.48 109.94 178.377 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 0.68000000000000005 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.8100000000000001 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 0.56999999999999995 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 1.8300000000000001 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.898 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 1.1499999999999999 110.822 175.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.0299999999999998 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.308 173.072 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 0.93000000000000005 111.462 175.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 0.87 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 0.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 0.40999999999999998 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.7000000000000002 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 0.40000000000000002 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 1.6000000000000001 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 1.79 111.321 -172.173 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.0699999999999998 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.87 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 0.95999999999999996 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.8799999999999999 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 0.78000000000000003 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.69999999999999996 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 0.95999999999999996 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 0.70999999999999996 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 0.63 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 0.72999999999999998 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.1899999999999999 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.5299999999999998 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 2.4300000000000002 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 0.56000000000000005 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.1400000000000001 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 2.6699999999999999 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 1.99 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.62 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CE2' HD11 ' A' ' 24' ' ' ILE . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 109.838 -178.139 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 2.1499999999999999 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 0.77000000000000002 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 0.78000000000000003 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.9199999999999999 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 4.2599999999999998 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 0.62 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.7200000000000002 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 1.75 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 114' ' ' VAL . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 0.59999999999999998 109.637 -167.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.3799999999999999 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.3899999999999999 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.0 110.559 176.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 113.259 0.837 . . . . 1.9399999999999999 113.259 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.847 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 0.63 111.242 173.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.1099999999999999 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 4.6500000000000004 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 1.8500000000000001 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.3399999999999999 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 4.7400000000000002 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 3.0299999999999998 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 1.71 111.322 -174.575 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.6299999999999999 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 4.7199999999999998 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 2.48 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.4900000000000002 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.67000000000000004 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 0.54000000000000004 108.027 178.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.65000000000000002 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89000000000000001 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 0.53000000000000003 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.58999999999999997 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.847 HG11 ' HB1' ' A' ' 89' ' ' ALA . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 2.3300000000000001 109.472 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.8900000000000001 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 3.98 112.028 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 1.6000000000000001 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 1.4199999999999999 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.7200000000000002 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 0.68999999999999995 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.447 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 0.60999999999999999 108.516 168.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 0.77000000000000002 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 0.58999999999999997 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.8599999999999999 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 1.76 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 2.3700000000000001 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.58999999999999997 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 6.6799999999999997 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 0.53000000000000003 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 2.29 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 2.27 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 0.95999999999999996 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.0299999999999998 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 0.94999999999999996 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 3.1600000000000001 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.04 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 1.6499999999999999 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.8300000000000001 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 3.27 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 1.24 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.75 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 1.9099999999999999 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 2.77 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 1.4299999999999999 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.1099999999999999 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 1.5900000000000001 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 2.98 109.67 178.793 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.1400000000000001 108.68 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 2.5899999999999999 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.5499999999999998 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 2.5299999999999998 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 0.75 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 2.2400000000000002 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 1.73 110.374 172.817 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 0.66000000000000003 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 0.77000000000000002 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.63 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 4.1299999999999999 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 1.46 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.04 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 3.3700000000000001 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 1.3799999999999999 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 0.82999999999999996 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 0.72999999999999998 111.856 169.279 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 0.84999999999999998 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 4.29 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 0.62 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 3.3199999999999998 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.58999999999999997 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 60' ' ' ILE . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 2.8900000000000001 110.81 -178.255 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 2.0499999999999998 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 2.9100000000000001 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 2.0800000000000001 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.4299999999999999 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.67000000000000004 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 1.3400000000000001 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 0.84999999999999998 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.0899999999999999 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 0.63 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 1.8700000000000001 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 1.6499999999999999 111.183 174.221 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 2.71 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 2.6499999999999999 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.1499999999999999 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 0.84999999999999998 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.0600000000000001 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 1.1100000000000001 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 0.54000000000000004 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.1299999999999999 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 0.46999999999999997 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 1.1899999999999999 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 1.8100000000000001 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.0499999999999998 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 0.89000000000000001 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.1899999999999999 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.1200000000000001 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 1.0600000000000001 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 0.97999999999999998 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 1.1299999999999999 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 1.03 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 0.93999999999999995 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 28' ' ' LEU . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 1.8600000000000001 109.466 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.5600000000000001 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.8999999999999999 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 2.3999999999999999 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 0.51000000000000001 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.1800000000000002 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 2.2200000000000002 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.62 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 2.1400000000000001 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 2.4100000000000001 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 0.57999999999999996 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 0.97999999999999998 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 0.90000000000000002 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.8700000000000001 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 2.8700000000000001 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 0.68000000000000005 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.4500000000000002 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 2.0499999999999998 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 114' ' ' VAL . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 0.67000000000000004 109.103 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.3399999999999999 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.725 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 37.8 mtm . . . . . 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.04 112.514 178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 N-CA-C 109.851 -0.425 . . . . 2.46 109.851 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 0.93000000000000005 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 0.67000000000000004 111.651 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.1899999999999999 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 4.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 2.9500000000000002 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 2.9399999999999999 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.0800000000000001 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 1.4099999999999999 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' HB3' ' HD2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.45 113.762 174.48 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 6.6600000000000001 110.164 176.713 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 1.3500000000000001 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.6200000000000001 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 0.80000000000000004 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 0.78000000000000003 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 0.96999999999999997 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.1100000000000001 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 0.81000000000000005 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.70999999999999996 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 89' ' ' ALA . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 3.1800000000000002 110.658 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 3.1800000000000002 112.979 -176.154 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 1.5800000000000001 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 2.1400000000000001 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.6899999999999999 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 1.0 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 0.42999999999999999 107.477 163.615 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 0.60999999999999999 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.9399999999999999 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 1.8600000000000001 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 2.23 108.846 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64000000000000001 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 5.46 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.6200000000000001 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 0.64000000000000001 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.0600000000000001 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 1.54 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 0.72999999999999998 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.1899999999999999 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.70999999999999996 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 3.6499999999999999 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.2200000000000002 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 0.56999999999999995 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 1.45 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.3100000000000001 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 3.6600000000000001 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 0.80000000000000004 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.76000000000000001 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 2.04 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.0600000000000001 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 1.55 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.1000000000000001 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 1.5700000000000001 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 3.9500000000000002 110.097 -179.452 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.302 -0.629 . . . . 2.3300000000000001 109.302 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 2.21 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.1299999999999999 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.0600000000000001 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 0.59999999999999998 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 1.9199999999999999 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.2599999999999998 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 0.65000000000000002 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 1.03 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.64000000000000001 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 39' ' ' VAL . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 3.8500000000000001 109.615 175.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 1.5 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.0899999999999999 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.3900000000000001 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 1.25 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 0.80000000000000004 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 0.87 109.437 177.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 1.02 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.0600000000000001 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 0.69999999999999996 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.0199999999999996 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 2.7400000000000002 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.93999999999999995 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 1.6000000000000001 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.2000000000000002 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 3.6899999999999999 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 1.3600000000000001 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 0.68000000000000005 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 1.5600000000000001 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 0.85999999999999999 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.3500000000000001 112.53 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 0.78000000000000003 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.1499999999999999 110.481 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 0.91000000000000003 109.468 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.3300000000000001 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 1.8799999999999999 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 1.03 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 0.82999999999999996 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.1499999999999999 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 0.78000000000000003 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 0.37 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 2.8199999999999998 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 0.46000000000000002 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 1.1699999999999999 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 1.8200000000000001 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.2799999999999998 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.03 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 1.0800000000000001 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.2799999999999998 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 0.75 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.69999999999999996 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 0.84999999999999998 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 0.76000000000000001 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 0.64000000000000001 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 0.64000000000000001 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.8899999999999999 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 3.3999999999999999 110.581 -176.67 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 0.63 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 2.1899999999999999 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 2.1600000000000001 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.65000000000000002 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 2.0099999999999998 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 2.2200000000000002 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 0.62 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 1.01 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.4199999999999999 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 2.6699999999999999 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 116' ' ' VAL . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 0.97999999999999998 109.135 178.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.4700000000000002 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 1.98 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.6799999999999999 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 0.63 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.9900000000000002 108.878 172.124 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 4.1900000000000004 113.728 -177.421 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 113.105 0.779 . . . . 2.2799999999999998 113.105 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.0800000000000001 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 1.1000000000000001 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2000000000000002 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 3.98 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 1.8 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.6899999999999999 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.0699999999999998 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 3.2999999999999998 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 1.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.52 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 4.21 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 1.3400000000000001 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.70999999999999996 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 0.54000000000000004 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 0.68000000000000005 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 0.89000000000000001 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 0.45000000000000001 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.54000000000000004 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 2.3100000000000001 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 1.75 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 2.4500000000000002 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 1.25 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 0.77000000000000002 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 0.46000000000000002 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 0.68999999999999995 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 -179.378 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.0099999999999998 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 1.9399999999999999 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 2.2799999999999998 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 7.79 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.3799999999999999 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 0.51000000000000001 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.0499999999999998 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG11 HD21 ' A' ' 141' ' ' LEU . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 1.47 110.781 173.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 0.66000000000000003 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.68999999999999995 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' VAL . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 2.9100000000000001 110.702 174.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7000000000000002 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 0.47999999999999998 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 139' ' ' LEU . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 1.8500000000000001 110.038 -175.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.0899999999999999 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 2.6000000000000001 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 0.91000000000000003 112.236 169.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.69999999999999996 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 2.0899999999999999 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 3.7599999999999998 107.383 176.05 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 132' ' ' VAL . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 1.3899999999999999 108.299 178.19 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 2.9399999999999999 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.447 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 1.6599999999999999 108.691 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt . . . . . 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 3.4900000000000002 108.585 175.373 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 2.7400000000000002 110.322 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 1.6000000000000001 110.564 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 2.7400000000000002 110.322 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 1.6000000000000001 110.564 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.712 -1.218 . . . . 13.31 107.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.5 pt? -83.74 -172.97 4.45 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.828 0.705 . . . . 8.8499999999999996 109.432 167.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m 84.92 146.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.781 2.032 . . . . 4.5199999999999996 109.158 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -138.81 81.9 1.87 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.775 -1.194 . . . . 5.8499999999999996 107.775 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -48.91 129.05 16.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.496 -1.229 . . . . 2.5699999999999998 109.712 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 2.52 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.1499999999999999 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 0.79000000000000004 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 2.1600000000000001 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.2400000000000002 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 0.62 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 0.90000000000000002 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.85999999999999999 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 2.3599999999999999 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 2.1800000000000002 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.2699999999999996 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 2.5499999999999998 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 1.27 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 0.87 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 0.73999999999999999 109.046 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 0.98999999999999999 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 4.0300000000000002 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 0.58999999999999997 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.9700000000000002 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 4.3200000000000003 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.64000000000000001 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 1.5700000000000001 109.588 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 1.71 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 3.23 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 1.5700000000000001 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.64000000000000001 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 1.3899999999999999 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 0.83999999999999997 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.1400000000000001 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 0.69999999999999996 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 1.79 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 21' ' ' ALA . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 0.95999999999999996 106.877 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.0800000000000001 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 1.71 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.0600000000000001 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 0.91000000000000003 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.6599999999999999 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 1.22 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 0.57999999999999996 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 3.9700000000000002 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 0.51000000000000001 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 1.02 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 1.76 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.4199999999999999 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.28 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 0.98999999999999999 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 0.72999999999999998 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.70999999999999996 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.85999999999999999 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 0.76000000000000001 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 0.62 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 0.64000000000000001 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.8500000000000001 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.0499999999999998 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' HD22 ' A' ' 28' ' ' LEU . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 108.997 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 0.56000000000000005 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.5600000000000001 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.0299999999999998 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 2.2599999999999998 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.65000000000000002 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 1.8999999999999999 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 1.9099999999999999 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 0.53000000000000003 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 0.93999999999999995 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 0.81999999999999995 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.3300000000000001 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 2.7000000000000002 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 0.80000000000000004 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.8900000000000001 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 2.1600000000000001 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 114' ' ' VAL . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 0.58999999999999997 108.926 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 138' ' ' LYS . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.5800000000000001 109.865 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.5800000000000001 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 165.39 4.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 4.0899999999999999 113.177 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 t -179.53 -53.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.957 -1.498 . . . . 3.4199999999999999 106.957 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.8 t -92.5 32.57 1.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.342 -0.849 . . . . 5.1600000000000001 110.451 -165.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 41.87 27.37 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.165 1.786 . . . . 5.6200000000000001 114.159 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -116.57 -50.81 2.61 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.865 0.866 . . . . 1.99 109.733 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 0.98999999999999999 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 0.90000000000000002 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.3199999999999998 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.0599999999999996 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 2.79 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 3.8199999999999998 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 3.6499999999999999 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 1.27 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.28 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 4.5899999999999999 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 1.3600000000000001 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.77000000000000002 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 0.56000000000000005 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 0.59999999999999998 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79000000000000004 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 0.47999999999999998 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.53000000000000003 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 1.72 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.76 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 3.0800000000000001 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 1.3200000000000001 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 1.8200000000000001 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 0.71999999999999997 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 0.38 107.847 166.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 0.58999999999999997 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 0.56999999999999995 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.5299999999999998 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 1.8 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 2.1000000000000001 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.63 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 7.3799999999999999 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.6400000000000001 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 0.69999999999999996 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.3799999999999999 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 1.4099999999999999 114.604 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.9199999999999999 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.84999999999999998 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.0800000000000001 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.8300000000000001 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 0.75 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 1.55 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.1400000000000001 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.0499999999999998 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 0.90000000000000002 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.90000000000000002 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 2.1699999999999999 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.0299999999999998 106.37 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 1.8 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.1099999999999999 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.44 83.05 5.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 3.6800000000000002 107.516 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.82 -54.96 4.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.484 0.564 . . . . 2.0899999999999999 112.056 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 59.02 32.44 22.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.944 1.297 . . . . 5.1299999999999999 111.454 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.85 -47.34 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.736 -0.603 . . . . 6.29 110.392 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.84 52.95 5.04 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 123.164 1.459 . . . . 8.7100000000000009 109.013 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m 63.75 16.05 9.46 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.989 1.716 . . . . 7.75 114.069 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.12 72.54 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.9 0.773 . . . . 9.2699999999999996 109.65 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -112.76 131.01 55.87 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.407 -1.701 . . . . 14.18 106.407 161.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.31 -74.06 0.34 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.482 -1.047 . . . . 15.09 110.482 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 N-CA-C 103.996 -2.594 . . . . 15.83 103.996 161.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.044 -0.724 . . . . 16.989999999999998 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.76 127.76 1.36 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 106.094 -1.817 . . . . 9.3800000000000008 106.094 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -173.08 165.2 4.95 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.767 2.027 . . . . 5.5 106.499 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.43 62.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.732 1.613 . . . . 5.75 108.317 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -86.79 158.62 19.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.27 -0.877 . . . . 2.6000000000000001 108.906 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 4.8499999999999996 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.5300000000000002 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 1.8700000000000001 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 0.76000000000000001 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 2.1699999999999999 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 0.71999999999999997 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 0.72999999999999998 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.67000000000000004 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 3.79 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 1.3 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 3.8399999999999999 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 1.4399999999999999 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 0.81000000000000005 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 0.78000000000000003 110.147 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 0.85999999999999999 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 3.4500000000000002 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 0.78000000000000003 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' OE2' HG12 ' A' ' 39' ' ' VAL . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.6099999999999999 110.538 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 1.8999999999999999 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.79000000000000004 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 60' ' ' ILE . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 2.4900000000000002 110.748 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 2.2000000000000002 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 2.71 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 1.3999999999999999 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.55000000000000004 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 1.3100000000000001 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.0800000000000001 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 0.68999999999999995 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.774 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 1.1399999999999999 110.14 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.7 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 1.53 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.03 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 0.90000000000000002 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1000000000000001 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 0.81000000000000005 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 0.44 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 2.6299999999999999 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 0.48999999999999999 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 1.23 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 1.8 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6000000000000001 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.1499999999999999 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 1.6499999999999999 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.9199999999999999 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.87 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 1.24 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 0.91000000000000003 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 0.75 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 0.78000000000000003 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.3700000000000001 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 3.4900000000000002 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 0.55000000000000004 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.1800000000000002 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 2.3900000000000001 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 2.25 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.93999999999999995 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 2.1499999999999999 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 1.8500000000000001 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 0.62 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.90000000000000002 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.4399999999999999 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 3.1699999999999999 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.0 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.9399999999999999 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 2.2000000000000002 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.5299999999999998 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 0.69999999999999996 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.3599999999999999 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp -51.61 73.33 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 2.6600000000000001 114.676 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t -77.03 51.16 0.79 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.068 0.947 . . . . 4.5599999999999996 109.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t 68.95 -132.95 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 4.9900000000000002 108.029 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.58 -78.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.16 1.784 . . . . 3.5699999999999998 110.738 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.52 40.28 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.039 2.136 . . . . 1.74 108.704 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 0.90000000000000002 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 0.80000000000000004 110.209 175.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.4500000000000002 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 5.1100000000000003 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 3.1299999999999999 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 3.4500000000000002 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 2.8799999999999999 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 1.3400000000000001 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.6499999999999999 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 4.5800000000000001 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 1.3500000000000001 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.6699999999999999 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.70999999999999996 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 0.55000000000000004 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 0.62 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.78000000000000003 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 0.54000000000000004 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.71999999999999997 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 89' ' ' ALA . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 2.4700000000000002 109.342 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 1.8 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 2.73 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.1299999999999999 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 1.3400000000000001 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.0499999999999998 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 0.79000000000000004 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 0.66000000000000003 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 0.84999999999999998 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 0.59999999999999998 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.8500000000000001 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 2.5099999999999998 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67000000000000004 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 5.2999999999999998 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.7200000000000002 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.70999999999999996 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.0099999999999998 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 1.6399999999999999 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.59999999999999998 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1000000000000001 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 0.79000000000000004 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 4.25 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.77000000000000002 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 139' ' ' LEU . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 1.5600000000000001 111.796 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.0699999999999998 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 2.6600000000000001 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 0.93000000000000005 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 2.02 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 3.8199999999999998 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 132' ' ' VAL . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 2.5499999999999998 108.547 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.0699999999999998 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 3.0 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 74.65 4.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 3.0899999999999999 108.861 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.83 -59.12 3.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.376 -1.09 . . . . 2.75 110.376 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.61 47.34 24.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.997 1.319 . . . . 5.3799999999999999 109.995 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.75 -53.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.234 1.813 . . . . 7.3200000000000003 107.795 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.83 -5.57 11.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.411 1.084 . . . . 7.0 112.18 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -153.88 30.5 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.964 1.306 . . . . 7.3499999999999996 110.013 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.3 mt -43.37 -66.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.774 1.23 . . . . 8.3599999999999994 111.195 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.65 167.42 1.39 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.963 2.105 . . . . 14.529999999999999 106.851 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -89.89 94.64 2.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.184 -1.566 . . . . 14.98 109.184 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.85 -1.548 . . . . 17.5 109.829 174.009 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 106.233 -1.766 . . . . 13.33 106.233 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.31 121.48 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.087 -1.079 . . . . 10.16 108.087 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m 72.73 126.7 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.125 1.77 . . . . 4.1799999999999997 112.93 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 54.42 1.68 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.481 1.134 . . . . 4.7699999999999996 109.731 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -57.96 155.96 9.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.937 1.295 . . . . 2.8100000000000001 109.141 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 2.6499999999999999 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 2.77 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 3.04 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 0.57999999999999996 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 1.8999999999999999 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.1499999999999999 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 0.87 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.04 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.95999999999999996 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 2.3799999999999999 109.11 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 1.96 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.25 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 3.0800000000000001 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 1.1899999999999999 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 0.75 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.098 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 0.72999999999999998 110.985 172.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 0.77000000000000002 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.2599999999999998 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 0.78000000000000003 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' OE2' HG12 ' A' ' 39' ' ' VAL . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 1.99 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.64000000000000001 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 60' ' ' ILE . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 3.3700000000000001 110.56 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 1.74 112.18 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 3.1600000000000001 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 1.3600000000000001 111.382 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.68999999999999995 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 2.25 109.448 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 1.1599999999999999 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.0499999999999998 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 0.68999999999999995 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.3799999999999999 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.098 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 0.93999999999999995 108.925 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.1000000000000001 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.23 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.1899999999999999 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 1.0700000000000001 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.5800000000000001 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 0.84999999999999998 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 0.5 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 2.7999999999999998 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 0.46000000000000002 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 1.5800000000000001 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 1.8100000000000001 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.0899999999999999 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 0.92000000000000004 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 1.25 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1000000000000001 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 0.84999999999999998 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.76000000000000001 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.0 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 0.68999999999999995 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 0.64000000000000001 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 28' ' ' LEU . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 1.79 110.095 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.6299999999999999 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.6299999999999999 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 2.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 0.57999999999999996 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.1899999999999999 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 4.5899999999999999 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 2.4500000000000002 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.57999999999999996 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 2.0899999999999999 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 1.9399999999999999 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 0.56000000000000005 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 1.3600000000000001 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.1400000000000001 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 3.2799999999999998 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 0.81000000000000005 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.4500000000000002 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 116' ' ' VAL . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 2.0 108.764 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 0.72999999999999998 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.1400000000000001 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.3300000000000001 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm 45.74 -136.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 4.2300000000000004 109.524 -171.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.0 p 36.56 56.21 1.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.394 2.677 . . . . 5.4800000000000004 114.056 159.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.82 -160.58 1.18 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.493 -1.669 . . . . 5.46 106.493 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.07 -47.99 8.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.323 1.049 . . . . 4.3399999999999999 112.25 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.33 48.58 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 1.74 110.974 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 0.90000000000000002 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.68000000000000005 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.0 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 4.4000000000000004 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 1.73 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 2.79 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 2.7400000000000002 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 1.72 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.24 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 4.7999999999999998 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 1.3700000000000001 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.7599999999999998 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.72999999999999998 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 0.53000000000000003 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 0.64000000000000001 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.71999999999999997 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 0.52000000000000002 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.66000000000000003 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 1.7 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 2.1800000000000002 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 2.8799999999999999 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 1.3400000000000001 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 1.52 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2000000000000002 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 1.1299999999999999 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 0.56999999999999995 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 0.67000000000000004 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 78' ' ' PHE . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 1.04 107.373 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.6099999999999999 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 2.1699999999999999 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 2.5099999999999998 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.66000000000000003 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 5.6500000000000004 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.9399999999999999 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 0.68999999999999995 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 1.8500000000000001 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 125' ' ' VAL . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 1.74 111.14 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.67000000000000004 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.0699999999999998 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 1.4299999999999999 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 3.21 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.0499999999999998 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 0.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' A' ' 139' ' ' LEU . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 1.8799999999999999 111.04 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.6400000000000001 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 2.4500000000000002 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.1100000000000001 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.3700000000000001 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 2.0099999999999998 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 4.7000000000000002 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.564 ' HG ' HG11 ' A' ' 132' ' ' VAL . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 1.4199999999999999 108.489 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 1.96 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 2.9500000000000002 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -79.96 82.91 5.95 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 3.3399999999999999 108.594 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.6 3.52 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.459 -1.056 . . . . 2.4100000000000001 110.459 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 44.09 49.23 7.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.395 1.078 . . . . 3.9900000000000002 110.919 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -166.19 -54.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.345 2.258 . . . . 7.8399999999999999 107.309 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.66 -25.94 11.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.444 1.098 . . . . 7.6500000000000004 112.033 -170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.9 m -109.45 23.83 13.92 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.157 1.383 . . . . 7.79 111.261 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.76 78.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.828 0.823 . . . . 8.0299999999999994 108.992 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -81.08 60.74 4.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 15.15 111.215 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.43 147.0 4.74 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.826 -2.109 . . . . 12.99 107.826 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.354 -2.091 . . . . 16.370000000000001 105.354 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.826 -0.435 . . . . 16.41 109.826 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -78.91 67.82 4.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.464 -0.569 . . . . 11.85 109.464 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.5 m -75.37 53.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.214 1.406 . . . . 5.5099999999999998 112.864 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -84.51 79.31 9.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.493 -1.299 . . . . 4.9800000000000004 107.493 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -45.41 149.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.904 -1.498 . . . . 2.79 110.25 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 1.95 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.7400000000000002 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 10' ' ' MET . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 2.9700000000000002 107.834 171.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 0.64000000000000001 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.426 ' HG3' HD11 ' A' ' 8' ' ' ILE . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.0899999999999999 110.426 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 1.79 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 0.71999999999999997 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 0.93999999999999995 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.67000000000000004 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 2.5299999999999998 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 1.54 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 41' ' ' LEU . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.3100000000000001 109.558 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 2.6299999999999999 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 1.5700000000000001 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 0.93000000000000005 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.873 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 0.71999999999999997 109.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 0.78000000000000003 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 2.5499999999999998 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 0.58999999999999997 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 39' ' ' VAL . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.5299999999999998 110.342 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 1.9299999999999999 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.64000000000000001 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 1.55 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 3.0600000000000001 112.415 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 3.6299999999999999 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.497 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 1.3300000000000001 110.018 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.1599999999999999 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 0.71999999999999997 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 2.2200000000000002 110.41 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 0.75 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.2599999999999998 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 0.71999999999999997 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.6200000000000001 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.873 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 1.21 109.848 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.458 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 1.5600000000000001 111.87 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 1.1100000000000001 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 0.93000000000000005 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.9099999999999999 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 0.81999999999999995 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 0.40999999999999998 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 2.9300000000000002 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 0.45000000000000001 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 1.76 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 1.74 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.0699999999999998 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 0.88 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 0.98999999999999999 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.8899999999999999 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 0.72999999999999998 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.67000000000000004 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 0.78000000000000003 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 0.70999999999999996 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.9399999999999999 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 3.6099999999999999 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 0.81999999999999995 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 3.3700000000000001 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 2.5600000000000001 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.76000000000000001 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 1.96 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 2.3300000000000001 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 0.93000000000000005 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 72' ' ' VAL . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.72 111.582 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.1899999999999999 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.1500000000000004 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.04 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 0.87 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.3799999999999999 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 1.79 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.6299999999999999 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 0.56000000000000005 110.144 -167.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.3599999999999999 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.25 138.73 9.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 4.3600000000000003 113.131 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 44.36 0.91 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.668 -0.864 . . . . 3.6699999999999999 108.668 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.8 t 67.43 45.0 1.66 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.906 0.86 . . . . 5.3899999999999997 111.133 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.53 43.33 3.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.588 1.155 . . . . 4.0300000000000002 108.144 168.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.4 25.62 4.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.441 1.496 . . . . 1.3700000000000001 113.148 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 0.80000000000000004 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 0.67000000000000004 110.839 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2000000000000002 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 4.54 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 1.97 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.8900000000000001 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 3.3799999999999999 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 5.9500000000000002 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 1.71 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.3200000000000001 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 4.9199999999999999 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 1.4199999999999999 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.75 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 0.59999999999999998 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 0.85999999999999999 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 0.53000000000000003 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.58999999999999997 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 89' ' ' ALA . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 2.5499999999999998 109.209 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 2.23 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 2.4900000000000002 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 1.4399999999999999 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 1.6899999999999999 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.6699999999999999 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 0.95999999999999996 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 0.52000000000000002 108.837 168.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 0.76000000000000001 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 0.68000000000000005 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 1.74 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.04 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.60999999999999999 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 5.8200000000000003 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.0600000000000001 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 0.53000000000000003 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.3300000000000001 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 1.98 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.90000000000000002 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.1699999999999999 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 132' ' ' VAL . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 0.71999999999999997 109.603 -175.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 2.9399999999999999 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.6899999999999999 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 0.57999999999999996 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' LEU . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 1.71 109.1 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.0699999999999998 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 2.3700000000000001 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 1.03 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.64000000000000001 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 2.1800000000000002 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 3.1899999999999999 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 1.54 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 2.6899999999999999 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 1.6599999999999999 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -81.02 79.99 7.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 2.6499999999999999 108.914 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -65.84 3.62 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.129 -1.188 . . . . 2.0600000000000001 110.129 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 35.73 56.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.224 1.409 . . . . 4.2699999999999996 111.513 -168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.07 -53.24 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 106.676 -1.601 . . . . 6.7800000000000002 106.676 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.7 t0 54.29 98.24 0.01 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.805 1.642 . . . . 9.7100000000000009 110.98 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m 57.34 30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.09 -0.505 . . . . 7.7300000000000004 110.293 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 62.78 -71.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.261 2.224 . . . . 9.4900000000000002 111.899 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . 0.403 0.0 OUTLIER 52.61 -24.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.746 3.218 . . . . 11.369999999999999 118.6 -174.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.58 161.93 28.6 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.944 -2.462 . . . . 11.119999999999999 106.944 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.576 -1.678 . . . . 15.109999999999999 109.603 168.408 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.28 9.3 ptt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.936 0.717 . . . . 18.059999999999999 112.936 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.32 139.84 48.19 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.443 -1.317 . . . . 12.630000000000001 107.443 167.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m 63.49 169.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.256 1.023 . . . . 6.1799999999999997 110.708 -167.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -75.41 33.85 0.11 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.772 1.229 . . . . 5.3899999999999997 111.535 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -125.45 140.78 52.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.767 1.227 . . . . 3.5699999999999998 107.927 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 3.1400000000000001 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.8700000000000001 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 2.6000000000000001 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 0.72999999999999998 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 1.8899999999999999 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 1.6799999999999999 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 0.5 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 0.88 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 2.5299999999999998 111.286 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 2.6499999999999999 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 4.54 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 3.25 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 1.55 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 1.1799999999999999 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 15' ' ' MET . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 0.69999999999999996 111.09 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 0.85999999999999999 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.1000000000000001 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 0.67000000000000004 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.2799999999999998 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.1400000000000001 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.66000000000000003 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 2.5800000000000001 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 2.3900000000000001 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 3.3300000000000001 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 1.5 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.4199999999999999 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.63 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 1.3700000000000001 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 0.73999999999999999 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 0.90000000000000002 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.3199999999999998 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 0.93000000000000005 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.1299999999999999 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 1.6000000000000001 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 1.04 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 0.91000000000000003 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 0.84999999999999998 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 0.33000000000000002 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 3.8500000000000001 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 0.54000000000000004 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 1.28 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 1.8600000000000001 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.2200000000000002 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.02 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 1.1699999999999999 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.0099999999999998 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 0.71999999999999997 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.68999999999999995 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 0.69999999999999996 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 0.80000000000000004 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 0.79000000000000004 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 0.73999999999999999 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.8500000000000001 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 2.4100000000000001 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 0.58999999999999997 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.3199999999999998 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 3.5 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 2.3100000000000001 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.59999999999999998 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 2.2400000000000002 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 2.3100000000000001 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 0.54000000000000004 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 0.83999999999999997 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 0.92000000000000004 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.4199999999999999 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 3.3599999999999999 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 0.56999999999999995 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.2799999999999998 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 1.8200000000000001 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.5800000000000001 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 0.73999999999999999 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.29 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.8100000000000001 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.35 145.12 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 3.5699999999999998 112.738 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -121.88 28.09 7.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.768 0.827 . . . . 4.1399999999999997 109.911 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.8 t 63.96 64.29 0.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 122.623 1.201 . . . . 6.1900000000000004 110.88 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.73 -75.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.202 -1.407 . . . . 3.52 107.202 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.36 22.74 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 1.3 111.852 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 0.93000000000000005 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 92' ' ' ILE . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 1.01 109.946 172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 4.4400000000000004 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 89' ' ' ALA . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.02 110.926 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.1400000000000001 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.0700000000000003 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 2.7599999999999998 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 1.8899999999999999 111.264 -177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.8100000000000001 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 5.8600000000000003 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 1.49 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.5099999999999998 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.79000000000000004 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 96' ' ' LEU . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 0.71999999999999997 107.496 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 0.82999999999999996 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.1399999999999999 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 0.59999999999999998 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.78000000000000003 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 1.9299999999999999 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.6699999999999999 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 3.2799999999999998 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 1.8500000000000001 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' A' ' 113' ' ' THR . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 2.0600000000000001 110.467 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 1.04 110.45 -176.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 0.55000000000000004 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 0.75 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 0.63 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 1.8899999999999999 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 2.6099999999999999 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.80000000000000004 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 5.3899999999999997 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.8500000000000001 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 0.71999999999999997 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 1.54 112.684 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.02 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 0.89000000000000001 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 3.73 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.0499999999999998 110.065 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 0.60999999999999999 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 139' ' ' LEU . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 1.4099999999999999 110.604 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1000000000000001 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 2.46 113.295 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 0.81999999999999995 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.58999999999999997 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 2.0299999999999998 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 3.3599999999999999 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 1.74 106.839 -172.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 2.2599999999999998 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 1.6399999999999999 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -116.24 94.47 4.66 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 3.6499999999999999 108.384 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.74 -62.24 3.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.836 -0.906 . . . . 3.6099999999999999 110.836 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.76 37.78 21.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.937 1.295 . . . . 4.5 111.512 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -176.21 -38.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.219 0.607 . . . . 8.6400000000000006 111.297 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t0 50.79 92.24 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.156 2.182 . . . . 12.52 112.322 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.83 28.36 18.12 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.578 -0.737 . . . . 9.6199999999999992 110.595 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.3 mt 53.92 57.25 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.608 1.163 . . . . 9.0600000000000005 109.487 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -67.69 155.29 39.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.504 -0.747 . . . . 14.99 109.705 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.43 103.05 0.18 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.936 -2.466 . . . . 15.449999999999999 106.936 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.853 2.461 . . . . 19.23 105.793 -175.93 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.267 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 117.477 -1.249 . . . . 14.58 110.389 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.5 53.95 1.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.391 1.905 . . . . 8.8800000000000008 110.96 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t 48.26 34.27 4.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.022 1.329 . . . . 4.5700000000000003 112.473 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -82.59 48.69 1.34 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.173 0.589 . . . . 5.5700000000000003 109.61 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -73.54 138.96 45.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.386 -0.821 . . . . 2.1499999999999999 109.181 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 1.95 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.7400000000000002 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 2.6499999999999999 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 0.58999999999999997 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 1.79 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.3199999999999998 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 0.69999999999999996 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 1.1799999999999999 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 2.54 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 1.3100000000000001 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.1800000000000002 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.3799999999999999 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 1.76 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 0.90000000000000002 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 0.72999999999999998 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 0.93000000000000005 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 2.3599999999999999 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 0.58999999999999997 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.6499999999999999 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.02 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.66000000000000003 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 1.6000000000000001 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 2.1899999999999999 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 4.9800000000000004 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 1.52 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.1799999999999999 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.53000000000000003 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 1.3600000000000001 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 0.73999999999999999 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 0.69999999999999996 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 0.84999999999999998 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 1.96 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 2.0499999999999998 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 1.49 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 1.48 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 0.87 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 0.46999999999999997 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.4100000000000001 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 0.41999999999999998 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 1.0700000000000001 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 1.97 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.0099999999999998 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.80000000000000004 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.2400000000000002 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.3999999999999999 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 0.85999999999999999 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 0.87 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 0.87 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 0.78000000000000003 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 0.80000000000000004 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.8599999999999999 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.0499999999999998 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 2.9500000000000002 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 0.56999999999999995 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.6699999999999999 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.02 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 2.5899999999999999 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.66000000000000003 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 2.0699999999999998 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 2.4900000000000002 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 0.54000000000000004 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 0.76000000000000001 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 3.54 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 0.92000000000000004 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.9199999999999999 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 2.1299999999999999 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.6200000000000001 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 0.72999999999999998 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.5600000000000001 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.47 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -58.01 168.78 0.9 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 2.9700000000000002 112.047 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 p -149.04 -50.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.686 -1.143 . . . . 3.5899999999999999 110.184 -173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.1 t -178.4 -48.88 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.833 -1.173 . . . . 5.1600000000000001 107.833 -166.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 165.21 1.56 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.433 -0.803 . . . . 3.5699999999999998 110.53 166.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.89 38.28 0.07 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.091 1.756 . . . . 1.49 113.742 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 0.77000000000000002 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 0.65000000000000002 110.408 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.9199999999999999 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 4.5300000000000002 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 1.76 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.4500000000000002 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.02 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 5.0999999999999996 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 1.6000000000000001 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.5 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 4.3099999999999996 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.2599999999999998 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.5999999999999996 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.65000000000000002 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 0.63 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 0.73999999999999999 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.71999999999999997 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 0.46000000000000002 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 2.5099999999999998 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 1.9099999999999999 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 2.4500000000000002 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.29 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 1.3400000000000001 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.9199999999999999 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 0.69999999999999996 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 0.48999999999999999 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.25 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 0.77000000000000002 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 1.76 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 2.52 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.68999999999999995 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 7.6100000000000003 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.5899999999999999 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 0.57999999999999996 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 1.98 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 1.5 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 0.58999999999999997 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 3.5699999999999998 109.136 165.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.4299999999999997 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 0.58999999999999997 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 1.7 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.7799999999999998 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 2.4100000000000001 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 0.93000000000000005 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.69999999999999996 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 2.0099999999999998 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.1099999999999999 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 2.6699999999999999 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 2.77 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 2.3700000000000001 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 86.34 5.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 3.0600000000000001 109.196 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.13 -50.0 4.22 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.68 -0.511 . . . . 1.98 111.905 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 61.61 28.4 17.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.011 0.925 . . . . 5.1600000000000001 110.946 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.09 -47.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.662 -0.649 . . . . 6.5700000000000003 110.51 -170.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t0 59.55 33.33 22.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.325 1.45 . . . . 8.9900000000000002 111.498 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -158.59 32.36 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.236 1.814 . . . . 7.5999999999999996 108.986 171.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt 66.11 -65.71 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.404 1.882 . . . . 10.93 111.478 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.76 -161.64 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.122 0.969 . . . . 15.109999999999999 108.89 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.67 -126.91 5.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.482 -1.447 . . . . 12.93 109.482 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.068 1.747 . . . . 15.550000000000001 106.718 -174.342 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 118.748 -0.644 . . . . 15.69 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.83 92.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.128 0.971 . . . . 12.609999999999999 109.593 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m 70.32 168.74 0.31 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.734 1.614 . . . . 5.5199999999999996 110.369 -167.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -76.3 49.73 0.6 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.398 0.679 . . . . 6.71 110.153 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -121.23 149.58 42.64 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.3500000000000001 105.316 167.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 2.4300000000000002 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.0 108.868 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.0699999999999998 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 0.68999999999999995 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 1.8899999999999999 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.04 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 64' ' ' ILE . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 0.76000000000000001 108.883 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 0.93999999999999995 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 3.1600000000000001 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 1.54 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.3300000000000001 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 3.8199999999999998 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 1.8899999999999999 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 0.82999999999999996 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 1.55 110.882 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 1.1399999999999999 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 3.5600000000000001 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 0.71999999999999997 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.3300000000000001 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 3.6499999999999999 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.68999999999999995 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 28' ' ' LEU . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 2.7200000000000002 110.086 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 1.8600000000000001 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 4.25 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 1.77 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.54000000000000004 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 1.27 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 1.1100000000000001 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.8500000000000001 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 0.82999999999999996 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 1.78 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.618 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.054 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 1.78 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 1.1299999999999999 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.02 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 0.77000000000000002 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 0.39000000000000001 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 4.04 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.55000000000000004 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 1.48 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 1.98 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.3700000000000001 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.04 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 1.22 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.9199999999999999 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 0.85999999999999999 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.87 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.01 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 0.94999999999999996 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 0.78000000000000003 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 0.70999999999999996 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.5600000000000001 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 3.6499999999999999 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 69' ' ' TYR . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.88 109.866 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.1299999999999999 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 3.0099999999999998 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 2.2200000000000002 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.68999999999999995 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 64' ' ' ILE . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 1.9299999999999999 109.275 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 2.0 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 0.57999999999999996 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 0.88 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 0.97999999999999998 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.6899999999999999 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 3.3999999999999999 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 0.68999999999999995 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.6899999999999999 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 2.27 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.8600000000000001 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 114' ' ' VAL . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 1.3100000000000001 109.778 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.6499999999999999 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.6399999999999999 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.36 159.7 2.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 3.3100000000000001 112.83 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -126.58 -54.56 1.44 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.965 -1.47 . . . . 4.1900000000000004 108.598 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.6 t 177.74 -41.94 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.563 1.145 . . . . 5.75 110.163 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -42.3 -77.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.395 1.478 . . . . 3.4199999999999999 113.391 -172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.11 27.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.81 0.844 . . . . 1.47 111.087 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 0.65000000000000002 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.1800000000000002 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 5.8700000000000001 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 2.1499999999999999 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.4900000000000002 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.1299999999999999 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 135' ' ' LEU . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.0499999999999998 111.192 168.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 1.73 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.25 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 3.8900000000000001 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 1.3700000000000001 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.6099999999999999 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.80000000000000004 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 0.60999999999999999 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 0.66000000000000003 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.85999999999999999 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 0.46999999999999997 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.64000000000000001 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 1.72 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.8200000000000001 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 2.48 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.1399999999999999 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 1.3100000000000001 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.6099999999999999 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 0.90000000000000002 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 0.69999999999999996 107.664 156.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 0.70999999999999996 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 0.52000000000000002 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.6699999999999999 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 1.8600000000000001 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 2.29 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.85999999999999999 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 5.8099999999999996 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.4100000000000001 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 0.84999999999999998 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 2.5699999999999998 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 1.97 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 0.91000000000000003 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.8300000000000001 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 1.27 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 3.1299999999999999 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.9199999999999999 110.403 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 0.58999999999999997 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 1.6899999999999999 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.5800000000000001 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 2.8399999999999999 113.022 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 95' ' ' ARG . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 0.81000000000000005 111.966 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76000000000000001 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 2.21 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 3.7999999999999998 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 1.5900000000000001 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 2.6099999999999999 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 1.6799999999999999 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.5 98.22 9.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 3.0299999999999998 109.519 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.8 -47.57 3.83 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.01 -1.236 . . . . 2.1699999999999999 110.01 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -47.63 -35.97 10.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.752 0.821 . . . . 5.2999999999999998 111.524 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -26.25 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.046 -1.034 . . . . 9.8399999999999999 113.696 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.73 -2.59 32.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.846 1.658 . . . . 7.9299999999999997 111.662 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.6 m -151.44 24.11 0.71 Allowed 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.126 -0.984 . . . . 8.5500000000000007 113.207 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.1 pt -33.38 -43.61 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.712 2.005 . . . . 11.19 115.124 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -154.82 165.36 36.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.702 -1.592 . . . . 15.67 106.702 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.15 -54.07 0.23 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.666 0.651 . . . . 14.390000000000001 112.9 -166.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.454 -2.212 . . . . 17.879999999999999 105.395 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 118.685 -0.674 . . . . 14.77 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.6 -50.01 73.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.37 0.532 . . . . 12.49 111.867 -174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m 158.63 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.971 2.909 . . . . 5.04 106.902 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 22.04 72.89 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 127.378 2.271 . . . . 6.1399999999999997 113.013 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.33 157.51 19.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.8799999999999999 106.605 172.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 2.3900000000000001 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.8399999999999999 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 3.1299999999999999 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 0.59999999999999998 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 2.0099999999999998 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 1.9199999999999999 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 0.76000000000000001 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 0.83999999999999997 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 3.8799999999999999 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 1.24 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.4100000000000001 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 4.3200000000000003 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 1.4299999999999999 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 0.73999999999999999 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 1.01 110.56 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 0.77000000000000002 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 3.02 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG ' ' A' ' 69' ' ' TYR . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.0300000000000002 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 2.25 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.65000000000000002 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 1.7 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 1.75 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 2.96 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 1.54 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.1400000000000001 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 1.0600000000000001 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 1.45 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.02 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 0.73999999999999999 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.02 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG11 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 1.3300000000000001 109.288 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.1600000000000001 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 1.74 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 1.47 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 1.26 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.8799999999999999 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 0.72999999999999998 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 0.38 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.6600000000000001 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 0.56000000000000005 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 1.0900000000000001 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 2.1000000000000001 111.909 -171.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.7599999999999998 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.26 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 1.46 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.0499999999999998 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 0.82999999999999996 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.63 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 0.95999999999999996 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 0.70999999999999996 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 0.56999999999999995 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 0.65000000000000002 108.15 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.9099999999999999 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.3999999999999999 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 3.3700000000000001 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 0.57999999999999996 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 2.6800000000000002 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 1.95 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.68999999999999995 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' HD11 ' A' ' 24' ' ' ILE . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 1.98 109.466 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 2.1499999999999999 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 0.52000000000000002 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 0.76000000000000001 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 0.75 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 2.7200000000000002 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 0.78000000000000003 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 1.74 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 0.80000000000000004 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.5800000000000001 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.4099999999999999 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -60.35 120.27 9.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 2.9100000000000001 110.07 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 p -135.8 38.42 2.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.851 1.26 . . . . 3.9700000000000002 108.749 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.4 t 70.42 46.65 0.56 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.891 0.876 . . . . 5.3200000000000003 111.27 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.76 46.64 2.6 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.404 1.081 . . . . 4.3499999999999996 108.52 169.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.33 27.34 4.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.265 1.426 . . . . 1.22 113.273 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 0.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 0.64000000000000001 110.674 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 1.8200000000000001 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 4.5300000000000002 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 1.9199999999999999 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 3.52 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 3.2400000000000002 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 114' ' ' VAL . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 1.6399999999999999 111.011 -169.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.48 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 4.4699999999999998 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 1.8100000000000001 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.7999999999999998 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.67000000000000004 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 0.57999999999999996 107.755 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 0.68000000000000005 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.83999999999999997 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 0.52000000000000002 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.51000000000000001 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 114' ' ' VAL . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 2.3700000000000001 109.28 -173.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 2.1699999999999999 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 2.5499999999999998 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 1.1399999999999999 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.3999999999999999 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.7799999999999998 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 0.95999999999999996 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 107' ' ' VAL . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 0.56999999999999995 108.971 164.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 0.76000000000000001 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 0.93999999999999995 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.8300000000000001 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 2.0099999999999998 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 2.3199999999999998 107.342 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.84999999999999998 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 4.9699999999999998 108.364 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 0.69999999999999996 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.8700000000000001 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 1.6399999999999999 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.68000000000000005 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 0.73999999999999999 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 3.6699999999999999 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.2200000000000002 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 0.73999999999999999 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 1.7 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.6299999999999999 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.0699999999999998 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 1.0800000000000001 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.84999999999999998 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 2.1099999999999999 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 5.9299999999999997 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 1.49 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 2.5 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 1.75 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -81.78 67.04 7.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 3.25 108.669 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.59 -64.55 2.18 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.707 -0.957 . . . . 2.5800000000000001 110.707 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 56.18 30.93 17.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.617 1.167 . . . . 5.5099999999999998 111.087 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -163.34 -58.13 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.535 1.534 . . . . 6.2999999999999998 108.593 -169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.3 t0 59.31 86.27 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.165 1.786 . . . . 9.5500000000000007 111.587 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 t 67.85 21.22 9.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.564 1.146 . . . . 7.6500000000000004 112.628 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.8 100.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 125.21 1.404 . . . . 9.0999999999999996 107.347 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -142.02 109.76 5.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.359 -1.349 . . . . 13.48 107.359 173.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.92 -97.3 0.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.37 0.509 . . . . 13.859999999999999 112.092 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 CA-C-O 115.951 -1.976 . . . . 16.510000000000002 106.145 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttm . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 106.056 -1.831 . . . . 15.449999999999999 106.056 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.8 125.12 0.96 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.009 -1.478 . . . . 11.15 107.009 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t 59.99 -175.91 0.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 5.0800000000000001 111.802 -174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -84.74 30.84 0.55 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.756 1.222 . . . . 3.8999999999999999 111.509 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -73.44 -176.1 2.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.3199999999999998 112.477 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 2.8700000000000001 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.0800000000000001 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.0299999999999998 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 0.78000000000000003 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 2.73 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 2.6600000000000001 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 0.70999999999999996 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 0.77000000000000002 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.85999999999999999 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 3.1600000000000001 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.1299999999999999 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.5800000000000001 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 3.0099999999999998 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 1.1699999999999999 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 0.84999999999999998 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 0.71999999999999997 112.278 167.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 0.78000000000000003 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.23 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 0.68000000000000005 108.157 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.1200000000000001 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 1.8100000000000001 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 1.5800000000000001 109.99 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 2.4300000000000002 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 3.4300000000000002 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 1.7 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.1400000000000001 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 0.94999999999999996 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 1.45 111.311 172.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 1.47 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.3100000000000001 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 0.66000000000000003 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.3799999999999999 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.0800000000000001 108.731 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.3500000000000001 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 3.8700000000000001 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 1.3700000000000001 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.9199999999999999 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 1.47 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 0.40000000000000002 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.2599999999999998 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 0.73999999999999999 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 1.3100000000000001 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 2.0 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.1299999999999999 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 1.1399999999999999 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.8700000000000001 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 0.69999999999999996 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.67000000000000004 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 0.96999999999999997 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 0.92000000000000004 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 0.73999999999999999 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 0.83999999999999997 107.609 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7000000000000002 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.4500000000000002 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 2.2400000000000002 108.155 -175.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 0.58999999999999997 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.6799999999999999 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 2.6899999999999999 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 1.8300000000000001 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.68000000000000005 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 2.02 108.769 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 1.75 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 0.77000000000000002 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.4500000000000002 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 4.54 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.0600000000000001 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.8700000000000001 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 2.25 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 0.81000000000000005 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.9900000000000002 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.53 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.42 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -67.56 74.74 0.17 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 4.9699999999999998 109.499 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.6 t -58.4 -9.16 1.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.701 2.0 . . . . 3.9300000000000002 111.594 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.4 t 92.0 64.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.336 0 C-N-CA 126.373 1.869 . . . . 6.0800000000000001 109.511 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.04 -82.5 0.23 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.249 -1.341 . . . . 3.4199999999999999 107.381 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.55 25.82 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.477 0.311 . . . . 1.29 111.433 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 0.68999999999999995 110.237 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.5499999999999998 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 3.77 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 1.8899999999999999 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 3.6200000000000001 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 2.9199999999999999 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 1.6799999999999999 111.465 -177.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.29 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 4.4800000000000004 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 2.0699999999999998 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.7400000000000002 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.82999999999999996 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 0.84999999999999998 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77000000000000002 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 0.46999999999999997 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.57999999999999996 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.441 HG11 ' HB1' ' A' ' 89' ' ' ALA . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 2.5499999999999998 108.727 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.6000000000000001 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 2.2999999999999998 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.51 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 1.51 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 0.95999999999999996 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 0.66000000000000003 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.3400000000000001 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 0.78000000000000003 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.6499999999999999 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 1.97 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 2.1699999999999999 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.79000000000000004 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 5.2400000000000002 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.2599999999999998 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 0.93999999999999995 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 1.79 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 1.78 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 0.77000000000000002 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.2799999999999998 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 0.77000000000000002 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 3.9700000000000002 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.3100000000000001 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 0.69999999999999996 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 1.6000000000000001 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.2400000000000002 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 1.1299999999999999 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 2.2400000000000002 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 3.8199999999999998 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 1.6200000000000001 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 2.7200000000000002 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 1.77 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -113.42 118.14 33.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 2.6400000000000001 108.116 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.62 -44.06 3.03 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.901 -1.28 . . . . 3.0099999999999998 109.901 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -61.77 -28.81 69.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.818 -0.813 . . . . 4.9100000000000001 112.668 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -79.46 -13.59 59.47 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.4 0.519 . . . . 8.5299999999999994 112.4 174.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.95 48.23 1.62 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.358 0.981 . . . . 6.5899999999999999 108.769 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.3 m 45.33 43.24 8.16 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.874 2.07 . . . . 8.9700000000000006 114.135 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.7 mt -21.2 -69.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.71 2.004 . . . . 7.9699999999999998 113.486 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -127.96 32.9 4.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.881 1.673 . . . . 12.42 108.767 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 63.67 -79.6 0.04 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.161 0.886 . . . . 12.77 111.445 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.155 1.782 . . . . 17.329999999999998 111.87 -170.37 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 106.826 -1.546 . . . . 14.109999999999999 106.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -173.4 166.78 4.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.142 1.377 . . . . 9.9000000000000004 108.452 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t 68.65 156.01 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.424 1.89 . . . . 5.0899999999999999 112.078 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.4 72.65 1.28 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.766 1.226 . . . . 4.0999999999999996 109.795 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -67.35 137.98 56.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.9199999999999999 108.415 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 3.04 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.8100000000000001 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 2.02 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 0.76000000000000001 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 1.79 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.04 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 0.54000000000000004 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 0.77000000000000002 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.72999999999999998 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 2.4900000000000002 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 1.46 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 5.4900000000000002 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 3.52 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 1.6599999999999999 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 0.81000000000000005 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 0.91000000000000003 110.732 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 1.3600000000000001 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.23 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 0.67000000000000004 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 2.3300000000000001 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.65000000000000002 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 1.6299999999999999 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 1.95 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 2.5299999999999998 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 1.6599999999999999 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.3500000000000001 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 1.46 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.66000000000000003 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.7799999999999998 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 0.68000000000000005 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 1.8200000000000001 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 110.081 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 1.8600000000000001 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 2.1000000000000001 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.0 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 1.1000000000000001 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.0699999999999998 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 0.82999999999999996 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 0.5 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 2.7999999999999998 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 0.46999999999999997 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 1.01 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 2.0600000000000001 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.0899999999999999 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.27 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 1.4099999999999999 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.1499999999999999 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 0.81999999999999995 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.64000000000000001 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.1000000000000001 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 0.76000000000000001 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 0.67000000000000004 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.1600000000000001 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.6499999999999999 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 3.8300000000000001 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 0.62 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.4399999999999999 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.1899999999999999 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 2.0899999999999999 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.87 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 1.9099999999999999 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 1.96 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 0.51000000000000001 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 0.80000000000000004 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 0.93000000000000005 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.5099999999999998 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.0700000000000003 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 0.66000000000000003 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.0499999999999998 110.88 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 2.0499999999999998 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.2200000000000002 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 0.84999999999999998 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.3500000000000001 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.1299999999999999 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 88' ' ' CYS . 33.7 mmt -92.03 -6.8 50.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 6.3399999999999999 112.673 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -111.23 35.51 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 126.649 1.98 . . . . 4.9100000000000001 108.428 -156.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.38 -40.58 5.1 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.897 1.279 . . . . 6.7400000000000002 110.176 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.9 -69.7 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.974 0.91 . . . . 3.71 108.979 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.42 41.42 0.18 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.222 1.009 . . . . 1.4099999999999999 108.631 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' MET . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 1.1699999999999999 108.445 -171.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 0.66000000000000003 110.397 170.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.8899999999999999 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 5.3399999999999999 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.609 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 2.0 111.387 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.8500000000000001 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 3.8100000000000001 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 3.1299999999999999 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 1.24 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 5.7300000000000004 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 1.53 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.6200000000000001 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.68000000000000005 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 118' ' ' TYR . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 0.68000000000000005 107.97 175.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 0.70999999999999996 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.69999999999999996 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 0.51000000000000001 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.58999999999999997 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 1.6899999999999999 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.75 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 2.3999999999999999 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.04 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 1.22 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 0.64000000000000001 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 0.42999999999999999 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 0.66000000000000003 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 0.54000000000000004 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2000000000000002 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 102' ' ' VAL . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 1.8100000000000001 111.003 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 2.3799999999999999 107.058 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 5.7300000000000004 110.764 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.5199999999999996 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 0.68000000000000005 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.1800000000000002 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 2.46 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 0.85999999999999999 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.2799999999999998 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 1.0 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 3.9500000000000002 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.0499999999999998 111.25 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 0.63 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 1.79 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.4900000000000002 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 2.8399999999999999 112.869 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.609 ' HG ' HG22 ' A' ' 92' ' ' ILE . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 1.01 112.032 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.85999999999999999 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 1.9299999999999999 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 4.5 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 1.4399999999999999 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.0199999999999996 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 1.71 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 34.3 mtpt -81.31 76.9 8.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 2.8700000000000001 107.938 172.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.13 -69.41 2.49 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.177 -1.169 . . . . 2.1600000000000001 110.177 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 46.98 47.54 15.75 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.924 1.29 . . . . 4.6200000000000001 110.304 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.07 -44.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.188 1.795 . . . . 7.4500000000000002 108.835 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.9 37.05 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.967 1.307 . . . . 6.1399999999999997 111.997 -164.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m 44.07 47.92 7.4 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.246 1.418 . . . . 8.6300000000000008 111.46 -170.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.0 67.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.599 0.76 . . . . 9.6199999999999992 112.448 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -157.43 169.14 25.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.464 -1.31 . . . . 15.17 107.464 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.52 20.42 46.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.912 -0.938 . . . . 17.68 112.85 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.334 -1.317 . . . . 19.66 108.309 177.116 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.6 mtt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.422 -0.584 . . . . 15.9 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.11 156.47 41.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.666 -1.235 . . . . 8.7100000000000009 107.666 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p 176.74 144.26 0.08 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.731 -1.952 . . . . 5.46 105.731 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -145.91 48.54 1.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.499 1.142 . . . . 4.0 108.371 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -72.11 148.86 45.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.6099999999999999 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 3.02 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.2999999999999998 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 0.57999999999999996 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 0.90000000000000002 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 0.95999999999999996 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 3.2599999999999998 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.1699999999999999 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 3.4900000000000002 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.2400000000000002 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 2.2200000000000002 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.02 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 1.4399999999999999 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.76 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 3.6600000000000001 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 1.6100000000000001 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.1100000000000003 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.0699999999999998 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.5900000000000001 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 1.75 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 2.8100000000000001 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 3.4100000000000001 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.2999999999999998 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 1.8100000000000001 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.02 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 1.4199999999999999 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 1.0900000000000001 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.8100000000000001 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 0.93000000000000005 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.7200000000000002 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 0.93000000000000005 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.3500000000000001 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 2.1699999999999999 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.04 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 0.83999999999999997 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.1299999999999999 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 0.96999999999999997 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 0.55000000000000004 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 3.71 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 0.81000000000000005 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 1.9299999999999999 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 2.0899999999999999 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.3500000000000001 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.6699999999999999 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 1.6699999999999999 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 1.25 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.2 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 1.4299999999999999 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 1.3799999999999999 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 1.25 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.94999999999999996 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.4700000000000002 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.1800000000000002 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.1099999999999999 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 0.89000000000000001 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 3.3900000000000001 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 2.4399999999999999 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.5700000000000001 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 2.0800000000000001 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 2.71 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 0.93000000000000005 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 0.94999999999999996 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.21 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.6299999999999999 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 2.8799999999999999 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 1.99 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 113' ' ' THR . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.8300000000000001 107.827 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 0.71999999999999997 109.444 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.2599999999999998 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 0.0 OUTLIER -61.2 135.64 57.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 3.0299999999999998 111.521 -177.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.1 p -92.9 -47.01 7.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.351 1.06 . . . . 4.1900000000000004 109.168 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 172.02 -44.62 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.275 1.43 . . . . 6.5700000000000003 109.443 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -35.63 -74.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.197 1.799 . . . . 3.2599999999999998 113.594 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.94 34.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.808 1.243 . . . . 1.8 110.159 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.0900000000000001 107.896 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 0.60999999999999999 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.21 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 5.4100000000000001 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 1.8400000000000001 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.0600000000000001 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 3.23 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 1.9399999999999999 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 4.7800000000000002 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 1.5900000000000001 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.5800000000000001 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 0.87 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 0.81999999999999995 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 0.82999999999999996 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 0.95999999999999996 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 0.72999999999999998 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.87 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 1.6699999999999999 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 2.27 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.8 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' THR . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 1.6499999999999999 110.659 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 111' ' ' LEU . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 0.83999999999999997 111.545 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.564 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.54000000000000004 108.314 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 0.94999999999999996 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 0.68000000000000005 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.4700000000000002 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.96 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.0099999999999998 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.90000000000000002 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 7.8499999999999996 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.8900000000000001 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 0.69999999999999996 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 2.27 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 1.6899999999999999 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.76000000000000001 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.2200000000000002 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 0.96999999999999997 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 3.7000000000000002 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.1099999999999999 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 0.69999999999999996 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 1.6699999999999999 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.4700000000000002 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 3.7400000000000002 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 0.90000000000000002 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89000000000000001 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 2.0099999999999998 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 3.8799999999999999 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 1.4099999999999999 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 3.0600000000000001 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 3.3700000000000001 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -82.33 51.68 1.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.0699999999999998 110.667 -173.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.05 70.29 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.108 -0.995 . . . . 4.0499999999999998 111.778 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.79 -30.17 69.53 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.933 0.893 . . . . 6.1500000000000004 109.486 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.09 -65.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.406 1.082 . . . . 6.4199999999999999 108.869 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -158.62 41.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.561 0.744 . . . . 7.3099999999999996 110.691 -166.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.5 m 50.74 42.37 27.38 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.175 -0.953 . . . . 8.2200000000000006 112.936 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.5 mt 56.92 61.42 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 12.73 109.358 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.56 146.14 54.84 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.665 -0.647 . . . . 14.24 109.486 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.97 70.52 0.03 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.488 -2.245 . . . . 18.390000000000001 107.488 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.15 -1.405 . . . . 23.379999999999999 110.471 -170.264 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 106.447 -1.686 . . . . 16.829999999999998 106.447 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 156.57 1.26 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 105.997 -1.853 . . . . 8.7599999999999998 105.997 -174.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 p -175.3 178.65 1.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.329 1.852 . . . . 4.6900000000000004 106.057 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.8 59.56 1.66 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.908 -0.775 . . . . 3.9700000000000002 108.908 -176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.66 157.74 29.19 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.018 -0.537 . . . . 3.0099999999999998 110.49 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.0099999999999998 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.7200000000000002 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.405 HD11 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 2.8799999999999999 107.851 165.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 0.68999999999999995 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 8' ' ' ILE . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 2.1600000000000001 108.407 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 2.5800000000000001 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 0.57999999999999996 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.05 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.93999999999999995 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 2.8300000000000001 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 1.5800000000000001 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.2000000000000002 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 3.27 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 1.3500000000000001 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 0.79000000000000004 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 0.69999999999999996 110.929 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 0.80000000000000004 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 3.98 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 0.56000000000000005 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.8399999999999999 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 1.79 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.68999999999999995 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 1.6599999999999999 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 1.79 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 2.96 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' VAL . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 1.9399999999999999 110.6 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 0.71999999999999997 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 2.3500000000000001 110.538 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 0.84999999999999998 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.1499999999999999 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 0.66000000000000003 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 1.97 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 1.6399999999999999 111.254 171.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.0099999999999998 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 3.3700000000000001 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 1.3799999999999999 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 1.0600000000000001 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.5600000000000001 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 0.48999999999999999 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 2.6600000000000001 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 0.46999999999999997 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 1.1000000000000001 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 1.95 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.2200000000000002 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 0.92000000000000004 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 0.97999999999999998 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.0499999999999998 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 0.76000000000000001 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.63 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 0.89000000000000001 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 0.69999999999999996 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 0.71999999999999997 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.1699999999999999 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1000000000000001 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 3.1699999999999999 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.58999999999999997 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 4.7300000000000004 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 2.2200000000000002 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.72999999999999998 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 2.1200000000000001 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 2.1899999999999999 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 0.59999999999999998 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 1.25 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 0.81999999999999995 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 2.54 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 0.80000000000000004 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 2.0699999999999998 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.3700000000000001 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 0.87 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 2.9300000000000002 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.9299999999999999 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.05 121.23 5.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 2.9500000000000002 112.089 -175.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 t -163.1 24.5 0.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.607 0.718 . . . . 3.9900000000000002 109.939 171.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -167.78 160.04 12.2 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.661 -1.274 . . . . 4.79 108.474 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 49.66 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.305 1.842 . . . . 3.7200000000000002 111.825 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 90' ' ' ASN . . . -176.37 46.18 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.309 1.044 . . . . 1.6399999999999999 109.497 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 0.78000000000000003 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 0.69999999999999996 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.498 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.5499999999999998 110.884 -178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 5.0899999999999999 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 1.9199999999999999 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.4300000000000002 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 3.27 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 3.7200000000000002 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 2.02 111.328 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.3100000000000001 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 4.5499999999999998 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 1.6899999999999999 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.3999999999999999 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.80000000000000004 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 0.72999999999999998 108.831 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 0.79000000000000004 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.82999999999999996 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 0.66000000000000003 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.87 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 1.76 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 1.97 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 2.77 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 1.04 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 1.6100000000000001 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.2799999999999998 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 0.80000000000000004 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 0.54000000000000004 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 0.88 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 0.56000000000000005 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7000000000000002 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 2.1499999999999999 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 2.3900000000000001 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.71999999999999997 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 5.6699999999999999 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6000000000000001 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 0.58999999999999997 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 1.9199999999999999 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 1.54 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.79000000000000004 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 0.80000000000000004 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.1699999999999999 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.2200000000000002 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 0.54000000000000004 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 1.72 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.6299999999999999 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 2.3900000000000001 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 0.88 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.81999999999999995 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 2.1699999999999999 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 3.4199999999999999 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 1.3999999999999999 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 3.02 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 1.76 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -80.23 93.84 5.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 2.9199999999999999 108.622 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.95 -46.92 3.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.436 -1.066 . . . . 2.4500000000000002 110.436 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -37.65 -33.02 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.554 1.941 . . . . 4.3799999999999999 114.223 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -135.88 8.44 3.26 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.474 1.287 . . . . 7.9900000000000002 114.474 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.49 -8.83 14.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.917 0.887 . . . . 8.6799999999999997 112.036 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.0 m -172.54 55.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.339 2.255 . . . . 5.6900000000000004 108.965 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 pt -49.69 -37.11 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 113.876 1.065 . . . . 8.1899999999999995 113.876 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 51.64 62.71 2.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.625 1.17 . . . . 12.029999999999999 111.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.59 122.01 6.84 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 107.017 -2.433 . . . . 11.77 107.017 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.057 -1.925 . . . . 15.119999999999999 106.571 177.622 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.835 -1.172 . . . . 13.09 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -146.39 -77.12 0.19 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 105.029 -2.211 . . . . 8.0500000000000007 105.029 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 t -176.8 115.56 0.1 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.282 1.433 . . . . 5.0199999999999996 107.449 165.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -148.59 36.43 0.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.651 -0.87 . . . . 4.8499999999999996 108.651 169.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -64.43 141.14 58.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.02 109.424 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 1.9199999999999999 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.5699999999999998 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 2.7599999999999998 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 0.56000000000000005 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 1.6799999999999999 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.1800000000000002 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 0.68999999999999995 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 1.0800000000000001 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.88 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 39' ' ' VAL . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 2.8100000000000001 112.049 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 1.98 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 3.1800000000000002 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 2.02 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.6599999999999999 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 1.1299999999999999 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 1.4099999999999999 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.2400000000000002 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 0.68999999999999995 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.04 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.56999999999999995 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 1.5700000000000001 110.558 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 2.1000000000000001 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 3.4399999999999999 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 1.3400000000000001 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.3300000000000001 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.56000000000000005 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 1.3999999999999999 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 0.73999999999999999 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 0.69999999999999996 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.6899999999999999 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' SD ' ' A' ' 15' ' ' MET . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 1.04 113.2 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 1.98 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 1.52 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.0900000000000001 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 1.0800000000000001 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.8400000000000001 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 0.72999999999999998 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 0.41999999999999998 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.4100000000000001 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 0.45000000000000001 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 1.0600000000000001 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 1.9199999999999999 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.8700000000000001 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 0.95999999999999996 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.03 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 0.80000000000000004 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.72999999999999998 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 0.81000000000000005 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 0.88 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 0.68999999999999995 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 0.79000000000000004 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.29 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.0499999999999998 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 -175.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 0.56000000000000005 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 2.3900000000000001 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 1.9099999999999999 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.82999999999999996 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 2.1000000000000001 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 2.04 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 0.53000000000000003 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 0.87 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 0.81000000000000005 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.6400000000000001 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 2.7799999999999998 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 0.56999999999999995 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.9199999999999999 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 2.3199999999999998 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.4100000000000001 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 114' ' ' VAL . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 0.78000000000000003 110.17 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.1699999999999999 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6000000000000001 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.95 113.17 2.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 2.98 112.202 -171.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.3 p -84.09 -21.86 31.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.95 0.9 . . . . 4.2400000000000002 111.248 173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.85 176.94 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.686 -1.227 . . . . 4.96 107.686 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.47 47.23 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.759 1.224 . . . . 6.3700000000000001 113.466 -171.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -121.94 -49.92 2.07 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.325 1.45 . . . . 2.1000000000000001 109.426 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 0.81999999999999995 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 1.0700000000000001 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.8799999999999999 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 4.25 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 1.8999999999999999 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.4100000000000001 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 3.29 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 2.8300000000000001 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 1.4399999999999999 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.3999999999999999 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 5.0199999999999996 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 2.27 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.9300000000000002 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.70999999999999996 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 0.66000000000000003 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 0.68999999999999995 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78000000000000003 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 0.46000000000000002 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.60999999999999999 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 1.7 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.75 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 3.1600000000000001 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 1.3500000000000001 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 2.4100000000000001 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.6899999999999999 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 0.46000000000000002 107.922 167.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 0.63 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 0.54000000000000004 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.8300000000000001 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 1.97 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 2.2000000000000002 108.554 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.71999999999999997 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 5.4199999999999999 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 0.51000000000000001 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.1299999999999999 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 125' ' ' VAL . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 1.48 113.831 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 0.75 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 3.3500000000000001 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.6400000000000001 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 0.48999999999999999 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 1.6799999999999999 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.5800000000000001 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 2.8199999999999998 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 0.81999999999999995 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.59999999999999998 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 1.8799999999999999 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 3.5699999999999998 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 1.49 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 2.7200000000000002 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 1.6299999999999999 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.32 99.82 10.24 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 5.75 109.042 162.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.99 -49.52 4.24 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 118.374 -1.237 . . . . 2.3799999999999999 111.417 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -28.48 -62.32 0.11 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.74 . . . . 5.3300000000000001 112.391 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.38 -10.75 14.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.995 1.318 . . . . 8.6099999999999994 112.364 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.97 -20.18 59.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 122.074 0.94 . . . . 8.5899999999999999 111.597 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.7 m -152.33 35.62 0.52 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.628 1.571 . . . . 6.2800000000000002 111.005 173.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 mt 48.61 66.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.89 1.276 . . . . 9.1199999999999992 110.86 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 156.67 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.981 -1.118 . . . . 10.65 107.981 168.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.48 -76.45 0.22 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 114.767 0.667 . . . . 13.17 114.767 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 116.287 -1.816 . . . . 14.970000000000001 106.406 -156.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.147 -1.427 . . . . 18.949999999999999 107.147 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.35 167.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.571 1.149 . . . . 12.81 111.032 -154.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -76.68 77.08 3.33 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.872 1.669 . . . . 6.7199999999999998 110.033 -173.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.21 103.49 3.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.205 -1.776 . . . . 6.2699999999999996 106.205 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -57.1 115.36 2.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.936 0.894 . . . . 2.4300000000000002 109.316 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 2.3500000000000001 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.9199999999999999 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 2.6600000000000001 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 0.62 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 2.4300000000000002 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.8399999999999999 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 0.96999999999999997 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 1.1100000000000001 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.3 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 2.8700000000000001 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 1.6299999999999999 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.0499999999999998 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 3.54 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 1.5900000000000001 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 1.6299999999999999 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 1.26 110.109 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 1.3100000000000001 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 2.6299999999999999 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.94999999999999996 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.6800000000000002 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 2.4700000000000002 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.82999999999999996 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 1.6899999999999999 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 2.21 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 2.79 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 1.9299999999999999 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.73999999999999999 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 1.46 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 0.73999999999999999 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.6699999999999999 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 0.55000000000000004 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.0600000000000001 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 21' ' ' ALA . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 1.3400000000000001 111.873 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2000000000000002 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 2.1800000000000002 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 1.4099999999999999 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 1.3700000000000001 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.3599999999999999 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 0.87 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 0.44 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.0600000000000001 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 0.5 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 0.95999999999999996 108.117 -178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 1.8 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.0800000000000001 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 1.1100000000000001 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.2999999999999998 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.80000000000000004 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 0.94999999999999996 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 0.98999999999999999 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 0.73999999999999999 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 0.73999999999999999 107.57 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.9099999999999999 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 2.3500000000000001 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 0.58999999999999997 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.3399999999999999 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.1699999999999999 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 2.48 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.87 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 4.0599999999999996 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 1.8200000000000001 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 0.97999999999999998 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 0.96999999999999997 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.7300000000000004 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.0 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 0.73999999999999999 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.8599999999999999 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 2.3700000000000001 109.745 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.6599999999999999 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 0.96999999999999997 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.499 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.1600000000000001 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.6200000000000001 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm -60.35 178.89 0.17 Allowed 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 3.3700000000000001 114.042 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.255 4.1 t 53.45 39.14 29.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.645 -1.616 . . . . 5.5300000000000002 109.841 -174.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -147.72 -61.8 0.27 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 114.816 -1.084 . . . . 6.3600000000000003 109.395 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.24 49.1 2.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.006 0.922 . . . . 5.7300000000000004 110.207 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 49.83 36.71 11.79 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.616 1.166 . . . . 1.9099999999999999 112.124 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 1.53 110.815 -165.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 0.68000000000000005 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 2.2200000000000002 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 5.3899999999999997 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 1.8999999999999999 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 2.7200000000000002 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 3.9700000000000002 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 1.73 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.7999999999999998 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 4.6900000000000004 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 1.45 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.76000000000000001 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 0.71999999999999997 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 0.59999999999999998 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.68000000000000005 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 0.44 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.56000000000000005 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 1.9099999999999999 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 1.97 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 2.3199999999999998 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.0700000000000001 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 1.28 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.6800000000000002 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 0.71999999999999997 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 0.65000000000000002 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 0.66000000000000003 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 128' ' ' LEU . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 0.56000000000000005 104.877 166.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.8500000000000001 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 2.0899999999999999 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.0600000000000001 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65000000000000002 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 7.6200000000000001 109.315 171.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.8100000000000001 109.243 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 0.68999999999999995 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.0600000000000001 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 125' ' ' VAL . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 2.25 113.915 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 0.81999999999999995 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 78' ' ' PHE . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 1.4299999999999999 111.447 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 2.7000000000000002 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.1600000000000001 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 0.73999999999999999 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 139' ' ' LEU . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 1.6899999999999999 111.85 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 2.73 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 0.94999999999999996 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91000000000000003 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 2.3199999999999998 108.331 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.0199999999999996 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.719 ' HB2' HG11 ' A' ' 132' ' ' VAL . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 2.5899999999999999 106.624 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 3.1699999999999999 108.071 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 2.4300000000000002 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -76.3 99.6 4.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 3.5699999999999998 106.92 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.65 -40.94 3.07 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.041 -0.981 . . . . 3.6000000000000001 111.511 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.37 57.47 0.7 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.159 0.984 . . . . 5.3300000000000001 110.384 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -178.71 -55.75 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 128.587 2.755 . . . . 11.460000000000001 104.887 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 35.15 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.374 1.07 . . . . 11.970000000000001 111.133 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.93 25.97 7.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.036 1.734 . . . . 10.76 113.647 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -83.05 74.11 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.915 -1.116 . . . . 10.77 109.106 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -145.43 154.52 42.34 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 105.981 -1.859 . . . . 12.039999999999999 105.981 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.18 -178.0 47.0 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.9 -1.28 . . . . 11.800000000000001 109.9 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 126.201 1.8 . . . . 14.68 110.36 -169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.141 -0.457 . . . . 13.01 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.4 mt 70.5 -61.32 0.47 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.672 1.589 . . . . 10.68 111.9 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m -74.13 48.25 0.31 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.892 1.277 . . . . 4.5199999999999996 112.725 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.82 73.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.427 1.891 . . . . 4.6699999999999999 107.332 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -57.7 129.83 43.66 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.038 -0.983 . . . . 2.0600000000000001 108.735 172.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 4.4699999999999998 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 2.5 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 2.2400000000000002 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 0.93999999999999995 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.0 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 1.8400000000000001 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 0.62 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 0.77000000000000002 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.64000000000000001 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 2.7999999999999998 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 1.5700000000000001 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.1900000000000004 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 2.5 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 1.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 0.71999999999999997 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 0.89000000000000001 109.028 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 1.1299999999999999 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 2.4199999999999999 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 0.58999999999999997 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 2.6499999999999999 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.01 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 1.5800000000000001 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 1.9299999999999999 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 2.7799999999999998 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 1.8100000000000001 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.76000000000000001 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 1.3799999999999999 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 0.73999999999999999 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.6799999999999999 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 0.57999999999999996 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.0299999999999998 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 0.93999999999999995 107.981 -174.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.7799999999999998 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 1.76 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.1200000000000001 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 0.98999999999999999 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 0.48999999999999999 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 2.8199999999999998 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 0.44 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 1.3799999999999999 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 2.3300000000000001 111.909 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.2400000000000002 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.93000000000000005 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.1499999999999999 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.0299999999999998 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 0.94999999999999996 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.87 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 1.1499999999999999 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.1899999999999999 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 0.96999999999999997 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 0.91000000000000003 108.406 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.0699999999999998 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.9199999999999999 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 3.8300000000000001 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 0.5 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.5800000000000001 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 3.1299999999999999 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 2.3500000000000001 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.60999999999999999 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 2.1200000000000001 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 2.1699999999999999 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 0.58999999999999997 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.1000000000000001 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 1.05 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.2999999999999998 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 2.8399999999999999 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 0.66000000000000003 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.8900000000000001 111.717 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 2.3599999999999999 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.5700000000000001 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 0.95999999999999996 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.6299999999999999 104.648 168.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.76 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -46.17 152.14 0.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.1100000000000003 112.512 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.261 14.9 t 62.57 32.26 16.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.508 1.923 . . . . 4.75 112.638 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.6 t -116.51 -47.55 2.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.913 0.885 . . . . 7.4900000000000002 110.635 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.9 65.72 0.08 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.868 0.867 . . . . 5.3600000000000003 110.665 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.3 34.63 9.17 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 1.75 112.095 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 1.1000000000000001 110.143 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 1.1299999999999999 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.1899999999999999 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 4.96 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 1.8100000000000001 110.623 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 2.9199999999999999 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 3.21 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 2.1200000000000001 111.151 -177.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.54 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 5.8300000000000001 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 2.0499999999999998 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.6099999999999999 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 0.98999999999999999 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 0.91000000000000003 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.97999999999999998 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 0.94999999999999996 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.0600000000000001 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 2.1099999999999999 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.02 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 3.1899999999999999 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 1.55 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 1.98 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 0.88 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 0.42999999999999999 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 1.04 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 0.62 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.3300000000000001 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 2.3300000000000001 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 2.4700000000000002 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.1399999999999999 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 5.6299999999999999 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.7200000000000002 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 0.81000000000000005 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 2.4500000000000002 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 1.55 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 0.79000000000000004 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 0.97999999999999998 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.0 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.7400000000000002 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 0.85999999999999999 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 1.75 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 3.9399999999999999 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 1.1000000000000001 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.94999999999999996 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 1.8500000000000001 108.126 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 4.3200000000000003 107.616 172.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 2.54 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 3.48 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 1.8999999999999999 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 41.3 mtpt -80.77 96.02 6.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 2.7400000000000002 107.199 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.92 3.62 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.432 -1.067 . . . . 2.6400000000000001 110.432 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 46.57 54.19 9.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.609 1.164 . . . . 5.5700000000000003 110.638 -173.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -174.83 -45.73 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.677 1.191 . . . . 6.7800000000000002 109.269 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -114.55 -6.94 12.82 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.626 0.77 . . . . 6.8399999999999999 112.097 -170.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 p -123.36 4.38 9.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.536 1.934 . . . . 7.5300000000000002 112.157 -170.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.69 77.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.854 0.835 . . . . 7.96 110.608 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.76 94.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.791 1.236 . . . . 14.109999999999999 110.044 165.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 169.48 -50.82 0.21 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.538 -0.839 . . . . 14.119999999999999 114.736 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.064 -1.445 . . . . 16.07 110.481 -161.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.59 1.33 . . . . 13.0 114.59 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.29 111.12 2.13 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.914 1.234 . . . . 8.9499999999999993 107.921 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 62.95 74.73 0.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.784 0.834 . . . . 4.3899999999999997 111.454 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -72.27 56.34 0.34 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.393 1.077 . . . . 4.3099999999999996 110.193 171.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -69.21 157.29 37.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.2000000000000002 108.078 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.8500000000000001 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.04 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 0.56999999999999995 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 2.0699999999999998 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.413 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.6800000000000002 109.244 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 0.83999999999999997 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 0.89000000000000001 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.81000000000000005 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 2.77 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 1.48 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.6299999999999999 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 3.23 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 1.6499999999999999 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 0.94999999999999996 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 0.83999999999999997 110.475 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 1.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 3.5699999999999998 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 0.85999999999999999 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.0300000000000002 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 1.79 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.67000000000000004 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 1.6000000000000001 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 2.25 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 2.5299999999999998 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 1.5800000000000001 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.58999999999999997 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 1.3400000000000001 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 0.73999999999999999 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 0.66000000000000003 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.8200000000000001 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG13 ' HB1' ' A' ' 21' ' ' ALA . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 1.48 111.915 170.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 1.79 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 2.7000000000000002 111.565 167.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 1.6799999999999999 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 1.45 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 0.95999999999999996 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 2.9100000000000001 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 0.46000000000000002 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 1.21 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 1.75 111.078 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.2999999999999998 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.87 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.02 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.8100000000000001 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 0.71999999999999997 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.66000000000000003 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 0.88 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 1.03 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 0.81999999999999995 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 0.64000000000000001 107.726 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 2.3300000000000001 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 0.87 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.8600000000000001 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 2.7000000000000002 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 2.0899999999999999 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.1100000000000001 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 2.2000000000000002 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 1.96 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 0.56000000000000005 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 1.04 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.47 HG23 ' C ' ' A' ' 118' ' ' TYR . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 0.82999999999999996 108.671 -166.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.1699999999999999 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 4.5300000000000002 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 0.64000000000000001 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.7799999999999998 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 1.79 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.5699999999999998 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 0.82999999999999996 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.8399999999999999 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.793 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -100.93 -24.19 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 3.7799999999999998 111.708 167.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.3 m -79.87 71.12 6.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.079 1.352 . . . . 4.8799999999999999 109.889 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.6 t -143.73 84.0 1.78 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.334 -0.987 . . . . 6.29 108.334 166.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.57 -67.46 0.16 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.783 1.633 . . . . 3.6000000000000001 110.899 -166.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 41.47 0.11 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.525 0.33 . . . . 1.77 110.759 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 1.47 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 0.68000000000000005 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.2000000000000002 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 3.8399999999999999 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 2.8300000000000001 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.6400000000000001 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 2.9900000000000002 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 5.3899999999999997 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 99' ' ' ILE . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 2.0099999999999998 111.68 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 5.9299999999999997 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 96' ' ' LEU . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.5800000000000001 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.71999999999999997 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 0.60999999999999999 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 0.65000000000000002 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.73999999999999999 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 0.64000000000000001 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.69999999999999996 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 89' ' ' ALA . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 2.5299999999999998 108.99 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 1.9199999999999999 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 2.54 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 1.6599999999999999 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 1.3500000000000001 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.3799999999999999 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 0.84999999999999998 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 0.59999999999999998 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 0.70999999999999996 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 128' ' ' LEU . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 0.60999999999999999 106.337 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6000000000000001 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.47 ' C ' HG23 ' A' ' 73' ' ' THR . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 2.0099999999999998 112.017 -172.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 2.25 109.203 -170.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.60999999999999999 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 7.3700000000000001 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.5899999999999999 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 0.52000000000000002 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.1699999999999999 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 1.73 113.644 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 0.81000000000000005 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.2200000000000002 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 116' ' ' VAL . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 1.52 110.494 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 3.1000000000000001 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.8900000000000001 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 0.79000000000000004 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' A' ' 139' ' ' LEU . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 1.55 112.035 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.0599999999999996 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 2.6099999999999999 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 0.98999999999999999 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 1.9199999999999999 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 4.5199999999999996 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 1.8 108.731 -175.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 2.1899999999999999 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 1.73 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -78.33 79.47 4.77 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 2.8199999999999998 108.647 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 -60.81 3.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.412 1.006 . . . . 2.4700000000000002 110.909 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 51.13 38.43 20.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.333 1.453 . . . . 4.1299999999999999 111.8 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -156.84 -55.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.546 1.939 . . . . 6.5700000000000003 107.693 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -128.36 1.33 5.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.174 0.99 . . . . 7.0899999999999999 111.325 -161.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -132.32 23.61 4.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.696 1.198 . . . . 7.8700000000000001 108.875 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.0 mt -70.29 76.04 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.362 -0.607 . . . . 8.0899999999999999 109.362 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -51.01 99.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.83 1.252 . . . . 15.039999999999999 110.941 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.24 -34.62 1.62 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.715 -1.047 . . . . 14.609999999999999 114.56 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-N 118.649 1.224 . . . . 15.32 109.944 -162.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.518 -0.919 . . . . 14.74 108.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.15 167.83 20.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.196 0.998 . . . . 8.2100000000000009 108.833 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -169.77 162.14 9.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.162 -1.792 . . . . 4.0 106.162 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -144.34 60.67 1.35 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.186 -1.042 . . . . 5.0999999999999996 108.186 170.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -63.46 153.24 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.782 -0.644 . . . . 2.2999999999999998 109.635 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 2.2799999999999998 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.4900000000000002 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 2.54 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 0.87 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 1.78 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 2.7200000000000002 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 0.82999999999999996 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 1.5900000000000001 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.0600000000000001 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.595 ' HE2' HD12 ' A' ' 24' ' ' ILE . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 3.3100000000000001 110.691 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 1.52 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.0800000000000001 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 3.5600000000000001 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 1.4299999999999999 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 0.93000000000000005 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 0.67000000000000004 111.478 171.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 0.93000000000000005 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.25 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 15' ' ' MET . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 0.67000000000000004 108.447 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 1.8999999999999999 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.64000000000000001 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 1.6200000000000001 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 2.2200000000000002 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 4.4199999999999999 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 1.45 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.3200000000000001 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 0.85999999999999999 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 1.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.91000000000000003 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.9199999999999999 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 0.71999999999999997 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 1.03 109.623 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 2.4100000000000001 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 3.1499999999999999 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 1.5700000000000001 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 1.45 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.0099999999999998 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.1399999999999999 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 0.46999999999999997 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.3900000000000001 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 0.47999999999999998 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 1.21 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CZ ' HG13 ' A' ' 60' ' ' ILE . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 2.4100000000000001 112.126 -170.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.0800000000000001 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 1.1799999999999999 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.9399999999999999 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 0.92000000000000004 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.83999999999999997 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 0.88 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 0.90000000000000002 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 0.82999999999999996 107.344 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.04 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.0099999999999998 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 2.3100000000000001 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 1.8999999999999999 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 2.5699999999999998 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 1.9399999999999999 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.59999999999999998 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CG ' HD11 ' A' ' 24' ' ' ILE . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 1.99 108.929 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 2.5699999999999998 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 0.56000000000000005 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 1.48 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 0.81000000000000005 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 4.4800000000000004 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 0.58999999999999997 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 2.04 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 114' ' ' VAL . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 0.80000000000000004 111.123 -165.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.4100000000000001 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.09 125.3 21.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 2.7200000000000002 110.11 172.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -124.63 -4.94 7.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.027 1.331 . . . . 3.46 109.952 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.92 161.53 42.5 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.34 -1.355 . . . . 5.2800000000000002 107.34 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.1 69.72 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.738 1.215 . . . . 6.7300000000000004 110.768 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 -57.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.528 1.131 . . . . 1.96 109.778 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.1200000000000001 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 0.88 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 1.73 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 3.8900000000000001 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 2.7599999999999998 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.3599999999999999 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 3.6899999999999999 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 3.29 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 1.55 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 4.4900000000000002 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 102' ' ' VAL . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.0800000000000001 107.557 159.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.8900000000000001 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 0.68999999999999995 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ILE . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 0.60999999999999999 108.832 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 0.85999999999999999 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 0.5 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.56000000000000005 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 1.79 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 1.73 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 2.8199999999999998 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 1.46 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 1.4299999999999999 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.7400000000000002 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 0.76000000000000001 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 0.40000000000000002 107.24 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 0.68000000000000005 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 0.67000000000000004 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.5299999999999998 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' A' ' 102' ' ' VAL . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 2.0899999999999999 112.318 -165.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 2.4500000000000002 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79000000000000004 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 6.7599999999999998 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.2599999999999998 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 0.67000000000000004 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.1200000000000001 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.613 ' HA ' HD12 ' A' ' 128' ' ' LEU . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 1.9299999999999999 112.854 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 0.81000000000000005 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.0899999999999999 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 125' ' ' VAL . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 1.0600000000000001 109.669 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 3.4300000000000002 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.8900000000000001 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 0.73999999999999999 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 1.48 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.6099999999999999 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 3.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 0.69999999999999996 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.72999999999999998 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 2.25 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 4.3700000000000001 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 1.3600000000000001 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 2.8300000000000001 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 1.6200000000000001 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -79.38 84.95 5.23 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 2.9700000000000002 107.793 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.73 -68.92 3.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.984 -1.246 . . . . 2.2200000000000002 109.984 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 43.99 56.56 4.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.382 1.073 . . . . 3.7400000000000002 111.254 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -178.6 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.356 1.862 . . . . 6.3399999999999999 108.162 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.98 -11.19 14.67 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.243 0.617 . . . . 7.1200000000000001 112.571 -165.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 p -102.18 -14.6 16.97 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.0 1.72 . . . . 7.3099999999999996 113.007 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.1 mm -81.63 57.94 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.948 0.899 . . . . 8.4800000000000004 110.13 -168.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -152.78 -75.23 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.199 1.8 . . . . 12.27 108.584 170.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.4 75.57 1.21 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 107.877 -2.089 . . . . 15.08 107.877 -161.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.156 0 CA-C-O 116.996 -1.478 . . . . 19.190000000000001 110.173 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 105.52 -2.029 . . . . 13.48 105.52 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 92.33 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.381 0.992 . . . . 10.640000000000001 111.147 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -168.88 54.04 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.648 0.779 . . . . 4.71 110.118 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -121.87 50.43 1.44 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.613 0.72 . . . . 4.9699999999999998 109.239 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -66.93 141.32 57.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.777 -0.577 . . . . 2.0499999999999998 110.113 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 2.3300000000000001 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7000000000000002 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.0600000000000001 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 0.75 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.0800000000000001 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 1.79 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 0.53000000000000003 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 0.70999999999999996 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.67000000000000004 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 2.5899999999999999 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.4399999999999999 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 4.1500000000000004 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 1.46 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 0.70999999999999996 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 0.77000000000000002 110.629 171.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.78000000000000003 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 2.3700000000000001 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 69' ' ' TYR . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.5899999999999999 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 1.74 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.78000000000000003 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 63' ' ' LYS . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 1.45 110.291 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 2.3100000000000001 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 2.8999999999999999 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 1.46 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.75 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 1.5 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 0.97999999999999998 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 0.63 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.6200000000000001 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 0.93000000000000005 108.914 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.29 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 1.74 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 1.48 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 1.3899999999999999 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.1099999999999999 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 0.52000000000000002 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 2.8700000000000001 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 0.48999999999999999 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 1.25 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 1.9399999999999999 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.3300000000000001 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.91000000000000003 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.52 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 0.83999999999999997 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.66000000000000003 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 0.81999999999999995 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 0.93999999999999995 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 0.78000000000000003 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 0.63 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.1899999999999999 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.4700000000000002 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.0 109.047 -173.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.5499999999999998 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 4.1900000000000004 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 2.0899999999999999 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.59999999999999998 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 24' ' ' ILE . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 2.0600000000000001 108.235 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 2.4700000000000002 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 0.94999999999999996 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.1599999999999999 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 1.01 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.6499999999999999 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 2.6800000000000002 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 0.84999999999999998 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.3100000000000001 108.816 -173.391 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 2.3100000000000001 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.8700000000000001 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 114' ' ' VAL . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 0.62 110.295 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.7999999999999998 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 1.78 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.66 81.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 4.6900000000000004 111.271 172.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -156.94 30.79 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.143 0.977 . . . . 3.9900000000000002 110.021 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 t -160.98 168.47 24.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 6.1299999999999999 107.821 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -5.72 -69.8 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 129.278 3.031 . . . . 3.8500000000000001 115.339 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.32 48.49 0.37 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 1.8999999999999999 109.447 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 0.76000000000000001 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.5099999999999998 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 4.0899999999999999 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 3.1400000000000001 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 94' ' ' LYS . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.0299999999999998 107.241 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 3.8500000000000001 111.908 -178.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 3.1600000000000001 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 1.53 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.5900000000000001 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.0199999999999996 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 1.54 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.6600000000000001 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.81999999999999995 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.68000000000000005 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 0.93000000000000005 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.1799999999999999 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 0.83999999999999997 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 0.93999999999999995 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 1.99 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.0899999999999999 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 3.7200000000000002 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 1.3100000000000001 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 2.1299999999999999 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.6499999999999999 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 0.84999999999999998 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' A' ' 80' ' ' ILE . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 0.51000000000000001 108.347 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 1.1200000000000001 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 0.67000000000000004 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.8999999999999999 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 1.8300000000000001 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.1200000000000001 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.69999999999999996 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 5.7800000000000002 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.0299999999999998 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 0.51000000000000001 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 2.2400000000000002 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 1.6200000000000001 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 0.62 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.6099999999999999 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 0.81000000000000005 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.0499999999999998 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.2400000000000002 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 0.83999999999999997 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 1.8100000000000001 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 2.6299999999999999 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 0.92000000000000004 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.81999999999999995 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 2.1400000000000001 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 2.8300000000000001 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 1.6699999999999999 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 4.5700000000000003 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 1.9399999999999999 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 1.3 mptm? -77.27 86.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 3.1600000000000001 108.185 173.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.87 -48.77 4.11 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 118.939 -0.923 . . . . 2.73 112.11 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 49.19 21.4 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.173 1.789 . . . . 7.2400000000000002 114.059 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -148.14 -54.88 0.21 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.48 1.512 . . . . 6.3700000000000001 108.687 -172.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.31 22.45 0.84 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.497 0.719 . . . . 8.1400000000000006 110.461 -165.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.64 16.3 2.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.642 -0.661 . . . . 6.96 111.335 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.9 -62.4 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.439 0.296 . . . . 8.3900000000000006 110.758 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.6 -178.9 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.684 -1.598 . . . . 12.949999999999999 106.684 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -76.92 -104.79 0.15 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.957 1.265 . . . . 11.32 113.597 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.304 -1.808 . . . . 14.94 108.91 -169.782 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 118.463 -0.779 . . . . 14.24 109.834 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp 59.7 54.65 4.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.0 -1.111 . . . . 12.359999999999999 108.0 -160.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m 65.52 174.19 0.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.745 1.618 . . . . 4.9500000000000002 110.803 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.74 55.47 1.07 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.666 0.786 . . . . 6.25 109.966 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -103.73 165.14 11.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.0099999999999998 106.215 164.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.0899999999999999 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.0699999999999998 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.1099999999999999 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 0.64000000000000001 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 1.9099999999999999 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 1.9199999999999999 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 0.55000000000000004 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 1.1000000000000001 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.73999999999999999 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.04 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 1.21 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.6800000000000002 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 2.5600000000000001 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 1.2 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.0 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 0.92000000000000004 111.067 169.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 0.81999999999999995 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.0899999999999999 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 0.67000000000000004 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.6499999999999999 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.0699999999999998 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.66000000000000003 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 60' ' ' ILE . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 2.6899999999999999 111.479 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 3.3399999999999999 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 3.2599999999999998 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 1.3600000000000001 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.3999999999999999 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.65000000000000002 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 1.3799999999999999 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 0.85999999999999999 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.6400000000000001 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 0.65000000000000002 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 1.6399999999999999 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 0.85999999999999999 109.692 168.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.2799999999999998 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 2.1600000000000001 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 1.1599999999999999 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 1.1299999999999999 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.8100000000000001 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 0.90000000000000002 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 0.39000000000000001 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 2.9900000000000002 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 0.53000000000000003 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 1.4299999999999999 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 2.02 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.4099999999999999 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.0899999999999999 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.9099999999999999 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 1.01 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.70999999999999996 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 1.3100000000000001 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 1.1399999999999999 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 0.95999999999999996 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG23 HD21 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 0.68999999999999995 107.067 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.6200000000000001 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.1800000000000002 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 0.57999999999999996 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.1699999999999999 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 2.1800000000000002 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.65000000000000002 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 1.8600000000000001 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 1.8200000000000001 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 0.48999999999999999 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 0.81999999999999995 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 0.81999999999999995 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.3300000000000001 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 3.8500000000000001 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 0.76000000000000001 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.3300000000000001 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 2.2000000000000002 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 0.57999999999999996 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.4900000000000002 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.58 121.39 11.47 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 3.2400000000000002 111.825 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.9 p -135.69 10.11 3.39 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.996 0.918 . . . . 3.8999999999999999 111.2 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.85 -107.26 0.32 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.123 -1.066 . . . . 4.4100000000000001 108.123 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -166.0 43.6 0.07 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.835 0.854 . . . . 5.0499999999999998 108.776 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.5 -48.48 0.13 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.069 0.548 . . . . 2.1200000000000001 111.662 -169.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 0.89000000000000001 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 0.77000000000000002 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.02 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 5.1399999999999997 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.0299999999999998 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.0699999999999998 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 4.46 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 3.75 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 1.4399999999999999 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.53 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 5.54 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 1.6100000000000001 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.0300000000000002 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.71999999999999997 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 0.60999999999999999 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 0.63 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.81999999999999995 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 0.56000000000000005 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.72999999999999998 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 1.75 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.2400000000000002 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 3.1000000000000001 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.46 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 1.53 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.9399999999999999 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 0.69999999999999996 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 0.46999999999999997 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 0.68999999999999995 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.67000000000000004 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.8399999999999999 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 1.8500000000000001 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 2.5099999999999998 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.69999999999999996 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 5.7300000000000004 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.6899999999999999 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 0.56000000000000005 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 141' ' ' LEU . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 1.48 110.841 176.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.70999999999999996 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.1400000000000001 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 0.97999999999999998 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.0 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.6400000000000001 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 0.56999999999999995 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 1.49 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 2.5699999999999998 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 0.79000000000000004 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 2.6400000000000001 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 3.3799999999999999 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 1.4199999999999999 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 2.77 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 125' ' ' VAL . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 1.71 107.793 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -80.84 94.98 6.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 3.1899999999999999 108.901 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.53 -46.16 3.61 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.21 -1.156 . . . . 1.99 110.21 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -44.31 -28.04 0.49 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.892 1.677 . . . . 4.4800000000000004 114.012 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -140.06 19.18 2.45 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.241 -0.912 . . . . 8.5700000000000003 112.94 163.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.61 1.33 10.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.55 1.14 . . . . 10.220000000000001 111.537 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 t -164.51 34.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.793 0.837 . . . . 6.4000000000000004 111.465 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.6 mm -75.97 -67.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.484 0.584 . . . . 8.5700000000000003 110.593 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.31 176.87 5.9 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.604 -0.887 . . . . 16.239999999999998 108.604 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.83 6.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.588 1.09 . . . . 16.0 110.381 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 116.204 -1.855 . . . . 21.219999999999999 111.31 176.228 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.482 -1.303 . . . . 15.49 107.482 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 174.12 3.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.829 0.452 . . . . 8.6300000000000008 110.053 166.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.4 t -156.95 138.46 13.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.675 -1.972 . . . . 4.7300000000000004 105.675 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -121.46 59.39 0.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.036 1.334 . . . . 5.4900000000000002 108.369 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.09 141.94 38.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.07 1.348 . . . . 2.4399999999999999 109.925 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 2.4500000000000002 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.8999999999999999 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 2.7999999999999998 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 1.6699999999999999 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 2.4700000000000002 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 0.56999999999999995 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 0.80000000000000004 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68000000000000005 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 2.7799999999999998 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 1.8799999999999999 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 4.4800000000000004 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 2.9300000000000002 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 0.90000000000000002 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 0.79000000000000004 111.158 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 0.82999999999999996 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 2.5899999999999999 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 1.26 108.556 173.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 2.1000000000000001 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 0.93000000000000005 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 1.6299999999999999 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 2.75 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 4.3300000000000001 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 1.3600000000000001 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.21 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 0.72999999999999998 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 2.23 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 1.23 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.4500000000000002 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.21 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.1499999999999999 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG13 ' HB1' ' A' ' 21' ' ' ALA . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 1.3200000000000001 112.312 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.9100000000000001 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 2.02 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 1.21 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 1.5 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.9399999999999999 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.3700000000000001 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.45000000000000001 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.5699999999999998 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 0.5 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 1.0600000000000001 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 1.96 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.8399999999999999 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91000000000000003 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 0.96999999999999997 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.76000000000000001 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 0.78000000000000003 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 0.78000000000000003 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 0.73999999999999999 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.1200000000000001 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.8300000000000001 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 3.71 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 0.60999999999999999 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.4399999999999999 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.1899999999999999 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 2.5899999999999999 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.78000000000000003 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 1.98 109.318 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 2.29 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 0.70999999999999996 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 1.5600000000000001 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 0.78000000000000003 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 2.6200000000000001 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 0.81000000000000005 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.0499999999999998 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 1.73 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.2999999999999998 108.194 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.76000000000000001 109.971 -168.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.1499999999999999 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.6299999999999999 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm 30.24 51.71 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 3.1499999999999999 113.696 -168.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.9 t -143.58 53.03 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.37 1.081 . . . . 3.8500000000000001 108.28 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.5 t -148.77 163.83 36.19 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.575 -1.639 . . . . 7.5199999999999996 106.575 169.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -9.06 -63.73 0.0 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.956 2.902 . . . . 5.0899999999999999 114.561 -172.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 90' ' ' ASN . . . -160.54 72.6 0.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.1800000000000002 108.807 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 0.93999999999999995 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 0.93999999999999995 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.04 109.064 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 4.5499999999999998 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 80' ' ' ILE . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 1.72 111.651 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.1899999999999999 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 4.3700000000000001 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' HG11 ' A' ' 102' ' ' VAL . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 1.5900000000000001 110.705 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.3200000000000001 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 4.6699999999999999 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 1.4199999999999999 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.6099999999999999 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.69999999999999996 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 96' ' ' LEU . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 0.56999999999999995 107.638 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.97999999999999998 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 0.45000000000000001 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.51000000000000001 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 2.3100000000000001 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.79 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 2.7200000000000002 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.3300000000000001 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 1.8400000000000001 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.3099999999999996 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 1.1100000000000001 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 80' ' ' ILE . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 0.40999999999999998 107.131 161.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 0.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 0.76000000000000001 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.8799999999999999 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 1.96 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 2.23 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.69999999999999996 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 5.5300000000000002 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.7999999999999998 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 0.55000000000000004 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.0299999999999998 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 1.47 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 0.81000000000000005 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 0.79000000000000004 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 2.8399999999999999 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 0.62 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 1.6200000000000001 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 4.4500000000000002 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 1.1399999999999999 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.65000000000000002 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 2.2999999999999998 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 2.8300000000000001 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 1.47 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 2.48 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.0099999999999998 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -82.09 70.26 8.97 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 4.7199999999999998 108.679 176.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.81 2.75 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.878 -1.512 . . . . 2.5099999999999998 112.034 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 38.35 52.44 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.381 1.472 . . . . 4.3300000000000001 111.539 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 69.49 -15.03 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.666 1.987 . . . . 10.9 114.852 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.4 -32.9 20.66 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.796 1.238 . . . . 9.5899999999999999 111.19 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -137.37 34.6 2.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.54 -1.209 . . . . 6.5899999999999999 111.956 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.9 pt -75.9 54.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.262 -0.899 . . . . 7.9100000000000001 112.894 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -154.83 -172.78 4.32 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.52 -0.737 . . . . 13.17 109.553 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.53 73.63 0.22 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.41 -1.476 . . . . 15.66 109.41 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.17 -1.395 . . . . 19.23 108.917 174.787 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 105.475 -2.046 . . . . 18.82 105.475 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -158.41 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.689 -1.597 . . . . 11.68 106.689 175.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 p -64.08 -174.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.466 0.706 . . . . 6.2800000000000002 110.448 167.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 86.79 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 129.017 2.927 . . . . 6.9100000000000001 108.536 -175.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -58.26 119.56 7.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.2999999999999998 109.227 -177.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 2.1699999999999999 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.1799999999999997 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 0.56000000000000005 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 2.2400000000000002 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 1.72 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 0.91000000000000003 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.0900000000000001 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 2.71 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 1.3 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.2999999999999998 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 3.3799999999999999 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 1.99 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.1100000000000001 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.861 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 0.73999999999999999 109.961 173.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 0.96999999999999997 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.2599999999999998 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 0.90000000000000002 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' OE2' HG12 ' A' ' 39' ' ' VAL . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.5600000000000001 110.706 -178.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.0099999999999998 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 0.94999999999999996 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 1.75 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.1400000000000001 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 4.5899999999999999 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 1.76 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.3300000000000001 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.58999999999999997 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 1.3700000000000001 109.973 176.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 0.93999999999999995 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.8500000000000001 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 0.67000000000000004 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 1.72 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 1.25 110.215 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.3700000000000001 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 1.6599999999999999 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.21 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 1.0700000000000001 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.5499999999999998 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 1.1100000000000001 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 0.38 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 2.6600000000000001 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 0.68999999999999995 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 1.0800000000000001 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 2.0299999999999998 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 0.93999999999999995 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.4299999999999999 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.05 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 0.94999999999999996 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.1100000000000001 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 0.96999999999999997 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 0.87 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 0.81999999999999995 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.72 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 2.8300000000000001 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 0.82999999999999996 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.8799999999999999 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 4.9000000000000004 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 2.7599999999999998 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.0700000000000001 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 2.9900000000000002 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 2.1800000000000002 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 0.94999999999999996 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 1.3600000000000001 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 0.97999999999999998 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.5699999999999998 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 2.8500000000000001 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 2.0699999999999998 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.6299999999999999 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 92' ' ' ILE . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 0.65000000000000002 107.647 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.1399999999999997 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 2.1299999999999999 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.569 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 6.9 ptt? -93.71 -30.07 15.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.4199999999999999 112.441 -176.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.3 p -81.1 56.46 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.279 -0.888 . . . . 5.5800000000000001 109.55 -175.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 38.5 t -113.64 -48.93 2.91 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.746 0.818 . . . . 6.6399999999999997 109.623 -178.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.51 65.2 0.61 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.516 -0.92 . . . . 4.2699999999999996 108.516 171.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.12 42.46 31.56 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.397 0.679 . . . . 1.8500000000000001 110.685 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 0.80000000000000004 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB1' HG21 ' A' ' 107' ' ' VAL . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 0.84999999999999998 109.683 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 4.8200000000000003 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 80' ' ' ILE . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 1.99 110.719 -178.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 3.7599999999999998 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 4.0899999999999999 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.429 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 1.9299999999999999 111.942 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.2 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 3.8399999999999999 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 1.3899999999999999 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.4300000000000002 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.65000000000000002 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 96' ' ' LEU . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 0.54000000000000004 108.008 178.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 0.57999999999999996 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.78000000000000003 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.73999999999999999 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.694 HG21 ' HB1' ' A' ' 89' ' ' ALA . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 2.6800000000000002 110.968 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.1600000000000001 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 2.4500000000000002 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 1.0900000000000001 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 1.3899999999999999 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7000000000000002 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 1.0 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 0.62 107.873 168.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 0.80000000000000004 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 0.54000000000000004 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 2.02 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.0600000000000001 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.58999999999999997 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 5.6900000000000004 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 0.56999999999999995 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.0699999999999998 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 1.8600000000000001 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 0.78000000000000003 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 0.76000000000000001 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 3.6800000000000002 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 0.52000000000000002 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 1.5800000000000001 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.3100000000000001 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 3.1400000000000001 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 0.77000000000000002 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.68999999999999995 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 2.1600000000000001 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 3.5800000000000001 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 1.4099999999999999 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 2.3399999999999999 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 3.7400000000000002 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 79.78 9.2 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 4.8200000000000003 108.826 170.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.71 -46.14 2.27 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.562 1.077 . . . . 2.3500000000000001 112.591 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 60.6 34.93 20.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.564 1.545 . . . . 4.75 111.769 -175.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -161.53 -65.21 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.187 -1.783 . . . . 8.0899999999999999 106.187 172.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -160.46 38.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.281 -0.872 . . . . 10.25 109.698 -162.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.0 t 52.81 35.91 20.03 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.502 -0.749 . . . . 7.5599999999999996 111.879 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.54 -59.79 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.363 0.665 . . . . 9.2699999999999996 110.246 -170.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 52.67 56.41 7.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.688 1.195 . . . . 14.81 111.573 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 125.55 116.75 2.14 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.717 -0.953 . . . . 13.369999999999999 110.717 177.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.059 1.343 . . . . 15.91 110.689 -174.455 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.647 -0.501 . . . . 15.529999999999999 109.647 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.98 110.66 4.28 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.454 -1.313 . . . . 9.1500000000000004 107.454 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -170.55 165.6 8.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.98 2.112 . . . . 4.3600000000000003 106.248 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -109.31 36.22 3.0 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.171 0.988 . . . . 4.7300000000000004 109.556 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -62.46 154.58 28.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.893 0.877 . . . . 2.98 109.505 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.1099999999999999 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.3100000000000001 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 3.0600000000000001 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 1.5800000000000001 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 5.1100000000000003 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.04 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 0.73999999999999999 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 1.01 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.1100000000000001 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 21' ' ' ALA . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 3.8399999999999999 110.667 176.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 1.95 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 41' ' ' LEU . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 2.9100000000000001 109.523 174.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 3.6099999999999999 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 2.2400000000000002 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 1.1799999999999999 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 1.23 109.925 168.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 1.5900000000000001 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 2.6899999999999999 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 0.87 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.6400000000000001 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 2.73 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.1599999999999999 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 1.5900000000000001 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 1.76 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.0999999999999996 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 1.6799999999999999 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.3600000000000001 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 0.92000000000000004 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 1.3999999999999999 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 0.56999999999999995 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.1800000000000002 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.94999999999999996 109.65 175.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.72 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 17' ' ' CYS . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 1.76 111.652 174.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 1.22 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 1.22 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.9900000000000002 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 1.1399999999999999 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 0.53000000000000003 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.79 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 0.56000000000000005 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 2.0600000000000001 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.8100000000000001 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.3700000000000001 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 1.8400000000000001 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.4300000000000002 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 0.95999999999999996 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.80000000000000004 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 1.28 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 1.0 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 1.25 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.0 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.5099999999999998 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 3.98 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 0.81999999999999995 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.1200000000000001 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 2.3399999999999999 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 3.0800000000000001 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.89000000000000001 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 2.27 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 2.2599999999999998 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 0.88 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 1.2 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 1.74 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.4900000000000002 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 2.75 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 0.92000000000000004 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.2200000000000002 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 1.8799999999999999 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 0.71999999999999997 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.1200000000000001 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -173.4 1.19 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 3.77 111.297 170.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 83.64 -8.73 1.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.196 1.799 . . . . 6.9900000000000002 110.541 -173.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.91 -40.96 12.06 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 121.835 -0.541 . . . . 4.71 110.527 -173.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.87 -99.16 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.936 0.894 . . . . 3.3300000000000001 108.937 172.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.98 31.89 2.69 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.037 0.935 . . . . 2.1899999999999999 110.12 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.27 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 1.0900000000000001 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.6899999999999999 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 4.1900000000000004 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 1.9399999999999999 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7000000000000002 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 3.6899999999999999 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.1299999999999999 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 1.8400000000000001 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.3 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 4.5700000000000003 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 1.8400000000000001 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.8199999999999998 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.6899999999999999 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 102' ' ' VAL . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 1.3 112.828 -170.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 1.04 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.1899999999999999 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 1.95 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.1200000000000001 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 2.5699999999999998 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 1.75 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 1.8999999999999999 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.9100000000000001 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 0.77000000000000002 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 1.0700000000000001 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 0.93999999999999995 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.2799999999999998 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 2.4700000000000002 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 2.8500000000000001 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 8.2599999999999998 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.3600000000000003 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.1899999999999999 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 2.6499999999999999 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 2.0899999999999999 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 0.95999999999999996 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.9100000000000001 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 0.92000000000000004 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 3.6000000000000001 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.7200000000000002 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 0.67000000000000004 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 139' ' ' LEU . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 1.5 110.223 -178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.5699999999999998 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 3.23 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 1.1599999999999999 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.23 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 2.02 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 3.3700000000000001 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 132' ' ' VAL . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 1.3600000000000001 110.404 173.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 2.52 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 3.4199999999999999 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 149' ' ' GLU . 3.0 mmmp? -79.16 78.06 5.64 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 176.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.32 -49.53 3.59 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.691 -1.061 . . . . 2.0499999999999998 112.992 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 38.19 47.76 1.03 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.079 1.752 . . . . 4.1200000000000001 111.214 -174.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 70.71 -14.98 0.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.17 1.388 . . . . 8.7100000000000009 113.97 177.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.52 -43.27 19.01 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.159 1.784 . . . . 8.6899999999999995 108.963 -175.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.6 m -122.25 58.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 112.805 -1.998 . . . . 8.3200000000000003 109.021 169.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.3 mt 20.26 72.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.986 2.514 . . . . 9.6600000000000001 112.862 160.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 8.1 tp10 41.73 51.2 4.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 13.5 112.712 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.63 -9.54 76.8 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.695 -1.058 . . . . 16.199999999999999 113.62 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.53 1.165 . . . . 20.469999999999999 108.728 173.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.714 -0.184 . . . . 14.41 111.48 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp 66.36 -57.22 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 11.4 112.803 -174.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -152.85 60.08 0.79 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.8 1.24 . . . . 7.3899999999999997 108.153 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -161.43 36.15 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.976 0.91 . . . . 8.1199999999999992 108.717 -164.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 61.88 148.4 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 2.7599999999999998 116.764 -174.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 2.3500000000000001 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.2599999999999998 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 1.9099999999999999 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 0.63 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 2.1299999999999999 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.0 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 0.81000000000000005 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 0.97999999999999998 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.84999999999999998 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 3.5099999999999998 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 1.77 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.25 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 2.8700000000000001 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 1.45 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 0.88 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 110.089 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 0.90000000000000002 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.1699999999999999 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 0.85999999999999999 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.1699999999999999 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 1.99 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.65000000000000002 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 1.6299999999999999 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 2.21 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 3.79 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 2.3500000000000001 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.1599999999999999 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.54000000000000004 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 1.3 110.079 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 0.93999999999999995 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.1800000000000002 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 0.65000000000000002 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.3199999999999998 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.721 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 0.85999999999999999 111.952 -173.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 1.52 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 0.91000000000000003 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 0.93999999999999995 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 1.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 0.51000000000000001 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 3.8399999999999999 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 0.40999999999999998 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 2.1699999999999999 109.604 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.2999999999999998 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.80000000000000004 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.8300000000000001 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 0.76000000000000001 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.60999999999999999 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 0.75 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 0.75 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 0.70999999999999996 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.1400000000000001 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.6299999999999999 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 2.3999999999999999 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 0.57999999999999996 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.8500000000000001 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 2.4199999999999999 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 2.6099999999999999 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.65000000000000002 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 2.1299999999999999 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 2.0800000000000001 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 0.58999999999999997 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 1.0 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 0.92000000000000004 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2000000000000002 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 2.7200000000000002 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 0.76000000000000001 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 1.7 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.8799999999999999 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 0.81000000000000005 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.0199999999999996 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.54 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.3 ttp -64.1 -175.82 0.17 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 3.4300000000000002 111.21 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t 50.14 32.46 5.97 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.074 1.75 . . . . 5.2400000000000002 110.984 -168.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.4 t -110.08 -48.73 3.15 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.677 -0.49 . . . . 6.3600000000000003 109.677 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.81 -76.88 0.18 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.225 -0.657 . . . . 3.5600000000000001 109.225 166.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.64 40.75 0.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.469 -0.937 . . . . 1.46 108.469 -175.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.23 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' MET . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 109.612 168.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 4.21 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 1.6699999999999999 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 2.5099999999999998 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 3.5699999999999998 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.401 ' O ' HG11 ' A' ' 102' ' ' VAL . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 1.8899999999999999 112.109 -176.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 1.97 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 6.46 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 1.6799999999999999 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6000000000000001 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.81999999999999995 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 96' ' ' LEU . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 0.71999999999999997 107.886 175.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 0.98999999999999999 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 0.65000000000000002 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.87 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 1.8200000000000001 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 2.4199999999999999 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 1.1699999999999999 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 1.6599999999999999 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.4900000000000002 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 0.65000000000000002 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 0.65000000000000002 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.8700000000000001 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 1.77 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 2.3500000000000001 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 0.93000000000000005 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 7.2800000000000002 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.6200000000000001 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 0.66000000000000003 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.0299999999999998 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 1.7 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 0.68999999999999995 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.2200000000000002 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 0.81999999999999995 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.04 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 0.51000000000000001 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 1.5900000000000001 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.5600000000000001 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 3.8900000000000001 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 0.80000000000000004 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.71999999999999997 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 2.1800000000000002 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.1000000000000001 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 1.3700000000000001 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 2.5499999999999998 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 1.72 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -81.96 71.72 9.0 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.0199999999999996 108.567 172.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.39 -64.73 3.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.604 -0.999 . . . . 2.5899999999999999 110.604 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 51.37 34.45 11.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.72 1.208 . . . . 5.4900000000000002 112.154 173.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -179.35 -49.36 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.996 1.318 . . . . 6.46 108.565 -176.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 80.29 -49.62 0.34 Allowed 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 126.594 1.958 . . . . 8.6600000000000001 110.947 178.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.9 p -95.89 69.01 2.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.861 1.265 . . . . 9.1500000000000004 109.825 165.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.89 -70.05 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.885 -0.413 . . . . 9.5600000000000005 109.885 170.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -166.48 165.38 16.98 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.162 -2.162 . . . . 16.100000000000001 105.162 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -172.83 58.82 0.15 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.751 -1.027 . . . . 14.73 112.005 177.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 128.052 2.541 . . . . 19.27 109.397 -179.524 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.772 -1.196 . . . . 16.719999999999999 107.772 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -171.99 0.42 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.952 2.101 . . . . 11.609999999999999 105.392 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -158.89 167.86 28.3 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.195 0.907 . . . . 5.4800000000000004 108.753 168.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -103.12 75.24 1.35 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.616 1.567 . . . . 5.5499999999999998 110.205 -173.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -78.71 140.59 38.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.6499999999999999 108.695 -178.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 3.0800000000000001 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.6299999999999999 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 1.9299999999999999 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 0.65000000000000002 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 1.79 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 2.52 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 1.0 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 1.0600000000000001 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 0.92000000000000004 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 3.4500000000000002 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 1.73 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.2699999999999996 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 4.5099999999999998 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.02 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.1599999999999999 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 0.84999999999999998 110.452 170.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 1.26 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 2.9399999999999999 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 0.80000000000000004 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.6899999999999999 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 2.2400000000000002 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 0.92000000000000004 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 1.5800000000000001 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 2.0699999999999998 112.774 174.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 3.8700000000000001 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 1.5600000000000001 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.1899999999999999 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 0.68999999999999995 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 1.49 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 0.95999999999999996 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.5800000000000001 112.925 172.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 0.81999999999999995 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 1.7 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.863 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 0.94999999999999996 110.641 177.096 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 1.9199999999999999 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 1.48 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 1.5900000000000001 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.5699999999999998 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.3200000000000001 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 0.56999999999999995 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.6699999999999999 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 0.5 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 1.79 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 1.79 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 1.4399999999999999 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 1.3100000000000001 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.22 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 1.0600000000000001 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 1.3 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 1.1299999999999999 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 0.93999999999999995 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.4199999999999999 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.5800000000000001 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 0.92000000000000004 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 2.8199999999999998 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 2.25 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.04 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 2.4500000000000002 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 1.05 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.0800000000000001 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 2.1200000000000001 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.6799999999999997 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 4.3300000000000001 109.257 174.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 0.81999999999999995 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 2.1400000000000001 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.7799999999999998 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.0600000000000001 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 2.7200000000000002 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.3999999999999999 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.46 177.17 0.1 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 3.3700000000000001 112.126 167.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 t -177.87 -47.73 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.79 1.236 . . . . 4.5999999999999996 108.0 172.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 t 178.45 21.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.12 0.785 . . . . 6.1500000000000004 113.12 -168.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -123.25 39.14 4.03 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.327 1.051 . . . . 3.6200000000000001 109.382 -176.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.66 23.08 4.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.024 1.33 . . . . 1.74 112.994 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 1.0600000000000001 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 1.03 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 1.75 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 3.5099999999999998 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 132' ' ' VAL . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 1.8200000000000001 111.812 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 3.5099999999999998 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 3.3500000000000001 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 1.53 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.0299999999999998 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 5.4199999999999999 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 1.71 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.1099999999999999 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.1000000000000001 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 0.85999999999999999 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 1.0800000000000001 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.1699999999999999 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 0.77000000000000002 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 0.90000000000000002 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 1.8400000000000001 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 1.8500000000000001 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 2.4900000000000002 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.0499999999999998 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 1.8799999999999999 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.5899999999999999 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 0.63 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 0.81000000000000005 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 0.68999999999999995 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.7200000000000002 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 2.0699999999999998 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.1299999999999999 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.3500000000000001 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 5.4400000000000004 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.7599999999999998 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 0.95999999999999996 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 2.27 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 2.4300000000000002 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 0.83999999999999997 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.8100000000000001 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 0.77000000000000002 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.02 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.9299999999999997 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 0.68000000000000005 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 139' ' ' LEU . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 1.72 111.51 -178.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.2799999999999998 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 2.27 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 1.03 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 2.4900000000000002 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 3.8100000000000001 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.84 ' CB ' HG11 ' A' ' 132' ' ' VAL . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 2.6200000000000001 106.482 -175.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 2.9700000000000002 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.0 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -78.35 74.78 4.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 2.48 109.166 174.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.82 -69.7 1.81 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.49 -1.444 . . . . 2.8500000000000001 109.49 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 45.22 47.24 10.15 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.68 1.592 . . . . 4.3399999999999999 111.199 -176.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.3 -67.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.289 2.635 . . . . 6.4199999999999999 104.942 -177.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.89 -45.52 57.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.611 1.196 . . . . 6.79 110.184 -169.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.6 m -99.43 10.72 40.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.233 -1.803 . . . . 6.5599999999999996 112.661 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.6 mt 67.93 -65.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.842 1.657 . . . . 9.0199999999999996 111.686 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -139.42 177.94 7.56 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.69 1.996 . . . . 13.470000000000001 108.126 -178.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.42 10.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.16 0.41 . . . . 14.630000000000001 112.493 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 . . . . . 0 C--O 1.251 1.155 0 CA-C-N 117.678 0.739 . . . . 23.170000000000002 109.435 -171.812 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.43 -0.319 . . . . 16.109999999999999 111.374 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.26 -55.13 20.15 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.029 -1.1 . . . . 12.960000000000001 108.029 173.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -100.35 -172.21 2.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 127.935 2.494 . . . . 7.6299999999999999 108.101 168.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 85.69 52.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 127.902 2.481 . . . . 7.0899999999999999 107.27 -171.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.63 169.5 0.16 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 127.153 2.181 . . . . 2.73 109.592 -176.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 1.95 106.168 166.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6000000000000001 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 2.5600000000000001 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 0.67000000000000004 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 1.8 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.4300000000000002 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 0.5 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 0.83999999999999997 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.62 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 3.21 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 1.47 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' HD13 ' A' ' 41' ' ' LEU . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.1800000000000002 109.699 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 2.9100000000000001 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 2.1200000000000001 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.05 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 0.91000000000000003 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 1.3400000000000001 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 2.8100000000000001 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 0.67000000000000004 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.7200000000000002 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 2.75 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.78000000000000003 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 60' ' ' ILE . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 3.0 110.528 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' HG11 ' A' ' 34' ' ' VAL . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 4.3300000000000001 112.555 175.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 2.8199999999999998 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 1.3500000000000001 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.62 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 2.6000000000000001 109.212 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 1.25 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.0600000000000001 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 0.78000000000000003 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 1.99 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 0.84999999999999998 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 1.72 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 1.6399999999999999 111.14 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 1.02 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 0.88 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 0.95999999999999996 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 0.46000000000000002 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.6499999999999999 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 0.45000000000000001 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 1.8300000000000001 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.6800000000000002 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.0 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.03 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.88 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 0.96999999999999997 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 0.77000000000000002 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 0.68999999999999995 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 28' ' ' LEU . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 0.85999999999999999 107.64 177.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.0099999999999998 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.1499999999999999 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 3.6299999999999999 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 0.67000000000000004 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 2.6800000000000002 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 2.3900000000000001 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 0.92000000000000004 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 1.95 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 1.79 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 0.54000000000000004 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 0.93999999999999995 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 0.79000000000000004 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.7599999999999998 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 0.58999999999999997 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.4900000000000002 111.216 -176.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 114' ' ' VAL . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 0.59999999999999998 110.255 -173.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2000000000000002 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 3.4 ptt? -49.02 127.8 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 3.02 113.618 -175.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -154.58 36.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.773 0.797 . . . . 3.5099999999999998 110.187 177.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.3 t -161.18 39.84 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.41 -0.807 . . . . 4.8499999999999996 110.892 178.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 35.66 51.45 0.68 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.029 1.732 . . . . 5.7699999999999996 113.798 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.43 -43.71 0.05 Allowed 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 122.913 0.485 . . . . 1.75 111.707 -170.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 0.81999999999999995 109.404 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 0.68999999999999995 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.3100000000000001 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 3.5299999999999998 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 1.98 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6000000000000001 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 3.4700000000000002 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 2.9300000000000002 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 1.6499999999999999 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.3799999999999999 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 4.3200000000000003 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 1.3899999999999999 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.67000000000000004 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 0.59999999999999998 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 0.58999999999999997 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.72999999999999998 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 0.46000000000000002 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.53000000000000003 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 1.71 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 2.96 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 1.24 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 1.6799999999999999 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.7599999999999998 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 0.73999999999999999 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 0.44 107.749 172.262 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 0.59999999999999998 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 0.55000000000000004 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.6099999999999999 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 2.0699999999999998 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.4700000000000002 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.70999999999999996 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 4.7199999999999998 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.3700000000000001 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 0.63 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.0099999999999998 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 1.55 112.758 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.68999999999999995 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.5499999999999998 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 1.02 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 3.1000000000000001 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.8599999999999999 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 0.57999999999999996 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 1.73 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.6200000000000001 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 4.1200000000000001 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 1.0600000000000001 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.73999999999999999 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 1.98 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 3.2799999999999998 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 1.3899999999999999 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 3.1699999999999999 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 1.6399999999999999 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 8.5 mtpt -80.38 75.48 7.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.21 109.188 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.24 -13.04 47.68 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.512 -1.16 . . . . 2.3799999999999999 112.471 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.84 57.33 0.6 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.271 1.536 . . . . 5.46 110.755 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -47.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.248 3.019 . . . . 7.4400000000000004 108.191 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.07 -10.23 12.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.191 1.397 . . . . 8.3699999999999992 112.487 -165.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -152.34 33.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.929 1.692 . . . . 5.4100000000000001 109.713 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.75 -58.82 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.218 -0.66 . . . . 7.5999999999999996 109.218 173.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.1 150.61 31.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.741 0.816 . . . . 12.130000000000001 109.725 -178.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.04 4.75 5.68 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.815 -0.991 . . . . 12.48 113.834 -173.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.156 -1.878 . . . . 16.559999999999999 107.501 177.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.115 -0.698 . . . . 14.640000000000001 109.115 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.94 -72.13 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 106.889 -1.522 . . . . 9.0 106.889 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -178.86 166.38 1.64 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.136 -1.802 . . . . 4.3300000000000001 106.136 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -143.59 52.57 1.33 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.007 0.908 . . . . 4.54 108.724 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -64.14 151.55 43.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.283 -0.871 . . . . 2.2599999999999998 111.592 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 2.2000000000000002 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7000000000000002 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 1.9299999999999999 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 0.55000000000000004 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 2.3199999999999998 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.54 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 0.66000000000000003 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.1200000000000001 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 0.93999999999999995 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 2.5899999999999999 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 1.5800000000000001 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' SG ' HD13 ' A' ' 41' ' ' LEU . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.1099999999999999 109.511 179.088 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 2.73 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 1.5600000000000001 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.1499999999999999 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.898 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 0.85999999999999999 109.402 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 0.76000000000000001 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 2.3599999999999999 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.507 HD11 ' CE2' ' A' ' 69' ' ' TYR . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 0.56000000000000005 108.488 174.393 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' OE2' HG12 ' A' ' 39' ' ' VAL . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.7799999999999998 111.285 -175.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 1.8700000000000001 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.57999999999999996 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 1.6000000000000001 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 2.5 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 3.1699999999999999 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 1.23 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.57999999999999996 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 1.48 109.94 178.377 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 0.68000000000000005 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.8100000000000001 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 0.56999999999999995 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 1.8300000000000001 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.898 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 1.1499999999999999 110.822 175.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.0299999999999998 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.308 173.072 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 0.93000000000000005 111.462 175.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 0.87 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 0.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 0.40999999999999998 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.7000000000000002 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 0.40000000000000002 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 1.6000000000000001 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 1.79 111.321 -172.173 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.0699999999999998 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.87 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 0.95999999999999996 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.8799999999999999 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 0.78000000000000003 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.69999999999999996 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 0.95999999999999996 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 0.70999999999999996 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 0.63 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 0.72999999999999998 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.1899999999999999 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.5299999999999998 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 2.4300000000000002 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 0.56000000000000005 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.1400000000000001 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 2.6699999999999999 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 1.99 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.62 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CE2' HD11 ' A' ' 24' ' ' ILE . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 109.838 -178.139 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 2.1499999999999999 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 0.77000000000000002 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 0.78000000000000003 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.9199999999999999 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 4.2599999999999998 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 0.62 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.7200000000000002 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 1.75 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 114' ' ' VAL . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 0.59999999999999998 109.637 -167.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.3799999999999999 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.3899999999999999 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.24 128.84 39.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.0 110.559 176.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 t -154.35 31.73 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.996 0.903 . . . . 4.04 108.978 177.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -141.92 -112.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.957 -1.127 . . . . 4.5099999999999998 107.957 173.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.91 41.02 0.39 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.715 1.143 . . . . 5.9100000000000001 109.742 -178.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 -42.41 0.09 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.259 0.837 . . . . 1.9399999999999999 113.259 -170.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.847 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 0.63 111.242 173.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.1099999999999999 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 4.6500000000000004 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 1.8500000000000001 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.3399999999999999 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 4.7400000000000002 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 3.0299999999999998 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 1.71 111.322 -174.575 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.6299999999999999 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 4.7199999999999998 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 2.48 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.4900000000000002 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.67000000000000004 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 0.54000000000000004 108.027 178.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.65000000000000002 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89000000000000001 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 0.53000000000000003 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.58999999999999997 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.847 HG11 ' HB1' ' A' ' 89' ' ' ALA . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 2.3300000000000001 109.472 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.8900000000000001 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 3.98 112.028 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 1.6000000000000001 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 1.4199999999999999 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.7200000000000002 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 0.68999999999999995 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.447 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 0.60999999999999999 108.516 168.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 0.77000000000000002 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 0.58999999999999997 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.8599999999999999 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 1.76 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 2.3700000000000001 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.58999999999999997 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 6.6799999999999997 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 0.53000000000000003 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 2.29 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 2.27 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 0.95999999999999996 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.0299999999999998 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 0.94999999999999996 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 3.1600000000000001 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.04 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 1.6499999999999999 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.8300000000000001 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 3.27 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 1.24 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.75 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 1.9099999999999999 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 2.77 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 1.4299999999999999 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.1099999999999999 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 1.5900000000000001 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -82.44 78.86 9.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 2.98 109.67 178.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -60.23 4.35 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.514 -1.034 . . . . 2.0299999999999998 110.514 176.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 47.49 49.48 15.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.264 1.026 . . . . 4.0199999999999996 110.78 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.21 -36.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.118 1.367 . . . . 7.8700000000000001 109.869 178.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.7 t0 48.63 99.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.683 2.393 . . . . 9.4800000000000004 111.635 -175.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.1 m 57.36 26.86 12.99 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.804 -0.635 . . . . 7.3300000000000001 110.718 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.4 mt 55.73 52.99 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.087 1.755 . . . . 8.8200000000000003 110.31 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.17 106.21 8.74 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.866 -1.161 . . . . 12.210000000000001 107.866 167.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.79 -94.83 0.1 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.515 -1.034 . . . . 12.619999999999999 110.515 177.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 105.126 -2.176 . . . . 15.109999999999999 105.126 179.216 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtm . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 116.131 -1.89 . . . . 19.280000000000001 106.647 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.46 -165.36 0.16 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.823 1.192 . . . . 13.1 108.671 -175.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 m -74.37 -166.55 0.43 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.601 0.637 . . . . 7.04 110.098 171.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 81.77 121.18 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.569 2.348 . . . . 5.71 109.05 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -61.7 117.22 5.53 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.1400000000000001 108.68 176.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 2.5899999999999999 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.5499999999999998 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 2.5299999999999998 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 0.75 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 2.2400000000000002 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 1.73 110.374 172.817 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 0.66000000000000003 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 0.77000000000000002 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.63 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 4.1299999999999999 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 1.46 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.04 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 3.3700000000000001 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 1.3799999999999999 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 0.82999999999999996 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 0.72999999999999998 111.856 169.279 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 0.84999999999999998 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 4.29 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 0.62 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 3.3199999999999998 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.58999999999999997 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 60' ' ' ILE . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 2.8900000000000001 110.81 -178.255 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 2.0499999999999998 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 2.9100000000000001 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 2.0800000000000001 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.4299999999999999 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.67000000000000004 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 1.3400000000000001 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 0.84999999999999998 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.0899999999999999 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 0.63 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 1.8700000000000001 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 1.6499999999999999 111.183 174.221 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 2.71 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 2.6499999999999999 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.1499999999999999 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 0.84999999999999998 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.0600000000000001 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 1.1100000000000001 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 0.54000000000000004 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.1299999999999999 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 0.46999999999999997 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 1.1899999999999999 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 1.8100000000000001 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.0499999999999998 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 0.89000000000000001 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.1899999999999999 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.1200000000000001 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 1.0600000000000001 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 0.97999999999999998 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 1.1299999999999999 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 1.03 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 0.93999999999999995 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 28' ' ' LEU . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 1.8600000000000001 109.466 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.5600000000000001 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.8999999999999999 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 2.3999999999999999 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 0.51000000000000001 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.1800000000000002 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 2.2200000000000002 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.62 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 2.1400000000000001 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 2.4100000000000001 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 0.57999999999999996 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 0.97999999999999998 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 0.90000000000000002 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.8700000000000001 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 2.8700000000000001 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 0.68000000000000005 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.4500000000000002 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 2.0499999999999998 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 114' ' ' VAL . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 0.67000000000000004 109.103 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.3399999999999999 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.725 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 37.8 mtm -52.97 93.77 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.04 112.514 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -54.34 -24.71 20.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.659 -0.686 . . . . 4.4400000000000004 112.442 173.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.74 0.7 . . . . 5.3399999999999999 109.549 167.298 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.1 66.83 0.91 Allowed 'General case' 0 N--CA 1.458 -0.065 0 CA-C-O 121.328 0.585 . . . . 5.79 110.418 -172.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.62 -52.18 0.09 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.454 0.702 . . . . 2.46 109.851 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 0.93000000000000005 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 0.67000000000000004 111.651 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.1899999999999999 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 4.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 2.9500000000000002 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 2.9399999999999999 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.0800000000000001 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 1.4099999999999999 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' HB3' ' HD2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.45 113.762 174.48 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 6.6600000000000001 110.164 176.713 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 1.3500000000000001 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.6200000000000001 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 0.80000000000000004 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 0.78000000000000003 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 0.96999999999999997 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.1100000000000001 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 0.81000000000000005 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.70999999999999996 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 89' ' ' ALA . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 3.1800000000000002 110.658 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 3.1800000000000002 112.979 -176.154 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 1.5800000000000001 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 2.1400000000000001 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.6899999999999999 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 1.0 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 0.42999999999999999 107.477 163.615 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 0.60999999999999999 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.9399999999999999 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 1.8600000000000001 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 2.23 108.846 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64000000000000001 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 5.46 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.6200000000000001 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 0.64000000000000001 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.0600000000000001 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 1.54 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 0.72999999999999998 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.1899999999999999 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.70999999999999996 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 3.6499999999999999 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.2200000000000002 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 0.56999999999999995 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 1.45 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.3100000000000001 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 3.6600000000000001 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 0.80000000000000004 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.76000000000000001 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 2.04 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.0600000000000001 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 1.55 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.1000000000000001 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 1.5700000000000001 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -81.38 58.95 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 3.9500000000000002 110.097 -179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.17 33.54 30.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.506 0.574 . . . . 2.6299999999999999 112.376 -176.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -26.6 66.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.565 0.698 . . . . 3.75 112.23 -176.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.33 -64.3 1.05 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.192 0.997 . . . . 6.71 109.486 161.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.1 t70 73.75 147.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.081 1.752 . . . . 7.8099999999999996 109.793 -156.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t 59.04 36.69 24.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.021 1.328 . . . . 11.869999999999999 111.333 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -65.38 66.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.828 1.251 . . . . 14.33 113.155 174.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -123.12 153.02 40.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.553 1.541 . . . . 19.5 108.281 170.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -114.06 -81.5 1.02 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.046 -0.822 . . . . 19.66 111.046 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.367 0 N-CA-C 104.149 -2.537 . . . . 23.649999999999999 104.149 169.154 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mtp . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.192 -1.781 . . . . 12.300000000000001 106.192 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -171.16 60.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.253 0.933 . . . . 9.7899999999999991 110.149 -172.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 p -169.63 125.99 0.87 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.675 -1.155 . . . . 4.0999999999999996 109.262 -167.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.23 70.32 1.23 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.341 -0.985 . . . . 5.4199999999999999 108.341 174.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.89 144.48 55.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.635 -0.666 . . . . 2.3300000000000001 109.302 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 2.21 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.1299999999999999 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.0600000000000001 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 0.59999999999999998 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 1.9199999999999999 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.2599999999999998 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 0.65000000000000002 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 1.03 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.64000000000000001 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 39' ' ' VAL . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 3.8500000000000001 109.615 175.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 1.5 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.0899999999999999 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.3900000000000001 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 1.25 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 0.80000000000000004 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 0.87 109.437 177.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 1.02 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.0600000000000001 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 0.69999999999999996 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.0199999999999996 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 2.7400000000000002 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.93999999999999995 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 1.6000000000000001 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.2000000000000002 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 3.6899999999999999 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 1.3600000000000001 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 0.68000000000000005 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 1.5600000000000001 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 0.85999999999999999 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.3500000000000001 112.53 179.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 0.78000000000000003 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.1499999999999999 110.481 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 0.91000000000000003 109.468 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.3300000000000001 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 1.8799999999999999 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 1.03 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 0.82999999999999996 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.1499999999999999 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 0.78000000000000003 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 0.37 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 2.8199999999999998 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 0.46000000000000002 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 1.1699999999999999 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 1.8200000000000001 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.2799999999999998 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.03 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 1.0800000000000001 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.2799999999999998 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 0.75 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.69999999999999996 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 0.84999999999999998 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 0.76000000000000001 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 0.64000000000000001 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 0.64000000000000001 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.8899999999999999 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 3.3999999999999999 110.581 -176.67 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 0.63 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 2.1899999999999999 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 2.1600000000000001 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.65000000000000002 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 2.0099999999999998 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 2.2200000000000002 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 0.62 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 1.01 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.4199999999999999 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 2.6699999999999999 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 116' ' ' VAL . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 0.97999999999999998 109.135 178.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.4700000000000002 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 1.98 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.6799999999999999 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 0.63 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.9900000000000002 108.878 172.124 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp -50.47 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 4.1900000000000004 113.728 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 t -52.11 -37.87 55.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.359 -0.837 . . . . 4.8399999999999999 111.248 172.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -166.15 -52.51 0.03 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 119.814 -0.754 . . . . 4.8099999999999996 110.087 -178.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.07 -166.78 2.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.788 -1.56 . . . . 4.3499999999999996 106.788 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 70.75 -48.18 0.66 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.345 1.458 . . . . 2.2799999999999998 113.105 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.0800000000000001 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 1.1000000000000001 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2000000000000002 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 3.98 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 1.8 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.6899999999999999 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.0699999999999998 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 3.2999999999999998 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 1.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.52 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 4.21 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 1.3400000000000001 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.70999999999999996 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 0.54000000000000004 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 0.68000000000000005 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 0.89000000000000001 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 0.45000000000000001 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.54000000000000004 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 2.3100000000000001 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 1.75 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 2.4500000000000002 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 1.25 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 0.77000000000000002 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 0.46000000000000002 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 0.68999999999999995 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 -179.378 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.0099999999999998 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 1.9399999999999999 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 2.2799999999999998 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 7.79 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.3799999999999999 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 0.51000000000000001 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.0499999999999998 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG11 HD21 ' A' ' 141' ' ' LEU . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 1.47 110.781 173.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 0.66000000000000003 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.68999999999999995 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' VAL . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 2.9100000000000001 110.702 174.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7000000000000002 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 0.47999999999999998 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 139' ' ' LEU . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 1.8500000000000001 110.038 -175.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.0899999999999999 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 2.6000000000000001 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 0.91000000000000003 112.236 169.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.69999999999999996 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 2.0899999999999999 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 3.7599999999999998 107.383 176.05 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 132' ' ' VAL . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 1.3899999999999999 108.299 178.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 2.9399999999999999 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.447 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 1.6599999999999999 108.691 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -81.26 84.36 6.62 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 3.4900000000000002 108.585 175.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.96 -14.38 38.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.533 -1.148 . . . . 2.5499999999999998 112.775 170.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.04 53.12 0.59 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.169 1.485 . . . . 5.6299999999999999 112.079 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -174.22 -45.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.996 2.918 . . . . 7.9699999999999998 107.793 -176.658 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -112.47 -11.74 13.59 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.646 1.178 . . . . 8.5 112.922 -167.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 31.97 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.894 1.678 . . . . 5.5999999999999996 109.748 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.6 mt -52.06 -57.93 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.115 0.566 . . . . 8.1699999999999999 110.188 176.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -161.16 174.8 13.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.921 -1.511 . . . . 12.029999999999999 106.921 -177.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.99 -78.17 1.4 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.323 0.487 . . . . 11.699999999999999 112.055 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.838 2.455 . . . . 14.42 104.716 -169.586 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.119999999999999 109.212 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.1999999999999993 108.504 175.084 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.46 112.684 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.2400000000000002 108.988 -176.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 2.7400000000000002 110.322 176.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.0999999999999996 110.594 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 4.9900000000000002 110.399 174.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 3.75 107.368 174.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 1.6000000000000001 110.564 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.3900000000000001 111.46 174.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.3200000000000003 112.205 -162.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.2200000000000006 109.3 -173.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.2699999999999996 112.492 -167.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 10.17 108.566 178.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.059999999999999 108.149 178.063 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.119999999999999 109.212 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.1999999999999993 108.504 175.084 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.46 112.684 -179.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.2400000000000002 108.988 -176.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 2.7400000000000002 110.322 176.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.0999999999999996 110.594 175.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 4.9900000000000002 110.399 174.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 3.75 107.368 174.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 1.6000000000000001 110.564 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.3900000000000001 111.46 174.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.3200000000000003 112.205 -162.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.2200000000000006 109.3 -173.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.2699999999999996 112.492 -167.286 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 10.17 108.566 178.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.059999999999999 108.149 178.063 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.712 -0.477 . . . . 2.5699999999999998 109.712 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 2.52 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.1499999999999999 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 0.79000000000000004 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 2.1600000000000001 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.489 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.2400000000000002 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 0.62 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 0.90000000000000002 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.85999999999999999 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 2.3599999999999999 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 2.1800000000000002 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.2699999999999996 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 2.5499999999999998 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 1.27 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 0.87 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 0.73999999999999999 109.046 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 0.98999999999999999 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 4.0300000000000002 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 0.58999999999999997 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.9700000000000002 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 4.3200000000000003 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.64000000000000001 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 1.5700000000000001 109.588 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 1.71 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 3.23 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 1.5700000000000001 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.64000000000000001 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 1.3899999999999999 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 0.83999999999999997 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.1400000000000001 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 0.69999999999999996 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 1.79 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 21' ' ' ALA . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 0.95999999999999996 106.877 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.0800000000000001 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 1.71 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.0600000000000001 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 0.91000000000000003 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.6599999999999999 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 1.22 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 0.57999999999999996 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 3.9700000000000002 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 0.51000000000000001 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 1.02 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 1.76 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.4199999999999999 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.28 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 0.98999999999999999 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 0.72999999999999998 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.70999999999999996 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.85999999999999999 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 0.76000000000000001 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 0.62 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 0.64000000000000001 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.8500000000000001 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.0499999999999998 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' HD22 ' A' ' 28' ' ' LEU . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 108.997 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 0.56000000000000005 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.5600000000000001 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.0299999999999998 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 2.2599999999999998 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.65000000000000002 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 1.8999999999999999 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 1.9099999999999999 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 0.53000000000000003 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 0.93999999999999995 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 0.81999999999999995 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.3300000000000001 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 2.7000000000000002 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 0.80000000000000004 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.8900000000000001 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 2.1600000000000001 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 114' ' ' VAL . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 0.58999999999999997 108.926 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 138' ' ' LYS . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.5800000000000001 109.865 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.5800000000000001 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 4.0899999999999999 113.177 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.733 -0.469 . . . . 1.99 109.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 0.98999999999999999 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 0.90000000000000002 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.3199999999999998 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.0599999999999996 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 2.79 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 3.8199999999999998 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 3.6499999999999999 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 1.27 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.28 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 4.5899999999999999 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 1.3600000000000001 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.77000000000000002 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 0.56000000000000005 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 0.59999999999999998 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79000000000000004 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 0.47999999999999998 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.53000000000000003 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 1.72 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.76 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 3.0800000000000001 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 1.3200000000000001 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 1.8200000000000001 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 0.71999999999999997 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 0.38 107.847 166.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 0.58999999999999997 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 0.56999999999999995 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.5299999999999998 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 1.8 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 2.1000000000000001 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.63 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 7.3799999999999999 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.6400000000000001 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 0.69999999999999996 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.3799999999999999 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 1.4099999999999999 114.604 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.9199999999999999 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.84999999999999998 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.0800000000000001 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.8300000000000001 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 0.75 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 1.55 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.1400000000000001 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.0499999999999998 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 0.90000000000000002 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.90000000000000002 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 2.1699999999999999 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.0299999999999998 106.37 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 1.8 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.1099999999999999 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 3.6800000000000002 107.516 173.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 108.906 -0.775 . . . . 2.6000000000000001 108.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 4.8499999999999996 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.5300000000000002 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 1.8700000000000001 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 0.76000000000000001 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 2.1699999999999999 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 0.71999999999999997 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 0.72999999999999998 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.67000000000000004 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 3.79 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 1.3 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 3.8399999999999999 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 1.4399999999999999 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 0.81000000000000005 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 0.78000000000000003 110.147 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 0.85999999999999999 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 3.4500000000000002 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 0.78000000000000003 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' OE2' HG12 ' A' ' 39' ' ' VAL . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.6099999999999999 110.538 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 1.8999999999999999 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.79000000000000004 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 60' ' ' ILE . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 2.4900000000000002 110.748 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 2.2000000000000002 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 2.71 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 1.3999999999999999 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.55000000000000004 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 1.3100000000000001 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.0800000000000001 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 0.68999999999999995 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.774 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 1.1399999999999999 110.14 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.7 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 1.53 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.03 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 0.90000000000000002 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1000000000000001 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 0.81000000000000005 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 0.44 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 2.6299999999999999 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 0.48999999999999999 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 1.23 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 1.8 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6000000000000001 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.1499999999999999 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 1.6499999999999999 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.9199999999999999 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.87 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 1.24 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 0.91000000000000003 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 0.75 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 0.78000000000000003 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.3700000000000001 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 3.4900000000000002 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 0.55000000000000004 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.1800000000000002 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 2.3900000000000001 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 2.25 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.93999999999999995 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 2.1499999999999999 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 1.8500000000000001 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 0.62 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.90000000000000002 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.4399999999999999 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 3.1699999999999999 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.0 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.9399999999999999 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 2.2000000000000002 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.5299999999999998 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 0.69999999999999996 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.3599999999999999 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp . . . . . 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 2.6600000000000001 114.676 177.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.704 -0.85 . . . . 1.74 108.704 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 0.90000000000000002 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 0.80000000000000004 110.209 175.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.4500000000000002 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 5.1100000000000003 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 3.1299999999999999 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 3.4500000000000002 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 2.8799999999999999 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 1.3400000000000001 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.6499999999999999 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 4.5800000000000001 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 1.3500000000000001 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.6699999999999999 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.70999999999999996 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 0.55000000000000004 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 0.62 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.78000000000000003 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 0.54000000000000004 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.71999999999999997 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 89' ' ' ALA . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 2.4700000000000002 109.342 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 1.8 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 2.73 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.1299999999999999 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 1.3400000000000001 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.0499999999999998 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 0.79000000000000004 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 0.66000000000000003 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 0.84999999999999998 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 0.59999999999999998 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.8500000000000001 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 2.5099999999999998 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67000000000000004 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 5.2999999999999998 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.7200000000000002 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.70999999999999996 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.0099999999999998 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 1.6399999999999999 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.59999999999999998 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1000000000000001 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 0.79000000000000004 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 4.25 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.77000000000000002 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 139' ' ' LEU . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 1.5600000000000001 111.796 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.0699999999999998 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 2.6600000000000001 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 0.93000000000000005 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 2.02 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 3.8199999999999998 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 132' ' ' VAL . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 2.5499999999999998 108.547 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.0699999999999998 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 3.0 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 3.0899999999999999 108.861 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.141 -0.689 . . . . 2.8100000000000001 109.141 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 2.6499999999999999 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 2.77 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 3.04 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 0.57999999999999996 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 1.8999999999999999 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.1499999999999999 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 0.87 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.04 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.95999999999999996 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 2.3799999999999999 109.11 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 1.96 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.25 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 3.0800000000000001 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 1.1899999999999999 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 0.75 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.098 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 0.72999999999999998 110.985 172.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 0.77000000000000002 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.2599999999999998 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 0.78000000000000003 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' OE2' HG12 ' A' ' 39' ' ' VAL . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 1.99 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.64000000000000001 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 60' ' ' ILE . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 3.3700000000000001 110.56 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 1.74 112.18 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 3.1600000000000001 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 1.3600000000000001 111.382 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.68999999999999995 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 2.25 109.448 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 1.1599999999999999 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.0499999999999998 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 0.68999999999999995 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.3799999999999999 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.098 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 0.93999999999999995 108.925 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.1000000000000001 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.23 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.1899999999999999 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 1.0700000000000001 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.5800000000000001 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 0.84999999999999998 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 0.5 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 2.7999999999999998 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 0.46000000000000002 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 1.5800000000000001 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 1.8100000000000001 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.0899999999999999 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 0.92000000000000004 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 1.25 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1000000000000001 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 0.84999999999999998 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.76000000000000001 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.0 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 0.68999999999999995 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 0.64000000000000001 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 28' ' ' LEU . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 1.79 110.095 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.6299999999999999 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.6299999999999999 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 2.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 0.57999999999999996 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.1899999999999999 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 4.5899999999999999 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 2.4500000000000002 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.57999999999999996 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 2.0899999999999999 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 1.9399999999999999 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 0.56000000000000005 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 1.3600000000000001 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.1400000000000001 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 3.2799999999999998 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 0.81000000000000005 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.4500000000000002 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 116' ' ' VAL . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 2.0 108.764 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 0.72999999999999998 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.1400000000000001 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.3300000000000001 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 4.2300000000000004 109.524 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 1.74 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 0.90000000000000002 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.68000000000000005 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.0 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 4.4000000000000004 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 1.73 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 2.79 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 2.7400000000000002 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 1.72 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.24 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 4.7999999999999998 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 1.3700000000000001 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.7599999999999998 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.72999999999999998 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 0.53000000000000003 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 0.64000000000000001 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.71999999999999997 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 0.52000000000000002 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.66000000000000003 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 1.7 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 2.1800000000000002 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 2.8799999999999999 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 1.3400000000000001 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 1.52 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2000000000000002 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 1.1299999999999999 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 0.56999999999999995 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 0.67000000000000004 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 78' ' ' PHE . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 1.04 107.373 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.6099999999999999 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 2.1699999999999999 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 2.5099999999999998 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.66000000000000003 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 5.6500000000000004 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.9399999999999999 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 0.68999999999999995 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 1.8500000000000001 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 125' ' ' VAL . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 1.74 111.14 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.67000000000000004 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.0699999999999998 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 1.4299999999999999 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 3.21 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.0499999999999998 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 0.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' A' ' 139' ' ' LEU . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 1.8799999999999999 111.04 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.6400000000000001 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 2.4500000000000002 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.1100000000000001 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.3700000000000001 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 2.0099999999999998 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 4.7000000000000002 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.564 ' HG ' HG11 ' A' ' 132' ' ' VAL . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 1.4199999999999999 108.489 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 1.96 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 2.9500000000000002 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 3.3399999999999999 108.594 172.648 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 110.25 -0.278 . . . . 2.79 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 1.95 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.7400000000000002 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 10' ' ' MET . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 2.9700000000000002 107.834 171.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 0.64000000000000001 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.426 ' HG3' HD11 ' A' ' 8' ' ' ILE . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.0899999999999999 110.426 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 1.79 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 0.71999999999999997 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 0.93999999999999995 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.67000000000000004 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 2.5299999999999998 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 1.54 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 41' ' ' LEU . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.3100000000000001 109.558 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 2.6299999999999999 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 1.5700000000000001 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 0.93000000000000005 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.873 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 0.71999999999999997 109.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 0.78000000000000003 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 2.5499999999999998 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 0.58999999999999997 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 39' ' ' VAL . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.5299999999999998 110.342 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 1.9299999999999999 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.64000000000000001 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 1.55 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 3.0600000000000001 112.415 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 3.6299999999999999 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.497 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 1.3300000000000001 110.018 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.1599999999999999 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 0.71999999999999997 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 2.2200000000000002 110.41 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 0.75 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.2599999999999998 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 0.71999999999999997 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.6200000000000001 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.873 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 1.21 109.848 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.458 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 1.5600000000000001 111.87 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 1.1100000000000001 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 0.93000000000000005 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.9099999999999999 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 0.81999999999999995 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 0.40999999999999998 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 2.9300000000000002 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 0.45000000000000001 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 1.76 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 1.74 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.0699999999999998 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 0.88 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 0.98999999999999999 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.8899999999999999 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 0.72999999999999998 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.67000000000000004 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 0.78000000000000003 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 0.70999999999999996 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.9399999999999999 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 3.6099999999999999 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 0.81999999999999995 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 3.3700000000000001 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 2.5600000000000001 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.76000000000000001 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 1.96 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 2.3300000000000001 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 0.93000000000000005 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 72' ' ' VAL . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.72 111.582 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.1899999999999999 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.1500000000000004 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.04 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 0.87 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.3799999999999999 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 1.79 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.6299999999999999 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 0.56000000000000005 110.144 -167.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.3599999999999999 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 4.3600000000000003 113.131 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 113.148 0.796 . . . . 1.3700000000000001 113.148 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 0.80000000000000004 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 0.67000000000000004 110.839 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2000000000000002 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 4.54 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 1.97 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.8900000000000001 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 3.3799999999999999 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 5.9500000000000002 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 1.71 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.3200000000000001 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 4.9199999999999999 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 1.4199999999999999 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.75 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 0.59999999999999998 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 0.85999999999999999 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 0.53000000000000003 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.58999999999999997 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 89' ' ' ALA . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 2.5499999999999998 109.209 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 2.23 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 2.4900000000000002 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 1.4399999999999999 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 1.6899999999999999 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.6699999999999999 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 0.95999999999999996 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 0.52000000000000002 108.837 168.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 0.76000000000000001 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 0.68000000000000005 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 1.74 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.04 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.60999999999999999 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 5.8200000000000003 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.0600000000000001 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 0.53000000000000003 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.3300000000000001 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 1.98 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.90000000000000002 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.1699999999999999 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 132' ' ' VAL . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 0.71999999999999997 109.603 -175.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 2.9399999999999999 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.6899999999999999 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 0.57999999999999996 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' LEU . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 1.71 109.1 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.0699999999999998 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 2.3700000000000001 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 1.03 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.64000000000000001 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 2.1800000000000002 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 3.1899999999999999 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 1.54 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 2.6899999999999999 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 1.6599999999999999 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 2.6499999999999999 108.914 178.322 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 . . . . . 0 C--O 1.239 0.506 0 N-CA-C 107.927 -1.138 . . . . 3.5699999999999998 107.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 3.1400000000000001 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.8700000000000001 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 2.6000000000000001 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 0.72999999999999998 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 1.8899999999999999 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 1.6799999999999999 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 0.5 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 0.88 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 2.5299999999999998 111.286 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 2.6499999999999999 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 4.54 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 3.25 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 1.55 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 1.1799999999999999 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 15' ' ' MET . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 0.69999999999999996 111.09 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 0.85999999999999999 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.1000000000000001 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 0.67000000000000004 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.2799999999999998 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.1400000000000001 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.66000000000000003 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 2.5800000000000001 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 2.3900000000000001 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 3.3300000000000001 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 1.5 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.4199999999999999 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.63 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 1.3700000000000001 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 0.73999999999999999 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 0.90000000000000002 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.3199999999999998 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 0.93000000000000005 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.1299999999999999 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 1.6000000000000001 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 1.04 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 0.91000000000000003 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 0.84999999999999998 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 0.33000000000000002 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 3.8500000000000001 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 0.54000000000000004 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 1.28 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 1.8600000000000001 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.2200000000000002 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.02 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 1.1699999999999999 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.0099999999999998 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 0.71999999999999997 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.68999999999999995 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 0.69999999999999996 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 0.80000000000000004 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 0.79000000000000004 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 0.73999999999999999 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.8500000000000001 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 2.4100000000000001 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 0.58999999999999997 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.3199999999999998 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 3.5 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 2.3100000000000001 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.59999999999999998 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 2.2400000000000002 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 2.3100000000000001 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 0.54000000000000004 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 0.83999999999999997 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 0.92000000000000004 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.4199999999999999 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 3.3599999999999999 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 0.56999999999999995 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.2799999999999998 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 1.8200000000000001 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.5800000000000001 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 0.73999999999999999 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.29 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.8100000000000001 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 3.5699999999999998 112.738 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 1.3 111.852 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 0.93000000000000005 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 92' ' ' ILE . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 1.01 109.946 172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 4.4400000000000004 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 89' ' ' ALA . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.02 110.926 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.1400000000000001 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.0700000000000003 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 2.7599999999999998 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 1.8899999999999999 111.264 -177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.8100000000000001 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 5.8600000000000003 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 1.49 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.5099999999999998 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.79000000000000004 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 96' ' ' LEU . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 0.71999999999999997 107.496 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 0.82999999999999996 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.1399999999999999 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 0.59999999999999998 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.78000000000000003 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 1.9299999999999999 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.6699999999999999 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 3.2799999999999998 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 1.8500000000000001 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' A' ' 113' ' ' THR . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 2.0600000000000001 110.467 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 1.04 110.45 -176.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 0.55000000000000004 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 0.75 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 0.63 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 1.8899999999999999 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 2.6099999999999999 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.80000000000000004 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 5.3899999999999997 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.8500000000000001 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 0.71999999999999997 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 1.54 112.684 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.02 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 0.89000000000000001 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 3.73 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.0499999999999998 110.065 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 0.60999999999999999 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 139' ' ' LEU . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 1.4099999999999999 110.604 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1000000000000001 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 2.46 113.295 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 0.81999999999999995 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.58999999999999997 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 2.0299999999999998 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 3.3599999999999999 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 1.74 106.839 -172.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 2.2599999999999998 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 1.6399999999999999 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 3.6499999999999999 108.384 174.57 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.181 -0.674 . . . . 2.1499999999999999 109.181 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 1.95 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.7400000000000002 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 2.6499999999999999 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 0.58999999999999997 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 1.79 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.3199999999999998 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 0.69999999999999996 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 1.1799999999999999 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 2.54 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 1.3100000000000001 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.1800000000000002 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.3799999999999999 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 1.76 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 0.90000000000000002 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 0.72999999999999998 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 0.93000000000000005 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 2.3599999999999999 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 0.58999999999999997 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.6499999999999999 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.02 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.66000000000000003 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 1.6000000000000001 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 2.1899999999999999 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 4.9800000000000004 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 1.52 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.1799999999999999 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.53000000000000003 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 1.3600000000000001 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 0.73999999999999999 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 0.69999999999999996 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 0.84999999999999998 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 1.96 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 2.0499999999999998 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 1.49 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 1.48 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 0.87 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 0.46999999999999997 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.4100000000000001 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 0.41999999999999998 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 1.0700000000000001 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 1.97 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.0099999999999998 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.80000000000000004 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.2400000000000002 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.3999999999999999 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 0.85999999999999999 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 0.87 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 0.87 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 0.78000000000000003 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 0.80000000000000004 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.8599999999999999 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.0499999999999998 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 2.9500000000000002 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 0.56999999999999995 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.6699999999999999 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.02 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 2.5899999999999999 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.66000000000000003 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 2.0699999999999998 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 2.4900000000000002 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 0.54000000000000004 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 0.76000000000000001 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 3.54 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 0.92000000000000004 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.9199999999999999 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 2.1299999999999999 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.6200000000000001 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 0.72999999999999998 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.5600000000000001 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.47 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 2.9700000000000002 112.047 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.742 1.015 . . . . 1.49 113.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 0.77000000000000002 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 0.65000000000000002 110.408 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.9199999999999999 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 4.5300000000000002 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 1.76 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.4500000000000002 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.02 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 5.0999999999999996 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 1.6000000000000001 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.5 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 4.3099999999999996 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.2599999999999998 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.5999999999999996 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.65000000000000002 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 0.63 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 0.73999999999999999 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.71999999999999997 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 0.46000000000000002 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 2.5099999999999998 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 1.9099999999999999 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 2.4500000000000002 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.29 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 1.3400000000000001 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.9199999999999999 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 0.69999999999999996 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 0.48999999999999999 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.25 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 0.77000000000000002 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 1.76 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 2.52 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.68999999999999995 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 7.6100000000000003 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.5899999999999999 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 0.57999999999999996 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 1.98 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 1.5 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 0.58999999999999997 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 3.5699999999999998 109.136 165.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.4299999999999997 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 0.58999999999999997 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 1.7 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.7799999999999998 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 2.4100000000000001 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 0.93000000000000005 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.69999999999999996 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 2.0099999999999998 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.1099999999999999 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 2.6699999999999999 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 2.77 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 2.3700000000000001 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 3.0600000000000001 109.196 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.3500000000000001 105.316 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 2.4300000000000002 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.0 108.868 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.0699999999999998 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 0.68999999999999995 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 1.8899999999999999 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.04 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 64' ' ' ILE . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 0.76000000000000001 108.883 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 0.93999999999999995 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 3.1600000000000001 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 1.54 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.3300000000000001 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 3.8199999999999998 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 1.8899999999999999 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 0.82999999999999996 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 1.55 110.882 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 1.1399999999999999 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 3.5600000000000001 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 0.71999999999999997 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.3300000000000001 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 3.6499999999999999 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.68999999999999995 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 28' ' ' LEU . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 2.7200000000000002 110.086 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 1.8600000000000001 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 4.25 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 1.77 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.54000000000000004 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 1.27 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 1.1100000000000001 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.8500000000000001 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 0.82999999999999996 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 1.78 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.618 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.054 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 1.78 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 1.1299999999999999 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.02 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 0.77000000000000002 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 0.39000000000000001 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 4.04 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.55000000000000004 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 1.48 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 1.98 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.3700000000000001 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.04 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 1.22 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.9199999999999999 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 0.85999999999999999 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.87 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.01 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 0.94999999999999996 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 0.78000000000000003 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 0.70999999999999996 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.5600000000000001 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 3.6499999999999999 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 69' ' ' TYR . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.88 109.866 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.1299999999999999 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 3.0099999999999998 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 2.2200000000000002 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.68999999999999995 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 64' ' ' ILE . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 1.9299999999999999 109.275 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 2.0 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 0.57999999999999996 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 0.88 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 0.97999999999999998 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.6899999999999999 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 3.3999999999999999 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 0.68999999999999995 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.6899999999999999 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 2.27 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.8600000000000001 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 114' ' ' VAL . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 1.3100000000000001 109.778 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.6499999999999999 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.6399999999999999 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 3.3100000000000001 112.83 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.214 0.054 . . . . 1.47 111.087 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 0.65000000000000002 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.1800000000000002 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 5.8700000000000001 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 2.1499999999999999 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.4900000000000002 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.1299999999999999 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 135' ' ' LEU . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.0499999999999998 111.192 168.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 1.73 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.25 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 3.8900000000000001 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 1.3700000000000001 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.6099999999999999 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.80000000000000004 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 0.60999999999999999 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 0.66000000000000003 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.85999999999999999 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 0.46999999999999997 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.64000000000000001 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 1.72 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.8200000000000001 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 2.48 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.1399999999999999 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 1.3100000000000001 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.6099999999999999 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 0.90000000000000002 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 0.69999999999999996 107.664 156.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 0.70999999999999996 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 0.52000000000000002 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.6699999999999999 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 1.8600000000000001 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 2.29 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.85999999999999999 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 5.8099999999999996 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.4100000000000001 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 0.84999999999999998 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 2.5699999999999998 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 1.97 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 0.91000000000000003 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.8300000000000001 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 1.27 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 3.1299999999999999 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.9199999999999999 110.403 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 0.58999999999999997 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 1.6899999999999999 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.5800000000000001 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 2.8399999999999999 113.022 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 95' ' ' ARG . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 0.81000000000000005 111.966 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76000000000000001 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 2.21 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 3.7999999999999998 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 1.5900000000000001 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 2.6099999999999999 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 1.6799999999999999 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt . . . . . 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 3.0299999999999998 109.519 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.8799999999999999 106.605 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 2.3900000000000001 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.8399999999999999 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 3.1299999999999999 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 0.59999999999999998 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 2.0099999999999998 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 1.9199999999999999 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 0.76000000000000001 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 0.83999999999999997 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 3.8799999999999999 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 1.24 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.4100000000000001 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 4.3200000000000003 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 1.4299999999999999 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 0.73999999999999999 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 1.01 110.56 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 0.77000000000000002 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 3.02 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG ' ' A' ' 69' ' ' TYR . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.0300000000000002 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 2.25 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.65000000000000002 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 1.7 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 1.75 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 2.96 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 1.54 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.1400000000000001 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 1.0600000000000001 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 1.45 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.02 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 0.73999999999999999 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.02 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG11 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 1.3300000000000001 109.288 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.1600000000000001 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 1.74 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 1.47 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 1.26 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.8799999999999999 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 0.72999999999999998 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 0.38 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.6600000000000001 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 0.56000000000000005 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 1.0900000000000001 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 2.1000000000000001 111.909 -171.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.7599999999999998 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.26 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 1.46 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.0499999999999998 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 0.82999999999999996 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.63 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 0.95999999999999996 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 0.70999999999999996 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 0.56999999999999995 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 0.65000000000000002 108.15 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.9099999999999999 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.3999999999999999 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 3.3700000000000001 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 0.57999999999999996 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 2.6800000000000002 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 1.95 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.68999999999999995 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' HD11 ' A' ' 24' ' ' ILE . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 1.98 109.466 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 2.1499999999999999 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 0.52000000000000002 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 0.76000000000000001 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 0.75 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 2.7200000000000002 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 0.78000000000000003 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 1.74 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 0.80000000000000004 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.5800000000000001 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.4099999999999999 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? . . . . . 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 2.9100000000000001 110.07 172.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.273 0.842 . . . . 1.22 113.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 0.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 0.64000000000000001 110.674 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 1.8200000000000001 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 4.5300000000000002 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 1.9199999999999999 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 3.52 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 3.2400000000000002 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 114' ' ' VAL . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 1.6399999999999999 111.011 -169.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.48 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 4.4699999999999998 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 1.8100000000000001 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.7999999999999998 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.67000000000000004 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 0.57999999999999996 107.755 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 0.68000000000000005 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.83999999999999997 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 0.52000000000000002 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.51000000000000001 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 114' ' ' VAL . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 2.3700000000000001 109.28 -173.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 2.1699999999999999 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 2.5499999999999998 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 1.1399999999999999 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.3999999999999999 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.7799999999999998 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 0.95999999999999996 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 107' ' ' VAL . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 0.56999999999999995 108.971 164.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 0.76000000000000001 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 0.93999999999999995 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.8300000000000001 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 2.0099999999999998 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 2.3199999999999998 107.342 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.84999999999999998 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 4.9699999999999998 108.364 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 0.69999999999999996 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.8700000000000001 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 1.6399999999999999 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.68000000000000005 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 0.73999999999999999 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 3.6699999999999999 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.2200000000000002 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 0.73999999999999999 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 1.7 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.6299999999999999 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.0699999999999998 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 1.0800000000000001 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.84999999999999998 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 2.1099999999999999 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 5.9299999999999997 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 1.49 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 2.5 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 1.75 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 3.25 108.669 172.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.3199999999999998 112.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 2.8700000000000001 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.0800000000000001 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.0299999999999998 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 0.78000000000000003 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 2.73 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 2.6600000000000001 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 0.70999999999999996 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 0.77000000000000002 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.85999999999999999 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 3.1600000000000001 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.1299999999999999 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.5800000000000001 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 3.0099999999999998 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 1.1699999999999999 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 0.84999999999999998 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 0.71999999999999997 112.278 167.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 0.78000000000000003 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.23 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 0.68000000000000005 108.157 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.1200000000000001 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 1.8100000000000001 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 1.5800000000000001 109.99 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 2.4300000000000002 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 3.4300000000000002 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 1.7 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.1400000000000001 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 0.94999999999999996 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 1.45 111.311 172.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 1.47 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.3100000000000001 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 0.66000000000000003 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.3799999999999999 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.0800000000000001 108.731 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.3500000000000001 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 3.8700000000000001 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 1.3700000000000001 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.9199999999999999 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 1.47 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 0.40000000000000002 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.2599999999999998 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 0.73999999999999999 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 1.3100000000000001 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 2.0 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.1299999999999999 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 1.1399999999999999 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.8700000000000001 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 0.69999999999999996 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.67000000000000004 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 0.96999999999999997 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 0.92000000000000004 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 0.73999999999999999 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 0.83999999999999997 107.609 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7000000000000002 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.4500000000000002 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 2.2400000000000002 108.155 -175.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 0.58999999999999997 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.6799999999999999 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 2.6899999999999999 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 1.8300000000000001 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.68000000000000005 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 2.02 108.769 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 1.75 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 0.77000000000000002 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.4500000000000002 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 4.54 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.0600000000000001 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.8700000000000001 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 2.25 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 0.81000000000000005 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.9900000000000002 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.53 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.42 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 4.9699999999999998 109.499 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 111.433 0.16 . . . . 1.29 111.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 0.68999999999999995 110.237 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.5499999999999998 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 3.77 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 1.8899999999999999 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 3.6200000000000001 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 2.9199999999999999 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 1.6799999999999999 111.465 -177.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.29 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 4.4800000000000004 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 2.0699999999999998 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.7400000000000002 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.82999999999999996 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 0.84999999999999998 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77000000000000002 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 0.46999999999999997 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.57999999999999996 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.441 HG11 ' HB1' ' A' ' 89' ' ' ALA . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 2.5499999999999998 108.727 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.6000000000000001 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 2.2999999999999998 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.51 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 1.51 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 0.95999999999999996 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 0.66000000000000003 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.3400000000000001 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 0.78000000000000003 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.6499999999999999 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 1.97 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 2.1699999999999999 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.79000000000000004 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 5.2400000000000002 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.2599999999999998 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 0.93999999999999995 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 1.79 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 1.78 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 0.77000000000000002 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.2799999999999998 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 0.77000000000000002 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 3.9700000000000002 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.3100000000000001 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 0.69999999999999996 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 1.6000000000000001 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.2400000000000002 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 1.1299999999999999 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 2.2400000000000002 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 3.8199999999999998 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 1.6200000000000001 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 2.7200000000000002 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 1.77 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 2.6400000000000001 108.116 172.237 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.9199999999999999 108.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 3.04 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.8100000000000001 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 2.02 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 0.76000000000000001 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 1.79 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.04 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 0.54000000000000004 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 0.77000000000000002 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.72999999999999998 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 2.4900000000000002 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 1.46 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 5.4900000000000002 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 3.52 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 1.6599999999999999 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 0.81000000000000005 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 0.91000000000000003 110.732 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 1.3600000000000001 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.23 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 0.67000000000000004 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 2.3300000000000001 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.65000000000000002 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 1.6299999999999999 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 1.95 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 2.5299999999999998 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 1.6599999999999999 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.3500000000000001 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 1.46 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.66000000000000003 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.7799999999999998 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 0.68000000000000005 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 1.8200000000000001 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 110.081 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 1.8600000000000001 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 2.1000000000000001 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.0 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 1.1000000000000001 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.0699999999999998 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 0.82999999999999996 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 0.5 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 2.7999999999999998 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 0.46999999999999997 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 1.01 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 2.0600000000000001 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.0899999999999999 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.27 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 1.4099999999999999 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.1499999999999999 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 0.81999999999999995 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.64000000000000001 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.1000000000000001 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 0.76000000000000001 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 0.67000000000000004 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.1600000000000001 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.6499999999999999 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 3.8300000000000001 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 0.62 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.4399999999999999 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.1899999999999999 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 2.0899999999999999 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.87 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 1.9099999999999999 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 1.96 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 0.51000000000000001 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 0.80000000000000004 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 0.93000000000000005 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.5099999999999998 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.0700000000000003 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 0.66000000000000003 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.0499999999999998 110.88 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 2.0499999999999998 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.2200000000000002 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 0.84999999999999998 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.3500000000000001 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.1299999999999999 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 88' ' ' CYS . 33.7 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 6.3399999999999999 112.673 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.631 -0.877 . . . . 1.4099999999999999 108.631 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' MET . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 1.1699999999999999 108.445 -171.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 0.66000000000000003 110.397 170.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.8899999999999999 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 5.3399999999999999 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.609 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 2.0 111.387 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.8500000000000001 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 3.8100000000000001 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 3.1299999999999999 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 1.24 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 5.7300000000000004 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 1.53 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.6200000000000001 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.68000000000000005 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 118' ' ' TYR . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 0.68000000000000005 107.97 175.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 0.70999999999999996 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.69999999999999996 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 0.51000000000000001 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.58999999999999997 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 1.6899999999999999 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.75 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 2.3999999999999999 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.04 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 1.22 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 0.64000000000000001 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 0.42999999999999999 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 0.66000000000000003 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 0.54000000000000004 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2000000000000002 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 102' ' ' VAL . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 1.8100000000000001 111.003 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 2.3799999999999999 107.058 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 5.7300000000000004 110.764 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.5199999999999996 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 0.68000000000000005 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.1800000000000002 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 2.46 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 0.85999999999999999 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.2799999999999998 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 1.0 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 3.9500000000000002 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.0499999999999998 111.25 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 0.63 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 1.79 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.4900000000000002 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 2.8399999999999999 112.869 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.609 ' HG ' HG22 ' A' ' 92' ' ' ILE . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 1.01 112.032 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.85999999999999999 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 1.9299999999999999 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 4.5 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 1.4399999999999999 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.0199999999999996 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 1.71 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 34.3 mtpt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 2.8700000000000001 107.938 172.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.6099999999999999 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 3.02 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.2999999999999998 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 0.57999999999999996 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 0.90000000000000002 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 0.95999999999999996 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 3.2599999999999998 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.1699999999999999 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 3.4900000000000002 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.2400000000000002 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 2.2200000000000002 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.02 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 1.4399999999999999 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.76 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 3.6600000000000001 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 1.6100000000000001 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.1100000000000003 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.0699999999999998 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.5900000000000001 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 1.75 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 2.8100000000000001 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 3.4100000000000001 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.2999999999999998 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 1.8100000000000001 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.02 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 1.4199999999999999 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 1.0900000000000001 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.8100000000000001 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 0.93000000000000005 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.7200000000000002 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 0.93000000000000005 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.3500000000000001 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 2.1699999999999999 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.04 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 0.83999999999999997 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.1299999999999999 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 0.96999999999999997 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 0.55000000000000004 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 3.71 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 0.81000000000000005 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 1.9299999999999999 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 2.0899999999999999 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.3500000000000001 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.6699999999999999 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 1.6699999999999999 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 1.25 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.2 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 1.4299999999999999 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 1.3799999999999999 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 1.25 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.94999999999999996 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.4700000000000002 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.1800000000000002 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.1099999999999999 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 0.89000000000000001 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 3.3900000000000001 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 2.4399999999999999 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.5700000000000001 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 2.0800000000000001 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 2.71 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 0.93000000000000005 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 0.94999999999999996 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.21 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.6299999999999999 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 2.8799999999999999 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 1.99 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 113' ' ' THR . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.8300000000000001 107.827 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 0.71999999999999997 109.444 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.2599999999999998 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 3.0299999999999998 111.521 -177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.305 0.574 . . . . 1.8 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.0900000000000001 107.896 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 0.60999999999999999 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.21 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 5.4100000000000001 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 1.8400000000000001 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.0600000000000001 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 3.23 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 1.9399999999999999 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 4.7800000000000002 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 1.5900000000000001 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.5800000000000001 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 0.87 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 0.81999999999999995 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 0.82999999999999996 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 0.95999999999999996 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 0.72999999999999998 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.87 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 1.6699999999999999 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 2.27 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.8 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' THR . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 1.6499999999999999 110.659 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 111' ' ' LEU . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 0.83999999999999997 111.545 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.564 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.54000000000000004 108.314 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 0.94999999999999996 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 0.68000000000000005 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.4700000000000002 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.96 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.0099999999999998 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.90000000000000002 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 7.8499999999999996 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.8900000000000001 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 0.69999999999999996 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 2.27 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 1.6899999999999999 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.76000000000000001 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.2200000000000002 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 0.96999999999999997 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 3.7000000000000002 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.1099999999999999 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 0.69999999999999996 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 1.6699999999999999 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.4700000000000002 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 3.7400000000000002 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 0.90000000000000002 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89000000000000001 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 2.0099999999999998 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 3.8799999999999999 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 1.4099999999999999 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 3.0600000000000001 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 3.3700000000000001 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.0699999999999998 110.667 -173.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.779 0.323 . . . . 3.0099999999999998 110.49 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.0099999999999998 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.7200000000000002 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.405 HD11 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 2.8799999999999999 107.851 165.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 0.68999999999999995 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 8' ' ' ILE . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 2.1600000000000001 108.407 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 2.5800000000000001 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 0.57999999999999996 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.05 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.93999999999999995 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 2.8300000000000001 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 1.5800000000000001 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.2000000000000002 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 3.27 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 1.3500000000000001 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 0.79000000000000004 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 0.69999999999999996 110.929 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 0.80000000000000004 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 3.98 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 0.56000000000000005 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.8399999999999999 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 1.79 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.68999999999999995 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 1.6599999999999999 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 1.79 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 2.96 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' VAL . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 1.9399999999999999 110.6 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 0.71999999999999997 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 2.3500000000000001 110.538 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 0.84999999999999998 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.1499999999999999 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 0.66000000000000003 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 1.97 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 1.6399999999999999 111.254 171.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.0099999999999998 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 3.3700000000000001 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 1.3799999999999999 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 1.0600000000000001 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.5600000000000001 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 0.48999999999999999 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 2.6600000000000001 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 0.46999999999999997 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 1.1000000000000001 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 1.95 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.2200000000000002 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 0.92000000000000004 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 0.97999999999999998 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.0499999999999998 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 0.76000000000000001 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.63 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 0.89000000000000001 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 0.69999999999999996 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 0.71999999999999997 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.1699999999999999 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1000000000000001 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 3.1699999999999999 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.58999999999999997 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 4.7300000000000004 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 2.2200000000000002 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.72999999999999998 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 2.1200000000000001 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 2.1899999999999999 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 0.59999999999999998 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 1.25 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 0.81999999999999995 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 2.54 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 0.80000000000000004 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 2.0699999999999998 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.3700000000000001 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 0.87 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 2.9300000000000002 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.9299999999999999 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 2.9500000000000002 112.089 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 90' ' ' ASN . . . . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.497 -0.557 . . . . 1.6399999999999999 109.497 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 0.78000000000000003 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 0.69999999999999996 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.498 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.5499999999999998 110.884 -178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 5.0899999999999999 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 1.9199999999999999 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.4300000000000002 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 3.27 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 3.7200000000000002 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 2.02 111.328 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.3100000000000001 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 4.5499999999999998 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 1.6899999999999999 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.3999999999999999 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.80000000000000004 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 0.72999999999999998 108.831 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 0.79000000000000004 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.82999999999999996 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 0.66000000000000003 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.87 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 1.76 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 1.97 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 2.77 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 1.04 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 1.6100000000000001 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.2799999999999998 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 0.80000000000000004 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 0.54000000000000004 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 0.88 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 0.56000000000000005 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7000000000000002 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 2.1499999999999999 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 2.3900000000000001 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.71999999999999997 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 5.6699999999999999 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6000000000000001 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 0.58999999999999997 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 1.9199999999999999 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 1.54 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.79000000000000004 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 0.80000000000000004 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.1699999999999999 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.2200000000000002 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 0.54000000000000004 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 1.72 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.6299999999999999 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 2.3900000000000001 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 0.88 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.81999999999999995 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 2.1699999999999999 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 3.4199999999999999 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 1.3999999999999999 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 3.02 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 1.76 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 2.9199999999999999 108.622 178.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.02 109.424 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 1.9199999999999999 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.5699999999999998 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 2.7599999999999998 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 0.56000000000000005 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 1.6799999999999999 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.1800000000000002 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 0.68999999999999995 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 1.0800000000000001 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.88 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 39' ' ' VAL . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 2.8100000000000001 112.049 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 1.98 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 3.1800000000000002 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 2.02 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.6599999999999999 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 1.1299999999999999 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 1.4099999999999999 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.2400000000000002 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 0.68999999999999995 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.04 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.56999999999999995 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 1.5700000000000001 110.558 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 2.1000000000000001 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 3.4399999999999999 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 1.3400000000000001 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.3300000000000001 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.56000000000000005 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 1.3999999999999999 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 0.73999999999999999 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 0.69999999999999996 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.6899999999999999 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' SD ' ' A' ' 15' ' ' MET . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 1.04 113.2 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 1.98 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 1.52 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.0900000000000001 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 1.0800000000000001 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.8400000000000001 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 0.72999999999999998 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 0.41999999999999998 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.4100000000000001 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 0.45000000000000001 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 1.0600000000000001 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 1.9199999999999999 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.8700000000000001 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 0.95999999999999996 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.03 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 0.80000000000000004 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.72999999999999998 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 0.81000000000000005 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 0.88 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 0.68999999999999995 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 0.79000000000000004 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.29 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.0499999999999998 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 -175.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 0.56000000000000005 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 2.3900000000000001 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 1.9099999999999999 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.82999999999999996 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 2.1000000000000001 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 2.04 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 0.53000000000000003 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 0.87 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 0.81000000000000005 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.6400000000000001 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 2.7799999999999998 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 0.56999999999999995 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.9199999999999999 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 2.3199999999999998 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.4100000000000001 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 114' ' ' VAL . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 0.78000000000000003 110.17 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.1699999999999999 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6000000000000001 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 2.98 112.202 -171.262 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.426 -0.583 . . . . 2.1000000000000001 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 0.81999999999999995 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 1.0700000000000001 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.8799999999999999 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 4.25 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 1.8999999999999999 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.4100000000000001 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 3.29 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 2.8300000000000001 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 1.4399999999999999 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.3999999999999999 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 5.0199999999999996 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 2.27 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.9300000000000002 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.70999999999999996 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 0.66000000000000003 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 0.68999999999999995 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78000000000000003 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 0.46000000000000002 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.60999999999999999 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 1.7 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.75 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 3.1600000000000001 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 1.3500000000000001 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 2.4100000000000001 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.6899999999999999 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 0.46000000000000002 107.922 167.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 0.63 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 0.54000000000000004 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.8300000000000001 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 1.97 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 2.2000000000000002 108.554 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.71999999999999997 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 5.4199999999999999 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 0.51000000000000001 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.1299999999999999 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 125' ' ' VAL . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 1.48 113.831 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 0.75 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 3.3500000000000001 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.6400000000000001 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 0.48999999999999999 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 1.6799999999999999 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.5800000000000001 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 2.8199999999999998 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 0.81999999999999995 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.59999999999999998 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 1.8799999999999999 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 3.5699999999999998 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 1.49 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 2.7200000000000002 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 1.6299999999999999 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 5.75 109.042 162.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.316 -0.624 . . . . 2.4300000000000002 109.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 2.3500000000000001 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.9199999999999999 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 2.6600000000000001 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 0.62 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 2.4300000000000002 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.8399999999999999 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 0.96999999999999997 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 1.1100000000000001 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.3 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 2.8700000000000001 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 1.6299999999999999 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.0499999999999998 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 3.54 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 1.5900000000000001 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 1.6299999999999999 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 1.26 110.109 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 1.3100000000000001 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 2.6299999999999999 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.94999999999999996 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.6800000000000002 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 2.4700000000000002 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.82999999999999996 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 1.6899999999999999 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 2.21 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 2.79 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 1.9299999999999999 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.73999999999999999 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 1.46 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 0.73999999999999999 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.6699999999999999 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 0.55000000000000004 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.0600000000000001 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 21' ' ' ALA . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 1.3400000000000001 111.873 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2000000000000002 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 2.1800000000000002 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 1.4099999999999999 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 1.3700000000000001 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.3599999999999999 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 0.87 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 0.44 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.0600000000000001 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 0.5 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 0.95999999999999996 108.117 -178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 1.8 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.0800000000000001 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 1.1100000000000001 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.2999999999999998 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.80000000000000004 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 0.94999999999999996 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 0.98999999999999999 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 0.73999999999999999 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 0.73999999999999999 107.57 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.9099999999999999 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 2.3500000000000001 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 0.58999999999999997 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.3399999999999999 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.1699999999999999 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 2.48 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.87 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 4.0599999999999996 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 1.8200000000000001 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 0.97999999999999998 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 0.96999999999999997 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.7300000000000004 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.0 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 0.73999999999999999 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.8599999999999999 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 2.3700000000000001 109.745 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.6599999999999999 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 0.96999999999999997 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.499 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.1600000000000001 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.6200000000000001 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 3.3700000000000001 114.042 -174.791 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.124 0.416 . . . . 1.9099999999999999 112.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 1.53 110.815 -165.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 0.68000000000000005 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 2.2200000000000002 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 5.3899999999999997 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 1.8999999999999999 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 2.7200000000000002 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 3.9700000000000002 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 1.73 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.7999999999999998 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 4.6900000000000004 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 1.45 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.76000000000000001 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 0.71999999999999997 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 0.59999999999999998 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.68000000000000005 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 0.44 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.56000000000000005 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 1.9099999999999999 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 1.97 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 2.3199999999999998 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.0700000000000001 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 1.28 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.6800000000000002 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 0.71999999999999997 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 0.65000000000000002 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 0.66000000000000003 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 128' ' ' LEU . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 0.56000000000000005 104.877 166.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.8500000000000001 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 2.0899999999999999 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.0600000000000001 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65000000000000002 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 7.6200000000000001 109.315 171.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.8100000000000001 109.243 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 0.68999999999999995 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.0600000000000001 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 125' ' ' VAL . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 2.25 113.915 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 0.81999999999999995 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 78' ' ' PHE . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 1.4299999999999999 111.447 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 2.7000000000000002 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.1600000000000001 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 0.73999999999999999 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 139' ' ' LEU . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 1.6899999999999999 111.85 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 2.73 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 0.94999999999999996 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91000000000000003 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 2.3199999999999998 108.331 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.0199999999999996 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.719 ' HB2' HG11 ' A' ' 132' ' ' VAL . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 2.5899999999999999 106.624 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 3.1699999999999999 108.071 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 2.4300000000000002 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 3.5699999999999998 106.92 172.17 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.735 -0.839 . . . . 2.0600000000000001 108.735 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 4.4699999999999998 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 2.5 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 2.2400000000000002 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 0.93999999999999995 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.0 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 1.8400000000000001 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 0.62 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 0.77000000000000002 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.64000000000000001 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 2.7999999999999998 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 1.5700000000000001 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.1900000000000004 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 2.5 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 1.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 0.71999999999999997 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 0.89000000000000001 109.028 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 1.1299999999999999 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 2.4199999999999999 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 0.58999999999999997 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 2.6499999999999999 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.01 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 1.5800000000000001 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 1.9299999999999999 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 2.7799999999999998 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 1.8100000000000001 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.76000000000000001 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 1.3799999999999999 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 0.73999999999999999 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.6799999999999999 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 0.57999999999999996 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.0299999999999998 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 0.93999999999999995 107.981 -174.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.7799999999999998 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 1.76 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.1200000000000001 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 0.98999999999999999 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 0.48999999999999999 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 2.8199999999999998 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 0.44 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 1.3799999999999999 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 2.3300000000000001 111.909 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.2400000000000002 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.93000000000000005 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.1499999999999999 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.0299999999999998 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 0.94999999999999996 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.87 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 1.1499999999999999 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.1899999999999999 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 0.96999999999999997 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 0.91000000000000003 108.406 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.0699999999999998 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.9199999999999999 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 3.8300000000000001 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 0.5 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.5800000000000001 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 3.1299999999999999 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 2.3500000000000001 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.60999999999999999 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 2.1200000000000001 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 2.1699999999999999 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 0.58999999999999997 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.1000000000000001 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 1.05 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.2999999999999998 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 2.8399999999999999 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 0.66000000000000003 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.8900000000000001 111.717 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 2.3599999999999999 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.5700000000000001 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 0.95999999999999996 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.6299999999999999 104.648 168.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.76 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.1100000000000003 112.512 176.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 122.031 0.92 . . . . 1.75 112.095 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 1.1000000000000001 110.143 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 1.1299999999999999 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.1899999999999999 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 4.96 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 1.8100000000000001 110.623 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 2.9199999999999999 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 3.21 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 2.1200000000000001 111.151 -177.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.54 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 5.8300000000000001 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 2.0499999999999998 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.6099999999999999 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 0.98999999999999999 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 0.91000000000000003 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.97999999999999998 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 0.94999999999999996 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.0600000000000001 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 2.1099999999999999 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.02 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 3.1899999999999999 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 1.55 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 1.98 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 0.88 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 0.42999999999999999 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 1.04 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 0.62 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.3300000000000001 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 2.3300000000000001 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 2.4700000000000002 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.1399999999999999 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 5.6299999999999999 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.7200000000000002 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 0.81000000000000005 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 2.4500000000000002 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 1.55 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 0.79000000000000004 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 0.97999999999999998 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.0 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.7400000000000002 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 0.85999999999999999 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 1.75 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 3.9399999999999999 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 1.1000000000000001 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.94999999999999996 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 1.8500000000000001 108.126 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 4.3200000000000003 107.616 172.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 2.54 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 3.48 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 1.8999999999999999 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 41.3 mtpt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 2.7400000000000002 107.199 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.2000000000000002 108.078 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.8500000000000001 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.04 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 0.56999999999999995 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 2.0699999999999998 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.413 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.6800000000000002 109.244 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 0.83999999999999997 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 0.89000000000000001 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.81000000000000005 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 2.77 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 1.48 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.6299999999999999 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 3.23 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 1.6499999999999999 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 0.94999999999999996 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 0.83999999999999997 110.475 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 1.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 3.5699999999999998 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 0.85999999999999999 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.0300000000000002 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 1.79 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.67000000000000004 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 1.6000000000000001 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 2.25 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 2.5299999999999998 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 1.5800000000000001 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.58999999999999997 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 1.3400000000000001 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 0.73999999999999999 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 0.66000000000000003 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.8200000000000001 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG13 ' HB1' ' A' ' 21' ' ' ALA . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 1.48 111.915 170.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 1.79 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 2.7000000000000002 111.565 167.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 1.6799999999999999 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 1.45 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 0.95999999999999996 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 2.9100000000000001 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 0.46000000000000002 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 1.21 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 1.75 111.078 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.2999999999999998 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.87 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.02 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.8100000000000001 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 0.71999999999999997 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.66000000000000003 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 0.88 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 1.03 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 0.81999999999999995 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 0.64000000000000001 107.726 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 2.3300000000000001 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 0.87 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.8600000000000001 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 2.7000000000000002 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 2.0899999999999999 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.1100000000000001 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 2.2000000000000002 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 1.96 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 0.56000000000000005 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 1.04 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.47 HG23 ' C ' ' A' ' 118' ' ' TYR . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 0.82999999999999996 108.671 -166.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.1699999999999999 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 4.5300000000000002 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 0.64000000000000001 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.7799999999999998 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 1.79 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.5699999999999998 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 0.82999999999999996 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.8399999999999999 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.793 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 3.7799999999999998 111.708 167.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 110.759 -0.089 . . . . 1.77 110.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 1.47 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 0.68000000000000005 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.2000000000000002 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 3.8399999999999999 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 2.8300000000000001 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.6400000000000001 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 2.9900000000000002 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 5.3899999999999997 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 99' ' ' ILE . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 2.0099999999999998 111.68 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 5.9299999999999997 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 96' ' ' LEU . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.5800000000000001 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.71999999999999997 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 0.60999999999999999 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 0.65000000000000002 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.73999999999999999 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 0.64000000000000001 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.69999999999999996 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 89' ' ' ALA . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 2.5299999999999998 108.99 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 1.9199999999999999 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 2.54 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 1.6599999999999999 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 1.3500000000000001 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.3799999999999999 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 0.84999999999999998 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 0.59999999999999998 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 0.70999999999999996 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 128' ' ' LEU . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 0.60999999999999999 106.337 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6000000000000001 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.47 ' C ' HG23 ' A' ' 73' ' ' THR . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 2.0099999999999998 112.017 -172.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 2.25 109.203 -170.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.60999999999999999 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 7.3700000000000001 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.5899999999999999 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 0.52000000000000002 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.1699999999999999 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 1.73 113.644 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 0.81000000000000005 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.2200000000000002 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 116' ' ' VAL . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 1.52 110.494 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 3.1000000000000001 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.8900000000000001 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 0.79000000000000004 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' A' ' 139' ' ' LEU . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 1.55 112.035 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.0599999999999996 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 2.6099999999999999 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 0.98999999999999999 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 1.9199999999999999 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 4.5199999999999996 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 1.8 108.731 -175.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 2.1899999999999999 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 1.73 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 2.8199999999999998 108.647 173.289 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.635 -0.506 . . . . 2.2999999999999998 109.635 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 2.2799999999999998 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.4900000000000002 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 2.54 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 0.87 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 1.78 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 2.7200000000000002 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 0.82999999999999996 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 1.5900000000000001 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.0600000000000001 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.595 ' HE2' HD12 ' A' ' 24' ' ' ILE . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 3.3100000000000001 110.691 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 1.52 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.0800000000000001 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 3.5600000000000001 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 1.4299999999999999 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 0.93000000000000005 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 0.67000000000000004 111.478 171.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 0.93000000000000005 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.25 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 15' ' ' MET . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 0.67000000000000004 108.447 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 1.8999999999999999 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.64000000000000001 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 1.6200000000000001 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 2.2200000000000002 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 4.4199999999999999 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 1.45 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.3200000000000001 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 0.85999999999999999 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 1.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.91000000000000003 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.9199999999999999 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 0.71999999999999997 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 1.03 109.623 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 2.4100000000000001 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 3.1499999999999999 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 1.5700000000000001 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 1.45 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.0099999999999998 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.1399999999999999 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 0.46999999999999997 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.3900000000000001 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 0.47999999999999998 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 1.21 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CZ ' HG13 ' A' ' 60' ' ' ILE . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 2.4100000000000001 112.126 -170.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.0800000000000001 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 1.1799999999999999 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.9399999999999999 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 0.92000000000000004 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.83999999999999997 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 0.88 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 0.90000000000000002 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 0.82999999999999996 107.344 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.04 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.0099999999999998 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 2.3100000000000001 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 1.8999999999999999 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 2.5699999999999998 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 1.9399999999999999 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.59999999999999998 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CG ' HD11 ' A' ' 24' ' ' ILE . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 1.99 108.929 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 2.5699999999999998 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 0.56000000000000005 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 1.48 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 0.81000000000000005 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 4.4800000000000004 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 0.58999999999999997 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 2.04 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 114' ' ' VAL . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 0.80000000000000004 111.123 -165.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.4100000000000001 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 2.7200000000000002 110.11 172.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.778 -0.453 . . . . 1.96 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.1200000000000001 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 0.88 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 1.73 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 3.8900000000000001 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 2.7599999999999998 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.3599999999999999 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 3.6899999999999999 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 3.29 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 1.55 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 4.4900000000000002 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 102' ' ' VAL . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.0800000000000001 107.557 159.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.8900000000000001 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 0.68999999999999995 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ILE . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 0.60999999999999999 108.832 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 0.85999999999999999 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 0.5 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.56000000000000005 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 1.79 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 1.73 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 2.8199999999999998 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 1.46 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 1.4299999999999999 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.7400000000000002 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 0.76000000000000001 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 0.40000000000000002 107.24 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 0.68000000000000005 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 0.67000000000000004 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.5299999999999998 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' A' ' 102' ' ' VAL . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 2.0899999999999999 112.318 -165.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 2.4500000000000002 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79000000000000004 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 6.7599999999999998 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.2599999999999998 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 0.67000000000000004 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.1200000000000001 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.613 ' HA ' HD12 ' A' ' 128' ' ' LEU . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 1.9299999999999999 112.854 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 0.81000000000000005 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.0899999999999999 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 125' ' ' VAL . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 1.0600000000000001 109.669 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 3.4300000000000002 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.8900000000000001 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 0.73999999999999999 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 1.48 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.6099999999999999 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 3.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 0.69999999999999996 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.72999999999999998 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 2.25 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 4.3700000000000001 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 1.3600000000000001 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 2.8300000000000001 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 1.6200000000000001 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 2.9700000000000002 107.793 175.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 110.113 -0.329 . . . . 2.0499999999999998 110.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 2.3300000000000001 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7000000000000002 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.0600000000000001 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 0.75 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.0800000000000001 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 1.79 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 0.53000000000000003 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 0.70999999999999996 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.67000000000000004 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 2.5899999999999999 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.4399999999999999 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 4.1500000000000004 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 1.46 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 0.70999999999999996 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 0.77000000000000002 110.629 171.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.78000000000000003 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 2.3700000000000001 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 69' ' ' TYR . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.5899999999999999 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 1.74 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.78000000000000003 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 63' ' ' LYS . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 1.45 110.291 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 2.3100000000000001 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 2.8999999999999999 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 1.46 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.75 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 1.5 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 0.97999999999999998 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 0.63 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.6200000000000001 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 0.93000000000000005 108.914 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.29 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 1.74 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 1.48 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 1.3899999999999999 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.1099999999999999 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 0.52000000000000002 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 2.8700000000000001 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 0.48999999999999999 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 1.25 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 1.9399999999999999 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.3300000000000001 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.91000000000000003 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.52 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 0.83999999999999997 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.66000000000000003 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 0.81999999999999995 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 0.93999999999999995 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 0.78000000000000003 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 0.63 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.1899999999999999 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.4700000000000002 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.0 109.047 -173.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.5499999999999998 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 4.1900000000000004 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 2.0899999999999999 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.59999999999999998 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 24' ' ' ILE . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 2.0600000000000001 108.235 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 2.4700000000000002 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 0.94999999999999996 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.1599999999999999 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 1.01 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.6499999999999999 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 2.6800000000000002 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 0.84999999999999998 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.3100000000000001 108.816 -173.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 2.3100000000000001 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.8700000000000001 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 114' ' ' VAL . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 0.62 110.295 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.7999999999999998 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 1.78 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 4.6900000000000004 111.271 172.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 1.8999999999999999 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 0.76000000000000001 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.5099999999999998 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 4.0899999999999999 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 3.1400000000000001 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 94' ' ' LYS . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.0299999999999998 107.241 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 3.8500000000000001 111.908 -178.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 3.1600000000000001 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 1.53 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.5900000000000001 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.0199999999999996 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 1.54 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.6600000000000001 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.81999999999999995 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.68000000000000005 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 0.93000000000000005 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.1799999999999999 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 0.83999999999999997 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 0.93999999999999995 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 1.99 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.0899999999999999 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 3.7200000000000002 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 1.3100000000000001 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 2.1299999999999999 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.6499999999999999 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 0.84999999999999998 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' A' ' 80' ' ' ILE . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 0.51000000000000001 108.347 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 1.1200000000000001 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 0.67000000000000004 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.8999999999999999 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 1.8300000000000001 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.1200000000000001 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.69999999999999996 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 5.7800000000000002 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.0299999999999998 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 0.51000000000000001 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 2.2400000000000002 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 1.6200000000000001 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 0.62 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.6099999999999999 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 0.81000000000000005 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.0499999999999998 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.2400000000000002 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 0.83999999999999997 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 1.8100000000000001 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 2.6299999999999999 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 0.92000000000000004 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.81999999999999995 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 2.1400000000000001 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 2.8300000000000001 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 1.6699999999999999 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 4.5700000000000003 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 1.9399999999999999 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 1.3 mptm? . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 3.1600000000000001 108.185 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.0099999999999998 106.215 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.0899999999999999 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.0699999999999998 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.1099999999999999 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 0.64000000000000001 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 1.9099999999999999 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 1.9199999999999999 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 0.55000000000000004 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 1.1000000000000001 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.73999999999999999 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.04 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 1.21 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.6800000000000002 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 2.5600000000000001 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 1.2 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.0 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 0.92000000000000004 111.067 169.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 0.81999999999999995 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.0899999999999999 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 0.67000000000000004 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.6499999999999999 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.0699999999999998 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.66000000000000003 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 60' ' ' ILE . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 2.6899999999999999 111.479 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 3.3399999999999999 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 3.2599999999999998 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 1.3600000000000001 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.3999999999999999 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.65000000000000002 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 1.3799999999999999 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 0.85999999999999999 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.6400000000000001 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 0.65000000000000002 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 1.6399999999999999 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 0.85999999999999999 109.692 168.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.2799999999999998 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 2.1600000000000001 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 1.1599999999999999 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 1.1299999999999999 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.8100000000000001 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 0.90000000000000002 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 0.39000000000000001 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 2.9900000000000002 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 0.53000000000000003 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 1.4299999999999999 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 2.02 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.4099999999999999 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.0899999999999999 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.9099999999999999 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 1.01 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.70999999999999996 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 1.3100000000000001 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 1.1399999999999999 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 0.95999999999999996 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.506 HG23 HD21 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 0.68999999999999995 107.067 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.6200000000000001 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.1800000000000002 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 0.57999999999999996 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.1699999999999999 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 2.1800000000000002 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.65000000000000002 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 1.8600000000000001 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 1.8200000000000001 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 0.48999999999999999 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 0.81999999999999995 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 0.81999999999999995 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.3300000000000001 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 3.8500000000000001 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 0.76000000000000001 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.3300000000000001 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 2.2000000000000002 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 0.57999999999999996 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.4900000000000002 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 3.2400000000000002 111.825 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 111.662 0.245 . . . . 2.1200000000000001 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 0.89000000000000001 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 0.77000000000000002 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.02 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 5.1399999999999997 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.0299999999999998 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.0699999999999998 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 4.46 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 3.75 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 1.4399999999999999 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.53 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 5.54 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 1.6100000000000001 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.0300000000000002 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.71999999999999997 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 0.60999999999999999 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 0.63 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.81999999999999995 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 0.56000000000000005 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.72999999999999998 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 1.75 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.2400000000000002 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 3.1000000000000001 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.46 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 1.53 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.9399999999999999 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 0.69999999999999996 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 0.46999999999999997 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 0.68999999999999995 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.67000000000000004 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.8399999999999999 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 1.8500000000000001 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 2.5099999999999998 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.69999999999999996 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 5.7300000000000004 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.6899999999999999 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 0.56000000000000005 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 141' ' ' LEU . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 1.48 110.841 176.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.70999999999999996 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.1400000000000001 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 0.97999999999999998 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.0 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.6400000000000001 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 0.56999999999999995 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 1.49 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 2.5699999999999998 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 0.79000000000000004 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 2.6400000000000001 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 3.3799999999999999 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 1.4199999999999999 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 2.77 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 125' ' ' VAL . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 1.71 107.793 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 3.1899999999999999 108.901 -175.606 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.925 -0.398 . . . . 2.4399999999999999 109.925 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 2.4500000000000002 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.8999999999999999 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 2.7999999999999998 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 1.6699999999999999 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 2.4700000000000002 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 0.56999999999999995 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 0.80000000000000004 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68000000000000005 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 2.7799999999999998 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 1.8799999999999999 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 4.4800000000000004 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 2.9300000000000002 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 0.90000000000000002 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 0.79000000000000004 111.158 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 0.82999999999999996 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 2.5899999999999999 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 1.26 108.556 173.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 2.1000000000000001 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 0.93000000000000005 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 1.6299999999999999 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 2.75 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 4.3300000000000001 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 1.3600000000000001 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.21 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 0.72999999999999998 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 2.23 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 1.23 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.4500000000000002 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.21 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.1499999999999999 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG13 ' HB1' ' A' ' 21' ' ' ALA . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 1.3200000000000001 112.312 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.9100000000000001 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 2.02 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 1.21 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 1.5 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.9399999999999999 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.3700000000000001 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.45000000000000001 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.5699999999999998 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 0.5 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 1.0600000000000001 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 1.96 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.8399999999999999 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91000000000000003 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 0.96999999999999997 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.76000000000000001 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 0.78000000000000003 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 0.78000000000000003 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 0.73999999999999999 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.1200000000000001 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.8300000000000001 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 3.71 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 0.60999999999999999 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.4399999999999999 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.1899999999999999 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 2.5899999999999999 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.78000000000000003 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 1.98 109.318 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 2.29 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 0.70999999999999996 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 1.5600000000000001 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 0.78000000000000003 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 2.6200000000000001 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 0.81000000000000005 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.0499999999999998 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 1.73 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.2999999999999998 108.194 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.76000000000000001 109.971 -168.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.1499999999999999 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.6299999999999999 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 3.1499999999999999 113.696 -168.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 90' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.1800000000000002 108.807 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 0.93999999999999995 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 0.93999999999999995 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.04 109.064 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 4.5499999999999998 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 80' ' ' ILE . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 1.72 111.651 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.1899999999999999 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 4.3700000000000001 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' HG11 ' A' ' 102' ' ' VAL . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 1.5900000000000001 110.705 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.3200000000000001 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 4.6699999999999999 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 1.4199999999999999 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.6099999999999999 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.69999999999999996 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 96' ' ' LEU . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 0.56999999999999995 107.638 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.97999999999999998 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 0.45000000000000001 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.51000000000000001 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 2.3100000000000001 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.79 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 2.7200000000000002 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.3300000000000001 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 1.8400000000000001 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.3099999999999996 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 1.1100000000000001 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 80' ' ' ILE . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 0.40999999999999998 107.131 161.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 0.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 0.76000000000000001 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.8799999999999999 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 1.96 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 2.23 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.69999999999999996 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 5.5300000000000002 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.7999999999999998 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 0.55000000000000004 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.0299999999999998 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 1.47 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 0.81000000000000005 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 0.79000000000000004 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 2.8399999999999999 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 0.62 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 1.6200000000000001 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 4.4500000000000002 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 1.1399999999999999 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.65000000000000002 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 2.2999999999999998 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 2.8300000000000001 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 1.47 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 2.48 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.0099999999999998 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 4.7199999999999998 108.679 176.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.2999999999999998 109.227 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 2.1699999999999999 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.1799999999999997 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 0.56000000000000005 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 2.2400000000000002 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 1.72 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 0.91000000000000003 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.0900000000000001 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 2.71 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 1.3 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.2999999999999998 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 3.3799999999999999 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 1.99 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.1100000000000001 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.861 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 0.73999999999999999 109.961 173.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 0.96999999999999997 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.2599999999999998 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 0.90000000000000002 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.491 ' OE2' HG12 ' A' ' 39' ' ' VAL . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.5600000000000001 110.706 -178.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.0099999999999998 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 0.94999999999999996 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 1.75 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.1400000000000001 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 4.5899999999999999 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 1.76 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.3300000000000001 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.58999999999999997 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 1.3700000000000001 109.973 176.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 0.93999999999999995 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.8500000000000001 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 0.67000000000000004 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 1.72 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 1.25 110.215 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.3700000000000001 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 1.6599999999999999 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.21 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 1.0700000000000001 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.5499999999999998 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 1.1100000000000001 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 0.38 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 2.6600000000000001 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 0.68999999999999995 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 1.0800000000000001 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 2.0299999999999998 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 0.93999999999999995 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.4299999999999999 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.05 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 0.94999999999999996 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.1100000000000001 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 0.96999999999999997 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 0.87 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 0.81999999999999995 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.72 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 2.8300000000000001 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 0.82999999999999996 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.8799999999999999 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 4.9000000000000004 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 2.7599999999999998 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.0700000000000001 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 2.9900000000000002 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 2.1800000000000002 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 0.94999999999999996 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 1.3600000000000001 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 0.97999999999999998 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.5699999999999998 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 2.8500000000000001 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 2.0699999999999998 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.6299999999999999 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 92' ' ' ILE . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 0.65000000000000002 107.647 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.1399999999999997 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 2.1299999999999999 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.569 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 6.9 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.4199999999999999 112.441 -176.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.56 0.219 . . . . 1.8500000000000001 110.685 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 0.80000000000000004 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB1' HG21 ' A' ' 107' ' ' VAL . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 0.84999999999999998 109.683 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 4.8200000000000003 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 80' ' ' ILE . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 1.99 110.719 -178.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 3.7599999999999998 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 4.0899999999999999 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.429 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 1.9299999999999999 111.942 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.2 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 3.8399999999999999 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 1.3899999999999999 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.4300000000000002 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.65000000000000002 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 96' ' ' LEU . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 0.54000000000000004 108.008 178.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 0.57999999999999996 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.78000000000000003 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.73999999999999999 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.694 HG21 ' HB1' ' A' ' 89' ' ' ALA . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 2.6800000000000002 110.968 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.1600000000000001 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 2.4500000000000002 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 1.0900000000000001 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 1.3899999999999999 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7000000000000002 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 1.0 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 0.62 107.873 168.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 0.80000000000000004 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 0.54000000000000004 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 2.02 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.0600000000000001 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.58999999999999997 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 5.6900000000000004 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 0.56999999999999995 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.0699999999999998 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 1.8600000000000001 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 0.78000000000000003 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 0.76000000000000001 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 3.6800000000000002 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 0.52000000000000002 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 1.5800000000000001 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.3100000000000001 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 3.1400000000000001 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 0.77000000000000002 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.68999999999999995 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 2.1600000000000001 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 3.5800000000000001 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 1.4099999999999999 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 2.3399999999999999 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 3.7400000000000002 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 4.8200000000000003 108.826 170.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.505 -0.554 . . . . 2.98 109.505 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.1099999999999999 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.3100000000000001 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 3.0600000000000001 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 1.5800000000000001 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 5.1100000000000003 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.04 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 0.73999999999999999 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 1.01 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.1100000000000001 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 21' ' ' ALA . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 3.8399999999999999 110.667 176.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 1.95 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 41' ' ' LEU . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 2.9100000000000001 109.523 174.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 3.6099999999999999 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 2.2400000000000002 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 1.1799999999999999 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 1.23 109.925 168.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 1.5900000000000001 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 2.6899999999999999 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 0.87 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.6400000000000001 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 2.73 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.1599999999999999 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 1.5900000000000001 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 1.76 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.0999999999999996 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 1.6799999999999999 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.3600000000000001 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 0.92000000000000004 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 1.3999999999999999 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 0.56999999999999995 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.1800000000000002 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.94999999999999996 109.65 175.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.72 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 17' ' ' CYS . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 1.76 111.652 174.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 1.22 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 1.22 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.9900000000000002 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 1.1399999999999999 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 0.53000000000000003 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.79 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 0.56000000000000005 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 2.0600000000000001 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.8100000000000001 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.3700000000000001 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 1.8400000000000001 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.4300000000000002 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 0.95999999999999996 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.80000000000000004 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 1.28 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 1.0 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 1.25 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.0 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.5099999999999998 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 3.98 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 0.81999999999999995 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.1200000000000001 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 2.3399999999999999 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 3.0800000000000001 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.89000000000000001 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 2.27 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 2.2599999999999998 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 0.88 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 1.2 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 1.74 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.4900000000000002 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 2.75 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 0.92000000000000004 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.2200000000000002 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 1.8799999999999999 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 0.71999999999999997 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.1200000000000001 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 3.77 111.297 170.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.173 0.511 . . . . 2.1899999999999999 110.12 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.27 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 1.0900000000000001 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.6899999999999999 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 4.1900000000000004 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 1.9399999999999999 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7000000000000002 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 3.6899999999999999 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.1299999999999999 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 1.8400000000000001 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.3 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 4.5700000000000003 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 1.8400000000000001 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.8199999999999998 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.6899999999999999 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 102' ' ' VAL . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 1.3 112.828 -170.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 1.04 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.1899999999999999 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 1.95 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.1200000000000001 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 2.5699999999999998 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 1.75 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 1.8999999999999999 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.9100000000000001 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 0.77000000000000002 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 1.0700000000000001 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 0.93999999999999995 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.2799999999999998 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 2.4700000000000002 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 2.8500000000000001 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 8.2599999999999998 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.3600000000000003 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.1899999999999999 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 2.6499999999999999 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 2.0899999999999999 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 0.95999999999999996 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.9100000000000001 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 0.92000000000000004 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 3.6000000000000001 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.7200000000000002 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 0.67000000000000004 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 139' ' ' LEU . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 1.5 110.223 -178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.5699999999999998 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 3.23 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 1.1599999999999999 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.23 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 2.02 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 3.3700000000000001 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 132' ' ' VAL . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 1.3600000000000001 110.404 173.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 2.52 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 3.4199999999999999 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 176.513 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 2.7599999999999998 116.764 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 2.3500000000000001 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.2599999999999998 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 1.9099999999999999 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 0.63 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 2.1299999999999999 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.0 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 0.81000000000000005 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 0.97999999999999998 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.84999999999999998 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 3.5099999999999998 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 1.77 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.25 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 2.8700000000000001 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 1.45 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 0.88 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 110.089 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 0.90000000000000002 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.1699999999999999 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 0.85999999999999999 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.1699999999999999 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 1.99 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.65000000000000002 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 1.6299999999999999 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 2.21 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 3.79 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 2.3500000000000001 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.1599999999999999 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.54000000000000004 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 1.3 110.079 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 0.93999999999999995 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.1800000000000002 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 0.65000000000000002 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.3199999999999998 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.721 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 0.85999999999999999 111.952 -173.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 1.52 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 0.91000000000000003 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 0.93999999999999995 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 1.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 0.51000000000000001 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 3.8399999999999999 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 0.40999999999999998 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 2.1699999999999999 109.604 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.2999999999999998 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.80000000000000004 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.8300000000000001 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 0.76000000000000001 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.60999999999999999 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 0.75 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 0.75 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 0.70999999999999996 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.1400000000000001 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.6299999999999999 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 2.3999999999999999 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 0.57999999999999996 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.8500000000000001 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 2.4199999999999999 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 2.6099999999999999 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.65000000000000002 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 2.1299999999999999 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 2.0800000000000001 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 0.58999999999999997 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 1.0 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 0.92000000000000004 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2000000000000002 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 2.7200000000000002 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 0.76000000000000001 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 1.7 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.8799999999999999 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 0.81000000000000005 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.0199999999999996 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.54 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.3 ttp . . . . . 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 3.4300000000000002 111.21 173.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 108.469 -0.937 . . . . 1.46 108.469 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.23 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' MET . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 109.612 168.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 4.21 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 1.6699999999999999 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 2.5099999999999998 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 3.5699999999999998 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.401 ' O ' HG11 ' A' ' 102' ' ' VAL . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 1.8899999999999999 112.109 -176.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 1.97 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 6.46 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 1.6799999999999999 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6000000000000001 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.81999999999999995 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 96' ' ' LEU . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 0.71999999999999997 107.886 175.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 0.98999999999999999 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 0.65000000000000002 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.87 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 1.8200000000000001 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 2.4199999999999999 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 1.1699999999999999 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 1.6599999999999999 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.4900000000000002 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 0.65000000000000002 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 0.65000000000000002 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.8700000000000001 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 1.77 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 2.3500000000000001 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 0.93000000000000005 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 7.2800000000000002 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.6200000000000001 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 0.66000000000000003 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.0299999999999998 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 1.7 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 0.68999999999999995 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.2200000000000002 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 0.81999999999999995 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.04 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 0.51000000000000001 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 1.5900000000000001 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.5600000000000001 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 3.8900000000000001 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 0.80000000000000004 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.71999999999999997 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 2.1800000000000002 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.1000000000000001 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 1.3700000000000001 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 2.5499999999999998 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 1.72 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.0199999999999996 108.567 172.004 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.6499999999999999 108.695 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 3.0800000000000001 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.6299999999999999 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 1.9299999999999999 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 0.65000000000000002 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 1.79 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 2.52 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 1.0 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 1.0600000000000001 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 0.92000000000000004 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 3.4500000000000002 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 1.73 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.2699999999999996 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 4.5099999999999998 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.02 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.1599999999999999 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 0.84999999999999998 110.452 170.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 1.26 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 2.9399999999999999 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 0.80000000000000004 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.6899999999999999 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 2.2400000000000002 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 0.92000000000000004 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 1.5800000000000001 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 2.0699999999999998 112.774 174.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 3.8700000000000001 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 1.5600000000000001 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.1899999999999999 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 0.68999999999999995 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 1.49 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 0.95999999999999996 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.5800000000000001 112.925 172.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 0.81999999999999995 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 1.7 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.863 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 0.94999999999999996 110.641 177.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 1.9199999999999999 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 1.48 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 1.5900000000000001 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.5699999999999998 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.3200000000000001 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 0.56999999999999995 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.6699999999999999 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 0.5 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 1.79 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 1.79 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 1.4399999999999999 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 1.3100000000000001 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.22 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 1.0600000000000001 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 1.3 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 1.1299999999999999 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 0.93999999999999995 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.4199999999999999 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.5800000000000001 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 0.92000000000000004 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 2.8199999999999998 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 2.25 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.04 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 2.4500000000000002 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 1.05 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.0800000000000001 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 2.1200000000000001 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.6799999999999997 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 4.3300000000000001 109.257 174.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 0.81999999999999995 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 2.1400000000000001 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.7799999999999998 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.0600000000000001 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 2.7200000000000002 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.3999999999999999 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 3.3700000000000001 112.126 167.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 112.994 0.738 . . . . 1.74 112.994 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 1.0600000000000001 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 1.03 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 1.75 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 3.5099999999999998 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 132' ' ' VAL . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 1.8200000000000001 111.812 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 3.5099999999999998 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 3.3500000000000001 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 1.53 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.0299999999999998 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 5.4199999999999999 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 1.71 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.1099999999999999 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.1000000000000001 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 0.85999999999999999 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 1.0800000000000001 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.1699999999999999 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 0.77000000000000002 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 0.90000000000000002 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 1.8400000000000001 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 1.8500000000000001 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 2.4900000000000002 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.0499999999999998 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 1.8799999999999999 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.5899999999999999 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 0.63 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 0.81000000000000005 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 0.68999999999999995 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.7200000000000002 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 2.0699999999999998 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.1299999999999999 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.3500000000000001 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 5.4400000000000004 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.7599999999999998 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 0.95999999999999996 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 2.27 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 2.4300000000000002 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 0.83999999999999997 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.8100000000000001 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 0.77000000000000002 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.02 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.9299999999999997 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 0.68000000000000005 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 139' ' ' LEU . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 1.72 111.51 -178.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.2799999999999998 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 2.27 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 1.03 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 2.4900000000000002 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 3.8100000000000001 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.84 ' CB ' HG11 ' A' ' 132' ' ' VAL . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 2.6200000000000001 106.482 -175.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 2.9700000000000002 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.0 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 2.48 109.166 174.985 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.425 -1.723 0 CA-C-O 121.895 0.855 . . . . 2.73 109.592 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 1.95 106.168 166.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6000000000000001 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 2.5600000000000001 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 0.67000000000000004 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 1.8 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.4300000000000002 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 0.5 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 0.83999999999999997 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.62 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 3.21 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 1.47 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' HD13 ' A' ' 41' ' ' LEU . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.1800000000000002 109.699 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 2.9100000000000001 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 2.1200000000000001 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.05 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 0.91000000000000003 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 1.3400000000000001 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 2.8100000000000001 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 0.67000000000000004 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.7200000000000002 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 2.75 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.78000000000000003 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 60' ' ' ILE . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 3.0 110.528 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' HG11 ' A' ' 34' ' ' VAL . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 4.3300000000000001 112.555 175.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 2.8199999999999998 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 1.3500000000000001 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.62 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 2.6000000000000001 109.212 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 1.25 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.0600000000000001 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 0.78000000000000003 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 1.99 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 0.84999999999999998 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 1.72 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 1.6399999999999999 111.14 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 1.02 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 0.88 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 0.95999999999999996 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 0.46000000000000002 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.6499999999999999 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 0.45000000000000001 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 1.8300000000000001 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.6800000000000002 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.0 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.03 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.88 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 0.96999999999999997 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 0.77000000000000002 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 0.68999999999999995 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 28' ' ' LEU . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 0.85999999999999999 107.64 177.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.0099999999999998 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.1499999999999999 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 3.6299999999999999 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 0.67000000000000004 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 2.6800000000000002 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 2.3900000000000001 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 0.92000000000000004 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 1.95 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 1.79 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 0.54000000000000004 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 0.93999999999999995 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 0.79000000000000004 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.7599999999999998 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 0.58999999999999997 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.4900000000000002 111.216 -176.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 114' ' ' VAL . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 0.59999999999999998 110.255 -173.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2000000000000002 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 3.4 ptt? . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 3.02 113.618 -175.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 111.707 0.262 . . . . 1.75 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 0.81999999999999995 109.404 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 0.68999999999999995 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.3100000000000001 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 3.5299999999999998 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 1.98 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6000000000000001 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 3.4700000000000002 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 2.9300000000000002 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 1.6499999999999999 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.3799999999999999 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 4.3200000000000003 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 1.3899999999999999 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.67000000000000004 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 0.59999999999999998 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 0.58999999999999997 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.72999999999999998 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 0.46000000000000002 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.53000000000000003 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 1.71 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 2.96 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 1.24 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 1.6799999999999999 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.7599999999999998 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 0.73999999999999999 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 0.44 107.749 172.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 0.59999999999999998 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 0.55000000000000004 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.6099999999999999 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 2.0699999999999998 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.4700000000000002 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.70999999999999996 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 4.7199999999999998 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.3700000000000001 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 0.63 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.0099999999999998 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 1.55 112.758 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.68999999999999995 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.5499999999999998 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 1.02 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 3.1000000000000001 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.8599999999999999 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 0.57999999999999996 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 1.73 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.6200000000000001 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 4.1200000000000001 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 1.0600000000000001 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.73999999999999999 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 1.98 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 3.2799999999999998 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 1.3899999999999999 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 3.1699999999999999 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 1.6399999999999999 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 8.5 mtpt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.21 109.188 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.843 0.354 . . . . 2.2599999999999998 111.592 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 2.2000000000000002 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7000000000000002 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 1.9299999999999999 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 0.55000000000000004 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 2.3199999999999998 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.54 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 0.66000000000000003 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.1200000000000001 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 0.93999999999999995 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 2.5899999999999999 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 1.5800000000000001 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.464 ' SG ' HD13 ' A' ' 41' ' ' LEU . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.1099999999999999 109.511 179.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 2.73 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 1.5600000000000001 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.1499999999999999 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.898 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 0.85999999999999999 109.402 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 0.76000000000000001 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 2.3599999999999999 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.507 HD11 ' CE2' ' A' ' 69' ' ' TYR . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 0.56000000000000005 108.488 174.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' OE2' HG12 ' A' ' 39' ' ' VAL . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.7799999999999998 111.285 -175.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 1.8700000000000001 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.57999999999999996 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 1.6000000000000001 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 2.5 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 3.1699999999999999 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 1.23 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.57999999999999996 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 1.48 109.94 178.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 0.68000000000000005 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.8100000000000001 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 0.56999999999999995 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 1.8300000000000001 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.898 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 1.1499999999999999 110.822 175.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.0299999999999998 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.308 173.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 0.93000000000000005 111.462 175.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 0.87 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 0.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 0.40999999999999998 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.7000000000000002 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 0.40000000000000002 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 1.6000000000000001 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 1.79 111.321 -172.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.0699999999999998 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.87 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 0.95999999999999996 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.8799999999999999 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 0.78000000000000003 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.69999999999999996 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 0.95999999999999996 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 0.70999999999999996 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 0.63 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 0.72999999999999998 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.1899999999999999 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.5299999999999998 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 2.4300000000000002 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 0.56000000000000005 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.1400000000000001 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 2.6699999999999999 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 1.99 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.62 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CE2' HD11 ' A' ' 24' ' ' ILE . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 109.838 -178.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 2.1499999999999999 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 0.77000000000000002 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 0.78000000000000003 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.9199999999999999 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 4.2599999999999998 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 0.62 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.7200000000000002 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 1.75 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 114' ' ' VAL . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 0.59999999999999998 109.637 -167.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.3799999999999999 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.3899999999999999 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.0 110.559 176.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 113.259 0.837 . . . . 1.9399999999999999 113.259 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.847 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 0.63 111.242 173.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.1099999999999999 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 4.6500000000000004 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 1.8500000000000001 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.3399999999999999 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 4.7400000000000002 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 3.0299999999999998 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 1.71 111.322 -174.575 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.6299999999999999 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 4.7199999999999998 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 2.48 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.4900000000000002 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.67000000000000004 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 0.54000000000000004 108.027 178.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.65000000000000002 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89000000000000001 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 0.53000000000000003 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.58999999999999997 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.847 HG11 ' HB1' ' A' ' 89' ' ' ALA . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 2.3300000000000001 109.472 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.8900000000000001 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 3.98 112.028 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 1.6000000000000001 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 1.4199999999999999 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.7200000000000002 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 0.68999999999999995 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.447 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 0.60999999999999999 108.516 168.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 0.77000000000000002 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 0.58999999999999997 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.8599999999999999 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 1.76 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 2.3700000000000001 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.58999999999999997 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 6.6799999999999997 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 0.53000000000000003 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 2.29 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 2.27 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 0.95999999999999996 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.0299999999999998 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 0.94999999999999996 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 3.1600000000000001 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.04 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 1.6499999999999999 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.8300000000000001 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 3.27 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 1.24 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.75 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 1.9099999999999999 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 2.77 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 1.4299999999999999 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.1099999999999999 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 1.5900000000000001 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 2.98 109.67 178.793 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.1400000000000001 108.68 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 2.5899999999999999 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.5499999999999998 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 2.5299999999999998 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 0.75 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 2.2400000000000002 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 1.73 110.374 172.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 0.66000000000000003 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 0.77000000000000002 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.63 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 4.1299999999999999 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 1.46 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.04 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 3.3700000000000001 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 1.3799999999999999 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 0.82999999999999996 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 0.72999999999999998 111.856 169.279 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 0.84999999999999998 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 4.29 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 0.62 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 3.3199999999999998 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.58999999999999997 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 60' ' ' ILE . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 2.8900000000000001 110.81 -178.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 2.0499999999999998 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 2.9100000000000001 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 2.0800000000000001 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.4299999999999999 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.67000000000000004 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 1.3400000000000001 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 0.84999999999999998 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.0899999999999999 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 0.63 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 1.8700000000000001 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 1.6499999999999999 111.183 174.221 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 2.71 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 2.6499999999999999 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.1499999999999999 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 0.84999999999999998 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.0600000000000001 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 1.1100000000000001 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 0.54000000000000004 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.1299999999999999 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 0.46999999999999997 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 1.1899999999999999 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 1.8100000000000001 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.0499999999999998 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 0.89000000000000001 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.1899999999999999 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.1200000000000001 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 1.0600000000000001 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 0.97999999999999998 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 1.1299999999999999 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 1.03 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 0.93999999999999995 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 28' ' ' LEU . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 1.8600000000000001 109.466 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.5600000000000001 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.8999999999999999 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 2.3999999999999999 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 0.51000000000000001 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.1800000000000002 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 2.2200000000000002 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.62 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 2.1400000000000001 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 2.4100000000000001 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 0.57999999999999996 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 0.97999999999999998 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 0.90000000000000002 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.8700000000000001 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 2.8700000000000001 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 0.68000000000000005 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.4500000000000002 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 2.0499999999999998 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 114' ' ' VAL . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 0.67000000000000004 109.103 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.3399999999999999 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.725 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 37.8 mtm . . . . . 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.04 112.514 178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 N-CA-C 109.851 -0.425 . . . . 2.46 109.851 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 0.93000000000000005 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 0.67000000000000004 111.651 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.1899999999999999 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 4.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 2.9500000000000002 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 2.9399999999999999 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.0800000000000001 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 1.4099999999999999 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.469 ' HB3' ' HD2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.45 113.762 174.48 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 6.6600000000000001 110.164 176.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 1.3500000000000001 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.6200000000000001 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 0.80000000000000004 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 0.78000000000000003 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 0.96999999999999997 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.1100000000000001 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 0.81000000000000005 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.70999999999999996 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 89' ' ' ALA . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 3.1800000000000002 110.658 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 3.1800000000000002 112.979 -176.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 1.5800000000000001 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 2.1400000000000001 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.6899999999999999 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 1.0 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 0.42999999999999999 107.477 163.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 0.60999999999999999 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.9399999999999999 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 1.8600000000000001 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 2.23 108.846 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64000000000000001 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 5.46 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.6200000000000001 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 0.64000000000000001 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.0600000000000001 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 1.54 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 0.72999999999999998 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.1899999999999999 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.70999999999999996 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 3.6499999999999999 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.2200000000000002 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 0.56999999999999995 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 1.45 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.3100000000000001 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 3.6600000000000001 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 0.80000000000000004 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.76000000000000001 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 2.04 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.0600000000000001 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 1.55 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.1000000000000001 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 1.5700000000000001 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 3.9500000000000002 110.097 -179.452 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.302 -0.629 . . . . 2.3300000000000001 109.302 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 2.21 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.1299999999999999 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.0600000000000001 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 0.59999999999999998 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 1.9199999999999999 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.2599999999999998 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 0.65000000000000002 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 1.03 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.64000000000000001 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 39' ' ' VAL . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 3.8500000000000001 109.615 175.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 1.5 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.0899999999999999 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.3900000000000001 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 1.25 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 0.80000000000000004 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 0.87 109.437 177.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 1.02 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.0600000000000001 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 0.69999999999999996 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.0199999999999996 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 2.7400000000000002 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.93999999999999995 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 1.6000000000000001 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.2000000000000002 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 3.6899999999999999 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 1.3600000000000001 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 0.68000000000000005 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 1.5600000000000001 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 0.85999999999999999 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' CG ' HD21 ' A' ' 38' ' ' ASN . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.3500000000000001 112.53 179.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 0.78000000000000003 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.493 HD21 ' CG ' ' A' ' 36' ' ' ASP . 43.4 m-80 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.1499999999999999 110.481 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 0.91000000000000003 109.468 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.3300000000000001 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 1.8799999999999999 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 1.03 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 0.82999999999999996 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.1499999999999999 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 0.78000000000000003 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 0.37 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 2.8199999999999998 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 0.46000000000000002 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 1.1699999999999999 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 1.8200000000000001 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.2799999999999998 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.03 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 1.0800000000000001 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.2799999999999998 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 0.75 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.69999999999999996 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 0.84999999999999998 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 0.76000000000000001 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 0.64000000000000001 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 0.64000000000000001 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.8899999999999999 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 3.3999999999999999 110.581 -176.67 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 0.63 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 2.1899999999999999 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 2.1600000000000001 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.65000000000000002 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 2.0099999999999998 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 2.2200000000000002 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 0.62 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 1.01 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.4199999999999999 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 2.6699999999999999 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 116' ' ' VAL . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 0.97999999999999998 109.135 178.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.4700000000000002 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 1.98 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.6799999999999999 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 0.63 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.9900000000000002 108.878 172.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp . . . . . 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 4.1900000000000004 113.728 -177.421 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 113.105 0.779 . . . . 2.2799999999999998 113.105 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.0800000000000001 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 1.1000000000000001 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2000000000000002 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 3.98 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 1.8 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.6899999999999999 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.0699999999999998 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 3.2999999999999998 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 1.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.52 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 4.21 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 1.3400000000000001 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.70999999999999996 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 0.54000000000000004 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 0.68000000000000005 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 0.89000000000000001 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 0.45000000000000001 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.54000000000000004 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 2.3100000000000001 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 1.75 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 2.4500000000000002 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 1.25 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 0.77000000000000002 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 0.46000000000000002 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 0.68999999999999995 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 -179.378 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.0099999999999998 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 1.9399999999999999 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 2.2799999999999998 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 7.79 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.3799999999999999 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 0.51000000000000001 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.0499999999999998 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG11 HD21 ' A' ' 141' ' ' LEU . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 1.47 110.781 173.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 0.66000000000000003 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.68999999999999995 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' VAL . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 2.9100000000000001 110.702 174.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7000000000000002 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 0.47999999999999998 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 139' ' ' LEU . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 1.8500000000000001 110.038 -175.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.0899999999999999 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 2.6000000000000001 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 0.91000000000000003 112.236 169.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.69999999999999996 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 2.0899999999999999 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 3.7599999999999998 107.383 176.05 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 132' ' ' VAL . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 1.3899999999999999 108.299 178.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 2.9399999999999999 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.447 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 1.6599999999999999 108.691 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt . . . . . 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 3.4900000000000002 108.585 175.373 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 2.7400000000000002 110.322 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 1.6000000000000001 110.564 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 121.146 0.498 . . . . 2.7400000000000002 110.322 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp . . . . . 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 110.564 -0.161 . . . . 1.6000000000000001 110.564 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 107.712 -1.218 . . . . 13.31 107.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.5 pt? -83.74 -172.97 4.45 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.828 0.705 . . . . 8.8499999999999996 109.432 167.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m 84.92 146.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.781 2.032 . . . . 4.5199999999999996 109.158 -174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -138.81 81.9 1.87 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 107.775 -1.194 . . . . 5.8499999999999996 107.775 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -48.91 129.05 16.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.496 -1.229 . . . . 2.5699999999999998 109.712 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -89.44 162.43 15.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 120.046 -0.662 . . . . 2.52 109.42 165.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -107.82 141.93 38.63 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.868 3.267 . . . . 3.1499999999999999 104.687 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 tp -128.67 124.81 62.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 165.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.26 109.36 15.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.444 1.02 . . . . 0.79000000000000004 108.623 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.9 mtp -135.33 157.07 47.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.101 0.96 . . . . 2.1600000000000001 109.305 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.489 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 40.0 tt0 -93.21 130.01 39.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.395 1.078 . . . . 2.2400000000000002 110.018 175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -119.5 143.6 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 125.829 1.652 . . . . 0.62 108.406 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -112.91 169.5 8.87 Favored 'General case' 0 N--CA 1.458 -0.029 0 C-N-CA 124.34 1.056 . . . . 0.90000000000000002 110.676 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.17 -8.13 79.87 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.101 0.858 . . . . 0.85999999999999999 111.228 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.1 mtm -67.95 126.6 29.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.532 0.666 . . . . 2.3599999999999999 111.432 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m -68.75 -15.19 63.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.591 0.756 . . . . 2.1800000000000002 110.936 161.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.8 m 71.83 47.24 0.33 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.295 1.038 . . . . 5.2699999999999996 109.336 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.85 -110.17 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.993 1.717 . . . . 2.5499999999999998 106.571 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.12 58.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.757 0.823 . . . . 1.27 112.439 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -64.4 -56.5 13.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.791 0.805 . . . . 0.87 108.901 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.36 -52.9 57.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.697 -1.138 . . . . 0.73999999999999999 109.046 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.33 80.78 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.094 -0.379 . . . . 0.98999999999999999 111.893 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -44.43 95.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.289 0.636 . . . . 4.0300000000000002 109.768 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.5 -59.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 108.208 -1.034 . . . . 0.58999999999999997 108.208 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -58.14 -41.97 84.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.075 0.852 . . . . 3.9700000000000002 112.035 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -62.78 -44.88 95.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 121.685 -0.634 . . . . 4.3200000000000003 110.884 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.56 -40.98 99.45 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.849 -0.9 . . . . 0.64000000000000001 110.849 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.1 mm? -70.19 -38.38 75.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.856 -0.79 . . . . 1.5700000000000001 109.588 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -17.57 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.275 0.843 . . . . 1.71 113.275 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -60.01 -29.62 68.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.451 1.023 . . . . 3.23 111.615 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.3 mmt -75.31 146.64 81.71 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.207 0.603 . . . . 1.5700000000000001 110.33 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.77 -43.63 2.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.826 2.351 . . . . 1.26 111.684 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.27 -36.2 91.39 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.561 -1.016 . . . . 0.64000000000000001 110.561 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.29 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 125.346 1.458 . . . . 1.3899999999999999 110.055 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -83.87 -42.19 16.65 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.28 -1.327 . . . . 0.83999999999999997 107.961 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -145.62 156.74 43.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.344 -0.984 . . . . 2.1400000000000001 108.344 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.3 115.39 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.546 -1.279 . . . . 0.69999999999999996 107.546 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -133.91 160.74 36.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.221 1.008 . . . . 1.79 109.152 -172.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 21' ' ' ALA . 6.6 p -148.64 104.23 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 106.877 -1.527 . . . . 0.95999999999999996 106.877 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -81.48 68.34 7.78 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.378 -2.082 . . . . 2.0800000000000001 105.378 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -54.12 -27.63 34.47 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.328 1.451 . . . . 1.71 111.807 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.57 -36.06 66.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.822 0.849 . . . . 1.0600000000000001 111.252 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.2 p -116.65 15.85 15.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 0.91000000000000003 111.272 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 49.74 36.22 10.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.6 1.96 . . . . 1.6599999999999999 113.62 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -112.91 115.64 28.75 Favored 'General case' 0 C--N 1.338 0.083 0 N-CA-C 107.977 -1.12 . . . . 1.22 107.977 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.1 p -83.83 123.31 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.534 -1.284 . . . . 0.57999999999999996 107.534 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -123.21 113.61 19.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.836 1.254 . . . . 3.9700000000000002 108.903 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.61 134.45 64.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.669 -0.863 . . . . 0.51000000000000001 108.669 -172.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.0 mt -121.37 116.95 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.514 1.125 . . . . 1.02 108.97 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.81 164.42 38.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.589 0.756 . . . . 1.76 110.898 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.53 132.3 45.1 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 118.354 0.524 . . . . 2.4199999999999999 110.145 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.84 48.99 2.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.989 2.459 . . . . 1.28 112.226 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.16 25.97 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.865 0.691 . . . . 0.98999999999999999 112.865 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -147.33 -44.82 0.17 Allowed 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.559 1.143 . . . . 1.77 109.939 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 m -110.21 -84.31 0.56 Allowed 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.322 -0.992 . . . . 0.72999999999999998 108.322 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.19 123.3 4.38 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.291 -1.524 . . . . 0.70999999999999996 109.291 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.2 t -38.01 -44.1 0.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.415 1.486 . . . . 0.85999999999999999 112.763 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.34 96.97 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.714 -0.616 . . . . 0.76000000000000001 111.639 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.21 76.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.917 -1.114 . . . . 0.62 110.562 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.88 -54.98 22.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.192 -1.04 . . . . 0.64000000000000001 108.192 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.51 -45.06 89.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.242 -0.651 . . . . 1.8500000000000001 109.242 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -56.22 -39.39 72.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.436 -0.506 . . . . 3.0499999999999998 110.893 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' HD22 ' A' ' 28' ' ' LEU . 1.5 tpmt? -67.35 -44.24 79.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.301 -0.874 . . . . 2.3300000000000001 108.997 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -52.99 -50.22 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.163 0.438 . . . . 0.56000000000000005 109.906 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -59.17 -50.67 73.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.654 0.382 . . . . 2.5600000000000001 110.222 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.89 -35.02 68.46 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.505 -0.747 . . . . 3.0299999999999998 112.482 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.62 -14.15 56.69 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.666 0.667 . . . . 2.2599999999999998 112.281 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.06 40.8 3.67 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.012 -0.835 . . . . 0.65000000000000002 111.012 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -130.11 177.7 7.11 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.79 1.236 . . . . 1.8999999999999999 109.22 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.47 142.06 37.37 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.368 -0.604 . . . . 1.9099999999999999 109.368 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.72 136.64 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 124.767 1.227 . . . . 0.53000000000000003 109.393 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.1 t -84.28 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.704 -1.221 . . . . 0.93999999999999995 107.704 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.69 130.63 52.94 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.898 -1.149 . . . . 0.81999999999999995 107.898 -167.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -127.09 142.72 51.45 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.629 0.772 . . . . 4.3300000000000001 111.29 -171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -83.96 81.6 8.71 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.991 1.716 . . . . 2.7000000000000002 109.859 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.26 131.52 34.72 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.64 -0.874 . . . . 0.80000000000000004 108.64 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.17 135.83 34.01 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.153 0.888 . . . . 2.8900000000000001 110.609 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -129.99 157.19 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.492 1.517 . . . . 2.1600000000000001 108.403 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -111.1 147.22 35.32 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 129.109 2.963 . . . . 1.76 106.908 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 114' ' ' VAL . 15.3 mt -122.02 138.6 51.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 CA-C-N 119.61 1.095 . . . . 0.58999999999999997 108.926 -173.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HB3' ' HG3' ' A' ' 138' ' ' LYS . 1.7 mt-10 -125.3 38.25 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.924 0.869 . . . . 2.5800000000000001 109.865 -175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.66 -44.06 0.16 Allowed Glycine 0 N--CA 1.463 0.435 0 O-C-N 121.01 -1.056 . . . . 1.5800000000000001 112.865 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 165.39 4.67 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 122.463 1.125 . . . . 4.0899999999999999 113.177 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 t -179.53 -53.05 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.957 -1.498 . . . . 3.4199999999999999 106.957 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.8 t -92.5 32.57 1.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.342 -0.849 . . . . 5.1600000000000001 110.451 -165.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 41.87 27.37 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.165 1.786 . . . . 5.6200000000000001 114.159 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -116.57 -50.81 2.61 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 123.865 0.866 . . . . 1.99 109.733 -171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.6 m -56.96 -43.37 81.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.249 -1.019 . . . . 0.98999999999999999 108.249 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.4 -48.04 80.13 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.028 0.442 . . . . 0.90000000000000002 110.672 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -61.34 -47.57 85.29 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.698 -0.626 . . . . 2.3199999999999998 110.176 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -46.66 89.55 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.621 -0.675 . . . . 5.0599999999999996 111.14 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 tt -62.85 -35.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 118.878 -0.582 . . . . 2.79 110.123 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -54.66 44.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.426 -0.953 . . . . 2.23 108.426 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.17 -27.73 68.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 3.8199999999999998 111.229 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.01 -70.63 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.021 -0.425 . . . . 3.6499999999999999 111.111 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 55.3 mt -46.85 -37.45 8.79 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.365 1.466 . . . . 1.27 110.747 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -27.19 -48.92 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.157 2.183 . . . . 1.28 112.943 171.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.74 61.0 0.8 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.341 0.401 . . . . 4.5899999999999999 111.437 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mm -61.38 -49.0 86.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.631 -0.668 . . . . 1.3600000000000001 110.716 175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.14 -65.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.596 0.712 . . . . 3.04 110.434 174.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.52 46.54 1.1 Allowed Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.842 -1.303 . . . . 0.77000000000000002 109.842 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -103.15 123.64 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.141 -1.429 . . . . 0.56000000000000005 107.141 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.97 -47.67 17.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.076 -0.713 . . . . 0.59999999999999998 109.076 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -149.03 163.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.799 -0.445 . . . . 0.79000000000000004 109.799 -176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.46 60.07 2.41 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 113.641 0.978 . . . . 0.47999999999999998 113.641 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.24 135.72 32.45 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.889 1.726 . . . . 0.53000000000000003 111.319 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -102.08 147.07 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.371 1.469 . . . . 1.72 109.789 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -116.13 130.95 57.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.988 1.315 . . . . 1.76 109.019 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -95.53 5.86 50.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.439 0.696 . . . . 3.0800000000000001 111.937 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.13 7.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.474 0.71 . . . . 1.3200000000000001 109.718 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.91 5.04 14.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.952 0.901 . . . . 1.8200000000000001 111.345 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 60.63 45.28 10.53 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.061 0.934 . . . . 2.75 110.33 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.3 p -113.52 161.65 17.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.379 1.472 . . . . 0.71999999999999997 110.348 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -128.78 129.57 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.847 -1.168 . . . . 0.38 107.847 166.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.3 m -85.43 123.02 30.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.558 -2.016 . . . . 0.58999999999999997 105.558 163.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 p -105.75 114.79 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 106.583 -1.636 . . . . 0.56999999999999995 106.583 173.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.4 91.08 4.1 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.944 -1.873 . . . . 3.5299999999999998 105.944 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -145.72 172.75 12.84 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.466 0.543 . . . . 1.8 112.466 -166.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 7.2 t-20 -97.03 106.23 29.59 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.522 1.129 . . . . 2.1000000000000001 111.46 -173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.19 4.52 5.77 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.235 2.624 . . . . 0.63 113.594 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -42.71 9.03 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.487 -0.931 . . . . 7.3799999999999999 108.487 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -74.7 -43.54 54.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.32 0.648 . . . . 2.6400000000000001 110.129 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.52 -179.81 5.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.42 0.688 . . . . 0.69999999999999996 109.694 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.9 m -159.39 160.63 35.16 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 121.248 -0.908 . . . . 2.3799999999999999 109.712 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.7 t -35.37 -45.17 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.036 1.734 . . . . 1.4099999999999999 114.604 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.6 m -53.1 -42.63 66.12 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 111.919 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.55 -43.96 97.91 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.27 0.628 . . . . 1.9199999999999999 109.711 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.1 -50.95 71.68 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.84999999999999998 109.808 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -55.16 -55.32 32.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.431 -0.581 . . . . 3.0800000000000001 109.431 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -56.53 -38.71 72.23 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.725 0.639 . . . . 4.8300000000000001 112.725 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.26 -54.11 34.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.431 0.692 . . . . 0.75 109.959 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.88 -33.27 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.536 -0.728 . . . . 1.55 110.97 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -56.55 -38.91 72.56 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 123.06 0.544 . . . . 3.1400000000000001 109.562 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -41.93 75.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.214 0.606 . . . . 4.0499999999999998 110.341 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.32 -26.82 66.84 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.841 0.291 . . . . 0.90000000000000002 111.273 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.87 37.66 5.69 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.63 -0.988 . . . . 0.90000000000000002 110.63 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -128.8 178.89 6.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.645 -1.243 . . . . 2.1699999999999999 107.645 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.2 pttt -123.13 140.72 52.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.37 -1.715 . . . . 3.0299999999999998 106.37 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.36 133.22 52.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.592 -1.633 . . . . 1.8 106.592 -168.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -120.63 156.15 32.29 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 125.755 1.622 . . . . 2.1099999999999999 107.641 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.51 144.31 25.9 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.818 -0.808 . . . . 1.5900000000000001 108.818 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.44 83.05 5.49 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.516 -1.29 . . . . 3.6800000000000002 107.516 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.82 -54.96 4.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.484 0.564 . . . . 2.0899999999999999 112.056 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 59.02 32.44 22.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.944 1.297 . . . . 5.1299999999999999 111.454 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.85 -47.34 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.736 -0.603 . . . . 6.29 110.392 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.84 52.95 5.04 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 123.164 1.459 . . . . 8.7100000000000009 109.013 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m 63.75 16.05 9.46 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.989 1.716 . . . . 7.75 114.069 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 25.2 mm -79.12 72.54 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.9 0.773 . . . . 9.2699999999999996 109.65 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -112.76 131.01 55.87 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 106.407 -1.701 . . . . 14.18 106.407 161.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.31 -74.06 0.34 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.482 -1.047 . . . . 15.09 110.482 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 N-CA-C 103.996 -2.594 . . . . 15.83 103.996 161.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.044 -0.724 . . . . 16.989999999999998 109.044 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.76 127.76 1.36 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 106.094 -1.817 . . . . 9.3800000000000008 106.094 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -173.08 165.2 4.95 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.767 2.027 . . . . 5.5 106.499 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.43 62.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.732 1.613 . . . . 5.75 108.317 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -86.79 158.62 19.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.27 -0.877 . . . . 2.6000000000000001 108.906 -170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.85 136.48 52.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.835 0.289 . . . . 4.8499999999999996 111.654 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -83.29 121.16 26.76 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 124.626 1.204 . . . . 6.5300000000000002 107.826 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 tt -106.37 109.72 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.865 -1.531 . . . . 1.8700000000000001 106.865 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.87 121.91 38.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.868 -1.16 . . . . 0.76000000000000001 107.868 174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 84.4 mtp -143.82 161.83 37.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.784 0.834 . . . . 2.1699999999999999 110.164 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -95.39 148.06 22.85 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.371 173.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -148.51 143.98 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.885 1.274 . . . . 0.71999999999999997 107.721 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -107.32 172.26 6.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.284 1.034 . . . . 0.72999999999999998 110.76 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.88 59.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.851 0.739 . . . . 0.67000000000000004 111.402 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 97.86 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.666 0.733 . . . . 3.79 111.924 175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 -9.24 58.43 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.45 0.7 . . . . 1.3 110.918 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m 73.41 23.03 2.59 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.842 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.75 111.72 4.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.35 -2.463 . . . . 3.8399999999999999 104.35 173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.7 -31.99 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.314 1.598 . . . . 1.4399999999999999 115.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.8 m -63.5 -55.5 23.52 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.982 1.265 . . . . 0.81000000000000005 109.793 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -55.92 -47.26 77.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.705 -1.134 . . . . 0.78000000000000003 110.147 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.25 84.43 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.896 0.478 . . . . 0.85999999999999999 111.447 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -44.2 94.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.89 -0.506 . . . . 3.4500000000000002 110.0 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.1 mt -66.44 -48.39 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.7 -0.667 . . . . 0.78000000000000003 110.113 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' OE2' HG12 ' A' ' 39' ' ' VAL . 72.3 mt-10 -55.14 -51.48 66.32 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.208 0.913 . . . . 3.6099999999999999 110.538 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -63.94 -41.88 97.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.812 -0.555 . . . . 1.8999999999999999 110.666 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.48 -40.25 94.12 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.039 0.828 . . . . 0.79000000000000004 111.109 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' A' ' 60' ' ' ILE . 11.1 mt -69.03 -42.5 76.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.87 0.868 . . . . 2.4900000000000002 110.748 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -18.96 6.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.74 0.7 . . . . 2.2000000000000002 112.467 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -58.86 -30.26 67.58 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.744 -0.598 . . . . 2.71 112.208 172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 mmt -81.28 146.76 58.82 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.813 0.845 . . . . 1.3999999999999999 109.934 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.59 -46.59 1.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.806 2.337 . . . . 1.22 112.299 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.63 75.31 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.477 -0.649 . . . . 0.55000000000000004 111.477 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.28 100.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 124.178 0.991 . . . . 1.3100000000000001 109.161 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 m -86.66 -46.99 9.55 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -149.07 149.55 31.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.148 -0.621 . . . . 2.0800000000000001 109.757 164.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.73 -1.582 . . . . 0.68999999999999995 106.73 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -131.7 157.22 44.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.911 -0.774 . . . . 2.25 108.911 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.774 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.9 p -150.25 106.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 122.165 0.983 . . . . 1.1399999999999999 110.14 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -79.97 73.94 6.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.98 -1.859 . . . . 1.7 105.98 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -52.98 -30.42 34.94 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.834 -0.621 . . . . 1.53 111.013 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.78 -31.71 59.13 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.837 1.255 . . . . 1.03 111.747 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.2 p -125.87 24.42 7.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.716 0.806 . . . . 0.90000000000000002 109.99 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 40.75 54.71 3.09 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.896 1.278 . . . . 2.1000000000000001 112.899 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -134.25 113.52 12.06 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.17 -1.048 . . . . 0.81000000000000005 108.17 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.86 130.13 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.417 1.087 . . . . 0.44 108.595 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -123.8 109.03 13.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.177 -1.416 . . . . 2.6299999999999999 107.177 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.59 131.69 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.338 -0.616 . . . . 0.48999999999999999 109.338 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -111.26 113.45 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.541 -1.281 . . . . 1.23 107.541 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 60' ' ' ILE . 29.7 p90 -143.53 166.43 24.82 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.361 0.601 . . . . 1.8 112.137 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -76.37 117.21 62.73 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 113.655 -1.611 . . . . 2.6000000000000001 109.314 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.66 37.9 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.796 1.664 . . . . 1.1499999999999999 111.378 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.66 27.5 0.1 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.642 0.777 . . . . 1.6499999999999999 112.331 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -139.31 -47.12 0.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.633 1.173 . . . . 1.9199999999999999 109.357 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.7 m -107.56 -81.53 0.56 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.745 -1.206 . . . . 1.0800000000000001 107.745 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.83 126.89 3.74 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.161 -1.576 . . . . 0.87 109.161 174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -38.61 -45.94 1.14 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.585 1.554 . . . . 1.24 112.875 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.63 75.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.525 0.73 . . . . 0.91000000000000003 111.834 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.73 71.55 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.142 -0.974 . . . . 0.75 111.015 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' CE2' ' A' ' 50' ' ' TYR . 6.8 mm -66.08 -50.0 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.316 -1.364 . . . . 0.78000000000000003 107.316 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.11 -40.24 95.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.313 -0.555 . . . . 2.25 110.272 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -55.24 -40.75 71.25 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.837 -0.431 . . . . 2.3700000000000001 109.837 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -48.35 82.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 121.636 -0.665 . . . . 3.4900000000000002 111.196 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -53.99 -45.22 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.426 0.557 . . . . 0.55000000000000004 109.56 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -62.08 -52.93 61.92 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.343 -0.223 . . . . 2.1800000000000002 111.332 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -55.15 -41.1 71.36 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.044 0.938 . . . . 2.3900000000000001 112.249 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.18 -21.13 58.94 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.476 0.547 . . . . 2.25 112.476 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.45 38.35 3.75 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.699 1.142 . . . . 0.93999999999999995 111.219 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -127.67 175.12 8.54 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.086 0.955 . . . . 2.1499999999999999 109.37 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -136.88 144.51 43.58 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.138 0.975 . . . . 1.8500000000000001 109.096 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -91.32 143.94 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.862 1.265 . . . . 0.62 109.865 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.63 72.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.06 19.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.90000000000000002 110.448 -170.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -117.04 137.42 52.26 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.571 1.148 . . . . 3.4399999999999999 108.861 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -83.83 86.93 7.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.766 0.827 . . . . 3.1699999999999999 108.952 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.69 129.33 34.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.53 -0.731 . . . . 1.0 109.876 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -84.0 120.29 25.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.36 0.982 . . . . 2.9399999999999999 110.738 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -109.28 146.75 33.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.845 1.258 . . . . 2.2000000000000002 109.09 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.56 144.8 30.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 127.189 2.195 . . . . 2.5299999999999998 107.236 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.98 129.98 73.31 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 CA-C-N 120.378 1.444 . . . . 0.69999999999999996 109.185 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 138' ' ' LYS . 14.9 mt-10 -120.68 132.82 55.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.377 -0.972 . . . . 3.3599999999999999 108.377 166.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.49 -23.67 2.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.523 -0.598 . . . . 1.48 113.09 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.9 mtp -51.61 73.33 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.355 2.662 . . . . 2.6600000000000001 114.676 177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t -77.03 51.16 0.79 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.068 0.947 . . . . 4.5599999999999996 109.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t 68.95 -132.95 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 4.9900000000000002 108.029 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 55.58 -78.64 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.16 1.784 . . . . 3.5699999999999998 110.738 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.52 40.28 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.039 2.136 . . . . 1.74 108.704 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.99 -46.67 70.67 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 120.299 1.409 . . . . 0.90000000000000002 109.563 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.05 -46.21 79.0 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 110.209 -0.293 . . . . 0.80000000000000004 110.209 175.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.16 -45.22 93.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.718 0.295 . . . . 2.4500000000000002 110.966 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -55.63 -52.38 64.0 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.626 -0.671 . . . . 5.1100000000000003 110.46 173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -40.13 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 122.96 0.504 . . . . 3.1299999999999999 110.814 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.84 -64.69 0.86 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.67 -1.604 . . . . 2.73 106.67 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -51.02 -35.09 32.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 3.4500000000000002 111.552 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -68.98 -70.36 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.784 -0.367 . . . . 2.8799999999999999 110.137 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.5 mt -48.37 -41.67 29.41 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.999 1.32 . . . . 1.3400000000000001 110.871 -172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -29.94 -49.96 0.11 Allowed 'General case' 0 C--N 1.339 0.122 0 C-N-CA 127.572 2.349 . . . . 1.6499999999999999 111.988 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.96 76.54 0.72 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.34 0.4 . . . . 4.5800000000000001 111.2 174.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.13 -76.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.308 -0.997 . . . . 1.3500000000000001 108.308 166.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -117.33 -105.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.764 1.225 . . . . 2.6699999999999999 107.831 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.0 54.69 2.55 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.3 -1.12 . . . . 0.70999999999999996 110.3 -170.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.4 t -105.63 125.18 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.646 -0.872 . . . . 0.55000000000000004 108.646 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.65 -53.2 8.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.653 -0.869 . . . . 0.62 108.653 172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -151.99 166.2 32.28 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.094 0.474 . . . . 0.78000000000000003 109.918 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.92 60.72 2.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.514 -0.766 . . . . 0.54000000000000004 112.897 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -68.59 137.5 39.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.966 1.777 . . . . 0.71999999999999997 111.095 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 89' ' ' ALA . 15.5 t -116.15 145.1 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.196 0 C-N-CA 125.411 1.484 . . . . 2.4700000000000002 109.342 -175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -112.03 144.82 40.76 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 123.68 0.792 . . . . 1.8 109.894 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.74 8.04 45.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.626 1.17 . . . . 2.73 112.293 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.5 -47.55 3.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.739 -0.837 . . . . 1.1299999999999999 108.739 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -89.83 -20.97 22.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.002 -0.999 . . . . 1.3400000000000001 110.47 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 63.21 56.44 1.73 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.26 1.824 . . . . 3.0499999999999998 111.016 -170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.9 p -136.26 150.18 48.83 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.638 1.175 . . . . 0.79000000000000004 109.894 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -122.4 127.69 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.652 0.781 . . . . 0.66000000000000003 109.11 167.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 48.6 m -83.02 120.69 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.732 -2.321 . . . . 0.84999999999999998 104.732 164.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.02 115.52 47.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.6 -1.259 . . . . 0.59999999999999998 107.6 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -101.68 92.66 4.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.754 -1.572 . . . . 2.8500000000000001 106.754 174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -139.77 156.24 46.87 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 -177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -71.74 113.58 21.19 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.054 -1.091 . . . . 2.5099999999999998 108.054 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -77.87 17.06 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.271 1.981 . . . . 0.67000000000000004 111.715 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -103.34 -56.05 2.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.505 0.593 . . . . 5.2999999999999998 110.081 170.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.67 -52.38 60.17 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.926 -0.398 . . . . 2.7200000000000002 109.926 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -121.43 -176.45 3.3 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.70999999999999996 109.186 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.6 p -156.55 171.73 19.79 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 2.0099999999999998 109.444 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.4 t -35.37 -48.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.718 1.607 . . . . 1.6399999999999999 111.868 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.5 m -49.96 -48.28 52.19 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.974 0.91 . . . . 0.59999999999999998 112.593 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.96 -48.29 82.04 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 121.538 0.685 . . . . 2.1000000000000001 109.607 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.0 -46.01 92.51 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.86 0.864 . . . . 0.79000000000000004 110.527 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -57.01 -52.53 64.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.591 0.756 . . . . 4.25 109.316 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -60.9 -40.55 93.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.578 0.704 . . . . 2.73 110.394 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.22 -55.62 32.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.713 -0.617 . . . . 0.77000000000000002 109.926 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 139' ' ' LEU . 38.5 t -66.1 -30.89 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 O-C-N 121.163 -0.961 . . . . 1.5600000000000001 111.796 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.81 -53.17 58.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.402 -0.592 . . . . 3.0699999999999998 109.402 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -57.49 -41.47 80.8 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.498 0.555 . . . . 2.6600000000000001 112.498 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.74 -28.39 69.4 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.731 0.696 . . . . 0.93000000000000005 111.851 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.49 38.14 4.83 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 123.918 0.771 . . . . 0.88 111.585 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -132.99 -177.02 4.32 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 106.348 -1.723 . . . . 2.02 106.348 169.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 36.3 pttt -120.04 135.24 55.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.689 1.131 . . . . 3.8199999999999998 109.205 173.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 132' ' ' VAL . 7.6 tp -103.71 128.95 51.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.068 0.947 . . . . 2.5499999999999998 108.547 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -119.21 171.86 7.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.327 2.251 . . . . 2.0699999999999998 106.875 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 159.9 17.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.077 -0.712 . . . . 3.0 109.077 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 74.65 4.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.046 0.927 . . . . 3.0899999999999999 108.861 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.83 -59.12 3.03 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.376 -1.09 . . . . 2.75 110.376 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.61 47.34 24.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.997 1.319 . . . . 5.3799999999999999 109.995 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -169.75 -53.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.234 1.813 . . . . 7.3200000000000003 107.795 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.83 -5.57 11.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.411 1.084 . . . . 7.0 112.18 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -153.88 30.5 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.964 1.306 . . . . 7.3499999999999996 110.013 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.3 mt -43.37 -66.45 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.774 1.23 . . . . 8.3599999999999994 111.195 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.65 167.42 1.39 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.963 2.105 . . . . 14.529999999999999 106.851 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -89.89 94.64 2.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.184 -1.566 . . . . 14.98 109.184 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.85 -1.548 . . . . 17.5 109.829 174.009 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 106.233 -1.766 . . . . 13.33 106.233 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.31 121.48 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.087 -1.079 . . . . 10.16 108.087 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.1 m 72.73 126.7 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.125 1.77 . . . . 4.1799999999999997 112.93 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.3 54.42 1.68 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.481 1.134 . . . . 4.7699999999999996 109.731 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -57.96 155.96 9.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.937 1.295 . . . . 2.8100000000000001 109.141 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.35 149.02 45.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.438 -0.578 . . . . 2.6499999999999999 109.438 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.45 155.18 16.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.517 1.527 . . . . 2.77 110.005 175.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.54 123.02 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.244 -1.391 . . . . 3.04 107.244 163.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.37 123.6 47.71 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.569 -1.271 . . . . 0.57999999999999996 107.569 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.4 mtm -146.31 169.17 19.37 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 117.905 0.321 . . . . 1.8999999999999999 110.157 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.21 140.93 29.2 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.301 0.641 . . . . 2.1499999999999999 109.646 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.0 149.62 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.769 1.628 . . . . 0.87 107.511 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 m -111.59 170.61 8.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.856 0.862 . . . . 1.04 110.842 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.67 -7.46 40.83 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.342 0.496 . . . . 0.95999999999999996 112.3 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.615 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -58.31 95.02 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.39 1.076 . . . . 2.3799999999999999 109.11 177.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -81.79 -23.94 36.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.366 -0.605 . . . . 1.96 109.366 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 t -174.24 168.73 3.98 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 108.769 -0.826 . . . . 4.25 108.769 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.67 -43.19 1.89 Allowed 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.919 1.288 . . . . 3.0800000000000001 112.825 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.03 -41.38 59.8 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.3 0.64 . . . . 1.1899999999999999 112.679 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.3 m -64.63 -54.21 35.41 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.351 -0.981 . . . . 0.75 108.351 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.098 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -46.44 -58.69 3.53 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.564 -1.198 . . . . 0.72999999999999998 110.985 172.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.37 -36.59 69.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.085 1.354 . . . . 0.77000000000000002 111.398 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -47.0 87.02 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.847 -0.533 . . . . 2.2599999999999998 109.987 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.3 mt -62.67 -50.04 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.8 -0.815 . . . . 0.78000000000000003 108.8 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' OE2' HG12 ' A' ' 39' ' ' VAL . 76.1 mt-10 -54.88 -49.71 70.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.763 0.711 . . . . 3.54 110.75 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -65.71 -41.45 92.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.603 -0.686 . . . . 1.99 110.326 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.23 80.8 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.523 -0.631 . . . . 0.64000000000000001 111.523 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HG23 ' A' ' 60' ' ' ILE . 2.4 mt -70.27 -48.73 55.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.741 1.216 . . . . 3.3700000000000001 110.56 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -53.41 -19.68 3.78 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.442 1.097 . . . . 1.74 112.18 177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.9 -29.78 67.3 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.25 1.02 . . . . 3.1600000000000001 113.034 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.4 ' O ' HG12 ' A' ' 34' ' ' VAL . 4.8 mmt -76.48 158.52 81.18 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 123.646 0.778 . . . . 1.3600000000000001 111.382 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.15 -48.22 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.561 2.174 . . . . 1.25 111.354 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 -13.55 82.93 Favored Glycine 0 CA--C 1.527 0.805 0 O-C-N 121.71 -0.619 . . . . 0.68999999999999995 112.908 -169.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.8 p -61.7 124.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.524 0.73 . . . . 2.25 109.448 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 m -87.6 -53.63 4.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.747 -1.205 . . . . 1.1599999999999999 107.747 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -154.13 162.75 40.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.457 0.646 . . . . 2.0499999999999998 111.341 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 122.51 24.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.852 -1.907 . . . . 0.68999999999999995 105.852 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -128.6 155.39 45.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.009 -1.108 . . . . 2.3799999999999999 108.009 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.098 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.1 p -156.67 138.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.925 -0.768 . . . . 0.93999999999999995 108.925 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -116.48 84.61 2.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.131 -1.433 . . . . 2.1000000000000001 107.131 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.2 -19.9 15.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.936 0.495 . . . . 2.23 112.134 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.97 -33.62 75.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.775 0.83 . . . . 1.1899999999999999 110.974 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -119.92 -1.02 10.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.16 0.984 . . . . 1.0700000000000001 112.312 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 68.01 31.74 5.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.587 2.355 . . . . 2.5800000000000001 112.147 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -110.81 118.22 35.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.049 -1.463 . . . . 0.84999999999999998 107.049 -170.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -91.95 130.25 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.769 1.228 . . . . 0.5 108.097 171.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.23 109.1 14.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.252 -1.388 . . . . 2.7999999999999998 107.252 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -109.6 136.82 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.401 -0.592 . . . . 0.46000000000000002 109.401 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.14 117.98 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.518 1.127 . . . . 1.5800000000000001 108.979 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -154.18 172.05 18.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.86 0.464 . . . . 1.8100000000000001 109.791 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.31 121.81 70.09 Favored Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 109.339 -0.615 . . . . 2.0899999999999999 109.339 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.15 35.53 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.202 1.935 . . . . 0.92000000000000004 111.92 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.8 27.52 0.22 Allowed 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.595 0.758 . . . . 1.25 112.483 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -138.99 -50.75 0.53 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.571 1.149 . . . . 2.1000000000000001 109.136 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 m -98.57 -80.71 0.45 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.653 -0.869 . . . . 0.84999999999999998 108.653 -165.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.83 121.07 2.47 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 109.648 -1.381 . . . . 0.76000000000000001 109.648 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 t -48.32 -43.47 33.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.038 0.535 . . . . 1.0 110.975 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.72 -42.63 89.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.373 0.669 . . . . 0.68999999999999995 111.053 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.61 -38.92 77.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.151 -0.968 . . . . 0.64000000000000001 110.48 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 28' ' ' LEU . 59.3 mt -63.81 -51.49 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 122.159 -0.338 . . . . 1.79 110.095 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -58.63 -40.26 82.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.492 -0.558 . . . . 2.6299999999999999 109.492 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -60.44 -37.08 79.81 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.915 -0.491 . . . . 3.6299999999999999 110.265 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.63 -42.67 95.33 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 120.636 -1.29 . . . . 2.52 110.729 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.9 mt -52.46 -46.65 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.457 -0.572 . . . . 0.57999999999999996 109.457 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -59.21 -54.54 45.79 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.968 -0.693 . . . . 2.1899999999999999 111.656 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -66.61 -26.09 66.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.303 0.241 . . . . 4.5899999999999999 111.069 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -16.42 62.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.601 0.76 . . . . 2.4500000000000002 112.202 169.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.85 41.14 2.73 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.692 1.139 . . . . 0.57999999999999996 110.854 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -132.93 178.58 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.379 1.072 . . . . 2.0899999999999999 109.96 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -131.98 164.38 26.29 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 107.955 -1.128 . . . . 1.9399999999999999 107.955 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.59 142.51 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.388 1.475 . . . . 0.56000000000000005 108.569 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -83.86 85.21 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.165 -2.161 . . . . 1.3600000000000001 105.165 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -150.73 130.11 12.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.534 -0.913 . . . . 0.75 108.534 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -116.49 133.66 55.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.922 0.889 . . . . 3.1400000000000001 109.89 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -84.54 82.45 8.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.148 1.779 . . . . 3.2799999999999998 109.191 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.44 171.37 12.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.082 -0.711 . . . . 0.81000000000000005 109.082 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -131.36 132.91 44.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.296 0.498 . . . . 2.4500000000000002 110.094 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 116' ' ' VAL . 23.4 m-30 -119.56 140.2 50.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.99 0.916 . . . . 2.0 108.764 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.91 157.57 24.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.6 1.56 . . . . 2.29 107.806 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.6 138.27 55.25 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.105 0 CA-C-N 119.79 1.177 . . . . 0.72999999999999998 109.697 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -107.42 134.89 49.8 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.209 0.528 . . . . 3.1400000000000001 111.183 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.53 -82.44 0.42 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.032 1.777 . . . . 3.3300000000000001 109.132 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.8 mtm 45.74 -136.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.426 1.091 . . . . 4.2300000000000004 109.524 -171.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.0 p 36.56 56.21 1.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.394 2.677 . . . . 5.4800000000000004 114.056 159.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.82 -160.58 1.18 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.493 -1.669 . . . . 5.46 106.493 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.07 -47.99 8.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.323 1.049 . . . . 4.3399999999999999 112.25 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.33 48.58 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 118.845 -0.598 . . . . 1.74 110.974 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.22 -58.25 5.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.832 1.651 . . . . 0.90000000000000002 110.566 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.37 -33.94 71.8 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.68000000000000005 110.404 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.38 -47.32 73.71 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.339 -0.851 . . . . 2.0 110.295 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -55.88 -54.7 41.4 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.487 -0.758 . . . . 4.4000000000000004 109.886 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.11 -35.05 70.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 118.244 -0.884 . . . . 1.73 111.521 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -56.81 -63.37 1.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.798 -1.186 . . . . 2.21 107.798 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -52.03 -33.97 41.02 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 123.476 0.485 . . . . 2.79 110.533 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -71.07 -70.44 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.944 -0.302 . . . . 2.7400000000000002 110.366 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.92 -45.42 3.74 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.52 1.528 . . . . 1.72 111.109 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -29.73 -47.32 0.07 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.356 2.263 . . . . 1.24 112.351 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 69.32 0.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.285 0.634 . . . . 4.7999999999999998 109.779 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.8 mm -62.74 -61.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 109.226 -0.657 . . . . 1.3700000000000001 109.226 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.92 -105.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.356 1.462 . . . . 3.7599999999999998 107.11 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.63 54.22 4.93 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 120.992 -1.067 . . . . 0.72999999999999998 110.52 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -109.09 127.36 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.58 1.152 . . . . 0.53000000000000003 107.908 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.33 -53.52 7.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.822 -0.807 . . . . 0.64000000000000001 108.822 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.08 165.75 33.77 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 122.888 0.475 . . . . 0.71999999999999997 109.939 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.63 71.05 3.28 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.899 0.703 . . . . 0.52000000000000002 112.899 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.25 125.71 11.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.749 1.633 . . . . 0.66000000000000003 110.632 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.73 150.72 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.816 1.246 . . . . 1.7 110.222 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -116.17 143.93 44.84 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.464 1.106 . . . . 2.1800000000000002 109.505 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -0.81 23.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.173 0.989 . . . . 2.8799999999999999 112.307 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.08 -47.16 6.19 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.759 0.824 . . . . 1.3400000000000001 109.161 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.7 mt -85.46 -24.38 27.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.294 -0.86 . . . . 1.52 111.484 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 76.2 38.57 0.32 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 126.14 1.776 . . . . 3.2000000000000002 110.222 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -142.05 170.38 15.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.217 0.607 . . . . 1.1299999999999999 110.566 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.44 134.66 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.941 1.696 . . . . 0.56999999999999995 109.584 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -83.29 139.2 33.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.258 -1.756 . . . . 0.67000000000000004 106.258 166.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 78' ' ' PHE . 1.4 p -128.31 105.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.224 1.41 . . . . 1.04 107.373 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -95.38 102.05 13.82 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.862 -1.162 . . . . 2.6099999999999999 107.862 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.16 163.89 32.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.081 0.238 . . . . 2.1699999999999999 110.705 -177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -84.72 111.11 32.61 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 107.799 -1.185 . . . . 2.5099999999999998 107.799 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.92 15.37 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.398 2.065 . . . . 0.66000000000000003 112.065 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -102.32 -58.18 1.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.691 0.678 . . . . 5.6500000000000004 109.424 171.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.81 -44.11 90.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.549 0.74 . . . . 2.9399999999999999 109.79 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.54 177.34 5.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.027 0.931 . . . . 0.68999999999999995 108.793 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.9 t -149.37 160.77 43.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.306 -0.998 . . . . 1.8500000000000001 108.306 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 125' ' ' VAL . 12.7 t -46.32 -40.26 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.89 1.276 . . . . 1.74 111.14 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.4 m -52.86 -42.1 64.91 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.32 0.859 . . . . 0.67000000000000004 113.32 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.14 -48.53 81.26 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.926 0.869 . . . . 2.0699999999999998 109.396 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.04 -40.69 94.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.473 -0.785 . . . . 1.4299999999999999 110.631 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -61.91 -44.5 96.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.319 -0.372 . . . . 3.21 110.866 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.21 -46.37 88.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.24 0.927 . . . . 3.0499999999999998 110.296 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.16 65.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.035 0.534 . . . . 0.87 110.036 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' A' ' 139' ' ' LEU . 7.9 p -70.08 -29.07 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 119.065 -0.493 . . . . 1.8799999999999999 111.04 -175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -44.83 73.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.234 -0.654 . . . . 2.6400000000000001 109.234 169.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.39 -13.13 57.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.897 1.073 . . . . 2.4500000000000002 113.897 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.41 -7.84 57.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.137 . . . . 1.1100000000000001 111.253 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.01 -16.34 58.81 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.193 0.901 . . . . 1.3700000000000001 113.18 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.12 -152.49 0.21 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.28 -1.007 . . . . 2.0099999999999998 108.28 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.19 152.73 24.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.569 -1.271 . . . . 4.7000000000000002 107.569 165.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.564 ' HG ' HG11 ' A' ' 132' ' ' VAL . 89.8 mt -105.53 151.03 24.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.489 -0.93 . . . . 1.4199999999999999 108.489 173.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -128.21 172.56 10.91 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.444 1.898 . . . . 1.96 107.312 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.06 138.99 34.54 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.415 -0.803 . . . . 2.9500000000000002 109.914 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -79.96 82.91 5.95 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.594 -0.891 . . . . 3.3399999999999999 108.594 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.6 3.52 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.459 -1.056 . . . . 2.4100000000000001 110.459 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 44.09 49.23 7.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.395 1.078 . . . . 3.9900000000000002 110.919 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -166.19 -54.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.345 2.258 . . . . 7.8399999999999999 107.309 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.66 -25.94 11.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.444 1.098 . . . . 7.6500000000000004 112.033 -170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.9 m -109.45 23.83 13.92 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.157 1.383 . . . . 7.79 111.261 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.76 78.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.828 0.823 . . . . 8.0299999999999994 108.992 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -81.08 60.74 4.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.295 1.038 . . . . 15.15 111.215 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.43 147.0 4.74 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.826 -2.109 . . . . 12.99 107.826 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.354 -2.091 . . . . 16.370000000000001 105.354 -172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.826 -0.435 . . . . 16.41 109.826 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -78.91 67.82 4.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.464 -0.569 . . . . 11.85 109.464 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.5 m -75.37 53.12 0.65 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.214 1.406 . . . . 5.5099999999999998 112.864 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -84.51 79.31 9.62 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.493 -1.299 . . . . 4.9800000000000004 107.493 173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -45.41 149.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.904 -1.498 . . . . 2.79 110.25 163.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.49 156.05 36.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.584 -0.895 . . . . 1.95 108.584 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -107.33 108.27 19.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.832 1.653 . . . . 2.7400000000000002 108.892 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' HG3' ' A' ' 10' ' ' MET . 0.0 OUTLIER -93.57 120.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.834 -1.173 . . . . 2.9700000000000002 107.834 171.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 121.43 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.869 1.267 . . . . 0.64000000000000001 109.189 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.426 ' HG3' HD11 ' A' ' 8' ' ' ILE . 17.5 mtm -137.64 166.53 23.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.674 0.67 . . . . 2.0899999999999999 110.426 173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -94.1 135.66 35.23 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.618 0.767 . . . . 1.79 110.402 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.36 139.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.094 1.758 . . . . 0.71999999999999997 107.933 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 m -105.78 170.24 8.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.54 1.136 . . . . 0.93999999999999995 110.61 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.86 -0.05 88.85 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.38 -0.688 . . . . 0.67000000000000004 111.38 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 36.4 mtm -68.6 105.35 2.22 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.916 -0.755 . . . . 2.5299999999999998 111.28 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -67.95 -20.22 65.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.856 0.862 . . . . 1.54 112.775 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' HD13 ' A' ' 41' ' ' LEU . 24.9 t 73.81 97.78 0.07 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.272 1.429 . . . . 3.3100000000000001 109.558 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 136.94 -119.99 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.832 3.253 . . . . 2.6299999999999999 105.559 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.59 69.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.218 0.822 . . . . 1.5700000000000001 113.218 -172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.6 m -66.68 -56.21 11.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.356 0.98 . . . . 0.93000000000000005 109.922 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.873 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.56 -49.63 75.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.964 -1.016 . . . . 0.71999999999999997 109.063 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.49 -37.33 72.77 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.338 0.655 . . . . 0.78000000000000003 112.012 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.54 -43.32 97.47 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.481 -0.762 . . . . 2.5499999999999998 109.806 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -63.68 -54.96 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.718 -1.216 . . . . 0.58999999999999997 107.718 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' OE2' HG12 ' A' ' 39' ' ' VAL . 67.0 mt-10 -50.84 -53.3 33.4 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.905 0.775 . . . . 3.5299999999999998 110.342 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -62.12 -48.73 78.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.162 -0.336 . . . . 1.9299999999999999 111.035 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.96 -45.73 79.95 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.13 -0.788 . . . . 0.64000000000000001 111.13 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.41 -40.96 73.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.372 -0.487 . . . . 1.55 109.898 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -58.53 -17.03 18.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.213 0.605 . . . . 3.0600000000000001 112.415 176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -20.62 64.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.113 1.365 . . . . 3.6299999999999999 113.41 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.497 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -72.82 160.79 82.02 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 118.915 0.78 . . . . 1.3300000000000001 110.018 178.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.29 -45.85 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.915 1.744 . . . . 1.1599999999999999 111.308 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.69 74.96 Favored Glycine 0 C--N 1.339 0.721 0 O-C-N 121.959 -0.463 . . . . 0.71999999999999997 112.915 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.9 p -62.29 127.84 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 123.046 0.538 . . . . 2.2200000000000002 110.41 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -95.23 -51.21 4.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.422 -0.955 . . . . 0.75 108.422 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -152.81 157.76 41.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.616 -0.513 . . . . 2.2599999999999998 109.616 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.95 123.47 23.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.408 -1.701 . . . . 0.71999999999999997 106.408 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -128.74 146.1 50.99 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.062 -1.088 . . . . 2.6200000000000001 108.062 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.873 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -133.84 106.09 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 122.543 1.163 . . . . 1.21 109.848 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.01 71.48 6.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.942 -1.873 . . . . 1.99 105.942 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.458 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.1 pp -57.97 -19.72 32.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.236 1.015 . . . . 1.5600000000000001 111.87 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -29.43 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.603 0.761 . . . . 1.1100000000000001 111.676 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.2 p -128.55 11.81 6.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.071 0.949 . . . . 0.93000000000000005 111.366 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.91 45.36 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.674 1.59 . . . . 1.9099999999999999 112.828 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -122.75 111.31 16.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.212 -1.403 . . . . 0.81999999999999995 107.212 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.2 123.29 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.355 1.062 . . . . 0.40999999999999998 108.231 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -117.08 110.37 18.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.054 1.342 . . . . 2.9300000000000002 107.689 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.51 133.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.837 -0.431 . . . . 0.45000000000000001 109.837 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -119.59 115.48 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 125.165 1.386 . . . . 1.76 107.985 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 44.5 p90 -155.45 167.54 30.04 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.022 0.929 . . . . 1.74 108.959 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.39 127.19 69.48 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-O 119.201 -0.428 . . . . 2.0699999999999998 110.272 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.51 40.02 0.59 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.629 2.219 . . . . 0.88 112.334 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.56 28.83 0.16 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 118.447 0.567 . . . . 0.98999999999999999 112.426 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -148.44 -48.02 0.15 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.606 1.162 . . . . 1.8899999999999999 109.589 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -105.44 -80.0 0.55 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.523 -0.917 . . . . 0.72999999999999998 108.523 -167.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.18 121.57 4.15 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.25 -1.54 . . . . 0.67000000000000004 109.25 171.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -35.92 -44.5 0.36 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.727 1.611 . . . . 0.78000000000000003 113.446 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.26 97.25 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 110.782 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.99 -35.86 79.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.162 -0.961 . . . . 0.76000000000000001 110.795 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 9.0 mm -57.28 -56.43 15.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.501 -0.925 . . . . 0.70999999999999996 108.501 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -38.87 89.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.6 -0.518 . . . . 2.9399999999999999 109.6 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -57.91 -39.82 78.85 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.615 -0.513 . . . . 2.27 109.615 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -41.52 88.77 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 121.261 -0.899 . . . . 3.6099999999999999 109.531 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -53.49 -45.7 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 118.977 0.808 . . . . 0.81999999999999995 109.681 173.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -59.1 -56.41 22.56 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.688 -0.405 . . . . 1.77 111.624 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.65 69.8 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.64 -0.662 . . . . 3.3700000000000001 112.731 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.74 -12.97 58.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.925 0.784 . . . . 2.5600000000000001 111.472 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 40.28 3.87 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.509 -1.036 . . . . 0.76000000000000001 110.509 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.19 176.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.494 1.117 . . . . 1.96 108.843 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.47 142.4 50.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.584 -1.265 . . . . 2.3300000000000001 107.584 174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -89.7 151.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.548 1.139 . . . . 0.93000000000000005 108.607 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 72' ' ' VAL . 65.5 t -88.57 18.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.275 1.036 . . . . 1.72 111.582 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.43 155.88 35.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.786 1.234 . . . . 1.1899999999999999 111.543 -174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -131.96 144.71 51.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 110.142 -0.318 . . . . 5.1500000000000004 110.142 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -93.3 108.48 20.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.685 1.594 . . . . 3.04 108.272 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -118.95 162.33 18.71 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.141 0.576 . . . . 0.87 110.313 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -121.15 132.03 54.6 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.245 1.018 . . . . 2.3799999999999999 110.819 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -119.13 151.17 38.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.228 1.411 . . . . 1.79 108.537 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -106.96 135.48 48.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.835 2.054 . . . . 1.6299999999999999 108.066 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.9 mt -107.79 133.6 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 119.058 0.845 . . . . 0.56000000000000005 110.144 -167.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.85 90.19 3.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.444 0.64 . . . . 3.3599999999999999 110.545 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.96 -50.21 0.08 OUTLIER Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.993 -0.442 . . . . 1.53 113.208 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.25 138.73 9.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.936 0.894 . . . . 4.3600000000000003 113.131 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 44.36 0.91 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.668 -0.864 . . . . 3.6699999999999999 108.668 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.8 t 67.43 45.0 1.66 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.906 0.86 . . . . 5.3899999999999997 111.133 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.53 43.33 3.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.588 1.155 . . . . 4.0300000000000002 108.144 168.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.4 25.62 4.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.441 1.496 . . . . 1.3700000000000001 113.148 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.3 m -65.91 -49.27 68.58 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.214 -0.929 . . . . 0.80000000000000004 109.43 -168.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.73 -34.78 67.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.289 1.036 . . . . 0.67000000000000004 110.839 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -71.94 -42.35 66.72 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.347 -0.845 . . . . 2.2000000000000002 109.735 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -50.78 71.94 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.46 -0.775 . . . . 4.54 110.842 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.33 -36.42 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 118.234 -0.888 . . . . 1.97 111.389 174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.56 -61.4 2.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 120.226 1.375 . . . . 2.8900000000000001 109.387 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -50.1 -32.37 15.65 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 123.347 0.404 . . . . 3.3799999999999999 111.445 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -72.24 -69.8 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.225 -0.59 . . . . 5.9500000000000002 110.071 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -47.07 5.21 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.619 1.168 . . . . 1.71 111.314 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -30.27 -43.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.856 2.462 . . . . 1.3200000000000001 113.194 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.45 61.65 0.55 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.733 0.413 . . . . 4.9199999999999999 110.841 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -60.03 -67.97 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.421 -0.585 . . . . 1.4199999999999999 109.421 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -141.17 -104.99 0.15 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.956 -1.498 . . . . 2.52 106.956 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.89 50.09 3.83 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 121.859 -0.526 . . . . 0.75 112.076 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.52 122.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.267 -1.383 . . . . 0.59999999999999998 107.267 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.5 -42.87 19.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 122.932 0.493 . . . . 0.85999999999999999 109.728 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -153.59 161.89 41.77 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 108.998 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.66 67.17 2.17 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.951 0.723 . . . . 0.53000000000000003 112.951 172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.16 148.14 68.28 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.868 1.712 . . . . 0.58999999999999997 111.076 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 89' ' ' ALA . 29.5 t -123.41 146.04 29.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 125.246 1.418 . . . . 2.5499999999999998 109.209 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -108.8 152.33 25.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.223 1.009 . . . . 2.23 109.696 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.58 1.98 18.42 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.884 0.874 . . . . 2.4900000000000002 112.494 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.49 -47.71 3.34 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.304 1.041 . . . . 1.4399999999999999 109.496 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -80.64 -22.2 40.76 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.213 0.605 . . . . 1.6899999999999999 111.291 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 64.69 44.3 3.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.871 1.268 . . . . 2.6699999999999999 110.279 -173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.5 p -125.77 153.32 44.16 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.913 1.285 . . . . 0.95999999999999996 110.882 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -122.54 129.07 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.685 1.194 . . . . 0.52000000000000002 108.837 168.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -82.3 142.13 32.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 105.842 -1.91 . . . . 0.76000000000000001 105.842 165.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.02 116.34 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.01 -1.848 . . . . 0.68000000000000005 106.01 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.42 94.54 5.12 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.65 -2.352 . . . . 3.71 104.65 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.05 158.9 44.64 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.301 -0.249 . . . . 1.74 111.161 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -82.86 112.79 40.62 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 108.299 -1.001 . . . . 2.04 108.299 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.41 11.8 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.083 1.855 . . . . 0.60999999999999999 111.291 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.33 -52.69 3.31 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.837 0.744 . . . . 5.8200000000000003 110.149 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.73 -49.34 77.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.181 0.446 . . . . 3.0600000000000001 110.494 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.92 179.96 4.63 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.717 0.807 . . . . 0.53000000000000003 109.189 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.2 m -161.49 165.09 29.17 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.58 -1.267 . . . . 2.3300000000000001 107.58 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.56 -34.28 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 115.334 1.605 . . . . 1.98 115.334 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -50.83 -43.58 59.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.333 0.97 . . . . 0.90000000000000002 112.12 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.2 -52.61 64.08 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 122.164 0.983 . . . . 2.1699999999999999 108.831 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 132' ' ' VAL . 90.0 mt -60.09 -47.75 84.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.812 -1.086 . . . . 0.71999999999999997 109.603 -175.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -48.97 -58.62 4.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.286 -0.864 . . . . 2.9399999999999999 109.233 171.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.5 -44.93 95.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.28 0.945 . . . . 2.6899999999999999 110.599 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.04 -49.22 77.63 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.946 0.498 . . . . 0.57999999999999996 110.114 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 128' ' ' LEU . 59.0 t -70.24 -35.83 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.1 -0.704 . . . . 1.71 109.1 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -55.17 -52.48 63.18 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.248 -0.649 . . . . 3.0699999999999998 109.248 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.17 -42.25 76.75 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.012 0.925 . . . . 2.3700000000000001 112.212 175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.99 -21.84 66.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.858 -0.526 . . . . 1.03 112.138 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.98 26.45 6.05 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.953 1.263 . . . . 0.64000000000000001 112.516 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -141.47 -163.88 1.65 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.111 -1.07 . . . . 2.1800000000000002 108.111 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 160.64 40.61 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.327 0.967 . . . . 3.1899999999999999 109.811 165.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.8 mt -109.09 146.86 33.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.679 1.192 . . . . 1.54 109.568 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.35 167.02 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.451 1.9 . . . . 2.6899999999999999 107.884 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.66 128.85 50.93 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.599 0.759 . . . . 1.6599999999999999 108.97 -172.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -81.02 79.99 7.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.767 0.794 . . . . 2.6499999999999999 108.914 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -65.84 3.62 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.129 -1.188 . . . . 2.0600000000000001 110.129 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 35.73 56.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.224 1.409 . . . . 4.2699999999999996 111.513 -168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.07 -53.24 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 106.676 -1.601 . . . . 6.7800000000000002 106.676 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 62.7 t0 54.29 98.24 0.01 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.805 1.642 . . . . 9.7100000000000009 110.98 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m 57.34 30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.09 -0.505 . . . . 7.7300000000000004 110.293 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 62.78 -71.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.261 2.224 . . . . 9.4900000000000002 111.899 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . 0.403 0.0 OUTLIER 52.61 -24.75 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.746 3.218 . . . . 11.369999999999999 118.6 -174.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.58 161.93 28.6 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.944 -2.462 . . . . 11.119999999999999 106.944 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.576 -1.678 . . . . 15.109999999999999 109.603 168.408 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.28 9.3 ptt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 112.936 0.717 . . . . 18.059999999999999 112.936 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.32 139.84 48.19 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.443 -1.317 . . . . 12.630000000000001 107.443 167.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m 63.49 169.19 0.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.256 1.023 . . . . 6.1799999999999997 110.708 -167.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -75.41 33.85 0.11 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.772 1.229 . . . . 5.3899999999999997 111.535 -174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -125.45 140.78 52.48 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.767 1.227 . . . . 3.5699999999999998 107.927 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.52 166.18 11.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.167 -0.444 . . . . 3.1400000000000001 110.832 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -124.58 92.91 3.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 129.265 3.026 . . . . 2.8700000000000001 107.395 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.38 114.52 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.927 -1.509 . . . . 2.6000000000000001 106.927 177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -104.35 122.27 45.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 106.68 -1.6 . . . . 0.72999999999999998 106.68 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -140.92 169.22 18.03 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.316 -0.994 . . . . 1.8899999999999999 108.316 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.82 126.17 54.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.22 1.008 . . . . 1.6799999999999999 108.877 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.02 139.34 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.814 1.645 . . . . 0.5 109.189 -173.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 m -100.07 175.2 5.83 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.76 0.824 . . . . 0.88 111.452 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.61 61.59 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.647 0.642 . . . . 0.87 111.706 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 5.1 ttm -66.85 71.86 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.571 1.548 . . . . 2.5299999999999998 111.286 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -81.43 -13.99 57.61 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.499 -0.751 . . . . 2.6499999999999999 110.857 -166.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.82 156.09 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.622 -1.251 . . . . 4.54 107.622 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.58 -38.1 2.82 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.302 1.041 . . . . 3.25 112.068 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.23 72.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.804 0.668 . . . . 1.55 112.804 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.4 m -62.83 -55.1 29.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.836 -1.172 . . . . 1.1799999999999999 107.836 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' SD ' ' A' ' 15' ' ' MET . . . -49.36 -53.91 19.96 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.16 -1.382 . . . . 0.69999999999999996 111.09 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.01 71.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 125.742 1.617 . . . . 0.85999999999999999 111.827 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -62.7 -48.29 79.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.674 -0.641 . . . . 2.1000000000000001 110.198 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.69 -49.57 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.215 -0.661 . . . . 0.67000000000000004 109.215 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -48.21 -59.3 3.52 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.013 1.325 . . . . 3.2799999999999998 110.812 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -59.32 -34.73 72.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.809 -0.632 . . . . 2.1400000000000001 110.199 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.54 -44.7 57.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.445 -1.062 . . . . 0.66000000000000003 110.445 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.17 -45.97 91.28 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.789 -0.83 . . . . 2.5800000000000001 110.138 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.94 -15.06 2.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.602 0.964 . . . . 2.3900000000000001 113.602 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 -56.81 -34.86 68.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.292 0.951 . . . . 3.3300000000000001 111.756 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.7 mmt -80.75 147.37 62.43 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.392 1.077 . . . . 1.5 110.891 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.57 -43.82 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.945 2.43 . . . . 1.4199999999999999 112.879 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.98 75.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 119.008 0.822 . . . . 0.63 111.705 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.35 101.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.932 0.893 . . . . 1.3700000000000001 108.884 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.4 m -84.53 -47.27 10.76 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.121 -1.437 . . . . 0.73999999999999999 107.121 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.81 110.25 3.11 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.433 -0.951 . . . . 2.6000000000000001 108.433 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.53 132.56 35.62 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.521 -1.289 . . . . 0.90000000000000002 107.521 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.95 157.46 45.97 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.343 1.057 . . . . 2.3199999999999998 109.034 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.41 116.44 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.641 -0.662 . . . . 0.93000000000000005 109.626 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -90.42 99.3 12.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.685 -1.228 . . . . 2.1299999999999999 107.685 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -31.91 69.53 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.222 0.609 . . . . 1.6000000000000001 110.887 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.34 79.62 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.691 0.796 . . . . 1.04 110.559 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 74.6 p -111.29 14.19 21.65 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.094 0.957 . . . . 0.91000000000000003 110.982 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 40.66 41.47 1.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.256 1.422 . . . . 2.04 112.93 -172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.2 m -111.26 114.31 27.43 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.068 -1.456 . . . . 0.84999999999999998 107.068 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 p -91.5 126.13 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.202 -1.407 . . . . 0.33000000000000002 107.202 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.23 117.42 21.5 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.54 -0.911 . . . . 3.8500000000000001 108.54 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.42 123.24 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.084 -1.08 . . . . 0.54000000000000004 108.084 -172.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.76 119.0 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.55 -1.648 . . . . 1.28 106.55 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.97 165.29 36.89 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.837 0.68 . . . . 1.8600000000000001 112.837 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.95 126.32 68.31 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.181 -1.372 . . . . 2.2200000000000002 110.099 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -82.97 27.86 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.483 2.789 . . . . 1.02 112.142 -175.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.08 6.11 2.15 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.786 0.661 . . . . 1.1699999999999999 112.786 -174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -124.83 -33.9 2.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.5 1.12 . . . . 2.0099999999999998 111.618 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 28.4 m -126.27 -83.07 0.62 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.207 -1.405 . . . . 0.71999999999999997 107.207 -157.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 134.01 7.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.48 -1.448 . . . . 0.68999999999999995 109.48 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 t -37.67 -45.7 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.754 1.622 . . . . 0.69999999999999996 113.251 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.934 0.494 . . . . 0.80000000000000004 111.008 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.91 77.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.566 -0.709 . . . . 0.79000000000000004 110.674 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -59.04 -52.88 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.571 -1.27 . . . . 0.73999999999999999 107.571 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.17 -42.02 98.87 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.246 -0.582 . . . . 1.8500000000000001 110.192 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -52.66 -41.49 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.999 0.428 . . . . 2.23 109.863 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -53.83 53.93 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.972 -0.455 . . . . 2.4100000000000001 110.082 177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.7 mt -50.82 -48.4 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.278 0.631 . . . . 0.58999999999999997 109.982 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -60.06 -54.23 48.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.375 -0.375 . . . . 2.3199999999999998 110.823 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -26.03 68.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.411 0.522 . . . . 3.5 112.411 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -9.46 50.07 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.265 0.939 . . . . 2.3100000000000001 112.717 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.92 42.55 5.97 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.835 -0.906 . . . . 0.59999999999999998 110.835 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.9 175.28 8.99 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.121 0.968 . . . . 2.2400000000000002 108.934 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.06 141.28 40.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.093 -0.706 . . . . 2.3100000000000001 109.093 -176.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.9 140.43 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.837 1.255 . . . . 0.54000000000000004 109.388 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.61 56.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.928 -1.138 . . . . 0.83999999999999997 107.928 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -119.73 134.6 55.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.66 1.184 . . . . 0.92000000000000004 108.571 -169.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -126.63 138.15 53.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.423 1.489 . . . . 3.4199999999999999 110.171 -164.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.12 70.58 3.88 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.62 1.968 . . . . 3.3599999999999999 110.97 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.9 148.56 26.88 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.109 -0.472 . . . . 0.56999999999999995 110.007 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.14 139.86 37.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.811 0.815 . . . . 3.2799999999999998 110.316 173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -128.78 150.53 50.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.852 1.661 . . . . 1.8200000000000001 107.631 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -105.61 152.24 23.34 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.711 2.004 . . . . 1.5800000000000001 107.438 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.0 mt -122.52 128.36 75.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 107.546 -1.279 . . . . 0.73999999999999999 107.546 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -118.48 14.97 13.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.152 0.887 . . . . 2.29 109.213 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.73 -38.95 1.5 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.968 1.271 . . . . 1.8100000000000001 113.843 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -51.35 145.12 8.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.344 1.572 . . . . 3.5699999999999998 112.738 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -121.88 28.09 7.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.768 0.827 . . . . 4.1399999999999997 109.911 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.8 t 63.96 64.29 0.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 122.623 1.201 . . . . 6.1900000000000004 110.88 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.73 -75.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.202 -1.407 . . . . 3.52 107.202 172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.36 22.74 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 111.852 0.316 . . . . 1.3 111.852 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.61 -46.32 66.55 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.582 -1.324 . . . . 0.93000000000000005 109.153 -171.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' CG1' ' A' ' 92' ' ' ILE . . . -56.42 -34.57 66.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.839 -0.619 . . . . 1.01 109.946 172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.36 -42.13 98.86 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.197 -0.939 . . . . 2.98 110.558 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -49.98 57.23 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.284 1.034 . . . . 4.4400000000000004 110.327 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 89' ' ' ALA . 2.4 pp -62.92 -37.33 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 119.0 -0.524 . . . . 2.02 110.926 175.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.5 -60.86 2.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.451 1.1 . . . . 2.1400000000000001 109.166 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -27.12 41.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 119.033 -0.508 . . . . 4.0700000000000003 111.366 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -72.68 -71.23 0.3 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.954 -0.698 . . . . 2.7599999999999998 110.666 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.4 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -41.23 -51.91 3.46 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.86 1.264 . . . . 1.8899999999999999 111.264 -177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -36.07 -40.48 0.21 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.918 2.487 . . . . 1.8100000000000001 112.518 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 78.55 1.18 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.852 0.751 . . . . 5.8600000000000003 111.275 166.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.42 -74.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.279 -1.008 . . . . 1.49 108.279 166.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -138.8 -98.22 0.17 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.927 -1.138 . . . . 2.5099999999999998 107.927 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.03 53.04 4.71 Favored Glycine 0 C--N 1.336 0.583 0 O-C-N 121.43 -0.794 . . . . 0.79000000000000004 111.344 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 96' ' ' LEU . 38.2 t -116.46 120.17 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.496 -1.298 . . . . 0.71999999999999997 107.496 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.25 -48.06 25.14 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.367 -0.605 . . . . 0.82999999999999996 109.367 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -153.35 167.14 30.4 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.168 -0.679 . . . . 1.1399999999999999 109.168 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.63 75.88 2.03 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.738 0.644 . . . . 0.59999999999999998 112.738 169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.55 143.4 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.0 1.8 . . . . 0.78000000000000003 111.162 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.34 140.61 18.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 C-N-CA 125.016 1.326 . . . . 1.9299999999999999 110.671 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.88 -36.28 28.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.822 0.449 . . . . 2.6699999999999999 110.665 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 65.56 -59.62 0.28 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.471 1.908 . . . . 3.2799999999999998 113.003 -169.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.63 79.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.945 0.898 . . . . 1.8500000000000001 110.022 -163.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' A' ' 113' ' ' THR . 9.2 mt -95.46 2.92 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.026 -0.988 . . . . 2.0600000000000001 110.467 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 56.36 61.12 2.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.013 1.325 . . . . 3.02 111.266 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.498 HG23 ' HB2' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -142.93 162.42 35.51 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.553 -0.717 . . . . 1.04 110.45 -176.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.18 127.46 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 126.027 1.731 . . . . 0.55000000000000004 108.105 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.1 m -82.1 141.65 32.94 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.508 -2.034 . . . . 0.75 105.508 164.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -124.08 117.76 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.432 -1.692 . . . . 0.63 106.432 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -104.81 94.32 5.21 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.823 -2.288 . . . . 3.27 104.823 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.56 169.03 21.22 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 111.832 0.308 . . . . 1.8899999999999999 111.832 -168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.32 96.87 9.02 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.053 0.941 . . . . 2.6099999999999999 109.163 -168.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 30.74 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.192 2.595 . . . . 0.80000000000000004 112.508 -167.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -110.59 -45.46 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.694 1.598 . . . . 5.3899999999999997 108.689 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -65.35 -57.66 7.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.35 0.66 . . . . 3.8500000000000001 109.238 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.38 -173.74 2.43 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.972 0.909 . . . . 0.71999999999999997 110.335 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 96.1 p -161.0 170.6 20.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 109.257 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 125' ' ' VAL . 12.0 t -42.47 -36.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.661 1.185 . . . . 1.54 112.684 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.6 m -56.25 -43.61 78.88 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.936 -0.478 . . . . 1.02 111.576 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -61.22 -51.63 68.17 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.039 -0.726 . . . . 2.25 109.039 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.62 -46.11 77.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.497 0.719 . . . . 0.89000000000000001 109.877 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 117.835 -1.079 . . . . 3.73 110.303 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.48 -46.5 85.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.991 0.807 . . . . 3.0499999999999998 110.065 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.38 59.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.36 0.664 . . . . 0.60999999999999999 109.528 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 139' ' ' LEU . 98.9 t -68.14 -33.02 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.828 -0.545 . . . . 1.4099999999999999 110.604 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -54.26 -53.12 58.0 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 3.1000000000000001 109.203 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -55.84 -43.33 76.92 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.295 0.85 . . . . 2.46 113.295 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.97 -21.57 66.2 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.395 0.998 . . . . 0.81999999999999995 111.607 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.84 43.95 5.58 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.124 -0.791 . . . . 0.58999999999999997 111.124 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -137.59 174.08 10.98 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 107.872 -1.159 . . . . 2.0299999999999998 107.872 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -120.27 122.91 41.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.32 -1.733 . . . . 3.3599999999999999 106.32 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -105.07 134.27 48.45 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.839 -1.541 . . . . 1.74 106.839 -172.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -118.88 162.38 18.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.904 1.681 . . . . 2.2599999999999998 107.654 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.97 141.04 34.42 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.873 -0.788 . . . . 1.6399999999999999 108.873 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -116.24 94.47 4.66 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.384 -0.969 . . . . 3.6499999999999999 108.384 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.74 -62.24 3.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.836 -0.906 . . . . 3.6099999999999999 110.836 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 51.76 37.78 21.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.937 1.295 . . . . 4.5 111.512 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -176.21 -38.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.219 0.607 . . . . 8.6400000000000006 111.297 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.1 t0 50.79 92.24 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.156 2.182 . . . . 12.52 112.322 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.83 28.36 18.12 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.578 -0.737 . . . . 9.6199999999999992 110.595 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.3 mt 53.92 57.25 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.608 1.163 . . . . 9.0600000000000005 109.487 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -67.69 155.29 39.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.504 -0.747 . . . . 14.99 109.705 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.43 103.05 0.18 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 106.936 -2.466 . . . . 15.449999999999999 106.936 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.853 2.461 . . . . 19.23 105.793 -175.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.267 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 117.477 -1.249 . . . . 14.58 110.389 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mt -77.5 53.95 1.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 121.391 1.905 . . . . 8.8800000000000008 110.96 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t 48.26 34.27 4.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.022 1.329 . . . . 4.5700000000000003 112.473 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -82.59 48.69 1.34 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.173 0.589 . . . . 5.5700000000000003 109.61 -173.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -73.54 138.96 45.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.386 -0.821 . . . . 2.1499999999999999 109.181 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -103.48 177.34 4.87 Favored 'General case' 0 N--CA 1.458 -0.04 0 N-CA-C 108.857 -0.794 . . . . 1.95 108.857 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.67 120.41 30.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.332 1.853 . . . . 2.7400000000000002 106.144 166.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.81 122.31 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.167 -1.79 . . . . 2.6499999999999999 106.167 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.47 120.69 42.98 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.697 -1.224 . . . . 0.58999999999999997 107.697 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.2 175.2 9.83 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.461 1.104 . . . . 1.79 109.606 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.77 120.25 36.82 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.88 1.272 . . . . 3.3199999999999998 109.351 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.19 142.22 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.418 1.087 . . . . 0.69999999999999996 109.769 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -87.46 177.88 6.97 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 123.296 0.638 . . . . 1.1799999999999999 111.662 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.45 21.85 78.64 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.0 mtp -73.38 83.0 1.43 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.283 0.475 . . . . 2.54 112.283 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -61.0 -20.28 62.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.385 0.674 . . . . 1.3100000000000001 112.649 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t 87.49 142.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.624 1.97 . . . . 3.1800000000000002 111.702 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 45.79 38.17 4.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.359 1.864 . . . . 3.3799999999999999 113.817 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.71 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.428 -0.953 . . . . 1.76 108.428 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 m -62.56 -55.97 22.28 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.18 0.992 . . . . 0.90000000000000002 108.593 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.76 -64.06 0.63 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.749 -1.114 . . . . 0.72999999999999998 109.978 166.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.25 64.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.346 0.258 . . . . 0.93000000000000005 111.186 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -62.49 -47.49 83.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.026 0.53 . . . . 2.3599999999999999 110.69 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.71 -57.48 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.155 -1.054 . . . . 0.58999999999999997 108.155 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -55.4 -43.63 75.42 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 119.037 0.835 . . . . 3.6499999999999999 110.685 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.11 -51.64 68.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.491 0.587 . . . . 2.02 110.65 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.75 -42.47 91.49 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.423 -0.671 . . . . 0.66000000000000003 111.423 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.75 -41.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.617 0.767 . . . . 1.6000000000000001 109.979 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -21.14 14.43 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.071 0.851 . . . . 2.1899999999999999 112.327 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -59.61 -28.81 67.51 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.645 -0.659 . . . . 4.9800000000000004 111.916 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -78.38 148.51 74.09 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 123.603 0.761 . . . . 1.52 110.556 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.75 -44.37 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.718 2.279 . . . . 1.1799999999999999 112.019 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.31 -16.55 79.79 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.524 -1.153 . . . . 0.53000000000000003 111.852 -173.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.57 105.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 118.468 1.134 . . . . 1.3600000000000001 108.955 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.2 m -82.66 -46.43 13.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.212 -1.033 . . . . 0.73999999999999999 108.212 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -151.0 123.13 8.24 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.755 -0.461 . . . . 1.71 109.755 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.82 113.09 25.41 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.409 1.084 . . . . 0.69999999999999996 108.676 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -130.03 171.27 12.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.958 1.303 . . . . 3.25 111.142 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 p -150.33 116.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.682 0.753 . . . . 0.84999999999999998 110.957 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -84.56 78.24 9.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.859 -1.163 . . . . 1.96 107.859 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 pp -52.14 -30.6 27.38 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.744 0.818 . . . . 2.0499999999999998 111.561 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.313 1.045 . . . . 1.49 111.956 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 p -117.12 8.68 13.36 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.154 0.982 . . . . 1.48 111.168 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 46.71 64.43 1.53 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 110.436 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -135.76 106.01 6.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.938 -0.476 . . . . 0.87 109.88 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.87 124.48 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.417 -1.697 . . . . 0.46999999999999997 106.417 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -126.63 105.67 8.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.617 1.167 . . . . 3.4100000000000001 108.595 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.17 126.86 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.694 0.798 . . . . 0.41999999999999998 109.097 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.6 mt -112.35 120.54 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 127.283 2.233 . . . . 1.0700000000000001 107.343 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -157.97 169.93 23.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.174 0.19 . . . . 1.97 111.249 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -88.33 126.46 60.41 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 123.962 0.789 . . . . 2.0099999999999998 109.079 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.41 42.18 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.83 3.02 . . . . 0.80000000000000004 112.114 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.14 -47.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.213 1.405 . . . . 2.2400000000000002 108.834 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -75.14 -14.47 60.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.228 1.411 . . . . 3.3999999999999999 111.445 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.3 m -145.47 -81.67 0.15 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 121.07 -1.019 . . . . 0.85999999999999999 108.531 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 135.14 7.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.064 -0.814 . . . . 0.87 111.064 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -34.88 -49.52 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.545 1.938 . . . . 0.87 113.307 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.54 84.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.78000000000000003 109.837 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.55 73.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.669 -0.644 . . . . 0.78000000000000003 111.084 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.87 -57.92 9.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.478 -1.304 . . . . 0.80000000000000004 107.478 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -39.12 92.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.943 -0.571 . . . . 2.8599999999999999 110.086 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.94 -45.52 71.3 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.702 -0.851 . . . . 3.0499999999999998 108.702 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.58 -39.33 73.93 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 121.131 -0.98 . . . . 2.9500000000000002 110.054 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.91 -49.97 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.052 -0.721 . . . . 0.56999999999999995 109.052 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -62.82 -47.92 81.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 119.9 -0.72 . . . . 1.6699999999999999 111.449 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -63.77 -24.5 67.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.182 0.808 . . . . 3.02 113.182 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -5.96 39.36 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.296 0.953 . . . . 2.5899999999999999 112.011 171.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.11 44.02 4.53 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.67 -0.972 . . . . 0.66000000000000003 110.67 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -132.98 178.34 6.96 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 124.468 1.107 . . . . 2.0699999999999998 109.893 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 129.01 22.47 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.404 -1.332 . . . . 2.4900000000000002 107.404 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 m -84.86 136.42 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.98 -0.748 . . . . 0.54000000000000004 108.98 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.92 65.5 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.5 m -124.18 134.35 53.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.994 1.318 . . . . 0.76000000000000001 107.698 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -120.88 141.3 50.73 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.31 -0.626 . . . . 3.71 109.31 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -83.31 103.7 12.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.51 -1.663 . . . . 3.54 106.51 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.61 123.4 43.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.485 -0.561 . . . . 0.92000000000000004 109.485 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -83.68 96.8 8.8 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 4.9199999999999999 110.186 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -88.43 156.38 19.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.327 1.051 . . . . 2.1299999999999999 110.081 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -114.66 150.92 34.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.363 2.265 . . . . 1.6200000000000001 107.802 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 mt -128.35 134.74 64.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 119.27 0.941 . . . . 0.72999999999999998 108.482 -172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -135.31 49.35 2.19 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 122.689 1.233 . . . . 2.5600000000000001 108.531 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.86 -50.96 0.05 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.621 -1.172 . . . . 1.47 113.358 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -58.01 168.78 0.9 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.124 0.962 . . . . 2.9700000000000002 112.047 174.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.2 p -149.04 -50.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.686 -1.143 . . . . 3.5899999999999999 110.184 -173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.1 t -178.4 -48.88 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.833 -1.173 . . . . 5.1600000000000001 107.833 -166.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 165.21 1.56 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.433 -0.803 . . . . 3.5699999999999998 110.53 166.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.89 38.28 0.07 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.091 1.756 . . . . 1.49 113.742 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.2 m -71.75 -48.41 47.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.587 -1.321 . . . . 0.77000000000000002 108.791 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -58.07 -36.16 72.43 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.782 0.833 . . . . 0.65000000000000002 110.408 173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -69.71 -43.37 72.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.259 -0.901 . . . . 1.9199999999999999 109.288 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -56.38 -53.32 58.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.317 -0.864 . . . . 4.5300000000000002 111.083 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pt -60.58 -38.27 77.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 118.203 -0.904 . . . . 1.76 111.057 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.27 -62.14 1.98 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.734 1.152 . . . . 2.4500000000000002 108.558 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -63.07 -20.88 65.76 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.706 -0.679 . . . . 3.02 111.502 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -74.01 0.2 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.3 0.5 . . . . 5.0999999999999996 111.882 161.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.8 mt -46.28 -45.73 17.5 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.646 1.178 . . . . 1.6000000000000001 111.422 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -36.16 -43.04 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.801 2.041 . . . . 1.5 112.088 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.76 84.88 1.62 Allowed 'General case' 0 CA--C 1.533 0.324 0 O-C-N 122.24 -0.288 . . . . 4.3099999999999996 110.535 165.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.66 -114.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 104.645 -2.354 . . . . 2.2599999999999998 104.645 153.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.29 -100.29 0.24 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.961 -1.126 . . . . 4.5999999999999996 107.961 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.65 56.59 5.03 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.394 -0.816 . . . . 0.65000000000000002 112.087 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.92 125.71 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.105 1.362 . . . . 0.63 108.92 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.63 -56.94 5.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.684 -0.858 . . . . 0.73999999999999999 108.684 170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -153.98 169.67 22.92 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.164 1.386 . . . . 0.71999999999999997 109.293 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.57 64.65 2.81 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.575 0.584 . . . . 0.46000000000000002 112.575 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.96 128.35 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.071 1.847 . . . . 0.53000000000000003 111.342 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.13 140.87 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 125.621 1.568 . . . . 2.5099999999999998 108.808 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -96.04 159.35 15.01 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 108.703 -0.851 . . . . 1.9099999999999999 108.703 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.87 5.35 11.44 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.2 0.6 . . . . 2.4500000000000002 112.472 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.65 -45.32 3.37 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.709 1.204 . . . . 1.29 109.381 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.8 mt -83.33 -20.96 33.39 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.628 0.771 . . . . 1.3400000000000001 112.044 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 59.39 49.43 8.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.537 1.135 . . . . 2.9199999999999999 110.387 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 77.8 p -130.79 160.45 34.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.342 1.057 . . . . 0.69999999999999996 110.743 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.18 125.07 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.503 1.121 . . . . 0.48999999999999999 109.185 166.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -87.17 104.45 16.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.572 -1.64 . . . . 1.25 106.572 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.11 114.41 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 N-CA-C 108.846 -0.798 . . . . 0.77000000000000002 108.846 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.54 100.8 12.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.072 -1.084 . . . . 3.04 108.072 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -146.77 171.3 15.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.817 0.341 . . . . 1.76 111.593 -174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.94 104.27 18.04 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.493 1.117 . . . . 2.52 109.743 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.75 13.99 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.544 2.162 . . . . 0.68999999999999995 113.186 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.75 -38.69 11.15 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.082 0.953 . . . . 7.6100000000000003 108.857 168.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -86.88 -45.01 11.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.385 -0.968 . . . . 4.5899999999999999 108.385 -169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.67 -172.43 2.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.986 0.914 . . . . 0.57999999999999996 109.685 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 99.2 p -160.2 174.73 13.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.463 0.705 . . . . 1.98 110.426 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -44.28 -43.69 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.265 1.026 . . . . 1.5 110.968 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.9 m -60.53 -42.75 97.14 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.3 0.24 . . . . 0.58999999999999997 111.297 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.84 -47.41 80.89 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 121.353 0.597 . . . . 2.21 109.82 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.25 -47.71 84.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.41 0.624 . . . . 0.85999999999999999 110.207 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -47.13 -66.49 0.4 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.105 -0.952 . . . . 3.5699999999999998 109.136 165.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -50.96 -39.35 54.97 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 123.51 0.506 . . . . 4.4299999999999997 111.877 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.17 -56.28 22.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.5 0.72 . . . . 0.58999999999999997 110.157 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.54 -33.03 48.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 O-C-N 121.194 -0.941 . . . . 1.7 111.522 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -57.46 -42.21 82.12 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.875 -1.157 . . . . 3.7799999999999998 107.875 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.22 -49.92 75.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.773 0.829 . . . . 2.4100000000000001 112.014 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.25 -32.99 57.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.431 0.56 . . . . 0.93000000000000005 110.751 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.99 42.95 2.71 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 109.958 -1.257 . . . . 0.69999999999999996 109.958 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -129.0 -171.88 2.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.372 -1.714 . . . . 2.0099999999999998 106.372 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -132.17 126.87 34.65 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.863 -1.162 . . . . 3.1099999999999999 107.863 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.59 146.87 27.51 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.551 1.54 . . . . 2.6699999999999999 108.149 -171.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -137.69 175.67 9.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.05 1.74 . . . . 2.77 107.379 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -129.7 145.04 51.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.526 0.731 . . . . 2.3700000000000001 110.15 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -79.63 86.34 5.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.547 0.689 . . . . 3.0600000000000001 109.196 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.13 -50.0 4.22 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.68 -0.511 . . . . 1.98 111.905 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 61.61 28.4 17.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.011 0.925 . . . . 5.1600000000000001 110.946 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.09 -47.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.662 -0.649 . . . . 6.5700000000000003 110.51 -170.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t0 59.55 33.33 22.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.325 1.45 . . . . 8.9900000000000002 111.498 -173.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -158.59 32.36 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.236 1.814 . . . . 7.5999999999999996 108.986 171.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt 66.11 -65.71 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.404 1.882 . . . . 10.93 111.478 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.76 -161.64 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.122 0.969 . . . . 15.109999999999999 108.89 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.67 -126.91 5.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.482 -1.447 . . . . 12.93 109.482 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.068 1.747 . . . . 15.550000000000001 106.718 -174.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 118.748 -0.644 . . . . 15.69 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 67.83 92.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.128 0.971 . . . . 12.609999999999999 109.593 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m 70.32 168.74 0.31 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.734 1.614 . . . . 5.5199999999999996 110.369 -167.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -76.3 49.73 0.6 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.398 0.679 . . . . 6.71 110.153 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -121.23 149.58 42.64 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.316 -2.105 . . . . 2.3500000000000001 105.316 167.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.0 147.03 34.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.847 -1.168 . . . . 2.4300000000000002 107.847 174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.1 pm0 -83.83 153.14 24.21 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.758 1.223 . . . . 3.0 108.868 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.4 tt -144.16 114.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.366 -1.346 . . . . 2.0699999999999998 107.366 161.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.29 131.39 39.96 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 107.82 -1.178 . . . . 0.68999999999999995 107.82 171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtm -146.6 167.09 24.6 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.379 0.99 . . . . 1.8899999999999999 110.268 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 19.4 tt0 -101.9 115.72 31.16 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.138 1.775 . . . . 2.04 108.249 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 64' ' ' ILE . 13.6 p -115.01 146.56 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.214 1.406 . . . . 0.76000000000000001 108.883 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 m -92.8 177.76 5.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.545 0.738 . . . . 0.93999999999999995 111.541 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.28 87.11 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.455 0.55 . . . . 1.05 111.876 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.83 74.5 0.86 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.639 0.733 . . . . 3.1600000000000001 110.286 172.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -51.82 -46.31 64.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.615 0.766 . . . . 1.54 110.344 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.31 -165.49 0.06 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.859 0.864 . . . . 3.3300000000000001 109.638 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.08 65.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.997 2.119 . . . . 3.8199999999999998 111.558 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.05 -52.57 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.278 1.431 . . . . 1.8899999999999999 107.869 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -59.25 -58.87 6.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.069 0.948 . . . . 0.82999999999999996 109.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -62.45 -45.37 93.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.585 -0.446 . . . . 1.55 110.882 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.46 -42.37 54.24 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.324 -0.235 . . . . 1.1399999999999999 110.965 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -48.89 79.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.351 0.66 . . . . 3.5600000000000001 110.656 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.55 -59.32 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.756 -0.831 . . . . 0.71999999999999997 108.756 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -56.68 -45.4 81.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.096 0.862 . . . . 4.3300000000000001 111.296 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -66.46 -18.92 65.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.198 0.999 . . . . 3.6499999999999999 112.27 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.27 8.97 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.757 1.17 . . . . 0.68999999999999995 110.6 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 28' ' ' LEU . 5.4 mt -65.07 -41.44 95.1 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -1.136 . . . . 2.7200000000000002 110.086 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -16.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.107 0.781 . . . . 1.8600000000000001 113.107 173.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 tpt85 -60.83 -28.61 68.95 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 4.25 111.919 172.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mmt -80.07 147.54 65.74 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.764 0.825 . . . . 1.77 110.423 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.55 -42.66 1.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.062 2.508 . . . . 1.3 111.978 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.16 -25.15 74.63 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 111.45 -0.66 . . . . 0.54000000000000004 111.45 -170.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.91 104.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.857 0.863 . . . . 1.27 109.637 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.1 m -89.85 -47.97 7.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.484 -0.932 . . . . 1.1100000000000001 108.484 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -149.34 113.41 5.17 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.348 -0.612 . . . . 2.8500000000000001 109.348 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.6 116.4 28.69 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.245 -1.02 . . . . 0.82999999999999996 108.245 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -135.55 165.59 25.18 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.72 1.208 . . . . 1.78 110.188 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.618 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.1 p -154.07 116.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.925 0.869 . . . . 0.96999999999999997 110.054 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.29 84.08 7.27 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.966 1.306 . . . . 3.27 107.618 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -23.09 67.14 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 1.78 111.304 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.92 77.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.741 0.417 . . . . 1.1299999999999999 110.416 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.9 p -115.81 13.18 16.06 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.617 0.767 . . . . 1.02 111.211 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 42.06 70.58 0.27 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.467 1.107 . . . . 1.77 111.486 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -141.08 113.84 8.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.886 -1.134 . . . . 0.77000000000000002 108.528 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.17 132.09 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 106.314 -1.736 . . . . 0.39000000000000001 106.314 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -132.77 114.21 13.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.524 -0.917 . . . . 4.04 108.524 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.81 135.38 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.55000000000000004 107.972 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 mt -120.64 120.65 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 106.465 -1.679 . . . . 1.48 106.465 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -155.43 170.77 21.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.908 0.385 . . . . 1.98 111.155 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -79.6 117.0 64.86 Favored Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 114.116 -1.402 . . . . 2.3700000000000001 109.44 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.65 36.53 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.966 2.444 . . . . 1.04 111.209 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.9 20.87 0.2 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.248 0.833 . . . . 1.22 113.248 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -131.77 -48.63 0.96 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.109 1.364 . . . . 1.9199999999999999 108.792 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.2 m -97.85 -80.07 0.46 Allowed 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.092 0.957 . . . . 0.85999999999999999 108.515 -163.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.82 119.56 3.81 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 108.171 -1.972 . . . . 0.87 108.171 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -31.36 -50.82 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.899 1.68 . . . . 1.01 113.394 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.2 88.84 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.712 0.405 . . . . 0.94999999999999996 111.508 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.27 -37.62 74.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.291 -0.88 . . . . 0.78000000000000003 110.932 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -55.43 -55.37 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.957 -1.497 . . . . 0.70999999999999996 106.957 175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.275 0.0 OUTLIER -63.04 -38.78 92.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 119.236 -0.412 . . . . 3.5600000000000001 110.86 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -55.91 -42.68 76.42 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.474 -0.565 . . . . 2.04 109.474 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -45.75 91.59 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.479 -0.563 . . . . 3.6499999999999999 109.479 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 69' ' ' TYR . 50.1 mt -61.91 -45.04 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.88 109.866 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.09 -44.51 84.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.738 -0.785 . . . . 3.1299999999999999 111.135 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -52.23 -41.57 62.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.932 1.293 . . . . 3.0099999999999998 111.552 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -16.18 54.15 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.836 -0.602 . . . . 2.2200000000000002 112.618 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.85 42.25 3.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.305 0.955 . . . . 0.68999999999999995 110.996 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 64' ' ' ILE . 83.3 m-85 -130.95 178.06 6.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.957 1.303 . . . . 1.9299999999999999 109.275 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -143.08 146.26 33.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.547 0.739 . . . . 2.0 109.031 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.16 140.88 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.544 1.537 . . . . 0.57999999999999996 109.8 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -84.11 60.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.464 -1.309 . . . . 0.88 107.464 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.4 m -120.43 136.81 54.62 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.625 1.17 . . . . 0.97999999999999998 108.904 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -130.19 144.37 51.32 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.791 0.836 . . . . 3.6899999999999999 109.418 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -97.57 91.8 5.61 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.914 1.286 . . . . 3.3999999999999999 109.708 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.52 155.85 18.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.799 -0.637 . . . . 0.68999999999999995 109.725 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -116.45 115.16 25.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.93 1.292 . . . . 3.6899999999999999 109.777 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -114.17 135.78 53.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.245 1.018 . . . . 2.27 108.671 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -84.83 142.07 30.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.91 1.684 . . . . 1.8600000000000001 108.208 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 114' ' ' VAL . 1.1 mt -118.53 131.14 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 119.438 1.017 . . . . 1.3100000000000001 109.778 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.0 111.25 21.35 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.489 -1.671 . . . . 2.6499999999999999 106.489 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.55 -54.78 0.23 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-O 119.508 -0.607 . . . . 1.6399999999999999 112.077 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.36 159.7 2.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.068 0.937 . . . . 3.3100000000000001 112.83 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -126.58 -54.56 1.44 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 113.965 -1.47 . . . . 4.1900000000000004 108.598 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 13.6 t 177.74 -41.94 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.563 1.145 . . . . 5.75 110.163 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -42.3 -77.28 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.395 1.478 . . . . 3.4199999999999999 113.391 -172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.11 27.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.81 0.844 . . . . 1.47 111.087 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.7 m -67.82 -49.66 61.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.131 -1.063 . . . . 0.90000000000000002 108.131 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.61 -36.94 67.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.487 0.661 . . . . 0.65000000000000002 110.18 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.39 -43.91 69.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.324 -0.86 . . . . 2.1800000000000002 110.341 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -55.01 39.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.751 -0.593 . . . . 5.8700000000000001 110.081 172.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.4 pp -62.49 -31.46 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 119.043 -0.503 . . . . 2.1499999999999999 111.261 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.7 -61.83 2.32 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.051 -1.092 . . . . 2.4900000000000002 108.051 173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.05 -26.17 25.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.153 0.427 . . . . 3.1299999999999999 112.153 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HG3' HD11 ' A' ' 135' ' ' LEU . 4.8 mmp_? -71.94 -70.58 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 121.165 -0.214 . . . . 3.0499999999999998 111.192 168.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.83 -37.51 19.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.403 1.081 . . . . 1.73 112.124 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -29.72 -43.01 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.745 2.818 . . . . 1.25 112.66 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.15 72.68 0.44 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.228 0.611 . . . . 3.8900000000000001 110.083 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mm -64.15 -68.29 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.46 -0.941 . . . . 1.3700000000000001 108.46 169.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -136.34 -107.1 0.2 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.679 -1.6 . . . . 3.6099999999999999 106.679 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.15 54.05 4.47 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 118.847 0.748 . . . . 0.80000000000000004 113.106 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.1 116.89 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.273 1.429 . . . . 0.60999999999999999 108.395 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.93 52.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.324 -0.621 . . . . 0.66000000000000003 109.324 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -151.52 167.46 27.97 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.781 0.833 . . . . 0.85999999999999999 109.208 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.74 62.41 1.92 Allowed Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 113.447 0.906 . . . . 0.46999999999999997 113.447 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.7 138.84 35.69 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.782 1.654 . . . . 0.64000000000000001 111.521 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.22 148.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 125.047 1.339 . . . . 1.72 110.908 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.93 127.24 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.039 1.336 . . . . 1.8200000000000001 109.881 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 -12.04 44.05 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.956 0.724 . . . . 2.48 112.956 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.77 -39.4 13.15 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 122.889 0.475 . . . . 1.1399999999999999 109.995 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.25 -14.21 19.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.034 0.934 . . . . 1.3100000000000001 111.675 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 52.78 47.69 24.12 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.276 1.03 . . . . 3.6099999999999999 110.563 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.7 p -116.34 161.24 19.33 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.492 0.717 . . . . 0.90000000000000002 109.962 173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.3 p -118.22 130.36 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 107.664 -1.236 . . . . 0.69999999999999996 107.664 156.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.4 m -83.1 121.37 26.96 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 104.607 -2.368 . . . . 0.70999999999999996 104.607 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.4 116.68 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.898 -1.519 . . . . 0.52000000000000002 106.898 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 92.79 4.2 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.214 -1.773 . . . . 2.6699999999999999 106.214 -175.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -147.23 171.81 14.81 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.775 0.321 . . . . 1.8600000000000001 111.846 -165.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 8.9 t-20 -98.65 101.36 11.63 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.669 1.188 . . . . 2.29 109.859 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 13.77 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.049 2.499 . . . . 0.85999999999999999 112.404 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -101.38 -37.95 8.24 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.848 0.859 . . . . 5.8099999999999996 109.58 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.15 -50.08 15.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.684 -0.858 . . . . 4.4100000000000001 108.684 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.06 -175.63 3.16 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.64 0.776 . . . . 0.84999999999999998 109.044 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.9 m -156.27 161.27 40.24 Favored 'General case' 0 CA--C 1.527 0.062 0 O-C-N 121.278 -0.888 . . . . 2.5699999999999998 108.701 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.2 t -48.61 -38.16 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.483 1.113 . . . . 1.97 112.6 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 m -50.77 -44.54 58.74 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.281 0.633 . . . . 0.91000000000000003 112.259 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -58.78 -50.42 74.01 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.938 0.875 . . . . 1.8300000000000001 109.588 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.16 -43.3 99.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.492 1.117 . . . . 1.27 109.8 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -59.33 -48.4 81.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.738 -0.648 . . . . 3.1299999999999999 110.629 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.43 -46.09 83.92 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.629 1.104 . . . . 2.9199999999999999 110.403 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.46 -55.83 29.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.091 0.557 . . . . 0.58999999999999997 109.622 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.39 -32.73 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.787 -0.571 . . . . 1.6899999999999999 110.384 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -48.51 73.43 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.156 -0.683 . . . . 2.5800000000000001 109.156 171.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -31.53 71.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.796 0.838 . . . . 2.8399999999999999 113.022 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 95' ' ' ARG . 3.8 mm? -69.36 -18.21 63.77 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.699 0.682 . . . . 0.81000000000000005 111.966 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.18 27.83 9.06 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.663 1.125 . . . . 0.76000000000000001 112.064 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.26 176.32 8.94 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.968 -1.123 . . . . 2.21 107.968 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 145.89 49.84 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.887 1.221 . . . . 3.7999999999999998 111.757 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.56 146.03 26.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.867 1.267 . . . . 1.5900000000000001 108.795 171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.09 163.49 27.53 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.436 2.694 . . . . 2.6099999999999999 106.412 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.2 137.97 45.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.305 -0.998 . . . . 1.6799999999999999 108.305 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.5 98.22 9.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.217 -0.927 . . . . 3.0299999999999998 109.519 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.8 -47.57 3.83 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.01 -1.236 . . . . 2.1699999999999999 110.01 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -47.63 -35.97 10.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.752 0.821 . . . . 5.2999999999999998 111.524 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -26.25 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.046 -1.034 . . . . 9.8399999999999999 113.696 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.73 -2.59 32.08 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.846 1.658 . . . . 7.9299999999999997 111.662 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.6 m -151.44 24.11 0.71 Allowed 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.126 -0.984 . . . . 8.5500000000000007 113.207 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.1 pt -33.38 -43.61 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.712 2.005 . . . . 11.19 115.124 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -154.82 165.36 36.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.702 -1.592 . . . . 15.67 106.702 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.15 -54.07 0.23 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.666 0.651 . . . . 14.390000000000001 112.9 -166.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.454 -2.212 . . . . 17.879999999999999 105.395 -179.369 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 118.685 -0.674 . . . . 14.77 109.693 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.6 -50.01 73.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.37 0.532 . . . . 12.49 111.867 -174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m 158.63 107.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.971 2.909 . . . . 5.04 106.902 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 22.04 72.89 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 127.378 2.271 . . . . 6.1399999999999997 113.013 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.33 157.51 19.43 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.605 -1.628 . . . . 2.8799999999999999 106.605 172.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.93 145.1 32.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.446 -0.575 . . . . 2.3900000000000001 109.446 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -86.38 151.81 23.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.131 1.772 . . . . 2.8399999999999999 109.744 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.41 132.12 19.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.426 -1.694 . . . . 3.1299999999999999 106.426 162.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.74 120.39 39.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.392 1.477 . . . . 0.59999999999999998 107.646 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 90.9 mtp -144.8 169.48 17.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 2.0099999999999998 110.14 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -98.25 136.88 37.8 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.78 0.718 . . . . 1.9199999999999999 111.808 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.97 148.13 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.11 1.764 . . . . 0.76000000000000001 108.373 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -106.29 172.78 6.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.254 1.021 . . . . 0.83999999999999997 110.612 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.91 75.41 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.445 -0.662 . . . . 1.03 111.445 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 70.8 2.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.051 1.34 . . . . 3.8799999999999999 109.819 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -61.06 -23.72 65.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.921 0.889 . . . . 1.24 111.952 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 t 65.9 41.06 3.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.172 1.463 . . . . 3.4100000000000001 109.428 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.82 90.51 1.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.983 -2.599 . . . . 4.3200000000000003 103.983 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.03 -23.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.385 1.624 . . . . 1.4299999999999999 115.385 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.6 m -57.23 -64.48 0.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 120.206 1.367 . . . . 0.73999999999999999 108.871 -167.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.616 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -60.09 -44.64 94.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.922 -1.036 . . . . 1.01 110.56 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.68 71.96 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.098 -0.376 . . . . 0.77000000000000002 110.852 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -43.23 99.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.389 0.676 . . . . 3.02 110.464 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG ' ' A' ' 69' ' ' TYR . 84.4 mt -58.8 -65.77 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.137 -1.06 . . . . 0.64000000000000001 108.137 174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -51.67 -43.39 62.68 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.371 0.987 . . . . 4.0300000000000002 111.153 -174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.84 -45.49 82.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.965 0.906 . . . . 2.25 111.898 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.61 -45.13 96.95 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.254 -1.138 . . . . 0.65000000000000002 110.254 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.24 -40.72 98.23 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.762 -0.846 . . . . 1.7 109.971 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -55.12 -21.25 12.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.785 0.721 . . . . 1.75 112.061 174.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -63.22 -29.39 70.73 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.661 -0.649 . . . . 2.96 111.595 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.53 122.56 87.48 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-O 118.543 -0.741 . . . . 1.54 109.852 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.18 77.81 1.56 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.042 2.495 . . . . 3.1400000000000001 107.97 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 -36.73 0.05 OUTLIER Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.155 1.836 . . . . 1.0600000000000001 109.424 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -56.22 117.15 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.155 0 CA-C-N 118.046 0.923 . . . . 1.45 111.275 171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -82.93 -53.37 5.9 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.699 -1.593 . . . . 1.02 106.699 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 41.4 t0 -150.66 165.04 34.62 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 171.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.38 113.14 5.71 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.8 -1.926 . . . . 0.73999999999999999 105.8 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.01 162.82 30.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.54 1.136 . . . . 2.02 108.539 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG11 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -152.08 106.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.875 0.845 . . . . 1.3300000000000001 109.288 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.2 74.24 7.02 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.548 -2.019 . . . . 2.1600000000000001 105.548 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 pp -53.93 -28.68 38.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.794 -1.093 . . . . 1.74 111.655 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.32 -35.97 52.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.877 0.871 . . . . 1.47 111.373 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.2 p -115.62 13.42 16.31 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.97 0.908 . . . . 1.26 111.347 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 47.83 41.84 15.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.342 1.457 . . . . 1.8799999999999999 112.509 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.2 m -112.21 108.04 17.13 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.754 -1.202 . . . . 0.72999999999999998 107.754 -172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 p -82.01 123.82 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.49 -1.3 . . . . 0.38 107.49 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.42 106.08 13.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.029 -1.471 . . . . 2.6600000000000001 107.029 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -108.04 138.57 33.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.222 -1.029 . . . . 0.56000000000000005 108.222 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.0 mt -122.46 117.3 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.956 -1.498 . . . . 1.0900000000000001 106.956 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 60' ' ' ILE . 38.3 p90 -153.44 170.69 20.09 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.168 0.508 . . . . 2.1000000000000001 111.909 -171.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.55 126.3 81.05 Favored Pre-proline 0 N--CA 1.442 -0.875 0 CA-C-N 114.302 -1.317 . . . . 2.7599999999999998 110.868 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.83 9.75 2.56 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.812 3.008 . . . . 1.26 113.509 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.4 -11.49 3.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.067 0.849 . . . . 1.46 112.593 -169.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -106.83 -37.97 6.22 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.952 0.901 . . . . 2.0499999999999998 111.588 177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 m -113.57 -79.23 0.58 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.852 -1.166 . . . . 0.82999999999999996 107.852 -164.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.59 126.87 5.7 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.905 -1.678 . . . . 0.63 108.905 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -42.76 -39.92 2.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.545 1.538 . . . . 0.95999999999999996 112.779 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.04 96.87 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.3 -0.875 . . . . 0.70999999999999996 111.217 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.94 74.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.057 -1.027 . . . . 0.56999999999999995 110.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG13 ' CE2' ' A' ' 50' ' ' TYR . 8.7 mm -57.02 -54.65 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.15 -1.055 . . . . 0.65000000000000002 108.15 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.27 -43.42 96.21 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.056 -0.657 . . . . 1.9099999999999999 110.228 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -50.97 -45.44 60.86 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 109.648 -0.501 . . . . 2.3999999999999999 109.648 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -48.93 68.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.536 -0.542 . . . . 3.3700000000000001 109.536 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.38 -48.87 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.598 -0.519 . . . . 0.57999999999999996 109.598 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -62.56 -51.78 66.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.601 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -55.8 -35.19 66.04 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.598 -0.689 . . . . 2.6800000000000002 112.556 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -12.41 54.27 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.365 0.53 . . . . 1.95 112.093 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.94 41.93 3.68 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.702 -0.959 . . . . 0.68999999999999995 110.702 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CG ' HD11 ' A' ' 24' ' ' ILE . 91.8 m-85 -133.71 177.8 7.43 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.568 1.147 . . . . 1.98 109.466 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.8 144.27 35.33 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.983 -0.747 . . . . 2.1499999999999999 108.983 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 m -96.41 140.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.866 1.266 . . . . 0.52000000000000002 109.455 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.73 65.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.681 -1.229 . . . . 0.76000000000000001 107.681 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 144.11 50.96 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.193 -0.317 . . . . 0.75 110.637 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -128.07 144.54 51.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.563 1.145 . . . . 3.54 109.444 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -86.7 90.02 8.13 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.577 1.151 . . . . 2.7200000000000002 109.394 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.78 159.01 21.52 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.999 -0.524 . . . . 0.78000000000000003 109.667 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.94 122.34 32.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.182 0.993 . . . . 2.79 112.053 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.34 145.77 42.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.481 0.713 . . . . 1.74 109.338 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.11 149.69 23.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.698 1.999 . . . . 2.04 107.356 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.89 118.92 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 119.968 1.258 . . . . 0.80000000000000004 111.272 -167.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.94 87.38 2.77 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 106.754 -1.572 . . . . 2.5800000000000001 106.754 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.88 -49.92 0.12 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.508 -0.853 . . . . 1.4099999999999999 112.146 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -60.35 120.27 9.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.96 0.88 . . . . 2.9100000000000001 110.07 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.1 p -135.8 38.42 2.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.851 1.26 . . . . 3.9700000000000002 108.749 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.4 t 70.42 46.65 0.56 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.891 0.876 . . . . 5.3200000000000003 111.27 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.76 46.64 2.6 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.404 1.081 . . . . 4.3499999999999996 108.52 169.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.33 27.34 4.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.265 1.426 . . . . 1.22 113.273 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.3 m -70.77 -45.54 64.56 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.079 -1.013 . . . . 0.88 108.758 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -54.76 -40.02 68.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.723 1.209 . . . . 0.64000000000000001 110.674 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -67.2 -37.66 84.0 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.06 -1.025 . . . . 1.8200000000000001 110.486 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.78 -54.23 38.53 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.527 0.731 . . . . 4.5300000000000002 111.032 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt -64.84 -32.44 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 119.15 -0.452 . . . . 1.9199999999999999 111.446 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.49 -61.53 2.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.722 1.209 . . . . 2.71 108.248 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -22.73 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.887 0.699 . . . . 3.52 112.887 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -72.23 0.27 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.075 0.852 . . . . 3.2400000000000002 110.48 166.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 114' ' ' VAL . 7.3 mt -50.14 -41.61 49.24 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.735 0.814 . . . . 1.6399999999999999 111.011 -169.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -30.74 -43.48 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.393 2.677 . . . . 1.48 112.959 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.73 82.29 0.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.229 0.468 . . . . 4.4699999999999998 111.415 165.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.07 -77.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 108.805 -0.813 . . . . 1.8100000000000001 108.805 166.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -131.01 -96.83 0.34 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.336 -1.357 . . . . 2.7999999999999998 107.336 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.42 50.28 4.38 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.426 -0.67 . . . . 0.67000000000000004 111.426 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.9 t -106.85 122.44 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.755 -1.202 . . . . 0.57999999999999996 107.755 177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.47 -54.98 7.76 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.51 -0.922 . . . . 0.68000000000000005 108.51 171.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -153.15 171.69 18.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.719 -0.474 . . . . 0.83999999999999997 109.719 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.77 72.44 2.43 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.914 0.709 . . . . 0.52000000000000002 112.914 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.29 140.69 37.59 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.862 1.708 . . . . 0.51000000000000001 110.814 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.542 HG22 HG23 ' A' ' 114' ' ' VAL . 4.0 t -122.06 145.51 28.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 124.657 1.183 . . . . 2.3700000000000001 109.28 -173.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -109.75 159.56 17.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.308 0.643 . . . . 2.1699999999999999 109.729 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.59 15.37 10.29 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.474 1.109 . . . . 2.5499999999999998 111.569 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.04 -47.41 1.5 Allowed 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.597 1.159 . . . . 1.1399999999999999 109.016 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -77.1 -24.1 51.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.684 -0.689 . . . . 1.3999999999999999 110.599 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 69.75 45.58 0.76 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.844 1.658 . . . . 2.7799999999999998 110.324 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.6 p -128.93 158.75 37.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.981 1.312 . . . . 0.95999999999999996 111.429 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.542 HG23 HG22 ' A' ' 107' ' ' VAL . 4.1 p -125.02 123.59 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.105 1.362 . . . . 0.56999999999999995 108.971 164.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.8 m -85.0 138.3 32.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.456 -2.053 . . . . 0.76000000000000001 105.456 164.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.37 120.52 39.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.67 0.788 . . . . 0.93999999999999995 109.338 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -100.56 96.71 7.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.248 -1.39 . . . . 2.8300000000000001 107.248 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -145.69 154.09 41.71 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.502 0.321 . . . . 2.0099999999999998 110.608 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.15 114.53 38.47 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 107.342 -1.355 . . . . 2.3199999999999998 107.342 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -80.05 40.15 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.898 1.732 . . . . 0.84999999999999998 110.695 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -127.09 -60.43 1.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.099 1.359 . . . . 4.9699999999999998 108.364 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -58.62 -38.61 78.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.765 0.826 . . . . 3.21 111.044 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.58 172.75 12.55 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.433 0.693 . . . . 0.69999999999999996 109.314 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 55.0 m -146.67 168.06 22.25 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.843 1.257 . . . . 1.8700000000000001 109.525 -174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -25.31 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 121.284 -0.885 . . . . 1.6399999999999999 112.086 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.4 m -61.44 -42.31 98.56 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.002 -1.686 . . . . 0.68000000000000005 112.125 171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -61.94 -49.75 74.89 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 108.97 -0.752 . . . . 2.25 108.97 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.12 -49.43 77.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.385 -0.825 . . . . 0.73999999999999999 109.959 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -53.79 -54.94 31.27 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 117.672 -1.156 . . . . 3.6699999999999999 109.493 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.39 -45.04 69.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.903 1.229 . . . . 3.2200000000000002 111.207 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.89 41.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.857 -0.527 . . . . 0.73999999999999999 110.823 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.46 -35.3 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.614 -0.679 . . . . 1.7 110.846 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -58.11 -53.61 56.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.422 1.089 . . . . 3.6299999999999999 108.907 173.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -59.53 -38.17 80.3 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.686 0.794 . . . . 3.0699999999999998 111.578 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.77 -19.06 65.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.507 0.723 . . . . 1.0800000000000001 112.336 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 31.48 5.51 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.378 0.989 . . . . 0.84999999999999998 112.729 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.62 178.11 7.36 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.518 -1.289 . . . . 2.1099999999999999 107.518 176.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.15 152.28 48.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.813 1.188 . . . . 5.9299999999999997 109.315 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.69 151.44 22.02 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.86 0.725 . . . . 1.49 111.789 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -118.32 159.85 22.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 129.247 3.019 . . . . 2.5 106.155 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.31 130.88 47.55 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.172 -1.047 . . . . 1.75 108.172 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -81.78 67.04 7.6 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.454 1.024 . . . . 3.25 108.669 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.59 -64.55 2.18 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.707 -0.957 . . . . 2.5800000000000001 110.707 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 56.18 30.93 17.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.617 1.167 . . . . 5.5099999999999998 111.087 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -163.34 -58.13 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.535 1.534 . . . . 6.2999999999999998 108.593 -169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 52.3 t0 59.31 86.27 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.165 1.786 . . . . 9.5500000000000007 111.587 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 t 67.85 21.22 9.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.564 1.146 . . . . 7.6500000000000004 112.628 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.8 100.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 125.21 1.404 . . . . 9.0999999999999996 107.347 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -142.02 109.76 5.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.359 -1.349 . . . . 13.48 107.359 173.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.92 -97.3 0.23 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 123.37 0.509 . . . . 13.859999999999999 112.092 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 CA-C-O 115.951 -1.976 . . . . 16.510000000000002 106.145 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 ttm . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 106.056 -1.831 . . . . 15.449999999999999 106.056 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.8 125.12 0.96 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.009 -1.478 . . . . 11.15 107.009 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t 59.99 -175.91 0.1 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.466 1.106 . . . . 5.0800000000000001 111.802 -174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -84.74 30.84 0.55 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.756 1.222 . . . . 3.8999999999999999 111.509 -169.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -73.44 -176.1 2.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 122.089 0.947 . . . . 3.3199999999999998 112.477 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.8 ptmt -142.67 159.78 41.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.53 1.132 . . . . 2.8700000000000001 108.07 174.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.31 100.92 6.92 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.345 1.858 . . . . 3.0800000000000001 106.248 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.77 111.2 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.95 -1.5 . . . . 3.0299999999999998 106.95 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.25 113.33 25.16 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.331 1.052 . . . . 0.78000000000000003 109.304 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -137.41 177.31 7.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.054 1.342 . . . . 2.73 110.468 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -102.25 139.36 37.97 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.12 0.568 . . . . 2.6600000000000001 110.563 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.72 137.18 58.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.223 1.409 . . . . 0.70999999999999996 109.08 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -99.77 176.27 5.51 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.225 0.536 . . . . 0.77000000000000002 110.969 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.75 83.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.028 -0.829 . . . . 0.85999999999999999 111.028 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.17 81.69 1.3 Allowed 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.349 -0.501 . . . . 3.1600000000000001 110.149 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -62.97 -29.89 71.16 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.062 -0.399 . . . . 2.1299999999999999 110.603 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.08 171.61 4.91 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.139 -0.689 . . . . 4.5800000000000001 109.139 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.17 8.36 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.098 0.959 . . . . 3.0099999999999998 112.361 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.97 85.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.859 -0.526 . . . . 1.1699999999999999 112.28 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.25 -59.09 5.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.505 -1.295 . . . . 0.84999999999999998 107.505 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -36.5 -64.38 0.34 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.361 -1.29 . . . . 0.71999999999999997 112.278 167.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.57 70.42 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.771 -0.581 . . . . 0.78000000000000003 111.497 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.18 -45.65 93.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 119.12 -0.467 . . . . 2.23 110.448 175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 94.9 mt -59.55 -59.8 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.157 -1.053 . . . . 0.68000000000000005 108.157 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.84 -38.65 76.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.749 0.704 . . . . 4.1200000000000001 111.359 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -66.78 -45.99 76.73 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.853 0.751 . . . . 1.8100000000000001 111.196 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.17 -36.72 83.6 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.468 -0.653 . . . . 0.75 111.468 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 63' ' ' LYS . 4.3 mm? -71.28 -44.19 65.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.942 0.897 . . . . 1.5800000000000001 109.99 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.27 33.38 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.982 0.913 . . . . 2.4300000000000002 111.822 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -51.74 -28.93 16.66 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.138 0.975 . . . . 3.4300000000000002 112.626 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.99 124.78 84.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.769 0.827 . . . . 1.7 110.928 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.95 82.53 0.79 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.688 2.259 . . . . 3.1400000000000001 107.279 174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.86 -40.11 0.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.361 -1.896 . . . . 0.94999999999999996 108.361 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 69.7 t -61.14 121.15 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.01 0.524 . . . . 1.45 111.311 172.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.8 m -97.84 -65.56 0.96 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.362 -0.977 . . . . 1.47 108.362 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -130.85 97.3 4.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.553 -0.906 . . . . 2.3100000000000001 108.553 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.85 115.87 30.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.35 1.46 . . . . 0.66000000000000003 107.827 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -134.18 155.57 49.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.342 0.657 . . . . 2.3799999999999999 109.256 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -153.48 124.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.731 -0.84 . . . . 1.0800000000000001 108.731 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -90.42 89.28 7.52 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.419 -1.697 . . . . 2.3500000000000001 106.419 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -29.34 48.82 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.954 0.407 . . . . 3.8700000000000001 111.106 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.07 69.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.297 1.039 . . . . 1.9199999999999999 111.281 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.7 p -117.25 18.9 14.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 1.3700000000000001 109.993 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 39.44 36.73 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 2.9199999999999999 113.477 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.7 m -102.57 106.09 16.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.574 -1.269 . . . . 1.47 107.574 -170.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 p -89.24 122.85 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.807 -1.182 . . . . 0.40000000000000002 107.807 175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -129.42 102.7 6.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.43 1.092 . . . . 3.2599999999999998 108.978 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.6 t -111.72 133.13 58.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.169 0.588 . . . . 0.73999999999999999 109.634 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 mt -116.37 121.14 66.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 125.21 1.404 . . . . 1.3100000000000001 108.123 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 35.3 p90 -158.71 169.19 24.95 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.383 0.673 . . . . 2.0 109.609 -169.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.28 131.04 43.7 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.144 0.424 . . . . 3.23 112.144 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.96 40.62 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.771 2.98 . . . . 1.1299999999999999 112.89 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.2 21.39 0.43 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.763 1.024 . . . . 1.1399999999999999 113.763 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -145.29 -41.43 0.23 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.874 0.869 . . . . 1.8700000000000001 111.198 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.3 m -110.04 -76.4 0.61 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.302 -1.37 . . . . 0.69999999999999996 107.302 -170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.33 131.1 6.74 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.018 -1.633 . . . . 0.67000000000000004 109.018 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.6 t -44.69 -42.23 7.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.595 1.158 . . . . 0.96999999999999997 112.685 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.008 0.523 . . . . 0.92000000000000004 110.106 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -36.37 75.68 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.54 -0.725 . . . . 0.73999999999999999 110.733 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 8.9 mm -54.62 -57.02 7.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 107.609 -1.256 . . . . 0.83999999999999997 107.609 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -63.22 -38.23 90.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.997 -0.547 . . . . 2.7000000000000002 110.37 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -56.99 -42.85 80.99 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.53 -0.545 . . . . 2.4500000000000002 109.53 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -67.54 -44.84 77.37 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.155 -1.054 . . . . 2.2400000000000002 108.155 -175.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.5 mt -52.25 -51.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.721 0.408 . . . . 0.58999999999999997 109.978 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -59.95 -51.24 70.51 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.355 -0.216 . . . . 1.6799999999999999 111.101 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -56.66 -35.59 68.57 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.653 0.781 . . . . 2.6899999999999999 112.611 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.53 -14.79 59.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.603 0.594 . . . . 1.8300000000000001 112.603 175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.83 40.75 3.74 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.069 0.842 . . . . 0.68000000000000005 111.093 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 84.3 m-85 -130.54 176.98 7.71 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.614 1.166 . . . . 2.02 108.769 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.92 155.22 48.23 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.709 -1.219 . . . . 1.75 107.709 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.0 m -105.34 144.54 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.243 1.417 . . . . 0.77000000000000002 109.455 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.37 56.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 136.75 46.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.021 -1.103 . . . . 1.22 108.021 -165.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -132.84 151.76 51.96 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 112.536 0.569 . . . . 4.4500000000000002 112.536 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -92.58 79.26 4.87 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 127.999 2.52 . . . . 4.54 108.775 -170.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.68 122.99 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.6 -0.889 . . . . 1.0600000000000001 108.6 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.44 109.93 17.11 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.043 -0.725 . . . . 2.8700000000000001 109.043 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -105.39 144.7 31.81 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.578 -0.897 . . . . 2.25 108.578 175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -96.78 154.87 17.04 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.084 1.754 . . . . 1.53 107.918 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mt -131.64 133.78 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 118.69 0.677 . . . . 0.81000000000000005 109.682 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -113.64 119.2 36.64 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.479 -1.304 . . . . 2.9900000000000002 107.479 160.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.17 -37.48 0.2 Allowed Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.573 -0.285 . . . . 1.53 112.598 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.42 ' CG ' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -67.56 74.74 0.17 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.915 1.686 . . . . 4.9699999999999998 109.499 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.6 t -58.4 -9.16 1.43 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.701 2.0 . . . . 3.9300000000000002 111.594 167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.4 t 92.0 64.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.336 0 C-N-CA 126.373 1.869 . . . . 6.0800000000000001 109.511 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.04 -82.5 0.23 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.249 -1.341 . . . . 3.4199999999999999 107.381 175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.55 25.82 0.23 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.477 0.311 . . . . 1.29 111.433 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 60.1 m -66.21 -45.09 81.94 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 108.685 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -56.68 -39.68 74.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 122.938 0.495 . . . . 0.68999999999999995 110.237 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -64.89 -50.44 66.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.418 0.628 . . . . 2.5499999999999998 109.543 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.95 -52.26 63.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.906 0.482 . . . . 3.77 110.644 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 pp -66.99 -35.88 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 118.607 -0.711 . . . . 1.8899999999999999 110.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -55.35 -52.8 62.31 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.946 1.248 . . . . 2.98 108.859 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -60.02 -29.98 68.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.95 -0.568 . . . . 3.6200000000000001 111.048 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -72.3 -70.16 0.36 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.296 0.498 . . . . 2.9199999999999999 110.814 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -42.85 -40.19 2.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.361 1.465 . . . . 1.6799999999999999 111.465 -177.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -29.45 -46.83 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.343 1.857 . . . . 1.29 113.401 171.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.45 67.16 0.4 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.005 0.922 . . . . 4.4800000000000004 109.727 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.68 -64.32 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 108.16 -1.052 . . . . 2.0699999999999998 108.16 168.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -142.07 -106.64 0.14 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.918 -1.141 . . . . 2.7400000000000002 107.918 171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.69 52.49 4.17 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.372 -0.691 . . . . 0.82999999999999996 111.372 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 96' ' ' LEU . 21.7 t -103.22 122.49 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 107.527 -1.286 . . . . 0.68999999999999995 107.527 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.96 -47.35 18.75 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.119 0.568 . . . . 0.84999999999999998 109.535 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -153.44 167.21 30.19 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.869 -0.419 . . . . 0.77000000000000002 109.869 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.14 65.69 2.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.728 0.64 . . . . 0.46999999999999997 112.728 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.0 137.38 48.39 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.645 1.563 . . . . 0.57999999999999996 110.392 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.441 HG11 ' HB1' ' A' ' 89' ' ' ALA . 48.6 t -113.15 146.42 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.721 1.608 . . . . 2.5499999999999998 108.727 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -108.86 133.55 52.74 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.449 1.1 . . . . 1.6000000000000001 109.785 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.1 -9.08 54.39 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.872 0.693 . . . . 2.2999999999999998 112.872 172.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.14 -23.18 15.82 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.577 0.751 . . . . 1.51 111.462 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 mt -119.8 -15.12 8.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.549 1.14 . . . . 1.51 111.496 -174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 56.44 47.26 19.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.145 1.378 . . . . 3.71 110.767 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.6 p -119.63 155.31 32.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.893 1.277 . . . . 0.95999999999999996 110.547 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.56 127.34 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 124.108 0.963 . . . . 0.66000000000000003 108.784 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.0 m -88.13 98.77 11.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.271 -1.752 . . . . 1.3400000000000001 106.271 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.42 108.48 19.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 108.404 -0.962 . . . . 0.78000000000000003 108.404 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -92.29 95.3 9.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.003 -1.11 . . . . 2.6499999999999999 108.003 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -142.4 158.46 43.68 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.006 0.366 . . . . 1.97 111.532 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.67 108.97 13.82 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 107.102 -1.444 . . . . 2.1699999999999999 107.102 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -79.13 27.57 0.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.532 2.155 . . . . 0.79000000000000004 111.475 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -113.12 -56.8 2.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.763 0.825 . . . . 5.2400000000000002 108.834 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -52.78 -50.47 63.5 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.202 1.801 . . . . 3.2599999999999998 109.839 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.46 -176.8 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.928 0.891 . . . . 0.93999999999999995 109.435 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.0 m -162.03 168.83 22.08 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.704 1.202 . . . . 1.79 109.023 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 t -37.37 -46.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.805 1.642 . . . . 1.78 112.058 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 m -52.13 -46.73 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.284 1.033 . . . . 0.77000000000000002 112.777 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -63.37 -48.93 75.86 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.615 0.722 . . . . 2.2799999999999998 109.687 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -58.19 -48.28 80.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.386 0.675 . . . . 0.77000000000000002 110.12 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -49.81 -61.24 2.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 118.132 -0.937 . . . . 3.9700000000000002 108.708 169.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 2.4 tm-20 -49.48 -46.51 48.2 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.545 0.528 . . . . 3.3100000000000001 110.44 -176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.39 45.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.201 0.6 . . . . 0.69999999999999996 111.077 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.03 -34.12 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.361 -0.837 . . . . 1.6000000000000001 110.925 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 96.7 m-20 -60.21 -46.38 89.95 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.239 1.016 . . . . 3.29 108.522 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 17.4 ttmt -64.89 -39.24 93.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.775 1.23 . . . . 2.2400000000000002 111.783 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -29.72 71.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.795 -0.566 . . . . 1.1299999999999999 111.485 169.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.24 41.83 2.33 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.364 0.983 . . . . 0.75 112.152 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -137.16 -170.04 2.63 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.105 -1.072 . . . . 2.2400000000000002 108.105 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -130.1 132.34 46.09 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.528 1.058 . . . . 3.8199999999999998 110.384 173.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.5 mt -87.46 151.88 22.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.815 -0.439 . . . . 1.6200000000000001 109.815 167.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -133.38 166.92 21.39 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.842 2.057 . . . . 2.7200000000000002 106.638 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.21 150.84 24.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.815 0.846 . . . . 1.77 109.233 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -113.42 118.14 33.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.116 -1.068 . . . . 2.6400000000000001 108.116 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.62 -44.06 3.03 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.901 -1.28 . . . . 3.0099999999999998 109.901 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -61.77 -28.81 69.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.818 -0.813 . . . . 4.9100000000000001 112.668 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -79.46 -13.59 59.47 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 112.4 0.519 . . . . 8.5299999999999994 112.4 174.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -86.95 48.23 1.62 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.358 0.981 . . . . 6.5899999999999999 108.769 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.3 m 45.33 43.24 8.16 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.874 2.07 . . . . 8.9700000000000006 114.135 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.7 mt -21.2 -69.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.71 2.004 . . . . 7.9699999999999998 113.486 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -127.96 32.9 4.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.881 1.673 . . . . 12.42 108.767 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 63.67 -79.6 0.04 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.161 0.886 . . . . 12.77 111.445 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.155 1.782 . . . . 17.329999999999998 111.87 -170.37 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 106.826 -1.546 . . . . 14.109999999999999 106.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -173.4 166.78 4.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.142 1.377 . . . . 9.9000000000000004 108.452 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t 68.65 156.01 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.424 1.89 . . . . 5.0899999999999999 112.078 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -102.4 72.65 1.28 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.766 1.226 . . . . 4.0999999999999996 109.795 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -67.35 137.98 56.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.415 -0.957 . . . . 2.9199999999999999 108.415 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 12.2 ptmt -108.88 146.61 33.45 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.586 0.754 . . . . 3.04 109.378 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -102.62 139.91 37.58 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.595 1.558 . . . . 2.8100000000000001 109.248 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 tt -137.16 125.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.263 -1.014 . . . . 2.02 108.263 164.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.09 132.07 52.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.886 -1.524 . . . . 0.76000000000000001 106.886 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 50.5 mtm -152.66 175.7 12.53 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.433 0.693 . . . . 1.79 109.37 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -105.41 138.06 42.22 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.886 0.874 . . . . 2.04 110.302 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.37 145.78 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.115 2.166 . . . . 0.54000000000000004 108.196 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 m -108.23 175.59 5.42 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.039 1.336 . . . . 0.77000000000000002 110.73 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.84 4.78 89.58 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.561 0.601 . . . . 0.72999999999999998 111.678 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 84.9 mtp -65.39 91.83 0.12 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.876 0.87 . . . . 2.4900000000000002 110.109 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -70.39 -30.66 67.61 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.456 -0.778 . . . . 1.46 110.089 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -177.16 170.31 2.2 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.473 0.709 . . . . 5.4900000000000002 110.455 -169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.96 -38.02 34.87 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.234 1.013 . . . . 3.52 112.068 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.4 81.4 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.275 0.489 . . . . 1.6599999999999999 111.414 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.53 -58.23 7.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.257 -1.386 . . . . 0.81000000000000005 107.257 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -47.81 -55.36 9.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.471 -1.24 . . . . 0.91000000000000003 110.732 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.96 80.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.835 0.854 . . . . 1.3600000000000001 111.514 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -60.8 -44.4 96.91 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.802 -0.561 . . . . 2.23 110.045 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -58.23 -62.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.839 -1.171 . . . . 0.67000000000000004 107.839 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.35 -37.26 74.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.011 0.823 . . . . 4.5 111.688 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -68.43 -42.96 78.13 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 118.787 0.721 . . . . 2.3300000000000001 110.932 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.01 94.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.165 -0.774 . . . . 0.65000000000000002 111.165 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -41.2 74.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.864 0.866 . . . . 1.6299999999999999 109.68 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -56.09 -20.97 19.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.123 0.874 . . . . 1.95 111.917 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.36 -33.87 68.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.4 0.68 . . . . 2.5299999999999998 112.058 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.5 mmt -67.35 125.84 91.68 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-O 118.818 -0.61 . . . . 1.6599999999999999 110.878 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.05 82.59 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 N-CA-C 106.434 -2.179 . . . . 3.3500000000000001 106.434 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.85 -38.45 0.15 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.3 t -58.09 118.19 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 117.55 0.675 . . . . 1.46 110.697 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.2 m -88.44 -54.7 4.05 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.66000000000000003 107.997 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -152.94 80.91 1.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.534 1.159 . . . . 2.7799999999999998 112.199 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.73 124.57 29.72 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.055 1.342 . . . . 0.68000000000000005 109.192 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -139.8 157.28 45.99 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.814 2.045 . . . . 1.8200000000000001 110.778 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -155.05 118.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 110.081 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.58 95.95 9.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.394 -1.336 . . . . 1.8600000000000001 107.394 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -29.07 69.62 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 120.717 0.294 . . . . 2.1000000000000001 110.704 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.0 75.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.685 0.794 . . . . 1.0 110.496 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.3 p -112.26 16.6 19.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.53 1.132 . . . . 1.1000000000000001 110.896 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 38.45 50.92 1.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.545 1.538 . . . . 2.0699999999999998 112.672 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.3 m -126.09 117.91 24.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.788 -1.19 . . . . 0.82999999999999996 107.788 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.48 129.13 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.748 1.219 . . . . 0.5 108.004 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -123.91 110.79 15.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.218 -1.401 . . . . 2.7999999999999998 107.218 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.31 128.09 68.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.703 -1.221 . . . . 0.46999999999999997 107.703 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.4 mt -119.32 119.45 60.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.751 -1.203 . . . . 1.01 107.751 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.432 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 56.1 p90 -156.5 174.57 15.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.203 0.445 . . . . 2.0600000000000001 112.203 -170.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -87.55 126.75 60.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.236 0.458 . . . . 2.0899999999999999 112.236 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.62 23.03 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.316 2.677 . . . . 1.27 114.449 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.82 18.91 1.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.567 1.076 . . . . 1.4099999999999999 112.93 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.17 -41.88 0.42 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.778 1.231 . . . . 2.1499999999999999 110.301 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -113.25 -83.78 0.59 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.72 -1.215 . . . . 0.81999999999999995 107.72 -163.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.98 125.39 5.49 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.15 -1.58 . . . . 0.64000000000000001 109.15 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.0 t -29.83 -49.29 0.1 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.749 2.019 . . . . 1.1000000000000001 113.111 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.27 95.38 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.888 -0.507 . . . . 0.76000000000000001 111.047 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.45 -37.46 80.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.66 -0.65 . . . . 0.65000000000000002 110.342 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 mm -54.86 -56.25 11.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.416 -0.957 . . . . 0.67000000000000004 108.416 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -62.03 -38.7 89.7 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.75 -0.463 . . . . 2.1600000000000001 109.75 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.64 -44.63 81.46 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.25 0.477 . . . . 2.6499999999999999 110.561 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -45.51 78.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.626 -0.671 . . . . 3.8300000000000001 109.372 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.32 -49.64 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.366 -0.605 . . . . 0.62 109.366 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -62.1 -48.38 80.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.337 -0.545 . . . . 2.4399999999999999 111.835 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -56.42 -35.12 67.44 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.671 0.788 . . . . 2.1899999999999999 112.564 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -14.23 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.905 0.706 . . . . 2.0899999999999999 112.905 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.74 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.429 -1.068 . . . . 0.87 110.429 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -136.34 178.94 6.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.068 1.347 . . . . 1.9099999999999999 108.97 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -138.24 159.06 43.02 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.322 -0.992 . . . . 1.96 108.322 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.56 140.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.41 1.484 . . . . 0.51000000000000001 109.194 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -82.95 53.26 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.126 -1.065 . . . . 0.80000000000000004 108.126 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -133.56 137.23 45.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.939 -0.763 . . . . 0.93000000000000005 108.939 -163.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -140.01 142.71 36.24 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.755 0.422 . . . . 3.5099999999999998 111.385 -168.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -84.97 81.04 9.08 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.834 1.654 . . . . 4.0700000000000003 110.097 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.37 154.97 23.75 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.536 -0.542 . . . . 0.66000000000000003 109.536 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 46.5 mt-10 -110.16 120.85 43.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.124 0.875 . . . . 3.0499999999999998 110.88 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -112.67 150.91 30.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.079 0.951 . . . . 2.0499999999999998 108.826 173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.58 148.37 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.069 2.148 . . . . 2.2200000000000002 106.902 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.98 132.27 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 120.291 1.405 . . . . 0.84999999999999998 110.332 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -116.84 94.34 4.55 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 108.959 -0.756 . . . . 2.3500000000000001 108.959 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.45 30.25 0.1 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.995 0.807 . . . . 2.1299999999999999 113.988 170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.408 ' HA ' ' HB2' ' A' ' 88' ' ' CYS . 33.7 mmt -92.03 -6.8 50.41 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.546 1.173 . . . . 6.3399999999999999 112.673 -176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -111.23 35.51 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 126.649 1.98 . . . . 4.9100000000000001 108.428 -156.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.38 -40.58 5.1 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.897 1.279 . . . . 6.7400000000000002 110.176 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.9 -69.7 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.974 0.91 . . . . 3.71 108.979 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.42 41.42 0.18 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.222 1.009 . . . . 1.4099999999999999 108.631 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' MET . 87.5 m -70.32 -35.46 73.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.445 -0.946 . . . . 1.1699999999999999 108.445 -171.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 92' ' ' ILE . . . -52.57 -51.8 58.08 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.552 1.541 . . . . 0.66000000000000003 110.397 170.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -60.44 -46.63 89.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.872 -0.418 . . . . 1.8899999999999999 109.872 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -57.87 -48.98 78.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 119.642 -0.823 . . . . 5.3399999999999999 111.497 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.609 HG22 ' HG ' ' A' ' 135' ' ' LEU . 25.1 pt -65.95 -31.04 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 118.499 -0.763 . . . . 2.0 111.387 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -56.06 -56.87 15.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.833 -1.173 . . . . 2.8500000000000001 107.833 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -54.56 -32.82 59.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.227 0.611 . . . . 3.8100000000000001 111.285 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -73.43 -68.64 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.644 0.259 . . . . 3.1299999999999999 111.137 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.15 -38.38 2.42 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.211 1.804 . . . . 1.24 111.346 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -29.36 -49.96 0.09 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 127.507 2.323 . . . . 1.52 112.263 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 50.35 0.36 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.345 0.869 . . . . 5.7300000000000004 113.345 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 mm -41.58 -67.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.738 0.815 . . . . 1.53 110.078 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -132.99 -110.57 0.23 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.123 -1.806 . . . . 3.6200000000000001 106.123 170.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.12 54.11 4.93 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 119.377 0.989 . . . . 0.68000000000000005 112.171 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 118' ' ' TYR . 6.4 t -106.78 118.86 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.644 1.177 . . . . 0.68000000000000005 107.97 175.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.05 -48.08 22.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.024 -0.732 . . . . 0.70999999999999996 109.024 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -148.06 164.87 32.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.246 -0.65 . . . . 0.69999999999999996 109.246 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.39 67.48 1.19 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.991 0.738 . . . . 0.51000000000000001 112.991 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.36 130.87 15.61 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.521 2.148 . . . . 0.58999999999999997 111.178 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.3 m -97.0 149.35 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.64 1.176 . . . . 1.6899999999999999 109.994 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -111.9 140.57 46.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.043 0.937 . . . . 1.75 109.483 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -5.84 42.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.584 0.754 . . . . 2.3999999999999999 112.741 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.52 -40.75 11.8 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.859 -0.422 . . . . 1.04 109.859 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 mt -101.67 -15.24 17.08 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.938 0.895 . . . . 1.22 111.692 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 59.37 44.23 15.49 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.486 1.114 . . . . 2.52 110.225 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.7 p -124.3 159.34 30.47 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.914 1.286 . . . . 0.64000000000000001 110.035 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.56 131.37 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 124.48 1.112 . . . . 0.42999999999999999 109.053 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -84.47 122.33 28.84 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.054 -1.832 . . . . 0.66000000000000003 106.054 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.74 116.78 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.414 -1.328 . . . . 0.54000000000000004 107.414 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.01 85.46 2.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.963 -1.866 . . . . 3.2000000000000002 105.963 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 102' ' ' VAL . 1.8 p90 -137.95 166.24 24.54 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 123.481 0.712 . . . . 1.8100000000000001 111.003 -170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -96.07 102.35 10.55 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 107.058 -1.46 . . . . 2.3799999999999999 107.058 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.33 16.19 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.865 2.376 . . . . 0.75 111.544 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -103.79 -31.2 9.93 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.823 0.849 . . . . 5.7300000000000004 110.764 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.86 -51.47 12.46 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.278 -1.008 . . . . 4.5199999999999996 108.278 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.95 179.75 5.68 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.08 0.952 . . . . 0.68000000000000005 109.341 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.2 m -147.8 174.97 11.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.663 1.185 . . . . 2.1800000000000002 108.736 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 m -49.69 -38.28 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 124.273 1.029 . . . . 2.46 113.1 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -53.94 -38.47 64.96 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.951 0.901 . . . . 0.85999999999999999 111.714 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.95 -47.93 70.15 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 109.019 -0.734 . . . . 2.2799999999999998 109.019 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.7 mt -56.36 -45.31 80.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.063 0.545 . . . . 1.0 109.625 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -56.26 -55.84 28.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.824 -0.626 . . . . 3.9500000000000002 109.452 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.35 -42.28 73.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.629 0.728 . . . . 3.0499999999999998 111.25 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.38 -52.51 61.37 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.19 0.996 . . . . 0.63 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 p -70.49 -31.61 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 121.672 -0.642 . . . . 1.79 110.556 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -47.53 84.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.077 -0.712 . . . . 2.4900000000000002 109.077 169.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -57.25 -39.77 76.26 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.869 0.692 . . . . 2.8399999999999999 112.869 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.609 ' HG ' HG22 ' A' ' 92' ' ' ILE . 4.4 mm? -65.16 -25.64 67.83 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.873 0.76 . . . . 1.01 112.032 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.88 32.21 6.62 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.991 1.282 . . . . 0.85999999999999999 111.972 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -135.86 -166.67 1.9 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.927 -1.138 . . . . 1.9299999999999999 107.927 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 147.06 50.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.306 0.957 . . . . 4.5 109.091 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.55 151.08 26.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.099 0.952 . . . . 1.4399999999999999 110.063 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -122.37 163.17 20.23 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.998 2.919 . . . . 4.0199999999999996 106.801 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.19 136.65 44.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.313 -1.365 . . . . 1.71 107.313 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 34.3 mtpt -81.31 76.9 8.23 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.938 -1.134 . . . . 2.8700000000000001 107.938 172.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.13 -69.41 2.49 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.177 -1.169 . . . . 2.1600000000000001 110.177 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 46.98 47.54 15.75 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.924 1.29 . . . . 4.6200000000000001 110.304 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.07 -44.6 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 126.188 1.795 . . . . 7.4500000000000002 108.835 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.9 37.05 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.967 1.307 . . . . 6.1399999999999997 111.997 -164.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m 44.07 47.92 7.4 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.246 1.418 . . . . 8.6300000000000008 111.46 -170.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.0 67.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.599 0.76 . . . . 9.6199999999999992 112.448 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -157.43 169.14 25.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.464 -1.31 . . . . 15.17 107.464 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.52 20.42 46.78 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.912 -0.938 . . . . 17.68 112.85 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.334 -1.317 . . . . 19.66 108.309 177.116 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.6 mtt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.422 -0.584 . . . . 15.9 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.11 156.47 41.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.666 -1.235 . . . . 8.7100000000000009 107.666 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 p 176.74 144.26 0.08 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.731 -1.952 . . . . 5.46 105.731 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -145.91 48.54 1.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.499 1.142 . . . . 4.0 108.371 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -72.11 148.86 45.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.294 -1.002 . . . . 3.0 108.294 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 3.0 ptmt -99.89 173.32 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.936 -0.765 . . . . 2.0800000000000001 108.936 172.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -123.09 127.91 49.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.939 -2.245 . . . . 3.6099999999999999 104.939 165.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.92 120.24 64.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 N-CA-C 105.94 -1.874 . . . . 3.02 105.94 171.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.33 115.78 29.3 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.3 mtp -137.67 163.75 30.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.452 1.101 . . . . 2.2999999999999998 109.035 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -103.12 120.54 40.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.883 0.873 . . . . 2.29 110.081 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -109.71 148.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 126.012 1.725 . . . . 0.57999999999999996 109.267 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -98.62 170.58 8.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.308 0.643 . . . . 0.90000000000000002 111.395 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.47 10.3 57.22 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.817 -0.513 . . . . 0.95999999999999996 111.817 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.04 74.15 2.92 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.985 0.897 . . . . 3.2599999999999998 112.068 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 m -73.78 4.11 5.63 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.02 -1.05 . . . . 2.1699999999999999 112.373 175.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 56.72 -167.9 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.122 1.369 . . . . 3.4900000000000002 112.002 -173.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.04 -79.88 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 125.951 1.7 . . . . 3.2400000000000002 110.963 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.23 17.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.636 0.774 . . . . 2.2200000000000002 110.156 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -69.37 -57.71 4.94 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.732 -0.84 . . . . 1.02 108.732 -169.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.12 -57.17 5.38 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 115.996 -0.547 . . . . 1.4399999999999999 109.945 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -38.25 69.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.76 111.108 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -45.73 79.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 118.694 -0.67 . . . . 3.6600000000000001 110.475 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mm -61.23 -55.05 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.905 -1.517 . . . . 1.6100000000000001 106.905 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -55.35 -51.97 65.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.022 0.929 . . . . 4.1100000000000003 109.88 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -63.24 -44.31 95.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.202 0.601 . . . . 3.0699999999999998 111.514 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.98 -47.26 90.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.616 -0.994 . . . . 1.5900000000000001 110.616 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.18 -35.57 76.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.18 -0.6 . . . . 1.75 110.194 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -19.93 4.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.74 0.7 . . . . 2.8100000000000001 112.724 169.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -23.9 66.84 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.277 0.944 . . . . 3.4100000000000001 111.889 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mmt -82.69 147.12 54.59 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 123.842 0.857 . . . . 2.2999999999999998 109.623 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.39 -47.76 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.676 2.251 . . . . 1.8100000000000001 112.146 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.52 -21.13 77.56 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.552 -0.582 . . . . 1.02 112.016 -171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.82 102.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.782 0.833 . . . . 1.4199999999999999 109.193 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 m -83.1 -47.9 11.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.291 -1.744 . . . . 1.0900000000000001 106.291 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -149.78 157.48 43.25 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.557 -0.534 . . . . 2.8100000000000001 109.557 163.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.03 122.94 26.29 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.753 -1.203 . . . . 0.93000000000000005 107.753 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -135.28 162.4 32.68 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.406 -0.961 . . . . 2.7200000000000002 108.406 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.51 118.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 121.71 -0.619 . . . . 0.93000000000000005 110.213 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.28 93.13 8.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 3.3500000000000001 108.562 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.34 -31.12 61.46 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.269 0.628 . . . . 2.1699999999999999 111.572 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.78 68.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.47 0.708 . . . . 1.04 110.924 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -124.77 17.55 8.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.854 -0.593 . . . . 0.83999999999999997 110.749 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 37.25 54.65 1.32 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.342 1.457 . . . . 2.1299999999999999 111.953 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.4 m -121.66 107.73 12.72 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.741 -0.837 . . . . 0.96999999999999997 108.741 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 123.92 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.744 -1.576 . . . . 0.55000000000000004 106.744 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.78 100.11 6.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.355 1.062 . . . . 3.71 108.399 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.03 131.82 54.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.562 -0.903 . . . . 0.81000000000000005 108.562 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.28 118.67 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.884 1.274 . . . . 1.9299999999999999 108.077 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 39.7 p90 -156.78 167.83 29.28 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.489 0.551 . . . . 2.0899999999999999 112.489 -170.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -82.88 123.59 77.77 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 115.355 -0.839 . . . . 2.3500000000000001 110.908 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.48 35.02 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.569 2.179 . . . . 1.6699999999999999 112.667 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.68 25.41 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.562 0.619 . . . . 1.6699999999999999 112.207 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -140.33 -42.89 0.41 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.981 1.312 . . . . 2.25 109.949 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.3 m -113.56 -74.31 0.63 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.054 -0.721 . . . . 1.25 109.054 -163.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.32 125.98 5.33 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.583 -1.407 . . . . 1.2 109.583 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 t -39.57 -43.36 1.3 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.657 1.583 . . . . 1.4299999999999999 112.62 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.44 98.88 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.541 -0.724 . . . . 1.3799999999999999 111.098 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.07 78.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.258 -0.901 . . . . 1.25 110.273 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mm -56.96 -57.68 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.708 -1.219 . . . . 0.94999999999999996 107.708 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -38.77 84.45 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.966 -0.383 . . . . 2.4700000000000002 109.966 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.5 -34.36 72.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.902 -0.407 . . . . 3.1800000000000002 109.902 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.74 82.46 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.13 -0.982 . . . . 2.1099999999999999 108.907 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.69 -50.54 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.694 0.798 . . . . 0.89000000000000001 109.223 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.3 -49.02 79.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.485 0.18 . . . . 1.97 111.485 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -56.33 -37.62 70.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.61 0.764 . . . . 3.3900000000000001 111.79 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -15.65 36.55 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.196 0.813 . . . . 2.4399999999999999 113.196 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.0 28.59 20.4 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.398 0.999 . . . . 1.5700000000000001 111.136 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -110.02 175.89 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.636 -1.246 . . . . 2.0800000000000001 107.636 174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 149.49 47.8 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.028 -1.101 . . . . 2.71 108.028 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 m -110.53 144.24 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.591 1.156 . . . . 0.93000000000000005 109.378 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.7 t -84.48 55.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.478 -1.304 . . . . 0.94999999999999996 107.478 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 m -126.34 123.77 38.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.175 -1.417 . . . . 1.21 107.175 -169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -117.96 134.49 54.91 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.01 0.924 . . . . 3.6299999999999999 109.699 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -84.56 87.77 7.28 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.757 1.223 . . . . 2.8799999999999999 109.471 175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.03 21.91 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.706 -0.85 . . . . 0.68000000000000005 108.706 173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.46 131.94 56.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.765 0.826 . . . . 2.73 110.01 172.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -122.97 140.21 53.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.034 0.934 . . . . 1.99 108.97 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 113' ' ' THR . 1.5 t70 -86.73 146.76 26.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.132 1.773 . . . . 1.8300000000000001 107.827 177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD11 ' HB ' ' A' ' 114' ' ' VAL . 4.1 mt -123.6 129.91 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 119.998 1.272 . . . . 0.71999999999999997 109.444 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.79 124.43 50.73 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.552 -1.277 . . . . 3.2599999999999998 107.552 165.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.91 -53.97 0.39 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.893 -0.483 . . . . 1.46 111.893 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.415 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 0.0 OUTLIER -61.2 135.64 57.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.082 0.941 . . . . 3.0299999999999998 111.521 -177.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.1 p -92.9 -47.01 7.23 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.351 1.06 . . . . 4.1900000000000004 109.168 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 172.02 -44.62 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 125.275 1.43 . . . . 6.5700000000000003 109.443 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -35.63 -74.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.197 1.799 . . . . 3.2599999999999998 113.594 -169.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.94 34.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.808 1.243 . . . . 1.8 110.159 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 87.9 m -71.67 -47.76 52.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.896 -1.149 . . . . 1.0900000000000001 107.896 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.15 66.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.363 0.665 . . . . 0.60999999999999999 110.73 172.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.09 -41.75 73.62 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.074 -1.016 . . . . 2.21 109.277 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.49 -53.56 56.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.571 -0.706 . . . . 5.4100000000000001 111.034 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.69 -33.07 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 119.958 -0.697 . . . . 1.8400000000000001 111.493 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.23 -61.61 2.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.717 -1.216 . . . . 2.25 107.717 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -56.26 -30.88 63.02 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.395 -0.336 . . . . 3.0600000000000001 111.424 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -69.27 -69.92 0.31 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.292 -0.563 . . . . 3.23 110.716 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -52.19 -31.75 33.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.796 0.838 . . . . 1.9399999999999999 111.649 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -30.19 -45.42 0.06 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 127.444 2.298 . . . . 1.53 112.939 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -159.85 70.75 0.45 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.383 0.673 . . . . 4.7800000000000002 109.798 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 mm -67.13 -59.94 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.326 -0.62 . . . . 1.5900000000000001 109.326 170.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.35 -109.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.69 -1.226 . . . . 3.5800000000000001 107.69 174.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.73 4.69 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 120.304 1.411 . . . . 0.87 111.163 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.39 124.54 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 125.191 1.396 . . . . 0.81999999999999995 107.349 173.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.66 -50.42 15.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.172 -0.677 . . . . 0.82999999999999996 109.172 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -149.99 165.57 32.29 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.681 0.392 . . . . 0.95999999999999996 110.5 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.29 66.24 2.86 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.926 0.713 . . . . 0.72999999999999998 112.926 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.37 142.3 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.103 1.869 . . . . 0.87 110.962 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.2 m -108.53 152.57 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.782 1.233 . . . . 1.6899999999999999 110.992 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -115.28 144.97 42.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.016 1.326 . . . . 1.6699999999999999 109.248 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.89 6.12 25.07 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.368 1.067 . . . . 2.27 112.348 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.07 -22.11 10.2 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.465 1.106 . . . . 1.8 112.037 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.604 ' O ' HG23 ' A' ' 113' ' ' THR . 13.5 mt -114.12 -7.13 13.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.595 1.158 . . . . 1.6499999999999999 110.659 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 50.02 43.22 25.5 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.282 1.833 . . . . 4.25 112.552 -171.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 111' ' ' LEU . 25.8 p -124.07 158.54 31.95 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.487 0.715 . . . . 0.83999999999999997 111.545 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.564 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.7 p -121.89 128.31 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 125.76 1.624 . . . . 0.54000000000000004 108.314 173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -82.6 135.87 34.95 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.304 -2.11 . . . . 0.94999999999999996 105.304 164.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.9 116.27 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.037 -1.468 . . . . 0.68000000000000005 107.037 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -112.06 90.56 3.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 105.915 -1.883 . . . . 3.4700000000000002 105.915 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -145.92 168.7 20.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.955 -0.566 . . . . 1.96 111.142 -166.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -98.48 102.24 13.92 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.056 0.942 . . . . 2.0099999999999998 109.531 -169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.33 10.83 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.305 2.67 . . . . 0.90000000000000002 113.496 -169.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 -34.88 15.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.945 1.298 . . . . 7.8499999999999996 108.478 169.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.18 -31.55 16.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 2.8900000000000001 109.79 -168.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.68 -172.4 3.81 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.845 0.858 . . . . 0.69999999999999996 109.05 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 36.0 t -153.67 174.18 14.84 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.298 0.639 . . . . 2.27 109.742 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.11 -38.36 38.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.744 1.218 . . . . 1.6899999999999999 110.45 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -50.13 -44.37 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.5 1.12 . . . . 0.76000000000000001 112.411 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -62.06 -50.45 71.92 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.46 1.124 . . . . 2.2200000000000002 109.002 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.54 -43.71 98.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.963 1.305 . . . . 0.96999999999999997 110.275 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 133' ' ' ASP . 0.7 OUTLIER -50.93 -65.94 0.47 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 118.168 -0.92 . . . . 3.7000000000000002 108.762 166.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.76 -43.98 18.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.762 0.71 . . . . 3.1099999999999999 110.848 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.5 -56.56 20.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.135 0.574 . . . . 0.69999999999999996 111.373 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.92 -37.0 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.105 -0.997 . . . . 1.6699999999999999 110.704 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 2.4 m-20 -58.43 -47.63 83.33 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.808 0.843 . . . . 3.4700000000000002 108.854 174.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -57.25 -44.79 84.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.493 -0.754 . . . . 3.7400000000000002 112.403 171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.56 -23.88 64.98 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.692 0.678 . . . . 0.90000000000000002 111.738 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 95.0 38.85 4.74 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 123.8 0.714 . . . . 0.89000000000000001 111.365 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -136.93 178.93 6.7 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.864 -1.902 . . . . 2.0099999999999998 105.864 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -127.15 144.11 51.11 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.08 1.309 . . . . 3.8799999999999999 110.761 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.8 mt -95.13 156.88 16.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.741 0.816 . . . . 1.4099999999999999 110.427 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -136.23 173.94 11.16 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.141 2.577 . . . . 3.0600000000000001 107.451 168.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 140.61 32.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.93 0.892 . . . . 3.3700000000000001 108.62 -178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -82.33 51.68 1.87 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.357 0.981 . . . . 3.0699999999999998 110.667 -173.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.05 70.29 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.108 -0.995 . . . . 4.0499999999999998 111.778 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.79 -30.17 69.53 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.933 0.893 . . . . 6.1500000000000004 109.486 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -62.09 -65.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.406 1.082 . . . . 6.4199999999999999 108.869 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -158.62 41.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.561 0.744 . . . . 7.3099999999999996 110.691 -166.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.5 m 50.74 42.37 27.38 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.175 -0.953 . . . . 8.2200000000000006 112.936 176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.5 mt 56.92 61.42 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.198 1.399 . . . . 12.73 109.358 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.56 146.14 54.84 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.665 -0.647 . . . . 14.24 109.486 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.97 70.52 0.03 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.488 -2.245 . . . . 18.390000000000001 107.488 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.15 -1.405 . . . . 23.379999999999999 110.471 -170.264 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 106.447 -1.686 . . . . 16.829999999999998 106.447 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.2 156.57 1.26 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 105.997 -1.853 . . . . 8.7599999999999998 105.997 -174.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 p -175.3 178.65 1.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.329 1.852 . . . . 4.6900000000000004 106.057 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.8 59.56 1.66 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.908 -0.775 . . . . 3.9700000000000002 108.908 -176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.66 157.74 29.19 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.018 -0.537 . . . . 3.0099999999999998 110.49 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 148.76 45.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.155 0.982 . . . . 2.0099999999999998 109.316 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.97 154.93 16.98 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.341 1.457 . . . . 2.7200000000000002 109.618 168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.405 HD11 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER -148.47 128.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.851 -1.166 . . . . 2.8799999999999999 107.851 165.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.86 120.8 43.6 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.86 1.264 . . . . 0.68999999999999995 108.191 176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 8' ' ' ILE . 97.9 mtp -139.87 174.82 10.13 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.407 -0.96 . . . . 2.1600000000000001 108.407 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -106.35 152.67 23.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.787 0.722 . . . . 2.5800000000000001 110.004 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.51 152.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 125.382 1.473 . . . . 0.57999999999999996 108.379 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -130.37 162.59 28.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.196 1.399 . . . . 1.05 110.65 -177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.98 -15.18 58.29 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.085 1.326 . . . . 0.93999999999999995 110.515 -172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtm -59.41 102.57 0.14 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.522 0.677 . . . . 2.8300000000000001 110.103 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -83.16 -25.46 31.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.135 -0.938 . . . . 1.5800000000000001 109.458 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.8 t -173.04 170.95 4.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.882 0.473 . . . . 4.2000000000000002 110.172 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.67 -33.84 7.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.062 1.345 . . . . 3.27 112.485 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.14 74.55 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.655 -0.653 . . . . 1.3500000000000001 112.054 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 98.1 m -67.35 -54.28 22.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.875 -1.157 . . . . 0.79000000000000004 107.875 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.62 -61.29 1.27 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.847 -1.07 . . . . 0.69999999999999996 110.929 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.34 69.85 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.911 0.884 . . . . 0.80000000000000004 112.055 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.03 -44.82 96.83 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.646 -0.659 . . . . 3.98 110.247 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 93.3 mt -61.88 -54.73 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.298 -1.001 . . . . 0.56000000000000005 108.298 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -49.74 -53.02 27.37 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.535 0.607 . . . . 3.8399999999999999 109.854 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -63.96 -45.69 87.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.158 0.583 . . . . 1.79 111.357 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.95 -47.63 71.53 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.972 -0.851 . . . . 0.68999999999999995 110.972 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.45 -36.71 74.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.499 0.72 . . . . 1.6599999999999999 110.262 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -54.26 -19.18 4.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.116 0.966 . . . . 1.79 111.384 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ttt85 -70.42 -19.92 62.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.115 0.966 . . . . 2.96 113.201 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 34' ' ' VAL . 8.8 mtt -76.05 159.55 80.29 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.922 0.783 . . . . 1.9399999999999999 110.6 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.16 -43.81 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.001 1.801 . . . . 1.22 111.688 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.24 -19.27 75.69 Favored Glycine 0 C--N 1.34 0.79 0 O-C-N 121.843 -0.535 . . . . 0.71999999999999997 112.373 -173.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 29' ' ' LYS . 9.3 p -58.2 123.15 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.755 -0.85 . . . . 2.3500000000000001 110.538 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 m -90.3 -58.68 2.41 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.703 -1.591 . . . . 0.84999999999999998 106.703 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 32.2 t0 -155.4 139.35 16.33 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.75 -0.463 . . . . 2.1499999999999999 109.75 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.4 124.17 48.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.44 -1.689 . . . . 0.66000000000000003 106.44 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -129.57 140.59 51.17 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 124.686 1.241 . . . . 1.97 108.0 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -141.52 110.77 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.567 1.175 . . . . 1.6399999999999999 111.254 171.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.25 85.45 7.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.266 -1.383 . . . . 3.0099999999999998 107.266 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -28.97 10.03 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.149 -0.478 . . . . 3.3700000000000001 111.545 170.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -28.21 67.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.925 0.89 . . . . 1.3799999999999999 112.12 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.4 p -120.81 14.16 11.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.823 0.449 . . . . 1.0600000000000001 110.696 171.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 51.84 37.61 21.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.188 1.795 . . . . 2.5600000000000001 113.821 -176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.6 m -119.93 122.06 40.4 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.605 -0.887 . . . . 0.87 108.605 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -95.68 123.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 125.313 1.445 . . . . 0.48999999999999999 109.473 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -120.75 104.07 9.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.668 -1.604 . . . . 2.6600000000000001 106.668 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.96 136.3 45.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 108.301 -0.999 . . . . 0.46999999999999997 108.301 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -121.15 121.65 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.35 1.46 . . . . 1.1000000000000001 107.268 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.83 174.86 14.71 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 122.072 -0.392 . . . . 1.95 111.469 -175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.59 121.7 70.89 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 122.777 0.431 . . . . 2.2200000000000002 110.539 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.82 34.0 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.746 2.297 . . . . 0.92000000000000004 112.429 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.13 22.63 0.37 Allowed 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.811 0.671 . . . . 0.97999999999999998 112.811 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -136.39 -47.33 0.63 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.56 1.144 . . . . 2.0499999999999998 109.975 174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 m -105.12 -81.89 0.53 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.693 -1.225 . . . . 0.76000000000000001 107.693 -167.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.33 123.89 4.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.92 -2.072 . . . . 0.63 107.92 175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.9 t -39.57 -43.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.152 1.781 . . . . 0.89000000000000001 113.654 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.63 -37.45 81.49 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.593 -0.692 . . . . 0.82999999999999996 111.379 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -31.13 68.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.998 -1.064 . . . . 0.69999999999999996 110.923 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mm -61.83 -53.6 45.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.018 -1.104 . . . . 0.71999999999999997 108.018 177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -59.33 -43.46 92.72 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.149 -0.686 . . . . 2.1699999999999999 109.149 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -54.85 -45.42 74.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.154 -0.313 . . . . 2.1000000000000001 110.154 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -47.57 81.0 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.983 -0.532 . . . . 3.1699999999999999 110.157 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.3 mt -50.96 -46.22 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.58999999999999997 109.542 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -61.0 -53.77 53.19 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.518 -0.473 . . . . 1.7 112.072 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -33.24 65.76 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.435 -0.791 . . . . 4.7300000000000004 112.508 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -16.62 58.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.203 0.911 . . . . 2.2200000000000002 112.652 173.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.0 41.7 3.0 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.509 1.052 . . . . 0.72999999999999998 110.795 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.01 175.88 8.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.442 1.097 . . . . 2.1200000000000001 109.392 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -132.45 139.5 48.02 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 108.724 -0.843 . . . . 2.1899999999999999 108.724 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -84.79 140.37 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.516 0.726 . . . . 0.59999999999999998 109.528 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.4 t -81.94 79.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.073 -1.825 . . . . 1.25 106.073 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.51 147.51 33.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.858 -0.61 . . . . 0.81999999999999995 109.756 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.19 133.62 47.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.752 -0.833 . . . . 3.54 108.752 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -83.65 85.67 7.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.006 1.322 . . . . 2.54 108.618 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.75 163.66 16.37 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.949 -0.389 . . . . 0.80000000000000004 109.949 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -130.86 127.31 38.31 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.691 0.796 . . . . 3.02 110.082 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -118.85 153.54 34.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.334 1.453 . . . . 2.0699999999999998 108.342 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -102.87 152.24 21.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.832 2.053 . . . . 2.3700000000000001 107.568 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.8 mt -123.25 119.0 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 120.436 1.471 . . . . 0.87 110.046 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -111.03 88.06 2.69 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.957 0.884 . . . . 2.9300000000000002 109.382 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 174.25 -62.26 0.12 Allowed Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.794 -0.639 . . . . 1.9299999999999999 111.835 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.05 121.23 5.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.837 0.855 . . . . 2.9500000000000002 112.089 -175.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 t -163.1 24.5 0.09 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.607 0.718 . . . . 3.9900000000000002 109.939 171.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.2 t -167.78 160.04 12.2 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.661 -1.274 . . . . 4.79 108.474 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 49.66 -88.52 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.305 1.842 . . . . 3.7200000000000002 111.825 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 90' ' ' ASN . . . -176.37 46.18 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.309 1.044 . . . . 1.6399999999999999 109.497 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 83.1 m -62.9 -47.02 85.1 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.535 -1.353 . . . . 0.78000000000000003 110.01 -171.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.85 -44.75 70.59 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.546 0.739 . . . . 0.69999999999999996 110.087 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.498 ' CB ' ' HB1' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -63.03 -35.19 79.41 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.565 -0.709 . . . . 2.5499999999999998 110.884 -178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -67.81 -51.87 43.68 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.604 -0.685 . . . . 5.0899999999999999 110.297 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.9 pt -63.23 -27.35 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 121.802 -0.561 . . . . 1.9199999999999999 112.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.1 -63.75 1.08 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 2.4300000000000002 108.513 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -55.13 -33.18 62.66 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.921 0.488 . . . . 3.27 110.87 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -69.01 -70.05 0.29 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 120.56 -0.456 . . . . 3.7200000000000002 109.911 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 102' ' ' VAL . 11.1 mt -50.91 -34.46 28.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.935 0.894 . . . . 2.02 111.328 -174.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -30.54 -44.78 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.29 1.836 . . . . 1.3100000000000001 113.79 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 53.84 0.5 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.874 0.869 . . . . 4.5499999999999998 110.378 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mm -56.96 -52.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.66 -0.65 . . . . 1.6899999999999999 110.038 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 -104.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.843 -1.91 . . . . 3.3999999999999999 105.843 176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.89 52.46 4.73 Favored Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.646 -1.284 . . . . 0.80000000000000004 111.467 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.3 t -104.4 126.33 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 C-N-CA 123.902 0.881 . . . . 0.72999999999999998 108.831 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -50.56 9.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.114 -0.699 . . . . 0.79000000000000004 109.114 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -150.23 167.09 27.93 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.533 -0.543 . . . . 0.82999999999999996 109.533 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 66.61 1.55 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.833 0.679 . . . . 0.66000000000000003 112.833 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -72.48 142.62 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.983 1.789 . . . . 0.87 111.119 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.46 154.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.754 1.221 . . . . 1.76 110.726 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -113.0 157.46 21.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.639 1.176 . . . . 1.97 108.862 170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.28 3.35 10.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 2.77 111.91 175.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.1 -49.16 3.24 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.498 1.119 . . . . 1.04 109.664 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mt -83.48 -18.94 36.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.341 0.656 . . . . 1.6100000000000001 111.252 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.61 38.13 1.78 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.567 1.547 . . . . 3.2799999999999998 110.951 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 32.4 p -121.25 157.94 29.19 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.813 1.245 . . . . 0.80000000000000004 111.713 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.64 129.58 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 124.899 1.28 . . . . 0.54000000000000004 108.703 166.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -83.04 143.99 30.23 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.101 -1.815 . . . . 0.88 106.101 168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.6 p -131.71 112.48 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 107.568 -1.271 . . . . 0.56000000000000005 107.568 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -103.52 93.51 4.98 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.314 -1.736 . . . . 2.7000000000000002 106.314 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -142.66 156.26 45.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 109.917 -0.401 . . . . 2.1499999999999999 109.917 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -72.82 112.52 15.56 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 107.725 -1.213 . . . . 2.3900000000000001 107.725 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.33 10.3 2.19 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.008 1.805 . . . . 0.71999999999999997 111.662 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -98.0 -55.1 2.89 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.794 0.724 . . . . 5.6699999999999999 109.558 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.96 -48.82 75.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.418 0.287 . . . . 2.6000000000000001 110.786 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.96 177.7 6.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.639 -0.874 . . . . 0.58999999999999997 108.639 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 92.2 p -151.19 169.58 21.55 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.389 -0.597 . . . . 1.9199999999999999 109.389 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.8 t -35.75 -45.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 125.216 1.407 . . . . 1.54 112.765 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 m -58.16 -42.66 86.43 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.22 -0.925 . . . . 0.79000000000000004 112.386 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.34 -48.06 83.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.521 0.677 . . . . 1.98 109.286 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.4 mt -59.74 -42.73 93.85 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 115.873 -0.603 . . . . 0.80000000000000004 111.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -62.2 -41.97 98.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.733 -0.469 . . . . 3.1699999999999999 109.733 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -62.8 -44.79 95.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.227 0.921 . . . . 3.2200000000000002 110.935 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.4 47.53 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.549 -0.719 . . . . 0.54000000000000004 110.564 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -65.78 -31.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 O-C-N 121.289 -0.882 . . . . 1.72 110.448 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.17 -51.76 68.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.449 -0.574 . . . . 3.6299999999999999 109.449 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -53.77 -35.1 60.94 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.883 -0.599 . . . . 2.3900000000000001 112.562 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.22 -24.97 57.81 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.83 0.741 . . . . 0.88 112.545 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.61 40.27 4.47 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.669 1.128 . . . . 0.81999999999999995 112.378 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -138.99 -173.06 3.47 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.653 -1.24 . . . . 2.1699999999999999 107.653 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 147.77 38.51 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.12 0.873 . . . . 3.4199999999999999 108.677 170.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 78.1 mt -107.38 148.64 28.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.811 1.244 . . . . 1.3999999999999999 108.346 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.4 161.03 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.6 1.16 . . . . 3.02 108.991 174.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mp -101.4 118.34 36.77 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.74 0.816 . . . . 1.76 110.915 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -80.23 93.84 5.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.145 -0.972 . . . . 2.9199999999999999 108.622 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.95 -46.92 3.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.436 -1.066 . . . . 2.4500000000000002 110.436 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -37.65 -33.02 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.554 1.941 . . . . 4.3799999999999999 114.223 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -135.88 8.44 3.26 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.474 1.287 . . . . 7.9900000000000002 114.474 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.49 -8.83 14.24 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.917 0.887 . . . . 8.6799999999999997 112.036 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 18.0 m -172.54 55.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.339 2.255 . . . . 5.6900000000000004 108.965 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.5 pt -49.69 -37.11 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 113.876 1.065 . . . . 8.1899999999999995 113.876 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 51.64 62.71 2.57 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.625 1.17 . . . . 12.029999999999999 111.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.59 122.01 6.84 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 107.017 -2.433 . . . . 11.77 107.017 173.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 116.057 -1.925 . . . . 15.119999999999999 106.571 177.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 107.835 -1.172 . . . . 13.09 107.835 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -146.39 -77.12 0.19 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 105.029 -2.211 . . . . 8.0500000000000007 105.029 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 t -176.8 115.56 0.1 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.282 1.433 . . . . 5.0199999999999996 107.449 165.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -148.59 36.43 0.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.651 -0.87 . . . . 4.8499999999999996 108.651 169.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -64.43 141.14 58.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.424 -0.584 . . . . 2.02 109.424 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -111.24 175.66 5.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.645 -0.872 . . . . 1.9199999999999999 108.645 170.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -126.13 141.98 51.71 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.318 -2.104 . . . . 3.5699999999999998 105.318 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -126.17 114.32 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.219 -1.771 . . . . 2.7599999999999998 106.219 168.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.06 119.07 38.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.816 -1.55 . . . . 0.56000000000000005 106.816 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 86.6 mtp -142.29 152.75 43.3 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.837 . . . . 1.6799999999999999 108.756 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.01 138.17 31.72 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.423 1.011 . . . . 3.1800000000000002 110.997 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -119.47 151.85 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 126.628 1.971 . . . . 0.68999999999999995 109.562 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.71 172.23 6.98 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 124.033 0.933 . . . . 1.0800000000000001 111.828 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.52 57.64 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.714 0.673 . . . . 0.88 112.199 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 39' ' ' VAL . 7.6 mtp -68.35 119.91 13.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.529 0.681 . . . . 2.8100000000000001 112.049 -173.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.84 2.75 41.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.894 1.677 . . . . 1.98 110.982 171.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p 50.28 43.53 26.43 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.193 1.397 . . . . 3.1800000000000002 112.99 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.1 -87.56 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.624 -1.991 . . . . 2.4700000000000002 105.624 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.75 81.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.155 0.582 . . . . 2.02 111.609 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.7 m -65.22 -56.42 12.89 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.923 -0.769 . . . . 1.6599999999999999 108.923 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.31 -53.83 15.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.572 0.349 . . . . 1.1299999999999999 110.248 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.37 78.91 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.7 0.286 . . . . 1.4099999999999999 110.864 -178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -68.22 -42.81 79.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 118.907 -0.568 . . . . 2.2400000000000002 111.508 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.76 -54.6 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 107.512 -1.292 . . . . 0.68999999999999995 107.512 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.17 -50.23 69.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.654 -0.654 . . . . 3.98 109.997 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -60.77 -52.06 66.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.181 0.9 . . . . 2.04 110.942 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.79 -44.86 86.94 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.816 0.722 . . . . 0.56999999999999995 111.423 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.7 mm? -71.87 -44.63 63.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.621 0.768 . . . . 1.5700000000000001 110.558 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 16.9 mttp -55.78 -19.43 11.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.729 1.149 . . . . 2.1000000000000001 112.333 174.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -58.96 -30.54 67.99 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.505 -0.747 . . . . 3.4399999999999999 112.943 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.7 mmt -81.39 146.79 58.47 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.043 0.937 . . . . 1.3400000000000001 110.718 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.72 -42.09 1.9 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.789 2.326 . . . . 1.3300000000000001 112.04 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.99 -31.57 78.4 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.586 -1.006 . . . . 0.56000000000000005 110.586 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.18 106.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.568 -0.901 . . . . 1.3999999999999999 108.568 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.4 m -88.86 -43.6 11.09 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.452 -1.314 . . . . 0.73999999999999999 107.452 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 7.3 t0 -155.81 99.66 2.01 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.385 0.612 . . . . 1.99 111.992 172.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.43 122.67 28.82 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.818 0.847 . . . . 0.69999999999999996 109.972 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -138.39 157.83 45.45 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.537 0.735 . . . . 2.6899999999999999 109.921 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG21 ' SD ' ' A' ' 15' ' ' MET . 4.4 p -138.31 121.66 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 122.525 1.155 . . . . 1.04 113.2 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -82.11 80.28 8.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.005 -1.479 . . . . 1.98 107.005 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 pp -49.68 -31.0 10.11 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.52 0.728 . . . . 1.52 112.619 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.62 -33.41 54.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.403 0.681 . . . . 1.0900000000000001 111.622 176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.0 p -123.03 21.79 9.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.991 0.517 . . . . 1.0800000000000001 111.087 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 42.45 37.99 1.11 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.145 1.378 . . . . 1.8400000000000001 113.363 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -109.06 103.47 12.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.775 -1.195 . . . . 0.72999999999999998 107.775 -168.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 p -79.78 115.67 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.399 -1.704 . . . . 0.41999999999999998 106.399 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -118.35 101.0 7.85 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.238 1.415 . . . . 3.4100000000000001 107.995 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.28 123.94 65.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.808 -0.812 . . . . 0.45000000000000001 108.808 -171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 mt -105.7 124.9 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.491 -1.3 . . . . 1.0600000000000001 107.491 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -155.94 164.82 38.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.755 -0.202 . . . . 1.9199999999999999 111.033 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -84.82 122.14 74.5 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 124.496 1.123 . . . . 1.8700000000000001 109.147 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 27.86 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.41 2.74 . . . . 0.95999999999999996 113.21 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.55 3.52 1.14 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.835 1.05 . . . . 1.03 113.835 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.06 -39.59 2.8 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.161 0.984 . . . . 1.72 111.222 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -111.08 -77.45 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.277 -1.008 . . . . 0.80000000000000004 108.277 -165.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.7 126.51 5.63 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.808 -1.317 . . . . 0.72999999999999998 109.808 173.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -33.88 -47.97 0.28 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.178 1.791 . . . . 0.81000000000000005 113.005 174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.0 84.46 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 122.02 -0.425 . . . . 0.88 110.733 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.23 -39.61 74.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 121.56 -0.712 . . . . 0.68999999999999995 110.374 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mm -54.55 -57.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 107.573 -1.269 . . . . 0.79000000000000004 107.573 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.703 -0.681 . . . . 2.29 110.667 -177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.8 -43.03 85.39 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 108.004 -1.109 . . . . 2.0499999999999998 108.004 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.67 -49.33 75.55 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.233 -0.655 . . . . 2.21 109.233 -175.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.3 -48.3 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.572 -0.529 . . . . 0.56000000000000005 109.572 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -63.91 -47.57 80.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.095 -0.642 . . . . 1.72 112.273 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -61.28 -29.49 69.89 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.473 -0.767 . . . . 2.3900000000000001 111.94 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -2.87 9.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.375 0.509 . . . . 1.9099999999999999 112.375 173.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.81 38.41 5.8 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.501 1.048 . . . . 0.82999999999999996 111.012 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.78 178.65 6.6 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.815 1.246 . . . . 2.1000000000000001 109.272 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -134.65 140.49 46.07 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.567 -0.901 . . . . 2.04 108.567 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -84.34 149.11 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.212 1.005 . . . . 0.53000000000000003 108.752 173.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.69 42.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.054 0.93 . . . . 0.87 108.529 -176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -103.41 146.41 28.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.594 1.158 . . . . 0.81000000000000005 108.653 -171.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.3 144.47 44.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.963 -0.754 . . . . 3.6400000000000001 108.963 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -96.59 89.61 5.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.085 1.754 . . . . 2.7799999999999998 109.237 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.62 152.75 20.12 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.298 -0.63 . . . . 0.56999999999999995 109.298 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -109.9 124.2 50.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.157 1.383 . . . . 2.9199999999999999 110.534 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -120.98 153.87 36.74 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.387 1.075 . . . . 2.3199999999999998 109.493 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.04 140.12 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.563 2.345 . . . . 2.4100000000000001 108.533 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 ' HB ' ' A' ' 114' ' ' VAL . 2.6 mt -124.79 125.04 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 119.593 1.088 . . . . 0.78000000000000003 110.17 -168.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -114.18 114.19 25.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.973 -1.121 . . . . 2.1699999999999999 107.973 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.81 -49.41 0.27 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-O 120.116 -0.269 . . . . 1.6000000000000001 112.501 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.95 113.17 2.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.231 0.613 . . . . 2.98 112.202 -171.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.3 p -84.09 -21.86 31.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.95 0.9 . . . . 4.2400000000000002 111.248 173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.85 176.94 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.686 -1.227 . . . . 4.96 107.686 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.47 47.23 0.38 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.759 1.224 . . . . 6.3700000000000001 113.466 -171.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -121.94 -49.92 2.07 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.325 1.45 . . . . 2.1000000000000001 109.426 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.6 m -64.34 -40.22 95.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.116 -1.068 . . . . 0.81999999999999995 108.116 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.84 91.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.147 0.579 . . . . 1.0700000000000001 110.611 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -62.08 -48.68 79.14 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.575 -0.703 . . . . 2.8799999999999999 109.346 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.57 -58.63 7.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.445 0.698 . . . . 4.25 110.621 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pp -63.25 -36.61 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 119.085 -0.483 . . . . 1.8999999999999999 111.001 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.09 -61.74 2.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.972 -1.121 . . . . 2.4100000000000001 107.972 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -29.61 48.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 119.534 -0.27 . . . . 3.29 111.693 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -72.37 -70.88 0.32 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.807 0.276 . . . . 2.8300000000000001 110.356 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -42.05 -47.25 4.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.042 1.337 . . . . 1.4399999999999999 110.721 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -39.35 -34.38 0.2 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.077 2.151 . . . . 1.3999999999999999 114.318 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.79 62.76 0.66 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.599 1.091 . . . . 5.0199999999999996 111.868 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.3 -61.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.931 0.787 . . . . 2.27 109.582 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -145.69 -106.93 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.84 1.256 . . . . 3.9300000000000002 107.79 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.09 55.05 4.91 Favored Glycine 0 CA--C 1.525 0.697 0 O-C-N 120.928 -1.107 . . . . 0.70999999999999996 110.913 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.82 123.81 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.887 1.275 . . . . 0.66000000000000003 108.953 -177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.19 -51.73 12.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.757 -0.831 . . . . 0.68999999999999995 108.757 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -152.46 167.84 27.45 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.707 -0.479 . . . . 0.78000000000000003 109.707 -173.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.46 73.0 2.19 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.456 . . . . 0.46000000000000002 112.053 173.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.03 132.58 16.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.959 1.773 . . . . 0.60999999999999999 110.243 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.0 m -96.03 150.2 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.448 1.099 . . . . 1.7 109.538 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -108.96 156.68 19.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.33 1.452 . . . . 1.75 108.859 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -125.89 18.58 7.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.382 1.073 . . . . 3.1600000000000001 111.36 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.63 -40.91 6.78 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.942 1.297 . . . . 1.3500000000000001 110.847 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.47 18.47 4.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.116 1.366 . . . . 2.4100000000000001 110.089 177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 46.7 49.17 14.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.94 1.296 . . . . 3.6899999999999999 111.212 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.5 p -104.02 164.94 11.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 109.959 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 80' ' ' ILE . 7.4 p -137.94 130.63 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 107.922 -1.14 . . . . 0.46000000000000002 107.922 167.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -82.75 127.84 33.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.345 -2.465 . . . . 0.63 104.345 166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.3 116.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 106.919 -1.512 . . . . 0.54000000000000004 106.919 172.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -106.75 92.5 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.791 -1.559 . . . . 2.8300000000000001 106.791 -175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -148.29 168.48 22.44 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 122.345 -0.222 . . . . 1.97 111.161 -167.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.81 105.8 14.79 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.554 -0.906 . . . . 2.2000000000000002 108.554 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -78.95 30.75 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.763 2.309 . . . . 0.71999999999999997 111.26 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -114.12 -54.63 2.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.693 1.597 . . . . 5.4199999999999999 107.305 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.1 -50.04 74.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.29 1.036 . . . . 3.73 109.881 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.58 -177.65 3.7 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.727 0.811 . . . . 0.51000000000000001 109.425 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -162.68 163.7 26.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.643 -1.243 . . . . 2.1299999999999999 107.643 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 125' ' ' VAL . 11.5 t -36.01 -44.04 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.901 1.68 . . . . 1.48 113.831 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.8 m -54.29 -40.87 68.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.372 -0.83 . . . . 0.60999999999999999 112.243 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.99 -47.96 82.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.576 0.75 . . . . 1.96 109.75 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -57.8 -48.31 80.08 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.727 0.811 . . . . 0.75 110.116 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -58.6 -49.25 78.17 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.966 -0.561 . . . . 3.3500000000000001 109.798 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -51.35 -51.02 58.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.866 0.757 . . . . 2.6400000000000001 110.064 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.46 -51.69 68.39 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.411 0.685 . . . . 0.48999999999999999 110.613 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.5 -31.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 O-C-N 121.365 -0.835 . . . . 1.6799999999999999 110.732 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -46.88 88.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.679 -0.86 . . . . 2.5800000000000001 108.679 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -56.29 -41.58 76.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.486 1.114 . . . . 2.8199999999999998 111.165 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.43 -39.09 91.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.973 0.509 . . . . 0.81999999999999995 111.37 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.94 41.05 1.74 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.607 1.099 . . . . 0.59999999999999998 112.021 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -136.22 -178.88 5.35 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.169 -1.419 . . . . 1.8799999999999999 107.169 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 133.86 55.33 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.05 0.841 . . . . 3.5699999999999998 109.83 173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.3 mt -89.09 150.52 22.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 1.49 108.688 166.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -128.55 169.57 14.23 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.723 2.409 . . . . 2.7200000000000002 106.621 166.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -104.29 151.5 23.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.93 0.892 . . . . 1.6299999999999999 109.865 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.32 99.82 10.24 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.533 0.733 . . . . 5.75 109.042 162.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.99 -49.52 4.24 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 118.374 -1.237 . . . . 2.3799999999999999 111.417 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -28.48 -62.32 0.11 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.051 1.74 . . . . 5.3300000000000001 112.391 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.38 -10.75 14.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.995 1.318 . . . . 8.6099999999999994 112.364 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.97 -20.18 59.78 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 122.074 0.94 . . . . 8.5899999999999999 111.597 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.7 m -152.33 35.62 0.52 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.628 1.571 . . . . 6.2800000000000002 111.005 173.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 mt 48.61 66.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.89 1.276 . . . . 9.1199999999999992 110.86 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.44 156.67 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.981 -1.118 . . . . 10.65 107.981 168.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.48 -76.45 0.22 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 114.767 0.667 . . . . 13.17 114.767 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 116.287 -1.816 . . . . 14.970000000000001 106.406 -156.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 107.147 -1.427 . . . . 18.949999999999999 107.147 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.35 167.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.571 1.149 . . . . 12.81 111.032 -154.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -76.68 77.08 3.33 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.872 1.669 . . . . 6.7199999999999998 110.033 -173.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.21 103.49 3.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.205 -1.776 . . . . 6.2699999999999996 106.205 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -57.1 115.36 2.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.936 0.894 . . . . 2.4300000000000002 109.316 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -84.23 165.42 18.38 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.225 -0.893 . . . . 2.3500000000000001 108.988 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -126.54 88.04 2.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.649 1.98 . . . . 2.9199999999999999 107.357 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.77 113.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.77 -1.567 . . . . 2.6600000000000001 106.77 -177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.28 112.03 23.32 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.966 0.906 . . . . 0.62 109.516 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -130.17 163.43 26.68 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.281 0.632 . . . . 2.4300000000000002 111.063 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.25 123.96 33.38 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.443 1.097 . . . . 2.8399999999999999 109.083 167.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.47 155.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 126.437 1.895 . . . . 0.96999999999999997 107.603 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -112.76 170.27 8.31 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.151 0.98 . . . . 1.1100000000000001 111.198 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.07 5.41 37.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.035 1.302 . . . . 1.3 112.034 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.66 75.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.846 1.658 . . . . 2.8700000000000001 110.652 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m -75.81 -34.11 60.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.392 -1.276 . . . . 1.6299999999999999 108.73 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -173.64 168.88 4.36 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.373 0.269 . . . . 5.0499999999999998 110.936 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.02 -35.76 16.23 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 125.13 1.372 . . . . 3.54 111.72 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.12 76.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.857 -0.527 . . . . 1.5900000000000001 111.832 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.16 -52.23 20.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.811 -0.811 . . . . 1.6299999999999999 108.811 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.04 -61.97 1.03 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.624 0.769 . . . . 1.26 110.109 168.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.06 -40.15 66.88 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.122 0.969 . . . . 1.3100000000000001 111.49 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -42.52 99.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.937 -0.477 . . . . 2.6299999999999999 111.026 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -65.21 -52.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.94999999999999996 108.278 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -53.97 -50.71 65.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.382 0.537 . . . . 3.6800000000000002 109.953 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -67.78 -46.1 72.96 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 122.915 0.486 . . . . 2.4700000000000002 111.508 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.28 -43.76 84.36 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.353 -0.699 . . . . 0.82999999999999996 111.353 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.9 -40.56 68.78 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.822 0.849 . . . . 1.6899999999999999 110.003 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -20.22 6.34 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.633 1.106 . . . . 2.21 112.385 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -62.36 -22.98 66.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.657 0.614 . . . . 2.79 112.657 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -80.0 147.78 66.56 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.55 0.74 . . . . 1.9299999999999999 110.173 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.19 -44.98 3.13 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.678 2.252 . . . . 1.21 111.586 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.6 82.88 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.713 -0.955 . . . . 0.73999999999999999 110.713 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.03 103.75 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.388 0.675 . . . . 1.46 109.836 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.4 m -83.18 -52.6 6.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.407 -1.331 . . . . 0.73999999999999999 107.407 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -151.78 124.5 8.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.501 -0.48 . . . . 2.6699999999999999 111.696 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.47 127.6 53.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.774 -1.195 . . . . 0.55000000000000004 107.774 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -136.79 153.54 50.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.947 -0.76 . . . . 2.0600000000000001 108.947 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 21' ' ' ALA . 5.8 p -153.99 113.2 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-O 121.874 0.845 . . . . 1.3400000000000001 111.873 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -84.68 89.86 7.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.501 -0.926 . . . . 2.2000000000000002 108.501 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -22.52 5.14 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.931 0.492 . . . . 2.1800000000000002 112.027 166.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.77 -29.02 61.97 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.917 0.887 . . . . 1.4099999999999999 111.808 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 p -127.04 15.31 7.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.522 0.729 . . . . 1.3700000000000001 111.163 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 46.56 51.42 11.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.085 1.754 . . . . 2.3599999999999999 112.368 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -131.36 113.79 14.19 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.674 -1.232 . . . . 0.87 107.674 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.84 126.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.732 -1.581 . . . . 0.44 106.732 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.77 112.53 13.7 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.815 -1.18 . . . . 3.0600000000000001 107.815 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 t -118.76 126.48 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.179 -1.045 . . . . 0.5 108.179 -170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 11.4 mt -109.11 116.62 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.663 1.185 . . . . 0.95999999999999996 108.117 -178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 42.5 p90 -157.71 166.46 32.72 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.202 0.445 . . . . 1.8 112.202 -170.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -82.92 122.72 78.12 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 115.893 -0.594 . . . . 2.4300000000000002 111.117 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.98 46.47 2.08 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.454 2.102 . . . . 1.0800000000000001 112.655 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.34 25.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.79 0.836 . . . . 1.1100000000000001 112.865 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -139.92 -44.96 0.43 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.39 1.076 . . . . 2.2999999999999998 110.447 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -108.55 -76.56 0.61 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.904 -1.147 . . . . 0.79000000000000004 107.904 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.43 126.17 4.81 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.085 -2.006 . . . . 0.80000000000000004 108.085 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.9 t -45.31 -42.21 9.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.497 1.119 . . . . 0.94999999999999996 112.403 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.17 -38.94 84.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.557 0.343 . . . . 0.98999999999999999 110.874 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.38 73.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.61 -0.681 . . . . 0.73999999999999999 111.021 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 50' ' ' TYR . 4.9 mm -55.41 -57.47 7.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.57 -1.271 . . . . 0.73999999999999999 107.57 174.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -62.79 -38.83 92.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.949 -0.569 . . . . 1.9099999999999999 109.991 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -54.08 -41.04 67.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.389 0.54 . . . . 1.97 110.151 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.14 -42.48 72.51 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.778 -0.769 . . . . 2.3500000000000001 109.644 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.8 mt -50.93 -51.23 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.111 0.564 . . . . 0.58999999999999997 110.061 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -63.38 -43.54 97.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.863 -0.523 . . . . 2.3399999999999999 110.809 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -57.6 -37.31 73.03 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.697 -0.627 . . . . 2.1699999999999999 112.074 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -3.65 16.56 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.31 0.644 . . . . 2.48 112.699 172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.36 26.03 49.04 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.968 0.804 . . . . 0.87 111.882 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.94 176.07 5.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.398 0.679 . . . . 4.0599999999999996 110.031 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.02 134.82 20.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.713 0.805 . . . . 1.8200000000000001 109.497 178.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.61 132.71 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 125.503 1.521 . . . . 0.65000000000000002 109.506 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.14 68.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 107.443 -1.318 . . . . 0.97999999999999998 107.443 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -121.89 144.43 48.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.13 1.372 . . . . 0.96999999999999997 108.197 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -127.85 145.24 51.0 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.511 0.724 . . . . 5.7300000000000004 109.662 -176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -84.48 103.21 13.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.524 -1.287 . . . . 3.0 107.524 168.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.11 149.23 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.179 -1.045 . . . . 0.73999999999999999 108.179 169.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -121.7 113.31 19.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.816 0.734 . . . . 2.8599999999999999 109.85 -172.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 128' ' ' LEU . 16.9 m-85 -102.72 152.38 21.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.141 1.377 . . . . 2.3700000000000001 109.745 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -111.15 142.5 43.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.378 2.271 . . . . 1.6599999999999999 108.66 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.0 mt -120.78 122.89 69.05 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.07 0 CA-C-N 119.376 0.989 . . . . 0.96999999999999997 109.39 -168.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.499 ' HB3' ' CG ' ' A' ' 138' ' ' LYS . 1.7 tt0 -109.22 30.9 6.16 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.664 0.666 . . . . 2.1600000000000001 109.829 -172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.86 -40.32 0.22 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.524 1.535 . . . . 1.6200000000000001 112.33 -171.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.8 ptm -60.35 178.89 0.17 Allowed 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 114.042 1.127 . . . . 3.3700000000000001 114.042 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.255 4.1 t 53.45 39.14 29.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 113.645 -1.616 . . . . 5.5300000000000002 109.841 -174.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 54.0 t -147.72 -61.8 0.27 Allowed 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 114.816 -1.084 . . . . 6.3600000000000003 109.395 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.24 49.1 2.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.006 0.922 . . . . 5.7300000000000004 110.207 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 49.83 36.71 11.79 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.616 1.166 . . . . 1.9099999999999999 112.124 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.18 -43.3 95.52 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 119.435 -0.317 . . . . 1.53 110.815 -165.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.6 80.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.666 0.746 . . . . 0.68000000000000005 110.537 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -66.35 -40.89 90.1 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.512 -0.743 . . . . 2.2200000000000002 110.652 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -56.65 18.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.535 -0.728 . . . . 5.3899999999999997 111.661 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.01 -26.09 39.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-O 118.236 -0.887 . . . . 1.8999999999999999 111.41 -175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.46 -60.63 3.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.878 -1.156 . . . . 2.48 107.878 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -60.83 -33.03 72.42 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.321 -0.399 . . . . 2.7200000000000002 111.49 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -72.59 -71.25 0.3 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 119.963 -0.695 . . . . 3.9700000000000002 110.465 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 mt -53.78 -29.88 42.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.132 1.373 . . . . 1.73 111.454 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -34.72 -45.99 0.27 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.801 1.641 . . . . 2.7999999999999998 111.63 170.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.79 78.44 0.54 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.365 1.066 . . . . 4.6900000000000004 108.206 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.91 -68.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 107.291 -1.374 . . . . 1.45 107.291 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -136.41 -106.14 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.437 0.695 . . . . 2.71 109.233 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 54.14 4.69 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 118.696 0.68 . . . . 0.76000000000000001 111.521 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 117.94 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.824 1.65 . . . . 0.71999999999999997 108.115 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.91 -45.66 41.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.038 -0.727 . . . . 0.59999999999999998 109.038 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -152.24 166.82 30.58 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.876 -0.787 . . . . 0.68000000000000005 108.876 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.48 69.48 5.36 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.426 0.528 . . . . 0.44 112.426 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.3 130.94 18.22 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.842 1.695 . . . . 0.56000000000000005 110.677 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 m -93.86 137.56 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 1.9099999999999999 109.61 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -86.26 171.37 11.3 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.825 -1.176 . . . . 1.97 107.825 167.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.09 9.25 3.8 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.489 0.715 . . . . 2.3199999999999998 112.333 169.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.32 -51.13 3.01 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.693 1.197 . . . . 1.0700000000000001 109.601 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -86.39 -12.85 48.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.222 0.609 . . . . 1.28 111.076 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 63.5 44.13 5.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.998 1.719 . . . . 2.6800000000000002 111.573 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 34.8 p -122.27 163.91 18.82 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.238 1.415 . . . . 0.71999999999999997 110.809 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.32 133.58 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.779 1.232 . . . . 0.65000000000000002 108.485 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -82.12 136.18 35.2 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.378 -2.082 . . . . 0.66000000000000003 105.378 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 128' ' ' LEU . 12.4 p -110.88 126.46 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 104.877 -2.268 . . . . 0.56000000000000005 104.877 166.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.36 98.18 7.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 104.994 -2.225 . . . . 3.8500000000000001 104.994 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -149.79 169.71 20.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.562 0.949 . . . . 2.0899999999999999 113.562 -165.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.26 102.8 10.37 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.51 1.124 . . . . 2.0600000000000001 109.737 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.59 4.7 3.8 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.517 . . . . 0.65000000000000002 112.446 -171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -34.3 15.67 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.952 0.901 . . . . 7.6200000000000001 109.315 171.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -90.57 -33.79 15.75 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.596 0.758 . . . . 2.8100000000000001 109.243 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.76 -175.12 3.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.385 0.674 . . . . 0.68999999999999995 109.607 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.4 m -158.93 169.53 24.14 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.479 1.112 . . . . 2.0600000000000001 108.975 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' H ' HG13 ' A' ' 125' ' ' VAL . 4.0 m -48.29 -38.71 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 2.25 113.915 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 m -54.43 -40.18 68.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.349 -0.844 . . . . 0.81999999999999995 110.962 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.51 -45.74 92.7 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.718 -0.845 . . . . 2.25 108.718 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD12 ' CZ ' ' A' ' 78' ' ' PHE . 23.5 mt -61.52 -47.15 86.91 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.246 0.618 . . . . 1.4299999999999999 111.447 177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -58.46 -40.94 84.03 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 119.17 -0.443 . . . . 2.7000000000000002 110.721 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.65 -48.23 70.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.303 1.049 . . . . 3.1600000000000001 110.63 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.47 -49.96 66.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.513 1.125 . . . . 0.73999999999999999 110.039 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.719 HG11 ' HB2' ' A' ' 139' ' ' LEU . 2.4 p -68.36 -30.61 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 111.85 0.315 . . . . 1.6899999999999999 111.85 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.26 -38.78 84.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.268 -1.012 . . . . 3.73 108.268 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -63.19 -7.14 5.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.886 1.439 . . . . 2.73 114.886 173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.22 -26.06 14.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.294 1.037 . . . . 0.94999999999999996 111.037 164.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.75 40.74 7.54 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.494 1.045 . . . . 0.91000000000000003 111.133 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.38 -169.38 1.84 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.338 1.055 . . . . 2.3199999999999998 108.331 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -134.0 122.64 23.33 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.883 -1.155 . . . . 4.0199999999999996 107.883 175.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.719 ' HB2' HG11 ' A' ' 132' ' ' VAL . 15.4 tp -114.6 127.87 56.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.017 1.727 . . . . 2.5899999999999999 106.624 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -119.11 172.39 7.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.144 1.378 . . . . 3.1699999999999999 108.071 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mp -96.48 155.41 16.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.761 -1.199 . . . . 2.4300000000000002 107.761 169.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -76.3 99.6 4.84 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.92 -1.511 . . . . 3.5699999999999998 106.92 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.65 -40.94 3.07 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 115.041 -0.981 . . . . 3.6000000000000001 111.511 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -74.37 57.47 0.7 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.159 0.984 . . . . 5.3300000000000001 110.384 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -178.71 -55.75 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 128.587 2.755 . . . . 11.460000000000001 104.887 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.78 35.15 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.374 1.07 . . . . 11.970000000000001 111.133 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.93 25.97 7.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.036 1.734 . . . . 10.76 113.647 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -83.05 74.11 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.915 -1.116 . . . . 10.77 109.106 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -145.43 154.52 42.34 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 105.981 -1.859 . . . . 12.039999999999999 105.981 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.18 -178.0 47.0 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 109.9 -1.28 . . . . 11.800000000000001 109.9 -173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 126.201 1.8 . . . . 14.68 110.36 -169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 119.141 -0.457 . . . . 13.01 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.4 mt 70.5 -61.32 0.47 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.672 1.589 . . . . 10.68 111.9 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 m -74.13 48.25 0.31 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.892 1.277 . . . . 4.5199999999999996 112.725 -175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.82 73.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.427 1.891 . . . . 4.6699999999999999 107.332 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -57.7 129.83 43.66 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.038 -0.983 . . . . 2.0600000000000001 108.735 172.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 147.96 46.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.354 0.409 . . . . 4.4699999999999998 109.942 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -82.39 154.98 24.95 Favored 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 124.714 1.259 . . . . 2.5 109.196 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -138.13 130.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.422 -1.695 . . . . 2.2400000000000002 106.422 157.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.52 124.88 48.62 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.982 1.313 . . . . 0.93999999999999995 108.414 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 48.4 mtm -148.21 155.35 41.26 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.394 0.543 . . . . 2.0 111.138 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.94 123.48 30.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.914 1.286 . . . . 1.8400000000000001 109.445 173.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -118.49 138.16 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.341 1.456 . . . . 0.62 109.137 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 m -102.83 164.2 11.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.712 1.205 . . . . 0.77000000000000002 110.456 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.91 -3.74 74.18 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.808 -0.917 . . . . 0.64000000000000001 110.808 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 13.8 mtm -67.81 104.73 1.75 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.004 -0.703 . . . . 2.7999999999999998 111.479 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -67.3 -13.1 61.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.25 0.62 . . . . 1.5700000000000001 111.252 167.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.0 m 75.18 53.15 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.568 1.147 . . . . 5.1900000000000004 109.341 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -173.58 -117.08 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.057 -1.831 . . . . 2.5 106.057 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.16 -31.62 43.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.153 0.981 . . . . 1.21 112.607 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -65.08 -58.23 6.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.897 0.856 . . . . 0.71999999999999997 109.505 -174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.64 -53.41 52.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.709 -1.132 . . . . 0.89000000000000001 109.028 176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -39.16 72.7 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.32 -0.4 . . . . 1.1299999999999999 111.876 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -62.3 -42.99 99.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 121.698 -0.626 . . . . 2.4199999999999999 110.004 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -60.34 -60.98 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 107.88 -1.156 . . . . 0.58999999999999997 107.88 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.57 -41.59 81.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.109 0.868 . . . . 3.98 111.758 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -62.35 -46.28 89.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.921 -0.487 . . . . 2.6499999999999999 110.42 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.58 -43.2 94.31 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.2 -0.76 . . . . 1.01 111.2 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -39.24 79.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.027 -0.69 . . . . 1.5800000000000001 110.032 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -18.34 6.15 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.052 0.842 . . . . 1.9299999999999999 112.932 172.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -60.09 -29.7 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 2.7799999999999998 111.752 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.51 147.3 63.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.384 0.673 . . . . 1.8100000000000001 111.106 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.83 -43.97 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.871 2.38 . . . . 1.54 111.671 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.23 -31.22 79.89 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.012 -0.835 . . . . 0.76000000000000001 111.012 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.13 101.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.238 1.015 . . . . 1.3799999999999999 109.314 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 96.5 m -82.44 -47.4 12.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.894 -1.521 . . . . 0.73999999999999999 106.894 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -148.82 156.82 42.86 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.262 -1.014 . . . . 1.6799999999999999 108.262 162.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.15 116.74 13.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.033 -2.21 . . . . 0.57999999999999996 105.033 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.38 163.74 26.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.771 -1.196 . . . . 2.0299999999999998 107.771 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -151.86 116.41 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.981 -1.118 . . . . 0.93999999999999995 107.981 -174.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.75 88.87 6.73 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.021 -1.844 . . . . 3.7799999999999998 106.021 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.03 -3.15 24.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.56 0.744 . . . . 1.76 112.422 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.79 -36.78 28.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.794 0.725 . . . . 1.1200000000000001 109.507 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -106.71 -8.54 16.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.138 0.792 . . . . 0.98999999999999999 113.138 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 69.88 44.38 0.84 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.843 2.457 . . . . 2.25 113.219 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -122.33 111.66 17.17 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.315 -0.995 . . . . 1.3100000000000001 108.315 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.78 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.634 -1.617 . . . . 0.48999999999999999 106.634 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -133.95 103.11 5.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.411 1.084 . . . . 2.8199999999999998 108.155 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.24 132.28 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.42 -0.956 . . . . 0.44 108.42 -170.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.22 122.62 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.775 1.23 . . . . 1.3799999999999999 108.759 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' CE2' HG13 ' A' ' 60' ' ' ILE . 39.5 p90 -151.56 171.38 17.68 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 2.3300000000000001 111.909 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.65 120.21 74.92 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.312 -1.313 . . . . 2.2400000000000002 109.871 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -77.63 33.42 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.012 2.475 . . . . 0.93000000000000005 112.498 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.76 8.73 0.44 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.604 0.965 . . . . 1.1499999999999999 113.604 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -117.16 -45.16 2.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.398 1.079 . . . . 2.0299999999999998 110.231 170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.9 m -113.59 -85.72 0.59 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.682 -1.229 . . . . 0.94999999999999996 107.682 -161.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.93 129.06 4.22 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.526 -1.03 . . . . 0.87 110.526 168.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.9 t -30.83 -49.34 0.12 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.544 1.937 . . . . 1.1499999999999999 113.366 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.07 90.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.917 0.487 . . . . 1.1899999999999999 110.994 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.16 -35.18 79.13 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.505 -0.747 . . . . 0.96999999999999997 110.819 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.408 HG13 ' CE2' ' A' ' 50' ' ' TYR . 17.6 mm -61.3 -54.59 33.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 108.406 -0.961 . . . . 0.91000000000000003 108.406 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.63 -39.0 89.73 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.095 -0.335 . . . . 2.0699999999999998 110.095 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -56.5 -44.33 80.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.305 -0.628 . . . . 3.9199999999999999 109.305 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -63.84 -47.25 81.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 120.943 -1.098 . . . . 3.8300000000000001 110.276 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.5 mt -51.23 -49.78 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.682 -0.488 . . . . 0.5 109.682 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -64.75 -46.95 80.02 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.292 -0.563 . . . . 2.5800000000000001 112.01 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -56.28 -35.46 67.49 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.704 -0.622 . . . . 3.1299999999999999 111.779 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -11.89 59.54 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.404 0.52 . . . . 2.3500000000000001 112.404 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.05 41.91 4.81 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.22 0.915 . . . . 0.60999999999999999 111.275 176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -126.51 177.07 6.72 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.961 1.304 . . . . 2.1200000000000001 108.922 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -143.6 137.62 28.47 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.684 -0.487 . . . . 2.1699999999999999 109.684 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -89.76 139.32 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.618 1.167 . . . . 0.58999999999999997 109.175 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.56 59.22 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.711 -1.218 . . . . 1.1000000000000001 107.711 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 m -123.41 136.49 54.65 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.646 0.778 . . . . 1.05 109.445 -164.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.59 144.15 47.76 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.2 0.524 . . . . 4.2999999999999998 110.941 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -84.56 83.99 7.82 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 127.165 2.186 . . . . 2.8399999999999999 110.429 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 143.11 27.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.46 -0.781 . . . . 0.66000000000000003 109.229 177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 9.7 mt-10 -97.18 128.06 43.72 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.017 1.28 . . . . 2.8900000000000001 111.717 172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -112.7 144.28 42.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.427 1.491 . . . . 2.3599999999999999 108.618 171.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -100.17 151.5 21.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.304 1.842 . . . . 1.5700000000000001 107.903 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.7 mt -124.46 111.78 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 119.54 1.064 . . . . 0.95999999999999996 111.046 -168.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -93.38 76.67 4.5 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.648 -2.353 . . . . 2.6299999999999999 104.648 168.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.28 -50.09 0.03 OUTLIER Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.498 -1.228 . . . . 1.76 111.939 -168.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -46.17 152.14 0.43 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.648 1.179 . . . . 4.1100000000000003 112.512 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . 0.261 14.9 t 62.57 32.26 16.54 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.508 1.923 . . . . 4.75 112.638 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.6 t -116.51 -47.55 2.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.913 0.885 . . . . 7.4900000000000002 110.635 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -167.9 65.72 0.08 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.868 0.867 . . . . 5.3600000000000003 110.665 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.3 34.63 9.17 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 1.75 112.095 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.32 -47.63 60.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.784 -0.644 . . . . 1.1000000000000001 110.143 -162.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.17 -37.12 74.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.547 0.739 . . . . 1.1299999999999999 110.625 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -67.71 -45.53 74.82 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.338 -0.851 . . . . 2.1899999999999999 110.078 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -54.04 -55.51 26.7 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.572 -0.705 . . . . 4.96 111.096 174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.4 pt -60.83 -39.22 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 118.475 -0.774 . . . . 1.8100000000000001 110.623 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -54.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.599 1.09 . . . . 2.29 108.321 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -55.46 -28.72 56.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.442 0.464 . . . . 2.9199999999999999 111.061 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmt-85 -73.04 -71.64 0.29 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.785 0.266 . . . . 3.21 111.563 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -38.33 -47.97 1.28 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 126.379 1.872 . . . . 2.1200000000000001 111.151 -177.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -28.8 -44.87 0.03 OUTLIER 'General case' 0 C--N 1.34 0.168 0 C-N-CA 128.152 2.581 . . . . 1.54 112.369 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 83.34 0.96 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.706 -0.187 . . . . 5.8300000000000001 110.641 160.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.9 mt -65.3 -69.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.633 -0.506 . . . . 2.0499999999999998 109.633 169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -143.99 -58.92 0.39 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.097 0.559 . . . . 2.6099999999999999 110.334 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -128.65 47.58 1.01 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.331 -0.708 . . . . 0.98999999999999999 111.331 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.92 124.73 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.545 -1.28 . . . . 0.91000000000000003 107.545 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.09 16.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.185 -0.672 . . . . 1.0 109.185 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -151.48 168.14 25.81 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.371 0.668 . . . . 0.97999999999999998 110.024 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.42 63.23 3.6 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.612 0.967 . . . . 0.94999999999999996 113.612 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.22 137.2 36.44 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.613 1.542 . . . . 1.0600000000000001 111.073 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -102.05 135.66 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 C-N-CA 124.574 1.15 . . . . 2.1099999999999999 110.188 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.94 -33.67 51.52 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 119.416 -0.326 . . . . 3.02 110.893 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 68.23 -63.6 0.33 Allowed 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.675 1.59 . . . . 3.1899999999999999 111.584 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.96 85.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.32 1.048 . . . . 1.55 110.786 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.66 -3.25 57.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.468 0.707 . . . . 1.98 111.728 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 60.1 36.19 21.23 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.594 1.158 . . . . 3.52 111.924 -172.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.5 p -118.87 155.95 30.34 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 123.373 0.669 . . . . 0.88 111.333 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.31 126.72 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.986 1.714 . . . . 0.42999999999999999 108.211 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -83.73 124.12 30.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.048 -1.834 . . . . 1.04 106.048 165.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.09 114.48 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.881 -1.526 . . . . 0.62 106.881 173.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.79 99.09 11.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.295 -1.743 . . . . 3.3300000000000001 106.295 174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -148.27 168.84 21.49 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.008 0.373 . . . . 2.3300000000000001 112.008 -172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -96.16 106.19 26.99 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.81 -1.086 . . . . 2.4700000000000002 108.225 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -82.48 42.61 1.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.54 2.16 . . . . 1.1399999999999999 109.652 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -123.14 -60.43 1.5 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.147 -1.427 . . . . 5.6299999999999999 107.147 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -54.16 -47.88 71.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.966 0.506 . . . . 3.7200000000000002 111.111 169.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.27 -177.11 3.68 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.492 0.717 . . . . 0.81000000000000005 110.301 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.8 m -164.47 169.03 17.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 2.4500000000000002 109.8 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.1 t -36.52 -49.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 126.248 1.819 . . . . 1.55 112.67 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.5 m -61.12 -39.52 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.733 -0.651 . . . . 0.79000000000000004 112.254 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.77 -48.11 82.36 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.208 -0.664 . . . . 2.75 109.208 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -60.69 -46.41 90.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.375 0.67 . . . . 0.97999999999999998 110.296 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -57.23 -52.47 65.21 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.817 -0.611 . . . . 3.0 110.589 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.53 -41.77 73.64 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.786 0.721 . . . . 3.7400000000000002 110.718 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -52.7 64.44 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.309 -0.626 . . . . 0.85999999999999999 109.309 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.9 t -70.4 -27.86 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 118.991 -1.084 . . . . 1.75 111.705 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.22 -51.01 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.208 -0.664 . . . . 3.0 109.208 172.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -51.76 -45.37 63.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.939 0.896 . . . . 3.9399999999999999 112.456 171.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.63 -24.16 67.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.153 0.888 . . . . 1.1000000000000001 111.963 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.01 35.9 5.41 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.355 0.979 . . . . 0.94999999999999996 111.634 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -129.78 -164.57 1.42 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.126 -1.064 . . . . 1.8500000000000001 108.126 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -132.15 125.88 32.31 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.616 -1.254 . . . . 4.3200000000000003 107.616 172.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.0 131.09 54.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.742 -1.207 . . . . 2.54 107.742 -176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -127.68 177.37 6.84 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.326 1.05 . . . . 3.48 109.759 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mp -105.49 147.07 28.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.031 0.932 . . . . 1.8999999999999999 109.43 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 41.3 mtpt -80.77 96.02 6.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.199 -1.408 . . . . 2.7400000000000002 107.199 173.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.92 3.62 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.432 -1.067 . . . . 2.6400000000000001 110.432 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 46.57 54.19 9.04 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.609 1.164 . . . . 5.5700000000000003 110.638 -173.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -174.83 -45.73 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.677 1.191 . . . . 6.7800000000000002 109.269 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -114.55 -6.94 12.82 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.626 0.77 . . . . 6.8399999999999999 112.097 -170.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 p -123.36 4.38 9.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.536 1.934 . . . . 7.5300000000000002 112.157 -170.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.69 77.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.854 0.835 . . . . 7.96 110.608 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.76 94.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.791 1.236 . . . . 14.109999999999999 110.044 165.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 169.48 -50.82 0.21 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.538 -0.839 . . . . 14.119999999999999 114.736 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.064 -1.445 . . . . 16.07 110.481 -161.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.59 1.33 . . . . 13.0 114.59 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.29 111.12 2.13 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.914 1.234 . . . . 8.9499999999999993 107.921 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 62.95 74.73 0.42 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.784 0.834 . . . . 4.3899999999999997 111.454 171.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -72.27 56.34 0.34 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.393 1.077 . . . . 4.3099999999999996 110.193 171.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -69.21 157.29 37.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.078 -1.082 . . . . 2.2000000000000002 108.078 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.22 45.23 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.566 -1.272 . . . . 2.46 107.566 174.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.94 158.85 20.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.134 0.896 . . . . 3.8500000000000001 109.93 171.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.96 109.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.692 -1.225 . . . . 2.04 107.692 162.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.91 126.67 38.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.465 -0.939 . . . . 0.56999999999999995 108.465 173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 93.2 mtp -145.06 167.07 23.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.165 0.586 . . . . 2.0699999999999998 109.876 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.413 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 3.6 tt0 -105.31 126.27 51.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.154 1.382 . . . . 2.6800000000000002 109.244 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -125.66 152.57 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.662 1.985 . . . . 0.83999999999999997 107.22 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 m -118.49 165.88 13.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.467 1.107 . . . . 0.89000000000000001 109.93 174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.2 -10.35 28.99 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.311 1.434 . . . . 0.81000000000000005 110.448 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.39 103.28 1.96 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.868 -0.784 . . . . 2.77 111.421 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -58.47 -18.55 29.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.503 1.121 . . . . 1.48 111.454 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.5 t 82.95 27.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.237 1.415 . . . . 3.6299999999999999 111.014 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.7 123.56 3.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.322 -2.473 . . . . 3.23 104.322 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.3 -27.55 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 115.929 1.825 . . . . 1.6499999999999999 115.929 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.87 -54.72 34.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.727 1.211 . . . . 0.94999999999999996 109.601 -172.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.62 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -45.66 -57.16 4.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.659 -1.155 . . . . 0.83999999999999997 110.475 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.14 69.77 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.118 -0.364 . . . . 1.02 111.656 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -45.72 91.91 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.646 0.778 . . . . 3.5699999999999998 110.285 174.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.84 -56.1 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.444 -0.947 . . . . 0.85999999999999999 108.444 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -50.37 -51.35 46.68 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 119.603 1.092 . . . . 4.0300000000000002 110.209 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -63.26 -48.6 77.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.715 0.406 . . . . 1.79 111.138 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.97 -42.72 92.9 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.357 -0.697 . . . . 0.67000000000000004 111.357 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.26 -39.88 71.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.045 0.938 . . . . 1.6000000000000001 110.146 177.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -20.83 16.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.999 0.818 . . . . 2.25 112.253 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -61.05 -28.59 69.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.326 0.651 . . . . 2.5299999999999998 112.279 173.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -78.13 146.07 70.47 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 123.476 0.71 . . . . 1.5800000000000001 109.896 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.16 -47.18 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.802 2.335 . . . . 1.25 111.586 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.62 -15.62 77.68 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.328 -0.707 . . . . 0.58999999999999997 111.579 -172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.59 106.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 118.191 0.996 . . . . 1.3400000000000001 108.707 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.7 m -84.16 -49.91 8.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.048 -1.093 . . . . 0.73999999999999999 108.048 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -151.03 97.56 2.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.352 0.596 . . . . 2.75 109.971 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -95.06 116.41 28.67 Favored 'General case' 0 C--O 1.23 0.038 0 C-N-CA 124.401 1.08 . . . . 0.66000000000000003 109.35 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -129.68 150.88 50.81 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 109.127 -0.694 . . . . 1.8200000000000001 109.127 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG13 ' HB1' ' A' ' 21' ' ' ALA . 2.2 p -145.63 121.47 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 122.07 0.938 . . . . 1.48 111.915 170.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -81.48 84.35 6.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.737 -1.209 . . . . 1.79 107.737 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -48.28 -29.6 4.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.27 1.028 . . . . 2.7000000000000002 111.565 167.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.51 -25.54 62.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.501 1.12 . . . . 1.6799999999999999 112.369 -176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.3 p -126.5 15.09 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.026 0.375 . . . . 1.45 110.776 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 46.77 65.47 1.21 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.503 1.521 . . . . 1.98 110.923 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.1 m -144.99 113.0 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.835 -1.166 . . . . 0.95999999999999996 109.425 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.76 121.36 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 107.988 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -119.65 98.46 6.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.92 -1.141 . . . . 2.9100000000000001 107.92 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.8 130.97 50.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 108.309 -0.997 . . . . 0.46000000000000002 108.309 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.4 mt -112.54 123.4 68.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.733 -1.21 . . . . 1.21 107.733 174.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -153.13 173.62 15.26 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.524 0.202 . . . . 1.75 111.078 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -91.24 122.56 66.1 Favored Pre-proline 0 N--CA 1.447 -0.622 0 O-C-N 124.327 1.017 . . . . 2.2999999999999998 109.564 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.91 34.15 0.5 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.678 2.252 . . . . 0.87 112.233 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.35 21.93 0.29 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.036 0.754 . . . . 1.02 113.036 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -132.47 -46.85 0.89 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.548 1.139 . . . . 1.8100000000000001 109.692 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 m -104.69 -79.33 0.55 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.043 -1.095 . . . . 0.71999999999999997 108.043 -168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.07 124.0 4.69 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 109.011 -1.636 . . . . 0.66000000000000003 109.011 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.4 t -34.25 -45.26 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.282 1.833 . . . . 0.88 113.418 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.5 -42.08 86.83 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.551 -0.718 . . . . 1.03 111.796 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.41 -34.27 72.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.379 -0.826 . . . . 0.81999999999999995 110.846 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 mm -57.63 -54.59 29.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.726 -1.213 . . . . 0.64000000000000001 107.726 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.81 -39.78 95.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.44 -0.791 . . . . 1.74 110.388 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -49.6 -46.96 49.82 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.123 0.874 . . . . 3.48 109.438 174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -45.86 72.41 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.659 -0.497 . . . . 2.3300000000000001 109.659 -173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -51.24 -52.57 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 109.643 -0.502 . . . . 0.87 109.643 173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -59.63 -54.57 44.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.01 0.524 . . . . 1.8600000000000001 111.035 -176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -60.05 -31.55 70.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.541 0.571 . . . . 2.7000000000000002 112.541 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -12.84 50.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.94 0.791 . . . . 2.0899999999999999 112.335 173.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.83 42.3 2.31 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 124.679 1.133 . . . . 1.1100000000000001 110.794 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -131.55 176.01 8.68 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.431 1.092 . . . . 2.2000000000000002 110.24 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.03 134.98 22.56 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 117.788 0.267 . . . . 1.96 111.142 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.05 133.82 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.055 0.942 . . . . 0.56000000000000005 110.216 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.8 t -87.68 64.18 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.164 -1.05 . . . . 1.04 108.164 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.47 HG23 ' C ' ' A' ' 118' ' ' TYR . 8.7 m -128.9 132.03 47.65 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.99 0.916 . . . . 0.82999999999999996 108.671 -166.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -118.45 137.62 53.04 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.27 0.628 . . . . 3.1699999999999999 110.499 -169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.8 72.25 9.88 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.314 1.045 . . . . 4.5300000000000002 110.084 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 155.78 26.21 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.839 -0.8 . . . . 0.64000000000000001 108.839 -176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -121.43 130.18 53.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 122.073 0.939 . . . . 2.7799999999999998 111.33 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -127.87 155.94 43.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.401 1.481 . . . . 1.79 109.053 -172.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -113.29 145.99 40.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 128.215 2.606 . . . . 2.5699999999999998 107.884 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.27 138.83 47.69 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.067 0 N-CA-C 108.613 -0.884 . . . . 0.82999999999999996 108.613 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.93 85.33 2.24 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.054 -1.461 . . . . 2.23 107.054 166.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.08 54.61 0.09 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.299 -0.723 . . . . 2.8399999999999999 113.097 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.793 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -100.93 -24.19 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.373 1.087 . . . . 3.7799999999999998 111.708 167.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.3 m -79.87 71.12 6.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.079 1.352 . . . . 4.8799999999999999 109.889 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.6 t -143.73 84.0 1.78 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.334 -0.987 . . . . 6.29 108.334 166.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.57 -67.46 0.16 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.783 1.633 . . . . 3.6000000000000001 110.899 -166.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 41.47 0.11 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.525 0.33 . . . . 1.77 110.759 -168.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.9 m -71.89 -36.7 70.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.367 -0.933 . . . . 1.47 109.569 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' A' ' 83' ' ' MET . . . -54.01 -50.51 66.46 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.291 0.567 . . . . 0.68000000000000005 109.649 170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -57.48 -44.9 85.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.027 -0.669 . . . . 2.2000000000000002 110.073 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -61.56 -47.31 86.1 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.358 -0.839 . . . . 3.8399999999999999 111.601 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -38.2 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.044 0.938 . . . . 2.8300000000000001 109.355 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.6 -64.33 0.91 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.708 1.603 . . . . 2.6400000000000001 107.406 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -48.65 -36.74 16.62 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.876 0.47 . . . . 2.9900000000000002 111.418 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -72.56 -66.44 0.66 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.343 -0.543 . . . . 5.3899999999999997 110.713 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 99' ' ' ILE . 12.7 mt -52.98 -32.21 44.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.758 0.823 . . . . 2.0099999999999998 111.68 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -41.5 -39.4 1.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.96 2.104 . . . . 1.78 112.497 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 74.58 0.99 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.214 0.606 . . . . 5.9299999999999997 109.681 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 96' ' ' LEU . 35.3 mt -62.77 -59.83 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.149 -1.056 . . . . 3.3199999999999998 108.149 173.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.73 -99.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.19 -1.782 . . . . 4.5800000000000001 106.19 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.37 53.59 4.8 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 119.767 1.167 . . . . 0.71999999999999997 111.79 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.8 t -113.96 119.26 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.421 1.488 . . . . 0.60999999999999999 107.321 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -50.7 37.99 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.205 -0.665 . . . . 0.65000000000000002 109.205 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -151.71 167.46 28.13 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.337 1.055 . . . . 0.73999999999999999 108.783 -174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.6 68.84 2.35 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.252 0.464 . . . . 0.64000000000000001 112.252 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.47 133.98 25.46 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.814 1.676 . . . . 0.69999999999999996 110.896 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.597 HG11 ' HB1' ' A' ' 89' ' ' ALA . 55.4 t -107.84 144.67 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 126.089 1.755 . . . . 2.5299999999999998 108.99 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.91 156.64 18.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.806 0.842 . . . . 1.9199999999999999 109.048 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -7.67 14.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.391 1.076 . . . . 2.54 112.429 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 -45.25 5.24 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.028 0.931 . . . . 1.6599999999999999 109.549 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.4 mt -84.5 -17.93 37.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.491 0.716 . . . . 1.3500000000000001 111.922 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.91 48.01 23.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.817 1.247 . . . . 4.3799999999999999 111.229 -161.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 p -123.17 163.01 21.42 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.332 0.653 . . . . 0.84999999999999998 109.83 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.72 132.13 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.649 1.18 . . . . 0.59999999999999998 108.392 174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m -83.75 138.32 33.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.411 -2.07 . . . . 0.70999999999999996 105.411 164.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 128' ' ' LEU . 12.1 p -115.66 118.84 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.337 -1.727 . . . . 0.60999999999999999 106.337 169.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.5 92.83 4.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.919 -1.882 . . . . 2.6000000000000001 105.919 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.47 ' C ' HG23 ' A' ' 73' ' ' THR . 3.8 p90 -143.75 171.68 13.87 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.017 0.377 . . . . 2.0099999999999998 112.017 -172.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.5 t-20 -100.36 101.18 13.94 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.574 1.171 . . . . 2.25 109.203 -170.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.09 7.18 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.086 2.524 . . . . 0.60999999999999999 113.117 -169.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -37.33 13.13 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.175 0.99 . . . . 7.3700000000000001 108.439 171.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.6 -42.8 16.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.012 -0.736 . . . . 2.5899999999999999 109.012 -172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -131.77 -177.84 4.61 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.95 0.9 . . . . 0.52000000000000002 108.726 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 m -161.02 169.37 22.65 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 124.465 1.106 . . . . 2.1699999999999999 108.528 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.4 t -34.5 -47.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.876 1.67 . . . . 1.73 113.644 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 m -50.04 -44.24 51.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.322 0.649 . . . . 0.81000000000000005 112.126 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.85 -49.34 78.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.262 1.425 . . . . 2.2200000000000002 109.572 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 116' ' ' VAL . 39.5 mt -58.99 -50.88 72.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.695 0.798 . . . . 1.52 110.494 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -55.95 -47.97 76.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.484 -0.78 . . . . 3.1000000000000001 109.939 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.34 -44.54 94.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.742 0.701 . . . . 2.8900000000000001 110.498 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.12 -53.77 38.65 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.645 -1.284 . . . . 0.79000000000000004 109.634 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' A' ' 139' ' ' LEU . 76.5 t -65.74 -29.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.929 -0.482 . . . . 1.55 112.035 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -57.33 -52.3 65.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.351 0.523 . . . . 4.0599999999999996 110.091 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -44.97 82.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.206 0.602 . . . . 2.6099999999999999 111.028 176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.8 -37.8 80.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.141 0.882 . . . . 0.98999999999999999 111.288 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.08 42.42 3.04 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.673 1.13 . . . . 0.87 111.885 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.7 -154.02 0.61 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.721 -1.214 . . . . 1.9199999999999999 107.721 168.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 152.26 42.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.582 1.083 . . . . 4.5199999999999996 108.651 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -121.69 144.32 48.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.725 1.21 . . . . 1.8 108.731 -175.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -131.78 160.66 34.93 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.847 2.059 . . . . 2.1899999999999999 107.787 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mp -93.24 152.55 19.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.36 -0.607 . . . . 1.73 109.36 173.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -78.33 79.47 4.77 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.647 -0.872 . . . . 2.8199999999999998 108.647 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 -60.81 3.84 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.412 1.006 . . . . 2.4700000000000002 110.909 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 51.13 38.43 20.86 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.333 1.453 . . . . 4.1299999999999999 111.8 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -156.84 -55.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.546 1.939 . . . . 6.5700000000000003 107.693 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -128.36 1.33 5.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.174 0.99 . . . . 7.0899999999999999 111.325 -161.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t -132.32 23.61 4.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.696 1.198 . . . . 7.8700000000000001 108.875 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.0 mt -70.29 76.04 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.362 -0.607 . . . . 8.0899999999999999 109.362 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -51.01 99.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.83 1.252 . . . . 15.039999999999999 110.941 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.24 -34.62 1.62 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.715 -1.047 . . . . 14.609999999999999 114.56 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-N 118.649 1.224 . . . . 15.32 109.944 -162.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 108.518 -0.919 . . . . 14.74 108.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -135.15 167.83 20.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.196 0.998 . . . . 8.2100000000000009 108.833 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -169.77 162.14 9.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.162 -1.792 . . . . 4.0 106.162 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -144.34 60.67 1.35 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.186 -1.042 . . . . 5.0999999999999996 108.186 170.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -63.46 153.24 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.782 -0.644 . . . . 2.2999999999999998 109.635 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -106.68 168.45 9.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.472 -0.936 . . . . 2.2799999999999998 108.472 161.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.51 138.74 51.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.264 -2.495 . . . . 2.4900000000000002 104.264 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.24 127.28 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.906 -2.257 . . . . 2.54 104.906 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.92 107.24 11.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.375 -1.343 . . . . 0.87 107.375 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.2 mtp -132.11 168.44 17.99 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.122 0.969 . . . . 1.78 109.172 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.6 148.75 22.2 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.181 0.446 . . . . 2.7200000000000002 110.255 173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.99 163.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.746 1.618 . . . . 0.82999999999999996 108.205 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -149.28 162.78 39.35 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.763 -0.586 . . . . 1.5900000000000001 110.595 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -7.6 33.36 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.363 1.458 . . . . 1.0600000000000001 110.432 -165.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.595 ' HE2' HD12 ' A' ' 24' ' ' ILE . 46.4 mtt -74.44 117.31 16.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.796 -0.826 . . . . 3.3100000000000001 110.691 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 -30.16 22.56 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.666 -0.697 . . . . 1.52 109.641 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -173.42 171.29 4.0 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.886 -0.509 . . . . 4.0800000000000001 110.442 -172.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.08 -31.86 3.7 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.469 1.508 . . . . 3.5600000000000001 113.136 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.92 80.71 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.787 0.722 . . . . 1.4299999999999999 111.944 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.4 m -62.89 -53.79 48.63 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 122.187 0.994 . . . . 0.93000000000000005 108.375 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -45.4 -60.45 2.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.995 -1.457 . . . . 0.67000000000000004 111.478 171.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.58 72.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.434 0.694 . . . . 0.93000000000000005 110.804 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -48.57 80.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.082 -0.386 . . . . 2.25 110.617 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HE2' ' A' ' 15' ' ' MET . 58.7 mt -57.54 -62.06 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.447 -0.945 . . . . 0.67000000000000004 108.447 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -58.17 -37.19 74.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.968 0.804 . . . . 3.96 111.506 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -64.17 -44.16 92.93 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 118.381 0.537 . . . . 1.8999999999999999 110.763 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.07 94.14 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.447 -0.661 . . . . 0.64000000000000001 111.447 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.17 -36.38 71.98 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.608 1.163 . . . . 1.6200000000000001 110.726 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -25.76 3.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.221 1.008 . . . . 2.2200000000000002 111.662 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -18.27 65.27 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.722 0.638 . . . . 4.4199999999999999 112.722 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mmt -80.92 143.25 53.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 118.417 0.553 . . . . 1.45 110.716 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 -42.97 2.05 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.601 2.201 . . . . 1.3200000000000001 111.239 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.87 -16.54 74.63 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.845 -0.975 . . . . 0.85999999999999999 111.441 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -66.38 109.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 118.905 1.353 . . . . 1.3 109.356 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -88.29 -50.91 6.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.092 -0.707 . . . . 0.91000000000000003 109.092 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -148.52 99.88 3.06 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.008 0.432 . . . . 2.9199999999999999 110.419 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.68 117.24 30.59 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.925 1.29 . . . . 0.71999999999999997 109.534 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -139.04 165.83 26.09 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.492 0.717 . . . . 2.27 110.028 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -155.51 126.23 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.607 0.763 . . . . 1.03 109.623 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -85.67 85.63 7.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.893 -1.521 . . . . 2.4100000000000001 106.893 168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -28.95 46.83 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.834 0.35 . . . . 3.1499999999999999 111.253 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.92 -29.79 60.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.77 1.228 . . . . 1.5700000000000001 111.663 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.3 p -122.88 13.87 9.91 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.551 0.74 . . . . 1.45 110.43 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 46.29 39.69 6.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.314 1.446 . . . . 3.0099999999999998 112.892 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.5 m -106.59 104.15 13.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.522 -1.288 . . . . 1.1399999999999999 107.522 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -83.76 119.41 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.614 -1.254 . . . . 0.46999999999999997 107.614 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -123.8 101.17 7.13 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.866 1.266 . . . . 3.3900000000000001 109.055 -175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.09 132.6 65.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.46 -0.941 . . . . 0.47999999999999998 108.46 -172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.85 122.62 69.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.597 1.559 . . . . 1.21 107.334 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CZ ' HG13 ' A' ' 60' ' ' ILE . 34.4 p90 -158.7 169.22 24.88 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 112.126 0.417 . . . . 2.4100000000000001 112.126 -170.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -87.21 124.05 69.0 Favored Pre-proline 0 N--CA 1.449 -0.479 0 O-C-N 123.805 0.691 . . . . 2.48 110.282 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.74 38.78 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.794 2.33 . . . . 1.0800000000000001 111.792 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 27.63 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.151 0.501 . . . . 1.1799999999999999 112.336 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -143.69 -47.95 0.29 Allowed 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.196 1.399 . . . . 1.9399999999999999 107.991 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -102.53 -86.2 0.43 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.535 -1.283 . . . . 0.92000000000000004 107.535 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.45 121.07 3.86 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 107.165 -2.374 . . . . 0.83999999999999997 107.165 177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -41.06 -43.47 2.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.914 1.286 . . . . 0.88 113.453 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.38 73.13 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.03 -0.419 . . . . 0.90000000000000002 111.395 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.7 70.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 111.554 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 3.3 mm -61.16 -54.29 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 107.344 -1.354 . . . . 0.82999999999999996 107.344 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -63.1 -37.71 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.771 -0.455 . . . . 2.04 109.771 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -55.59 -40.33 71.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.756 0.422 . . . . 4.0099999999999998 110.029 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.3 -44.36 71.94 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 121.427 -0.796 . . . . 2.3100000000000001 109.362 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.6 mm -51.74 -50.0 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.934 0.494 . . . . 1.8999999999999999 109.713 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.53 -49.63 74.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.571 -0.252 . . . . 2.02 111.33 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -54.79 -36.68 65.17 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.376 -0.827 . . . . 2.5699999999999998 113.016 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -13.89 62.4 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.562 0.619 . . . . 1.9399999999999999 112.396 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.75 41.37 5.38 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.154 0.883 . . . . 0.59999999999999998 111.238 176.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CG ' HD11 ' A' ' 24' ' ' ILE . 72.7 m-85 -126.43 175.37 7.92 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.632 1.173 . . . . 1.99 108.929 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.27 51.52 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 108.886 -0.783 . . . . 2.5699999999999998 108.886 176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.6 m -94.92 140.77 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.712 0.805 . . . . 0.56000000000000005 109.454 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.8 t -85.46 89.64 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.943 -1.873 . . . . 1.48 105.943 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -156.81 130.77 8.36 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.267 -1.383 . . . . 0.81000000000000005 107.267 -172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -123.33 136.11 54.51 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.84 0.856 . . . . 3.75 111.043 -170.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -88.08 94.3 9.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.611 1.564 . . . . 4.4800000000000004 110.963 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.05 158.79 15.28 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.514 0.725 . . . . 0.58999999999999997 110.655 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -117.84 128.35 54.76 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.569 1.148 . . . . 3.54 110.303 173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -122.77 148.07 45.78 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.896 1.279 . . . . 2.04 108.93 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -103.1 139.68 38.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.723 2.009 . . . . 1.76 108.714 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.526 HD11 ' HB ' ' A' ' 114' ' ' VAL . 8.9 mt -116.32 125.96 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 120.433 1.47 . . . . 0.80000000000000004 111.123 -165.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -117.87 101.03 7.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.238 -1.023 . . . . 2.4100000000000001 108.238 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.94 -55.63 0.25 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.325 -1.11 . . . . 1.53 110.325 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.09 125.3 21.03 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 122.478 -0.425 . . . . 2.7200000000000002 110.11 172.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.8 t -124.63 -4.94 7.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.027 1.331 . . . . 3.46 109.952 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.92 161.53 42.5 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.34 -1.355 . . . . 5.2800000000000002 107.34 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.1 69.72 0.76 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.738 1.215 . . . . 6.7300000000000004 110.768 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 -57.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.528 1.131 . . . . 1.96 109.778 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.15 -44.39 95.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.481 -0.933 . . . . 1.1200000000000001 108.481 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.88 82.46 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.923 0.889 . . . . 0.88 109.989 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -60.5 -46.23 90.89 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.783 -0.573 . . . . 1.73 109.683 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -59.42 -48.6 81.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.607 -0.683 . . . . 3.8900000000000001 110.79 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.48 -43.73 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.576 -0.527 . . . . 2.7599999999999998 109.576 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -58.17 -58.79 6.9 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.646 -1.242 . . . . 2.3599999999999999 107.646 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -54.73 -28.08 45.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.082 0.553 . . . . 3.6899999999999999 111.259 -176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -72.51 -71.3 0.3 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.164 0.438 . . . . 3.29 111.063 169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.13 -40.69 11.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.007 1.323 . . . . 1.55 111.376 -173.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -29.62 -41.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.274 2.63 . . . . 1.7 113.314 172.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.85 60.62 0.93 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.529 0.332 . . . . 4.4900000000000002 111.118 173.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 102' ' ' VAL . 61.0 mt -74.12 94.11 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.557 -1.275 . . . . 4.0800000000000001 107.557 159.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 63.98 -74.15 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.098 1.759 . . . . 3.8900000000000001 114.277 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.42 41.99 1.46 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.142 0.877 . . . . 0.68999999999999995 110.962 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ILE . 81.7 t -97.01 129.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 124.294 1.038 . . . . 0.60999999999999999 108.832 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.11 -49.86 11.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.145 -0.687 . . . . 0.65000000000000002 109.145 169.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -145.67 162.72 36.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.044 -0.41 . . . . 0.85999999999999999 110.505 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.24 64.13 2.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.798 1.036 . . . . 0.5 113.798 176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.23 134.37 24.8 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.738 1.625 . . . . 0.56000000000000005 111.139 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.09 150.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 125.322 1.449 . . . . 1.79 110.103 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.35 153.64 32.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.012 1.325 . . . . 1.73 108.612 173.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -125.81 24.25 7.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.456 1.103 . . . . 2.8199999999999998 110.794 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.76 -37.47 1.54 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.961 1.704 . . . . 1.46 111.247 -173.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.77 -6.98 20.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.898 1.279 . . . . 1.4299999999999999 110.276 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 56.21 37.16 28.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.812 1.645 . . . . 3.7400000000000002 112.01 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.4 p -114.45 164.76 13.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.644 0.778 . . . . 0.76000000000000001 110.448 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' A' ' 80' ' ' ILE . 4.3 p -125.56 132.59 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.509 1.523 . . . . 0.40000000000000002 107.24 167.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -82.59 132.92 35.18 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.179 -2.156 . . . . 0.68000000000000005 105.179 164.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.6 131.77 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.484 -2.043 . . . . 0.67000000000000004 105.484 168.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -125.25 90.67 3.27 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.277 -1.749 . . . . 3.5299999999999998 106.277 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' A' ' 102' ' ' VAL . 6.2 p90 -145.75 167.6 22.76 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.318 0.488 . . . . 2.0899999999999999 112.318 -165.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -82.48 107.77 9.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.123 0.969 . . . . 2.4500000000000002 109.903 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -75.99 3.62 5.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.086 2.524 . . . . 0.79000000000000004 112.852 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -42.79 8.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.995 -1.113 . . . . 6.7599999999999998 107.995 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -52.07 54.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.473 -0.936 . . . . 4.2599999999999998 108.473 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.97 178.34 5.57 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 109.094 -0.706 . . . . 0.67000000000000004 109.094 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 84.2 p -153.27 167.57 28.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.803 -0.561 . . . . 2.1200000000000001 109.603 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.613 ' HA ' HD12 ' A' ' 128' ' ' LEU . 28.3 m -51.05 -38.44 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 123.511 0.724 . . . . 1.9299999999999999 112.854 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 m -53.44 -41.75 66.42 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.624 0.647 . . . . 0.81000000000000005 111.593 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.34 -46.86 78.56 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.971 0.891 . . . . 2.0899999999999999 109.041 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 125' ' ' VAL . 23.5 mt -59.6 -44.25 93.46 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.19 -0.913 . . . . 1.0600000000000001 109.669 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -54.47 -57.99 9.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.433 -0.58 . . . . 3.4300000000000002 109.433 170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -54.83 -39.43 68.54 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.397 0.544 . . . . 3.8900000000000001 111.99 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.08 -57.09 13.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.162 0.585 . . . . 0.73999999999999999 109.826 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.64 -30.79 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 121.55 -0.719 . . . . 1.48 111.179 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.29 -46.06 69.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.225 -0.657 . . . . 2.6099999999999999 109.225 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -39.04 91.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.003 0.521 . . . . 3.54 111.632 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.76 -29.2 70.44 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.348 0.522 . . . . 0.69999999999999996 111.282 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.91 36.78 8.21 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.987 -0.845 . . . . 0.72999999999999998 110.987 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.43 -159.27 0.93 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.176 -1.786 . . . . 2.25 106.176 166.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 153.24 40.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.741 0.701 . . . . 4.3700000000000001 109.311 168.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.46 149.26 25.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.82 0.7 . . . . 1.3600000000000001 109.935 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.52 167.47 12.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.067 1.747 . . . . 2.8300000000000001 107.944 165.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -111.79 136.47 51.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.296 -1.002 . . . . 1.6200000000000001 108.296 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -79.38 84.95 5.23 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.793 -1.188 . . . . 2.9700000000000002 107.793 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.73 -68.92 3.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.984 -1.246 . . . . 2.2200000000000002 109.984 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 43.99 56.56 4.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.382 1.073 . . . . 3.7400000000000002 111.254 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -178.6 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.356 1.862 . . . . 6.3399999999999999 108.162 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.98 -11.19 14.67 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.243 0.617 . . . . 7.1200000000000001 112.571 -165.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 p -102.18 -14.6 16.97 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.0 1.72 . . . . 7.3099999999999996 113.007 -177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.1 mm -81.63 57.94 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.948 0.899 . . . . 8.4800000000000004 110.13 -168.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -152.78 -75.23 0.13 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.199 1.8 . . . . 12.27 108.584 170.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.4 75.57 1.21 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 107.877 -2.089 . . . . 15.08 107.877 -161.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.156 0 CA-C-O 116.996 -1.478 . . . . 19.190000000000001 110.173 -174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 105.52 -2.029 . . . . 13.48 105.52 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 92.33 0.64 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.381 0.992 . . . . 10.640000000000001 111.147 -169.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -168.88 54.04 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.648 0.779 . . . . 4.71 110.118 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -121.87 50.43 1.44 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.613 0.72 . . . . 4.9699999999999998 109.239 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -66.93 141.32 57.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.777 -0.577 . . . . 2.0499999999999998 110.113 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -108.05 167.63 9.86 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.221 -1.029 . . . . 2.3300000000000001 108.221 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -118.35 140.65 49.51 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.145 1.378 . . . . 2.7000000000000002 108.054 166.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -133.37 124.99 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.926 -1.138 . . . . 2.0600000000000001 107.926 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.97 127.48 55.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.837 -1.542 . . . . 0.75 106.837 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.6 mtp -145.52 161.31 40.05 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.023 0.929 . . . . 2.0800000000000001 108.999 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -90.22 144.38 25.91 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.278 0.49 . . . . 1.79 110.108 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -132.68 150.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 126.196 1.798 . . . . 0.53000000000000003 107.165 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.1 m -114.1 167.31 10.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.983 0.913 . . . . 0.70999999999999996 111.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.66 -5.26 70.17 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.012 0.815 . . . . 0.67000000000000004 111.526 -176.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 ttm -62.2 95.87 0.07 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.009 0.909 . . . . 2.5899999999999999 110.535 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -82.59 -13.17 57.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.819 -0.628 . . . . 1.25 110.836 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 t 62.17 41.48 10.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 123.742 1.734 . . . . 3.4399999999999999 109.35 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.56 90.14 1.3 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.826 -2.657 . . . . 4.1500000000000004 103.826 175.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.79 -23.12 0.16 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.222 1.564 . . . . 1.46 115.222 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -59.94 -60.28 4.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 120.15 1.341 . . . . 0.70999999999999996 108.335 -173.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -45.26 -57.37 4.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.885 -1.052 . . . . 0.77000000000000002 110.629 171.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -38.52 73.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.78000000000000003 111.3 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -43.61 85.54 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.177 0.591 . . . . 2.3700000000000001 110.236 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 HD11 ' CD2' ' A' ' 69' ' ' TYR . 74.1 mt -64.09 -53.45 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.05 -51.31 62.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.688 -0.632 . . . . 3.5899999999999999 110.74 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -63.85 -46.69 83.85 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.972 -0.455 . . . . 1.74 110.852 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.96 94.76 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.775 0.702 . . . . 0.78000000000000003 111.393 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 63' ' ' LYS . 4.1 mm? -71.38 -46.06 61.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.211 -0.582 . . . . 1.45 110.291 177.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -59.33 -16.95 25.34 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.232 0.923 . . . . 2.3100000000000001 112.708 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -55.31 -33.89 63.69 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 2.8999999999999999 112.573 166.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.84 149.48 90.22 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.95 0.9 . . . . 1.46 110.766 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.47 -44.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.758 2.306 . . . . 1.54 111.574 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.44 73.53 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.116 -0.793 . . . . 0.75 111.116 -172.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -59.01 109.4 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.172 0.589 . . . . 1.5 110.0 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.7 m -81.29 -51.19 8.64 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.074 -1.824 . . . . 0.97999999999999998 106.074 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -149.68 156.12 41.35 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 1.79 109.691 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.14 116.55 19.4 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 105.175 -2.157 . . . . 0.63 105.175 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -121.96 160.43 24.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.405 -1.331 . . . . 2.6200000000000001 107.405 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 21' ' ' ALA . 12.7 p -148.75 110.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 122.351 1.072 . . . . 0.93000000000000005 108.914 176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -81.13 72.33 8.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.584 -2.006 . . . . 2.29 105.584 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -52.31 -28.38 18.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.539 1.536 . . . . 1.74 111.776 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.0 62.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.011 0.925 . . . . 1.48 111.492 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.5 p -117.01 13.27 14.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.615 1.166 . . . . 1.3899999999999999 111.119 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 48.72 43.26 20.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.977 1.311 . . . . 2.1099999999999999 113.052 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -113.73 112.67 23.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 133.4 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.87 -1.159 . . . . 0.52000000000000002 107.87 172.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -129.76 107.43 9.4 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.718 -1.586 . . . . 2.8700000000000001 106.718 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.98 130.5 63.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.386 -0.968 . . . . 0.48999999999999999 108.386 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.2 mt -116.06 117.34 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.445 -1.317 . . . . 1.25 107.445 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.41 172.0 19.28 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.123 -0.36 . . . . 1.9399999999999999 111.612 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.95 124.76 66.4 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.135 -0.691 . . . . 2.3300000000000001 109.135 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 43.0 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.745 2.297 . . . . 0.91000000000000003 111.37 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.01 29.34 0.08 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.261 0.553 . . . . 1.52 111.623 -173.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -149.36 -44.63 0.14 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.231 1.412 . . . . 1.77 108.507 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 m -113.0 -87.91 0.55 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.781 -1.192 . . . . 0.83999999999999997 107.781 -169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.57 126.0 3.99 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.186 -1.566 . . . . 0.66000000000000003 109.186 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -35.43 -46.74 0.4 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.723 1.609 . . . . 0.81999999999999995 113.244 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.14 -41.06 78.4 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.51 0.324 . . . . 0.93999999999999995 111.13 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.48 70.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.48 -0.763 . . . . 0.78000000000000003 111.374 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.4 mm -64.34 -56.11 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.685 -1.228 . . . . 0.63 107.685 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -59.02 -39.96 83.5 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.417 -0.586 . . . . 2.1899999999999999 109.417 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -55.52 -44.09 76.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.923 -0.399 . . . . 2.4700000000000002 109.923 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -66.73 -43.14 85.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 3.0 109.047 -173.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.62 -49.69 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.519 0.6 . . . . 0.66000000000000003 109.708 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -57.18 -54.24 49.05 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 120.794 -0.362 . . . . 2.5499999999999998 111.783 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.29 -22.54 62.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.804 0.298 . . . . 4.1900000000000004 111.804 -172.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.86 -10.03 59.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.545 0.738 . . . . 2.0899999999999999 111.629 168.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.28 36.49 7.53 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.221 0.915 . . . . 0.59999999999999998 111.429 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 24' ' ' ILE . 66.0 m-85 -126.89 153.01 46.29 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.235 -1.024 . . . . 2.0600000000000001 108.235 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.99 145.34 35.68 Favored 'General case' 0 C--N 1.334 -0.085 0 N-CA-C 108.669 -0.863 . . . . 2.4700000000000002 108.669 -177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.3 137.64 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.61 0.764 . . . . 0.94999999999999996 109.086 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.27 81.3 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 106.504 -1.665 . . . . 1.1599999999999999 106.504 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.76 136.88 29.34 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.322 -0.992 . . . . 1.01 108.322 -173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.39 141.24 50.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.747 0.654 . . . . 3.6499999999999999 110.598 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -84.18 82.76 8.23 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 127.374 2.27 . . . . 2.6800000000000002 109.096 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.51 140.56 32.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.966 -1.124 . . . . 0.84999999999999998 107.966 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -97.07 108.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.16 0.984 . . . . 3.3100000000000001 108.816 -173.391 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -106.59 148.15 28.63 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.003 0.921 . . . . 2.3100000000000001 109.2 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -101.68 153.6 19.63 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.828 2.051 . . . . 1.8700000000000001 108.922 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 114' ' ' VAL . 9.7 mt -126.81 124.61 65.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 119.753 1.16 . . . . 0.62 110.295 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -105.36 70.56 0.89 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 105.903 -1.888 . . . . 2.7999999999999998 105.903 169.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.15 -50.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.28 -0.873 . . . . 1.78 112.719 -168.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.66 81.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.051 2.14 . . . . 4.6900000000000004 111.271 172.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.8 t -156.94 30.79 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.143 0.977 . . . . 3.9900000000000002 110.021 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 t -160.98 168.47 24.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 6.1299999999999999 107.821 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -5.72 -69.8 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 C-N-CA 129.278 3.031 . . . . 3.8500000000000001 115.339 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.32 48.49 0.37 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.447 -0.575 . . . . 1.8999999999999999 109.447 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.29 -54.59 43.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.513 -0.551 . . . . 0.76000000000000001 109.513 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.78 71.09 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 110.74 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.99 -48.53 76.07 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.399 -0.813 . . . . 2.5099999999999998 109.891 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -58.52 -47.77 83.05 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.645 -0.659 . . . . 4.0899999999999999 110.874 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -45.85 45.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 C-N-CA 124.501 1.12 . . . . 3.1400000000000001 109.813 176.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 94' ' ' LYS . 1.5 tm-20 -59.66 -62.16 2.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.241 -1.392 . . . . 2.0299999999999998 107.241 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -51.94 -32.11 31.65 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.471 0.482 . . . . 3.8500000000000001 111.908 -178.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmt-85 -70.33 -70.68 0.28 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.007 0.367 . . . . 3.1600000000000001 111.239 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mt -43.03 -44.85 4.95 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.167 1.387 . . . . 1.53 110.715 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -28.37 -44.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 128.442 2.697 . . . . 1.5900000000000001 112.669 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.93 67.19 0.86 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 110.367 -0.234 . . . . 4.0199999999999996 110.367 170.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mm -61.85 -61.16 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.645 -0.502 . . . . 1.54 109.645 170.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.09 -93.88 0.11 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.82 -1.548 . . . . 2.6600000000000001 106.82 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.17 48.76 2.96 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.549 -0.719 . . . . 0.81999999999999995 111.674 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.87 127.49 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.067 -1.086 . . . . 0.68000000000000005 108.067 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.18 -48.89 10.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.048 -0.723 . . . . 0.93000000000000005 109.048 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -148.57 162.18 40.19 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 120.984 0.421 . . . . 1.1799999999999999 110.549 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.95 56.42 1.42 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 113.182 0.808 . . . . 0.83999999999999997 113.182 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.37 140.24 52.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.984 1.79 . . . . 0.93999999999999995 111.046 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -103.32 142.58 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.498 1.519 . . . . 1.99 109.634 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.3 -34.86 55.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 122.318 -0.239 . . . . 3.0899999999999999 110.662 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 65.45 -61.36 0.24 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 126.19 1.796 . . . . 3.7200000000000002 112.135 -167.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -28.51 68.34 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.175 0.99 . . . . 1.3100000000000001 112.29 -169.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.0 mt -108.68 -0.42 20.12 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.441 1.096 . . . . 2.1299999999999999 111.344 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 56.67 51.42 11.07 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.42 1.088 . . . . 2.6499999999999999 112.383 -174.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.1 p -130.1 158.46 39.59 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.911 0.884 . . . . 0.84999999999999998 111.634 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' A' ' 80' ' ' ILE . 10.3 p -135.96 124.29 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.23 1.412 . . . . 0.51000000000000001 108.347 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.5 m -85.32 109.35 18.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.166 -1.79 . . . . 1.1200000000000001 106.166 170.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.18 113.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.211 -1.403 . . . . 0.67000000000000004 107.211 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -106.52 92.15 3.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.483 -1.673 . . . . 2.8999999999999999 106.483 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -145.89 167.72 22.57 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.001 -0.545 . . . . 1.8300000000000001 111.603 -166.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -84.38 110.9 30.1 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.83 0.852 . . . . 2.1200000000000001 109.228 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -78.85 16.04 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.847 2.364 . . . . 0.69999999999999996 112.488 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -106.04 -49.25 3.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.954 0.902 . . . . 5.7800000000000002 109.992 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -57.09 -56.88 15.99 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.82 -0.437 . . . . 3.0299999999999998 109.82 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.0 -178.71 3.72 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.854 0.861 . . . . 0.51000000000000001 109.257 -174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -156.98 174.66 15.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.938 0.495 . . . . 2.2400000000000002 110.338 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.0 t -44.11 -47.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.43 1.492 . . . . 1.6200000000000001 110.688 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 -43.88 70.06 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.396 0.678 . . . . 0.62 111.733 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -66.34 -45.13 81.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 122.047 0.927 . . . . 2.6099999999999999 109.708 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.77 -42.08 92.5 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.518 -0.765 . . . . 0.81000000000000005 110.157 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -58.54 -56.29 24.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 4.0499999999999998 109.911 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -50.14 -40.94 47.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.127 0.876 . . . . 3.2400000000000002 111.532 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.99 -57.17 9.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.704 -0.623 . . . . 0.83999999999999997 110.702 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.54 -31.31 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 O-C-N 121.193 -0.942 . . . . 1.8100000000000001 111.464 -171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -35.73 71.25 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.829 -0.804 . . . . 3.25 108.829 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -73.56 -24.16 60.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.56 0.948 . . . . 2.6299999999999999 113.56 171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -22.59 61.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.708 1.14 . . . . 0.92000000000000004 110.443 166.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 36.14 10.14 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.894 -0.883 . . . . 0.81999999999999995 110.894 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -133.67 172.93 12.09 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 107.849 -1.167 . . . . 2.1400000000000001 107.849 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -120.34 123.72 43.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.691 -1.596 . . . . 2.8300000000000001 106.691 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.9 154.01 21.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.463 -0.569 . . . . 1.6699999999999999 109.463 168.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -132.58 171.5 13.72 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.855 2.062 . . . . 4.5700000000000003 106.869 173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.9 mp -120.69 150.04 41.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.822 0.849 . . . . 1.9399999999999999 111.428 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 1.3 mptm? -77.27 86.22 3.7 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.185 -1.043 . . . . 3.1600000000000001 108.185 173.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.87 -48.77 4.11 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 118.939 -0.923 . . . . 2.73 112.11 169.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 49.19 21.4 0.51 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.173 1.789 . . . . 7.2400000000000002 114.059 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -148.14 -54.88 0.21 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.48 1.512 . . . . 6.3700000000000001 108.687 -172.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -150.31 22.45 0.84 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.497 0.719 . . . . 8.1400000000000006 110.461 -165.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.64 16.3 2.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.642 -0.661 . . . . 6.96 111.335 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.9 -62.4 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 122.439 0.296 . . . . 8.3900000000000006 110.758 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.6 -178.9 6.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.684 -1.598 . . . . 12.949999999999999 106.684 -176.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -76.92 -104.79 0.15 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.957 1.265 . . . . 11.32 113.597 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.304 -1.808 . . . . 14.94 108.91 -169.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 118.463 -0.779 . . . . 14.24 109.834 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp 59.7 54.65 4.34 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.0 -1.111 . . . . 12.359999999999999 108.0 -160.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m 65.52 174.19 0.22 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.745 1.618 . . . . 4.9500000000000002 110.803 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -76.74 55.47 1.07 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.666 0.786 . . . . 6.25 109.966 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -103.73 165.14 11.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.215 -1.772 . . . . 3.0099999999999998 106.215 164.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 146.06 28.39 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.01 0.434 . . . . 2.0899999999999999 110.549 165.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.5 147.39 22.93 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.78 2.032 . . . . 3.0699999999999998 109.153 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.8 tt -144.13 132.7 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.219 -1.355 . . . . 2.1099999999999999 108.198 162.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.5 50.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.801 1.64 . . . . 0.64000000000000001 107.114 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 51.4 mtm -148.34 157.95 43.8 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 1.9099999999999999 110.559 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -86.86 139.94 30.16 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 122.942 0.497 . . . . 1.9199999999999999 111.621 171.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.44 146.55 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 127.291 2.236 . . . . 0.55000000000000004 109.266 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -101.95 175.88 5.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.454 1.101 . . . . 1.1000000000000001 112.12 -172.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.98 67.62 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.827 0.727 . . . . 0.73999999999999999 111.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 mmt -69.11 84.37 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.936 0.894 . . . . 3.04 110.212 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -67.61 -7.58 27.59 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.47 -0.787 . . . . 1.21 111.253 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.7 t 74.44 56.43 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.463 1.125 . . . . 3.6800000000000002 109.459 160.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 176.97 -105.81 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.333 2.253 . . . . 2.5600000000000001 106.312 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.29 -24.4 65.76 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.543 0.942 . . . . 1.2 113.543 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -60.13 -54.01 50.95 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.899 0.857 . . . . 1.0 109.714 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -47.32 -59.24 3.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.646 -1.161 . . . . 0.92000000000000004 111.067 169.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.64 70.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.415 0.447 . . . . 0.81999999999999995 110.655 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -48.99 74.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.059 0.543 . . . . 2.0899999999999999 110.735 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mt -63.35 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.322 -0.621 . . . . 0.67000000000000004 109.322 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -57.57 -51.35 69.85 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.112 0.565 . . . . 3.6499999999999999 110.46 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -60.14 -43.91 95.36 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.828 -0.545 . . . . 2.0699999999999998 110.383 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.81 96.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.773 -0.931 . . . . 0.66000000000000003 110.773 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 60' ' ' ILE . 11.7 mt -71.34 -50.48 31.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 2.6899999999999999 111.479 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -20.21 30.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.462 0.705 . . . . 3.3399999999999999 111.704 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -53.5 -33.25 53.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.155 0.982 . . . . 3.2599999999999998 112.71 169.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -81.14 139.9 49.25 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.09 1.356 . . . . 1.3600000000000001 108.962 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -64.17 -44.48 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.63 2.22 . . . . 1.3999999999999999 112.432 -172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.08 -12.87 83.61 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.782 -0.574 . . . . 0.65000000000000002 112.017 -168.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -60.04 106.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.531 -0.914 . . . . 1.3799999999999999 108.531 175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.8 m -82.93 -58.71 2.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.155 -2.165 . . . . 0.85999999999999999 105.155 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -142.82 103.93 4.27 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.42 -0.585 . . . . 2.6400000000000001 109.42 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.01 120.02 36.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 107.494 -1.298 . . . . 0.65000000000000002 107.494 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -132.1 153.41 50.5 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.239 -1.023 . . . . 1.6399999999999999 108.239 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -145.64 122.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.971 0.891 . . . . 0.85999999999999999 109.692 168.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -79.56 75.26 6.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.209 -2.145 . . . . 2.2799999999999998 105.209 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.41 -18.49 6.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.91 0.884 . . . . 2.1600000000000001 112.165 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.56 78.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.68 0.792 . . . . 1.1599999999999999 111.527 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.7 p -121.31 5.97 10.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.989 0.916 . . . . 1.1299999999999999 112.618 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 62.34 42.49 9.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.347 1.859 . . . . 1.8100000000000001 112.14 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -122.08 110.75 16.16 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.284 -1.006 . . . . 0.90000000000000002 108.284 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.8 127.41 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 124.412 1.085 . . . . 0.39000000000000001 108.696 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -123.75 112.48 17.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.081 -1.451 . . . . 2.9900000000000002 107.081 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -118.09 130.15 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.506 -0.924 . . . . 0.53000000000000003 108.506 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -113.6 123.65 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.861 -1.533 . . . . 1.4299999999999999 106.861 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -155.92 165.26 37.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 112.632 0.604 . . . . 2.02 112.632 -172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.12 126.67 90.19 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.913 0.885 . . . . 3.21 109.766 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.78 12.69 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.905 3.07 . . . . 1.4099999999999999 114.533 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.79 -34.15 2.42 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.733 1.213 . . . . 2.0899999999999999 111.2 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.23 -41.49 20.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.078 0.551 . . . . 1.9099999999999999 112.419 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 m -111.06 -80.62 0.58 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.043 -1.095 . . . . 1.01 108.043 -155.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.48 126.75 5.86 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.712 -1.355 . . . . 0.70999999999999996 109.712 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 t -29.71 -49.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.14 1.776 . . . . 1.3100000000000001 112.819 169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.73 98.42 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.669 0.387 . . . . 1.1399999999999999 110.956 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.97 -37.31 78.72 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.351 -0.843 . . . . 0.95999999999999996 110.61 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG23 HD21 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -61.71 -53.09 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.067 -1.457 . . . . 0.68999999999999995 107.067 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -37.62 88.21 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.88 -0.6 . . . . 3.48 109.883 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.86 -40.2 75.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.205 -0.665 . . . . 2.6200000000000001 109.205 175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -50.87 71.9 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 122.948 0.499 . . . . 2.1800000000000002 109.985 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.62 -47.03 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.74 -0.467 . . . . 0.57999999999999996 109.74 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -62.59 -54.4 40.23 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.692 0.256 . . . . 1.71 111.692 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -57.07 -34.04 67.87 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.662 0.785 . . . . 2.1699999999999999 111.917 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -4.87 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.044 0.538 . . . . 2.1800000000000002 112.037 176.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.25 40.78 5.37 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.824 -0.91 . . . . 0.65000000000000002 110.824 170.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -134.04 177.19 7.93 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.298 1.039 . . . . 1.8600000000000001 109.459 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -138.41 146.58 42.37 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.631 -0.877 . . . . 1.8200000000000001 108.631 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.16 142.91 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.831 1.252 . . . . 0.48999999999999999 109.433 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.32 55.99 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.844 -1.169 . . . . 0.81999999999999995 107.844 -175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -128.56 135.13 48.96 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 124.234 1.014 . . . . 0.81999999999999995 109.402 -165.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -133.77 139.65 46.46 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.824 0.85 . . . . 3.3300000000000001 110.135 -167.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -83.75 89.18 7.12 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.003 1.721 . . . . 3.8500000000000001 110.328 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.93 130.88 35.36 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.798 -0.445 . . . . 0.76000000000000001 109.798 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -91.87 114.12 26.57 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.96 0.8 . . . . 2.3300000000000001 110.075 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -111.22 142.61 43.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.61 -0.885 . . . . 2.2000000000000002 108.61 174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -92.94 149.19 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.909 1.684 . . . . 1.53 107.368 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 mt -120.67 129.23 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 120.305 1.412 . . . . 0.57999999999999996 112.101 -172.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.26 99.91 8.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.381 -0.97 . . . . 2.4900000000000002 108.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.42 -55.75 0.2 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.568 -0.349 . . . . 1.45 112.541 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.58 121.39 11.47 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.623 -0.34 . . . . 3.2400000000000002 111.825 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.9 p -135.69 10.11 3.39 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.996 0.918 . . . . 3.8999999999999999 111.2 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.85 -107.26 0.32 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.123 -1.066 . . . . 4.4100000000000001 108.123 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -166.0 43.6 0.07 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.835 0.854 . . . . 5.0499999999999998 108.776 -174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.5 -48.48 0.13 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.069 0.548 . . . . 2.1200000000000001 111.662 -169.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.9 m -57.27 -45.69 83.79 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.325 0.511 . . . . 0.89000000000000001 109.891 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.37 74.23 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.381 0.672 . . . . 0.77000000000000002 111.189 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -69.63 -42.16 74.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.466 -0.938 . . . . 2.02 108.466 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.58 -51.49 67.12 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.85 -0.531 . . . . 5.1399999999999997 111.399 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.23 -40.48 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 118.409 -0.805 . . . . 2.0299999999999998 110.684 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -54.67 -58.68 6.58 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.49 1.041 . . . . 3.0699999999999998 108.303 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -54.67 -27.41 39.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.843 -0.599 . . . . 4.46 112.07 -176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -73.85 -70.89 0.35 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 118.746 -1.182 . . . . 3.75 111.112 166.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.7 mt -42.8 -43.91 4.2 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.969 1.308 . . . . 1.4399999999999999 111.722 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -29.29 -47.49 0.06 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 128.12 2.568 . . . . 1.53 113.056 172.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.6 81.6 0.74 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.837 -0.431 . . . . 5.54 109.837 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.35 -82.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.283 -1.747 . . . . 1.6100000000000001 106.283 160.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -121.97 -102.03 0.41 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.39 -0.967 . . . . 4.0300000000000002 108.39 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.46 52.01 4.6 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 118.303 0.501 . . . . 0.71999999999999997 112.473 -169.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.24 114.97 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.318 -1.364 . . . . 0.60999999999999999 107.318 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.76 -48.01 60.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.373 -0.603 . . . . 0.63 109.373 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -152.32 169.03 23.51 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.215 1.006 . . . . 0.81999999999999995 108.852 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.26 64.11 2.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.952 1.093 . . . . 0.56000000000000005 113.952 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.2 133.37 26.41 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.77 1.647 . . . . 0.72999999999999998 111.735 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.8 m -99.49 145.07 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.718 1.607 . . . . 1.75 109.995 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -116.4 153.38 32.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.08 0.952 . . . . 2.2400000000000002 109.262 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.05 24.48 8.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.76 1.624 . . . . 3.1000000000000001 110.477 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -128.1 -35.21 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.984 1.314 . . . . 1.46 111.857 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.85 -15.77 18.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.622 1.169 . . . . 1.53 110.493 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.77 51.67 1.79 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.363 1.865 . . . . 3.9399999999999999 111.259 -172.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.8 p -136.49 162.58 32.68 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.629 -1.169 . . . . 0.69999999999999996 111.861 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.38 132.83 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 124.992 1.317 . . . . 0.46999999999999997 108.075 160.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 83.5 m -84.52 118.83 24.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.144 -2.169 . . . . 0.68999999999999995 105.144 160.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -103.9 113.07 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.67000000000000004 107.539 172.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -94.9 96.72 9.5 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 106.4 -1.704 . . . . 2.8399999999999999 106.4 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -144.23 169.9 17.02 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.002 0.43 . . . . 1.8500000000000001 111.611 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.26 96.06 7.76 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 125.652 1.581 . . . . 2.5099999999999998 107.221 -168.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.19 28.65 0.43 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.021 2.48 . . . . 0.69999999999999996 112.252 -166.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -112.18 -47.86 3.08 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.664 1.586 . . . . 5.7300000000000004 108.334 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -65.48 -52.85 49.93 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 110.159 -0.311 . . . . 2.6899999999999999 110.159 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.89 -176.51 3.06 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.962 0.905 . . . . 0.56000000000000005 110.23 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.4 169.07 25.08 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 110.153 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 141' ' ' LEU . 4.2 t -49.49 -42.64 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.66 0.784 . . . . 1.48 110.841 176.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -54.92 -45.39 74.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.486 -0.769 . . . . 0.70999999999999996 112.125 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.86 -49.37 78.01 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 122.193 0.997 . . . . 2.1400000000000001 109.664 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.9 mt -59.3 -47.68 84.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.768 -1.105 . . . . 0.97999999999999998 110.193 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -55.73 -53.46 56.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.552 -0.737 . . . . 3.0 109.977 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.6 -43.36 56.64 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.665 0.745 . . . . 2.6400000000000001 110.814 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.91 -52.75 62.79 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.804 -0.56 . . . . 0.56999999999999995 111.229 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.81 -29.4 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 O-C-N 121.274 -0.891 . . . . 1.49 111.041 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.09 -50.71 72.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.818 0.847 . . . . 3.23 108.791 170.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -51.67 -44.35 63.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.504 0.593 . . . . 2.5699999999999998 111.818 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.12 -19.22 65.88 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.337 0.517 . . . . 0.79000000000000004 111.902 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 28.94 9.53 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.365 0.983 . . . . 1.02 112.12 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -132.08 -168.98 2.13 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.808 -1.182 . . . . 2.6400000000000001 107.808 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 151.23 44.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.001 0.819 . . . . 3.3799999999999999 111.006 167.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.04 141.06 31.46 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.028 0.931 . . . . 1.4199999999999999 109.097 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -107.36 167.51 9.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.95 1.3 . . . . 2.77 107.706 162.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 125' ' ' VAL . 2.1 mp -115.14 135.27 54.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.793 -1.188 . . . . 1.71 107.793 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -80.84 94.98 6.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.975 0.807 . . . . 3.1899999999999999 108.901 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.53 -46.16 3.61 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.21 -1.156 . . . . 1.99 110.21 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -44.31 -28.04 0.49 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.892 1.677 . . . . 4.4800000000000004 114.012 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -140.06 19.18 2.45 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.241 -0.912 . . . . 8.5700000000000003 112.94 163.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.61 1.33 10.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.55 1.14 . . . . 10.220000000000001 111.537 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 30.1 t -164.51 34.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.793 0.837 . . . . 6.4000000000000004 111.465 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.6 mm -75.97 -67.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.484 0.584 . . . . 8.5700000000000003 110.593 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.31 176.87 5.9 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.604 -0.887 . . . . 16.239999999999998 108.604 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.42 -38.83 6.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.588 1.09 . . . . 16.0 110.381 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 . . . . . 0 C--O 1.252 1.209 0 CA-C-O 116.204 -1.855 . . . . 21.219999999999999 111.31 176.228 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 107.482 -1.303 . . . . 15.49 107.482 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.76 174.12 3.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.829 0.452 . . . . 8.6300000000000008 110.053 166.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.4 t -156.95 138.46 13.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.675 -1.972 . . . . 4.7300000000000004 105.675 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -121.46 59.39 0.96 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.036 1.334 . . . . 5.4900000000000002 108.369 -174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.09 141.94 38.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.07 1.348 . . . . 2.4399999999999999 109.925 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.7 ptmm? -91.61 160.67 15.27 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.691 -0.855 . . . . 2.4500000000000002 108.691 171.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.32 157.67 15.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.467 1.107 . . . . 2.8999999999999999 108.716 154.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.84 138.65 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.956 -1.498 . . . . 2.7999999999999998 106.956 153.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.15 129.69 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.185 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 32.7 mtm -143.89 175.66 9.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.682 0.793 . . . . 1.6699999999999999 109.374 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -100.7 151.46 21.63 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.04 0.936 . . . . 2.4700000000000002 109.497 171.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.76 149.41 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.411 1.484 . . . . 0.56999999999999995 107.838 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.2 m -116.16 168.14 10.38 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.89 1.276 . . . . 0.80000000000000004 110.889 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.52 -4.97 84.1 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.394 0.997 . . . . 0.68000000000000005 111.438 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.8 mtm -69.24 80.47 0.35 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.276 1.036 . . . . 2.7799999999999998 110.887 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.8 m -77.49 -28.34 52.19 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.282 -1.326 . . . . 1.8799999999999999 109.522 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.9 t -169.0 168.15 10.3 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.305 0.642 . . . . 4.4800000000000004 109.436 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.78 -44.62 2.27 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.337 1.455 . . . . 2.9300000000000002 113.121 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.86 -39.78 71.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.94 -54.6 36.03 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.502 -0.925 . . . . 0.90000000000000002 108.502 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -49.7 -49.48 47.51 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.708 0.766 . . . . 0.79000000000000004 111.158 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -34.0 74.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.629 1.172 . . . . 0.82999999999999996 111.507 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -46.8 87.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.658 0.663 . . . . 2.5899999999999999 110.622 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD11 ' CG ' ' A' ' 69' ' ' TYR . 3.1 mp -58.61 -54.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.556 -0.905 . . . . 1.26 108.556 173.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -51.14 -51.17 56.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.485 0.584 . . . . 3.73 110.86 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -68.48 -47.5 66.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.892 -0.41 . . . . 2.1000000000000001 109.892 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.49 58.22 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.765 -0.934 . . . . 0.93000000000000005 110.765 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.72 -43.46 62.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.807 -0.616 . . . . 1.6299999999999999 111.467 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -24.1 5.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.805 0.842 . . . . 2.75 111.359 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -64.49 -18.83 65.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.392 1.077 . . . . 4.3300000000000001 113.761 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.45 163.78 65.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 118.947 0.794 . . . . 1.3600000000000001 110.685 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 -46.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.226 1.951 . . . . 1.21 111.377 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.81 -15.09 81.91 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 118.416 0.553 . . . . 0.72999999999999998 112.087 -168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.74 127.0 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.701 0.8 . . . . 2.23 110.059 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.8 m -88.26 -52.25 5.32 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.914 -1.143 . . . . 1.23 107.914 164.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -149.95 162.9 39.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.561 0.696 . . . . 3.4500000000000002 109.456 173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.44 109.03 6.21 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 104.921 -2.252 . . . . 1.21 104.921 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -112.31 150.85 30.41 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.725 -1.213 . . . . 2.1499999999999999 107.725 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG13 ' HB1' ' A' ' 21' ' ' ALA . 1.5 p -148.91 111.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 122.258 1.028 . . . . 1.3200000000000001 112.312 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -83.12 85.94 7.1 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.307 -1.368 . . . . 2.9100000000000001 107.307 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.05 -33.13 10.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.698 0.799 . . . . 2.02 110.912 167.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.81 69.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.02 0.928 . . . . 1.21 111.756 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.6 p -114.19 14.89 18.26 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.688 0.795 . . . . 1.5 110.691 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 46.73 40.42 8.69 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.75 1.62 . . . . 2.9399999999999999 113.696 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 m -118.77 120.77 38.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.158 0.89 . . . . 1.3700000000000001 108.739 -169.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -92.81 129.05 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.026 0.93 . . . . 0.45000000000000001 108.988 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -121.3 114.45 21.37 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.257 -1.386 . . . . 2.5699999999999998 107.257 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.73 135.14 51.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 119.08 0.854 . . . . 0.5 109.011 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.4 112.3 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.901 1.28 . . . . 1.0600000000000001 107.759 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 52.2 p90 -155.76 177.79 10.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.765 -0.584 . . . . 1.96 110.702 -169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.17 126.01 56.5 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.086 0.955 . . . . 2.8399999999999999 110.034 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.57 15.45 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.286 2.657 . . . . 0.91000000000000003 114.835 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.4 -33.59 1.89 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.093 1.357 . . . . 1.79 111.583 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.21 -43.19 17.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.524 0.602 . . . . 1.97 112.462 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 m -115.83 -81.73 0.61 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.731 -0.84 . . . . 0.96999999999999997 108.731 -159.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.83 127.63 4.78 Favored Glycine 0 C--N 1.337 0.615 0 N-CA-C 109.913 -1.275 . . . . 0.76000000000000001 109.913 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 t -31.63 -47.23 0.12 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.86 2.064 . . . . 0.78000000000000003 113.521 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.37 -43.54 92.84 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.683 -0.636 . . . . 0.78000000000000003 111.413 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.48 73.37 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.017 -1.052 . . . . 0.69999999999999996 110.864 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.6 mm -57.18 -55.37 20.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.305 -0.998 . . . . 0.73999999999999999 108.305 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -61.28 -41.74 97.47 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.272 -0.571 . . . . 2.1200000000000001 109.901 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -53.8 -40.1 66.04 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.139 -0.319 . . . . 2.8300000000000001 110.139 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -45.7 70.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.473 -0.767 . . . . 3.71 109.77 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.8 mt -52.87 -48.19 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 119.222 0.919 . . . . 0.60999999999999999 109.629 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -58.14 -54.09 50.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.264 0.226 . . . . 2.4399999999999999 110.992 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -58.21 -35.2 71.3 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.947 0.721 . . . . 2.1899999999999999 112.947 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.95 -11.5 39.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.965 0.802 . . . . 2.5899999999999999 112.63 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.54 42.01 3.76 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.438 -1.065 . . . . 0.78000000000000003 110.438 173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CG ' HD11 ' A' ' 24' ' ' ILE . 97.0 m-85 -133.16 176.45 8.5 Favored 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 124.437 1.095 . . . . 1.98 109.318 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -135.39 138.22 43.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.422 -0.955 . . . . 2.29 108.422 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 m -83.76 141.42 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.999 0.92 . . . . 0.70999999999999996 108.647 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.3 t -82.84 89.4 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.542 -2.392 . . . . 1.5600000000000001 104.542 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.06 138.33 15.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.951 -0.759 . . . . 0.78000000000000003 108.951 -172.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -128.29 141.71 51.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.47 0.708 . . . . 3.27 109.818 -171.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -87.23 85.32 7.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.079 1.352 . . . . 2.6200000000000001 108.837 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.53 157.95 21.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.112 -0.699 . . . . 0.81000000000000005 109.112 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -123.08 127.06 48.21 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.576 0.75 . . . . 3.0499999999999998 109.42 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.4 136.58 54.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.756 -0.831 . . . . 1.73 108.756 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD2' ' NZ ' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -88.05 142.92 27.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.472 1.909 . . . . 2.2999999999999998 108.194 177.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 92' ' ' ILE . 1.6 mt -120.36 130.68 74.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 118.855 0.752 . . . . 0.76000000000000001 109.971 -168.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -102.03 138.93 38.33 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 120.641 -0.424 . . . . 2.1499999999999999 110.468 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.91 -84.43 0.37 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.531 -1.428 . . . . 3.6299999999999999 109.531 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.4 mtm 30.24 51.71 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.596 1.558 . . . . 3.1499999999999999 113.696 -168.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.9 t -143.58 53.03 1.32 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.37 1.081 . . . . 3.8500000000000001 108.28 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.5 t -148.77 163.83 36.19 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.575 -1.639 . . . . 7.5199999999999996 106.575 169.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -9.06 -63.73 0.0 OUTLIER 'General case' 0 C--N 1.342 0.279 0 C-N-CA 128.956 2.902 . . . . 5.0899999999999999 114.561 -172.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 90' ' ' ASN . . . -160.54 72.6 0.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.807 -0.812 . . . . 2.1800000000000002 108.807 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.1 -58.68 6.91 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.462 -0.773 . . . . 0.93999999999999995 109.289 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.88 66.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.369 1.868 . . . . 0.93999999999999995 109.964 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 2.8 m-20 -66.73 -43.71 83.5 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.064 -0.717 . . . . 2.04 109.064 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -52.74 63.95 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.891 -0.506 . . . . 4.5499999999999998 110.772 174.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.468 ' CD1' HD13 ' A' ' 80' ' ' ILE . 8.7 pt -62.76 -34.77 67.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 118.611 0.642 . . . . 1.72 111.651 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.56 -54.23 49.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.02 0.928 . . . . 2.48 108.609 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.79 -31.87 71.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.84 0.856 . . . . 3.1899999999999999 112.195 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -73.39 -69.68 0.41 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.409 0.55 . . . . 4.3700000000000001 111.095 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.431 ' O ' HG11 ' A' ' 102' ' ' VAL . 35.6 mt -49.2 -34.7 15.3 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.451 1.101 . . . . 1.5900000000000001 110.705 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -27.42 -49.85 0.05 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 127.052 2.141 . . . . 1.3200000000000001 113.515 168.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.92 71.33 0.47 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.314 0.645 . . . . 4.6699999999999999 110.773 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.54 -66.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.439 -0.949 . . . . 1.4199999999999999 108.439 167.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -140.55 -101.12 0.15 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.542 -0.911 . . . . 2.6099999999999999 108.542 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.66 54.6 4.94 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.92 -0.872 . . . . 0.69999999999999996 110.92 -174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 96' ' ' LEU . 28.9 t -110.13 123.27 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.848 1.259 . . . . 0.56999999999999995 107.638 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.86 -53.84 10.35 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.275 -1.009 . . . . 0.72999999999999998 108.275 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -152.75 175.59 12.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.381 1.072 . . . . 0.97999999999999998 109.057 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 68.34 0.62 Allowed Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.425 0.898 . . . . 0.45000000000000001 113.425 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.25 140.24 33.57 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.219 1.946 . . . . 0.51000000000000001 112.069 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.89 140.6 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.798 1.639 . . . . 2.3100000000000001 109.073 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -114.4 145.09 42.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.204 1.002 . . . . 1.79 109.892 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 2.8 35.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.497 1.119 . . . . 2.7200000000000002 112.793 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.62 -18.92 10.77 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.188 0.995 . . . . 2.3300000000000001 112.365 -172.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -112.22 -13.3 13.51 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.62 1.168 . . . . 1.8400000000000001 110.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 54.25 49.16 19.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.56 1.544 . . . . 4.3099999999999996 111.417 -168.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.4 p -130.92 156.04 45.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.354 -0.839 . . . . 1.1100000000000001 111.378 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 80' ' ' ILE . 3.9 p -116.06 130.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.289 1.435 . . . . 0.40999999999999998 107.131 161.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -88.83 125.58 34.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 104.535 -2.394 . . . . 0.63 104.535 163.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.88 120.58 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.386 -1.339 . . . . 0.76000000000000001 107.386 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -104.4 92.93 4.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.464 -1.68 . . . . 2.8799999999999999 106.464 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -146.49 162.51 38.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 111.744 0.275 . . . . 1.96 111.744 -167.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -80.13 110.53 16.65 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 107.916 -1.142 . . . . 2.23 107.916 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -74.64 8.9 2.08 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.928 1.752 . . . . 0.69999999999999996 111.306 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -96.64 -55.91 2.76 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.576 0.625 . . . . 5.5300000000000002 109.605 171.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -48.5 77.78 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.987 0.18 . . . . 2.7999999999999998 110.776 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -125.82 177.39 6.32 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.284 0.634 . . . . 0.55000000000000004 109.299 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 98.7 p -149.67 171.32 16.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.189 0.595 . . . . 2.0299999999999998 110.0 -176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -50.96 -35.08 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.404 0.682 . . . . 1.47 111.368 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.3 m -60.01 -41.35 91.94 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.685 -0.634 . . . . 0.81000000000000005 111.671 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.08 -48.35 82.09 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.713 0.768 . . . . 2.27 109.367 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.57 -45.97 91.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.531 -0.759 . . . . 0.79000000000000004 110.622 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -59.4 -48.18 82.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.221 -0.419 . . . . 2.8399999999999999 110.129 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -52.83 -46.85 67.95 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.189 0.904 . . . . 3.23 111.217 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.02 -55.76 28.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.487 0.715 . . . . 0.62 110.552 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.42 -31.09 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 121.703 -0.623 . . . . 1.6200000000000001 110.663 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -61.18 -42.91 99.42 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.278 -1.008 . . . . 2.96 108.278 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -36.65 79.92 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.838 -0.539 . . . . 4.4500000000000002 111.924 173.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.8 -20.46 65.95 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.74 0.7 . . . . 1.1399999999999999 112.103 170.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.5 30.8 39.19 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.627 0.632 . . . . 0.65000000000000002 111.654 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.72 -153.23 0.52 Allowed 'General case' 0 C--N 1.341 0.231 0 N-CA-C 107.295 -1.372 . . . . 2.2999999999999998 107.295 168.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.06 149.63 29.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.474 -0.935 . . . . 2.8300000000000001 108.474 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -115.41 154.12 29.8 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.959 0.904 . . . . 1.47 109.489 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -126.7 152.79 46.3 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.074 2.55 . . . . 2.48 106.551 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.81 129.08 36.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.358 0.663 . . . . 2.0099999999999998 109.455 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' NZ ' ' OD2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -82.09 70.26 8.97 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 122.554 1.169 . . . . 4.7199999999999998 108.679 176.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.05 -46.81 2.75 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.878 -1.512 . . . . 2.5099999999999998 112.034 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 38.35 52.44 1.69 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.381 1.472 . . . . 4.3300000000000001 111.539 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 69.49 -15.03 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.666 1.987 . . . . 10.9 114.852 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -86.4 -32.9 20.66 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.796 1.238 . . . . 9.5899999999999999 111.19 -171.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 t -137.37 34.6 2.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.54 -1.209 . . . . 6.5899999999999999 111.956 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.9 pt -75.9 54.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.262 -0.899 . . . . 7.9100000000000001 112.894 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -154.83 -172.78 4.32 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.52 -0.737 . . . . 13.17 109.553 172.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.53 73.63 0.22 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.41 -1.476 . . . . 15.66 109.41 -177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 117.17 -1.395 . . . . 19.23 108.917 174.787 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 105.475 -2.046 . . . . 18.82 105.475 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -158.41 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.689 -1.597 . . . . 11.68 106.689 175.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 p -64.08 -174.89 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.466 0.706 . . . . 6.2800000000000002 110.448 167.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 86.79 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 129.017 2.927 . . . . 6.9100000000000001 108.536 -175.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -58.26 119.56 7.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.227 -0.657 . . . . 2.2999999999999998 109.227 -177.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.4 ptmm? -81.96 160.59 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.28 -1.378 . . . . 2.1699999999999999 107.28 175.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.75 148.65 30.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.807 -1.553 . . . . 6.1799999999999997 106.807 161.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.0 tt -135.33 104.8 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.359 -0.978 . . . . 2.1099999999999999 108.359 164.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.7 122.75 33.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.75 1.22 . . . . 0.56000000000000005 109.095 177.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.5 mtp -147.11 163.31 36.72 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.666 0.786 . . . . 2.2400000000000002 109.418 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -91.92 143.4 26.54 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.976 0.807 . . . . 1.72 109.851 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.88 139.64 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -102.81 160.47 14.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.22 1.008 . . . . 0.91000000000000003 110.82 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.1 34.99 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.866 1.222 . . . . 1.0900000000000001 110.303 -172.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.1 mtm -62.05 104.31 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.286 -0.537 . . . . 2.71 111.011 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.1 m -82.93 -10.72 58.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.577 0.751 . . . . 1.3 111.224 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m 71.06 24.66 3.87 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.364 1.066 . . . . 4.2999999999999998 111.286 170.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 93.38 2.28 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.876 -2.268 . . . . 3.3799999999999999 104.876 175.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.84 -19.4 0.11 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.026 1.491 . . . . 1.99 115.026 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.73 -46.11 91.66 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.226 1.41 . . . . 1.1100000000000001 108.665 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.861 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -65.65 -48.17 73.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.24 0.616 . . . . 0.73999999999999999 109.961 173.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.83 66.07 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 123.448 0.699 . . . . 0.96999999999999997 111.629 -177.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -45.2 94.08 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.624 -0.673 . . . . 2.2599999999999998 110.18 174.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -65.19 -52.63 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.097 -1.075 . . . . 0.90000000000000002 108.097 175.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' OE2' HG12 ' A' ' 39' ' ' VAL . 62.4 mt-10 -52.04 -49.99 62.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.218 0.917 . . . . 3.5600000000000001 110.706 -178.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.724 0.81 . . . . 2.0099999999999998 111.254 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.09 -37.9 94.67 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.557 0.599 . . . . 0.94999999999999996 111.636 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.19 -40.13 65.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.936 0.894 . . . . 1.75 110.007 175.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -24.11 5.91 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.55 1.068 . . . . 2.1400000000000001 112.134 173.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -34.26 73.02 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.732 -0.605 . . . . 4.5899999999999999 112.202 173.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -72.49 149.68 91.16 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.924 0.89 . . . . 1.76 109.978 -177.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.27 -48.69 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.84 2.36 . . . . 1.3300000000000001 111.663 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.12 -30.26 73.79 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.91 -0.876 . . . . 0.58999999999999997 110.91 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 72.2 t -56.4 104.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.581 0.752 . . . . 1.3700000000000001 109.973 176.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.7 m -83.38 -55.51 4.28 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.447 -1.316 . . . . 0.93999999999999995 107.447 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.65 102.49 2.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.248 1.023 . . . . 1.8500000000000001 112.189 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.61 120.32 24.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.233 -1.395 . . . . 0.67000000000000004 107.233 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -121.6 157.77 30.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.931 1.292 . . . . 1.72 108.651 -177.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -148.49 107.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 122.512 1.148 . . . . 1.25 110.215 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.45 66.94 8.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.311 -1.366 . . . . 2.3700000000000001 107.311 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 pp -53.04 -28.71 25.89 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.205 1.002 . . . . 1.6599999999999999 112.015 -175.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.36 -27.39 64.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.041 0.936 . . . . 1.21 111.564 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.1 p -120.93 14.28 11.53 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.824 1.25 . . . . 1.0700000000000001 110.335 175.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 46.32 50.69 12.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.282 1.433 . . . . 2.5499999999999998 113.825 -176.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -124.93 131.39 53.43 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.686 -1.598 . . . . 1.1100000000000001 106.686 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.23 134.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.993 1.317 . . . . 0.38 107.877 171.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.65 99.06 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.416 -1.698 . . . . 2.6600000000000001 106.416 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.44 126.95 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.521 -0.918 . . . . 0.68999999999999995 108.521 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.53 120.95 65.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.582 -0.896 . . . . 1.0800000000000001 108.582 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 49.0 p90 -157.06 172.69 18.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.717 0.636 . . . . 2.0299999999999998 112.717 -173.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.84 122.58 68.97 Favored Pre-proline 0 C--O 1.238 0.457 0 N-CA-C 109.025 -0.731 . . . . 2.0 109.025 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.64 45.73 1.84 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.369 2.046 . . . . 0.93999999999999995 111.431 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.3 27.32 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.806 0.669 . . . . 1.4299999999999999 112.806 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -143.66 -45.43 0.28 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.092 1.357 . . . . 2.02 108.796 173.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 m -105.27 -82.3 0.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.194 -1.039 . . . . 1.05 108.194 -171.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.28 123.57 3.69 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.469 -1.852 . . . . 0.94999999999999996 108.469 175.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 t -46.3 -39.96 10.92 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.127 0.971 . . . . 1.1100000000000001 112.961 -175.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.42 -42.65 96.46 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.576 -0.702 . . . . 0.96999999999999997 111.21 176.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.142 -0.974 . . . . 0.87 110.968 179.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mm -55.83 -56.17 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.376 -0.972 . . . . 0.81999999999999995 108.376 174.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -62.54 -38.8 91.4 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 109.897 -0.408 . . . . 1.72 109.897 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -53.42 -40.68 65.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.849 0.295 . . . . 2.71 110.399 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -68.08 -42.0 81.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.017 -1.052 . . . . 2.8300000000000001 110.324 -178.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -54.75 -49.62 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.188 0.595 . . . . 0.82999999999999996 109.575 173.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -65.3 -38.93 91.74 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.121 -0.362 . . . . 1.8799999999999999 111.258 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -61.46 -31.98 71.95 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.135 -0.978 . . . . 4.9000000000000004 111.568 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.91 1.8 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.992 0.738 . . . . 2.7599999999999998 112.992 170.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.73 26.16 73.48 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.979 0.809 . . . . 1.0700000000000001 111.898 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -96.93 175.01 6.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.989 -0.745 . . . . 2.9900000000000002 108.989 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -139.97 138.88 35.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.045 -0.724 . . . . 2.1800000000000002 109.045 177.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.5 140.76 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.896 0.878 . . . . 0.94999999999999996 108.963 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.15 95.01 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.123 -2.177 . . . . 1.3600000000000001 105.123 173.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -155.97 139.54 15.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.115 -1.068 . . . . 0.97999999999999998 108.115 -172.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -129.36 131.39 46.84 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.663 -0.495 . . . . 3.5699999999999998 109.663 -174.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -84.07 84.54 7.56 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.283 1.033 . . . . 2.8500000000000001 109.309 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.82 156.46 18.48 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.928 -0.578 . . . . 0.59999999999999998 109.975 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -117.54 121.97 42.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.218 1.007 . . . . 2.96 111.481 -171.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.71 149.28 38.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.273 1.029 . . . . 2.0699999999999998 108.639 178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -101.09 151.44 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.324 1.85 . . . . 1.6299999999999999 107.997 174.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 92' ' ' ILE . 10.4 mt -127.19 127.19 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.647 -1.242 . . . . 0.65000000000000002 107.647 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -105.2 125.79 51.37 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.525 -0.917 . . . . 4.1399999999999997 108.525 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 44.01 10.66 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.914 1.245 . . . . 2.1299999999999999 113.429 174.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.569 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 6.9 ptt? -93.71 -30.07 15.09 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.262 1.031 . . . . 3.4199999999999999 112.441 -176.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.3 p -81.1 56.46 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.279 -0.888 . . . . 5.5800000000000001 109.55 -175.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 38.5 t -113.64 -48.93 2.91 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 123.746 0.818 . . . . 6.6399999999999997 109.623 -178.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.51 65.2 0.61 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.516 -0.92 . . . . 4.2699999999999996 108.516 171.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.12 42.46 31.56 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.397 0.679 . . . . 1.8500000000000001 110.685 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.9 m -70.29 -37.66 74.86 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.01 -1.076 . . . . 0.80000000000000004 108.274 -169.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' HB1' HG21 ' A' ' 107' ' ' VAL . . . -50.9 -46.03 60.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.68 1.192 . . . . 0.84999999999999998 109.683 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.41 -37.62 74.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.164 -0.335 . . . . 2.48 110.396 -178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.6 mmt-85 -57.56 -54.71 43.77 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.455 -0.778 . . . . 4.8200000000000003 111.72 170.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 80' ' ' ILE . 34.0 pt -62.97 -37.62 79.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.178 0.591 . . . . 1.99 110.719 -178.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.79 -58.96 4.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.523 1.529 . . . . 2.46 108.285 176.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -55.68 -27.65 51.34 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.029 0.377 . . . . 3.7599999999999998 112.012 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -73.36 -69.55 0.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.414 0.552 . . . . 4.0899999999999999 110.325 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.429 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -42.18 -39.24 1.97 Allowed 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.96 2.104 . . . . 1.9299999999999999 111.942 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -33.97 -43.15 0.14 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 127.143 2.177 . . . . 1.2 112.472 174.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -168.5 76.74 0.12 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 3.8399999999999999 108.094 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -68.92 -60.5 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 107.807 -1.182 . . . . 1.3899999999999999 107.807 167.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.04 -114.22 0.11 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.708 1.603 . . . . 3.4300000000000002 106.921 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.01 55.62 4.8 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 120.682 1.583 . . . . 0.65000000000000002 111.74 -178.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 96' ' ' LEU . 15.8 t -109.85 120.51 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.461 1.504 . . . . 0.54000000000000004 108.008 178.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.07 -48.19 21.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.738 -0.467 . . . . 0.57999999999999996 109.738 177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -149.02 166.38 28.86 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.838 -0.801 . . . . 0.78000000000000003 108.838 -175.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -165.02 74.65 1.45 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 111.977 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.84 141.48 33.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.339 2.026 . . . . 0.73999999999999999 111.007 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.694 HG21 ' HB1' ' A' ' 89' ' ' ALA . 10.4 p -102.55 149.92 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.194 1.398 . . . . 2.6800000000000002 110.968 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -124.3 90.33 3.24 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.908 1.283 . . . . 2.1600000000000001 110.272 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -12.67 10.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.238 1.415 . . . . 2.4500000000000002 114.295 176.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.85 -35.01 13.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.246 0.476 . . . . 1.0900000000000001 110.701 -173.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.08 -8.96 14.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.714 -0.66 . . . . 1.3899999999999999 111.467 -176.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 64.78 51.65 1.79 Allowed 'General case' 0 C--N 1.341 0.21 0 CA-C-O 122.555 1.169 . . . . 2.7000000000000002 109.014 -175.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 24.5 p -132.11 167.57 19.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.326 -1.306 . . . . 1.0 109.04 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.8 p -141.74 129.93 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.665 1.186 . . . . 0.62 107.873 168.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.5 m -82.55 139.43 33.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 105.3 -2.111 . . . . 0.80000000000000004 105.3 169.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.495 -1.298 . . . . 0.54000000000000004 107.495 170.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -109.11 93.79 4.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.456 -1.683 . . . . 2.5 106.456 175.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.14 169.19 18.22 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 122.503 0.321 . . . . 2.02 110.598 -176.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -86.62 110.32 31.09 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 124.141 0.901 . . . . 2.0600000000000001 109.189 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.86 10.92 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.676 2.25 . . . . 0.58999999999999997 112.786 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -101.06 -37.98 8.36 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.779 0.718 . . . . 5.6900000000000004 110.573 171.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.31 -41.86 60.44 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.072 -0.344 . . . . 2.96 110.072 177.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -133.07 -172.04 2.83 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.032 0.533 . . . . 0.56999999999999995 110.745 -176.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.6 p -160.12 168.3 25.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.559 0.744 . . . . 2.0699999999999998 110.539 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.9 t -41.13 -44.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 125.295 1.438 . . . . 1.8600000000000001 113.219 172.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 m -50.85 -44.12 59.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.721 0.691 . . . . 0.78000000000000003 112.065 177.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.57 -51.64 68.57 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.887 0.851 . . . . 1.95 109.178 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.2 mt -58.35 -47.69 82.97 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.592 1.157 . . . . 0.76000000000000001 110.387 -178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -57.36 -49.92 74.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.979 -1.01 . . . . 3.6800000000000002 110.277 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.02 -42.83 95.21 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.283 0.947 . . . . 2.77 110.197 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.34 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.594 -0.521 . . . . 0.52000000000000002 109.594 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.02 -28.41 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.172 -0.955 . . . . 1.5800000000000001 111.243 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.4 -52.83 63.77 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.467 -0.568 . . . . 3.3100000000000001 109.467 172.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -51.85 -48.14 64.12 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.487 0.715 . . . . 3.1400000000000001 112.058 171.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.01 -28.97 69.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.758 -0.589 . . . . 0.77000000000000002 112.021 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.9 40.37 4.36 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.829 0.728 . . . . 0.68999999999999995 111.788 172.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -133.39 -155.94 0.71 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.022 -1.103 . . . . 2.1600000000000001 108.022 171.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.79 143.55 31.4 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.509 -0.922 . . . . 3.5800000000000001 108.509 171.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.8 mt -100.7 153.53 19.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.352 0.661 . . . . 1.4099999999999999 109.554 171.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -129.82 170.5 13.8 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.748 2.419 . . . . 2.3399999999999999 107.344 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.24 130.7 55.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.29 1.036 . . . . 3.7400000000000002 109.091 -170.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 79.78 9.2 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.912 1.233 . . . . 4.8200000000000003 108.826 170.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.71 -46.14 2.27 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.562 1.077 . . . . 2.3500000000000001 112.591 178.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 60.6 34.93 20.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.564 1.545 . . . . 4.75 111.769 -175.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -161.53 -65.21 0.06 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.187 -1.783 . . . . 8.0899999999999999 106.187 172.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -160.46 38.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.281 -0.872 . . . . 10.25 109.698 -162.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.0 t 52.81 35.91 20.03 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.502 -0.749 . . . . 7.5599999999999996 111.879 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.54 -59.79 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.363 0.665 . . . . 9.2699999999999996 110.246 -170.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 52.67 56.41 7.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.688 1.195 . . . . 14.81 111.573 175.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 125.55 116.75 2.14 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.717 -0.953 . . . . 13.369999999999999 110.717 177.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.059 1.343 . . . . 15.91 110.689 -174.455 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.647 -0.501 . . . . 15.529999999999999 109.647 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.98 110.66 4.28 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.454 -1.313 . . . . 9.1500000000000004 107.454 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -170.55 165.6 8.39 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.98 2.112 . . . . 4.3600000000000003 106.248 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -109.31 36.22 3.0 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.171 0.988 . . . . 4.7300000000000004 109.556 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -62.46 154.58 28.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.893 0.877 . . . . 2.98 109.505 173.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 153.31 31.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.12 -1.067 . . . . 3.1099999999999999 108.12 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.42 142.45 27.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.15 1.38 . . . . 3.3100000000000001 109.348 173.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.86 120.17 58.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.163 -1.421 . . . . 3.0600000000000001 107.163 163.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.32 94.8 5.16 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.265 1.426 . . . . 1.5800000000000001 108.411 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.1 mmt -113.57 156.04 24.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.563 0.62 . . . . 5.1100000000000003 111.625 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -82.86 135.25 35.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.279 0.49 . . . . 2.04 110.962 174.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 p -117.93 155.45 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.295 1.438 . . . . 0.73999999999999999 108.355 177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -131.57 167.33 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.318 1.047 . . . . 1.01 109.512 173.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.97 -5.14 83.37 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.961 -0.856 . . . . 1.1100000000000001 110.961 -173.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 21' ' ' ALA . 1.8 mtp -62.71 103.63 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 117.492 0.646 . . . . 3.8399999999999999 110.667 176.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 m -67.17 -19.09 65.53 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.846 -0.533 . . . . 1.95 112.184 175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 41' ' ' LEU . 47.8 t 81.05 70.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.55 1.14 . . . . 2.9100000000000001 109.523 174.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 174.1 -123.52 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 127.689 2.396 . . . . 3.6099999999999999 105.048 -179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.11 -16.45 60.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 114.242 1.201 . . . . 2.2400000000000002 114.242 -175.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.6 m -59.87 -55.65 31.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.141 0.882 . . . . 1.1799999999999999 109.774 -174.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' ' CG1' ' A' ' 39' ' ' VAL . . . -44.9 -58.67 2.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 114.769 -1.105 . . . . 1.23 109.925 168.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.41 70.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 123.384 0.428 . . . . 1.5900000000000001 111.178 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -46.29 82.18 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.217 0.607 . . . . 2.6899999999999999 110.619 177.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -61.55 -58.28 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.798 -1.186 . . . . 0.87 107.798 177.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -49.4 -52.42 28.66 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.901 0.88 . . . . 3.6400000000000001 110.19 -177.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -63.4 -45.75 89.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.038 0.381 . . . . 2.73 111.362 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.69 96.73 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.327 -1.109 . . . . 1.1599999999999999 110.327 -177.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.92 -42.51 73.2 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.366 1.067 . . . . 1.5900000000000001 109.745 175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -54.04 -22.54 10.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.92 0.888 . . . . 1.76 112.366 175.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -55.34 -27.64 48.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.966 0.906 . . . . 6.0999999999999996 112.245 173.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.71 143.58 33.92 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.952 0.901 . . . . 1.6799999999999999 111.227 -178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.37 -41.82 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.08 2.52 . . . . 1.3600000000000001 112.456 -173.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.7 -21.5 74.87 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-O 118.364 -1.242 . . . . 0.92000000000000004 111.049 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.19 102.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.272 1.036 . . . . 1.3999999999999999 109.33 176.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -83.75 -47.76 10.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.997 -1.112 . . . . 0.68000000000000005 107.997 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.48 154.74 43.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.385 -0.969 . . . . 1.74 108.385 174.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.14 114.9 6.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.498 -1.667 . . . . 0.56999999999999995 106.498 -173.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -133.87 163.17 30.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 124.718 1.261 . . . . 2.1800000000000002 108.056 -174.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' CG1' ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -150.72 113.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 122.017 0.913 . . . . 0.94999999999999996 109.65 175.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.75 79.64 7.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.385 -2.08 . . . . 1.72 105.385 175.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 17' ' ' CYS . 2.9 pp -54.12 -27.76 35.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.752 -1.113 . . . . 1.76 111.652 174.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.66 62.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.538 0.735 . . . . 1.22 110.422 175.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.4 p -111.08 6.35 20.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.485 1.514 . . . . 1.22 112.477 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 45.65 45.13 10.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.078 1.351 . . . . 2.9900000000000002 111.947 -168.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.8 m -118.36 109.45 16.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.978 0.911 . . . . 1.1399999999999999 108.801 -173.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.96 122.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 124.817 1.247 . . . . 0.53000000000000003 108.307 178.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -115.16 101.95 9.44 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.466 -1.309 . . . . 2.79 107.466 -175.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.58 133.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.851 -0.796 . . . . 0.56000000000000005 108.851 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.5 118.14 54.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.67 1.188 . . . . 1.9099999999999999 108.123 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.72 169.96 22.69 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.935 -0.478 . . . . 2.0600000000000001 110.468 -171.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.17 122.37 68.75 Favored Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.767 0.667 . . . . 2.8100000000000001 109.376 178.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.33 39.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.914 2.409 . . . . 1.3700000000000001 111.789 -175.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.98 25.8 0.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.77 0.828 . . . . 1.8400000000000001 112.688 -177.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.84 -47.67 0.6 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.694 1.197 . . . . 2.4300000000000002 109.308 172.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.8 m -106.96 -76.23 0.62 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.381 0.672 . . . . 0.95999999999999996 109.755 -168.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.26 122.81 2.77 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.491 -1.043 . . . . 0.80000000000000004 110.491 175.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -48.58 -42.06 32.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 110.937 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.87 97.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.119 0.567 . . . . 1.28 111.062 177.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.22 -38.75 75.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.064 -1.023 . . . . 1.0 110.065 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -59.15 -53.63 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.255 -0.646 . . . . 1.25 109.255 176.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.51 -38.86 85.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.666 -0.414 . . . . 2.0 110.629 177.485 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -56.87 -38.4 72.67 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 109.517 -0.549 . . . . 2.5099999999999998 109.517 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.69 81.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.55 -0.719 . . . . 3.98 110.178 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.21 -48.86 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.037 -0.727 . . . . 0.81999999999999995 109.037 172.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.08 -51.51 63.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 120.755 -0.378 . . . . 3.1200000000000001 111.332 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -56.87 -32.85 66.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.831 0.852 . . . . 2.3399999999999999 112.494 177.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -11.15 45.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.437 0.562 . . . . 3.0800000000000001 111.945 175.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 43.14 3.52 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.359 -1.097 . . . . 0.89000000000000001 110.359 174.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -132.33 176.29 8.54 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.866 1.266 . . . . 2.27 108.729 177.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.4 157.66 46.34 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.265 -1.383 . . . . 2.2599999999999998 107.265 172.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.82 144.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.911 1.284 . . . . 0.88 109.887 -178.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -90.26 81.81 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 104.856 -2.276 . . . . 1.2 104.856 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.71 132.8 13.45 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.366 -1.346 . . . . 1.74 107.366 -172.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -113.95 133.11 55.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.033 -0.729 . . . . 4.4900000000000002 109.033 -173.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -81.63 87.19 6.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.972 -1.122 . . . . 2.75 107.972 178.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.84 154.79 24.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.18 -1.045 . . . . 0.92000000000000004 108.18 177.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -126.95 130.52 50.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.083 -0.71 . . . . 3.2200000000000002 109.083 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -128.09 140.66 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.957 1.303 . . . . 1.8799999999999999 108.987 -176.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -86.67 151.62 23.27 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.754 1.621 . . . . 2.0 109.339 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 mt -120.59 125.76 74.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 CA-C-N 119.333 0.969 . . . . 0.71999999999999997 110.788 -175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.16 99.76 9.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.549 -1.278 . . . . 3.1200000000000001 107.549 166.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.99 -41.98 0.45 Allowed Glycine 0 CA--C 1.526 0.755 0 O-C-N 121.994 -0.441 . . . . 1.8 112.572 176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.76 -173.4 1.19 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.202 -0.587 . . . . 3.77 111.297 170.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 83.64 -8.73 1.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.196 1.799 . . . . 6.9900000000000002 110.541 -173.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.1 t -89.91 -40.96 12.06 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 121.835 -0.541 . . . . 4.71 110.527 -173.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.87 -99.16 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.936 0.894 . . . . 3.3300000000000001 108.937 172.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.98 31.89 2.69 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.037 0.935 . . . . 2.1899999999999999 110.12 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 25.6 m -62.9 -37.8 88.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.572 -0.899 . . . . 1.27 108.572 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.13 81.7 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.277 0.231 . . . . 1.0900000000000001 111.223 174.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -70.07 -43.02 72.03 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.2 -0.938 . . . . 2.6899999999999999 108.636 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -55.79 -55.87 27.29 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.008 -0.433 . . . . 4.1900000000000004 111.607 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -64.71 -26.98 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.243 -0.884 . . . . 1.9399999999999999 111.75 -178.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -56.95 -58.89 6.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.857 1.208 . . . . 2.7000000000000002 108.023 171.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -57.16 -30.63 64.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 123.389 0.431 . . . . 3.6899999999999999 111.709 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -72.93 -71.48 0.3 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.731 -0.387 . . . . 3.1299999999999999 110.946 173.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.7 mt -52.7 -31.06 35.62 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.25 1.42 . . . . 1.8400000000000001 111.66 -173.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -28.32 -50.38 0.07 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.531 1.932 . . . . 1.3 112.112 166.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -163.14 58.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.7 0.8 . . . . 4.5700000000000003 110.261 -170.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.9 -65.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.801 0.441 . . . . 1.8400000000000001 110.029 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -120.46 -99.8 0.44 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.427 -1.694 . . . . 3.8199999999999998 106.427 175.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.66 69.79 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-O 119.422 -0.654 . . . . 2.6899999999999999 112.268 -173.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 102' ' ' VAL . 19.0 t -42.63 125.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.456 1.102 . . . . 1.3 112.828 -170.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.62 -47.64 30.97 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.28 -0.873 . . . . 1.6599999999999999 109.284 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -153.65 166.91 31.33 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.302 1.041 . . . . 1.52 109.474 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.53 73.19 2.16 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.797 0.666 . . . . 1.04 112.797 171.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.61 138.88 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.82 1.68 . . . . 1.1899999999999999 111.42 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.91 146.92 10.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.899 1.28 . . . . 1.95 110.058 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -113.93 150.35 33.88 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.656 -0.868 . . . . 2.1200000000000001 108.656 172.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.32 8.39 14.2 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.124 0.969 . . . . 2.5699999999999998 112.385 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.17 -44.35 4.79 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 124.673 1.189 . . . . 1.75 110.13 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.06 -21.68 25.92 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.623 0.769 . . . . 1.8999999999999999 111.335 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 41.8 mt-10 70.08 46.73 0.61 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.116 1.766 . . . . 2.9100000000000001 111.286 -173.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 63.8 p -135.97 163.26 30.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.424 1.089 . . . . 0.77000000000000002 110.568 -173.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.01 133.17 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 109.822 170.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -84.08 144.45 29.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.241 -1.392 . . . . 1.0700000000000001 107.241 165.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.34 125.08 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.648 1.179 . . . . 0.93999999999999995 108.024 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -111.79 96.63 6.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.486 -1.301 . . . . 2.2799999999999998 107.486 175.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -140.06 160.31 40.21 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.497 -0.927 . . . . 2.4700000000000002 108.497 -178.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -83.98 118.43 71.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 108.365 -0.976 . . . . 2.8500000000000001 108.365 -174.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.75 3.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.243 1.962 . . . . 1.54 113.179 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -39.2 10.35 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.331 0.969 . . . . 8.2599999999999998 109.3 172.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.81 -45.44 36.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.48 -0.933 . . . . 4.3600000000000003 108.48 -175.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -132.25 -173.01 3.04 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.857 -0.423 . . . . 1.1899999999999999 109.857 -178.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.3 p -156.04 165.14 37.32 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.715 -0.616 . . . . 2.6499999999999999 109.794 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -51.78 -37.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 123.761 0.824 . . . . 2.0899999999999999 112.749 178.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 m -53.16 -41.17 64.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.233 0.613 . . . . 0.95999999999999996 111.061 176.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.46 -47.5 78.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 109.113 -0.699 . . . . 2.9100000000000001 109.113 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.37 -41.68 94.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.639 0.776 . . . . 0.92000000000000004 110.179 -178.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -59.53 -48.92 79.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 119.087 -0.482 . . . . 3.6000000000000001 110.743 172.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.8 -46.81 84.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.237 0.926 . . . . 3.7200000000000002 110.378 177.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.99 62.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.346 1.058 . . . . 0.67000000000000004 110.247 -175.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG11 ' HG ' ' A' ' 139' ' ' LEU . 3.1 p -65.99 -34.67 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 121.623 -0.673 . . . . 1.5 110.223 -178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -57.6 -46.12 84.44 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 121.622 0.725 . . . . 3.5699999999999998 109.109 174.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.5 tttp -57.45 -25.91 60.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.748 1.219 . . . . 3.23 113.219 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.09 -16.14 41.59 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.33 1.052 . . . . 1.1599999999999999 112.136 172.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.39 33.25 7.7 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.578 1.085 . . . . 1.23 112.369 173.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -139.71 173.94 11.02 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.285 -1.376 . . . . 2.02 107.285 173.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -124.04 144.71 49.68 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.213 0.915 . . . . 3.3700000000000001 109.463 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.437 ' HG ' HG11 ' A' ' 132' ' ' VAL . 73.7 mt -100.88 147.8 25.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.516 0.726 . . . . 1.3600000000000001 110.404 173.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -122.3 160.03 26.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.31 1.444 . . . . 2.52 109.049 169.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.08 139.67 30.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.891 -0.781 . . . . 3.4199999999999999 108.891 -176.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 149' ' ' GLU . 3.0 mmmp? -79.16 78.06 5.64 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.073 -1.084 . . . . 2.98 108.073 176.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.32 -49.53 3.59 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.691 -1.061 . . . . 2.0499999999999998 112.992 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 38.19 47.76 1.03 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.079 1.752 . . . . 4.1200000000000001 111.214 -174.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 70.71 -14.98 0.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.17 1.388 . . . . 8.7100000000000009 113.97 177.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.52 -43.27 19.01 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 126.159 1.784 . . . . 8.6899999999999995 108.963 -175.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.6 m -122.25 58.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 112.805 -1.998 . . . . 8.3200000000000003 109.021 169.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.3 mt 20.26 72.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 127.986 2.514 . . . . 9.6600000000000001 112.862 160.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 142' ' ' LYS . 8.1 tp10 41.73 51.2 4.01 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 13.5 112.712 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 91.63 -9.54 76.8 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.695 -1.058 . . . . 16.199999999999999 113.62 177.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.53 1.165 . . . . 20.469999999999999 108.728 173.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 119.714 -0.184 . . . . 14.41 111.48 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp 66.36 -57.22 0.38 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.311 1.444 . . . . 11.4 112.803 -174.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -152.85 60.08 0.79 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.8 1.24 . . . . 7.3899999999999997 108.153 179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -161.43 36.15 0.14 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.976 0.91 . . . . 8.1199999999999992 108.717 -164.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 61.88 148.4 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 116.764 2.135 . . . . 2.7599999999999998 116.764 -174.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -122.23 146.18 47.51 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.329 -1.305 . . . . 2.3500000000000001 108.334 177.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -84.39 131.15 34.72 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.945 1.698 . . . . 3.2599999999999998 107.376 173.356 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.2 tt -123.94 111.96 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.147 -1.057 . . . . 1.9099999999999999 108.147 163.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.89 123.62 46.12 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.208 1.403 . . . . 0.63 108.49 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 74.1 mtp -150.25 174.56 12.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.3 1.04 . . . . 2.1299999999999999 110.734 -174.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -109.73 139.06 45.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 3.0 110.147 -177.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.51 139.53 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 124.258 1.023 . . . . 0.81000000000000005 108.691 -175.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 m -86.27 176.24 8.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.754 0.822 . . . . 0.97999999999999998 112.193 -174.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.63 13.17 78.05 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.191 -0.913 . . . . 0.84999999999999998 111.116 171.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 mmt -77.91 66.63 3.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.807 -0.812 . . . . 3.5099999999999998 108.807 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -48.6 -37.08 17.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.341 1.056 . . . . 1.77 112.313 -174.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 t 144.45 107.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.066 1.746 . . . . 3.25 109.046 171.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 54.74 -167.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.135 -0.691 . . . . 2.8700000000000001 109.135 -166.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 56.11 -71.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.492 1.917 . . . . 1.45 113.513 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.0 m -45.25 -61.08 1.8 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 127.354 2.262 . . . . 0.88 109.4 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.66 -53.45 58.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.673 -1.149 . . . . 0.90000000000000002 110.089 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.33 -41.14 65.42 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.268 0.627 . . . . 0.90000000000000002 111.613 -177.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -61.5 -45.86 92.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.358 0.663 . . . . 2.1699999999999999 110.429 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.02 -57.11 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 107.732 -1.21 . . . . 0.85999999999999999 107.732 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -55.92 -43.0 76.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.843 0.747 . . . . 4.1699999999999999 111.034 -176.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -60.71 -49.94 75.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.277 0.489 . . . . 1.99 110.654 176.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.54 -40.06 91.8 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.563 -0.615 . . . . 0.65000000000000002 111.563 179.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.58 -39.46 70.55 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.512 0.725 . . . . 1.6299999999999999 110.372 177.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.23 -20.06 9.83 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.816 0.846 . . . . 2.21 112.348 176.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -60.58 -30.23 69.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.314 0.646 . . . . 3.79 112.228 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 mmt -70.29 145.06 92.94 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 122.854 0.462 . . . . 2.3500000000000001 110.372 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.02 -42.9 3.69 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.592 2.195 . . . . 1.1599999999999999 111.301 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 -28.23 73.69 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.857 -0.969 . . . . 0.54000000000000004 111.054 -175.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 56.3 t -63.22 107.25 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.912 0.885 . . . . 1.3 110.079 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.0 m -82.97 -45.5 14.04 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.14 -1.059 . . . . 0.93999999999999995 108.14 175.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -149.25 164.9 33.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.543 0.687 . . . . 2.1800000000000002 110.597 167.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.59 4.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.359 -2.089 . . . . 0.65000000000000002 105.359 -175.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -127.49 161.77 27.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.66 1.584 . . . . 2.3199999999999998 108.854 -171.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.721 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.52 110.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.801 0.81 . . . . 0.85999999999999999 111.952 -173.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -81.84 75.95 8.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.061 -1.459 . . . . 2.1699999999999999 107.061 171.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.93 -25.81 5.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.166 0.586 . . . . 1.52 111.537 166.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.83 73.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.45 1.1 . . . . 0.91000000000000003 112.034 179.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 p -124.79 15.18 8.66 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 122.877 0.471 . . . . 0.93999999999999995 111.218 178.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 39.11 69.81 0.26 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 111.036 -169.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.39 117.17 15.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 106.406 -1.701 . . . . 1.23 106.406 168.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.72 138.88 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.255 -1.757 . . . . 0.51000000000000001 106.255 167.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 115.46 14.78 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.181 -1.044 . . . . 3.8399999999999999 108.181 177.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.18 134.35 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.461 -0.94 . . . . 0.40999999999999998 108.461 -174.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.8 mt -119.66 111.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.857 -1.164 . . . . 1.0600000000000001 107.857 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 51.5 p90 -147.79 165.37 30.77 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.604 -0.517 . . . . 2.1699999999999999 109.604 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.92 125.43 68.65 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 119.299 -0.381 . . . . 2.2999999999999998 110.656 -178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.29 43.29 1.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.146 2.564 . . . . 0.80000000000000004 112.385 -176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.96 0.2 0.83 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -119.19 -39.64 2.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.208 1.003 . . . . 1.8300000000000001 111.232 174.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 m -116.72 -83.85 0.63 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.319 -0.993 . . . . 0.76000000000000001 108.319 -160.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.56 125.52 4.67 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.828 -1.309 . . . . 0.60999999999999999 109.828 172.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -33.82 -46.41 0.22 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.244 1.818 . . . . 0.75 112.964 174.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.07 91.08 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.698 -0.626 . . . . 0.75 111.066 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.06 -35.91 72.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.038 -1.038 . . . . 0.70999999999999996 110.906 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.5 mm -54.78 -57.51 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.179 -1.045 . . . . 0.65000000000000002 108.179 175.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -60.68 -42.41 97.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.628 -0.508 . . . . 2.1400000000000001 109.628 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 47.4 tt0 -56.77 -38.72 72.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.745 -0.782 . . . . 2.6299999999999999 110.001 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -69.97 -40.76 75.2 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 121.267 -0.896 . . . . 2.3999999999999999 110.488 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 93.0 mt -53.07 -49.63 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 119.243 0.929 . . . . 0.57999999999999996 109.379 171.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.55 -53.07 61.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.626 0.37 . . . . 1.8500000000000001 110.526 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 21.0 mttp -58.31 -32.13 68.17 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.216 1.007 . . . . 2.4199999999999999 112.653 177.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -12.27 44.95 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.136 0.88 . . . . 2.6099999999999999 112.085 173.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.93 41.72 3.01 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 110.362 -1.095 . . . . 0.65000000000000002 110.362 173.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.29 178.64 6.87 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.718 1.207 . . . . 2.1299999999999999 109.348 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -138.21 138.52 38.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.529 -0.915 . . . . 2.0800000000000001 108.529 176.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.83 133.97 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.244 -1.021 . . . . 0.58999999999999997 108.244 175.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.3 t -84.77 63.17 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.054 0 N-CA-C 107.366 -1.346 . . . . 1.0 107.366 -176.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.66 152.93 48.63 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.045 -1.094 . . . . 0.92000000000000004 108.045 -172.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.34 152.64 49.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.802 0.441 . . . . 4.2000000000000002 110.208 178.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -95.0 82.56 3.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 125.03 1.456 . . . . 2.7200000000000002 109.15 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.4 162.06 21.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.822 -0.807 . . . . 0.76000000000000001 108.822 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -139.06 125.08 19.92 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.779 1.172 . . . . 3.02 111.649 -176.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.84 137.2 52.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.856 1.262 . . . . 1.7 109.212 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.02 155.93 22.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.706 1.602 . . . . 1.8799999999999999 108.841 173.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.3 mt -126.22 108.29 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 119.487 1.039 . . . . 0.81000000000000005 111.986 -169.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.78 62.57 4.41 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.933 1.349 . . . . 4.0199999999999996 107.649 -178.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.38 -28.6 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.763 -1.108 . . . . 1.54 114.638 -170.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.54 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.3 ttp -64.1 -175.82 0.17 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.035 0.917 . . . . 3.4300000000000002 111.21 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 t 50.14 32.46 5.97 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.074 1.75 . . . . 5.2400000000000002 110.984 -168.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.4 t -110.08 -48.73 3.15 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.677 -0.49 . . . . 6.3600000000000003 109.677 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.81 -76.88 0.18 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.225 -0.657 . . . . 3.5600000000000001 109.225 166.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.64 40.75 0.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.469 -0.937 . . . . 1.46 108.469 -175.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.2 m -70.32 -43.84 69.48 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.322 -0.621 . . . . 1.23 109.322 -163.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' MET . . . -49.93 -49.92 48.23 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 123.661 0.784 . . . . 0.95999999999999996 109.612 168.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -43.85 93.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.392 0.615 . . . . 2.71 109.924 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -61.69 -48.75 79.38 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.004 -0.435 . . . . 4.21 111.075 175.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 pt -69.24 -26.74 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 117.887 -1.054 . . . . 1.6699999999999999 111.974 -177.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.99 -65.4 0.57 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.869 -1.53 . . . . 3.54 106.869 172.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -55.61 -31.41 62.24 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 123.71 0.631 . . . . 2.5099999999999998 112.273 -175.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -72.35 -69.79 0.38 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.169 0.509 . . . . 3.5699999999999998 110.467 175.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.401 ' O ' HG11 ' A' ' 102' ' ' VAL . 17.8 mt -52.02 -30.28 24.68 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.031 0.932 . . . . 1.8899999999999999 112.109 -176.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -32.02 -47.25 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 127.278 2.231 . . . . 1.97 111.551 170.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.14 84.15 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.369 0.604 . . . . 6.46 110.298 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.35 -70.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.217 -1.401 . . . . 1.6799999999999999 107.217 162.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.41 -108.04 0.24 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.174 -1.047 . . . . 3.6000000000000001 108.174 171.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.68 56.05 4.9 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 118.828 0.74 . . . . 0.81999999999999995 111.982 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 96' ' ' LEU . 23.1 t -107.55 118.31 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.345 1.458 . . . . 0.71999999999999997 107.886 175.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.95 20.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.38 -0.6 . . . . 0.98999999999999999 109.38 173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -152.49 174.62 13.68 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 107.919 -1.141 . . . . 1.26 107.919 -174.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.76 65.09 0.52 Allowed Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.628 0.771 . . . . 0.65000000000000002 112.194 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.57 152.61 65.24 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.044 1.829 . . . . 0.87 111.281 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.03 148.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 C-N-CA 124.925 1.29 . . . . 1.8200000000000001 110.506 -173.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -117.93 135.79 53.9 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.206 0.602 . . . . 2.98 110.849 174.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.77 13.39 24.69 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.008 1.323 . . . . 2.4199999999999999 112.813 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.99 -50.42 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.103 -1.073 . . . . 1.1699999999999999 108.103 -170.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.66 -26.57 45.09 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.001 -0.999 . . . . 1.6599999999999999 110.389 174.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 69.24 43.82 1.04 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.957 1.703 . . . . 2.4900000000000002 110.042 -172.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -138.06 147.89 44.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 109.665 -174.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -109.96 130.16 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 126.02 1.728 . . . . 0.65000000000000002 108.891 174.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.9 m -82.22 143.12 31.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 165.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.87 115.25 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.829 -1.545 . . . . 0.65000000000000002 106.829 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -101.77 91.84 4.57 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.725 -1.954 . . . . 2.8700000000000001 105.725 -177.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -148.78 159.8 43.81 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.686 0.675 . . . . 1.77 112.637 -166.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.15 111.24 45.72 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 115.264 -0.88 . . . . 2.3500000000000001 110.497 -166.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -69.59 4.51 2.08 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.372 2.048 . . . . 0.93000000000000005 113.207 -177.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -35.91 11.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.452 0.701 . . . . 7.2800000000000002 109.543 171.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.37 -32.71 17.17 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.309 -0.626 . . . . 2.6200000000000001 109.309 -171.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.88 174.35 12.33 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.408 0.549 . . . . 0.66000000000000003 110.448 174.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -145.8 167.99 21.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.664 1.585 . . . . 2.0299999999999998 108.696 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 t -39.66 -40.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.736 1.615 . . . . 1.7 113.943 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.4 m -48.55 -44.41 36.51 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.329 -0.857 . . . . 0.68999999999999995 112.38 176.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.22 -45.69 92.32 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.875 0.87 . . . . 2.2200000000000002 110.241 177.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.0 mt -63.09 -47.36 83.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.338 0.655 . . . . 0.81999999999999995 109.791 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -58.14 -56.27 24.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.409 -0.805 . . . . 3.04 109.777 174.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -48.37 -46.7 37.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.698 0.799 . . . . 3.52 111.244 177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.34 -59.07 6.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.921 -0.487 . . . . 0.51000000000000001 109.751 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.8 -30.64 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 122.624 0.37 . . . . 1.5900000000000001 110.841 -174.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.11 -44.26 78.92 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.985 0.514 . . . . 2.5600000000000001 109.63 173.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -65.26 -25.45 67.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.111 0.782 . . . . 3.8900000000000001 113.111 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.44 -32.35 58.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.374 0.988 . . . . 0.80000000000000004 110.134 171.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.51 49.46 2.76 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.566 1.079 . . . . 0.71999999999999997 110.997 178.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.24 -173.79 3.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.34 -1.356 . . . . 2.1800000000000002 107.34 171.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -138.5 128.05 24.79 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.231 0.923 . . . . 3.1000000000000001 109.001 177.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.48 156.94 21.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.733 -0.469 . . . . 1.3700000000000001 109.733 174.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -130.75 148.85 52.58 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.236 1.415 . . . . 2.5499999999999998 108.281 170.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.69 126.1 33.69 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.191 0.596 . . . . 1.72 109.738 177.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -81.96 71.72 9.0 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.567 -0.901 . . . . 4.0199999999999996 108.567 172.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.39 -64.73 3.17 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.604 -0.999 . . . . 2.5899999999999999 110.604 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 51.37 34.45 11.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.72 1.208 . . . . 5.4900000000000002 112.154 173.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -179.35 -49.36 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.996 1.318 . . . . 6.46 108.565 -176.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 80.29 -49.62 0.34 Allowed 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 126.594 1.958 . . . . 8.6600000000000001 110.947 178.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 96.9 p -95.89 69.01 2.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.861 1.265 . . . . 9.1500000000000004 109.825 165.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.89 -70.05 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.885 -0.413 . . . . 9.5600000000000005 109.885 170.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -166.48 165.38 16.98 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.162 -2.162 . . . . 16.100000000000001 105.162 176.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -172.83 58.82 0.15 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.751 -1.027 . . . . 14.73 112.005 177.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 128.052 2.541 . . . . 19.27 109.397 -179.524 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.772 -1.196 . . . . 16.719999999999999 107.772 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.68 -171.99 0.42 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.952 2.101 . . . . 11.609999999999999 105.392 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -158.89 167.86 28.3 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.195 0.907 . . . . 5.4800000000000004 108.753 168.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -103.12 75.24 1.35 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.616 1.567 . . . . 5.5499999999999998 110.205 -173.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -78.71 140.59 38.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.695 -0.854 . . . . 2.6499999999999999 108.695 -178.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HD3' ' CE2' ' A' ' 50' ' ' TYR . 6.1 ptmt -85.97 148.3 25.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.28 -0.637 . . . . 3.0800000000000001 109.28 174.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 140.62 32.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.695 1.598 . . . . 2.6299999999999999 107.639 166.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.77 133.89 67.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.921 -1.14 . . . . 1.9299999999999999 107.921 157.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.04 125.38 48.2 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 125.121 1.368 . . . . 0.65000000000000002 108.525 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 54.7 mtm -151.18 169.27 22.3 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.187 0.595 . . . . 1.79 111.144 179.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -92.46 143.93 25.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.67 1.188 . . . . 2.52 110.644 167.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.74 137.23 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.94 1.296 . . . . 1.0 109.374 178.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -84.51 169.35 14.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.711 1.204 . . . . 1.0600000000000001 111.338 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.73 -6.19 48.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.924 0.773 . . . . 0.92000000000000004 112.178 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.42 83.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.65 1.58 . . . . 3.4500000000000002 109.513 173.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -78.88 -11.64 60.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.228 0.611 . . . . 1.73 111.292 -176.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.0 m 80.58 3.4 1.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.844 1.258 . . . . 4.2699999999999996 111.993 170.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.27 119.58 28.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.241 -2.133 . . . . 4.5099999999999998 105.241 166.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 66.89 -29.41 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.966 1.839 . . . . 2.02 115.966 173.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -61.36 -57.72 11.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.853 1.206 . . . . 1.1599999999999999 108.807 -171.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -44.8 -58.81 2.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.432 -1.258 . . . . 0.84999999999999998 110.452 170.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.58 -38.91 75.65 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.768 0.318 . . . . 1.26 111.292 -175.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -64.88 -45.48 85.82 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 123.096 0.558 . . . . 2.9399999999999999 110.299 178.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.29 -52.41 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.226 -1.027 . . . . 0.80000000000000004 108.226 178.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -52.65 -52.87 53.81 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.743 0.701 . . . . 3.6899999999999999 110.473 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.1 -47.44 82.83 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.123 0.42 . . . . 2.2400000000000002 110.671 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.24 96.08 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.704 -0.559 . . . . 0.92000000000000004 111.704 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.1 -46.44 61.75 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.438 0.695 . . . . 1.5800000000000001 109.77 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 21.1 mttp -54.65 -19.03 5.28 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.201 0.91 . . . . 2.0699999999999998 112.774 174.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -59.74 -31.25 69.45 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.4 -0.813 . . . . 3.8700000000000001 112.708 170.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 mmt -79.1 149.41 73.1 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 124.084 0.954 . . . . 1.5600000000000001 110.687 -178.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.94 -45.33 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.967 2.445 . . . . 1.1899999999999999 111.56 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.98 -33.24 78.8 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.572 -1.011 . . . . 0.68999999999999995 110.572 -172.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -55.82 101.56 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.754 0.788 . . . . 1.49 109.724 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -85.29 -46.27 11.17 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.997 -1.483 . . . . 0.95999999999999996 106.997 -178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 31.7 t0 -156.3 104.4 2.23 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.73 0.776 . . . . 2.5800000000000001 112.925 172.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.28 125.24 29.62 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.045 -0.724 . . . . 0.81999999999999995 109.045 168.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.72 158.36 35.04 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.541 2.336 . . . . 1.7 109.316 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.863 HG11 ' HB1' ' A' ' 21' ' ' ALA . 13.8 p -152.89 108.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-O 121.895 0.855 . . . . 0.94999999999999996 110.641 177.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -81.08 74.84 8.07 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.671 -1.974 . . . . 1.9199999999999999 105.671 170.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 pp -53.66 -30.1 41.59 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.762 -0.654 . . . . 1.78 110.899 172.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.14 65.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.813 0.845 . . . . 1.48 111.405 176.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.8 p -108.91 10.36 26.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.94 0.896 . . . . 1.5900000000000001 111.574 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 48.11 52.18 13.6 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.34 1.056 . . . . 2.5699999999999998 112.276 -171.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 61.5 m -124.99 119.08 27.71 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.928 -1.138 . . . . 1.3200000000000001 107.928 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.27 129.95 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.421 -0.955 . . . . 0.56999999999999995 108.421 171.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -125.03 114.71 19.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.652 -1.24 . . . . 2.6699999999999999 107.652 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 t -111.82 127.02 69.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.995 -0.743 . . . . 0.5 108.995 -177.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -113.67 121.79 66.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.317 -0.994 . . . . 1.0600000000000001 108.317 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 32.4 p90 -156.21 166.72 32.61 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 113.097 0.777 . . . . 1.79 113.097 -172.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -79.33 128.42 75.57 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 111.581 -175.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.83 27.71 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.023 2.482 . . . . 1.79 114.171 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.11 13.13 0.68 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.029 0.831 . . . . 1.4399999999999999 112.949 -172.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -137.8 -22.75 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.072 0.949 . . . . 1.75 113.056 -177.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.7 m -139.95 -81.45 0.27 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.66 1.118 . . . . 1.3100000000000001 108.22 -162.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.15 133.08 7.15 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.47 -1.052 . . . . 1.22 110.47 168.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -38.54 -43.84 0.9 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.279 1.832 . . . . 1.0600000000000001 112.379 178.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.1 96.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.962 -0.461 . . . . 1.3 110.553 -178.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.13 -37.61 75.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.48 -0.763 . . . . 1.1299999999999999 110.428 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.89 -55.29 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.955 -0.757 . . . . 0.93999999999999995 108.955 175.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -37.33 87.13 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.023 -0.535 . . . . 2.4199999999999999 110.214 -178.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -54.15 -45.03 71.91 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 109.382 -0.599 . . . . 2.5800000000000001 109.382 172.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -46.61 71.13 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 -173.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -49.24 -50.88 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.831 -0.433 . . . . 0.92000000000000004 109.831 172.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.88 -47.84 81.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.128 -0.629 . . . . 2.23 111.835 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -56.2 -35.48 67.34 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.716 -0.615 . . . . 2.8199999999999998 111.778 177.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.09 -15.56 63.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.218 -0.42 . . . . 2.25 112.102 177.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.4 41.94 3.08 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.268 0.937 . . . . 1.04 110.804 176.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -133.52 177.43 7.7 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.904 1.281 . . . . 2.4500000000000002 109.006 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -142.5 145.37 33.62 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.224 -0.658 . . . . 2.04 109.224 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.6 m -87.15 134.91 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.399 1.08 . . . . 1.05 110.823 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.92 75.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.871 -1.159 . . . . 1.0800000000000001 107.871 -179.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.3 p -125.74 142.65 51.4 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.546 0.738 . . . . 2.1200000000000001 112.364 -174.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.15 105.15 13.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.714 2.006 . . . . 6.6799999999999997 106.493 172.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -81.41 61.77 5.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.234 1.414 . . . . 4.3300000000000001 109.257 174.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.35 173.13 10.55 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.937 -0.574 . . . . 0.81999999999999995 111.405 -171.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -129.9 128.43 42.18 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.581 0.752 . . . . 2.77 110.032 174.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -113.54 137.1 52.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.671 -1.233 . . . . 2.1400000000000001 107.671 177.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -101.46 136.37 41.42 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.788 1.635 . . . . 2.7799999999999998 108.57 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.6 mt -114.39 135.75 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 120.072 1.305 . . . . 1.0600000000000001 109.289 -162.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -134.86 43.65 2.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.407 1.003 . . . . 2.7200000000000002 108.424 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.04 -43.41 0.04 OUTLIER Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.485 1.04 . . . . 1.3999999999999999 113.781 -172.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.46 177.17 0.1 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.356 1.078 . . . . 3.3700000000000001 112.126 167.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 t -177.87 -47.73 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.79 1.236 . . . . 4.5999999999999996 108.0 172.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.6 t 178.45 21.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.12 0.785 . . . . 6.1500000000000004 113.12 -168.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -123.25 39.14 4.03 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.327 1.051 . . . . 3.6200000000000001 109.382 -176.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.66 23.08 4.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.024 1.33 . . . . 1.74 112.994 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.2 m -68.74 -44.65 73.36 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.079 -1.082 . . . . 1.0600000000000001 108.079 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.54 -37.49 70.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.76 -0.654 . . . . 1.03 110.824 173.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.78 -45.89 73.57 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.853 -1.154 . . . . 1.75 108.454 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -53.42 -57.02 12.09 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.658 0.783 . . . . 3.5099999999999998 110.901 173.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' CG2' HG23 ' A' ' 132' ' ' VAL . 1.9 pt -62.85 -33.27 59.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-O 117.931 -1.033 . . . . 1.8200000000000001 111.812 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -57.91 -63.23 1.32 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.324 -1.361 . . . . 2.52 107.324 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -54.82 -35.4 63.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.882 0.473 . . . . 3.5099999999999998 111.376 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.55 -70.62 0.29 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 120.665 -0.414 . . . . 3.3500000000000001 110.691 176.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -46.77 -39.52 11.88 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.789 1.236 . . . . 1.53 110.864 -175.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -34.38 -43.97 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.059 1.744 . . . . 2.0299999999999998 113.092 173.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -156.82 71.89 0.7 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.493 0.717 . . . . 5.4199999999999999 109.635 174.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.52 -54.86 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.524 -0.917 . . . . 1.71 108.524 167.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -144.82 -86.38 0.12 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.803 -0.814 . . . . 3.1099999999999999 108.803 173.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.08 57.37 0.7 Allowed Glycine 0 CA--C 1.528 0.882 0 O-C-N 121.486 -0.758 . . . . 1.1000000000000001 111.723 -177.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.36 123.71 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 C-N-CA 124.046 0.938 . . . . 0.85999999999999999 109.801 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.18 -50.49 22.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.987 0.915 . . . . 1.0800000000000001 109.756 176.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -151.95 163.94 38.19 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.817 0.847 . . . . 1.1699999999999999 108.864 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.35 69.32 1.81 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.194 0.813 . . . . 0.77000000000000002 113.194 173.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.14 138.23 22.42 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.357 2.038 . . . . 0.90000000000000002 111.519 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 m -98.66 154.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.927 1.291 . . . . 1.8400000000000001 111.19 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -111.89 159.64 18.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.265 1.026 . . . . 1.8500000000000001 109.207 168.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 22.86 6.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.066 1.346 . . . . 2.4900000000000002 110.79 177.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.97 -30.17 0.75 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 2.0499999999999998 112.313 -170.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.6 mt -100.1 -20.23 16.1 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.522 1.129 . . . . 1.8799999999999999 110.524 170.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 66.49 52.91 1.0 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.56 1.944 . . . . 4.5899999999999999 110.44 -172.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.8 p -141.74 167.51 21.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 114.95 -1.023 . . . . 0.93999999999999995 111.028 -173.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.71 131.39 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.932 1.293 . . . . 0.63 108.694 170.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.3 m -81.96 144.16 31.11 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.878 -1.897 . . . . 0.81000000000000005 105.878 168.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.0 128.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.767 -1.568 . . . . 0.68999999999999995 106.767 177.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -117.9 99.07 6.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.757 -1.571 . . . . 2.7200000000000002 106.757 177.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.6 158.93 43.16 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.563 0.619 . . . . 2.0699999999999998 111.651 -171.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -80.66 112.67 33.55 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.996 -0.526 . . . . 3.1299999999999999 110.152 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.48 10.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.88 2.386 . . . . 1.3500000000000001 113.118 -177.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.47 -39.62 9.07 Favored 'General case' 0 N--CA 1.457 -0.084 0 O-C-N 121.569 -0.707 . . . . 5.4400000000000004 109.521 168.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.08 -51.56 45.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.884 -0.784 . . . . 2.7599999999999998 108.884 176.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.47 -171.68 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.193 0.597 . . . . 0.95999999999999996 110.001 -175.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 94.0 p -158.85 171.8 19.39 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.529 0.732 . . . . 2.27 109.778 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -48.94 -40.78 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.204 1.002 . . . . 2.4300000000000002 113.502 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 m -54.4 -45.4 72.9 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.501 -0.555 . . . . 0.83999999999999997 109.501 175.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.31 -40.3 95.86 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.099 0.476 . . . . 1.8100000000000001 109.809 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.56 -45.18 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.058 0.543 . . . . 0.77000000000000002 110.444 177.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -61.64 -48.79 79.25 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.991 -0.443 . . . . 3.02 111.591 175.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -34.41 77.43 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.383 -0.823 . . . . 5.9299999999999997 109.875 179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.31 -52.28 48.84 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.112 -0.699 . . . . 0.68000000000000005 109.112 178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.84 HG11 ' CB ' ' A' ' 139' ' ' LEU . 8.4 p -67.81 -29.58 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 119.236 -0.985 . . . . 1.72 111.51 -178.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.71 -42.43 79.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.482 -0.562 . . . . 3.2799999999999998 109.482 177.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -48.7 -35.56 14.26 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.395 1.078 . . . . 2.27 113.172 171.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.98 -15.45 47.7 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.634 0.774 . . . . 1.03 111.632 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.56 40.71 38.01 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.497 0.59 . . . . 1.02 111.838 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -125.02 171.32 10.34 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.886 -1.524 . . . . 2.4900000000000002 106.886 168.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -118.95 116.95 27.52 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.18 -1.415 . . . . 3.8100000000000001 107.18 179.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.84 ' CB ' HG11 ' A' ' 132' ' ' VAL . 30.7 tp -106.95 132.69 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.612 1.965 . . . . 2.6200000000000001 106.482 -175.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -122.46 174.48 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.322 1.049 . . . . 2.9700000000000002 108.662 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.23 148.15 30.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.53 1.132 . . . . 2.0 108.4 -173.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -78.35 74.78 4.88 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.359 1.076 . . . . 2.48 109.166 174.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.82 -69.7 1.81 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.49 -1.444 . . . . 2.8500000000000001 109.49 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 45.22 47.24 10.15 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.68 1.592 . . . . 4.3399999999999999 111.199 -176.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.3 -67.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.289 2.635 . . . . 6.4199999999999999 104.942 -177.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.89 -45.52 57.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 122.611 1.196 . . . . 6.79 110.184 -169.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.6 m -99.43 10.72 40.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.233 -1.803 . . . . 6.5599999999999996 112.661 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 82.6 mt 67.93 -65.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.842 1.657 . . . . 9.0199999999999996 111.686 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -139.42 177.94 7.56 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.69 1.996 . . . . 13.470000000000001 108.126 -178.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.73 -58.42 10.1 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.16 0.41 . . . . 14.630000000000001 112.493 178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 . . . . . 0 C--O 1.251 1.155 0 CA-C-N 117.678 0.739 . . . . 23.170000000000002 109.435 -171.812 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mtt . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.43 -0.319 . . . . 16.109999999999999 111.374 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.26 -55.13 20.15 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.029 -1.1 . . . . 12.960000000000001 108.029 173.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -100.35 -172.21 2.17 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 127.935 2.494 . . . . 7.6299999999999999 108.101 168.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 85.69 52.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.288 0 C-N-CA 127.902 2.481 . . . . 7.0899999999999999 107.27 -171.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.63 169.5 0.16 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 127.153 2.181 . . . . 2.73 109.592 -176.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 3.1 ptpt -146.83 174.79 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.168 -1.79 . . . . 1.95 106.168 166.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -125.5 125.51 43.39 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.609 2.364 . . . . 2.6000000000000001 105.732 172.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tp -113.71 121.91 66.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 105.646 -1.983 . . . . 2.5600000000000001 105.646 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.22 29.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.092 -1.447 . . . . 0.67000000000000004 107.092 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.1 mtp -146.17 172.55 13.27 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.468 0.707 . . . . 1.8 110.041 -173.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -110.56 142.76 41.94 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.54 0.736 . . . . 2.4300000000000002 110.425 175.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -138.16 144.45 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.288 1.435 . . . . 0.5 108.686 -174.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.51 175.38 5.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.55 1.14 . . . . 0.83999999999999997 111.238 -171.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.76 12.33 67.35 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.816 -0.513 . . . . 0.62 111.816 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.3 mmt -71.46 85.71 0.84 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.531 0.681 . . . . 3.21 110.492 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.9 m -59.63 -21.46 60.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.977 -0.556 . . . . 1.47 112.244 175.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' HD13 ' A' ' 41' ' ' LEU . 41.1 t 72.05 90.69 0.09 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.064 1.346 . . . . 3.1800000000000002 109.699 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 141.3 -112.71 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 129.531 3.132 . . . . 2.9100000000000001 105.887 -174.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.81 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.61 0.764 . . . . 2.1200000000000001 113.052 -173.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -63.97 -59.44 4.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.022 0.828 . . . . 1.05 110.258 -174.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.67 9.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.699 0.799 . . . . 0.91000000000000003 109.398 173.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.26 -38.63 71.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.254 -0.43 . . . . 1.3400000000000001 111.297 -176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -47.33 77.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.32 0.648 . . . . 2.8100000000000001 110.224 178.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.65 -48.86 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.439 -0.949 . . . . 0.67000000000000004 108.439 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.65 -49.6 74.55 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.127 0.571 . . . . 3.7200000000000002 110.623 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -59.05 -44.41 91.82 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.509 -0.745 . . . . 2.75 110.243 177.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -38.28 96.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.742 0.687 . . . . 0.78000000000000003 111.474 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 60' ' ' ILE . 6.5 mt -71.7 -46.11 59.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.012 0.925 . . . . 3.0 110.528 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' HG11 ' A' ' 34' ' ' VAL . 5.9 mtpm? -57.41 -15.77 7.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.663 1.185 . . . . 4.3300000000000001 112.555 175.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -62.13 -34.48 76.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.928 0.891 . . . . 2.8199999999999998 113.217 168.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.89 147.81 94.29 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.038 0.935 . . . . 1.3500000000000001 110.929 -173.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.64 -46.5 1.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.377 2.051 . . . . 1.2 112.204 -176.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.24 8.84 56.97 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 118.876 -0.958 . . . . 0.62 112.851 -172.434 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 29' ' ' LYS . 8.5 p -67.43 127.5 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 118.438 1.119 . . . . 2.6000000000000001 109.212 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.3 m -94.34 -57.51 2.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.237 -1.394 . . . . 1.25 107.237 174.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.38 130.68 8.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.618 -1.253 . . . . 2.0600000000000001 107.618 -175.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.06 116.54 29.32 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.068 -1.456 . . . . 0.78000000000000003 107.068 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -132.91 164.35 27.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.419 0.628 . . . . 1.99 109.468 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -155.55 115.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 121.822 0.82 . . . . 0.84999999999999998 109.556 176.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.08 74.11 6.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.635 -2.357 . . . . 1.72 104.635 169.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' SG ' ' A' ' 17' ' ' CYS . 4.3 pp -54.38 -25.74 26.14 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 115.623 -0.717 . . . . 1.6399999999999999 111.14 171.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.48 65.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.528 1.131 . . . . 1.02 111.359 174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.1 p -120.55 22.2 11.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.571 0.748 . . . . 0.88 110.283 172.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 42.32 48.37 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.451 1.1 . . . . 1.73 112.664 -175.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.8 m -123.87 108.87 12.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.785 -1.191 . . . . 0.95999999999999996 107.785 -173.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.64 128.27 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.331 -0.989 . . . . 0.46000000000000002 108.331 177.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -123.91 107.94 11.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.377 -1.342 . . . . 2.6499999999999999 107.377 -177.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -115.0 130.03 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.106 -0.701 . . . . 0.45000000000000001 109.106 -175.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 65.7 mt -114.8 122.35 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 107.051 -1.463 . . . . 1.1100000000000001 107.051 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -157.67 165.75 34.62 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.539 1.136 . . . . 1.8300000000000001 109.27 -174.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.08 131.03 45.92 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 119.829 1.195 . . . . 2.6800000000000002 109.923 175.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.18 47.89 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.075 2.517 . . . . 1.0 112.244 177.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.74 5.02 0.5 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.067 1.506 . . . . 1.03 115.067 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -129.76 -35.4 1.67 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.536 1.135 . . . . 1.78 111.583 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.0 m -117.58 -81.13 0.62 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.452 -1.314 . . . . 0.97999999999999998 107.452 -159.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.7 129.89 6.51 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.868 -1.293 . . . . 0.88 109.868 168.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 t -33.85 -48.12 0.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.902 1.681 . . . . 0.96999999999999997 112.249 172.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.05 97.29 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.564 0.345 . . . . 0.77000000000000002 111.254 -179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.28 75.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.131 -0.981 . . . . 0.68999999999999995 110.748 177.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 28' ' ' LEU . 1.3 mm -57.2 -52.5 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 107.64 -1.245 . . . . 0.85999999999999999 107.64 177.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -38.93 92.67 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 122.217 -0.302 . . . . 3.0099999999999998 110.563 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -56.4 -41.95 77.16 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 109.082 -0.71 . . . . 2.1499999999999999 109.082 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -50.31 74.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 122.923 0.489 . . . . 3.6299999999999999 110.155 178.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.05 -47.21 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.997 -0.371 . . . . 0.67000000000000004 109.997 176.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.79 -45.81 84.73 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.203 -0.599 . . . . 2.04 111.406 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -64.99 -25.74 68.0 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.499 -0.751 . . . . 2.6800000000000002 112.206 178.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -3.73 28.85 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.527 0.603 . . . . 2.3900000000000001 112.154 170.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.02 38.79 10.79 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.879 0.763 . . . . 0.92000000000000004 111.483 175.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -126.92 175.82 7.78 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.274 1.03 . . . . 1.95 108.662 174.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.48 137.81 42.52 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.912 0.885 . . . . 1.79 108.712 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.83 145.68 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.482 1.113 . . . . 0.54000000000000004 109.949 178.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -83.59 52.49 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.429 -0.952 . . . . 0.93999999999999995 108.429 -174.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 142.51 49.08 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.31 0.644 . . . . 0.79000000000000004 109.541 -161.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -134.45 143.0 47.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.95 0.5 . . . . 4.7599999999999998 111.307 -170.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -87.51 82.23 7.54 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.997 1.719 . . . . 3.0699999999999998 110.143 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.81 157.49 20.22 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.851 -0.595 . . . . 0.58999999999999997 110.17 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.426 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 88.9 mt-10 -117.23 117.2 28.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.547 1.139 . . . . 2.4900000000000002 111.216 -176.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -112.95 132.31 55.39 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.043 0.937 . . . . 2.0800000000000001 109.614 177.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.85 148.78 26.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.673 1.189 . . . . 1.76 108.879 173.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 114' ' ' VAL . 19.8 mt -123.72 124.71 69.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 120.068 1.304 . . . . 0.59999999999999998 110.255 -173.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -117.82 93.44 4.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.67 0.748 . . . . 3.2000000000000002 109.399 -178.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.67 -62.94 0.09 OUTLIER Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.818 -0.551 . . . . 1.8 112.409 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.419 ' CB ' ' HB2' ' A' ' 88' ' ' CYS . 3.4 ptt? -49.02 127.8 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.24 1.016 . . . . 3.02 113.618 -175.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.6 t -154.58 36.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.773 0.797 . . . . 3.5099999999999998 110.187 177.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 15.3 t -161.18 39.84 0.15 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.41 -0.807 . . . . 4.8499999999999996 110.892 178.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 35.66 51.45 0.68 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.029 1.732 . . . . 5.7699999999999996 113.798 176.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.43 -43.71 0.05 Allowed 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 122.913 0.485 . . . . 1.75 111.707 -170.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' CB ' ' A' ' 83' ' ' MET . 88.9 m -58.15 -47.95 81.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.404 -0.591 . . . . 0.81999999999999995 109.404 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.89 -41.82 71.38 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.997 0.919 . . . . 0.68999999999999995 110.906 172.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.45 -32.66 72.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.767 -0.583 . . . . 2.3100000000000001 109.752 -176.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -70.29 -53.78 15.41 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.46 0.704 . . . . 3.5299999999999998 111.039 173.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pp -60.6 -37.74 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 119.316 -0.373 . . . . 1.98 110.979 -179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -47.3 -59.61 3.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.412 1.885 . . . . 2.6000000000000001 109.577 174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -21.82 65.29 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.917 -0.563 . . . . 3.4700000000000002 111.937 -178.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.0 -71.12 0.32 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 119.465 -0.894 . . . . 2.9300000000000002 109.563 167.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -44.77 -46.14 10.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.727 1.211 . . . . 1.6499999999999999 111.006 -173.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -30.06 -49.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.816 2.046 . . . . 3.3799999999999999 113.026 174.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 75.26 1.0 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.28 -0.637 . . . . 4.3200000000000003 109.28 176.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.04 -68.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 107.47 -1.307 . . . . 1.3899999999999999 107.47 164.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -142.28 -102.47 0.13 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.69 -0.856 . . . . 2.48 108.69 174.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.69 55.16 4.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.89 0.757 . . . . 0.67000000000000004 111.423 -174.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.7 t -107.65 123.19 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.799 1.24 . . . . 0.59999999999999998 108.397 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.21 -55.03 10.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.304 -0.999 . . . . 0.58999999999999997 108.304 170.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -154.07 171.21 19.45 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.395 0.678 . . . . 0.72999999999999998 109.938 -175.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.95 71.25 2.36 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.163 0.801 . . . . 0.46000000000000002 113.163 174.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.18 127.7 13.04 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.91 1.74 . . . . 0.53000000000000003 111.279 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.61 154.34 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.902 1.281 . . . . 1.71 110.124 174.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -133.05 126.3 31.54 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.355 1.062 . . . . 2.3900000000000001 110.866 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 -0.74 57.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.322 1.049 . . . . 2.96 113.096 -178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.3 8.17 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.284 0.633 . . . . 1.24 109.355 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.1 mt -85.68 -24.66 26.92 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.512 -0.767 . . . . 1.6799999999999999 110.775 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 68.51 41.78 1.68 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.83 1.652 . . . . 2.7599999999999998 110.334 -170.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -137.17 162.47 33.36 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.212 0.605 . . . . 0.73999999999999999 109.658 -175.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 80' ' ' ILE . 5.6 p -125.96 131.09 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 125.987 1.715 . . . . 0.44 107.749 172.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.4 m -84.45 128.43 34.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.074 -2.195 . . . . 0.59999999999999998 105.074 165.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.66 119.36 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.447 -1.316 . . . . 0.55000000000000004 107.447 174.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -102.73 93.19 4.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.069 -1.456 . . . . 2.6099999999999999 107.069 174.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.96 162.07 37.1 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.008 0.433 . . . . 2.0699999999999998 111.804 -175.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -84.08 110.04 23.24 Favored Pre-proline 0 N--CA 1.445 -0.723 0 N-CA-C 106.975 -1.491 . . . . 2.4700000000000002 106.975 -173.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -78.89 13.0 2.06 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.594 2.196 . . . . 0.70999999999999996 111.227 -172.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -97.04 -57.37 2.29 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.635 -0.876 . . . . 4.7199999999999998 108.635 173.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -57.17 -50.98 71.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.234 1.414 . . . . 3.3700000000000001 110.556 -179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.63 178.98 4.48 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.575 0.75 . . . . 0.63 108.99 176.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -157.06 165.51 35.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.139 -1.059 . . . . 2.0099999999999998 108.139 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 125' ' ' VAL . 20.8 t -42.35 -44.69 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.563 1.145 . . . . 1.55 112.758 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.7 m -50.94 -46.28 60.95 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.538 -0.726 . . . . 0.68999999999999995 112.332 177.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.46 -49.53 77.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.163 -0.68 . . . . 2.5499999999999998 109.163 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.03 -41.35 92.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.149 0.58 . . . . 1.02 111.472 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -62.6 -41.22 98.85 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.899 -0.5 . . . . 3.1000000000000001 110.281 175.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -40.55 96.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.746 0.784 . . . . 2.8599999999999999 111.229 173.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.02 70.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 120.905 -1.122 . . . . 0.57999999999999996 110.289 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.56 -30.62 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 O-C-N 121.42 -0.8 . . . . 1.73 110.299 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -50.73 -50.81 54.55 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 121.322 0.582 . . . . 3.6200000000000001 110.029 170.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -32.22 64.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.27 0.628 . . . . 4.1200000000000001 111.844 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -80.34 -27.79 38.24 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.445 0.698 . . . . 1.0600000000000001 111.372 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.35 42.41 4.58 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.021 0.819 . . . . 0.73999999999999999 111.889 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -136.6 -173.62 3.48 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 106.61 -1.626 . . . . 1.98 106.61 169.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.36 153.97 46.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 119.21 0.913 . . . . 3.2799999999999998 109.535 171.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.8 mt -114.37 136.06 53.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.27 1.428 . . . . 1.3899999999999999 108.385 -177.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -108.88 160.61 15.86 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.224 1.81 . . . . 3.1699999999999999 107.705 172.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.09 133.28 43.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.317 -0.994 . . . . 1.6399999999999999 108.317 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 8.5 mtpt -80.38 75.48 7.22 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.155 0.889 . . . . 3.21 109.188 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.24 -13.04 47.68 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.512 -1.16 . . . . 2.3799999999999999 112.471 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -73.84 57.33 0.6 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.271 1.536 . . . . 5.46 110.755 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -47.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.248 3.019 . . . . 7.4400000000000004 108.191 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -115.07 -10.23 12.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.191 1.397 . . . . 8.3699999999999992 112.487 -165.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -152.34 33.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.929 1.692 . . . . 5.4100000000000001 109.713 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.75 -58.82 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.218 -0.66 . . . . 7.5999999999999996 109.218 173.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.1 150.61 31.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.741 0.816 . . . . 12.130000000000001 109.725 -178.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.04 4.75 5.68 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.815 -0.991 . . . . 12.48 113.834 -173.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.156 -1.878 . . . . 16.559999999999999 107.501 177.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.115 -0.698 . . . . 14.640000000000001 109.115 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -174.94 -72.13 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 106.889 -1.522 . . . . 9.0 106.889 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 p -178.86 166.38 1.64 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.136 -1.802 . . . . 4.3300000000000001 106.136 -177.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -143.59 52.57 1.33 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.007 0.908 . . . . 4.54 108.724 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -64.14 151.55 43.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.283 -0.871 . . . . 2.2599999999999998 111.592 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -123.38 137.6 54.79 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.91 0.884 . . . . 2.2000000000000002 109.806 169.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -84.8 153.26 23.09 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.174 1.39 . . . . 2.7000000000000002 109.022 168.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -154.18 129.08 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.019 -1.104 . . . . 1.9299999999999999 108.019 164.021 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.85 125.17 53.35 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.856 1.263 . . . . 0.55000000000000004 109.938 179.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 68.2 mtm -142.33 175.51 9.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.422 0.689 . . . . 2.3199999999999998 110.383 -179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.56 129.65 56.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.807 1.243 . . . . 3.54 110.524 -175.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.72 144.21 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.255 1.422 . . . . 0.66000000000000003 109.997 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.31 154.99 23.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.396 1.479 . . . . 1.1200000000000001 110.414 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.14 -3.0 37.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.334 1.445 . . . . 0.93999999999999995 110.725 -173.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.5 mtm -74.82 90.16 2.35 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.831 -0.805 . . . . 2.5899999999999999 112.338 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -50.88 -26.36 5.73 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.469 1.107 . . . . 1.5800000000000001 113.464 168.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' SG ' HD13 ' A' ' 41' ' ' LEU . 38.9 t 75.85 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.007 1.323 . . . . 3.1099999999999999 109.511 179.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 144.25 -122.56 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.756 3.222 . . . . 2.73 105.249 -174.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.96 -31.29 60.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.101 0.96 . . . . 1.5600000000000001 113.045 -175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 m -66.21 -57.33 7.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.255 1.026 . . . . 1.1499999999999999 109.981 -171.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.898 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.38 -48.37 79.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.173 -0.921 . . . . 0.85999999999999999 109.402 178.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.78 73.77 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.063 0.545 . . . . 0.76000000000000001 112.067 175.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.54 99.64 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.567 -0.708 . . . . 2.3599999999999999 109.849 178.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.507 HD11 ' CE2' ' A' ' 69' ' ' TYR . 50.9 mt -62.44 -55.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.488 -0.93 . . . . 0.56000000000000005 108.488 174.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' OE2' HG12 ' A' ' 39' ' ' VAL . 74.5 mt-10 -53.43 -45.22 69.34 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 118.929 0.786 . . . . 3.7799999999999998 111.285 -175.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -70.68 -47.68 58.69 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 122.973 0.509 . . . . 1.8700000000000001 111.293 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.13 -42.4 87.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.014 -0.834 . . . . 0.57999999999999996 111.014 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.79 -41.34 68.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.424 0.689 . . . . 1.6000000000000001 110.108 175.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -27.39 14.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.774 1.17 . . . . 2.5 112.232 174.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.95 -27.43 52.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.006 0.743 . . . . 3.1699999999999999 113.006 175.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -79.18 147.11 68.62 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.224 0.61 . . . . 1.23 111.241 -177.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.81 -44.76 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.822 2.348 . . . . 1.27 111.468 -175.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.8 85.15 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.627 -0.989 . . . . 0.57999999999999996 110.627 -176.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.43 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 79.5 t -56.05 99.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 124.17 0.988 . . . . 1.48 109.94 178.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.2 m -82.47 -42.62 18.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.295 -1.372 . . . . 0.68000000000000005 107.295 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -149.39 159.88 43.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.998 0.428 . . . . 1.8100000000000001 110.158 168.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.06 107.72 4.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.636 1.575 . . . . 0.56999999999999995 107.374 -177.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.26 139.7 52.31 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.662 1.185 . . . . 1.8300000000000001 109.002 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.898 HG11 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -120.89 110.27 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 122.13 0.967 . . . . 1.1499999999999999 110.822 175.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.48 71.44 7.32 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.815 -1.92 . . . . 2.0299999999999998 105.815 170.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.0 pp -57.1 -21.22 30.32 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.308 173.072 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -63.06 -35.86 81.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.059 0.944 . . . . 0.93000000000000005 111.462 175.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -113.27 5.44 16.91 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.645 0.778 . . . . 0.87 111.53 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 44.39 70.59 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.955 1.302 . . . . 1.74 110.244 -165.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.1 m -138.33 122.14 17.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.59 -1.633 . . . . 0.87 106.59 169.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -93.52 125.3 46.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.317 1.447 . . . . 0.40999999999999998 107.323 172.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -116.83 115.18 25.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.022 1.729 . . . . 2.7000000000000002 107.433 -177.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.05 133.6 63.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.07 -1.085 . . . . 0.40000000000000002 108.07 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.77 115.84 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.885 -1.154 . . . . 1.6000000000000001 107.885 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 34' ' ' VAL . 52.4 p90 -156.79 172.82 17.95 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 122.096 -0.378 . . . . 1.79 111.321 -172.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.08 128.22 52.6 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-O 119.135 -0.46 . . . . 2.0699999999999998 110.63 -172.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.64 37.31 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.735 2.29 . . . . 0.87 111.777 -175.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.52 17.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.149 0.796 . . . . 0.95999999999999996 113.149 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -132.65 -42.37 0.93 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 1.8799999999999999 110.857 175.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 m -120.43 -83.14 0.65 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.785 -1.191 . . . . 0.78000000000000003 107.785 -161.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.13 130.96 5.77 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.916 -1.274 . . . . 0.69999999999999996 109.916 168.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.2 t -37.81 -45.33 0.82 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.644 1.578 . . . . 0.95999999999999996 112.819 176.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.59 -43.17 93.76 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.079 0.466 . . . . 0.70999999999999996 111.044 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.44 -40.84 89.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.358 -0.839 . . . . 0.63 110.544 175.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mm -55.28 -56.52 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.056 -0.72 . . . . 0.72999999999999998 109.056 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -61.25 -38.93 88.43 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.021 -0.362 . . . . 2.1899999999999999 110.021 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.38 -37.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.73 -0.388 . . . . 2.5299999999999998 109.974 175.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -47.34 72.16 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.449 -0.945 . . . . 2.4300000000000002 108.449 -177.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.5 mt -49.4 -53.53 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.338 -0.615 . . . . 0.56000000000000005 109.338 174.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.96 -48.9 79.82 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.316 -0.553 . . . . 3.1400000000000001 111.685 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -56.88 -30.11 63.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.302 0.641 . . . . 2.6699999999999999 112.559 175.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.92 -13.81 62.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.855 0.752 . . . . 1.99 112.11 175.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.9 42.73 2.78 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.667 1.127 . . . . 0.62 111.185 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CE2' HD11 ' A' ' 24' ' ' ILE . 64.5 m-85 -129.71 177.18 7.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.982 1.313 . . . . 1.9399999999999999 109.838 -178.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.67 130.07 19.96 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.859 0.299 . . . . 2.1499999999999999 110.7 176.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 m -84.43 131.14 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.45 1.1 . . . . 0.77000000000000002 110.17 -174.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.71 65.87 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.32 140.51 46.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.26 -1.015 . . . . 0.78000000000000003 108.26 -172.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.65 142.36 51.37 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.238 0.615 . . . . 3.9199999999999999 110.918 -174.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -82.28 86.26 6.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.597 1.159 . . . . 4.2599999999999998 109.024 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.64 150.28 24.32 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.247 -0.649 . . . . 0.62 109.247 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.86 114.87 23.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.776 0.716 . . . . 2.7200000000000002 111.098 -174.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.6 151.73 24.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.966 1.306 . . . . 1.75 108.766 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -107.68 136.75 46.9 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.796 2.038 . . . . 1.5 107.801 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 114' ' ' VAL . 3.8 mt -110.29 119.72 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 119.054 0.843 . . . . 0.59999999999999998 109.637 -167.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -112.48 60.09 0.63 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.58 -1.637 . . . . 2.3799999999999999 106.58 -174.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.22 -60.33 0.01 OUTLIER Glycine 0 CA--C 1.527 0.798 0 CA-C-N 113.153 -1.84 . . . . 1.3899999999999999 112.155 -173.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.24 128.84 39.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.261 1.03 . . . . 3.0 110.559 176.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.6 t -154.35 31.73 0.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.996 0.903 . . . . 4.04 108.978 177.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -141.92 -112.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.957 -1.127 . . . . 4.5099999999999998 107.957 173.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.91 41.02 0.39 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.715 1.143 . . . . 5.9100000000000001 109.742 -178.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.83 -42.41 0.09 Allowed 'General case' 0 C--N 1.34 0.184 0 N-CA-C 113.259 0.837 . . . . 1.9399999999999999 113.259 -170.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.5 m -61.52 -41.01 96.68 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.166 -0.959 . . . . 0.82999999999999996 109.789 -169.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.847 ' HB1' HG11 ' A' ' 107' ' ' VAL . . . -59.2 -36.05 74.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.279 1.432 . . . . 0.63 111.242 173.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -70.32 -38.88 75.01 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.988 -1.07 . . . . 2.1099999999999999 110.16 174.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -59.22 -55.83 29.94 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.963 -1.086 . . . . 4.6500000000000004 110.634 175.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.38 -40.28 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-O 118.432 -0.794 . . . . 1.8500000000000001 110.601 178.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -59.62 4.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.093 0.957 . . . . 2.3399999999999999 109.018 179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -26.53 42.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.975 -0.536 . . . . 4.7400000000000002 111.504 -178.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.16 -70.22 0.35 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 119.316 -0.954 . . . . 3.0299999999999998 110.614 169.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -44.9 -43.58 8.99 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.541 1.137 . . . . 1.71 111.322 -174.575 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -29.83 -44.94 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 128.029 2.532 . . . . 1.6299999999999999 113.392 173.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -159.1 74.12 0.63 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.387 0.675 . . . . 4.7199999999999998 109.667 177.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.0 mt -66.81 -65.18 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.621 -0.881 . . . . 2.48 108.621 168.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.43 -89.5 0.15 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.459 -1.311 . . . . 3.4900000000000002 107.459 176.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.04 53.01 1.07 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.583 -1.007 . . . . 0.67000000000000004 110.583 -177.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 96' ' ' LEU . 19.5 t -105.88 116.17 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.027 -1.101 . . . . 0.54000000000000004 108.027 178.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.36 -51.46 51.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.864 -0.791 . . . . 0.65000000000000002 108.864 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -154.5 172.17 18.22 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.016 -0.735 . . . . 0.89000000000000001 109.016 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.49 69.46 3.23 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.822 0.675 . . . . 0.53000000000000003 112.822 174.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.74 137.68 33.11 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.834 1.689 . . . . 0.58999999999999997 110.58 179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.847 HG11 ' HB1' ' A' ' 89' ' ' ALA . 25.1 t -107.88 134.52 49.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.097 0.959 . . . . 2.3300000000000001 109.472 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.07 -35.85 59.22 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.358 0.663 . . . . 2.8900000000000001 111.172 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 4.2 m-85 66.23 -63.97 0.23 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.275 1.83 . . . . 3.98 112.028 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.59 81.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.603 0.761 . . . . 1.6000000000000001 110.721 -164.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.91 -6.83 59.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.78 0.832 . . . . 1.4199999999999999 111.727 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.75 47.01 10.85 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.624 1.17 . . . . 2.7200000000000002 110.797 -170.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.0 p -132.02 147.99 52.48 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 123.969 0.908 . . . . 0.68999999999999995 111.272 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.447 ' HB ' HD11 ' A' ' 80' ' ' ILE . 2.7 p -119.57 125.6 74.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 C-N-CA 125.109 1.363 . . . . 0.60999999999999999 108.516 168.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.1 m -83.58 135.47 34.61 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.859 -1.904 . . . . 0.77000000000000002 105.859 165.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.49 118.31 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.195 -1.409 . . . . 0.58999999999999997 107.195 174.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.08 96.08 7.27 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.113 -1.44 . . . . 2.8599999999999999 107.113 172.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.08 159.58 41.95 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.304 0.502 . . . . 1.76 111.425 -176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.16 108.21 14.8 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 108.173 -1.047 . . . . 2.3700000000000001 108.173 -172.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.36 5.58 2.68 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.492 2.128 . . . . 0.58999999999999997 112.294 -173.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 -38.73 10.48 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.72 0.808 . . . . 6.6799999999999997 109.919 172.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.78 -35.02 26.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.211 0.604 . . . . 2.96 109.551 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.44 -176.79 4.46 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.586 0.754 . . . . 0.53000000000000003 110.188 176.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -158.08 174.16 15.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.565 1.146 . . . . 2.29 108.853 177.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -47.46 -35.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 125.631 1.572 . . . . 2.27 113.97 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 m -51.05 -41.63 60.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.707 0.685 . . . . 0.95999999999999996 111.534 174.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -68.74 -41.44 78.93 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.892 0.853 . . . . 2.0299999999999998 109.262 -179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.66 -43.98 95.15 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.654 -0.654 . . . . 0.94999999999999996 109.773 179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.14 -60.48 3.27 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.592 -0.892 . . . . 3.1600000000000001 108.592 172.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.86 -46.38 51.38 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.899 0.856 . . . . 2.73 111.691 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.28 -45.4 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.729 0.812 . . . . 1.04 111.002 -176.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.89 -40.22 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.928 -0.483 . . . . 1.6499999999999999 109.743 -178.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.13 -38.93 84.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.222 0.609 . . . . 2.8300000000000001 109.461 177.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -56.73 -28.6 61.32 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.668 0.988 . . . . 3.27 113.668 172.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.92 -45.54 18.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.266 1.394 . . . . 1.24 109.443 169.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 109.13 51.79 0.66 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.877 1.227 . . . . 0.75 110.381 -177.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -141.5 -178.95 5.87 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.122 -1.807 . . . . 1.9099999999999999 106.122 169.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.46 138.04 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.548 1.067 . . . . 2.77 109.824 -177.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.69 148.53 23.75 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.405 1.082 . . . . 1.4299999999999999 110.424 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -127.07 173.74 9.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.247 1.819 . . . . 2.1099999999999999 108.031 169.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mp -115.79 129.29 56.38 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.056 0.942 . . . . 1.5900000000000001 109.311 -171.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -82.44 78.86 9.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.762 0.791 . . . . 2.98 109.67 178.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.59 -60.23 4.35 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.514 -1.034 . . . . 2.0299999999999998 110.514 176.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 47.49 49.48 15.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.264 1.026 . . . . 4.0199999999999996 110.78 179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.21 -36.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.118 1.367 . . . . 7.8700000000000001 109.869 178.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.7 t0 48.63 99.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.683 2.393 . . . . 9.4800000000000004 111.635 -175.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.1 m 57.36 26.86 12.99 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.804 -0.635 . . . . 7.3300000000000001 110.718 177.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.4 mt 55.73 52.99 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.087 1.755 . . . . 8.8200000000000003 110.31 -178.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.17 106.21 8.74 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.866 -1.161 . . . . 12.210000000000001 107.866 167.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -177.79 -94.83 0.1 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.515 -1.034 . . . . 12.619999999999999 110.515 177.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? . . . . . 0 C--O 1.253 1.239 0 N-CA-C 105.126 -2.176 . . . . 15.109999999999999 105.126 179.216 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtm . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 116.131 -1.89 . . . . 19.280000000000001 106.647 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.46 -165.36 0.16 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.823 1.192 . . . . 13.1 108.671 -175.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 m -74.37 -166.55 0.43 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.601 0.637 . . . . 7.04 110.098 171.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 81.77 121.18 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.569 2.348 . . . . 5.71 109.05 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -61.7 117.22 5.53 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.68 -0.859 . . . . 2.1400000000000001 108.68 176.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.9 170.13 13.39 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.796 -0.816 . . . . 2.5899999999999999 108.796 175.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -121.33 106.35 11.38 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.411 2.284 . . . . 2.5499999999999998 106.772 170.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tp -91.15 125.46 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.253 -1.758 . . . . 2.5299999999999998 106.253 169.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -116.91 128.82 55.6 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 119.062 0.846 . . . . 0.75 109.226 175.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtt -149.78 166.34 29.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 2.2400000000000002 111.289 178.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.0 127.2 40.88 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.325 1.45 . . . . 1.73 110.374 172.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 150.57 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.092 1.757 . . . . 0.66000000000000003 109.25 -177.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -119.0 168.83 10.43 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.988 0.915 . . . . 0.77000000000000002 111.982 -176.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.58 12.31 67.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.219 0.914 . . . . 0.63 111.55 -177.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 85.5 4.4 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.807 -0.812 . . . . 4.1299999999999999 108.807 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m -69.35 -32.96 72.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.846 -0.427 . . . . 1.46 109.846 178.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t -170.42 170.76 6.87 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.14 -0.689 . . . . 4.04 109.14 -174.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.64 -32.14 2.24 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.379 1.472 . . . . 3.3700000000000001 112.522 173.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.44 77.89 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.686 0.676 . . . . 1.3799999999999999 112.502 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.35 -56.08 12.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.199 -1.037 . . . . 0.82999999999999996 108.199 -176.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -42.27 -63.1 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.459 -1.246 . . . . 0.72999999999999998 111.856 169.279 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.04 -36.91 68.54 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.416 1.087 . . . . 0.84999999999999998 111.675 -177.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -45.24 92.37 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 121.903 -0.498 . . . . 4.29 110.056 174.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.94 -48.69 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 118.805 -0.617 . . . . 0.62 109.507 177.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -54.99 -49.32 71.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.841 0.746 . . . . 3.79 110.553 -179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -59.47 -46.77 87.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.609 1.164 . . . . 3.3199999999999998 110.708 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.6 -39.97 94.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.112 -0.795 . . . . 0.58999999999999997 111.112 176.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.611 HD21 HG23 ' A' ' 60' ' ' ILE . 8.0 mt -70.04 -45.33 67.36 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.867 0.867 . . . . 2.8900000000000001 110.81 -178.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -18.91 6.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.38 0.672 . . . . 2.0499999999999998 112.325 178.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -58.84 -30.98 68.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.092 0.957 . . . . 2.9100000000000001 112.152 172.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.2 146.47 48.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.967 0.907 . . . . 2.0800000000000001 109.812 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.56 -40.67 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.716 2.278 . . . . 1.4299999999999999 112.227 -175.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.74 -19.88 77.01 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.207 -0.774 . . . . 0.67000000000000004 111.33 -174.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.8 106.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 118.315 1.057 . . . . 1.3400000000000001 109.018 174.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -82.74 -49.24 9.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.514 -1.291 . . . . 0.84999999999999998 107.514 176.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -146.73 156.03 42.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.453 -0.943 . . . . 2.0899999999999999 108.453 173.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.5 113.36 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.607 -1.257 . . . . 0.63 107.607 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -134.4 134.16 41.36 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.475 -0.935 . . . . 1.8700000000000001 108.475 -171.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG13 ' HB1' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -135.16 110.04 11.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 122.262 1.03 . . . . 1.6499999999999999 111.183 174.221 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.21 89.52 7.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.629 -1.249 . . . . 2.71 107.629 177.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.48 -30.26 29.12 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 122.326 0.251 . . . . 2.6499999999999999 111.498 171.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.23 64.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.443 0.697 . . . . 1.1499999999999999 111.822 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.1 p -119.57 12.19 12.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.823 0.849 . . . . 0.84999999999999998 110.529 174.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.38 35.67 6.07 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.025 1.73 . . . . 2.0600000000000001 112.412 -173.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 85.1 m -108.85 107.64 18.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.353 -0.98 . . . . 1.1100000000000001 108.353 -169.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.48 127.46 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.816 -1.179 . . . . 0.54000000000000004 107.816 167.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -131.13 114.79 15.55 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.03 -1.1 . . . . 3.1299999999999999 108.03 174.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 t -115.3 131.31 67.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.202 -1.036 . . . . 0.46999999999999997 108.202 -175.082 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.26 113.76 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.245 1.018 . . . . 1.1899999999999999 108.356 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -157.86 168.7 26.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.734 -0.386 . . . . 1.8100000000000001 111.254 -171.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.25 121.02 70.66 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 115.204 -0.907 . . . . 2.0499999999999998 110.95 -173.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 36.41 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.548 2.165 . . . . 0.89000000000000001 113.044 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.29 19.33 0.42 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.082 0.855 . . . . 1.1899999999999999 113.304 -178.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -133.17 -41.99 0.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.544 1.138 . . . . 2.1200000000000001 111.142 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 3.4 m -116.3 -77.25 0.57 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.148 0.979 . . . . 1.0600000000000001 108.593 -156.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.56 128.56 4.04 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.143 -1.183 . . . . 0.97999999999999998 110.143 170.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.58 -41.47 54.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.52 0.728 . . . . 1.1299999999999999 110.005 176.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.15 91.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.304 0.642 . . . . 1.03 111.062 178.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.95 -43.24 68.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.477 -0.764 . . . . 0.93999999999999995 110.389 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.611 HG23 HD21 ' A' ' 28' ' ' LEU . 31.1 mt -57.33 -51.21 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.466 -0.568 . . . . 1.8600000000000001 109.466 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.0 -38.95 92.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.055 -0.497 . . . . 2.5600000000000001 110.865 177.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.14 -42.18 69.23 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.807 -0.812 . . . . 2.8999999999999999 108.807 174.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -49.59 76.84 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 118.845 -0.598 . . . . 2.3999999999999999 110.154 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.2 mt -50.67 -48.34 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 118.475 0.58 . . . . 0.51000000000000001 109.861 174.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.39 -50.67 70.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.783 0.325 . . . . 2.21 111.428 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -61.07 -29.3 69.66 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.48 1.112 . . . . 2.1800000000000002 112.278 178.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -6.21 29.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.604 0.638 . . . . 2.2200000000000002 112.18 172.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.06 41.56 5.85 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.56 -1.016 . . . . 0.62 110.56 174.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.03 177.75 7.49 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.798 1.239 . . . . 2.1400000000000001 109.219 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 152.64 42.12 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.391 -0.966 . . . . 2.4100000000000001 108.391 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.7 m -105.68 145.4 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.902 1.281 . . . . 0.57999999999999996 109.502 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.27 54.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.72 -1.215 . . . . 0.97999999999999998 107.72 -176.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 m -119.68 131.61 55.46 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.743 0.817 . . . . 0.90000000000000002 108.978 -168.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -128.41 142.96 50.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 123.727 0.642 . . . . 3.8700000000000001 111.329 -172.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -84.05 80.41 9.18 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.551 1.94 . . . . 2.8700000000000001 110.364 177.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.97 135.48 34.44 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.389 -0.597 . . . . 0.68000000000000005 109.389 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.24 121.98 32.75 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.429 0.691 . . . . 3.4500000000000002 109.3 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -118.05 145.0 45.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.719 1.208 . . . . 2.0499999999999998 108.864 -177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -99.48 145.16 27.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.643 1.577 . . . . 1.78 108.04 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 114' ' ' VAL . 5.6 mt -123.84 137.02 58.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 CA-C-N 119.698 1.136 . . . . 0.67000000000000004 109.103 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -134.04 54.4 1.95 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.49 0.662 . . . . 2.3399999999999999 109.809 -174.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.07 -35.42 0.06 OUTLIER Glycine 0 CA--C 1.539 1.582 0 C-N-CA 126.725 2.107 . . . . 1.52 115.427 -170.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.725 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 37.8 mtm -52.97 93.77 0.01 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.299 1.549 . . . . 3.04 112.514 178.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.0 t -54.34 -24.71 20.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.659 -0.686 . . . . 4.4400000000000004 112.442 173.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.74 0.7 . . . . 5.3399999999999999 109.549 167.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.1 66.83 0.91 Allowed 'General case' 0 N--CA 1.458 -0.065 0 CA-C-O 121.328 0.585 . . . . 5.79 110.418 -172.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.62 -52.18 0.09 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.454 0.702 . . . . 2.46 109.851 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -55.33 -47.11 76.18 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.792 -0.818 . . . . 0.93000000000000005 108.792 -177.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' ' SD ' ' A' ' 83' ' ' MET . . . -62.9 -38.13 89.72 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 119.093 -0.48 . . . . 0.67000000000000004 111.651 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -57.45 -47.32 82.15 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.897 0.772 . . . . 2.1899999999999999 109.123 177.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.02 -51.62 67.27 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.102 -0.374 . . . . 4.0 110.536 176.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -41.88 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.822 0.849 . . . . 2.9500000000000002 110.644 -177.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -60.66 -53.81 52.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.265 1.426 . . . . 3.02 107.802 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -65.89 -30.81 71.47 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.317 1.047 . . . . 2.9399999999999999 111.501 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -72.02 -70.91 0.3 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.868 0.758 . . . . 3.0800000000000001 111.211 175.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.4 mt -46.85 -37.25 8.48 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 125.99 1.716 . . . . 1.4099999999999999 110.088 -177.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' HB3' ' HD2' ' A' ' 98' ' ' LYS . 0.8 OUTLIER -27.65 -48.82 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 127.477 2.311 . . . . 1.45 113.762 174.48 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -164.56 74.79 0.27 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.225 0.61 . . . . 6.6600000000000001 110.164 176.713 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.86 -58.25 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 119.26 -0.4 . . . . 1.3500000000000001 109.991 169.198 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.48 -65.49 0.43 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.298 0.639 . . . . 2.6200000000000001 110.918 -175.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -131.26 48.79 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.387 -1.085 . . . . 0.80000000000000004 110.387 -176.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 121.0 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.872 -1.529 . . . . 0.78000000000000003 106.872 -179.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.11 -51.83 19.63 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.639 -0.875 . . . . 0.96999999999999997 108.639 176.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -151.52 165.72 33.35 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.419 0.687 . . . . 1.1100000000000001 109.685 -175.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.0 60.7 3.36 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.427 -0.806 . . . . 0.81000000000000005 112.79 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.1 147.99 39.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.164 1.91 . . . . 0.70999999999999996 111.531 -177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 89' ' ' ALA . 3.2 p -105.94 137.56 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.744 1.618 . . . . 3.1800000000000002 110.658 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.8 -34.99 24.61 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 123.756 0.822 . . . . 3.0 111.005 177.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.4 m-85 67.22 -61.87 0.33 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.467 1.907 . . . . 3.1800000000000002 112.979 -176.154 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.73 71.77 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.384 0.512 . . . . 1.5800000000000001 112.384 -167.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.42 8.68 35.78 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.965 0.906 . . . . 2.1400000000000001 110.913 178.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 53.57 60.78 3.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.669 1.588 . . . . 3.6899999999999999 112.624 -174.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.46 155.77 44.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.602 0.761 . . . . 1.0 110.801 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 80' ' ' ILE . 6.1 p -125.81 129.98 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 125.318 1.447 . . . . 0.42999999999999999 107.477 163.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -82.6 125.83 31.62 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.095 -2.187 . . . . 0.60999999999999999 105.095 165.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.13 109.29 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 174.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -93.65 98.09 10.9 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.856 -1.535 . . . . 2.9399999999999999 106.856 174.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.87 170.1 17.75 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.798 0.333 . . . . 1.8600000000000001 111.457 -175.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 5.1 t-20 -95.06 109.07 42.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 115.04 -0.982 . . . . 2.23 108.846 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -80.3 22.24 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.643 2.229 . . . . 0.64000000000000001 111.407 -175.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -103.73 -56.24 2.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.571 -0.9 . . . . 5.46 108.571 172.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -57.33 -55.99 27.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.893 0.477 . . . . 3.6200000000000001 110.502 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -116.23 -174.38 2.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.511 0.724 . . . . 0.64000000000000001 110.294 -174.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.6 p -161.24 169.19 22.67 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.453 0.701 . . . . 2.0600000000000001 110.477 -178.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.8 t -37.88 -46.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.981 1.312 . . . . 1.54 111.634 166.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 m -56.03 -46.93 78.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.559 0.744 . . . . 0.72999999999999998 112.229 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.76 -48.44 81.65 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-O 121.621 0.724 . . . . 2.1899999999999999 109.302 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.59 -49.07 78.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.69 -0.686 . . . . 0.70999999999999996 110.257 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -53.1 -53.46 49.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.246 -0.65 . . . . 3.6499999999999999 109.246 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.63 -43.51 97.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.349 0.595 . . . . 3.2200000000000002 110.655 -175.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.86 68.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.695 -0.628 . . . . 0.56999999999999995 109.845 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.64 -29.6 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 121.962 -0.461 . . . . 1.45 111.272 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.69 -48.68 78.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.681 -0.859 . . . . 3.3100000000000001 108.681 171.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -61.44 -36.3 79.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.204 0.602 . . . . 3.6600000000000001 112.401 176.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.51 -30.57 71.35 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.969 0.804 . . . . 0.80000000000000004 111.681 169.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.05 38.28 5.47 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.546 1.07 . . . . 0.76000000000000001 111.521 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -127.89 -169.66 2.1 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.302 -0.999 . . . . 2.04 108.302 171.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.73 122.18 17.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.754 0.707 . . . . 3.0600000000000001 109.42 178.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.3 mt -84.34 157.25 21.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.494 -0.775 . . . . 1.55 109.984 171.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -141.22 177.72 7.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.037 2.535 . . . . 2.1000000000000001 106.761 169.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.5 149.98 38.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.736 1.214 . . . . 1.5700000000000001 108.133 -174.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -81.38 58.95 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.966 0.889 . . . . 3.9500000000000002 110.097 -179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.17 33.54 30.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.506 0.574 . . . . 2.6299999999999999 112.376 -176.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -26.6 66.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.565 0.698 . . . . 3.75 112.23 -176.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.33 -64.3 1.05 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.192 0.997 . . . . 6.71 109.486 161.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.1 t70 73.75 147.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.081 1.752 . . . . 7.8099999999999996 109.793 -156.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t 59.04 36.69 24.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.021 1.328 . . . . 11.869999999999999 111.333 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.0 pt -65.38 66.55 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.828 1.251 . . . . 14.33 113.155 174.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -123.12 153.02 40.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.553 1.541 . . . . 19.5 108.281 170.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -114.06 -81.5 1.02 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.046 -0.822 . . . . 19.66 111.046 -171.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.367 0 N-CA-C 104.149 -2.537 . . . . 23.649999999999999 104.149 169.154 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mtp . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.192 -1.781 . . . . 12.300000000000001 106.192 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -171.16 60.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.253 0.933 . . . . 9.7899999999999991 110.149 -172.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 p -169.63 125.99 0.87 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.675 -1.155 . . . . 4.0999999999999996 109.262 -167.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.23 70.32 1.23 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.341 -0.985 . . . . 5.4199999999999999 108.341 174.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -67.89 144.48 55.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.635 -0.666 . . . . 2.3300000000000001 109.302 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 137.38 53.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.433 -0.58 . . . . 2.21 109.433 172.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.96 152.96 24.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.513 1.525 . . . . 3.1299999999999999 108.593 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.5 tt -143.32 134.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 107.608 -1.256 . . . . 2.0600000000000001 107.608 160.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.26 121.06 40.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.772 -1.566 . . . . 0.59999999999999998 106.772 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.5 mtm -142.5 175.65 9.62 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.742 0.701 . . . . 1.9199999999999999 110.837 178.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -115.17 136.01 53.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.885 1.674 . . . . 2.2599999999999998 109.172 -173.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -143.1 138.48 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 123.617 0.767 . . . . 0.65000000000000002 109.305 -169.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 m -105.81 168.2 9.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.764 1.226 . . . . 1.03 110.723 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.67 -20.82 32.96 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.292 -1.123 . . . . 0.64000000000000001 110.292 -174.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.455 ' SD ' HG21 ' A' ' 39' ' ' VAL . 49.8 mtt -64.45 102.36 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 117.696 0.748 . . . . 3.8500000000000001 109.615 175.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m -63.44 -15.88 58.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.613 0.765 . . . . 1.5 112.471 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m 85.55 8.06 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.371 1.468 . . . . 5.0899999999999999 111.109 171.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.79 130.29 21.23 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.512 -2.403 . . . . 3.3900000000000001 104.512 168.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.58 -47.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.727 1.611 . . . . 1.25 114.329 -178.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.1 m -61.34 -57.59 11.68 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.24 1.016 . . . . 0.80000000000000004 109.744 -170.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -53.42 -50.78 64.49 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.219 -1.355 . . . . 0.87 109.437 177.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.41 80.68 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.078 -0.389 . . . . 1.02 111.653 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -46.89 88.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.729 0.811 . . . . 2.0600000000000001 109.699 177.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.14 -59.39 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 108.334 -0.988 . . . . 0.69999999999999996 108.334 176.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -57.28 -41.86 80.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.459 1.027 . . . . 4.0199999999999996 111.603 -174.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -57.0 -48.66 77.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.366 0.53 . . . . 2.7400000000000002 110.245 173.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.95 -49.25 72.74 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.462 -0.655 . . . . 0.93999999999999995 111.462 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.39 -36.61 84.72 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.701 -0.882 . . . . 1.6000000000000001 109.693 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -19.13 2.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.174 1.39 . . . . 2.2000000000000002 112.36 171.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -26.14 65.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.946 0.793 . . . . 3.6899999999999999 112.416 175.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mmt -79.51 137.81 55.25 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.425 0.557 . . . . 1.3600000000000001 111.531 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.02 -45.14 4.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.853 2.369 . . . . 1.21 111.923 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.86 -11.49 66.36 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.314 -0.715 . . . . 0.68000000000000005 112.242 -178.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.19 121.42 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.009 1.405 . . . . 1.5600000000000001 108.478 -178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.7 m -88.8 -50.81 5.99 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.932 -1.136 . . . . 0.85999999999999999 107.932 174.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' CG ' HD21 ' A' ' 38' ' ' ASN . 17.1 t0 -153.97 107.06 2.9 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.3500000000000001 112.53 179.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.07 120.82 33.78 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.354 1.461 . . . . 0.78000000000000003 109.333 175.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.493 HD21 ' CG ' ' A' ' 36' ' ' ASP . 43.4 m-80 -140.2 172.82 12.21 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.194 0.998 . . . . 2.1499999999999999 110.481 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.6 p -155.39 120.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.645 0.736 . . . . 0.91000000000000003 109.468 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -80.88 73.57 7.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.6 -2.0 . . . . 2.3300000000000001 105.6 165.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 pp -51.47 -31.15 22.4 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.492 0.717 . . . . 1.8799999999999999 111.13 171.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -31.99 67.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.475 1.11 . . . . 1.03 111.448 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 p -120.2 24.9 10.19 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.237 0.615 . . . . 0.82999999999999996 110.114 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 40.57 52.83 3.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.309 1.444 . . . . 2.1499999999999999 112.219 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 108.44 10.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.78 -1.193 . . . . 0.78000000000000003 107.78 -175.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -83.29 127.72 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.844 -1.169 . . . . 0.37 107.844 178.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.19 106.54 9.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.661 1.184 . . . . 2.8199999999999998 107.911 -173.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.0 132.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.233 -0.655 . . . . 0.46000000000000002 109.233 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.4 mt -120.66 120.85 63.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 107.653 -1.24 . . . . 1.1699999999999999 107.653 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -155.42 173.16 17.07 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.146 -0.346 . . . . 1.8200000000000001 110.466 -173.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -89.95 124.15 64.29 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.69 0.619 . . . . 2.2799999999999998 109.806 -175.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.55 33.53 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.3 2.667 . . . . 1.03 112.245 -178.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.84 23.27 0.45 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.7 0.63 . . . . 1.0800000000000001 112.7 -179.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -136.67 -49.99 0.66 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.884 1.273 . . . . 2.2799999999999998 109.386 171.107 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -104.11 -83.69 0.49 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.703 -1.221 . . . . 0.75 107.703 -163.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.5 124.07 3.44 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.913 -1.675 . . . . 0.69999999999999996 108.913 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -42.94 -42.84 3.88 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.874 1.269 . . . . 0.84999999999999998 112.734 -177.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.66 89.25 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.017 -0.427 . . . . 0.76000000000000001 111.085 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.47 -34.07 76.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.242 -0.911 . . . . 0.64000000000000001 110.954 176.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 mm -59.33 -52.49 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.537 -0.912 . . . . 0.64000000000000001 108.537 176.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.56 -42.36 99.5 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.91 -0.716 . . . . 1.8899999999999999 109.987 177.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -51.7 -42.02 61.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.483 -0.562 . . . . 3.5 109.483 177.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.12 -46.8 73.06 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.976 -0.535 . . . . 3.3999999999999999 110.581 -176.67 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -50.01 -50.65 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 109.288 -0.634 . . . . 0.63 109.288 172.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.17 -51.9 67.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.245 -0.434 . . . . 1.79 110.294 -176.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -58.31 -35.53 72.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.232 1.013 . . . . 2.1899999999999999 112.545 176.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -14.47 52.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.065 -0.493 . . . . 2.1600000000000001 112.268 174.004 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.02 40.08 3.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.368 0.985 . . . . 0.65000000000000002 111.219 174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -128.55 177.53 6.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.732 1.213 . . . . 2.0099999999999998 109.568 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.97 139.83 32.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.231 0.612 . . . . 2.2200000000000002 109.709 177.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -90.08 138.87 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.833 1.253 . . . . 0.62 109.946 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.08 65.05 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.505 -1.294 . . . . 1.01 107.505 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.3 134.8 46.73 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.801 -1.185 . . . . 0.87 107.801 -169.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.45 133.17 56.09 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.089 0.556 . . . . 3.4199999999999999 110.746 -170.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -83.93 80.94 8.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.428 1.491 . . . . 2.6699999999999999 109.606 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 116' ' ' VAL . . . -82.55 163.13 21.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.135 -0.691 . . . . 0.97999999999999998 109.135 178.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -124.75 118.07 25.6 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.436 1.094 . . . . 2.4700000000000002 110.505 174.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.22 157.1 17.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.068 0.947 . . . . 1.98 108.506 173.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.48 157.18 17.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.164 2.186 . . . . 1.6799999999999999 107.439 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mt -127.41 139.86 50.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.039 0 CA-C-N 119.816 1.189 . . . . 0.63 109.95 -173.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -133.17 94.19 3.3 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.878 -0.786 . . . . 3.9900000000000002 108.878 172.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.82 -48.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 121.297 -0.877 . . . . 1.54 114.065 -174.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 13.8 ttp -50.47 93.6 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.809 1.644 . . . . 4.1900000000000004 113.728 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 t -52.11 -37.87 55.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.359 -0.837 . . . . 4.8399999999999999 111.248 172.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -166.15 -52.51 0.03 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 119.814 -0.754 . . . . 4.8099999999999996 110.087 -178.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.07 -166.78 2.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.788 -1.56 . . . . 4.3499999999999996 106.788 172.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 70.75 -48.18 0.66 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.345 1.458 . . . . 2.2799999999999998 113.105 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.93 -50.16 75.11 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 119.565 1.075 . . . . 1.0800000000000001 109.286 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.4 -36.07 68.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.839 0.855 . . . . 1.1000000000000001 110.521 175.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -54.59 29.06 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.817 0.818 . . . . 4.2000000000000002 109.409 178.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.6 mmt-85 -54.54 -55.61 27.42 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.121 0.968 . . . . 3.98 110.521 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 pp -60.53 -37.51 75.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.058 -0.972 . . . . 1.8 111.446 179.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.21 -63.0 1.46 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.958 1.254 . . . . 2.6899999999999999 108.749 177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -55.86 -30.46 61.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.467 0.307 . . . . 3.0699999999999998 110.928 -175.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -72.82 -68.03 0.51 Allowed 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.469 -0.144 . . . . 3.2999999999999998 110.727 174.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.8 mt -44.84 -43.07 8.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.353 1.461 . . . . 1.21 111.23 -177.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -34.53 -42.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.661 1.985 . . . . 1.52 113.164 174.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.5 78.09 0.79 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.711 0.804 . . . . 4.21 109.176 174.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 23.3 mm -67.47 -68.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 107.613 -1.254 . . . . 1.3400000000000001 107.613 162.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -138.92 -108.92 0.17 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.65 -1.241 . . . . 2.98 107.65 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -81.04 55.21 4.79 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.744 -0.597 . . . . 0.70999999999999996 111.67 -177.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.65 119.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.715 -1.217 . . . . 0.54000000000000004 107.715 174.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.99 -50.28 20.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.744 -0.836 . . . . 0.68000000000000005 108.744 174.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -150.22 157.49 43.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.756 0.423 . . . . 0.89000000000000001 110.185 -174.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.44 64.54 3.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.193 1.183 . . . . 0.45000000000000001 114.193 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.85 134.57 20.09 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.978 1.786 . . . . 0.54000000000000004 110.932 178.043 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.0 t -98.45 142.58 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.183 1.393 . . . . 2.3100000000000001 109.503 179.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.4 136.33 38.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.553 1.541 . . . . 1.75 108.789 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.1 -16.72 21.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.258 0.466 . . . . 2.4500000000000002 112.258 176.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.45 22.05 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 109.813 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.36 -18.07 17.7 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.104 0.962 . . . . 1.25 111.56 -171.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 55.12 52.66 11.32 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.447 1.099 . . . . 3.52 110.31 -163.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.4 p -129.98 163.74 25.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.222 0.609 . . . . 0.77000000000000002 109.378 176.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.96 134.26 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.085 0.954 . . . . 0.46000000000000002 108.91 178.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.6 m -81.5 137.99 35.53 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.722 -1.955 . . . . 0.68999999999999995 105.722 169.167 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -122.96 103.37 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.638 -1.986 . . . . 1.8500000000000001 105.638 -179.378 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 92.12 4.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.526 -2.027 . . . . 4.0099999999999998 105.526 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 161.4 40.08 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.273 0.629 . . . . 1.9399999999999999 110.786 -169.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.15 105.73 15.02 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 108.449 -0.945 . . . . 2.2799999999999998 108.449 -172.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.89 11.58 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.742 -173.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -41.67 9.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.35 1.06 . . . . 7.79 108.977 172.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.32 -45.35 15.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.88 -1.156 . . . . 3.3799999999999999 107.88 -170.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -129.68 -179.6 5.28 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.966 0.906 . . . . 0.51000000000000001 109.272 178.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 97.1 p -152.41 170.88 19.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.267 0.627 . . . . 2.0499999999999998 110.288 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG11 HD21 ' A' ' 141' ' ' LEU . 3.4 t -42.79 -46.96 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.307 1.043 . . . . 1.47 110.781 173.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.0 m -56.3 -43.68 79.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.777 -0.577 . . . . 0.66000000000000003 112.031 -178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.17 -48.59 80.88 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.521 0.677 . . . . 1.79 109.388 176.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.82 -43.24 80.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.944 -0.571 . . . . 0.68999999999999995 110.507 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' VAL . 6.6 mtmp? -62.3 -45.11 94.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.606 0.362 . . . . 2.9100000000000001 110.702 174.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 134' ' ' LYS . 3.5 tm-20 -55.69 -44.99 77.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.224 -0.922 . . . . 2.7000000000000002 110.58 175.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.42 33.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.552 0.741 . . . . 0.47999999999999998 110.986 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' HG ' ' A' ' 139' ' ' LEU . 4.8 p -66.03 -33.0 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.531 -0.731 . . . . 1.8500000000000001 110.038 -175.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.21 -46.22 86.23 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.835 -0.802 . . . . 3.0899999999999999 108.835 173.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 130' ' ' GLU . 61.8 mttt -61.41 -33.53 73.86 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.007 0.743 . . . . 2.6000000000000001 113.007 173.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.8 mm? -68.42 -16.02 63.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.316 0.962 . . . . 0.91000000000000003 112.236 169.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.74 27.89 33.66 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.948 0.785 . . . . 0.69999999999999996 111.504 177.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -130.09 -169.62 2.16 Favored 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.824 -1.176 . . . . 2.0899999999999999 107.824 173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -143.39 150.88 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.383 -1.34 . . . . 3.7599999999999998 107.383 176.05 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 132' ' ' VAL . 97.2 mt -113.67 142.27 46.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.906 1.283 . . . . 1.3899999999999999 108.299 178.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -108.43 168.9 8.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.288 1.435 . . . . 2.9399999999999999 108.266 169.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.447 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mp -110.95 131.07 55.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.973 0.909 . . . . 1.6599999999999999 108.691 178.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -81.26 84.36 6.62 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 119.419 1.009 . . . . 3.4900000000000002 108.585 175.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.96 -14.38 38.33 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.533 -1.148 . . . . 2.5499999999999998 112.775 170.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.04 53.12 0.59 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.169 1.485 . . . . 5.6299999999999999 112.079 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -174.22 -45.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.996 2.918 . . . . 7.9699999999999998 107.793 -176.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -112.47 -11.74 13.59 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.646 1.178 . . . . 8.5 112.922 -167.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.6 t -146.35 31.97 0.99 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.894 1.678 . . . . 5.5999999999999996 109.748 -178.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 92.6 mt -52.06 -57.93 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.115 0.566 . . . . 8.1699999999999999 110.188 176.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -161.16 174.8 13.12 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.921 -1.511 . . . . 12.029999999999999 106.921 -177.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -93.99 -78.17 1.4 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.323 0.487 . . . . 11.699999999999999 112.055 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.838 2.455 . . . . 14.42 104.716 -169.586 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.119999999999999 109.212 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.1999999999999993 108.504 175.084 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.46 112.684 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.2400000000000002 108.988 -176.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 2.7400000000000002 110.322 176.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.0999999999999996 110.594 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 4.9900000000000002 110.399 174.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 3.75 107.368 174.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 1.6000000000000001 110.564 177.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.3900000000000001 111.46 174.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.3200000000000003 112.205 -162.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.2200000000000006 109.3 -173.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.2699999999999996 112.492 -167.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 10.17 108.566 178.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.059999999999999 108.149 178.063 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.212 -0.662 . . . . 14.119999999999999 109.212 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.05 50.99 0.21 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.504 -0.924 . . . . 8.1999999999999993 108.504 175.084 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m 57.11 52.46 9.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.922 1.289 . . . . 4.46 112.684 -179.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -96.84 51.28 1.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.906 0.86 . . . . 5.2400000000000002 108.988 -176.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -72.91 172.23 11.28 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.948 -0.569 . . . . 2.7400000000000002 110.322 176.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.81 149.22 41.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.254 -0.647 . . . . 2.29 109.254 164.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pm0 -83.44 148.83 27.04 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.546 1.138 . . . . 3.0600000000000001 108.466 173.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.19 132.98 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.999 -1.852 . . . . 3.0800000000000001 105.999 158.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.49 123.31 39.86 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.198 -1.038 . . . . 0.81000000000000005 108.198 177.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.4 mtt -145.61 165.72 27.86 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.25 0.62 . . . . 2.0800000000000001 111.024 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.22 120.51 40.34 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.972 1.309 . . . . 2.8300000000000001 108.473 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.11 154.01 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.049 1.74 . . . . 0.56000000000000005 109.138 -177.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.23 162.04 19.36 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.275 1.03 . . . . 0.80000000000000004 110.971 -179.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.46 -0.37 68.11 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.484 1.04 . . . . 0.73999999999999999 110.965 -176.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.4 mtp -63.95 145.32 56.07 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 117.768 0.784 . . . . 3.04 110.596 177.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 m -122.25 -1.64 9.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.446 1.099 . . . . 1.71 111.392 173.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 41' ' ' LEU . 40.9 t 82.21 113.01 0.06 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.398 1.479 . . . . 3.8300000000000001 110.72 171.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 58.35 172.93 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.627 0.771 . . . . 2.8999999999999999 109.265 -156.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.85 -70.81 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.095 1.358 . . . . 1.6899999999999999 113.242 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.5 m -56.81 -65.68 0.57 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.357 1.463 . . . . 1.0600000000000001 108.636 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 39' ' ' VAL . . . -57.36 -48.24 79.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.178 -0.919 . . . . 0.93999999999999995 110.131 -179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.88 63.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.614 0.366 . . . . 1.0700000000000001 111.738 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -61.75 -46.07 91.19 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.02 -0.425 . . . . 2.25 110.344 177.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.44 -62.06 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.081 -1.081 . . . . 0.70999999999999996 108.081 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -56.09 -45.71 79.3 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.686 0.675 . . . . 4.04 111.055 -174.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -56.95 -47.77 79.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.601 0.637 . . . . 2.5899999999999999 110.684 175.176 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.64 -49.49 76.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.001 -0.839 . . . . 0.97999999999999998 111.001 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.51 -35.44 80.88 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.679 -0.895 . . . . 1.7 110.056 -179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 34' ' ' VAL . 1.1 tppt? -55.78 -17.68 6.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.782 0.833 . . . . 2.2400000000000002 112.233 172.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -72.26 -24.96 61.43 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.573 -0.705 . . . . 2.9700000000000002 112.364 175.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.5 ' O ' HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -74.51 143.39 79.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.926 0.785 . . . . 1.5600000000000001 110.122 -173.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.83 -39.45 11.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.261 1.974 . . . . 1.25 112.162 -169.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.88 -7.55 83.94 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-O 119.161 -0.799 . . . . 0.69999999999999996 111.914 -177.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 29' ' ' LYS . 2.8 p -63.29 132.15 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 118.93 1.365 . . . . 2.25 109.488 -177.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 m -109.11 -46.78 3.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.273 -1.38 . . . . 1.1799999999999999 107.273 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -151.77 166.66 30.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.468 0.651 . . . . 2.1800000000000002 110.055 161.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.03 112.33 4.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.598 -2.001 . . . . 0.66000000000000003 105.598 -176.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.83 171.0 13.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.335 1.064 . . . . 2.5600000000000001 109.769 -179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 21' ' ' ALA . 7.7 p -152.37 113.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 1.22 108.362 -177.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -79.38 78.82 5.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.717 -2.327 . . . . 2.7599999999999998 104.717 171.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD13 ' SG ' ' A' ' 17' ' ' CYS . 3.2 pp -55.17 -24.41 26.6 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.474 -0.785 . . . . 2.1699999999999999 111.69 175.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.34 67.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.931 0.892 . . . . 1.7 111.505 174.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.7 p -120.21 9.58 11.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.892 0.877 . . . . 1.54 111.804 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 50.48 38.42 18.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.654 1.182 . . . . 2.2999999999999998 111.755 -173.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -103.18 108.02 19.05 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.076 -1.824 . . . . 0.93000000000000005 106.076 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.86 127.19 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.079 -1.452 . . . . 0.37 107.079 173.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -128.45 116.63 20.02 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.719 0.808 . . . . 2.98 108.994 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 134.36 64.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 108.367 -0.975 . . . . 0.54000000000000004 108.367 -172.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.3 mt -119.61 120.16 62.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.586 -1.264 . . . . 1.3600000000000001 107.586 178.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' CE2' HG13 ' A' ' 60' ' ' ILE . 24.0 p90 -149.94 171.58 16.58 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.859 -0.793 . . . . 2.1699999999999999 108.859 -178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -84.86 122.14 74.43 Favored Pre-proline 0 N--CA 1.447 -0.607 0 O-C-N 123.914 0.759 . . . . 2.1899999999999999 109.729 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.05 37.13 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.151 2.567 . . . . 1.0700000000000001 112.158 -174.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.45 9.59 0.55 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.265 1.209 . . . . 1.29 114.265 -176.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -124.94 -43.02 2.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.515 1.126 . . . . 2.1299999999999999 110.993 174.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 m -110.51 -80.63 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 -163.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.93 125.96 4.47 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.383 -1.487 . . . . 0.93999999999999995 109.383 168.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 t -43.41 -39.95 3.48 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.406 1.482 . . . . 0.96999999999999997 112.929 -178.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.4 -43.93 92.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.891 -0.505 . . . . 1.04 110.98 176.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.23 75.19 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.295 -0.878 . . . . 0.92000000000000004 110.865 177.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' A' ' 50' ' ' TYR . 14.8 mm -56.31 -56.23 14.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.168 -1.049 . . . . 0.77000000000000002 108.168 175.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.75 -41.37 97.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.375 -0.53 . . . . 1.75 109.99 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -52.06 -42.82 63.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.508 -0.553 . . . . 2.6200000000000001 109.508 177.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -48.6 73.57 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 121.813 -0.554 . . . . 2.4100000000000001 109.763 -178.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.9 mt -51.66 -47.57 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.674 -0.491 . . . . 0.59999999999999998 109.674 176.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -61.97 -50.1 73.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.393 0.277 . . . . 1.5800000000000001 110.431 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -55.47 -38.26 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.204 -0.935 . . . . 2.3500000000000001 112.405 174.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.15 -12.91 58.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 119.145 -0.455 . . . . 2.3999999999999999 111.945 177.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.93 39.82 4.79 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.249 -0.74 . . . . 0.87 111.249 173.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -126.07 174.25 8.6 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.394 1.078 . . . . 2.0800000000000001 108.884 176.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 130.98 31.76 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.389 0.676 . . . . 2.0800000000000001 109.372 177.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.16 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.787 1.235 . . . . 0.54000000000000004 109.001 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.5 t -83.45 60.69 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.798 -1.186 . . . . 0.95999999999999996 107.798 -177.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.0 m -125.73 128.56 47.94 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.292 1.037 . . . . 1.1200000000000001 109.346 -168.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -126.09 137.84 53.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.014 0.926 . . . . 3.3799999999999999 109.998 -168.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.54 92.55 8.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.846 1.659 . . . . 4.4500000000000002 110.301 175.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.69 151.99 19.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.137 -0.459 . . . . 1.0900000000000001 110.232 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 26.4 mt-10 -105.24 127.72 53.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.115 0.87 . . . . 2.4500000000000002 111.424 176.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -121.21 155.8 33.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.505 1.522 . . . . 2.1800000000000002 109.333 178.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -113.12 152.99 28.94 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.143 2.177 . . . . 2.1099999999999999 108.253 -175.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.7 mt -125.28 120.38 57.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 119.581 1.082 . . . . 0.62 108.799 -171.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -117.18 48.45 1.33 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 -172.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.8 -47.47 0.05 OUTLIER Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.582 -1.19 . . . . 1.97 114.894 -167.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 mtp -45.08 117.68 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 118.688 1.244 . . . . 2.7599999999999998 112.694 -176.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -95.17 20.77 8.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.886 0.474 . . . . 5.0999999999999996 110.594 175.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 t 63.29 62.03 1.01 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.708 1.242 . . . . 4.9900000000000002 110.399 174.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.42 -74.28 0.37 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.368 -1.345 . . . . 3.75 107.368 174.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.79 28.07 0.12 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.958 0.503 . . . . 1.6000000000000001 110.564 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.4 m -66.8 -49.84 64.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 -171.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . . . -60.17 -38.74 84.12 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.462 -0.336 . . . . 0.80000000000000004 111.174 175.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.77 -50.27 74.55 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.362 0.983 . . . . 2.0800000000000001 110.089 177.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -51.21 68.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.953 0.501 . . . . 3.4900000000000002 109.896 176.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -43.64 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.507 0.723 . . . . 2.7200000000000002 110.423 -179.141 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.74 -54.48 45.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.41 1.484 . . . . 2.1000000000000001 108.159 -177.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -61.07 -24.5 66.26 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.906 0.335 . . . . 2.8100000000000001 111.906 -178.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -71.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.611 0.641 . . . . 2.6699999999999999 110.208 167.513 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -39.87 6.23 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.629 1.572 . . . . 1.8400000000000001 111.802 -173.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -28.08 -47.79 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.589 1.956 . . . . 1.6599999999999999 112.698 172.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 59.08 0.44 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.05 0.219 . . . . 4.1500000000000004 110.551 -173.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.5 mm -55.29 -67.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.574 -0.528 . . . . 1.3700000000000001 109.574 173.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -144.1 -59.08 0.39 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.438 -0.578 . . . . 3.4399999999999999 109.438 169.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -118.03 54.02 0.63 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.43 -0.668 . . . . 0.85999999999999999 111.43 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.5 t -115.88 129.05 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.5 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.98 -51.58 7.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.422 -0.955 . . . . 0.95999999999999996 108.422 175.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -151.36 163.29 39.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.413 -0.588 . . . . 0.93999999999999995 109.413 -174.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.05 63.81 3.14 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.516 -0.765 . . . . 0.67000000000000004 112.742 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.46 135.31 26.22 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.857 1.705 . . . . 0.71999999999999997 110.54 -178.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.7 m -94.44 135.36 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.818 1.247 . . . . 1.9399999999999999 109.363 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -79.2 -37.47 38.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 122.771 0.428 . . . . 2.8300000000000001 110.883 179.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 89' ' ' ALA . 2.0 m-85 66.79 -53.61 0.44 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.181 1.793 . . . . 3.4100000000000001 113.797 -170.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.15 80.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.308 0.643 . . . . 1.8200000000000001 111.41 -163.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.92 13.28 23.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.799 0.84 . . . . 2.2999999999999998 110.394 177.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 55.68 57.61 5.14 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.102 1.361 . . . . 3.2999999999999998 111.293 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -131.81 160.72 34.79 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.801 0.84 . . . . 1.23 110.238 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.71 130.87 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 125.236 1.414 . . . . 0.52000000000000002 108.703 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -83.17 137.29 34.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.02 -1.844 . . . . 0.79000000000000004 106.02 166.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.53 113.76 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.882 -1.525 . . . . 0.77000000000000002 106.882 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.28 99.27 10.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.884 -1.895 . . . . 2.8599999999999999 105.884 171.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.49 171.37 15.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.603 0.24 . . . . 2.1899999999999999 111.213 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.19 99.88 10.47 Favored Pre-proline 0 N--CA 1.447 -0.579 0 C-N-CA 124.561 1.144 . . . . 2.3199999999999998 108.518 -173.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -75.68 13.87 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.71 2.273 . . . . 0.89000000000000001 112.329 -171.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -96.28 -51.52 4.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.652 -0.87 . . . . 5.21 108.652 169.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.43 -42.3 79.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.122 -0.49 . . . . 3.02 111.132 -174.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.28 -179.15 5.08 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.216 1.006 . . . . 0.93999999999999995 108.854 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -155.83 167.95 28.78 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.547 0.612 . . . . 1.8999999999999999 111.858 -176.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 m -43.58 -37.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 113.774 1.027 . . . . 2.23 113.774 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 m -55.86 -43.81 77.46 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.114 0.87 . . . . 1.2 111.234 176.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.08 -45.06 67.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.021 0.929 . . . . 3.9399999999999999 109.051 -177.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.59 -45.21 91.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.87 110.121 -179.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -61.42 2.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.413 -0.958 . . . . 3.5699999999999998 108.413 170.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.3 mt-10 -51.12 -44.92 61.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.434 0.561 . . . . 3.6400000000000001 111.719 -177.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.49 -54.01 51.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.742 0.417 . . . . 0.56999999999999995 110.759 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG21 ' HG ' ' A' ' 139' ' ' LEU . 42.2 t -65.58 -36.27 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 121.665 -0.647 . . . . 1.51 110.836 -175.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -63.27 -46.75 85.36 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.919 -1.141 . . . . 3.7599999999999998 107.919 177.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -53.16 -46.16 68.77 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.802 -0.561 . . . . 3.1200000000000001 111.646 170.051 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -61.92 -12.12 16.51 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.42 0.688 . . . . 0.89000000000000001 112.556 176.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.83 28.21 63.29 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.127 0.876 . . . . 0.81999999999999995 111.609 178.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -119.96 -173.58 2.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 105.716 -1.957 . . . . 2.2000000000000002 105.716 165.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -142.26 127.06 18.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.718 1.144 . . . . 2.7999999999999998 108.599 176.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 132' ' ' VAL . 0.2 OUTLIER -97.63 140.94 31.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.199 1.8 . . . . 1.96 107.788 -171.634 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -135.14 172.52 12.89 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.088 0.955 . . . . 2.6000000000000001 109.172 179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -94.5 154.26 17.5 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.263 -0.643 . . . . 2.5600000000000001 109.263 172.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HD3' ' HB3' ' A' ' 77' ' ' GLU . 40.2 mtpt -79.91 89.44 5.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.915 -1.142 . . . . 3.27 107.915 174.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.78 -60.93 4.58 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.423 -0.808 . . . . 3.3900000000000001 111.46 174.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 39.54 37.07 0.27 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.396 1.479 . . . . 6.3200000000000003 112.205 -162.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -144.62 -51.86 0.29 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.937 1.295 . . . . 8.2200000000000006 109.3 -173.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.6 40.63 0.3 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.443 1.097 . . . . 8.2699999999999996 112.492 -167.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 m 53.28 32.86 14.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.447 1.499 . . . . 7.21 112.283 -172.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.2 mt -86.91 -63.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.566 -0.902 . . . . 10.17 108.566 178.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 67.63 160.73 0.17 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.071 1.749 . . . . 10.74 111.825 -177.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.8 102.34 0.82 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.371 -1.491 . . . . 14.43 109.371 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.225 -1.369 . . . . 18.059999999999999 108.149 178.063 . . . . . . . . 0 0 . 1 stop_ save_